Citrus Sinensis ID: 040641
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LYN8 | 1192 | Leucine-rich repeat recep | yes | no | 0.954 | 0.348 | 0.492 | 1e-113 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.931 | 0.347 | 0.379 | 5e-75 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.967 | 0.352 | 0.361 | 4e-73 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.951 | 0.355 | 0.385 | 4e-72 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.979 | 0.352 | 0.377 | 7e-72 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.979 | 0.352 | 0.381 | 1e-71 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.947 | 0.408 | 0.351 | 7e-68 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.949 | 0.398 | 0.344 | 2e-64 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.974 | 0.422 | 0.334 | 7e-62 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.563 | 0.239 | 0.439 | 6e-61 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 409 bits (1051), Expect = e-113, Method: Compositional matrix adjust.
Identities = 246/499 (49%), Positives = 298/499 (59%), Gaps = 84/499 (16%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G + SE KL GLY+ N+ TG IP LG L L L+++ N SG +PT + L
Sbjct: 712 LSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGL 771
Query: 61 KGLSHLDLSSNFFDGGWP---------RSL--GNLSYSTYLDLHDNKFTREIPQNLGNLA 109
L L+L+ N G P ++L GN + D K ++ +A
Sbjct: 772 PNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIA 831
Query: 110 QLE----------HLDVLRNMLCGKI-----PEKICKSRLEGLVSQSGICQNLSKISLAG 154
L + R + ++ PE++ +SRL+G V
Sbjct: 832 GLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFV---------------- 875
Query: 155 NKDYNLY-LSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYK 201
D NLY LS SRS+ PL INI+MF+QPLLK+ L DI+E DGGFGTVYK
Sbjct: 876 --DQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYK 933
Query: 202 ATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261
A LP KTVAVKK S+AKTQG+R+F AEMETLGKVKH NLV LLGYCSF EEKLLVYEYM
Sbjct: 934 ACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYM 993
Query: 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------- 301
VNGSLD WLRN TG EVLD +KR KIA +ARGLAFLH
Sbjct: 994 VNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDG 1053
Query: 302 -------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELV 354
DFGLARLISACE+HVST IAGT GYIPPEYGQS +TT+GDVYSFGVILLELV
Sbjct: 1054 DFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELV 1113
Query: 355 TAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVA 414
T KEPTGP+F+E EG NLVGW QK+ + +A DV+DP +++ K L++L+IA C+A
Sbjct: 1114 TGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLA 1173
Query: 415 DNPATRPTMLHVLKLLHEI 433
+ PA RP ML VLK L EI
Sbjct: 1174 ETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 5e-75, Method: Compositional matrix adjust.
Identities = 188/495 (37%), Positives = 256/495 (51%), Gaps = 90/495 (18%)
Query: 23 NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82
N ++G IP G +G L LNL N+ +G +P S G LK + LDLS N G P SLG
Sbjct: 649 NAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLG 708
Query: 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM-----------LCGKIPEKICK 131
+LS+ + LD+ +N T IP QL V R CG P +
Sbjct: 709 SLSFLSDLDVSNNNLTGPIPFG----GQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPIT 764
Query: 132 SRLEGL-----------VSQSGIC-----QNLSKISLAGNKDYNL--YLSSSRSKG---- 169
SR+ ++ S +C L ++ K+ Y+ S + G
Sbjct: 765 SRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSW 824
Query: 170 -------PLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTV 210
PL IN++ F++PL KLT +LE GGFG VYKA L DG V
Sbjct: 825 KLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVV 884
Query: 211 AVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL 270
A+KK + QG R+F AEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+ L
Sbjct: 885 AIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVL 944
Query: 271 RNATGSHE--VLDRAKRYKIACSSARGLAFLHQ--------------------------- 301
+ L+ A R KIA +ARGLAFLH
Sbjct: 945 HEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVS 1004
Query: 302 DFGLARLISACETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
DFG+ARL+SA +TH+S + +AGT GY+PPEY QS T +GDVYS+GVILLEL++ K+P
Sbjct: 1005 DFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPI 1064
Query: 361 GP-EFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPM-MLKMLRIAADCVADNPA 418
P EF E NLVGW Q ++++ ++LDP ++ S + + L+IA+ C+ D P
Sbjct: 1065 DPGEFGEDN--NLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPF 1122
Query: 419 TRPTMLHVLKLLHEI 433
RPTM+ ++ + E+
Sbjct: 1123 KRPTMIQLMAMFKEM 1137
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 190/525 (36%), Positives = 265/525 (50%), Gaps = 104/525 (19%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
G F ++ + L + N L+G IP+ +G + L LNL N SG +P +G+L+G
Sbjct: 644 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 703
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM-L 121
L+ LDLSSN DG P+++ L+ T +DL +N + IP+ +G L N L
Sbjct: 704 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-MGQFETFPPAKFLNNPGL 762
Query: 122 C----------------------GKIPEKICKSRLEGLVSQSGIC--------------- 144
C G+ P + S GL+ S +C
Sbjct: 763 CGYPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLLF-SFVCIFGLILVGREMRKRR 821
Query: 145 -------------QNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDIL 191
S A N ++ L + K L IN++ F++PL KLT D+L
Sbjct: 822 RKKEAELEMYAEGHGNSGDRTANNTNWKL----TGVKEALSINLAAFEKPLRKLTFADLL 877
Query: 192 E------------DGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
+ GGFG VYKA L DG VA+KK QG R+F AEMET+GK+KH+
Sbjct: 878 QATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHR 937
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
NLV LLGYC +E+LLVYE+M GSL+ L + + L+ + R KIA SARGLAFL
Sbjct: 938 NLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFL 997
Query: 300 HQ---------------------------DFGLARLISACETHVS-TDIAGTLGYIPPEY 331
H DFG+ARL+SA +TH+S + +AGT GY+PPEY
Sbjct: 998 HHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1057
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPT-GPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
QS +T+GDVYS+GV+LLEL+T K PT P+F + NLVGWV Q K + DV D
Sbjct: 1058 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDN---NLVGWVKQH-AKLRISDVFD 1113
Query: 391 PTVL--NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
P ++ + + +L+ L++A C+ D RPTM+ V+ + EI
Sbjct: 1114 PELMKEDPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEI 1158
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 4e-72, Method: Compositional matrix adjust.
Identities = 191/496 (38%), Positives = 253/496 (51%), Gaps = 82/496 (16%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW 77
L L N ++GSIP G +G L LNL N +G +P S G LK + LDLS N G
Sbjct: 644 LDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFL 703
Query: 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM-LCGKIPEKICKS---- 132
P SLG LS+ + LD+ +N T IP G L N LCG +P C S
Sbjct: 704 PGSLGGLSFLSDLDVSNNNLTGPIPFG-GQLTTFPLTRYANNSGLCG-VPLPPCSSGSRP 761
Query: 133 --------------RLEGLVSQSGICQNLSKISL-------AGNKDYNLYLSSSRSKGPL 171
+ + S +C + ++L K Y+ S + G
Sbjct: 762 TRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSS 821
Query: 172 RINISMFQQP-----------LLKLTLVDILE------------DGGFGTVYKATLPDGK 208
+S +P L KLT +LE GGFG VYKA L DG
Sbjct: 822 SWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGS 881
Query: 209 TVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268
VA+KK Q QG R+F AEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+
Sbjct: 882 VVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLET 941
Query: 269 WLRNATGSHEV-LDRAKRYKIACSSARGLAFLHQ-------------------------- 301
L T + LD + R KIA +ARGLAFLH
Sbjct: 942 VLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARV 1001
Query: 302 -DFGLARLISACETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
DFG+ARL+SA +TH+S + +AGT GY+PPEY QS T +GDVYS+GVILLEL++ K+P
Sbjct: 1002 SDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKP 1061
Query: 360 TGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPM-MLKMLRIAADCVADNPA 418
PE + E NLVGW Q ++++ ++LDP ++ S + +L L+IA+ C+ D P
Sbjct: 1062 IDPE-EFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPF 1120
Query: 419 TRPTMLHVLKLLHEIV 434
RPTM+ V+ + E+V
Sbjct: 1121 KRPTMIQVMTMFKELV 1136
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (693), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 187/496 (37%), Positives = 266/496 (53%), Gaps = 70/496 (14%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L GSIP E G L L LG+N L+G IP+ LG L + L+L+ N+F+G +P SL +L
Sbjct: 675 LEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSL 734
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIP-------QNLGNLAQLEH 113
L +DLS+N G P S ++ Y +++ +P ++ N Q H
Sbjct: 735 TLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPLPCSSGPKSDANQHQKSH 794
Query: 114 -----------LDVLRNMLC--GKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNL 160
+ +L ++ C G I I +++ ++ + + S + +
Sbjct: 795 RRQASLAGSVAMGLLFSLFCIFGLIIVAI-ETKKRRRKKEAALEAYMDGHSHSATANSAW 853
Query: 161 YLSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGK 208
+S+R L IN++ F++PL KLT D+LE GGFG VYKA L DG
Sbjct: 854 KFTSAREA--LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGS 911
Query: 209 TVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268
VA+KK QG R+FTAEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+
Sbjct: 912 VVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLED 971
Query: 269 WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------- 301
L + + L+ R KIA +ARGLAFLH
Sbjct: 972 VLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVS 1031
Query: 302 DFGLARLISACETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
DFG+ARL+SA +TH+S + +AGT GY+PPEY QS +T+GDVYS+GV+LLEL+T K+PT
Sbjct: 1032 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPT 1091
Query: 361 -GPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL--NAGSKPMMLKMLRIAADCVADNP 417
+F + NLVGWV + K + DV D +L +A + +L+ L++A C+ D
Sbjct: 1092 DSADFGDN---NLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRH 1147
Query: 418 ATRPTMLHVLKLLHEI 433
RPTM+ V+ + EI
Sbjct: 1148 WKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 189/496 (38%), Positives = 266/496 (53%), Gaps = 70/496 (14%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L GSIP E G L L LG+N L+G IP+ LG L + L+L+ N+F+G +P SL +L
Sbjct: 675 LEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSL 734
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDN--KFTREIPQNLG-----NLAQLEH 113
L +DLS+N G P S ++ Y +++ + IP + G N Q H
Sbjct: 735 TLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPIPCSSGPKSDANQHQKSH 794
Query: 114 -----------LDVLRNMLC--GKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNL 160
+ +L ++ C G I I +++ ++ + + S + +
Sbjct: 795 RRQASLAGSVAMGLLFSLFCIFGLIIVAI-ETKKRRRKKEAALEAYMDGHSHSATANSAW 853
Query: 161 YLSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGK 208
+S+R L IN++ F++PL KLT D+LE GGFG VYKA L DG
Sbjct: 854 KFTSAREA--LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGS 911
Query: 209 TVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268
VA+KK QG R+FTAEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+
Sbjct: 912 VVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLED 971
Query: 269 WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------- 301
L + L+ R KIA +ARGLAFLH
Sbjct: 972 VLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVS 1031
Query: 302 DFGLARLISACETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
DFG+ARL+SA +TH+S + +AGT GY+PPEY QS +T+GDVYS+GV+LLEL+T K+PT
Sbjct: 1032 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPT 1091
Query: 361 -GPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL--NAGSKPMMLKMLRIAADCVADNP 417
+F + NLVGWV + K + DV D +L +A + +L+ L++A C+ D
Sbjct: 1092 DSADFGDN---NLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRH 1147
Query: 418 ATRPTMLHVLKLLHEI 433
RPTM+ V+ + EI
Sbjct: 1148 WKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 169/481 (35%), Positives = 242/481 (50%), Gaps = 69/481 (14%)
Query: 20 LGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPR 79
LG+N L+G I G L L +L N SG +P+SL + L LDLS+N G P
Sbjct: 530 LGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPV 589
Query: 80 SLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVS 139
SL LS+ + + N + IP G + N LCG+ + L+
Sbjct: 590 SLQQLSFLSKFSVAYNNLSGVIPSG-GQFQTFPNSSFESNHLCGEHRFPCSEGTESALIK 648
Query: 140 QS--------GICQNLSKISL----------------AGNKDYNLYLSSSRSKGPL-RIN 174
+S G+ ++ S+ +G D + S S ++ L I
Sbjct: 649 RSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIG 708
Query: 175 ---ISMFQQPLLKLTLVDILED------------GGFGTVYKATLPDGKTVAVKKFSQAK 219
+ +FQ +L+ D+L+ GGFG VYKATLPDGK VA+KK S
Sbjct: 709 SKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDC 768
Query: 220 TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV 279
Q R+F AE+ETL + +H NLVLL G+C + ++LL+Y YM NGSLD WL +
Sbjct: 769 GQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPAL 828
Query: 280 LDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312
L R +IA +A+GL +LH+ DFGLARL+S
Sbjct: 829 LKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPY 888
Query: 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL 372
ETHVSTD+ GTLGYIPPEYGQ+ ++T +GDVYSFGV+LLEL+T K P + K +L
Sbjct: 889 ETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVD-MCKPKGCRDL 947
Query: 373 VGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432
+ WV + + +A +V DP + + + M ++L IA C+++NP RPT ++ L +
Sbjct: 948 ISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDD 1007
Query: 433 I 433
+
Sbjct: 1008 V 1008
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (629), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 169/491 (34%), Positives = 244/491 (49%), Gaps = 78/491 (15%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW 77
+YL NN+L G+I +G+L L L+L+RN F+G +P S+ L L LDLS N G
Sbjct: 541 IYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSI 600
Query: 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM-LCGKIPEKICKSRLEG 136
P S +L++ + + N+ T IP G H N+ LC I + C +
Sbjct: 601 PLSFQSLTFLSRFSVAYNRLTGAIPSG-GQFYSFPHSSFEGNLGLCRAI-DSPCDVLMSN 658
Query: 137 LVSQSGICQN-------------LSKISLA--------------GNKDYNLYLSS----- 164
+++ G + + ISLA KD + ++
Sbjct: 659 MLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDEET 718
Query: 165 ----SRSKGPLRINI-------SMFQQPLLKLT----LVDILEDGGFGTVYKATLPDGKT 209
S++ GP +I + + + LLK T +I+ GGFG VYKA PDG
Sbjct: 719 ISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSK 778
Query: 210 VAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLW 269
AVK+ S Q R+F AE+E L + +H+NLV L GYC ++LL+Y +M NGSLD W
Sbjct: 779 AAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYW 838
Query: 270 LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------D 302
L + L R KIA +ARGLA+LH+ D
Sbjct: 839 LHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLAD 898
Query: 303 FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362
FGLARL+ +THV+TD+ GTLGYIPPEY QS ++T RGDVYSFGV+LLELVT + P
Sbjct: 899 FGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPV-E 957
Query: 363 EFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT 422
+ K +LV VFQ +++ +++D T+ ++ +L+ML IA C+ P RP
Sbjct: 958 VCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEPRRRPL 1017
Query: 423 MLHVLKLLHEI 433
+ V+ L ++
Sbjct: 1018 IEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 179/535 (33%), Positives = 250/535 (46%), Gaps = 111/535 (20%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G +P G S+ L + L NNQL+G +P ++G G+ KL L NKF GP+P+ +G L
Sbjct: 443 LSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKL 502
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
+ LS +D S N F G + T++DL N+ + EIP + + L +L++ RN
Sbjct: 503 QQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNH 562
Query: 121 LCGKIPEKICK-----------SRLEGLVSQSGICQNLSKISLAGNKDY-NLYLS----- 163
L G IP I + L GLV +G + S GN D YL
Sbjct: 563 LVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDG 622
Query: 164 ------SSRSKGPLRIN-------------------------------------ISMFQQ 180
S SKGPL + ++ FQ+
Sbjct: 623 VAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQR 682
Query: 181 PLLKLTLVDILED---------GGFGTVYKATLPDGKTVAVKKF---SQAKTQGHRQFTA 228
L T D+L+ GG G VYK +P+G VAVK+ S+ + H F A
Sbjct: 683 --LDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDH-GFNA 739
Query: 229 EMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKI 288
E++TLG+++H+++V LLG+CS E LLVYEYM NGSL L G H L RYKI
Sbjct: 740 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH--LHWDTRYKI 797
Query: 289 ACSSARGLAFLHQ---------------------------DFGLARLISACET-HVSTDI 320
A +A+GL +LH DFGLA+ + T + I
Sbjct: 798 ALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAI 857
Query: 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380
AG+ GYI PEY + + DVYSFGV+LLELVT ++P G EF +G ++V WV +KM
Sbjct: 858 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG-EF--GDGVDIVQWV-RKM 913
Query: 381 KKQQADDVLDPTVLNAGSKPM--MLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
D VL S P+ + + +A CV + RPTM V+++L EI
Sbjct: 914 TDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEI 968
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 120/273 (43%), Positives = 161/273 (58%), Gaps = 28/273 (10%)
Query: 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGY 247
+I+ GGFG VYKATLPDG VA+K+ S Q R+F AE+ETL + +H NLV LLGY
Sbjct: 746 ANIIGCGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGY 805
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
C++ +KLL+Y YM NGSLD WL LD R +IA +A GLA+LHQ
Sbjct: 806 CNYKNDKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHI 865
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGLARLI +THV+TD+ GTLGYIPPEYGQ+ ++T +
Sbjct: 866 LHRDIKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYK 925
Query: 341 GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
GDVYSFGV+LLEL+T + P + + +L+ WV Q +++ ++ DP + +
Sbjct: 926 GDVYSFGVVLLELLTGRRPMD-VCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAE 984
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
ML +L IA C+ +NP TRPT ++ L I
Sbjct: 985 EMLLVLEIACRCLGENPKTRPTTQQLVSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | ||||||
| 356574479 | 1268 | PREDICTED: leucine-rich repeat receptor | 0.988 | 0.339 | 0.534 | 1e-149 | |
| 255539505 | 1303 | leucine-rich repeat receptor protein kin | 0.995 | 0.332 | 0.521 | 1e-146 | |
| 297741086 | 961 | unnamed protein product [Vitis vinifera] | 0.997 | 0.451 | 0.540 | 1e-145 | |
| 224136952 | 1215 | predicted protein [Populus trichocarpa] | 1.0 | 0.358 | 0.566 | 1e-144 | |
| 356534151 | 1269 | PREDICTED: leucine-rich repeat receptor | 0.986 | 0.338 | 0.513 | 1e-143 | |
| 224120068 | 1237 | predicted protein [Populus trichocarpa] | 1.0 | 0.351 | 0.539 | 1e-143 | |
| 225455406 | 1299 | PREDICTED: leucine-rich repeat receptor | 1.0 | 0.334 | 0.499 | 1e-141 | |
| 449446181 | 1298 | PREDICTED: leucine-rich repeat receptor | 1.0 | 0.335 | 0.486 | 1e-137 | |
| 449527203 | 1298 | PREDICTED: leucine-rich repeat receptor | 1.0 | 0.335 | 0.486 | 1e-137 | |
| 23304947 | 1192 | extra sporogenous cells [Arabidopsis tha | 0.995 | 0.363 | 0.509 | 1e-134 |
| >gi|356574479|ref|XP_003555374.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-149, Method: Compositional matrix adjust.
Identities = 320/599 (53%), Positives = 357/599 (59%), Gaps = 169/599 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+GSIP E G LKLQGLYLG NQL+G+IP S G+L LVKLNLT NK SGP+P S N+
Sbjct: 664 LSGSIPQELGGVLKLQGLYLGQNQLSGTIPESFGKLSSLVKLNLTGNKLSGPIPVSFQNM 723
Query: 61 KGLSHLDLSSN------------------------------------------------- 71
KGL+HLDLSSN
Sbjct: 724 KGLTHLDLSSNELSGELPSSLSGVQSLVGIYVQNNRISGQVGDLFSNSMTWRIETVNLSN 783
Query: 72 -FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEH----------------- 113
F+G P+SLGNLSY T LDLH N T EIP +LG+L QLE+
Sbjct: 784 NCFNGNLPQSLGNLSYLTNLDLHGNMLTGEIPLDLGDLMQLEYFDVSGNQLSGRIPDKLC 843
Query: 114 -------LDVLRNMLCGKIPEK-ICKS----RLEG---LVSQS-GI-CQN---------- 146
LD+ RN L G IP IC++ RL G L Q GI CQ+
Sbjct: 844 SLVNLNYLDLSRNRLEGPIPRNGICQNLSRVRLAGNKNLCGQMLGINCQDKSIGRSVLYN 903
Query: 147 -----------------------------------LSKISLAGNKDYNLY-LSSSRSKGP 170
L + L D+NLY LSSSRSK P
Sbjct: 904 AWRLAVITVTIILLTLSFAFLLHKWISRRQNDPEELKERKLNSYVDHNLYFLSSSRSKEP 963
Query: 171 LRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQA 218
L IN++MF+QPLLKLTLVDILE DGGFGTVYKATLP+GKTVAVKK S+A
Sbjct: 964 LSINVAMFEQPLLKLTLVDILEATDNFSKTNIIGDGGFGTVYKATLPNGKTVAVKKLSEA 1023
Query: 219 KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHE 278
KTQGHR+F AEMETLGKVKHQNLV LLGYCS EEKLLVYEYMVNGSLDLWLRN TG+ E
Sbjct: 1024 KTQGHREFMAEMETLGKVKHQNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLRNRTGALE 1083
Query: 279 VLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISA 311
+LD KRYKIA +ARGLAFLH DFGLARLISA
Sbjct: 1084 ILDWNKRYKIATGAARGLAFLHHGFTPHIIHRDVKASNILLSGDFEPKVADFGLARLISA 1143
Query: 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371
CETH++TDIAGT GYIPPEYGQS STTRGDVYSFGVILLELVT KEPTGP+F+E EG N
Sbjct: 1144 CETHITTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEIEGGN 1203
Query: 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
LVGWV QK+KK QA DVLDPTVL+A SK MML+ML+IA C++DNPA RPTML V K L
Sbjct: 1204 LVGWVCQKIKKGQAADVLDPTVLDADSKQMMLQMLQIAGVCISDNPANRPTMLQVHKFL 1262
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539505|ref|XP_002510817.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis] gi|223549932|gb|EEF51419.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1351), Expect = e-146, Method: Compositional matrix adjust.
Identities = 315/604 (52%), Positives = 353/604 (58%), Gaps = 171/604 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G IP EFG S KLQGLYLG NQL+G+IP +LG LG LVKLNLT NK G VP S GNL
Sbjct: 695 LSGPIPLEFGHSSKLQGLYLGKNQLSGAIPETLGGLGSLVKLNLTGNKLYGSVPLSFGNL 754
Query: 61 KGLSHLDLSSN------------------------------------------------- 71
K L+HLDLS+N
Sbjct: 755 KELTHLDLSNNDLVGQLPSSLSQMLNLVELYVQLNRLSGPIDELLSNSMAWRIETMNLSN 814
Query: 72 -FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL------------GN----------- 107
FFDG PRSLGNLSY TYLDLH NK T EIP L GN
Sbjct: 815 NFFDGDLPRSLGNLSYLTYLDLHGNKLTGEIPPELGNLMQLQYFDVSGNRLSGQIPEKIC 874
Query: 108 -LAQLEHLDVLRNML------------------------CGKIPEKICKSR--------- 133
L L +L+ N L CG+I C+ R
Sbjct: 875 TLVNLFYLNFAENNLEGPVPRSGICLSLSKISLAGNKNLCGRITGSACRIRNFGRLSLLN 934
Query: 134 ---LEGLV---------------------SQSGICQNLSKISLAGNKDYNLY-LSSSRSK 168
L G+ S+ G +++ + L+ D NLY LSSSRSK
Sbjct: 935 AWGLAGVAVGCMIIILGIAFVLRRWTTRGSRQGDPEDIEESKLSSFIDQNLYFLSSSRSK 994
Query: 169 GPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFS 216
PL INI+MF+QPLLK+TLVDILE DGGFGTVYKA LPDG+ VAVKK S
Sbjct: 995 EPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKAILPDGRRVAVKKLS 1054
Query: 217 QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS 276
+AKTQG+R+F AEMETLGKVKHQNLV LLGYCSF EEKLLVYEYMVNGSLDLWLRN +G+
Sbjct: 1055 EAKTQGNREFIAEMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWLRNRSGA 1114
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309
E+L+ KR KIA SARGLAFLH DFGLARLI
Sbjct: 1115 LEILNWTKRLKIAIGSARGLAFLHHGFIPHIIHRDIKASNILLNEDFEPKVADFGLARLI 1174
Query: 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG 369
SACETHVSTDIAGT GYIPPEYGQS STTRGDVYSFGVILLELVT KEPTGP+F+E EG
Sbjct: 1175 SACETHVSTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEVEG 1234
Query: 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
NLVGWVFQK+KK A DVLDPTV+N+ SK MML+ L+IA+ C++DNPA RPTML VLKL
Sbjct: 1235 GNLVGWVFQKIKKGHAADVLDPTVVNSDSKQMMLRALKIASRCLSDNPADRPTMLEVLKL 1294
Query: 430 LHEI 433
L I
Sbjct: 1295 LKGI 1298
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741086|emb|CBI31817.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1342), Expect = e-145, Method: Compositional matrix adjust.
Identities = 301/557 (54%), Positives = 349/557 (62%), Gaps = 123/557 (22%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTGSIP + G SLKLQGLYLGNNQLTG+IP SLG+L LVKLNLT N+ SG +P S GNL
Sbjct: 405 LTGSIPLKLGYSLKLQGLYLGNNQLTGTIPESLGRLSSLVKLNLTGNQLSGSIPFSFGNL 464
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDN------------------------K 96
GL+H DLSSN DG PRSLGNLSY T LDLH N +
Sbjct: 465 TGLTHFDLSSNELDG-LPRSLGNLSYLTNLDLHHNMFTGEIPTELGDLMQLEYFDVSGNR 523
Query: 97 FTREIPQNLGNLAQLEHLDVLRNML------------------------CGKIPEKICKS 132
+IP+ + +L L +L++ N L CG+ C+
Sbjct: 524 LCGQIPEKICSLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQF 583
Query: 133 R-------------LEGLV---------------------SQSGICQNLSKISLAGNKDY 158
+ L G+V S+ + + + L + D
Sbjct: 584 KTFGRKSSLVNTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQ 643
Query: 159 NLY-LSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLP 205
NLY LSSSRSK PL IN++MF+QPLLKLTLVDILE DGGFGTVYKA LP
Sbjct: 644 NLYFLSSSRSKEPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALP 703
Query: 206 DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265
+GK VAVKK +QAKTQGHR+F AEMETLGKVKH+NLV LLGYCSF EEK LVYEYMVNGS
Sbjct: 704 NGKIVAVKKLNQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGS 763
Query: 266 LDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301
LDLWLRN TG+ E LD KR+KIA +ARGLAFLH
Sbjct: 764 LDLWLRNRTGALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEA 823
Query: 302 ---DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKE 358
DFGLARLISACETHVSTDIAGT GYIPPEYG S STTRGDVYSFGVILLELVT KE
Sbjct: 824 KVADFGLARLISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKE 883
Query: 359 PTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPA 418
PTGP+F++ EG NLVGWVF+KM+K +A +VLDPTV+ A K +ML++L+IAA C+++NPA
Sbjct: 884 PTGPDFKDFEGGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPA 943
Query: 419 TRPTMLHVLKLLHEIVD 435
RPTMLHVLK L I D
Sbjct: 944 KRPTMLHVLKFLKGIKD 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136952|ref|XP_002322457.1| predicted protein [Populus trichocarpa] gi|222869453|gb|EEF06584.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1336), Expect = e-144, Method: Compositional matrix adjust.
Identities = 307/542 (56%), Positives = 343/542 (63%), Gaps = 107/542 (19%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTGSIP E GDS KLQGLYLGNNQL+G+IP LG LG LVKLNLT N+ GPVP S G+L
Sbjct: 673 LTGSIPPELGDSSKLQGLYLGNNQLSGTIPGRLGVLGSLVKLNLTGNQLYGPVPRSFGDL 732
Query: 61 KGLSHLDLSSNFFDGGWPRSL-----------GNLSYSTYLDLHDNKFTREIPQNLGNLA 109
K L+HLDLS N DG P SL GNL Y D+ N+ + +IP+ L L
Sbjct: 733 KELTHLDLSYNELDGELPSSLSGMLNLVGLYLGNLVQLAYFDVSGNRISGQIPEKLCALV 792
Query: 110 QLEHLDVLRNML------------------------CGKIPEKICKSR------------ 133
L +L++ N L CGKI C+ +
Sbjct: 793 NLFYLNLAENSLEGPVPGSGICLNLSKISLAGNKDLCGKIMGLDCRIKSFDKSYYLNAWG 852
Query: 134 LEGLVSQSGICQ------------------NLSKISLAGNKDYNLYL---SSSRSKGPLR 172
L G+ I +L + L D NLY SSSRSK PL
Sbjct: 853 LAGIAVGCMIVTLSIAFALRKWILKDSGQGDLDERKLNSFLDQNLYFLSSSSSRSKEPLS 912
Query: 173 INISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQAKT 220
INI+MF+QPLLK+TLVDILE DGGFGTVYKATLPD KTVAVKK SQAKT
Sbjct: 913 INIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKATLPDVKTVAVKKLSQAKT 972
Query: 221 QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL 280
QG+R+F AEMETLGKVKHQNLV LLGYCSF EEKLLVYEYMVNGSLDLWLRN + + +VL
Sbjct: 973 QGNREFIAEMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWLRNQSRALDVL 1032
Query: 281 DRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313
D KR KIA +ARGLAFLH DFGLARLISACE
Sbjct: 1033 DWPKRVKIATGAARGLAFLHHGFTPHIIHRDIKASNILLNEDFEPKVADFGLARLISACE 1092
Query: 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV 373
THVSTDIAGT GYIPPEYGQS STTRGDVYSFGVILLELVT KEPTGP+F+E EG NLV
Sbjct: 1093 THVSTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEVEGGNLV 1152
Query: 374 GWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
GWVFQK+KK QA DVLDPTVL+A SK MML++L+IAA C++DNPA RPTML VLK L I
Sbjct: 1153 GWVFQKIKKGQAADVLDPTVLSADSKQMMLQVLQIAAICLSDNPANRPTMLKVLKFLKGI 1212
Query: 434 VD 435
D
Sbjct: 1213 KD 1214
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534151|ref|XP_003535621.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 308/600 (51%), Positives = 346/600 (57%), Gaps = 171/600 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+GSIP EFG LKLQGLYLG NQL+G+IP S G+L LVKLNLT NK SGP+P S N+
Sbjct: 665 LSGSIPQEFGGVLKLQGLYLGQNQLSGTIPESFGKLSSLVKLNLTGNKLSGPIPVSFQNM 724
Query: 61 KGLSHLDLSSN------------------------------------------------- 71
KGL+HLDLSSN
Sbjct: 725 KGLTHLDLSSNELSGELPSSLSGVQSLVGIYVQNNRLSGQIGNLFSNSMTWRIEIVNLSN 784
Query: 72 -FFDGGWPRSLGNLSYSTYLDLHDNKFTRE------------------------IPQNLG 106
F G P+SL NLSY T LDLH N T E IP L
Sbjct: 785 NCFKGNLPQSLANLSYLTNLDLHGNMLTGEIPLDLGDLMQLEYFDVSGNQLSGRIPDKLC 844
Query: 107 NLAQLEHLD---------VLRNMLCGKIP-------EKICKSRLEGLVSQS-----GICQ 145
+L L HLD + RN +C + + +C L G+ SQ I
Sbjct: 845 SLVNLNHLDLSQNRLEGPIPRNGICQNLSRVRLAGNKNLCGQML-GIDSQDKSIGRSILY 903
Query: 146 NLSKIS-----------------------------------LAGNKDYNLY-LSSSRSKG 169
N +++ L D+NLY LSSSRSK
Sbjct: 904 NAWRLAVIAVTIILLSLSVAFLLHKWISRRQNDPEELKERKLNSYVDHNLYFLSSSRSKE 963
Query: 170 PLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQ 217
PL IN++MF+QPLLKLTLVDILE DGGFGTVYKATLP+GKTVAVKK S+
Sbjct: 964 PLSINVAMFEQPLLKLTLVDILEATDNFSKANIIGDGGFGTVYKATLPNGKTVAVKKLSE 1023
Query: 218 AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH 277
AKTQGHR+F AEMETLGKVKH NLV LLGYCS EEKLLVYEYMVNGSLDLWLRN TG+
Sbjct: 1024 AKTQGHREFMAEMETLGKVKHHNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLRNRTGAL 1083
Query: 278 EVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLIS 310
E+LD KRYKIA +ARGLAFLH DFGLARLIS
Sbjct: 1084 EILDWNKRYKIATGAARGLAFLHHGFIPHIIHRDVKASNILLNEDFEPKVADFGLARLIS 1143
Query: 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370
ACETH++TDIAGT GYIPPEYGQS STTRGDVYSFGVILLELVT KEPTGP+F+E EG
Sbjct: 1144 ACETHITTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEIEGG 1203
Query: 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
NLVGW QK+KK QA DVLDPTVL+A SK MML+ML+IA C++DNPA RPTML V K L
Sbjct: 1204 NLVGWACQKIKKGQAVDVLDPTVLDADSKQMMLQMLQIACVCISDNPANRPTMLQVHKFL 1263
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120068|ref|XP_002318234.1| predicted protein [Populus trichocarpa] gi|222858907|gb|EEE96454.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1323), Expect = e-143, Method: Compositional matrix adjust.
Identities = 304/564 (53%), Positives = 343/564 (60%), Gaps = 129/564 (22%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTGSIP E DS KLQGLYLGNNQLTG+IP LG L LVKLNLT N+ GPVP SLG+L
Sbjct: 673 LTGSIPPELVDSSKLQGLYLGNNQLTGTIPGRLGVLCSLVKLNLTGNQLHGPVPRSLGDL 732
Query: 61 KGLSHLDLSSNFFDGGWPRS--------------------------------LGNLSYST 88
K L+HLDLS N DG P S LGNL
Sbjct: 733 KALTHLDLSYNELDGELPSSVSQMLNLVGLYVQQNRLSGPLDELLSRTVPVELGNLMQLE 792
Query: 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML------------------------CGK 124
Y D+ N+ + +IP+N+ L L +L++ N L CG+
Sbjct: 793 YFDVSGNRLSGKIPENICVLVNLFYLNLAENSLEGPVPRSGICLNLSKISLAGNKDLCGR 852
Query: 125 IPEKICKSR------------LEGLV---------------------SQSGICQNLSKIS 151
I C+ + L G+ S G + + +
Sbjct: 853 ILGLDCRIKSFNKSYFLNAWGLAGIAVGCMIVALSTAFALRKWIMRDSGQGDPEEIEERK 912
Query: 152 LAGNKDYNLY-LSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGT 198
L D NLY LSSSRSK PL INI+MF+QPLLK+TLVDILE DGGFGT
Sbjct: 913 LNSFIDKNLYFLSSSRSKEPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGT 972
Query: 199 VYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258
VYKATL DGKTVAVKK SQAKTQG R+F AEMETLGKVKHQNLV LLGYCS EEKLLVY
Sbjct: 973 VYKATLRDGKTVAVKKLSQAKTQGDREFIAEMETLGKVKHQNLVALLGYCSLGEEKLLVY 1032
Query: 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------- 301
EYMVNGSLDLWLRN +G+ +VLD KR+KIA +A GLAFLH
Sbjct: 1033 EYMVNGSLDLWLRNRSGALDVLDWPKRFKIATGAACGLAFLHHGFTPHIIHRDIKASNIL 1092
Query: 302 ----------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILL 351
DFGLARLISACETHVSTDIAGT GYIPPEYGQS ST+RGDVYSFGVILL
Sbjct: 1093 LNENFEPRVADFGLARLISACETHVSTDIAGTFGYIPPEYGQSGRSTSRGDVYSFGVILL 1152
Query: 352 ELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAAD 411
ELVT KEPTGP+F+E EG NLVGWV QK+KK Q DVLDPTVL+A SKPMML++L+IAA
Sbjct: 1153 ELVTGKEPTGPDFKEVEGGNLVGWVSQKIKKGQTADVLDPTVLSADSKPMMLQVLQIAAV 1212
Query: 412 CVADNPATRPTMLHVLKLLHEIVD 435
C++DNPA RPTML VLK L I D
Sbjct: 1213 CLSDNPANRPTMLKVLKFLKGIRD 1236
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455406|ref|XP_002273978.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-141, Method: Compositional matrix adjust.
Identities = 303/607 (49%), Positives = 352/607 (57%), Gaps = 172/607 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTGSIP + G SLKLQGLYLGNNQLTG+IP SLG+L LVKLNLT N+ SG +P S GNL
Sbjct: 692 LTGSIPLKLGYSLKLQGLYLGNNQLTGTIPESLGRLSSLVKLNLTGNQLSGSIPFSFGNL 751
Query: 61 KGLSHLDLSSN------------------------------------------------- 71
GL+H DLSSN
Sbjct: 752 TGLTHFDLSSNELDGELPSALSSMVNLVGLYVQQNRLSGQVSKLFMNSIAWRIETLNLSW 811
Query: 72 -FFDGGWPRSLGNLSYSTYLDLHDN------------------------KFTREIPQNLG 106
FF+GG PRSLGNLSY T LDLH N + +IP+ +
Sbjct: 812 NFFNGGLPRSLGNLSYLTNLDLHHNMFTGEIPTELGDLMQLEYFDVSGNRLCGQIPEKIC 871
Query: 107 NLAQLEHLDVLRNML------------------------CGKIPEKICKSR--------- 133
+L L +L++ N L CG+ C+ +
Sbjct: 872 SLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQFKTFGRKSSLV 931
Query: 134 ----LEGLV---------------------SQSGICQNLSKISLAGNKDYNLY-LSSSRS 167
L G+V S+ + + + L + D NLY LSSSRS
Sbjct: 932 NTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQNLYFLSSSRS 991
Query: 168 KGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKF 215
K PL IN++MF+QPLLKLTLVDILE DGGFGTVYKA LP+GK VAVKK
Sbjct: 992 KEPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALPNGKIVAVKKL 1051
Query: 216 SQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG 275
+QAKTQGHR+F AEMETLGKVKH+NLV LLGYCSF EEK LVYEYMVNGSLDLWLRN TG
Sbjct: 1052 NQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGSLDLWLRNRTG 1111
Query: 276 SHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARL 308
+ E LD KR+KIA +ARGLAFLH DFGLARL
Sbjct: 1112 ALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEAKVADFGLARL 1171
Query: 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE 368
ISACETHVSTDIAGT GYIPPEYG S STTRGDVYSFGVILLELVT KEPTGP+F++ E
Sbjct: 1172 ISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKEPTGPDFKDFE 1231
Query: 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
G NLVGWVF+KM+K +A +VLDPTV+ A K +ML++L+IAA C+++NPA RPTMLHVLK
Sbjct: 1232 GGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPAKRPTMLHVLK 1291
Query: 429 LLHEIVD 435
L I D
Sbjct: 1292 FLKGIKD 1298
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446181|ref|XP_004140850.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 495 bits (1275), Expect = e-137, Method: Compositional matrix adjust.
Identities = 295/606 (48%), Positives = 344/606 (56%), Gaps = 171/606 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTG IP+E G +LKLQGLYLGNN+L G IP S L LVKLNLT N+ SG VP + G L
Sbjct: 692 LTGPIPAEIGKALKLQGLYLGNNRLMGMIPESFSHLNSLVKLNLTGNRLSGSVPKTFGGL 751
Query: 61 KGLSHLDLSSNFFDG----------------------------------GW--------- 77
K L+HLDLS N DG W
Sbjct: 752 KALTHLDLSCNELDGDLPSSLSSMLNLVGLYVQENRLSGQVVELFPSSMSWKIETLNLSD 811
Query: 78 -------PRSLGNLSYSTYLDLHDNKF------------------------TREIPQNLG 106
PR+LGNLSY T LDLH NKF + EIP+ +
Sbjct: 812 NYLEGVLPRTLGNLSYLTTLDLHGNKFAGTIPSDLGDLMQLEYLDVSNNSLSGEIPEKIC 871
Query: 107 NLAQLEHLDVLRNML------------------------CGKIPEKICKSR--------- 133
+L + +L++ N L CG+I C+ +
Sbjct: 872 SLVNMFYLNLAENSLEGPIPRSGICQNLSKSSLVGNKDLCGRILGFNCRIKSLERSAVLN 931
Query: 134 ---LEGLVSQSGIC---------------------QNLSKISLAGNKDYNLY-LSSSRSK 168
+ G++ S + + + + L D NLY LSSSRSK
Sbjct: 932 SWSVAGIIIVSVLIVLTVAFAMRRRIIGIQRDSDPEEMEESKLNSFIDPNLYFLSSSRSK 991
Query: 169 GPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFS 216
PL IN++MF+QPLLKLTLVDILE DGGFGTVYKATLPDGK VAVKK S
Sbjct: 992 EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNIIGDGGFGTVYKATLPDGKVVAVKKLS 1051
Query: 217 QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS 276
+AKTQGHR+F AEMET+GKVKH NLV LLGYCS EEKLLVYEYMVNGSLDLWLRN TG+
Sbjct: 1052 EAKTQGHREFIAEMETIGKVKHHNLVPLLGYCSLGEEKLLVYEYMVNGSLDLWLRNRTGT 1111
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309
E+L+ R+K+A +ARGLAFLH DFGLARLI
Sbjct: 1112 LEILNWETRFKVASGAARGLAFLHHGFIPHIIHRDVKASNILLNQDFEPKVADFGLARLI 1171
Query: 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG 369
SACETHV+T+IAGT GYIPPEYGQS STT+GDVYSFGVILLELVT KEPTGP+F+E EG
Sbjct: 1172 SACETHVTTEIAGTFGYIPPEYGQSGRSTTKGDVYSFGVILLELVTGKEPTGPDFKEIEG 1231
Query: 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
NLVGWVFQK+ K QA DVLD TVLNA SK MML+ L+IA C+++NPA RP+ML VLK
Sbjct: 1232 GNLVGWVFQKINKGQAADVLDATVLNADSKHMMLQTLQIACVCLSENPANRPSMLQVLKF 1291
Query: 430 LHEIVD 435
L I D
Sbjct: 1292 LKGIKD 1297
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449527203|ref|XP_004170602.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 495 bits (1274), Expect = e-137, Method: Compositional matrix adjust.
Identities = 295/606 (48%), Positives = 344/606 (56%), Gaps = 171/606 (28%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTG IP+E G +LKLQGLYLGNN+L G IP S L LVKLNLT N+ SG VP + G L
Sbjct: 692 LTGPIPAEIGKALKLQGLYLGNNRLMGMIPESFSHLNSLVKLNLTGNRLSGSVPKTFGGL 751
Query: 61 KGLSHLDLSSNFFDG----------------------------------GW--------- 77
K L+HLDLS N DG W
Sbjct: 752 KALTHLDLSCNELDGDLPSSLSSMLNLVGLYVQENRLSGQVVELFPSSMSWKIETLNLSD 811
Query: 78 -------PRSLGNLSYSTYLDLHDNKF------------------------TREIPQNLG 106
PR+LGNLSY T LDLH NKF + EIP+ +
Sbjct: 812 NYLEGVLPRTLGNLSYLTTLDLHGNKFAGTIPSDLGDLMQLEYLDVSNNSLSGEIPEKIC 871
Query: 107 NLAQLEHLDVLRNML------------------------CGKIPEKICKSR--------- 133
+L + +L++ N L CG+I C+ +
Sbjct: 872 SLVNMFYLNLAENSLEGPIPRSGICQNLSKSSLVGNKDLCGRILGFNCRIKSLERSAVLN 931
Query: 134 ---LEGLVSQSGIC---------------------QNLSKISLAGNKDYNLY-LSSSRSK 168
+ G++ S + + + + L D NLY LSSSRSK
Sbjct: 932 SWSVAGIIIVSVLIVLTVAFAMRRRIIGIQRDSDPEEMEESKLNSFIDPNLYFLSSSRSK 991
Query: 169 GPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFS 216
PL IN++MF+QPLLKLTLVDILE DGGFGTVYKATLPDGK VAVKK S
Sbjct: 992 EPLSINVAMFEQPLLKLTLVDILEATNNFCKTNIIGDGGFGTVYKATLPDGKVVAVKKLS 1051
Query: 217 QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS 276
+AKTQGHR+F AEMET+GKVKH NLV LLGYCS EEKLLVYEYMVNGSLDLWLRN TG+
Sbjct: 1052 EAKTQGHREFIAEMETIGKVKHHNLVPLLGYCSLGEEKLLVYEYMVNGSLDLWLRNRTGT 1111
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309
E+L+ R+K+A +ARGLAFLH DFGLARLI
Sbjct: 1112 LEILNWETRFKVASGAARGLAFLHHGFIPHIIHRDVKASNILLNQDFEPKVADFGLARLI 1171
Query: 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG 369
SACETHV+T+IAGT GYIPPEYGQS STT+GDVYSFGVILLELVT KEPTGP+F+E EG
Sbjct: 1172 SACETHVTTEIAGTFGYIPPEYGQSGRSTTKGDVYSFGVILLELVTGKEPTGPDFKEIEG 1231
Query: 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
NLVGWVFQK+ K QA DVLD TVLNA SK MML+ L+IA C+++NPA RP+ML VLK
Sbjct: 1232 GNLVGWVFQKINKGQAADVLDATVLNADSKHMMLQTLQIACVCLSENPANRPSMLQVLKF 1291
Query: 430 LHEIVD 435
L I D
Sbjct: 1292 LKGIKD 1297
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|23304947|emb|CAD42912.1| extra sporogenous cells [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1244), Expect = e-134, Method: Compositional matrix adjust.
Identities = 282/553 (50%), Positives = 332/553 (60%), Gaps = 120/553 (21%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTGSIP E G+SLKLQGL L NNQL G IP S G LG LVKLNLT+NK GPVP SLGNL
Sbjct: 640 LTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNL 699
Query: 61 KGLSHLDLS------------------------SNFFDGGWPRSLGNLSYSTYLDLHDNK 96
K L+H+DLS N F G P LGNL+ YLD+ +N
Sbjct: 700 KELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENL 759
Query: 97 FTREIPQNLGNLAQLEHLDVLRNMLCGKIP-EKICKS---------------------RL 134
+ EIP + L LE L++ +N L G++P + +C+ ++
Sbjct: 760 LSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKI 819
Query: 135 EG--LVSQSGIC--------------------------------QNLSKISLAGNKDYNL 160
EG L S GI + + + L G D NL
Sbjct: 820 EGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWVMTKRVKQRDDPERIEESRLKGFVDQNL 879
Query: 161 Y-LSSSRSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDG 207
Y LS SRS+ PL INI+MF+QPLLK+ L DI+E DGGFGTVYKA LP
Sbjct: 880 YFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGE 939
Query: 208 KTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLD 267
KTVAVKK S+AKTQG+R+F AEMETLGKVKH NLV LLGYCSF EEKLLVYEYMVNGSLD
Sbjct: 940 KTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLD 999
Query: 268 LWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------- 301
WLRN TG EVLD +KR KIA +ARGLAFLH
Sbjct: 1000 HWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKV 1059
Query: 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
DFGLARLISACE+H+ST IAGT GYIPPEYGQS +TT+GDVYSFGVILLELVT KEPT
Sbjct: 1060 ADFGLARLISACESHISTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPT 1119
Query: 361 GPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR 420
GP+F+E EG NLVGW QK+ + +A DV+DP +++ K L++L+IA C+A+ PA R
Sbjct: 1120 GPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKR 1179
Query: 421 PTMLHVLKLLHEI 433
P ML VLK L EI
Sbjct: 1180 PNMLDVLKALKEI 1192
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 435 | ||||||
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.381 | 0.139 | 0.653 | 1.9e-137 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.289 | 0.097 | 0.570 | 1.7e-90 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.301 | 0.112 | 0.534 | 6.1e-78 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.301 | 0.112 | 0.517 | 2.3e-75 | |
| TAIR|locus:2041150 | 1143 | BRL2 "BRI1-like 2" [Arabidopsi | 0.314 | 0.119 | 0.483 | 3.7e-69 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.675 | 0.262 | 0.376 | 1.5e-66 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.678 | 0.246 | 0.361 | 1.5e-64 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.298 | 0.125 | 0.473 | 2.6e-64 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.662 | 0.285 | 0.344 | 6.4e-64 | |
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.301 | 0.119 | 0.469 | 1e-62 |
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 1.9e-137, Sum P(3) = 1.9e-137
Identities = 117/179 (65%), Positives = 130/179 (72%)
Query: 138 VSQSGICQNLSKISLAGNKDYNLY-LSSSRSKGPLRINISMFQQPLLKLTLVDILE---- 192
V Q + + + L G D NLY LS SRS+ PL INI+MF+QPLLK+ L DI+E
Sbjct: 857 VKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDH 916
Query: 193 --------DGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
DGGFGTVYKA LP KTVAVKK S+AKTQG+R+F AEMETLGKVKH NLV L
Sbjct: 917 FSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSL 976
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQDF 303
LGYCSF EEKLLVYEYMVNGSLD WLRN TG EVLD +KR KIA +ARGLAFLH F
Sbjct: 977 LGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGF 1035
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 375 (137.1 bits), Expect = 1.7e-90, Sum P(3) = 1.7e-90
Identities = 73/128 (57%), Positives = 96/128 (75%)
Query: 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361
DFGLAR+ISACETHVSTDIAGT GYIPPEYG + STT+GDVYSFGV++LEL+T + PTG
Sbjct: 1147 DFGLARIISACETHVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTG 1206
Query: 362 PEFQEKEGANLVGWVFQKMKKQQADDVLDPTV-LNAGSKPMMLKMLRIAADCVADNPATR 420
E + + G NLVGWV + + + +++ DP + +++ + M ++L IA DC AD P R
Sbjct: 1207 QE-EVQGGGNLVGWVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKR 1265
Query: 421 PTMLHVLK 428
PTML V+K
Sbjct: 1266 PTMLEVVK 1273
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 344 (126.2 bits), Expect = 6.1e-78, Sum P(3) = 6.1e-78
Identities = 77/144 (53%), Positives = 92/144 (63%)
Query: 170 PLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQ 217
PL IN++ F++PL KLT +LE GGFG VYKA L DG VA+KK Q
Sbjct: 831 PLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQ 890
Query: 218 AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH 277
QG R+F AEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+ L T
Sbjct: 891 VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKG 950
Query: 278 EV-LDRAKRYKIACSSARGLAFLH 300
+ LD + R KIA +ARGLAFLH
Sbjct: 951 GIFLDWSARKKIAIGAARGLAFLH 974
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 326 (119.8 bits), Expect = 2.3e-75, Sum P(3) = 2.3e-75
Identities = 75/145 (51%), Positives = 91/145 (62%)
Query: 170 PLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQ 217
PL IN++ F++PL KLT +LE GGFG VYKA L DG VA+KK +
Sbjct: 832 PLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIR 891
Query: 218 AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH 277
QG R+F AEMET+GK+KH+NLV LLGYC EE+LLVYEYM GSL+ L +
Sbjct: 892 ITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKK 951
Query: 278 E--VLDRAKRYKIACSSARGLAFLH 300
L+ A R KIA +ARGLAFLH
Sbjct: 952 GGIYLNWAARKKIAIGAARGLAFLH 976
|
|
| TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 318 (117.0 bits), Expect = 3.7e-69, Sum P(3) = 3.7e-69
Identities = 73/151 (48%), Positives = 94/151 (62%)
Query: 166 RSKGPLRINISMFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVK 213
+ K PL IN++ FQ+ L KL ++E GGFG V+KATL DG +VA+K
Sbjct: 807 KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIK 866
Query: 214 KFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNA 273
K + QG R+F AEMETLGK+KH+NLV LLGYC EE+LLVYE+M GSL+ L
Sbjct: 867 KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGP 926
Query: 274 -TGS-HEVLDRAKRYKIACSSARGLAFLHQD 302
TG +L +R KIA +A+GL FLH +
Sbjct: 927 RTGEKRRILGWEERKKIAKGAAKGLCFLHHN 957
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 1.5e-66, Sum P(2) = 1.5e-66
Identities = 119/316 (37%), Positives = 167/316 (52%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G+IPS ++ KL L L NQL G IP S L L ++NL+ N+ +G +P LG+L
Sbjct: 617 LSGTIPSRLAEAKKLAVLDLSYNQLEGPIPNSFSALS-LSEINLSNNQLNGTIP-ELGSL 674
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQ--LEHLDVLR 118
+N G+P L +S+ +D++ R ++A L L +
Sbjct: 675 ATFPKSQYENNTGLCGFP--LPPCDHSSPRSSNDHQSHRRQASMASSIAMGLLFSLFCII 732
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMF 178
++ I K + + E + I + S N D+ LS + L IN++ F
Sbjct: 733 VIIIA-IGSKRRRLKNEEASTSRDIYIDSRSHSATMNSDWRQNLSGTNL---LSINLAAF 788
Query: 179 QQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQF 226
++PL LTL D++E GGFG VYKA L DGK VA+KK QG R+F
Sbjct: 789 EKPLQNLTLADLVEATNGFHIACQIGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGDREF 848
Query: 227 TAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY 286
TAEMET+GK+KH+NLV LLGYC EE+LLVY+YM GSL+ L + + L+ R
Sbjct: 849 TAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARR 908
Query: 287 KIACSSARGLAFLHQD 302
KIA +ARGLAFLH +
Sbjct: 909 KIAVGAARGLAFLHHN 924
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 1.5e-64, Sum P(2) = 1.5e-64
Identities = 115/318 (36%), Positives = 166/318 (52%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
++GSIP E GD L L L +N+L G IP+++ L L +++L+ N SGP+P +G
Sbjct: 690 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQF 748
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQ---LEHLDV 116
+ +N G+P + S + H R P +L G++A + +
Sbjct: 749 ETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRR-PASLAGSVAMGLLFSFVCI 807
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINIS 176
+L G+ K + + E + S A N ++ L + K L IN++
Sbjct: 808 FGLILVGREMRKRRRKK-EAELEMYAEGHGNSGDRTANNTNWKL----TGVKEALSINLA 862
Query: 177 MFQQPLLKLTLVDILE------------DGGFGTVYKATLPDGKTVAVKKFSQAKTQGHR 224
F++PL KLT D+L+ GGFG VYKA L DG VA+KK QG R
Sbjct: 863 AFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDR 922
Query: 225 QFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAK 284
+F AEMET+GK+KH+NLV LLGYC +E+LLVYE+M GSL+ L + + L+ +
Sbjct: 923 EFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWST 982
Query: 285 RYKIACSSARGLAFLHQD 302
R KIA SARGLAFLH +
Sbjct: 983 RRKIAIGSARGLAFLHHN 1000
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 294 (108.6 bits), Expect = 2.6e-64, Sum P(3) = 2.6e-64
Identities = 63/133 (47%), Positives = 89/133 (66%)
Query: 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361
DFGLARL+ +THV+TD+ GTLGYIPPEY QS ++T RGDVYSFGV+LLELVT + P
Sbjct: 898 DFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPV- 956
Query: 362 PEFQEKEGANLVGWVFQ-KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR 420
+ K +LV VFQ K +K++A+ ++D T+ ++ +L+ML IA C+ P R
Sbjct: 957 EVCKGKSCRDLVSRVFQMKAEKREAE-LIDTTIRENVNERTVLEMLEIACKCIDHEPRRR 1015
Query: 421 PTMLHVLKLLHEI 433
P + V+ L ++
Sbjct: 1016 PLIEEVVTWLEDL 1028
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 372 (136.0 bits), Expect = 6.4e-64, Sum P(2) = 6.4e-64
Identities = 105/305 (34%), Positives = 155/305 (50%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+GSIPS L+ L L NN+L+GSIP SL QL L K ++ N SG +P+ G
Sbjct: 559 LSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSG-GQF 617
Query: 61 KGLSHLDLSSNFFDGG--WPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
+ + SN G +P S G + S + +I +G L L
Sbjct: 618 QTFPNSSFESNHLCGEHRFPCSEG--TESALIKRSRRSRGGDIGMAIGIAFGSVFLLTLL 675
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSR--SKGPLRINIS 176
+++ + + ++ + +S N ++ G+K L+ S+ + S L + +
Sbjct: 676 SLIVLRARRR--SGEVDPEIEESE-SMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTN 732
Query: 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV 236
F Q +I+ GGFG VYKATLPDGK VA+KK S Q R+F AE+ETL +
Sbjct: 733 SFDQ-------ANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRA 785
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
+H NLVLL G+C + ++LL+Y YM NGSLD WL +L R +IA +A+GL
Sbjct: 786 QHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGL 845
Query: 297 AFLHQ 301
+LH+
Sbjct: 846 LYLHE 850
|
|
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 1.0e-62, Sum P(3) = 1.0e-62
Identities = 62/132 (46%), Positives = 85/132 (64%)
Query: 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361
DFGL+RLI THV+T++ GTLGYIPPEYGQ+ ++T RGDVYSFGV++LEL+T K P
Sbjct: 947 DFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPM- 1005
Query: 362 PEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRP 421
F+ K LV WV + + ++V D + +G++ ML++L IA CV NP RP
Sbjct: 1006 EVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRP 1065
Query: 422 TMLHVLKLLHEI 433
+ V+ L I
Sbjct: 1066 NIQQVVDWLKNI 1077
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 435 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-30 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 5e-36
Identities = 138/502 (27%), Positives = 219/502 (43%), Gaps = 93/502 (18%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
G +P FG S +L+ L L NQ +G++PR LG L L++L L+ NK SG +P L + K
Sbjct: 466 GGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122
L LDLS N G P S + + LDL N+ + EIP+NLGN+ L +++ N L
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 123 GKIPEK-----ICKSRLEGLV------SQSGI--CQNLSKISLAGNKDYNLYLSSS---- 165
G +P I S + G + + SG+ C+ + K + Y++ +
Sbjct: 585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-----TPSWWFYITCTLGAF 639
Query: 166 -------------RSKGPLRIN----------ISMFQQPLLK-LTLVDILE--------- 192
R + L + + F + K +T+ DIL
Sbjct: 640 LVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVIS 699
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
G G YK ++ +G VK+ + + A+M GK++H N+V L+G C +
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SSEIADM---GKLQHPNIVKLIGLCRSE 755
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQDFGLA----- 306
+ L++EY+ +L LRN L +R KIA A+ L FLH A
Sbjct: 756 KGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 307 --------------RLISACETHVSTDIAGTL--GYIPPEYGQSRMSTTRGDVYSFGVIL 350
L + + TD + Y+ PE +++ T + D+Y FG+IL
Sbjct: 809 LSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868
Query: 351 LELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS--KPMMLKMLRI 408
+EL+T K P EF ++V W D +DP++ S + +++++ +
Sbjct: 869 IELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926
Query: 409 AADCVADNPATRPTMLHVLKLL 430
A C A +P RP VLK L
Sbjct: 927 ALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDGKT---VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
LTL L +G FG VYK L GK VAVK + ++ + F E + K+ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
N+V LLG C+ +E +V EYM G L +LR + L + A ARG+ +
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEY 117
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
L DFGL+R + + + + ++ PE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 335 RMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393
T++ DV+SFGV+L E+ T ++P + ++ ++ + L
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLEYL-------KNGYRLPQ-- 224
Query: 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
++ + C A++P RPT ++++L
Sbjct: 225 ----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 46/269 (17%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKVKHQNLVL 243
+++ L +G FG VY A GK VA+K + K + R + E++ L K+KH N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L +++ LV EY G L L+ E D A+ Y L +LH
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--DEARFY--LRQILSALEYLHSKG 117
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGLAR + T GT Y+ PE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 340 RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399
D++S GVIL EL+T K P F G + + +F+K+ K + ++ +K
Sbjct: 176 AVDIWSLGVILYELLTGKPP----FP---GDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 400 PMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ K+L +P R T L+
Sbjct: 229 DLIRKLLVK-------DPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 60/282 (21%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGK-----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
LTL L +G FG VYK TL VAVK + ++ + F E + K+ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
N+V LLG C+ +E ++V EYM G L +LR + L + A ARG+ +
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEY 118
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R + + + G +P P
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG-----GKLPIRWMAP 173
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
E + T++ DV+SFGV+L E+ T +EP + A ++ ++ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP----YPGMSNAEVLEYL-------KKGYR 222
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
L ++ ++ C A++P RPT ++++L
Sbjct: 223 LPK------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 70/272 (25%), Positives = 104/272 (38%), Gaps = 44/272 (16%)
Query: 185 LTLVDILEDGGFGTVYKAT-LPDGKTVAVKKF--SQAKTQGHRQFTAEMETLGKVKHQNL 241
L+ L G FGTVYKA GK VAVK K++ + E+ L ++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V L+ + LV EY G L +L L + KIA RGL +LH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHS 116
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE-YGQSRM 336
DFGLA+ + + T GT Y+ PE
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
+ DV+S GVIL EL+T K P F + + + + + + D +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEFDEPKWS---- 227
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + C+ +P+ RPT +L+
Sbjct: 228 ---SGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 61/283 (21%)
Query: 189 DILEDGGFGTVYKATLPDGKT----VAVKKF-SQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L +G FG VYK L VAVK A + + F E + K+ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHE-----VLDRAKRYKIACSSARGLAF 298
LLG C+ +E LV EYM G L +LR + L A A+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R + + + T G +P P
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWMAP 176
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
E + + T++ DV+SFGV+L E+ T P + ++ ++ + + + +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431
D ++ + C +P RPT +++ L
Sbjct: 233 PD-------------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 57/193 (29%), Positives = 83/193 (43%), Gaps = 32/193 (16%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSFD 251
GGFGTVY A GK VA+K + + + E+E L K+ H N+V L G +
Sbjct: 4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE 63
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------- 301
LV EY GSL L+ G L + +I GL +LH
Sbjct: 64 NHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 302 ---------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYS 345
DFGL++L+++ + + I GT Y+ PE + + + D++S
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 346 FGVILLELVTAKE 358
GVIL EL K+
Sbjct: 180 LGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 43/211 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
L L L +G FG VYK TL VAVK + ++ R+ F E + K+ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
N+V LLG C+ E +V EYM G L +LR L ++A A+G+ +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEY 117
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R I + + G +P P
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG----GKLPIKWMAP 173
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
E + T++ DV+SFGV+L E+ T ++P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 72/183 (39%), Positives = 99/183 (54%), Gaps = 13/183 (7%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
LTG IPS G+ LQ L+L N+L+G IP S+ L L+ L+L+ N SG +P + L
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
+ L L L SN F G P +L +L L L NKF+ EIP+NLG L LD+ N
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 121 LCGKIPEKICKS-----------RLEGLVSQS-GICQNLSKISLAGNKDYNLYLSSSRSK 168
L G+IPE +C S LEG + +S G C++L ++ L N ++ L S +K
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN-SFSGELPSEFTK 426
Query: 169 GPL 171
PL
Sbjct: 427 LPL 429
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-25
Identities = 63/155 (40%), Positives = 81/155 (52%), Gaps = 6/155 (3%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L G IP E G L+ +YLG N L+G IP +G L L L+L N +GP+P+SLGNL
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
K L +L L N G P S+ +L LDL DN + EIP+ + L LE L + N
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319
Query: 121 LCGKIPEKICK-SRLEGLVSQS-----GICQNLSK 149
GKIP + RL+ L S I +NL K
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 55/131 (41%), Positives = 74/131 (56%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L G IP+ + L+ L L +NQL G IPR LGQ+ L + L N SG +P +G L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L+HLDL N G P SLGNL YL L+ NK + IP ++ +L +L LD+ N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 121 LCGKIPEKICK 131
L G+IPE + +
Sbjct: 296 LSGEIPELVIQ 306
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 52/129 (40%), Positives = 68/129 (52%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G IP++ G L+ L LG N L G IP SL L L L L N+ G +P LG +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
K L + L N G P +G L+ +LDL N T IP +LGNL L++L + +N
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271
Query: 121 LCGKIPEKI 129
L G IP I
Sbjct: 272 LSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK 237
+++P + TL L G FG V++ + VA+K + F E++ L +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR 60
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H++L+ L CS E ++ E M GSL +LR+ G +VL A +AC A G+A
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMA 118
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQ 333
+L + DFGLARLI + ++S+D + PE
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAAS 177
Query: 334 SRMSTTRGDVYSFGVILLELVT 355
+T+ DV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 89.8 bits (221), Expect = 1e-19
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 47/287 (16%)
Query: 186 TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQ-NL 241
++ L +G FG VY A D K VA+K ++ + +F E++ L + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V L + + LV EY+ GSL+ L+ G L ++ I L +LH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEYLHS 119
Query: 302 -------------------------DFGLARLISACETHVS-----TDIAGTLGYIPPEY 331
DFGLA+L+ + S + GT GY+ PE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 332 GQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
+++ D++S G+ L EL+T P E E + K+ +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPP-----FEGEKNSSATSQTLKIILELPTPS 234
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
L + + + + + +A +P R + L H+++
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS--SSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-19
Identities = 52/126 (41%), Positives = 65/126 (51%), Gaps = 2/126 (1%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
TGSIP G L+ L L NN L+G IP +G L L+L N G +P SL NL
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L L L+SN G PR LG + ++ L N + EIP +G L L HLD++ N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 121 LCGKIP 126
L G IP
Sbjct: 248 LTGPIP 253
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 59/195 (30%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
L L L G FG V+ T VAVK T F E + + K++H LV L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
CS +E +V EYM GSL +L++ G L + +A A G+A+L
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGLARLI E + + PE T +
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 341 GDVYSFGVILLELVT 355
DV+SFG++L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 51/130 (39%), Positives = 71/130 (54%), Gaps = 3/130 (2%)
Query: 1 LTGSIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
L+G IP + F S L+ L L NN TGSIPR G + L L+L+ N SG +P +G+
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGS 162
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L LDL N G P SL NL+ +L L N+ +IP+ LG + L+ + + N
Sbjct: 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222
Query: 120 MLCGKIPEKI 129
L G+IP +I
Sbjct: 223 NLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 68/284 (23%), Positives = 116/284 (40%), Gaps = 57/284 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDGK--TVAVKKF-SQAKTQGHRQFTAEMETLGKVKHQ 239
+T+ ++ G FG V + L P K VA+K + + + F E +G+ H
Sbjct: 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N++ L G + +++ EYM NGSLD +LR G V + + A G+ +L
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVG---QLVGMLRGIASGMKYL 122
Query: 300 ------HQ------------------DFGLARLISACETHVSTDIAGTLGYIP-----PE 330
H+ DFGL+R + E +T G G IP PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KG--GKIPIRWTAPE 178
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
R T+ DV+SFG+++ E+++ + E+ + Q + K D
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS--------YGERPYWD---MSNQDVIKAVEDGYRL 227
Query: 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
P ++ P L ++ DC + RPT ++ L +++
Sbjct: 228 PPPMDC---PSALY--QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-17
Identities = 46/137 (33%), Positives = 59/137 (43%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+G IP G L L L N LTG IP L G L KL L N G +P SLG
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
+ L + L N F G P L +LD+ +N I ++ L+ L + RN
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 121 LCGKIPEKICKSRLEGL 137
G +P+ RLE L
Sbjct: 464 FFGGLPDSFGSKRLENL 480
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 48/134 (35%), Positives = 70/134 (52%), Gaps = 3/134 (2%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLG-GLVKLNLTRNKFSGPVPTSLGN 59
++G I S +Q + L NNQL+G IP + L LNL+ N F+G +P G+
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GS 138
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
+ L LDLS+N G P +G+ S LDL N +IP +L NL LE L + N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 120 MLCGKIPEKICKSR 133
L G+IP ++ + +
Sbjct: 199 QLVGQIPRELGQMK 212
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+ L+ L G FG V++ + VAVK + T + F AE + + K++H L+ L
Sbjct: 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
C+ +E +V E M GSL +L+ G L + +A A G+A+L
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGLAR+I + + PE + +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 341 GDVYSFGVILLELVT 355
DV+SFG++L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 57/214 (26%), Positives = 84/214 (39%), Gaps = 56/214 (26%)
Query: 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKVKHQNLV 242
L V +L G G VYK P GK A+KK + R Q E++TL + +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 243 LLLGYCSFDEEKL--LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYK------IACSSAR 294
Y +F +E +V EYM GSL ++L + + IA +
Sbjct: 63 KC--YGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILK 110
Query: 295 GLAFLHQ-------------------------DFGLARLISA----CETHVSTDIAGTLG 325
GL +LH DFG+++++ C T V GT+
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVT 165
Query: 326 YIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
Y+ PE Q + D++S G+ LLE K P
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 58/279 (20%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
+L L + G FG V G+ VAVK T + F AE + ++H N
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPN 61
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL- 299
LV LLG +V EYM GSL +LR + V+ A++ A G+ +L
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 300 -----HQ------------------DFGLARLISACETHVSTDIAGTLGYIP-----PEY 331
H+ DFGLA+ A + S G +P PE
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDS-------GKLPVKWTAPEA 170
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
+ + +T+ DV+SFG++L E+ + P K+ V +K + +A +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEAPE---- 222
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
G P + K+++ DC +PA RPT + + L
Sbjct: 223 -----GCPPEVYKVMK---DCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 58/180 (32%), Positives = 83/180 (46%), Gaps = 37/180 (20%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT----- 55
LTG IP S L L L +N L G IP+SLG L ++ L N FSG +P+
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 56 --------SLGNLKG-----------LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNK 96
S NL+G L L L+ N F GG P S G+ LDL N+
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLEN-LDLSRNQ 486
Query: 97 FTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
F+ +P+ LG+L++L L + N L G+IP+++ C+ L + L+ N+
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS------------CKKLVSLDLSHNQ 534
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 65/224 (29%), Positives = 94/224 (41%), Gaps = 53/224 (23%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGK-TVAVKKF-SQAKTQGHRQFTAEMETL 233
P +LTL L +G FG V KA P+ TVAVK A + +EME +
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 234 GKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR---------NATGSHEVLDRA 283
+ KH+N++ LLG C+ + +V EY +G+L +LR + +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 284 KRYKI---ACSSARGLAFLHQ------------------------DFGLARLISACETHV 316
+ + A ARG+ FL DFGLAR I + +
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 317 STDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
T T G +P PE R+ T + DV+SFGV+L E+ T
Sbjct: 190 KT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 36/205 (17%)
Query: 184 KLTLVDILEDGGFGTVYKA-TLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQN 240
L D++ G FG VYK L G VA+K+ S K + + E++ L +KH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAF 298
+V +G + ++ EY NGSL ++ E L Y ++ +GLA+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--VAVYVYQV----LQGLAY 114
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
LH+ DFG+A ++ + + GT ++ PE +
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEM 173
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
++T D++S G ++EL+T P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 44/211 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATLPD-GKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQN 240
+ T ++L G FG+VY A D G+ +AVK S + E+ L ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 241 LVLLLGYCSFDEEKLLVY---EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR--- 294
+V G DEEK + EY+ GSL L+ E ++Y R
Sbjct: 61 IVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--PVIRKY------TRQIL 111
Query: 295 -GLAFLHQ------------------------DFGLARLI-SACETHVSTDIAGTLGYIP 328
GLA+LH DFG A+ + + + GT ++
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
PE + D++S G ++E+ T K P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKT------VAVKKFSQ-AKTQGHRQFTAEMETLGKVK 237
+ L L +G FG V+ + VAVK + A + F E E L +
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV-----------LDRAKRY 286
H+N+V G C+ + ++V+EYM +G L+ +LR + G L ++
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 287 KIACSSARGLA------FLHQ------------------DFGLARLISACETHVSTDIAG 322
+IA A G+ F+H+ DFG++R + + + + G
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGG 182
Query: 323 T----LGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
+ ++PPE R TT DV+SFGV+L E+ T K+P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 43/212 (20%)
Query: 191 LEDGGFGTVYKAT----LPDGKT--VAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
L +G FG V+ A LP+ VAVK +A + F E E L ++HQ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAK-----------RYKIACSSA 293
G C+ L+V+EYM +G L+ +LR+ ++L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 294 RG------LAFLHQ------------------DFGLARLISACETH-VSTDIAGTLGYIP 328
G L F+H+ DFG++R I + + + V + ++P
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
PE R TT D++SFGV+L E+ T K+P
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 41/205 (20%)
Query: 187 LVDILE---DGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
L +ILE GGFG VYKA GK VA+K + + E++ L K KH N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA---RGLAFL 299
G +E +V E+ GSL L++ +++ L + +IA +GL +L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTES---QIAYVCKELLKGLEYL 114
Query: 300 HQ------------------------DFGLA-RLISACETHVSTDIAGTLGYIPPEYGQS 334
H DFGL+ +L + + GT ++ PE
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVING 171
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
+ + D++S G+ +EL K P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
TG IP +LQ L L +N+ +G IP++LG+ L L+L+ N +G +P L +
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L L L SN +G P+SLG + L DN F+ E+P L + LD+ N
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 121 LCGKIPEK-----------ICKSRLEGLVSQSGICQNLSKISLAGNK 156
L G+I + + +++ G + S + L + L+ N+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 71/287 (24%), Positives = 109/287 (37%), Gaps = 58/287 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL-----PDGKT-VAVKKFSQAKTQGHR-QFTAEMETLGKV 236
K+TL+ L G FG VY+ + +T VA+K ++ + R +F E + +
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR------NATGSHEVLDRAKRYKIAC 290
++V LLG S + L+V E M G L +LR K ++A
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 291 SSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTL-- 324
A G+A+L DFG+ R I ET L
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 184
Query: 325 -GYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
++ PE + + TT+ DV+SFGV+L E+ T E +E V
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI--------- 235
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
LD +L+++R+ C NP RPT L ++ L
Sbjct: 236 -DGGHLDLP---ENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 37/90 (41%), Positives = 50/90 (55%)
Query: 17 GLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGG 76
GL L N L G IP + +L L +NL+ N G +P SLG++ L LDLS N F+G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 77 WPRSLGNLSYSTYLDLHDNKFTREIPQNLG 106
P SLG L+ L+L+ N + +P LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 42/210 (20%)
Query: 185 LTLVDILEDGGFGTVYKAT-LPDGKT----VAVKKFSQAKT-QGHRQFTAEMETLGKVKH 238
L + +L G FGTVYK +P+G+ VA+K + + + +++ E + V H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN---ATGSHEVLDRAKRYKIACSSARG 295
++V LLG C + L+ + M G L ++RN GS +L+ + A+G
Sbjct: 69 PHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 296 LAFLHQ------------------------DFGLARLISACETHVSTDIAGT-LGYIPPE 330
+++L + DFGLA+L+ E + + ++ E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 331 YGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
R+ T + DV+S+GV + EL+T +P
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 45/214 (21%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDGKT---VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
L + L +G FG V T VAVK + + + HR F E+E L + H
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65
Query: 239 QNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
+N+V G C + L+ EY+ +GSL +L+ + ++ + + +G+
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGM 122
Query: 297 AFLHQ------------------------DFGLARLISAC-ETHVSTDIAGTLGYIP--- 328
+L DFGLA+++ + + + G P
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE----PGESPIFW 178
Query: 329 --PEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
PE ++ ++ DV+SFGV L EL T +P+
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 58/199 (29%), Positives = 81/199 (40%), Gaps = 28/199 (14%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
P L LV L G FG V+ VA+K Q + F AE + +++H
Sbjct: 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPR 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
LV L + E ++ EYM NGSL +L+ G L K +A A G+AF+
Sbjct: 63 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE 119
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
+ DFGLARLI E + + PE
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 337 STTRGDVYSFGVILLELVT 355
T + DV+SFG++L E+VT
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 33/82 (40%), Positives = 46/82 (56%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L G IP++ LQ + L N + G+IP SLG + L L+L+ N F+G +P SLG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 61 KGLSHLDLSSNFFDGGWPRSLG 82
L L+L+ N G P +LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 61/212 (28%), Positives = 86/212 (40%), Gaps = 28/212 (13%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
P L L+ L +G FG V+ T VAVK + T F E + + K++H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
LV L S +E +V EYM GSL +L++ G L +A A G+A++
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAYIE 119
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
+ DFGLARLI E + + PE
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKE 368
T + DV+SFG++L ELVT P +E
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 34/196 (17%)
Query: 194 GGFGTVYKATL--PDGK--TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYC 248
G FG V++ L P K VA+K T+ RQ F +E +G+ H N++ L G
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA---FLHQ---- 301
+ + +++ EYM NG+LD +LR+ G + + + L+ ++H+
Sbjct: 76 TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAA 135
Query: 302 --------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGD 342
DFGL+R++ E + G IP PE R T+ D
Sbjct: 136 RNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASD 192
Query: 343 VYSFGVILLELVTAKE 358
V+SFG+++ E+++ E
Sbjct: 193 VWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 43/133 (32%), Positives = 74/133 (55%), Gaps = 4/133 (3%)
Query: 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL-KGLSHLDLS 69
+S ++ + L ++G I ++ +L + +NL+ N+ SGP+P + L +L+LS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 70 SNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129
+N F G PR G++ LDL +N + EIP ++G+ + L+ LD+ N+L GKIP +
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 130 CK-SRLEGLVSQS 141
+ LE L S
Sbjct: 185 TNLTSLEFLTLAS 197
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 64/270 (23%), Positives = 100/270 (37%), Gaps = 59/270 (21%)
Query: 194 GGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSFDE 252
G FG VYK L VAVK ++ F E E L + H N+V L+G C +
Sbjct: 6 GNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65
Query: 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------- 301
+V E + GSL +LR L K +++ +A G+ +L
Sbjct: 66 PIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122
Query: 302 -------------DFGLARLISACETHVSTDIAGTLGYIP-----PE---YGQSRMSTTR 340
DFG++R VS L IP PE YG+ T+
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWTAPEALNYGR---YTSE 175
Query: 341 GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
DV+S+G++L E + + P + M QQ + ++ +
Sbjct: 176 SDVWSYGILLWETFSLGD--TP--------------YPGMSNQQTRERIESGYRMPAPQL 219
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLKLL 430
++ R+ C A +P RP+ + L
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 34/193 (17%)
Query: 191 LEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
L G +G VY+ TVAVK + + +F E + ++KH NLV LLG C+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ ++ E+M G+L +LR + + ++ +A + + +L +
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 302 ----------------DFGLARLISACETHVSTDIAGT---LGYIPPEYGQSRMSTTRGD 342
DFGL+RL++ +T+ T AG + + PE + + D
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTG-DTY--TAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 343 VYSFGVILLELVT 355
V++FGV+L E+ T
Sbjct: 188 VWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 43/211 (20%)
Query: 191 LEDGGFGTVYKATL------PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
L +G FG V+ A D VAVK A + F E E L ++H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV----------LDRAKRYKIACSSAR 294
G C + ++V+EYM +G L+ +LR A G V L +++ IA A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 295 GLA------FLHQ------------------DFGLARLISACETH-VSTDIAGTLGYIPP 329
G+ F+H+ DFG++R + + + + V + ++PP
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
E R TT DV+S GV+L E+ T K+P
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 44/213 (20%)
Query: 191 LEDGGFGTVYKAT------LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
L +G FG V+ A D VAVK + F E E L ++H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLR------------NATGSHEVLDRAKRYKIACSS 292
G C + ++V+EYM +G L+ +LR + L ++ IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 293 ARGLA------FLHQDF-------GLARLISACETHVSTDIAGT------------LGYI 327
A G+ F+H+D G L+ + +S D+ T + ++
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192
Query: 328 PPEYGQSRMSTTRGDVYSFGVILLELVT-AKEP 359
PPE R TT DV+SFGVIL E+ T K+P
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 76/307 (24%), Positives = 115/307 (37%), Gaps = 76/307 (24%)
Query: 184 KLTLVDILEDGGFGTVYKAT------LPDGKTVAVKKFSQAKTQGH-RQFTAEMETLGKV 236
L L L +G FG V KAT TVAVK + + R +E L +V
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR------------NATGSHEVLD--- 281
H +++ L G CS D LL+ EY GSL +LR + + LD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 282 -RAKRYKIACSSA----RGLAFLHQ------------------------DFGLARLISAC 312
RA S A RG+ +L + DFGL+R +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 313 ETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367
+++V + G IP E + TT+ DV+SFGV+L E+VT P +
Sbjct: 181 DSYVKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427
NL+ ++ + + + +M + C P RPT +
Sbjct: 237 RLFNLLKTGYRMERPENCSE----------------EMYNLMLTCWKQEPDKRPTFADIS 280
Query: 428 KLLHEIV 434
K L +++
Sbjct: 281 KELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 44/217 (20%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATL--PDGK----TVAVKKFSQ-AKTQGHRQFTAEMETL 233
PL + ++ L +G FG VYK L P+ + +VA+K + A+ + ++F E E +
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62
Query: 234 GKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL-RNA-----------TGSHEVLD 281
++H N+V LLG C+ ++ +++EY+ +G L +L RN+ LD
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 282 RAKRYKIACSSARGLAFL------HQ------------------DFGLARLI-SACETHV 316
+ IA A G+ +L H+ DFGL+R I SA V
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLEL 353
+ + ++PPE TT D++SFGV+L E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
P L L L G FG V+ T VA+K + T F E + + K++H+
Sbjct: 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEK 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH----EVLDRAKRYKIACSSARGL 296
LV L S +E +V EYM GSL +L+ G + +++D A + + +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 297 AFLHQD------------------FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
++H+D FGLARLI E + + PE T
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKE 368
+ DV+SFG++L EL T P +E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 31/78 (39%), Positives = 48/78 (61%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G IP E KL L L +NQL+G IP S ++ L +L+L++N+ SG +P +LGN+
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 61 KGLSHLDLSSNFFDGGWP 78
+ L +++S N G P
Sbjct: 571 ESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 56/202 (27%), Positives = 82/202 (40%), Gaps = 28/202 (13%)
Query: 191 LEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250
L G FG V+ T VA+K + T F E + + K++H LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS- 71
Query: 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------- 301
+E +V E+M GSL +L+ G + L + +A A G+A++ +
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129
Query: 302 ---------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSF 346
DFGLARLI E + + PE T + DV+SF
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 347 GVILLELVTAKEPTGPEFQEKE 368
G++L ELVT P +E
Sbjct: 190 GILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 47/194 (24%), Positives = 78/194 (40%), Gaps = 28/194 (14%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+LTLV + G FG V+ + + VA+K + F E + + K+ H LV
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L G C+ LV+E+M +G L +LR G + + G+A+L
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN 120
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFG+ R + + ST + + PE ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 340 RGDVYSFGVILLEL 353
+ DV+SFGV++ E+
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 81/304 (26%), Positives = 109/304 (35%), Gaps = 92/304 (30%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
++ L +G +G VYKA G+ VA+KK + TA E+ L ++KH N+V L
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 245 LGYCSFDEEKL-LVYEYMVNGSLDLW--LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
L E KL LV+EY +DL L G L I RGLA+ H
Sbjct: 64 LDVI-HTERKLYLVFEYC---DMDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHS 116
Query: 302 ------------------------DFGLARLIS---ACETHVSTDIAGTLGYIPPE--YG 332
DFGLAR TH TL Y PE G
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILLG 172
Query: 333 QSRMSTTRGDVYSFGVILLELVTAK-----------------------EPTGPEFQEKEG 369
ST D++S G I E++T K E + P
Sbjct: 173 SKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV----- 226
Query: 370 ANLVGW--VFQKMKKQQADDV---LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTML 424
L + F K + + V LDP ++ ++ KML+ NPA R +
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGID-----LLSKMLQY-------NPAKRISAK 274
Query: 425 HVLK 428
LK
Sbjct: 275 EALK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 40/257 (15%)
Query: 189 DILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLG 246
+IL G GTVYKA L + +AVK T + +Q +E+E L K ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL------H 300
+ + E+M GSLD++ + VL R IA + +GL +L H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKI---PEHVLGR-----IAVAVVKGLTYLWSLKILH 118
Query: 301 QDFGLARL-------ISACETHVSTDI--------AGTLGYIPPEYGQSRMSTTRGDVYS 345
+D + + + C+ VST + GT Y+ PE DV+S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 346 FGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKM 405
G+ +EL + P P+ Q+ +G+ + + Q + + DP VL G K
Sbjct: 179 LGISFMELALGRFPY-PQIQKNQGSLMPLQLLQCIVDE------DPPVLPVGQ--FSEKF 229
Query: 406 LRIAADCVADNPATRPT 422
+ C+ P RP
Sbjct: 230 VHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 70/274 (25%), Positives = 106/274 (38%), Gaps = 50/274 (18%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
L L+ + G FG V G VAVK T + F AE + +++H NLV L
Sbjct: 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 64
Query: 245 LGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH--- 300
LG ++ L +V EYM GSL +LR+ S VL K + + +L
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 301 ---------------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGL + S+ + + T PE + + +T
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 340 RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399
+ DV+SFG++L E+ + P K+ V +K K A D P V +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGCPPVVYD---- 230
Query: 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ C + ATRP+ L + + L I
Sbjct: 231 --------VMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 53/199 (26%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
P + LV L G FG V+ + VAVK + T + F E + ++H
Sbjct: 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDK 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
LV L + +E ++ EYM GSL +L++ G +L K + A G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE 120
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
+ DFGLAR+I E + + PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 337 STTRGDVYSFGVILLELVT 355
T + DV+SFG++L E+VT
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 191 LEDGGFGTVYKATLP------DGKTVAVKKFSQ-AKTQGHRQFTAEMETLGKVKHQNLVL 243
+ G FG V++A P VAVK + A F E + + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRN---------ATGSHEV---------LDRAKR 285
LLG C+ + L++EYM G L+ +LR+ + + L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 286 YKIACSSARGLAFLHQ------------------------DFGLARLI-SACETHVSTDI 320
IA A G+A+L + DFGL+R I SA S +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLEL 353
A + ++PPE TT DV+++GV+L E+
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 58/289 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL-------PDGKTVAVKKFSQAKTQGHR-QFTAEMETLGK 235
K+T+ L G FG VY+ P+ + VA+K ++A + R +F E + +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 236 VKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN------ATGSHEVLDRAKRYKIA 289
++V LLG S + L++ E M G L +LR+ K ++A
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 290 CSSARGLAFLHQDFGLARLISACETHVSTDIAGTLG------------------------ 325
A G+A+L+ + + R ++A V+ D +G
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 326 -YIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
++ PE + + TT DV+SFGV+L E+ T A++P +Q ++ +V +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGMSNEQVLRFVMEGGLLD 241
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432
+ D+ D M+ +++R+ C NP RP+ L ++ + E
Sbjct: 242 KPDNCPD----------MLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 57/199 (28%), Positives = 80/199 (40%), Gaps = 43/199 (21%)
Query: 194 GGFGTVY----KATLPDGKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLG 246
G FG V K T GK A+K + K ++ E L ++ H +V L
Sbjct: 4 GSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 247 YCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
+ +F EEKL LV EY G L L E +RA+ Y A L +LH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY--AAEIVLALEYLHSLGI 114
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGLA+ +S+ + +T GT Y+ PE +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKA 173
Query: 341 GDVYSFGVILLELVTAKEP 359
D +S GV+L E++T K P
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 65/268 (24%), Positives = 104/268 (38%), Gaps = 50/268 (18%)
Query: 185 LTLVDILEDGGFGTVYKAT-LPDGKTVAVKKF-SQAKTQGHRQFTAEMETLGKVKHQNLV 242
L + L G G V K P GK +AVK + +Q E++ L K +V
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS--HEVLDRAKRYKIACSSARGLAFLH 300
G + + + EYM GSLD L+ G +L KIA + +GL +LH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH 117
Query: 301 QDFGLAR--------LISA------CETHVST--------DIAGTLGYIPPEYGQSRMST 338
+ + L+++ C+ VS GT Y+ PE Q +
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK--QQADDVLDPTVLNA 396
+ D++S G+ L+EL T + P PE +G +F+ ++ + P L +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDG------IFELLQYIVNE-----PPPRLPS 226
Query: 397 G--SKPMMLKMLRIAADCVADNPATRPT 422
G S C+ +P RP+
Sbjct: 227 GKFSPDFQD----FVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (152), Expect = 6e-11
Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 61/271 (22%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAK-TQGHRQFT-AEMETLGKVKHQNLVLLLGYCSF 250
G FG VY DGK +K+ + ++ R+ E++ L K+ H N++ Y SF
Sbjct: 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY--YESF 68
Query: 251 DEEKLL--VYEYMVNGSLDLWLRNATGS------HEVLDRAKRYKIACSSARGLAFLHQ- 301
+E+ L V EY G L ++ ++LD + + A L +LH
Sbjct: 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD----WFVQLCLA--LKYLHSR 122
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFG+++++S+ T + GT Y+ PE Q++
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPYN 181
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398
+ D++S G +L EL T K P F+ G NL+ + K+ K Q + P+ ++
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP----FE---GENLLE-LALKILKGQYPPI--PSQYSSEL 231
Query: 399 KPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
+ ++ +L+ +P RP++ +L+
Sbjct: 232 RNLVSSLLQK-------DPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 32/201 (15%)
Query: 189 DILEDGGFGTVYKATL-PDGK---TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
+++ G FG V + L GK VA+K T+ R+ F +E +G+ H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA---FLH 300
L G + +++ E+M NG+LD +LR G V+ + + + L+ ++H
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 301 Q------------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQSRMS 337
+ DFGL+R + +T T + G IP PE R
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 338 TTRGDVYSFGVILLELVTAKE 358
T+ DV+S+G+++ E+++ E
Sbjct: 189 TSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 51/199 (25%), Positives = 77/199 (38%), Gaps = 37/199 (18%)
Query: 194 GGFGTVYKA-TLPDGKTVAVK--KFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250
G FG VY A L G+ +AVK + + ++ EM+ L +KH NLV G
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70
Query: 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------- 301
E+ + EY G+L+ L + G + Y + GLA+LH
Sbjct: 71 REKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTL--QLLEGLAYLHSHGIVHRDIK 126
Query: 302 ---------------DFGLARLISACETHVSTDIAGTLG---YIPPEYGQSRMSTTRG-- 341
DFG A + T + ++ G Y+ PE G
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186
Query: 342 -DVYSFGVILLELVTAKEP 359
D++S G ++LE+ T K P
Sbjct: 187 ADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 69/273 (25%), Positives = 106/273 (38%), Gaps = 46/273 (16%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+LT + L G FG V+ VA+K + F E + + K+ H NLV
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLV 62
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG---SHEVLDRAKRYKIACSSARGL--- 296
L G C+ +V EYM NG L +LR G + +LD C + L
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD---VCEAMEYLESN 119
Query: 297 AFLHQ------------------DFGLARLISACETHVSTDIAGTLGYIPPE-YGQSRMS 337
F+H+ DFGLAR + + S + + PPE + SR S
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
++ DV+SFGV++ E+ + + F E V ++ + + A PT
Sbjct: 180 -SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA-----PT----- 228
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
++ I C + P RP +L L
Sbjct: 229 ------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 51/275 (18%)
Query: 194 GGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLG 246
G FG V+ A V VK + K + + F E++ K+ H+N+V LLG
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG 75
Query: 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV-----LDRAKRYKIACSSARGLA---- 297
C E ++ EY G L +LR E L ++ + A G+
Sbjct: 76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN 135
Query: 298 --FLHQDF------------------GLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
F+H+D L++ + E + + L ++ PE Q
Sbjct: 136 ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
+T+ DV+SFGV++ E+ T E ++E N + K++ +
Sbjct: 196 STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--AGKLELPVPEGCPS------- 246
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432
++ ++ C A NP RP+ ++ L E
Sbjct: 247 ------RLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 43/208 (20%)
Query: 190 ILEDGGFGTVYKATLPD-------GKTVAVKKFSQ-AKTQGHRQFTAEMETLGKVKHQNL 241
L G FG VY+ T D VAVK + A Q ++F E + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH---------EVLDRAKRYKIACSS 292
V LLG C +E + ++ E M G L +LR+A E+LD C
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 293 ARGLAFLHQ-----------------------DFGLARLISACETHVSTDIAGTLG--YI 327
+ F+H+ DFGLAR I + + + G L ++
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD-YYRKEGEGLLPVRWM 180
Query: 328 PPEYGQSRMSTTRGDVYSFGVILLELVT 355
PE TT+ DV+SFGV++ E++T
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 53/213 (24%)
Query: 189 DILEDGGFGTVYKATL-PDG--KTVAVKKFSQAKTQG-HRQFTAEMETLGKV-KHQNLVL 243
D++ +G FG V KA + DG A+K+ + ++ HR F E+E L K+ H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRN------------ATGSHEVLDRAKRYKIACS 291
LLG C L EY +G+L +LR A + L + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 292 SARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYI 327
ARG+ +L Q DFGL+R E +V T+G +
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK----TMGRL 185
Query: 328 PP-----EYGQSRMSTTRGDVYSFGVILLELVT 355
P E + TT DV+S+GV+L E+V+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 59/272 (21%), Positives = 109/272 (40%), Gaps = 53/272 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQFTA-EMETLGKVKHQNLV 242
++ L G +G+VYK L D + A+K+ + +Q R+ E+ L V H N++
Sbjct: 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 243 LLLGY--CSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
Y D KL +V EY G L + +++ + ++I RGL L
Sbjct: 63 ---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H+ D G++++ + T I GT Y+ PE + R
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPHYMAPEVWKGR 176
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ + D++S G +L E+ T P F+ + +L K+++ + + P + +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPP----FEARSMQDL----RYKVQRGKYPPI--PPIYS 226
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427
+ + ML++ P RP +L
Sbjct: 227 QDLQNFIRSMLQV-------KPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 194 GGFGTVY--KATLPDGK--TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYC 248
G FG V + LP + VA+K T+ R+ F +E +G+ H N++ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA---FLHQ---- 301
+ + ++V EYM NGSLD +LR G V+ + S + L+ ++H+
Sbjct: 75 TKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 134
Query: 302 --------------DFGLARLISACETHVSTDIAGTLG--YIPPEYGQSRMSTTRGDVYS 345
DFGL+R++ T G + + PE R T+ DV+S
Sbjct: 135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWS 194
Query: 346 FGVILLELVTAKE 358
+G+++ E+++ E
Sbjct: 195 YGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 41/207 (19%)
Query: 189 DILEDGGFGTVYKATLPDGKTVA---VKKF-SQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
D + +G FG V G + A VK+ + A F E++ ++ H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ- 301
LG C LLV E+ G L +LR+ G K ++AC A GL +LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 302 -----------------------DFGLARLISACETHVSTD--IAGTLGYIPPEYGQSRM 336
D+GLA L E + T A L ++ PE + R
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 337 S-------TTRGDVYSFGVILLELVTA 356
T + +++S GV + EL TA
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 37/193 (19%)
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFSQA-KTQGHRQFT-AEMETLGKVKHQNLVLLLGYCS 249
+G +G VYKA G+ VA+KK +++G + E++ L ++ H N++ LL
Sbjct: 9 EGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF- 67
Query: 250 FDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
+ L LV+E+M L G E L ++ Y++ GLAF H
Sbjct: 68 RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQ----GLAFCHSHGILHRD 123
Query: 302 -----------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGD 342
DFGLAR + T T Y PE G + +T D
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLG-DKGYSTPVD 181
Query: 343 VYSFGVILLELVT 355
++S G I EL++
Sbjct: 182 IWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 73/278 (26%), Positives = 114/278 (41%), Gaps = 52/278 (18%)
Query: 190 ILEDGGFGTVYKATL--PDGKTV--AVKKFSQ-AKTQGHRQFTAEMETLGKVKHQNLVLL 244
++ G FG VY TL DG+ + AVK ++ + QF E + H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 245 LGYCSFDE-EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
LG C E L+V YM +G L ++R+ T + V D A+G+ +L
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYLASKK 118
Query: 302 ----------------------DFGLARLISACE---THVSTDIAGTLGYIPPEYGQSRM 336
DFGLAR I E H T + ++ E Q++
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
TT+ DV+SFGV+L EL+T P P+ + ++ ++ Q + Q + DP
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQGRRLLQPEYCPDPLY--- 232
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
+ML C P RPT ++ + +I
Sbjct: 233 ---EVMLS-------CWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 53/207 (25%), Positives = 78/207 (37%), Gaps = 38/207 (18%)
Query: 185 LTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQ-AKTQGHRQFTAEMETLGKVK 237
+TL+ L G FG VY+ VAVK + Q F E + K
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL---RNATGSHEVLDRAKRYKIACSSAR 294
HQN+V L+G + ++ E M G L +L R L A A+
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 295 GLA------FLHQ---------------------DFGLARLISACETHVSTDIAG-TLGY 326
G F+H+ DFG+AR I + A + +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 327 IPPEYGQSRMSTTRGDVYSFGVILLEL 353
+PPE + T++ DV+SFGV+L E+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 79/309 (25%), Positives = 127/309 (41%), Gaps = 71/309 (22%)
Query: 177 MFQQPLLKLTLVDILEDGGFGTVYKATL--------PDGKTVAVKKFSQAKTQGH-RQFT 227
++ KLTL L +G FG V A + TVAVK T+
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 68
Query: 228 AEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN--------ATGSHE 278
+EME + + KH+N++ LLG C+ D ++ EY G+L +LR +
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 279 VLDRAKRYK--IACSS--ARGLAFL------HQ------------------DFGLARLIS 310
V D +K ++C+ ARG+ +L H+ DFGLAR ++
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 311 ACETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ 365
+ + T T G +P PE R+ T + DV+SFGV++ E+ T P
Sbjct: 189 NIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLH 425
+E +F+ +K+ +D MM++ DC P+ RPT
Sbjct: 245 VEE-------LFKLLKEGHR---MDKPANCTNELYMMMR------DCWHAIPSHRPTFKQ 288
Query: 426 VLKLLHEIV 434
+++ L I+
Sbjct: 289 LVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 61/208 (29%), Positives = 83/208 (39%), Gaps = 44/208 (21%)
Query: 185 LTLVDILEDGGFGTVYKAT---LPD--GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
L + L G FG+V L D G+ VAVKK + + R F E+E L ++H
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 240 NLVLLLGYC-SFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
N+V G C S L LV EY+ GSL +L+ E LD K A +G+
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGME 122
Query: 298 FL------HQDFGLARLISACETHVSTDIAGTLG------------------------YI 327
+L H+D ++ E V G G Y
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKI---GDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 328 PPEYGQSRMSTTRGDVYSFGVILLELVT 355
P +S+ S DV+SFGV+L EL T
Sbjct: 180 PESLTESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 39/210 (18%)
Query: 185 LTLVDILEDGGFGTVYKATLP-DGK--TVAVKKFSQ-AKTQGHRQFTAEMETLGKV-KHQ 239
+ D++ +G FG V +A + DG A+K + A HR F E+E L K+ H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNAT------------GSHEVLDRAKRYK 287
N++ LLG C + EY G+L +LR + G+ L + +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 288 IACSSARGLAFLHQDFGLARLISACETHVSTDIAG-----------------TLGYIPP- 329
A A G+ +L + + R ++A V ++A T+G +P
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 330 ----EYGQSRMSTTRGDVYSFGVILLELVT 355
E + TT+ DV+SFGV+L E+V+
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 59/204 (28%), Positives = 79/204 (38%), Gaps = 54/204 (26%)
Query: 194 GGFGTVYKA-TLPDGKTVAVKKF--SQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250
G +G VYKA G+ VA+KK K E++ L K++H N+V L
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIV-T 68
Query: 251 DEEK---LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR--------GLAFL 299
+ K +V+EYM DL TG +LD K S + GL +L
Sbjct: 69 SKGKGSIYMVFEYM---DHDL-----TG---LLDS-PEVKFTESQIKCYMKQLLEGLQYL 116
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQ 333
H DFGLAR + + T+ TL Y PPE G
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 334 SRMSTTRGDVYSFGVILLELVTAK 357
+R D++S G IL EL K
Sbjct: 177 TR-YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK-FSQAKT 220
SSS S + + L +L V+ + G GTVYK P G+ A+K + +
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED 113
Query: 221 QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL 280
RQ E+E L V H N+V + E ++ E+M GSL+ G+H +
Sbjct: 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTH-IA 165
Query: 281 DRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA----C 312
D +A G+A+LH+ DFG++R+++ C
Sbjct: 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 313 ETHVSTDIAGTLGYIPPE-----YGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361
+ V GT+ Y+ PE GD++S GV +LE + P G
Sbjct: 226 NSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 189 DILEDGGFGTVYKATLP-DG--KTVAVKKFSQ-AKTQGHRQFTAEMETLGKVKHQ-NLVL 243
D++ +G FG V KA + DG A+K+ + A HR F E+E L K+ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNAT------------GSHEVLDRAKRYKIACS 291
LLG C L EY +G+L +LR + + L + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 292 SARGLAFLHQDFGLARLISACETHVSTDIAG-----------------TLGYIPP----- 329
ARG+ +L Q + R ++A V + T+G +P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 180
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E + TT DV+S+GV+L E+V+
Sbjct: 181 ESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 58/210 (27%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKK-----FSQAKTQGHRQFTA--EMETLGKVK 237
L +G + VYKA G+ VA+KK +AK + FTA E++ L ++K
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELK 60
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL--DRAKRYKIACSSA-- 293
H N++ LL LV+E+M DL E + D++ A +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM---ETDL---------EKVIKDKSIVLTPADIKSYM 108
Query: 294 ----RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLG 325
RGL +LH DFGLAR + ++ + T
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 326 YIPPE--YGQSRMSTTRGDVYSFGVILLEL 353
Y PE +G +R D++S G I EL
Sbjct: 168 YRAPELLFG-ARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 57/215 (26%), Positives = 81/215 (37%), Gaps = 51/215 (23%)
Query: 194 GGFGTVY----KATLPDGKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLG 246
G +G V+ K+T G A+K +A Q E + L + + +V L
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 247 YCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
Y SF +K LV EY+ G L L N GS + D A+ Y IA L +LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDE-DVARIY-IA-EIVLALEYLHSNGI 114
Query: 302 ---------------------DFGLARL--------ISACETHVSTDIAGTLGYIPPEYG 332
DFGL+++ ++ E I GT YI PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYIAPEVI 173
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367
+ + D +S G IL E + P E E+
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 34/198 (17%)
Query: 191 LEDGGFGTVYKATLP-DGKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGY 247
+ G FG V+K D + A+K+ S+ + + E L K+ ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY--Y 65
Query: 248 CSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---- 301
SF ++ L V EY NG L L+ G L + ++ GLA LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 302 --------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG 341
D G+A+L+S T+ + I GT Y+ PE + + +
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 342 DVYSFGVILLELVTAKEP 359
DV++ GV+L E T K P
Sbjct: 183 DVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 48/197 (24%), Positives = 76/197 (38%), Gaps = 44/197 (22%)
Query: 193 DGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCS 249
+G +G V K G+ VA+KKF +++ + TA E++ L +++H+N+V L
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR 70
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
LV+EY+ L+L + G L + +A+ H
Sbjct: 71 RKGRLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPE-------YGQSRMST 338
DFG AR + A TD T Y PE YG+
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV--- 183
Query: 339 TRGDVYSFGVILLELVT 355
DV++ G I+ EL+
Sbjct: 184 ---DVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 47/207 (22%), Positives = 77/207 (37%), Gaps = 49/207 (23%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS- 249
G FGTV K DGK + K+ + + +Q +E+ L ++KH N+V Y
Sbjct: 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RYYDR 67
Query: 250 -FDEEKLLVY---EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA-------- 297
D +Y EY G L ++ + ++ ++I L
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 298 ---FLHQ------------------DFGLARLI----SACETHVSTDIAGTLGYIPPEYG 332
LH+ DFGLA+++ S +T+V GT Y+ PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQL 182
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G ++ EL P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 51/198 (25%), Positives = 82/198 (41%), Gaps = 25/198 (12%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
LT + L G FG V VA+K + + +F E + + K+ H+ LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH----EVLDRAKRYKIACSSARGLAFLH 300
G C+ +V EYM NG L +LR G ++L+ K + F+H
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 301 Q------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGD 342
+ DFGL+R + E S + + PPE +++ D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 343 VYSFGVILLELVT-AKEP 359
V++FGV++ E+ + K P
Sbjct: 184 VWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 68/267 (25%), Positives = 108/267 (40%), Gaps = 55/267 (20%)
Query: 194 GGFGTVYKA-TLPDGKTVAVKKFSQA----KTQGH-RQFTAEMETLGKVKHQNLVLLLGY 247
G FG+VY+ L DG AVK+ S A Q +Q E+ L K++H N+V LG
Sbjct: 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG- 69
Query: 248 CSFDEEKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301
+E+ L ++ E + GSL L+ E + R +I GL +LH
Sbjct: 70 TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI----LLGLEYLHDRNTVH 125
Query: 302 -------------------DFGLARLISACETHVSTDIAGTLGYIPPEY-GQSRMSTTRG 341
DFG+A+ + S G+ ++ PE Q
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGLAA 183
Query: 342 DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPM 401
D++S G +LE+ T K P V VF+ + ++ + P L+ +K
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPI--PDHLSDEAKDF 234
Query: 402 MLKMLRIAADCVADNPATRPTMLHVLK 428
+LK C+ +P+ RPT +L+
Sbjct: 235 ILK-------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 63/292 (21%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDG-------KTVAVKKFSQAKTQGHRQFTAEMETLGK 235
L L IL +G FG+V + L DG KT+ + + ++ + F +E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE---FLSEAACMKD 57
Query: 236 VKHQNLVLLLGYCSFDEEK------LLVYEYMVNGSLDLWL---RNATGSHEVLDRAKRY 286
H N++ L+G C +++ +M +G L +L R E L
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLL 116
Query: 287 KIACSSARGLA------FLHQD------------------FGLARLISACETHVSTDIAG 322
K A G+ F+H+D FGL++ I + + + IA
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 323 T-LGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381
+ +I E R+ T++ DV++FGV + E+ T + P + E + + +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY---LRHGNR 233
Query: 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+Q +D LD ++ + C +P RPT + ++L I
Sbjct: 234 LKQPEDCLD-------------ELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 50/202 (24%)
Query: 194 GGFGTVYKATL-PDGKTVAVKKFS-----QAKTQGHRQFTAEMETLGKVKHQNLVLLLGY 247
GGFG V + +T A+K + Q H +E E L + H +V L Y
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF--SEKEILEECNHPFIVKL--Y 59
Query: 248 CSF-DEEKL-LVYEYMVNGSLDLW--LRNATGSHEVLDRAK-RYKIACSSARGLAFLHQ- 301
+F D++ + ++ EY + G +LW LR + D R+ IAC +LH
Sbjct: 60 RTFKDKKYIYMLMEYCLGG--ELWTILR----DRGLFDEYTARFYIACV-VLAFEYLHNR 112
Query: 302 -----------------------DFGLARLI-SACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFG A+ + S +T GT Y+ PE ++
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 338 TTRGDVYSFGVILLELVTAKEP 359
D +S G++L EL+T + P
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 52/197 (26%), Positives = 77/197 (39%), Gaps = 50/197 (25%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCSF 250
G G V+KA G+TVA+KK + + +G A E++ L +H +V LL
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH 70
Query: 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR--------GLAFLHQ- 301
+LV EYM + EVL R + + + + G+A++H
Sbjct: 71 GSGFVLVMEYM-----------PSDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRM 336
DFGLARL S E + + T Y PE YG +R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-ARK 177
Query: 337 STTRGDVYSFGVILLEL 353
D+++ G I EL
Sbjct: 178 YDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 52/264 (19%)
Query: 194 GGFGTVYKAT--LPDGK--TVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYC 248
G FG+V K + GK VAVK Q G ++F E + ++ H +V L+G C
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL--------- 299
E +LV E G L +L+ + + ++A A G+A+L
Sbjct: 66 K-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120
Query: 300 -----------HQ----DFGLARLISACETHVSTDIAGT--LGYIPPEYGQSRMSTTRGD 342
HQ DFG++R + A + AG L + PE +++ D
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD 180
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402
V+S+GV L E + + E +GA ++ + + + ++ +M
Sbjct: 181 VWSYGVTLWEAFSYGAKP---YGEMKGAEVIAMLESGERLPRPEECPQEIY------SIM 231
Query: 403 LKMLRIAADCVADNPATRPTMLHV 426
L C P RPT +
Sbjct: 232 LS-------CWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 46/204 (22%)
Query: 193 DGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCS 249
+G +G V K + G+ VA+KKF +++ + A E+ L +++H+NLV L+
Sbjct: 11 EGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR 70
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ LV+E++ + LD + G E R ++I RG+ F H
Sbjct: 71 RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI----LRGIEFCHSHNIIHRDI 126
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPE-------YGQSRMST 338
DFG AR ++A V TD T Y PE YG++
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKYGRAV--- 182
Query: 339 TRGDVYSFGVILLELVTAKEPTGP 362
D+++ G ++ E++T EP P
Sbjct: 183 ---DIWAVGCLVTEMLTG-EPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 64/295 (21%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKTQGHR-QFTAEMETL 233
K+TL+ L G FG VY+ D VAVK +++ + R +F E +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 234 GKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR-------NATGSHEVLDRAKRY 286
++V LLG S + L+V E M +G L +LR N G + +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ-EMI 122
Query: 287 KIACSSARGLAFLHQDFGLARLISACETHVSTDIAGTLGY-------------------- 326
++A A G+A+L+ + R ++A V+ D +G
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 327 -----IPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKM 380
+ PE + + TT D++SFGV+L E+ + A++P +Q +
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-----------------YQGL 225
Query: 381 KKQQA-DDVLDPTVLN--AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432
+Q V+D L+ + ++R+ C NP RPT L ++ LL +
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 57/199 (28%), Positives = 83/199 (41%), Gaps = 28/199 (14%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN 240
P L L L G FG V+ AT VAVK + + F AE + ++H
Sbjct: 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDK 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
LV L + E ++ E+M GSL +L++ GS + L K + A G+AF+
Sbjct: 63 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE 119
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
Q DFGLAR+I E + + PE
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 337 STTRGDVYSFGVILLELVT 355
T + DV+SFG++L+E+VT
Sbjct: 180 FTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 64/280 (22%)
Query: 190 ILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ------FTAEMETLGKVKHQNLV 242
L G F + Y+A + G +AVK+ + + Q E+ + ++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
+LG D L E+M GS+ L E + ++ RGL++LH+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHEN 122
Query: 302 ------------------------DFGLARLISACET---HVSTDIAGTLGYIPPE---- 330
DFG A ++A T + GT+ ++ PE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 331 --YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
YG+S DV+S G +++E+ TAK P E + +N + +F+ A +
Sbjct: 183 EQYGRS------CDVWSVGCVIIEMATAKPPWNAE----KHSNHLALIFKIASATTAPSI 232
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
P L+ G + + L+ C+ P RP +LK
Sbjct: 233 --PEHLSPGLRDVTLR-------CLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 50/197 (25%), Positives = 76/197 (38%), Gaps = 40/197 (20%)
Query: 194 GGFGTVYKATLPDGKTV-AVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G FG V D K + A+K ++ K R E L ++ H LV L + S
Sbjct: 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--WYS 68
Query: 250 F-DEEKL-LVYEYMVNGSLDLWL-RNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301
F DEE + LV + ++ G L L + S E + K + C L +LH
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFW--ICEIVLALEYLHSKGIIH 123
Query: 302 -------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGD 342
DF +A ++ ++T +GT GY+ PE + + D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVD 181
Query: 343 VYSFGVILLELVTAKEP 359
+S GV E + K P
Sbjct: 182 WWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 85/302 (28%), Positives = 125/302 (41%), Gaps = 71/302 (23%)
Query: 184 KLTLVDILEDGGFGTVYKATL-------PDGKT-VAVKKF-SQAKTQGHRQFTAEMETLG 234
+L L L +G FG V A P+ T VAVK S A + +EME +
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 78
Query: 235 KV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR-----------NAT-GSHEVLD 281
+ KH+N++ LLG C+ D ++ EY G+L +LR N T E L
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 282 RAKRYKIACSSARGLAFL------HQ------------------DFGLARLISACETHVS 317
A ARG+ +L H+ DFGLAR I + +
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 318 TDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL 372
T T G +P PE R+ T + DV+SFGV+L E+ T P +E
Sbjct: 199 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 250
Query: 373 VGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432
+F+ +K+ D P+ N ++ M M+R DC P+ RPT +++ L
Sbjct: 251 ---LFKLLKEGHRMD--KPS--NCTNELYM--MMR---DCWHAVPSQRPTFKQLVEDLDR 298
Query: 433 IV 434
I+
Sbjct: 299 IL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 51/294 (17%)
Query: 178 FQQPLLKLTLVDILEDGGFGTV----YKATLPD-GKTVAVKKFSQAKTQGHRQ-FTAEME 231
F + LK + +L +G FG V Y G+ VAVK + Q + + E+
Sbjct: 1 FHKRYLKK--IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 232 TLGKVKHQNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWL-RNATGSHEVLDRAKRYKI 288
L + H+N+V G CS K L+ EY+ GSL +L ++ ++L A++
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI-- 116
Query: 289 ACSSARGLAFLHQ------------------------DFGLARLISACETH--VSTDIAG 322
G+A+LH DFGLA+ + + V D
Sbjct: 117 ----CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT---AKEPTGPEFQEKEGANLVGWVFQK 379
+ + E + + DV+SFGV L EL+T +K+ +F+E ++G +
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-----MIGPKQGQ 227
Query: 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
M + ++L+ + K ++ + +C RPT ++ +L E+
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 60/269 (22%), Positives = 106/269 (39%), Gaps = 45/269 (16%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKK---FSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G F VYKA L DG+ VA+KK F + + E++ L ++ H N++ L
Sbjct: 13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ E +V E G L +++ ++ +K L +H
Sbjct: 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDI 132
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYS 345
D GL R S+ +T + + GT Y+ PE + D++S
Sbjct: 133 KPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 346 FGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKM 405
G +L E+ + P F + NL + +K++K P + S+
Sbjct: 192 LGCLLYEMAALQSP----F-YGDKMNLYS-LCKKIEKCD----YPPLPADHYSEE----- 236
Query: 406 LR-IAADCVADNPATRPTMLHVLKLLHEI 433
LR + + C+ +P RP + +VL++ E+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 57/232 (24%)
Query: 176 SMFQQPLLKLTLVDILEDGGFGTVYKA-------TLPD-GKTVAVKKFS-QAKTQGHRQF 226
++ P +L L L +G FG V +A + PD TVAVK A +
Sbjct: 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL 64
Query: 227 TAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR-----------NAT 274
+EME + + KH+N++ LLG C+ + ++ EY G+L +LR + T
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 275 GSHEVLDRAKRYKIACS--SARGLAFLHQ------------------------DFGLARL 308
E K ++C+ ARG+ +L DFGLAR
Sbjct: 125 KVPEEQLSFKDL-VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 309 ISACETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+ + + T + G +P PE R+ T + DV+SFG+++ E+ T
Sbjct: 184 VHDIDYYKKT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 41/206 (19%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTV----AVKKFSQAK-TQGHRQFTAEMETLGKVK 237
+L V +L G FGTVYK +P+G+TV A+K ++ + + +F E + +
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL---RNATGSHEVLDRAKRYKIACSSAR 294
H +LV LLG C LV + M +G L ++ ++ GS +L+ + A+
Sbjct: 68 HPHLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGT-LGYIPP 329
G+ +L + DFGLARL+ E + D + ++
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R T + DV+S+GV + EL+T
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 49/197 (24%), Positives = 78/197 (39%), Gaps = 50/197 (25%)
Query: 193 DGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
+G G VYKAT GK VA+KK K E+ + KH N+V
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYLVG 87
Query: 252 EEKLLVYEYMVNGSL-DLWLRN---------ATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
+E +V EYM GSL D+ +N A EVL +GL +LH
Sbjct: 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-------------QGLEYLHS 134
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFG A ++ ++ ++ + GT ++ PE + +
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDY 193
Query: 338 TTRGDVYSFGVILLELV 354
+ D++S G++ +E+
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 33/205 (16%)
Query: 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMET--LGKVKHQN 240
+ ++ + +G FG +Y A D + +K+ K + ++ E L K+KH N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 241 LVLLLGYCSFDEEKLL--VYEYMVNGSL------------------DLWLRNATGSHEVL 280
+V + SF E L V EY G L +++ + G +
Sbjct: 61 IVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 281 DRA------KRYKIACSSARGLAFLHQDFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
DR K I S +A L DFG+AR ++ ++ GT Y+ PE Q+
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKL-GDFGIARQLND-SMELAYTCVGTPYYLSPEICQN 176
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
R + D++S G +L EL T K P
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 28/189 (14%)
Query: 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKVKHQNLVLLLGY 247
++L G FG V+K TL D VAVK + Q + +F +E L + H N+V L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH------- 300
C+ + +V E + G +LR + L + K A +A G+A+L
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 301 -----------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDV 343
DFG++R S + + PE ++ DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 344 YSFGVILLE 352
+S+G++L E
Sbjct: 178 WSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 56/203 (27%), Positives = 81/203 (39%), Gaps = 44/203 (21%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQFTA-EMETLGKVK---HQNL 241
+ + +G +GTVYKA L G+ VA+KK +G T E+ L +++ H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 242 VLLLGYCSF--DEEKL---LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
V LL C + +L LV+E+ V+ L +L L + RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKP--GLPPETIKDLMRQLLRGV 120
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE-- 330
FLH DFGLAR+ S T + TL Y PE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVL 178
Query: 331 YGQSRMSTTRGDVYSFGVILLEL 353
S + D++S G I EL
Sbjct: 179 LQSSYATPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 39/206 (18%)
Query: 189 DILEDGGFGTVYKATLPDGKTVAVKKFS------QAKTQGHRQFTAEMETLGKVKHQNLV 242
++L G +GTVY G+ +AVK+ A + + + E++ L +KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LG C D + E++ GS+ L E + +I G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNN 121
Query: 302 -----------------------DFGLARLISACETHVS-----TDIAGTLGYIPPEYGQ 333
DFG AR ++ H + + GT ++ PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G + E+ T K P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 51/215 (23%), Positives = 81/215 (37%), Gaps = 45/215 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNL 241
K+ + L +G G+V K L + + K +Q E+E K +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 242 VLLLGYCSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRY------KIACSSA 293
V G + + EY GSLD + +V R R KIA S
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYK------KVKKRGGRIGEKVLGKIAESVL 115
Query: 294 RGLAFLHQ------------------------DFGLA-RLISACETHVSTDIAGTLGYIP 328
+GL++LH DFG++ L+++ ++ GT Y+
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMA 171
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363
PE Q + + DV+S G+ LLE+ + P PE
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 28/196 (14%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+LT + L G FG V+ VA+K ++ F E + + K+ H LV
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQ 63
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L G C+ + +V E+M NG L +LR G L + + G+ +L +
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFG+ R + E S+ + + PPE ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 340 RGDVYSFGVILLELVT 355
+ DV+SFGV++ E+ T
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNL 241
L KLTL +I+ +G FG V + G+ VAVK T + F E + K+ H+NL
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNL 61
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V LLG +V E M G+L +LR T ++ + + + A G+ +L
Sbjct: 62 VRLLGVI-LHNGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 302 DFGLARLISACETHVSTDI-----------AGTLG---------YIPPEYGQSRMSTTRG 341
+ R ++A VS D G++G + PE + + +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178
Query: 342 DVYSFGVILLELVTAKEPTGPEFQEKE 368
DV+S+GV+L E+ + P+ KE
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKE 205
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 38/203 (18%)
Query: 190 ILEDGGFGTVYKATLPD-GKTVAVKKF----SQAKTQGH-RQFTAEMETLGKVKHQNLVL 243
+L G FG VY D G+ +AVK+ +T+ E++ L ++H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 244 LLGYCSFDEEKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
G C D+E L ++ EYM GS+ L+ E + R +I G+ +LH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN 123
Query: 302 -----------------------DFGLARLISA--CETHVSTDIAGTLGYIPPEYGQSRM 336
DFG ++ + + GT ++ PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 337 STTRGDVYSFGVILLELVTAKEP 359
+ DV+S G ++E++T K P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 184 KLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQN 240
K ++ + +G +G VYKA D G+ VA+KK + TA E++ L ++ H+N
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 241 LVLLLGYC-----SFDEEK-----LLVYEYM---VNGSLDLWLRNATGSHEVLDRAKRYK 287
+V L + D +K LV+EYM + G L+ L + + H + K+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-IKSFMKQLL 126
Query: 288 IACSSARGLAFLHQD------------------FGLARLISACETHVSTDIAGTLGYIPP 329
+ FLH+D FGLARL ++ E+ T+ TL Y PP
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 330 E--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ 365
E G+ R DV+S G IL EL T K P FQ
Sbjct: 187 ELLLGEERYGPAI-DVWSCGCILGELFTKK----PIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 38/209 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKT-----VAVKKFSQ--AKTQGHRQFTAEMETLGKV 236
++TL D+L++G FG ++ L D K V VK ++ Q L +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC-LLYGL 65
Query: 237 KHQNLVLLLGYCSFDEEKLLV-YEYMVNGSLDLWLRNA----TGSHEVLDRAKRYKIACS 291
HQN++ +L C D E V Y YM G+L L+L+ + + L + +A
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 292 SARGLAFLHQDFGLARLISA-------------CETHVSTDI----AGTLG--------Y 326
A G+++LH+ + + I+A + +S D+ LG +
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 327 IPPEYGQSRMSTTRGDVYSFGVILLELVT 355
+ E ++ ++ DV+SFGV+L EL+T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 66/288 (22%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGH-RQFTAEMETLG 234
PL + ++ L + FG +YK L + VA+K +F E +
Sbjct: 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA 62
Query: 235 KVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV-------------LD 281
++ H N+V LLG + ++ +++EY+ G L +L + +V LD
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 282 RAKRYKIACSSARGLA------FLHQ------------------DFGLARLISACETH-V 316
IA A G+ F+H+ D GL+R I + + + V
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 317 STDIAGTLGYIPPE---YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV 373
+ ++PPE YG+ ++ D++SFGV+L E+ + F +E
Sbjct: 183 QPKSLLPIRWMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----- 234
Query: 374 GWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRP 421
V + ++K+Q L S+ +M + +C + P+ RP
Sbjct: 235 --VIEMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 60/298 (20%), Positives = 100/298 (33%), Gaps = 100/298 (33%)
Query: 189 DILEDGGFGTVYKATL-PDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVK-HQNLVL 243
I+ +G F TV A K A+K + K + + E E L ++ H ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 244 LLGYCSF-DEEKL-LVYEYMVNGSLDLW--LRNATG---------SHEVLDRAKRYKIAC 290
L Y +F DEE L V EY NG +L +R + E+L
Sbjct: 67 L--YYTFQDEENLYFVLEYAPNG--ELLQYIRKYGSLDEKCTRFYAAEILL--------- 113
Query: 291 SSARGLAFLHQ------------------------DFGLARLISACETHVSTDIA----- 321
L +LH DFG A+++ + S
Sbjct: 114 ----ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 322 --------------GTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP--TGPEFQ 365
GT Y+ PE + + D+++ G I+ +++T K P E+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423
FQK+ K + P +K ++ K+L + +P R +
Sbjct: 230 ----------TFQKILKLE---YSFPPNFPPDAKDLIEKLLVL-------DPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 62/271 (22%)
Query: 194 GGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQ----------FTAEMETLGKVKHQNLV 242
G +G VY A + G+ +AVK+ T R +E+ETL + H N+V
Sbjct: 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71
Query: 243 LLLGYCSFDEEKLLVY----EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
LG+ E EY+ GS+ LR E L R ++ GLA+
Sbjct: 72 QYLGF----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAY 123
Query: 299 LHQ------------------------DFGLARLISACETHVS-TDIAGTLGYIPPE--Y 331
LH DFG+++ + + G++ ++ PE +
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
S+ + + D++S G ++LE+ + P E + +F+ K+ A +
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLGNKRSAPPIPPD 236
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPT 422
+N P+ L L C NP RPT
Sbjct: 237 VSMNL--SPVALDFLN---ACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + L L L N+++ +P + L L +L+L+ N + +SL NLK L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
S L+LS+N P S+GNLS LDL +N+ + +LG+L L LD+ N L
Sbjct: 235 SGLELSNNKL-EDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSN 291
Query: 124 KIPEKI----CKSRLEGLVSQS-GICQNLSKISLAGNKDYNLYLSSS 165
+P L L+ + L+ I L N N SS
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSP 338
|
Length = 394 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 55/223 (24%)
Query: 184 KLTLVDILEDGGFGTVYKATL--------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLG 234
+LTL L +G FG V A TVAVK T + +EME +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 235 KV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL--RNATGSHEVLDRAK------- 284
+ KH+N++ LLG C+ D ++ EY G+L +L R G D K
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 285 -RYKIACS--SARGLAFL------HQ------------------DFGLARLISACETHVS 317
+ ++C+ ARG+ +L H+ DFGLAR + + +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 318 TDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
T T G +P PE R+ T + DV+SFGV+L E+ T
Sbjct: 193 T----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 4e-07
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P K T + + G GTV+ A + G+ VA+K+ + K E+ + ++K+
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP 76
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L +E +V EY+ GSL + +D A+ + + L FL
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSL-----TDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 300 H------------------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG I+ ++ ST + GT ++ PE +
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G++ +E+V + P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 57/279 (20%)
Query: 187 LVDILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQF-TAEMETLGKVKHQNLVLL 244
L++++ G VY A LP+ + VA+K+ K Q E++ + + H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 245 LGYCSF--DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIAC---SSARGLAFL 299
Y SF +E LV Y+ GSL ++++ LD A IA +GL +L
Sbjct: 65 --YTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAI---IATVLKEVLKGLEYL 118
Query: 300 HQ------------------------DFGLARLISA---CETHVSTDIAGTLGYIPPEYG 332
H DFG++ ++ V GT ++ PE
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 333 QSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
+ + D++SFG+ +EL T P K V M Q DP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VL--MLTLQN----DP 224
Query: 392 TVL--NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
L A K ++ + C+ +P+ RPT +LK
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 58/210 (27%), Positives = 85/210 (40%), Gaps = 39/210 (18%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPD-GKT-----VAVKKFSQAKTQGHRQ-FTAE---M 230
P L+ L G FG V +AT K+ VAVK R+ +E M
Sbjct: 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 231 ETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIAC 290
LG H+N+V LLG C+ L++ EY G L +LR L +
Sbjct: 93 SHLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSY 148
Query: 291 SSARGLAFL------HQ------------------DFGLARLISACETHVSTDIAG-TLG 325
A+G+AFL H+ DFGLAR I +V A +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 326 YIPPEYGQSRMSTTRGDVYSFGVILLELVT 355
++ PE + + T DV+S+G++L E+ +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 36/200 (18%)
Query: 188 VDILEDGGFGTVYKA-TLPDGKTVAVKKFS-QAKTQGHRQFTA--EMETLGKVKHQNLVL 243
V+ + +G +G VYKA G+ VA+KK +T+G TA E+ L ++ H N+V
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNHPNIVK 63
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
LL + + LV+E++ + L ++ + S L K Y GLAF H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ--GLAFCHSHR 120
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMS 337
DFGLAR + ++ TL Y PE G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG-CKYY 178
Query: 338 TTRGDVYSFGVILLELVTAK 357
+T D++S G I E+VT +
Sbjct: 179 STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 56/193 (29%), Positives = 84/193 (43%), Gaps = 36/193 (18%)
Query: 191 LEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGY 247
L +G + TVYK + +GK VA+K + +G FTA E L +KH N+VLL
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
E LV+EY+ ++ G H + K + RGL+++HQ
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHP--ENVKLFLFQL--LRGLSYIHQRYILHR 127
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRG 341
DFGLAR S +H ++ TL Y PP+ G + ST
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGSTEYSTCL- 185
Query: 342 DVYSFGVILLELV 354
D++ G I +E++
Sbjct: 186 DMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 9e-07
Identities = 72/292 (24%), Positives = 114/292 (39%), Gaps = 85/292 (29%)
Query: 191 LEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--------EMETLGKVK-HQN 240
L DG FG+VY A G+ VA+KK + +F + E+++L K+ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHPN 59
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH--EVLDRAKRYKIACSSARGLAF 298
+V L ++E V+EYM G+L +++ G E + R+ Y+I GLA
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ----GLAH 114
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE-YGQ 333
+H+ DFGLAR I + + TD T Y PE +
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEILLR 172
Query: 334 SRMSTTRGDVYSFGVILLELVTAK--------------------EPTGPEFQEKEGANLV 373
S ++ D+++ G I+ EL T + PT ++ EG L
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW--PEGYKLA 230
Query: 374 ---GWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT 422
G+ F + ++ P ++ MLR +P RPT
Sbjct: 231 SKLGFRFPQFAPTSLHQLI-PNASPEAID-LIKDMLRW-------DPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 65/279 (23%), Positives = 115/279 (41%), Gaps = 48/279 (17%)
Query: 185 LTLVDILEDGGFGTVYKA--TLPDGKT--VAVKKF-SQAKTQGHRQFTAEMETLGKVKHQ 239
+ + IL G FG + + LP + VA+ + + R F AE TLG+ H
Sbjct: 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS 66
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L G + ++V EYM NG+LD +LR G L + + A G+ +L
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL 123
Query: 300 HQDFGLARLISACETHVSTDIA------------------GTLG------YIPPEYGQSR 335
+ + + ++A + V++D+ T+ + PE Q
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
++ DV+SFG+++ E+++ + E+ ++ G Q + K D P N
Sbjct: 184 HFSSASDVWSFGIVMWEVMS--------YGERPYWDMSG---QDVIKAVEDGFRLPAPRN 232
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
P +L L + DC RP + +L ++V
Sbjct: 233 C---PNLLHQLML--DCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 38/194 (19%)
Query: 191 LEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGY 247
L +G + TVYK + +G+ VA+K S +G FTA E L +KH N+VLL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
E V+EYM +++ G H R +++ RGLA++H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL----LRGLAYIHGQHILHR 127
Query: 302 ------------------DFGLARLIS-ACETHVSTDIAGTLGYIPPE--YGQSRMSTTR 340
DFGLAR S +T+ S + TL Y PP+ G + S+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSAL 185
Query: 341 GDVYSFGVILLELV 354
D++ G I +E++
Sbjct: 186 -DIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 66/273 (24%), Positives = 105/273 (38%), Gaps = 57/273 (20%)
Query: 190 ILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYC 248
+L G +G VY A L +A+K+ + ++ + E+ +KH+N+V LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
S + + E + GSL LR+ G + ++ + GL +LH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEGLKYLHDNQIVHRD 133
Query: 302 ------------------DFG----LARLISACETHVSTDIAGTLGYIPPE---YGQSRM 336
DFG LA + ET GTL Y+ PE G R
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPEVIDKGP-RG 187
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL-VGWVFQKMKKQQADDVLDPTVLN 395
D++S G ++E+ T K P E E + A VG M K + P L+
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMFKVG-----MFKIHPE---IPESLS 238
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
A +K +L+ C +P R + +L+
Sbjct: 239 AEAKNFILR-------CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 53/264 (20%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSF 250
G FG V+ D K V +K+ + T+ R E + L + H N++ Y +F
Sbjct: 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY--YENF 68
Query: 251 DEEKLL--VYEYMVNGSLDLWLRNATGS----HEVLDRAKRYKIACSSARGLAFLHQD-- 302
E+K L V EY G+L +++ S +L + +A LH+D
Sbjct: 69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLK 128
Query: 303 -----------------FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYS 345
FG+++++S+ ++ T + GT YI PE + + + D+++
Sbjct: 129 TQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPELCEGKPYNQKSDIWA 186
Query: 346 FGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA--DDVLDPTVLNAGSKPMML 403
G +L EL + K + E ANL V + M A D P + + ++L
Sbjct: 187 LGCVLYELASLK-------RAFEAANLPALVLKIMSGTFAPISDRYSPDL-----RQLIL 234
Query: 404 KMLRIAADCVADNPATRPTMLHVL 427
ML + +P+ RP + ++
Sbjct: 235 SMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 22/56 (39%), Positives = 36/56 (64%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS 56
L+G IP+ F + L L L NQL+G IP++LG + LV++N++ N G +P++
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 14 KLQGLYLGNNQLTGSIPRSLG-QLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN- 71
L L L NN +T IP +G L +L+L+ NK +P+ L NL L +LDLS N
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174
Query: 72 FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM----------L 121
D P+ L NLS LDL NK ++P + L+ LE LD+ N L
Sbjct: 175 LSDL--PKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSIIELLSSLSNL 231
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK----DY--------NLYLSSSRSKG 169
++ ++LE L G NL + L+ N+ L LS +
Sbjct: 232 KNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291
Query: 170 PLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPD 206
L + + L L L+ L+ +
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNN 328
|
Length = 394 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 30/200 (15%)
Query: 185 LTLVDILEDGGFGTVYKAT-LPDGKTVAVKK-FSQAKTQGHRQFTAEMETLGKVKHQNLV 242
L + L G G+V K +P G +A K AK+ +Q E++ + + + +V
Sbjct: 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG-SHEVLDRAKRYKIACSSARGLAFL-- 299
G + + E+M GSLD + E+L KIA + GL +L
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN 121
Query: 300 -----HQD-------FGLARLISACETHVSTDI--------AGTLGYIPPEYGQSRMSTT 339
H+D I C+ VS ++ GT Y+ PE Q T
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 340 RGDVYSFGVILLELVTAKEP 359
+ DV+S G+ ++EL K P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 41/202 (20%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKT----VAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNL 241
+ +L G FGTVYK +P+G+ VA+K+ +A + + +++ E + V + ++
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLR---NATGSHEVLDRAKRYKIACSSARGLAF 298
LLG C L+ + M G L ++R + GS +L+ + A+G+ +
Sbjct: 72 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 124
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGT-LGYIPPEYGQ 333
L + DFGLA+L+ A E + + ++ E
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 334 SRMSTTRGDVYSFGVILLELVT 355
R+ T + DV+S+GV + EL+T
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 45/197 (22%)
Query: 193 DGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCS 249
+G +G V+K + G+ VA+KKF +++ + A E+ L ++KH NLV L+
Sbjct: 11 EGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR 70
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ LV+EY + L+ +N G E L + KI + + + F H+
Sbjct: 71 RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK----KIIWQTLQAVNFCHKHNCIHRDV 126
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPE-------YGQSRMST 338
DFG AR+++ TD T Y PE YG
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELLVGDTQYGPPV--- 182
Query: 339 TRGDVYSFGVILLELVT 355
DV++ G + EL+T
Sbjct: 183 ---DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 44/213 (20%)
Query: 181 PLLKLTLVDILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P L+ + G +G VYKA + G+ VA+K E+ L + +H
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHP 60
Query: 240 NLVLLLG-YCSFDEEKL-LVYEYMVNGSL-DLWLRNATGSHEVLDRAKRYKIA---CSSA 293
N+V G Y +KL +V EY GSL D++ E+ IA +
Sbjct: 61 NIVAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------IAYVCRETL 111
Query: 294 RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPP 329
+GLA+LH+ DFG++ ++A + I GT ++ P
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAP 170
Query: 330 EYGQSRMS---TTRGDVYSFGVILLELVTAKEP 359
E + D+++ G+ +EL + P
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 41/195 (21%), Positives = 78/195 (40%), Gaps = 27/195 (13%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQ 239
+TL + +G FG VY+ + VAVK + R+ F E + + H
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL---RNATGSHEVLDRAKRYKIACSSARGL 296
++V L+G + + +V E G L +L + + ++ + + A +
Sbjct: 68 HIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 297 AFLHQ------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
F+H+ DFGL+R + + ++ + ++ PE R T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 339 TRGDVYSFGVILLEL 353
+ DV+ FGV + E+
Sbjct: 187 SASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 52/271 (19%), Positives = 103/271 (38%), Gaps = 53/271 (19%)
Query: 188 VDILEDGGFG--TVYKATLPDGKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+ +L G FG T+Y+ T D V K+ ++ + R E+ L ++H N++
Sbjct: 5 IRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 244 LLGYCSFDEEKLLV--YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
F ++ L+ EY G+L + G + Y SA ++++H+
Sbjct: 64 YYN--HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHK 119
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFG+++++ + E ++ + GT Y+ PE Q
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPYYMSPELCQGVKY 178
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
+ D+++ G +L EL+T K + N + V + ++ V
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTF-------DATNPLNLVVKIVQGNYTPVV--------- 222
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+++ + + +P RPT VL
Sbjct: 223 -SVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 65/275 (23%), Positives = 106/275 (38%), Gaps = 63/275 (22%)
Query: 191 LEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCS 249
L DG FG VYKA + +A K + K++ + + E+E L H +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRA---KRYKIACSSA-RGLAFLHQ---- 301
+D + ++ E+ G++D + LDR + ++ C L +LH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLE-------LDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 302 --------------------DFGL-ARLISACETHVSTDIAGTLGYIPPEYGQSR-MSTT 339
DFG+ A+ + + S GT ++ PE M T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 340 ----RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ D++S G+ L+E+ EP E V K+ K +P L+
Sbjct: 191 PYDYKADIWSLGITLIEMAQI-EPPHHELNPMR-------VLLKIAKS------EPPTLS 236
Query: 396 AGSK--PMMLKMLRIAADCVADNPATRPTMLHVLK 428
SK L+ A D +P TRP+ +L+
Sbjct: 237 QPSKWSMEFRDFLKTALD---KHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 45/206 (21%)
Query: 194 GGFGTVYKA-TLPDGKTVAVKKF------SQAKTQGHRQFTA---EMETLGKVKHQNLVL 243
G FG+VY G+ +AVK+ + +K + A E+ L +++H+N+V
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70
Query: 244 LLGYCSFDEEKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH-- 300
LG S D + L ++ EY+ GS+ L N E L R +I +GL +LH
Sbjct: 71 YLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLHNR 125
Query: 301 ----------------------QDFGLARLISACETHVSTDIA-----GTLGYIPPEYGQ 333
DFG+++ + A T+ A G++ ++ PE +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEP 359
T + D++S G +++E++T K P
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 38/257 (14%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKT----VAVKKFSQAKT-QGHRQFTAEMETLGKVK 237
+L V +L G FGTVYK +PDG+ VA+K + + + +++ E + V
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR---NATGSHEVLDRAKRYKIACSSAR 294
+ LLG C LV + M G L ++R + GS ++L+ + S
Sbjct: 68 SPYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 295 GLAFLHQD------------------FGLARLISACETHVSTDIAGT-LGYIPPEYGQSR 335
+ +H+D FGLARL+ ET D + ++ E R
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
T + DV+S+GV + EL+T +E +L+ ++ + + P +
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---------EKGERLPQPPICT 237
Query: 396 AGSKPMMLKMLRIAADC 412
+M+K I ++C
Sbjct: 238 IDVYMIMVKCWMIDSEC 254
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 6e-06
Identities = 20/58 (34%), Positives = 27/58 (46%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN 71
L+ L L NN+LT + L L L+L+ N + P + L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 67/270 (24%), Positives = 101/270 (37%), Gaps = 63/270 (23%)
Query: 191 LEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLL 245
L DG FG V + GK VAVK K F E + + H+NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 246 GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---- 301
G ++V E GSL LR H ++ Y A A G+ +L
Sbjct: 63 GVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLESKRFI 119
Query: 302 --------------------DFGLARLISACETHVSTDIAGTL--GYIPPEYGQSRMSTT 339
DFGL R + E H + + + PE ++R +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179
Query: 340 RGDVYSFGVILLELVT-AKEP----TGPEFQEKEGANLVGWVFQKMKKQQA--DDVLDPT 392
DV+ FGV L E+ T +EP +G + +K +++++ +A D+ +
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERLERPEACPQDIYN-- 232
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPT 422
+ML+ C A NPA RPT
Sbjct: 233 --------VMLQ-------CWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 31/204 (15%)
Query: 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P K T + + G GTVY A + G+ VA+K+ + + E+ + + KH
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP 76
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L +E +V EY+ GSL + +D + + + L FL
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFL 131
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG I+ ++ ST + GT ++ PE +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G++ +E+V + P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 53/195 (27%), Positives = 72/195 (36%), Gaps = 34/195 (17%)
Query: 194 GGFGTVYKATLPD-GKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
GGFG V + GK A KK + K +G + E + L KV ++ L Y
Sbjct: 4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAF 62
Query: 250 FDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQDFGLA 306
++ L LV M G L + N RA Y +I C GL LHQ +
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC----GLEHLHQRRIVY 118
Query: 307 R-------------------LISACETHVSTDI---AGTLGYIPPEYGQSRMSTTRGDVY 344
R L A E I AGT GY+ PE Q + D +
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWF 178
Query: 345 SFGVILLELVTAKEP 359
+ G L E++ + P
Sbjct: 179 ALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 56/204 (27%), Positives = 83/204 (40%), Gaps = 54/204 (26%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGYCS 249
G FG VY A + + VA+KK S + Q + ++ E+ L +++H N + G C
Sbjct: 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG-CY 84
Query: 250 FDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIA--CSSA-RGLAFLHQ---- 301
E LV EY + + D+ + EV +IA C A +GLA+LH
Sbjct: 85 LREHTAWLVMEYCLGSASDILEVHKKPLQEV-------EIAAICHGALQGLAYLHSHERI 137
Query: 302 --------------------DFGLARLISACETHVSTDIAGTLGYIPPEY------GQSR 335
DFG A L+S + V GT ++ PE GQ
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQY- 191
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ DV+S G+ +EL K P
Sbjct: 192 --DGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 53/200 (26%), Positives = 77/200 (38%), Gaps = 40/200 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQ---FTAEMETLGKVKHQN 240
+ L G FG V GK A+K S+AK +Q E L ++H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 241 LVLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
LV L G SF D+ L LV EY+ G L LR + G A+ Y A L +
Sbjct: 63 LVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKS-GRFP-EPVARFY--AAQVVLALEY 116
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
LH DFG A+ + + T + GT Y+ PE S
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPEIILS 172
Query: 335 RMSTTRGDVYSFGVILLELV 354
+ D ++ G+++ E++
Sbjct: 173 KGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361
DFG ARL+++ + T + GT Y+PPE ++ + D++S G IL EL T K P
Sbjct: 143 DFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP-- 199
Query: 362 PEFQEKEGANLV 373
FQ NL+
Sbjct: 200 --FQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 60/237 (25%), Positives = 91/237 (38%), Gaps = 68/237 (28%)
Query: 194 GGFGTVYKA---TLPDGKTVAVKKFSQAKTQ--GHRQFTA-EMETLGKVKHQNLVLLLGY 247
G +G VYKA DGK A+KKF K Q G Q E+ L ++KH+N+V L+
Sbjct: 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV 70
Query: 248 CSFDEEKL--LVYEYMVNGSLDLW----LRNATGSHEVLDRAKR---YKIACSSARGLAF 298
+K L+++Y DLW + + ++I G+ +
Sbjct: 71 FLEHADKSVYLLFDY---AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN----GVHY 123
Query: 299 LHQ----------------------------DFGLARLI-SACETHVSTD-IAGTLGYIP 328
LH D GLARL + + D + T+ Y
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 329 PE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
PE G +R T D+++ G I EL+T + P F+ +E K+KK
Sbjct: 184 PELLLG-ARHYTKAIDIWAIGCIFAELLTLE----PIFKGRE---------AKIKKS 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 33/196 (16%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKK---FSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G F VY+AT L DG VA+KK F + E++ L ++ H N++ Y S
Sbjct: 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY--YAS 70
Query: 250 FDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
F E+ L V E G L +++ ++ +K L +H
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDV 343
D GL R S+ +T + + GT Y+ PE + D+
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189
Query: 344 YSFGVILLELVTAKEP 359
+S G +L E+ + P
Sbjct: 190 WSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 44/194 (22%), Positives = 73/194 (37%), Gaps = 29/194 (14%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKK---FSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G F VY+AT L D K VA+KK F + + E++ L ++ H N++ L
Sbjct: 13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
D E +V E G L ++ ++ +K + +H
Sbjct: 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDI 132
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYS 345
D GL R S+ +T + + GT Y+ PE + D++S
Sbjct: 133 KPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 346 FGVILLELVTAKEP 359
G +L E+ + P
Sbjct: 192 LGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 40/199 (20%)
Query: 194 GGFGTVYKATLPDGKTVAVKKFS--QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
G G V K + +K + K Q E++ L + +V G D
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY------KIACSSARGLAFL------ 299
E + E+M GSLD +VL AKR K++ + RGLA+L
Sbjct: 76 GEISICMEHMDGGSLD----------QVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 300 -HQDFGLARL-------ISACETHVSTDI--------AGTLGYIPPEYGQSRMSTTRGDV 343
H+D + + I C+ VS + GT Y+ PE Q + + D+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 344 YSFGVILLELVTAKEPTGP 362
+S G+ L+EL + P P
Sbjct: 186 WSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 31/204 (15%)
Query: 181 PLLKLTLVDILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P K T + + G GTVY A + G+ VA+K+ + + E+ + + K+
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP 76
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L +E +V EY+ GSL + +D + + + L FL
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG I+ ++ ST + GT ++ PE +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G++ +E+V + P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 36/208 (17%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVK---KFSQAKT--QGHRQFTAEMETLGKVK 237
+L + +L G FGTV+K +P+G ++ + K Q ++ Q ++ T M +G +
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H +V LLG C +L V + GSL +R S LD + A+G+
Sbjct: 68 HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS---LDPQRLLNWCVQIAKGMY 123
Query: 298 FLHQ------------------------DFGLARLISACET-HVSTDIAGTLGYIPPEYG 332
+L + DFG+A L+ + + ++ + ++ E
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 333 QSRMSTTRGDVYSFGVILLELVT-AKEP 359
T + DV+S+GV + E+++ EP
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 34/196 (17%)
Query: 191 LEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGY 247
L +G + TVYK G+ VA+K+ +G TA E+ + ++KH+N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS-TAIREISLMKELKHENIVRLHDV 66
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
+ + +LV+EYM + L ++ + G LD +G+AF H+
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRG 341
DFGLAR S ++ TL Y P+ G SR +T
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG-SRTYSTSI 182
Query: 342 DVYSFGVILLELVTAK 357
D++S G I+ E++T +
Sbjct: 183 DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 41/203 (20%)
Query: 187 LVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLL 245
+++ L +G +G+VYKA G+ VA+K + ++ E+ L + +V
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 246 GYCSFDEEKLLVYEYMVNGS-LDLW-LRNATGSHEVLDRAKRYKIAC---SSARGLAFLH 300
G + + +V EY GS D+ + N T + E +IA + +GL +LH
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE--------EIAAILYQTLKGLEYLH 116
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
DFG++ ++ +T I GT ++ PE Q
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175
Query: 337 STTRGDVYSFGVILLELVTAKEP 359
+ D++S G+ +E+ K P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 63/219 (28%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 194 GGFGTVYKATLPD-GKTVAVKKFS-QAKTQGHRQFT----AEMETLGKVKHQNLVLLLGY 247
G +GTVYKA P G VA+K Q G T A ++ L H N+V L+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 248 CS---FDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH-- 300
C+ D E LV+E+ V+ L +L + K + RGL FLH
Sbjct: 71 CATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFLHAN 127
Query: 301 ----------------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGLAR+ S C+ + T + TL Y PE
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMAL-TPVVVTLWYRAPEVLLQSTYA 185
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVF 377
T D++S G I E+ K P F A+ +G +F
Sbjct: 186 TPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGKIF 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 58/199 (29%), Positives = 81/199 (40%), Gaps = 44/199 (22%)
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFS-QAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYC 248
+G +G VYKA G+ VA+KK + + +G TA E+ L ++ H N+V LL
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS-TAIREISLLKELNHPNIVRLLDVV 67
Query: 249 SFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
E KL LV+E++ LDL + LD +G+A+ H
Sbjct: 68 -HSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123
Query: 302 ------------------DFGLARLISA---CETHVSTDIAGTLGYIPPE--YGQSRMST 338
DFGLAR TH TL Y PE G SR +
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLG-SRQYS 178
Query: 339 TRGDVYSFGVILLELVTAK 357
T D++S G I E+V +
Sbjct: 179 TPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 60/208 (28%), Positives = 84/208 (40%), Gaps = 47/208 (22%)
Query: 189 DILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLL 245
D L +G + TVYK + G+ VA+K+ +G FTA E L +KH N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLH 69
Query: 246 GYCSFDEEKLLVYEYMVNGSLDL-----WLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ LV+EY+ DL H V R +++ RGLA+ H
Sbjct: 70 DIIHTKKTLTLVFEYLDT---DLKQYMDDCGGGLSMHNV--RLFLFQLL----RGLAYCH 120
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQS 334
Q DFGLAR S S ++ TL Y PP+ G S
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLG-S 178
Query: 335 RMSTTRGDVYSFGVILLELVTAKEPTGP 362
+T D++ G I E+ T + P P
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR-PLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 7/82 (8%)
Query: 222 GHRQFT-AEMET---LGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH 277
HR + A ET + +V H+++VLL G C D E ++V E++ G LDL++ +
Sbjct: 43 SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--- 99
Query: 278 EVLDRAKRYKIACSSARGLAFL 299
+VL ++K+A A L++L
Sbjct: 100 DVLTTPWKFKVAKQLASALSYL 121
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 41/244 (16%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKT---VAVK--KFSQAKTQGHRQFTAEMETLGKVKHQ 239
L L L +G FG+V + L + VAVK K + F +E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 240 NLVLLLGYCSFDEEK------LLVYEYMVNGSL-DLWLRNATGSHEV-LDRAKRYKIACS 291
N++ L+G C E +++ +M +G L L + G L K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 292 SARGLA------FLHQD------------------FGLARLISACETHVSTDIAGT-LGY 326
A G+ F+H+D FGL++ I + + IA + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 327 IPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386
I E R+ TT+ DV+SFGV + E+ T + P + E + ++ Q + +Q
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQGNRLKQPP 237
Query: 387 DVLD 390
D LD
Sbjct: 238 DCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 58/207 (28%), Positives = 84/207 (40%), Gaps = 47/207 (22%)
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCS 249
+G +G VYK G+ VA+KK + TA E+ L +++H N+V L
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM 69
Query: 250 FDEEKLLVYEYMVNGSLDL--WLRNATGSHEVLDRA--KRYK-------IACSSARGLAF 298
+ L++E++ S+DL +L ++ + +D K Y + C S R
Sbjct: 70 QESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR---V 122
Query: 299 LHQ------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMST 338
LH+ DFGLAR V T TL Y PE G R ST
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQ 365
D++S G I E+ T K P F
Sbjct: 182 PV-DIWSIGTIFAEMATKK----PLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 302 DFGLARLIS-ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP- 359
DFG ++ S + V++ GT Y+ PE + + + + D++S GVIL EL+T P
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 360 TGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPAT 419
GP +E + Q++ + D P +++G K ++ +L + NPA
Sbjct: 272 KGPSQRE---------IMQQVLYGKYDPF--PCPVSSGMKALLDPLL-------SKNPAL 313
Query: 420 RPT---------MLHVLKLLHEIV 434
RPT + +V L +IV
Sbjct: 314 RPTTQQLLHTEFLKYVANLFQDIV 337
|
Length = 478 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 62/263 (23%), Positives = 101/263 (38%), Gaps = 50/263 (19%)
Query: 193 DGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
+G G V AT G+ VAVKK K Q E+ + +H N+V +
Sbjct: 29 EGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG 88
Query: 252 EEKLLVYEYMVNGSL-DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH---------- 300
+E +V E++ G+L D+ +H ++ + + + + L+FLH
Sbjct: 89 DELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 301 --------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSF 346
DFG +S E + GT ++ PE T D++S
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 347 GVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS-KPMMLKM 405
G++++E+V EP P F E Q MK+ + D L P + N P +
Sbjct: 202 GIMVIEMVDG-EP--PYFNEPP--------LQAMKRIR--DNLPPKLKNLHKVSPRLRSF 248
Query: 406 LRIAADCVADNPATRPTMLHVLK 428
L + +PA R T +L
Sbjct: 249 LD---RMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 55/200 (27%), Positives = 79/200 (39%), Gaps = 46/200 (23%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGYCS 249
G FG VY AT + VAVKK S + Q + ++ E++ L ++KH N + G
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ LV EY + + DL + EV A I + +GLA+LH
Sbjct: 92 KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----ITHGALQGLAYLHSHNMIHRDI 147
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPEY------GQSRMSTT 339
DFG A S + V GT ++ PE GQ
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQY---DG 199
Query: 340 RGDVYSFGVILLELVTAKEP 359
+ DV+S G+ +EL K P
Sbjct: 200 KVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 60/216 (27%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFT-AEMETLGKVKHQNLVL 243
+ + +G +G V AT P G VA+KK S + Q Q T E++ L + KH+N++
Sbjct: 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 244 LL------GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL-------DRAKR--YKI 288
+L + SF + +V E M DL ++++ D + Y+I
Sbjct: 68 ILDIIRPPSFESF-NDVYIVQELM---ETDL--------YKLIKTQHLSNDHIQYFLYQI 115
Query: 289 ACSSARGLAFLHQ------------------------DFGLARLISACETHVS--TDIAG 322
RGL ++H DFGLAR+ H T+
Sbjct: 116 L----RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 323 TLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTAK 357
T Y PE S+ T D++S G IL E+++ +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 40/202 (19%)
Query: 191 LEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCS 249
L DG FG VYKA + +A K K++ + + E++ L H N+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRA---KRYKIAC-SSARGLAFLHQDFGL 305
++ ++ E+ G++D + L+R + ++ C + L +LH++ +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 306 ARLISACETHVSTD-----------------------IAGTLGYIPPEYGQSRMSTTR-- 340
R + A + D GT ++ PE S R
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 341 ---GDVYSFGVILLELVTAKEP 359
DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 40/211 (18%)
Query: 193 DGGFGTVYKATL----PDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLG 246
+G FG KA L DGK +K+ + +K + + E+ L +KH N+V
Sbjct: 10 EGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 247 YCSFDEEKLL--VYEYMVNGSLDLWLRNATGS----HEVLDRAKRYKIACSSARGLAFLH 300
SF+E L V +Y G L + G ++LD + +A LH
Sbjct: 67 --SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 301 QD------------------FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGD 342
+D FG+AR++++ T I GT Y+ PE ++R + D
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLV 373
+++ G +L E+ T K F+ NLV
Sbjct: 184 IWALGCVLYEMCTLKHA----FEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 31/204 (15%)
Query: 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P K T + + G GTVY A + G+ VA+++ + + E+ + + K+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L +E +V EY+ GSL + +D + + + L FL
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG I+ E + + GT ++ PE +
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ D++S G++ +E++ + P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK----FSQAKTQGHRQFTAEMETLGKVKH 238
++ ++D L G +G+VYK P G T+A+K+ ++K Q E++ L K
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK---FNQIIMELDILHKAVS 58
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+V G + + EYM GSLD L + E + +I + +GL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 299 LHQDFGLAR--------LISA------CETHVSTDIAGTLG--------YIPPEYGQSRM 336
L ++ + L++ C+ VS ++ +L Y+ PE +S
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 337 STTRG------DVYSFGVILLELVTAKEPTGPE 363
DV+S G+ +LE+ + P PE
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 52/203 (25%), Positives = 73/203 (35%), Gaps = 46/203 (22%)
Query: 191 LEDGGFGTVYKATL---PDGKTVAVKKFS--QAKT--QGHRQFTAEMET---LGKVKHQN 240
L G F +YK L D V + K HR A ET + ++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS---HEVLDRAKRYKIACSSARGLA 297
LV L G C DE ++V EY+ G LD++L + H LD AK+ A
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 298 FLH-------------------------QDFGLARLISACETHVSTDIAGTLGYIPPEY- 331
+H D G+ + + E V I +I PE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-RIP----WIAPECI 176
Query: 332 -GQSRMSTTRGDVYSFGVILLEL 353
T D +SFG LLE+
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 16/106 (15%)
Query: 181 PLLKLTLVDILEDGGFGTVY-------------KATLPDGK--TVAVKKFSQAKTQGHRQ 225
P +L L + L +G FG V+ A DG+ VAVK T+ R
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN 62
Query: 226 -FTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWL 270
F E++ + ++K+ N++ LLG C D+ ++ EYM NG L+ +L
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL 108
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 35/199 (17%)
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFS-QAKTQGHRQFTA-EMETLGKVKHQNLVLLLGYCS 249
+G +GTV+KA + VA+K+ +G E+ L ++KH+N+V L
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH 69
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
D++ LV+EY + L + + G +D +GLAF H
Sbjct: 70 SDKKLTLVFEY-CDQDLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDV 343
DFGLAR S ++ TL Y PP+ +G +++ +T D+
Sbjct: 126 KPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG-AKLYSTSIDM 183
Query: 344 YSFGVILLELVTAKEPTGP 362
+S G I EL A P P
Sbjct: 184 WSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 65/211 (30%), Positives = 83/211 (39%), Gaps = 65/211 (30%)
Query: 194 GGFGTVYKATLPD---GKTVAVKKFSQA---KTQGHRQFTAEM--ETLGKVKHQNLVLLL 245
G +G V+KA D + VA+KK A T R F M + LG H N+V LL
Sbjct: 18 GAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKLL 73
Query: 246 GYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRA-------KRYKIACSSARGL 296
+ +K LV+EYM DL H V+ RA KRY I + L
Sbjct: 74 NVIKAENDKDIYLVFEYM---ETDL--------HAVI-RANILEDVHKRY-IMYQLLKAL 120
Query: 297 AFLHQ------------------------DFGLARLISA----CETHVSTDIAGTLGYIP 328
++H DFGLAR +S E V TD T Y
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 329 PE--YGQSRMSTTRGDVYSFGVILLELVTAK 357
PE G S T D++S G IL E++ K
Sbjct: 181 PEILLG-STRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 38/140 (27%), Positives = 56/140 (40%), Gaps = 33/140 (23%)
Query: 247 YCSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEV-LDRAKRYKIACSSARGLAFLHQ-- 301
+C+F ++ L V EY+ G L + + S RA+ Y A GL FLH+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFY--AAEIICGLQFLHKKG 116
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFG+ + E ST GT YI PE + +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNE 175
Query: 340 RGDVYSFGVILLELVTAKEP 359
D +SFGV+L E++ + P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 56/210 (26%)
Query: 191 LEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGH-RQFTAEMETLGKVKHQNLVLLLGYCS 249
L DG FG VYKA + A K Q +++ F E++ L + KH N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 250 FDEEKLLVYEYMVNGSLD-LWLRNATG---------SHEVLDRAKRYKIACSSARGLAFL 299
++ + ++ E+ G+LD + L G ++L+ L FL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE-------------ALNFL 119
Query: 300 HQ------------------------DFGL-ARLISACETHVSTDIAGTLGYIPPEY--- 331
H DFG+ A+ S + T I GT ++ PE
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVAC 177
Query: 332 --GQSRMSTTRGDVYSFGVILLELVTAKEP 359
+ + D++S G+ L+EL + P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 57/201 (28%), Positives = 80/201 (39%), Gaps = 47/201 (23%)
Query: 193 DGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCS 249
+G +G VYKA +T+A+KK + TA E+ L +++H N+V L
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH 71
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKR------YKIACSSARGLAFLHQ-- 301
++ LV+EY LDL L+ S + R Y+I RG+A+ H
Sbjct: 72 SEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIAYCHSHR 122
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRM 336
DFGLAR T TL Y PE G SR
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLG-SRH 180
Query: 337 STTRGDVYSFGVILLELVTAK 357
+T D++S G I E+V K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 31/192 (16%)
Query: 193 DGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
+G G V AT GK VAVKK K Q E+ + H+N+V +
Sbjct: 32 EGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG 91
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH----------- 300
+E +V E++ G+L +H ++ + + S R L++LH
Sbjct: 92 DELWVVMEFLEGGAL-----TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 301 -------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFG 347
DFG +S E + GT ++ PE T D++S G
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 205
Query: 348 VILLELVTAKEP 359
++++E++ + P
Sbjct: 206 IMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 43/167 (25%), Positives = 66/167 (39%), Gaps = 38/167 (22%)
Query: 225 QFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAK 284
Q E++ L + +V G D E + E+M GSLD VL +A
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ----------VLKKAG 94
Query: 285 RY------KIACSSARGLAFL-------HQDFGLARL-------ISACETHVSTDI---- 320
R KI+ + RGL +L H+D + + I C+ VS +
Sbjct: 95 RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154
Query: 321 ----AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363
GT Y+ PE Q T + D++S G+ L+E+ + P P
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 46/194 (23%), Positives = 72/194 (37%), Gaps = 36/194 (18%)
Query: 194 GGFGTVYKATLPDGKT-VAVKKFS---QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G +G V A VA+KK S Q+ R + E+ L + H+N++ LL +
Sbjct: 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFT 84
Query: 250 FDEEKLLVYE-YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
+ Y+V + L N ++ D ++ + RGL ++H
Sbjct: 85 PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHSAGIIHRD 143
Query: 302 -----------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG-DV 343
DFGLAR T T Y PE + M + D+
Sbjct: 144 LKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDI 199
Query: 344 YSFGVILLELVTAK 357
+S G I+ EL+T K
Sbjct: 200 WSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 27/74 (36%), Positives = 42/74 (56%), Gaps = 10/74 (13%)
Query: 290 CSSARGLAFLHQDFGLARLISACETHVSTDIA----GTLGYIPPEYGQSRMSTTRGDVYS 345
CS+ GL L DFG +++ +A VS D+ GT Y+ PE + + + + D++S
Sbjct: 177 CSN--GLVKL-GDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 346 FGVILLELVTAKEP 359
GV+L EL+T K P
Sbjct: 231 LGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 48/191 (25%)
Query: 210 VAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268
VAVK + R+ F E++ L ++ N+ LLG C+ D ++ EYM NG L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 269 WLRNATGSHEVLDRAKRY---------------KIACSSARGLA---FLHQDFGLA---R 307
+L+ H +IA S R L F+H+D LA
Sbjct: 109 FLQ----KHVAETSGLACNSKSLSFSTLLYMATQIA-SGMRYLESLNFVHRD--LATRNC 161
Query: 308 LISACETHVSTDIAGTLGYIPPEYGQSR---------MS---------TTRGDVYSFGVI 349
L+ T D + +Y + + M+ TT+ DV++FGV
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 350 LLELVT-AKEP 359
L E++T +E
Sbjct: 222 LWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 56/250 (22%), Positives = 92/250 (36%), Gaps = 59/250 (23%)
Query: 145 QNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATL 204
Q L + L KD S +K P R N ++ + L G FG V AT
Sbjct: 2 QFLKNLQLHKKKD------SDSTKEPKRKNKMKYED----FNFIRTLGTGSFGRVILATY 51
Query: 205 PDGK--TVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259
+ VA+K+F ++K +Q +E + L + H V L G + LV E
Sbjct: 52 KNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111
Query: 260 YMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ---------------- 301
+++ G +LR R KR+ + C A + + +
Sbjct: 112 FVIGGEFFTFLR----------RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161
Query: 302 ------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVI 349
DFG A+++ +T T + GT YI PE + D ++ G+
Sbjct: 162 LLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIF 217
Query: 350 LLELVTAKEP 359
+ E++ P
Sbjct: 218 IYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 46/200 (23%)
Query: 194 GGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGYCS 249
G FG VY A + + + VA+KK S + Q + ++ E+ L K++H N + G
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ LV EY + + DL + EV A + + +GLA+LH
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----VTHGALQGLAYLHSHNMIHRDV 141
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPEY------GQSRMSTT 339
DFG A +++ V GT ++ PE GQ
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY---DG 193
Query: 340 RGDVYSFGVILLELVTAKEP 359
+ DV+S G+ +EL K P
Sbjct: 194 KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 188 VDILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
+D L +G + TV+K + VA+K+ +G TA E+ L +KH N+V L
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTL 68
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
+ LV+EY+ + L +L N G+ + K + RGL++ H+
Sbjct: 69 HDIIHTERCLTLVFEYL-DSDLKQYLDNC-GNLMSMHNVKIFMFQL--LRGLSYCHKRKI 124
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMST 338
DFGLAR S S ++ TL Y PP+ G + ST
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV 373
D++ G IL E+ T + P P KE +L+
Sbjct: 184 PI-DMWGVGCILYEMATGR-PMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 50/202 (24%)
Query: 194 GGFGTVYKATLPDGKT---VAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGY 247
G FG VY A D +T VA+KK S + Q + ++ E++ L ++KH N + G
Sbjct: 36 GSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93
Query: 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
+ LV EY + + DL + EV A I + +GLA+LH
Sbjct: 94 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----ITHGALQGLAYLHSHNMIHR 149
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPEY------GQSRMS 337
DFG A + S + V GT ++ PE GQ
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQY--- 201
Query: 338 TTRGDVYSFGVILLELVTAKEP 359
+ DV+S G+ +EL K P
Sbjct: 202 DGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 34/205 (16%)
Query: 187 LVDILEDGGFGTVY---KATLPD-GKTVAVKKF------SQAKTQGHRQFTAEMETLGKV 236
L+ +L G +G V+ K T D GK A+K +AKT H + E L V
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TERNVLEHV 61
Query: 237 KHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL--DLWLRNATGSHEVLDRAKRYKIACSSA 293
+ ++ L Y E KL L+ +Y+ G + L+ R+ EV + +A
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 294 RGLAFLHQDFGLARLISACETHVS-TDIA-----------------GTLGYIPPEYGQSR 335
L +++D L ++ E HV TD GT+ Y+ PE + +
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 336 MSTTRG-DVYSFGVILLELVTAKEP 359
+ D +S G+++ EL+T P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 53/225 (23%), Positives = 83/225 (36%), Gaps = 64/225 (28%)
Query: 193 DGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLV------- 242
+G +G VY+A G+ VA+KK + ++ E+ L ++H N+V
Sbjct: 17 EGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76
Query: 243 --------LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
L++ YC D LL + M ++ + R
Sbjct: 77 GKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFSESQVKCLMLQLLR 119
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
GL +LH+ DFGLAR ++ + TL Y PE
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 331 --YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV 373
G TT D+++ G IL EL+ A +P P E E +L+
Sbjct: 179 LLLG-CTTYTTAIDMWAVGCILAELL-AHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 37/198 (18%)
Query: 193 DGGFGTVYKATLPDGKT---VAVKKF-SQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYC 248
+G FG V + G T V VK+ A Q +F E + ++H NL+ LG C
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL-DRAKRYKIACSSARGLAFLHQ------ 301
+ LLV E+ G L +LR+ + + D ++AC A GL LH+
Sbjct: 65 TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHS 124
Query: 302 ------------------DFGLARLISACETHVSTD-IAGTLGYIPPEYGQSRMS----- 337
D+GL+ + +V+ D + L +I PE
Sbjct: 125 DLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVV 184
Query: 338 --TTRGDVYSFGVILLEL 353
T +V+S GV + EL
Sbjct: 185 DQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 19/55 (34%), Positives = 32/55 (58%), Gaps = 8/55 (14%)
Query: 223 HRQFT------AEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR 271
HR ++ A M + ++ H++LVL G C +E ++V EY+ GSLD +L+
Sbjct: 39 HRNYSESFFEAASM--MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK 91
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 42/192 (21%), Positives = 75/192 (39%), Gaps = 31/192 (16%)
Query: 193 DGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
+G G V AT+ GK VAVKK K Q E+ + +H+N+V +
Sbjct: 30 EGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 89
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH----------- 300
+E +V E++ G+L +H ++ + + + + L+ LH
Sbjct: 90 DELWVVMEFLEGGAL-----TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 301 -------------QDFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFG 347
DFG +S E + GT ++ PE D++S G
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 348 VILLELVTAKEP 359
++++E+V + P
Sbjct: 204 IMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 40/197 (20%)
Query: 191 LEDGGFGTVYKATLPDGKTVAVKKFS--------QAKTQGHRQFTAEMETLGKVKHQNLV 242
L G FGTVY + D K VA ++ + Q E + L K+ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 243 LLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ SF E ++ EY LD L + + L + + G+ ++H
Sbjct: 66 KF--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 301 Q-----------------------DFGLAR-LISACETHVSTDIAGTLGYIPPEYGQSRM 336
Q DFG++R L+ +C+ ++T GT Y+ PE + +
Sbjct: 124 QRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG 181
Query: 337 STTRGDVYSFGVILLEL 353
++ D++S G IL E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/75 (32%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 210 VAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268
VAVK + R F E++ L ++K N++ LLG C ++ ++ EYM NG L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 269 WLRNATGSHEVLDRA 283
+L SH + D+
Sbjct: 109 FL----SSHHLDDKE 119
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 40/205 (19%)
Query: 190 ILEDGGFGTVYKATLPD-GKTVAVKK--FSQAKTQGHRQFTA---EMETLGKVKHQNLVL 243
+L G FG VY D G+ +A K+ F + ++ +A E++ L ++H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 244 LLGYCSFD--EEKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
G C D E+ L ++ EYM GS+ L+ E + R +I G+++LH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123
Query: 301 Q------------------------DFGLA-RLISACETHVST-DIAGTLGYIPPEYGQS 334
DFG + RL + C + + GT ++ PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
+ DV+S G ++E++T K P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 39/208 (18%)
Query: 191 LEDGGFGTVYKATLPDGKT---VAVKKFSQAKTQGHRQFTAEMETLGKVKHQ----NLVL 243
L G FG V K K VA+K K + + EM ++ HQ +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWL---RNATGSHEVLDRAKRYKIACSSARGLAFLH 300
++G C E +LV E G L+ +L ++ V++ + + G F+H
Sbjct: 60 MIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 301 QD------------------FGLARLISACETHVSTDIAGT--LGYIPPEYGQSRMSTTR 340
+D FGL++ + A +++ AG L + PE R ++R
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 341 GDVYSFGVILLELVT-----AKEPTGPE 363
DV+S+G+ + E + K+ GPE
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 28/193 (14%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251
G G V+K + P G +A K + K Q E++ L + +V G D
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL-------HQDFG 304
E + E+M GSLD L+ A E + K++ + +GL +L H+D
Sbjct: 76 GEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHKIMHRDVK 131
Query: 305 LARL-------ISACETHVSTDI--------AGTLGYIPPEYGQSRMSTTRGDVYSFGVI 349
+ + I C+ VS + GT Y+ PE Q + + D++S G+
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 350 LLELVTAKEPTGP 362
L+E+ + P P
Sbjct: 192 LVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 58/212 (27%), Positives = 82/212 (38%), Gaps = 47/212 (22%)
Query: 187 LVDILEDGGFGTVY---KATLPD-GKTVAVKKF------SQAKTQGHRQFTAEMETLGKV 236
L+ +L G +G V+ K D GK A+K +AKT H + E + L V
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR--TERQVLEAV 61
Query: 237 KHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL--DLWLRNATGSHEVLDRAKRYKIACSSA 293
+ ++ L Y + KL L+ +Y+ G L L+ R EV R IA
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV-----RVYIA-EIV 115
Query: 294 RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPP 329
L LHQ DFGL++ A E + GT+ Y+ P
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 330 EY--GQSRMSTTRGDVYSFGVILLELVTAKEP 359
E G S D +S GV+ EL+T P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKTQG-HRQFTAEMETL 233
P +L L L G FG V +A+ +TVAVK + T ++ E++ L
Sbjct: 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKIL 64
Query: 234 GKVKHQ-NLVLLLGYCSFDEEKLLV-YEYMVNGSLDLWLR 271
+ H N+V LLG C+ L+V EY G+L +LR
Sbjct: 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 58/208 (27%), Positives = 79/208 (37%), Gaps = 60/208 (28%)
Query: 194 GGFGTVYKATLP-DGKTVAVKKFS---QAKTQGHRQFTAEMETLGKVKHQNL-----VLL 244
G FG V+ T P DGK VA+KK Q R F E++ L KH N+ +L
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALDILQ 69
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKR----------YKIACSSAR 294
+ EE +V E M DL H+++ + Y+I R
Sbjct: 70 PPHIDPFEEIYVVTELM---QSDL--------HKIIVSPQPLSSDHVKVFLYQIL----R 114
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
GL +LH DFGLAR+ E+ T T Y PE
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 331 -YGQSRMSTTRGDVYSFGVILLELVTAK 357
SR T+ D++S G I EL+ +
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 35/206 (16%)
Query: 187 LVDILEDGGFGTVY---KATLPD-GKTVAVKKF------SQAKTQGHRQFTAEMETLGKV 236
L+ +L G +G V+ K + D GK A+K +AKT H + E + L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR--TERQVLEHI 61
Query: 237 KHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL--DLWLRNATGSHEVLDRAKRYKIACSSA 293
+ ++ L Y + KL L+ +Y+ G L L R EV + +A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 294 RGLAFLHQD------------------FGLARLISACETHVSTDIAGTLGYIPPEY--GQ 333
L +++D FGL++ E + GT+ Y+ P+ G
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEP 359
D +S GV++ EL+T P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 38/137 (27%), Positives = 52/137 (37%), Gaps = 25/137 (18%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+ S + L GL L NN+L +P S+G L L L+L+ N+ S +SLG+L L
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNL 279
Query: 64 SHLDLSSNFF-------DGGWPRS--------------LGNLSYSTYLDLHDNKFTREIP 102
LDLS N L S ++ N T P
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET-SSP 338
Query: 103 QNLGNLAQLEHLDVLRN 119
+ L L L +L L N
Sbjct: 339 EALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 44/203 (21%)
Query: 188 VDILEDGGFGTVYK--ATLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVL 243
++ L +G + TV+K + L + VA+K+ +G TA E+ L +KH N+V
Sbjct: 11 LEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVT 68
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLR---NATGSHEVLDRAKRYKIACSSARGLAFLH 300
L D+ LV+EY+ + L ++ N H V + Y+I RGLA+ H
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNV--KIFLYQI----LRGLAYCH 121
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQS 334
+ DFGLAR S S ++ TL Y PP+ G S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 335 RMSTTRGDVYSFGVILLELVTAK 357
S T+ D++ G I E+ + +
Sbjct: 181 EYS-TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 46/190 (24%), Positives = 73/190 (38%), Gaps = 38/190 (20%)
Query: 194 GGFGTVYKATL-PDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKVKHQNLVLLLGYCSFD 251
G FG V+ L D VAVK + + +F E L + H N+V L+G C+
Sbjct: 6 GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 65
Query: 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH----------- 300
+ +V E + G +LR G L + ++ ++A G+ +L
Sbjct: 66 QPIYIVMELVQGGDFLTFLRT-EGPR--LKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122
Query: 301 -------------QDFGLARLISACETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGD 342
DFG++R E G + IP PE ++ D
Sbjct: 123 RNCLVTEKNVLKISDFGMSRE----EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 343 VYSFGVILLE 352
V+SFG++L E
Sbjct: 179 VWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 8/99 (8%)
Query: 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGK-----TVAVKKF-SQAKTQGHRQFTAEMETL 233
P L L G FG V +AT GK VAVK + A T +E++ L
Sbjct: 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKIL 95
Query: 234 GKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR 271
+ +H+N+V LLG C+ L++ EY G L +LR
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 58/233 (24%), Positives = 82/233 (35%), Gaps = 84/233 (36%)
Query: 191 LEDGGFGTVYKA-TLPDGKTVAVKKFSQAK----TQGHRQ--------FTA--EMETLGK 235
L +G +G V KA GK VA+KK + RQ FT E++ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 236 VKHQNLVLLLG-YCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIA---C- 290
+KH+N++ L+ Y D L V + M + DL +V+DR R + C
Sbjct: 77 IKHENIMGLVDVYVEGDFINL-VMDIMAS---DL--------KKVVDRKIRLTESQVKCI 124
Query: 291 --SSARGLAFLHQ------------------------DFGLAR-------------LISA 311
GL LH+ DFGLAR +
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 312 CETHVSTDIAGTLGYIPPE-------YGQSRMSTTRGDVYSFGVILLELVTAK 357
T TL Y PE Y + D++S G I EL+T K
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAV------DMWSVGCIFAELLTGK 231
|
Length = 335 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.91 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.86 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.86 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.79 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.76 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.72 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.47 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.46 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.44 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.42 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.4 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.39 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.38 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.37 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.32 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.31 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.26 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.26 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.25 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.24 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.2 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.18 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.18 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.17 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.15 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.11 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.1 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.09 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.93 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.92 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.84 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.84 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.84 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.75 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.71 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.64 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.62 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.59 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.41 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.36 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.32 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.26 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.19 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.17 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.16 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.05 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.94 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.77 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.75 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 97.53 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.5 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 97.24 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.2 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.09 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.06 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.89 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 96.78 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 96.76 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.72 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-55 Score=470.40 Aligned_cols=409 Identities=29% Similarity=0.485 Sum_probs=276.4
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
++|+.|+|++|++++.+|..+.++++|+.|+|++|.+.+.+|..++.+++|+.|+|++|.++|.+|..++.+++|++|++
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 45666666666666666767777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCcceecCCcccccccccc--cccCCCCcC-----------Cc----ce-eE---
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEG--LVSQSGICQ-----------NL----SK-IS--- 151 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~~~~~~~--~~~~~~~c~-----------~l----~~-l~--- 151 (435)
++|+++|.+|..+.++++|+.+++++|++.|.+|..-....+.. ...+.+.|. .. .. +.
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~ 634 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITC 634 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhH
Confidence 77777777777777777777777777777777775321111100 001112221 10 00 00
Q ss_pred --------------EeccccccccccCCCCCCCccccccc----------ccccccCcceeeeecccCcceEEEEEc-CC
Q 040641 152 --------------LAGNKDYNLYLSSSRSKGPLRINISM----------FQQPLLKLTLVDILEDGGFGTVYKATL-PD 206 (435)
Q Consensus 152 --------------l~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~ 206 (435)
+...+++................... .......+...++||+|+||.||+|+. .+
T Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~ 714 (968)
T PLN00113 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN 714 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCC
Confidence 00000000000000000000000000 011123455677899999999999986 56
Q ss_pred CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHH
Q 040641 207 GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY 286 (435)
Q Consensus 207 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~ 286 (435)
++.||||++...... ..+|++++++++|||||+++|+|...+..++|||||++|+|.++++. ++|..+.
T Consensus 715 ~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~ 783 (968)
T PLN00113 715 GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783 (968)
T ss_pred CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHH
Confidence 899999998653322 23568899999999999999999999999999999999999999953 7899999
Q ss_pred HHHHHhhhccceeec---------cccccccccccC------------ccccccccccCCCcCCcCCCCCCCCCcccchh
Q 040641 287 KIACSSARGLAFLHQ---------DFGLARLISACE------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYS 345 (435)
Q Consensus 287 ~i~~~ia~gl~yLH~---------DfGla~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S 345 (435)
+++.++|+||+|||. |...+.++-+.. ........||++|||||+..+..++.|+||||
T Consensus 784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S 863 (968)
T PLN00113 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863 (968)
T ss_pred HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccccCcccccCCCCCcccchhh
Confidence 999999999999994 222111111000 00112235789999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC--CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 346 FGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN--AGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 346 fGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
|||++|||+||+.|++..+. ....+..|+.............||.... ....+.+.++.+++.+||+.+|++||||
T Consensus 864 ~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 941 (968)
T PLN00113 864 FGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA 941 (968)
T ss_pred HHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence 99999999999999865433 2345666665544443344455554422 2345667788899999999999999999
Q ss_pred HHHHHHHhhhh
Q 040641 424 LHVLKLLHEIV 434 (435)
Q Consensus 424 ~evl~~L~~i~ 434 (435)
.||+++|+++.
T Consensus 942 ~evl~~L~~~~ 952 (968)
T PLN00113 942 NDVLKTLESAS 952 (968)
T ss_pred HHHHHHHHHhh
Confidence 99999999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=383.34 Aligned_cols=256 Identities=41% Similarity=0.703 Sum_probs=217.2
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-ee
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-EK 254 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~ 254 (435)
..+...+.+|.-..+||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||+|+++|||.+.+ +.
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 34455677888889999999999999999999999999887644331567999999999999999999999999988 59
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLAR 307 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~ 307 (435)
+||||||++|+|+++|+..... .++|.+|++||.++|+||+|||. |||+|+
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 9999999999999999876443 78999999999999999999996 999997
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.......+..+...||.+|+|||+...+..+.|+|||||||+++|++||++|.+... ......++.|+...+......+
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHCcchhh
Confidence 765311222211189999999999999999999999999999999999998876533 2334458999988888888999
Q ss_pred ccccccc-CCCCH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVL-NAGSK-PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~-~~~~~-~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
++||.+. ..... ..+.++..++..|++.+|++||+|.||+++|+.+.
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999986 44443 68888999999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=351.33 Aligned_cols=238 Identities=30% Similarity=0.461 Sum_probs=189.3
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccccc--HHHHHHHHHHhccCCCCCceeEEEEEEeCC-ee
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLVLLLGYCSFDE-EK 254 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~ 254 (435)
+.+....+.+.+.+|+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|..+. ..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 344555677778899999999999999754459999997644322 568999999999999999999999999887 79
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------ccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARL 308 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~ 308 (435)
.+|||||++|+|..+++.. ....+++..+++++.|||+||.|||+ |||+++.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999999999874 23569999999999999999999996 8999987
Q ss_pred ccccCccccccccccCCCcCCcCCC--CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQ--SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.... ....+........
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~-------~~~~~~~v~~~~~-- 263 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA-------PVQVASAVVVGGL-- 263 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcCC--
Confidence 65432 3344578999999999999 6699999999999999999999999985422 1222222222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.|.+... +...+..++.+||+.||++||+|.+|+..|+.+.
T Consensus 264 ---Rp~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 264 ---RPPIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ---CCCCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1111111 3345777888999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=346.03 Aligned_cols=239 Identities=28% Similarity=0.437 Sum_probs=194.7
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|.+++..+++.+.||+|.||.||.|.+.....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 4567788889999999999999999999987779999999754 334578999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
||||||++|+|.+||+.. ....+...+.+.++.|||+||+||++ |||+||.+.+
T Consensus 278 IVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999999999873 23458888999999999999999864 9999997766
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
+......+..-++.|.|||.+....++.|||||||||+||||+| |+.|+... ...+ +...+.++. .+
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-------sn~e-v~~~le~Gy--Rl-- 423 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-------SNEE-VLELLERGY--RL-- 423 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-------CHHH-HHHHHhccC--cC--
Confidence 66656666666789999999999999999999999999999999 55554322 1222 222222221 11
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+.+..+...+.++|..||..+|++||||..+...|+++.
T Consensus 424 -----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 424 -----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 112224457889999999999999999999999998874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.10 Aligned_cols=240 Identities=28% Similarity=0.449 Sum_probs=194.1
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
..+++.++.+.+.||+|+||+||+|+.. +...||||.++..... ...+|.+|+++++.++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4567778889999999999999999853 2457999999876655 67899999999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCC----------CCCCCHHHHHHHHHHhhhcccee------ec-------------
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGS----------HEVLDRAKRYKIACSSARGLAFL------HQ------------- 301 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gl~yL------H~------------- 301 (435)
++..+||+|||..|||.+||+..... ...++..+.+.||.|||.||+|| |+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999854321 22388899999999999999988 33
Q ss_pred -----cccccccccccCccccc-cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHH
Q 040641 302 -----DFGLARLISACETHVST-DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVG 374 (435)
Q Consensus 302 -----DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~ 374 (435)
|||++|.+...+.+... ...-.++|||||.+..+.||++||||||||||||++| |+.|++.... .+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~E--- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QE--- 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HH---
Confidence 99999987665543322 3334679999999999999999999999999999998 7778754322 11
Q ss_pred HHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 375 WVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+.+.++.+... +.+..+..++..||..||+.+|++||+|+||-..|++..
T Consensus 714 -VIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 -VIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -HHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 33444443321 223345568999999999999999999999999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.64 Aligned_cols=175 Identities=30% Similarity=0.454 Sum_probs=156.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|.+.+.||+|+||+||+|+++ ++..||||.+.... ....+....|+++|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46788888999999999999975 47899999997653 3445668899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------------cccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------------DFGLARLI 309 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------------DfGla~~~ 309 (435)
||.||+|..|++... .+++.....++.|+|.||+|||+ |||+||.+
T Consensus 90 yC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999998753 58889999999999999999985 99999998
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
.. .......||++.|||||++...+|+.|+|+||.|+|+|||++|+.||+..
T Consensus 166 ~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 74 34455689999999999999999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.80 Aligned_cols=239 Identities=28% Similarity=0.447 Sum_probs=187.0
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC--CC----EEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD--GK----TVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
.+...+++.+.||+|+||.||+|.+.+ |. .||||.+++.. .+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 457788999999999999999998643 43 49999997653 455678999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCC---CCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGS---HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
..+|++|||++|+|..||++.+.. ...+.....+.++.|||+|+.||++ |||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999976321 3457788889999999999999975 9999
Q ss_pred cccccccCccccccc-cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 306 ARLISACETHVSTDI-AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
||.+...+....... .-...|||||.+....++.|+|||||||++||++|...++++.. ...++.. ..+..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~---~n~~v~~---~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR---SNFEVLL---DVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc---chHHHHH---HHHhCC-
Confidence 997665444333222 23468999999999999999999999999999999655443322 1112221 112222
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+++. ..+..+++++|.+||+.+|++||+|..|++.+.+|.
T Consensus 922 ---RL~~P------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ---RLDPP------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---ccCCC------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 12221 123346789999999999999999999999988875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=297.14 Aligned_cols=230 Identities=26% Similarity=0.404 Sum_probs=184.6
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc-ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-eeEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA-KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-EKLLV 257 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv 257 (435)
...+++..+.||+|..|+|||++++ +++.+|+|.+... +....++..+|++++++.+||+||.+||+|..++ ...|+
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 3456778899999999999999975 5889999999443 3345678999999999999999999999999999 59999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISAC 312 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~ 312 (435)
||||.+|||++++... ..+++...-+|+.+|.+||.|||+ |||.++.+...
T Consensus 157 mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999998765 347888888999999999999994 99999987643
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
...+.+||..|||||.+.+..|+.++||||||++++|+++|+.|+.+.. .........+....... .|.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~p------pP~ 301 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEP------PPR 301 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCC------CCC
Confidence 4456899999999999999999999999999999999999999986641 12223333322222211 122
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... .+..++..++..|+++||.+||+..|+++
T Consensus 302 lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 302 LPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2221 23446677888999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=313.74 Aligned_cols=223 Identities=26% Similarity=0.385 Sum_probs=184.1
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccc---ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. +....+...+||+|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6789999999999999999997 78999999999763 3345567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|+|++|+|..+++.. ..+++.....+..||+.||.|||+ |||||..+...+
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 999999999988743 358999999999999999999996 999999887542
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
....+.||||.|+|||++....++..+||||+|||+|-|++|++||... -+.-.+..++.. +..-|...
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~---~Y~~P~~l 241 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLN---EYSMPSHL 241 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhc---Cccccccc
Confidence 3345689999999999999999999999999999999999999998542 122233444332 22233333
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+. +..+++.+.++.||.+|||+.+|+.
T Consensus 242 s~-------~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 242 SA-------EAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CH-------HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 32 3345666778899999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=314.34 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=185.9
Q ss_pred cccccccccccCcceeeeecccCcceEEEEEcCC--C--CE-EEEEEccc---cccccHHHHHHHHHHhccCCCCCceeE
Q 040641 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATLPD--G--KT-VAVKKFSQ---AKTQGHRQFTAEMETLGKVKHQNLVLL 244 (435)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l 244 (435)
+.-..|+....+..+.+.||+|+||.||+|++.. + .. ||||..+. .......+|.+|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3345677778888899999999999999998643 2 23 89999875 234456789999999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 245 ~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
+|++.....+++|||+|+||+|+++|+.... .++..+++.++.++|.||+|||+
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 9999999999999999999999999987532 58999999999999999999996
Q ss_pred -cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 -DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++.-... ........-...|+|||.+....|++++|||||||++||+++ |..|+... ....+..++.
T Consensus 304 SDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~----~~~~v~~kI~-- 376 (474)
T KOG0194|consen 304 SDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM----KNYEVKAKIV-- 376 (474)
T ss_pred CccccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC----CHHHHHHHHH--
Confidence 99998764311 111111235678999999999999999999999999999999 67776432 2222222221
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
....... .... ....+..++.+||..+|++||+|.+|.+.|+.+.
T Consensus 377 -~~~~r~~------~~~~---~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 377 -KNGYRMP------IPSK---TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -hcCccCC------CCCC---CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1110000 0111 2234556777999999999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.34 Aligned_cols=226 Identities=24% Similarity=0.424 Sum_probs=180.4
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|++|++.+.-.+-||.|+-|.||+|++. ++.||||+++..+ ..+|+-|++|+||||+.+.|+|....-++
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 457888888888899999999999999986 6899999986433 25788899999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
||||||+.|-|..+|+.. ..+.......+..+||.||+|||. |||.++...+
T Consensus 189 IiMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EeeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999864 346777788899999999999995 9999987764
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ...-.++||..|||||++...+.++|+||||||||||||+||..||..-.. ..+ ++ .+. ...+.-
T Consensus 265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAI---Iw-GVG----sNsL~L 330 (904)
T KOG4721|consen 265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAI---IW-GVG----SNSLHL 330 (904)
T ss_pred h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----hee---EE-ecc----CCcccc
Confidence 3 333468999999999999999999999999999999999999999843211 001 11 111 111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
.+.. .+...+.-++.+||+..|..||+|.+|+..|+
T Consensus 331 pvPs----tcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 331 PVPS----TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCcc----cCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1112 22234455678899999999999999998875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=288.06 Aligned_cols=235 Identities=24% Similarity=0.401 Sum_probs=187.0
Q ss_pred cccccCcceeeeecccCcceEEEEE-cCCCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEE-EEEeCCe-
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLG-YCSFDEE- 253 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~- 253 (435)
..++..|.+.+.||+|.||.|||+. ..+|+.||.|++.-. +....+....|+.+|++|+|||||++++ -+.++.+
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 4456789999999999999999997 568999999998632 3344567899999999999999999998 4444455
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGL 305 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGl 305 (435)
++||||||..|+|...++..+..+..+++...+++..|+++||..+|. |||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999999999999998766666789999999999999999998885 9999
Q ss_pred cccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
+|.+... .....+.+|||.||+||.+.+..|+.||||||+||++|||+.-++||... ++... ...+.....
T Consensus 175 ~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L-~~KI~qgd~ 245 (375)
T KOG0591|consen 175 GRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSL-CKKIEQGDY 245 (375)
T ss_pred HhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHH-HHHHHcCCC
Confidence 9998754 34456789999999999999999999999999999999999999998542 33322 233333322
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
..+. ..-....+..|+..|+..||+.||+...++..+
T Consensus 246 ~~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PPLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1111 123445677788899999999999855444443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=309.64 Aligned_cols=243 Identities=25% Similarity=0.401 Sum_probs=187.6
Q ss_pred cccccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
.....|+++...+.+.+.||+|.||+||+|+|. ..||||.++... .+..+.|++|+..+++-||.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 445678889999999999999999999999986 369999997654 3356789999999999999999999999988
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
++. .||+.+|+|.+|..+|+... ..++..+.+.||.|||+||.|||. |||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 777 99999999999999998754 458889999999999999999995 99998
Q ss_pred cccccc-CccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 307 RLISAC-ETHVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 307 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
..-..- .........|...|||||++.. .+|++.+||||||||+|||+||..||.....+ .+ ++ .+..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-----qI--if-mVGr 607 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-----QI--IF-MVGR 607 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-----he--EE-Eecc
Confidence 642211 1111223468889999998754 47899999999999999999999998622111 11 11 1111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+ .-..|...... .+..+|.+|+..||..++++||.|.+|+.+|+++.
T Consensus 608 G--~l~pd~s~~~s---~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 608 G--YLMPDLSKIRS---NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred c--ccCccchhhhc---cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1 01112222222 23346677888999999999999999999887753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=317.07 Aligned_cols=235 Identities=24% Similarity=0.421 Sum_probs=187.9
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC----CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
+....+.+.++||.|.||.||+|+++- ...||||.++....+ ..++|..|+.||.++.||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 344567889999999999999998752 357999999876543 567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhcccee------ec------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL------HQ------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL------H~------------------DfGla~~~~ 310 (435)
+||+|||+||+|+.||+...+ .+.+.+...+..+||.||.|| |+ |||++|.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999998653 378889999999999999877 43 999999887
Q ss_pred ccCccccccccc--cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACETHVSTDIAG--TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
++.....+...| .+.|.|||.+..++++.+|||||||||+||.++ |.+||.... ..+.+..+.+..+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----NQdVIkaIe~gyR------ 852 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVIKAIEQGYR------ 852 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----hHHHHHHHHhccC------
Confidence 654222222222 568999999999999999999999999999876 888875432 2223322222111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
-+.+.++...+.+||++||++|-.+||+|.+|+..|++++
T Consensus 853 -------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 853 -------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 1222334557899999999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=291.38 Aligned_cols=228 Identities=23% Similarity=0.328 Sum_probs=179.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc-------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ-------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
...|.+.+.||+|+||.|-+|.- .+|+.||||.+++.... ......+|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34677889999999999999974 56999999999754321 12235799999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLA 306 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla 306 (435)
.|||||||+||+|.+.+-... .+.+..-..++.|++.|+.|||+ |||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999998876532 35556667789999999999996 99999
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCC---CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRM---STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+... +...+.+.|||+.|.|||++.+.. +..|+|+||+|||||-+++|.+||..++.... +.+ .+.++
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~e----QI~~G 397 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKE----QILKG 397 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHH----HHhcC
Confidence 9876 345566799999999999987643 34588999999999999999999976654332 222 22222
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... . ..+.+.+...+.++++.+.+..||++|||+.|+++
T Consensus 398 ~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 1 12334455667788899999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.75 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=191.4
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccccc-HHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG-HRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
++|+..+.+.+.||+|.||.|..|....+..||||+++...... .++|.+|+++|.+++|||||+++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 56788899999999999999999998878999999998765544 58999999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
+|||++|+|.+|+.....+. +.-..-.+|+.|||.||+||.+ |||++|-+...+
T Consensus 614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999998653222 4555667899999999999854 999999765544
Q ss_pred c-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh--CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 T-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT--AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. +.....+-.+.|||||.+..+.+++++|||+|||++||+++ ...||..... ...++-.......+....+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQVV-- 765 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCccee--
Confidence 3 33344566789999999999999999999999999999876 6678754322 1222222222222221111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
...+.-+..++++++++||..+-++||+|+++...|++.
T Consensus 766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122223445788999999999999999999999988765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=298.59 Aligned_cols=242 Identities=28% Similarity=0.426 Sum_probs=181.7
Q ss_pred ccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 249 (435)
|..+..+|++.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.++.++ +|||||+++|+|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 566778999999999999999999974 2356899999975432 2346789999999999 8999999999987
Q ss_pred eC-CeeEEEEecccCCCHHHHHHhhCCC----------------------------------------------------
Q 040641 250 FD-EEKLLVYEYMVNGSLDLWLRNATGS---------------------------------------------------- 276 (435)
Q Consensus 250 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~---------------------------------------------------- 276 (435)
.. +..++||||+++|+|.++++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 4578999999999999998753210
Q ss_pred ------CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc-ccccccccCC
Q 040641 277 ------HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-VSTDIAGTLG 325 (435)
Q Consensus 277 ------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~-~~~~~~gt~~ 325 (435)
...+++.....++.|+++||+|||+ |||+++.+...... ......+|+.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1247778888999999999999996 99999865432221 1223456788
Q ss_pred CcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHH
Q 040641 326 YIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLK 404 (435)
Q Consensus 326 y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (435)
|||||++.+..++.++|||||||++|||+| |..||...... . .....+....... .+. .....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~---~~~~~~~~~~~~~--~~~-------~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----E---EFCQRLKDGTRMR--APE-------NATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----H---HHHHHHhcCCCCC--CCC-------CCCHH
Confidence 999999988899999999999999999997 88887532110 0 1112222111100 011 11235
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 405 MLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 405 ~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
+.+++.+||+.||++|||+.||++.|+++++
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.85 Aligned_cols=239 Identities=24% Similarity=0.412 Sum_probs=191.2
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..|+-.+.++++...||-|.||.||.|+|+. .-.||||.++... -..++|..|+.+|+.++|||+|+++|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4566677788999999999999999999875 5689999997543 3568999999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|||+|||.+|+|-+||+... ...+.....+.+|.||+.||+||.. |||++|++.
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999753 3456777788899999999998842 999999987
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.+.........=.+.|.|||.+....++.|+|||+|||+|||+.|- ..|| +. .++ ..++..+.+.-..
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PG------idl-SqVY~LLEkgyRM--- 485 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PG------IDL-SQVYGLLEKGYRM--- 485 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CC------ccH-HHHHHHHhccccc---
Confidence 6554444444456789999999888999999999999999999994 4554 22 222 2234444332111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+.-|..+++++|..||+.+|++||+|.|+-+.++.+.
T Consensus 486 ------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 ------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 112234457899999999999999999999999888764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=298.09 Aligned_cols=236 Identities=22% Similarity=0.386 Sum_probs=188.4
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCC---CC--EEEEEEccc-cccccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPD---GK--TVAVKKFSQ-AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
+...++.+++.++||.|.||.||+|.+.+ |+ .||||..+. ...++.+.|.+|..+|+.++|||||+++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 44556677888999999999999998643 33 589999876 445567889999999999999999999999975
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
...|||||.++-|.|..||.... ..++......++.|+..+|+|||+ |||++|
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 67899999999999999998643 458888888999999999999986 999999
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
.+.++.....+...-.+.|||||.+.-++++.++|||-|||.+||+++ |..||..- ...+.+. .+.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----kNsDVI~----~iE----- 606 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----KNSDVIG----HIE----- 606 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----cccceEE----Eec-----
Confidence 998766555554555678999999999999999999999999999987 77887431 1111111 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..-..+.+..+...+..++.+||+.+|.+||+|.++...|.+|.
T Consensus 607 ----nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 607 ----NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ----CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11112223334456789999999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=286.71 Aligned_cols=220 Identities=20% Similarity=0.297 Sum_probs=170.9
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEcccccccc---HHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeEEEEecc
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG---HRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKLLVYEYM 261 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey~ 261 (435)
..+|+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++|||||+++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5789999999999998 58899999997644332 4678899999999999999999999876 34678999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~ 316 (435)
++|+|.++++.. ..+++.....++.+++.||.|||+ |||+++......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999753 347889999999999999999995 788877543211
Q ss_pred cccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 317 STDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
....||..|+|||+..+ ..++.++|||||||++|||+||+.||..... ..+... ...... . +...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~---i~~~~~-~----~~~~ 244 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDL---IINKNN-S----LKLP 244 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHH---HHhcCC-C----CCCC
Confidence 23468899999999876 6789999999999999999999999853211 111111 111110 0 1111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
. .....+.+++.+||+.||++||||.||++.|+.+
T Consensus 245 ~----~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 L----DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 1223567888999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=295.67 Aligned_cols=229 Identities=23% Similarity=0.357 Sum_probs=185.5
Q ss_pred cccccCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..|...|+..+.||+|+.|.||.|. ..+++.||||++........+-..+|+.+|+..+|+|||.++..|...+++|+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3567788888999999999999997 456889999999876666667789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|.+.+.. ..+++.+...|+.++++||+|||. |||+...+....
T Consensus 349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999998864 348999999999999999999996 999998776533
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|||||+.....|++|+||||+|++++||+-|++||..+.. +. +...+......++-.+..
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lr--AlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LR--ALYLIATNGTPKLKNPEK 494 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HH--HHHHHhhcCCCCcCCccc
Confidence 355678999999999999999999999999999999999999999853221 11 112222222222222222
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+ ..+.++..+|+..||++||++.|+++
T Consensus 495 lS-------~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LS-------PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cC-------HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22 23456667899999999999999984
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=294.30 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=181.6
Q ss_pred cccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.+..+..+|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +|||||+++|+|
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3456677899999999999999999963 235689999996543 23345788999999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCCC----------------------------------------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATGS---------------------------------------------------- 276 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~---------------------------------------------------- 276 (435)
...+..++|||||++|+|.++++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 9999999999999999999998653210
Q ss_pred -------------------CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 277 -------------------HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 277 -------------------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
...+++.....++.++++||+|||+ |||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247888899999999999999996 999987654322
Q ss_pred cc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 314 TH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 314 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. ......++..|+|||+..+..++.++|||||||++|||+| |..||...... ..+. ..+..... ...|
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~--~~~~ 339 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFY----KMIKEGYR--MLSP 339 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHH----HHHHhCcc--CCCC
Confidence 11 1122345678999999998899999999999999999998 77776432111 1111 11221110 0011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.. ...++.+++.+||+.||++||||.||++.|++.
T Consensus 340 ~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 EC-------APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC-------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11 113567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=283.61 Aligned_cols=226 Identities=32% Similarity=0.557 Sum_probs=166.8
Q ss_pred ceeeeecccCcceEEEEEcC-----CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 186 TLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
++.+.||.|+||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999876 256899999965332 346789999999999999999999999998888999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-c
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-T 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-~ 314 (435)
|+++|+|.++|+.. ....+++..+..|+.|+|+||+|||+ |||+++...... .
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999875 23458999999999999999999996 788877652211 1
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+...|+|||......++.++||||||+++|||+| |+.|+... . ...+. ..+.+..... .+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~---~~~~~----~~~~~~~~~~--~~-- 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-D---NEEII----EKLKQGQRLP--IP-- 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-C---HHHHH----HHHHTTEETT--SB--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-c---ccccc----ccccccccce--ec--
Confidence 12223456788999999888889999999999999999999 56776322 1 11121 1122111111 01
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
. .+...+.+++.+||+.+|++||||.+|++.|
T Consensus 228 -~----~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -D----NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -T----TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -c----chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 1123567889999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=278.70 Aligned_cols=232 Identities=22% Similarity=0.345 Sum_probs=176.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC----CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
..+|++.++||+|+||.||+|.+. .+..||+|.++.... .....|.+|+.++++++||||++++|++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 356899999876432 234579999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|++++.... ..+++...+.++.+++.|++|||+ |||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999999997532 358899999999999999999996 67765443221
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.........++..|+|||...+..++.++|||||||++||+++ |+.||..... ..+. ..+..... ...+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~----~~~~~~~~--~~~~ 230 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVI----KAVEDGFR--LPAP 230 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHH----HHHHCCCC--CCCC
Confidence 1111112345678999999988899999999999999999775 9988753211 1111 11211110 0011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
..+...+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 231 -------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 -------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=274.76 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=183.9
Q ss_pred cccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.|......|++.+.||.|..++||+|++ +.++.||||+++-.+.. +.....+|+..|+.++|||||+++-.|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3445567899999999999999999984 56899999999765433 357889999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|+||.||.+||+.++++.... .-+++..+..|..++++||.|||+ |||.+..+.
T Consensus 100 WvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999987543 348888999999999999999996 898876654
Q ss_pred ccCccc--c-ccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 311 ACETHV--S-TDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 311 ~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
...... . ...+||++|||||++.. ..|+.|+|||||||+..||.+|..||..... .......+.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCCC
Confidence 432211 1 45689999999998433 5799999999999999999999999854221 1111222222111
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.- .-........+..-..+.+++..|+.+||++|||++++++
T Consensus 251 ~~-~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TL-LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Cc-ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0000111122233345677888999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=276.37 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=183.8
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|.....+|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 345667899999999999999999998888899999986533 2356799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.++++... ...+++..+..++.++++|++|||+ |||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 80 TEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999997643 2347888889999999999999996 899987654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........++..|+|||+.....++.++|||||||++|||+| |+.||..... .... ..+..... .+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~----~~~~~~~~----~~~ 225 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVM----SALQRGYR----MPR 225 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHH----HHHHcCCC----CCC
Confidence 222233456778999999988889999999999999999999 8888743211 1111 11111110 010
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.. .....+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 -~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 -ME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01 1223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=281.97 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=177.4
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-----------------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCce
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-----------------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLV 242 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv 242 (435)
+..+|.+.+.||+|+||.||+|.+.+ +..||+|.+..... ....+|.+|++++.+++|||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45678899999999999999997532 34699999875432 2346799999999999999999
Q ss_pred eEEEEEEeCCeeEEEEecccCCCHHHHHHhhCC---------------CCCCCCHHHHHHHHHHhhhccceeec------
Q 040641 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG---------------SHEVLDRAKRYKIACSSARGLAFLHQ------ 301 (435)
Q Consensus 243 ~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~------ 301 (435)
+++|++...+..++||||+++|+|.+++..... ....+++.....++.|++.||+|||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999865321 11346788899999999999999996
Q ss_pred ------------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhC--CCCC
Q 040641 302 ------------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTA--KEPT 360 (435)
Q Consensus 302 ------------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg--~~p~ 360 (435)
|||+++....... .......++..|||||+.....++.++|||||||++|||+++ ..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999876543221 122234567899999998888899999999999999999974 4555
Q ss_pred CCCcccccCCcHHHHHHHHhccCCCC-ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 361 GPEFQEKEGANLVGWVFQKMKKQQAD-DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.... .......+.......... ....+. .+...+.+++.+||+.+|++||||.+|.+.|++
T Consensus 243 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELT----DEQVIENAGEFFRDQGRQVYLFRPP-------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCC----HHHHHHHHHHHhhhccccccccCCC-------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 3221 112222222211111000 000110 112357789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=272.52 Aligned_cols=228 Identities=25% Similarity=0.431 Sum_probs=176.9
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|++++++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999998888899999886433 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.++++... ..+++.....++.+++.||+|||+ |||+++...........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 999999987542 247889999999999999999996 88887755332222222
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...++..|+|||+.....++.++||||||+++|||++ |+.||.... ..+.... +..... ...|..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~----i~~~~~--~~~~~~---- 225 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEM----ISRGFR--LYRPKL---- 225 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH----HHCCCC--CCCCCC----
Confidence 3345678999999988889999999999999999999 888875321 1112111 111110 111111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
....+.+++.+||+.+|++||+|.++++.|.
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1235778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=289.93 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=181.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.|..+..+|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++++.+ +|||||+++|+|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34566778999999999999999998742 24579999997543 23345688999999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC-----------------------------------------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG----------------------------------------------------- 275 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~----------------------------------------------------- 275 (435)
...+..++|||||++|+|.++++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999864311
Q ss_pred -------------CCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc-cc
Q 040641 276 -------------SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-VS 317 (435)
Q Consensus 276 -------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~-~~ 317 (435)
....+++....+++.|+++||+|||+ |||+++........ ..
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 01236788889999999999999995 89998765432211 11
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
....++..|||||+.....++.++|||||||++|||++ |+.||....... .. ........ ....+..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~----~~~~~~~~--~~~~~~~--- 339 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KF----YKMVKRGY--QMSRPDF--- 339 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HH----HHHHHccc--CccCCCC---
Confidence 22345678999999988889999999999999999998 999975422110 11 11111110 0011111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
....+.+++.+||+.||++|||+.+|+++|++++
T Consensus 340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1135678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.41 Aligned_cols=242 Identities=25% Similarity=0.383 Sum_probs=183.3
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~ 248 (435)
.|..+..+|++.+.||+|+||.||+|+.. .+..||||+++.... ...+.|.+|+++++++. |||||+++|+|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 46677889999999999999999999752 134799999965332 23467999999999996 99999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC-----------------------------------------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG----------------------------------------------------- 275 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~----------------------------------------------------- 275 (435)
...+..++|||||++|+|.++++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998865311
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHhhhccceeec---------------
Q 040641 276 ---------------------------------------SHEVLDRAKRYKIACSSARGLAFLHQ--------------- 301 (435)
Q Consensus 276 ---------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~--------------- 301 (435)
....+++.....++.|+++||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 01236778888999999999999996
Q ss_pred ---------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCC
Q 040641 302 ---------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 ---------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~ 370 (435)
|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---- 346 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---- 346 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----
Confidence 89998765432211 1223457788999999988889999999999999999997 88887532211
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
......+..... +... ......+.+++.+||+.+|++||++.+|.++|++++
T Consensus 347 ---~~~~~~~~~~~~-----~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 ---STFYNKIKSGYR-----MAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHHHhcCCC-----CCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111211110 0000 112245778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.48 Aligned_cols=229 Identities=25% Similarity=0.404 Sum_probs=175.0
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC--eeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE--EKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e 259 (435)
.++...+.||+|+||.||++...+ |...|||..........+.+.+|+++|++++|||||+++|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356778899999999999998654 8999999987653333567899999999999999999999855555 5889999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc--c
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA--C 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~--~ 312 (435)
|+++|+|.+++.+..+ .+++........|+++||+|||+ |||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999987543 48999999999999999999995 9999987653 1
Q ss_pred CccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.........||+.|||||++..+ ....++||||+||++.||+||++||... .....+++........ |
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL-----P 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC-----C
Confidence 12233457899999999998853 3345999999999999999999998532 1222333333322211 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.+... ......+++..|++.||++|||+.++++.
T Consensus 243 ~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 243 EIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 11111 12244567778999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.29 Aligned_cols=221 Identities=28% Similarity=0.390 Sum_probs=178.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+... ...+...+|++|+++++|||||.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778899999999999999865 578999999976543 345678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||.| +|..+|.+. ..+++.....|+.++..||.|||+ |||+||.+.. +..
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9987 999999864 358999999999999999999996 9999998765 567
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
+.+.+.|||.|||||...+..|+..+|.||+|||+||+.+|++||... .+.. .++.-..+++..|.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~----Lv~~I~~d~v~~p~--- 221 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQ----LVKSILKDPVKPPS--- 221 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHH----HHHHHhcCCCCCcc---
Confidence 778899999999999999999999999999999999999999998542 1222 22211112222222
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
. ....+..+...-+.+||.+|.|-.+++
T Consensus 222 -~---~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 222 -T---ASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred -c---ccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 1 122334455566789999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=263.75 Aligned_cols=236 Identities=22% Similarity=0.301 Sum_probs=177.9
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
++|+....+|+|+||+||||+.++ |+.||||++.....+ -.+-.++|+++|++++|||+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 356777889999999999999764 999999999765442 23457899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||+.--|+.+-+.. .-++.....+++.|+++|+.|+|+ |||+||.+.. ...
T Consensus 82 ~~dhTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecchHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 99987776654433 236777888999999999999996 9999999875 345
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-----------C
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK-----------Q 383 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~ 383 (435)
.-|+.+.|.+|.|||.+.+ .+|+..+||||.||++.||+||.+-|... .+.+..-.+...+.. .
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhccC
Confidence 5678899999999998777 78999999999999999999999776432 222222222221111 1
Q ss_pred C-CCc--cccccccCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 384 Q-ADD--VLDPTVLNA---GSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 384 ~-~~~--~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
. ... +.+|....+ .......-+++++..|+..||.+|++.++++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 0 111 112221111 1112233567899999999999999999986
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=291.99 Aligned_cols=231 Identities=27% Similarity=0.390 Sum_probs=181.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcC--CCC--EEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP--DGK--TVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
-++.+++.+.++||+|.||+|++|.|. .|+ .||||.++..... ...+|.+|+.+|.+|+|||+|++||+..+ ..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 356678889999999999999999875 344 6899999765543 56789999999999999999999999876 77
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
..||||.++.|+|.+.|++. ....+-......++.|||.||.||.. |||+.|.+
T Consensus 185 ~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 88999999999999999983 33456677788899999999999953 99999988
Q ss_pred cccCcc-cc-ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 310 SACETH-VS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 310 ~~~~~~-~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
...+.+ ++ ....-...|.|||.+....++.++|||+|||++|||+| |..||-.. .+..+ .+.+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----~g~qI----L~~i------ 328 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----RGIQI----LKNI------ 328 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----CHHHH----HHhc------
Confidence 654432 11 22334568999999999999999999999999999999 55676321 11111 2222
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
|..-.-+..+.+...++++|.+||+.+|++||||.+|.+.
T Consensus 329 ---D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 329 ---DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 2111223345567789999999999999999999999743
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=281.65 Aligned_cols=225 Identities=23% Similarity=0.351 Sum_probs=176.0
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
...|+..+.||+|+||.||||... .++.||+|.++-... ...++.++|+.++.+++++||.++||.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345667799999999999999854 588999999975443 345788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||.+|++.+.++... .+++....-|..++..|+.|||. |||.+..+......
T Consensus 92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999998886532 33555666688899999999996 89998776543322
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
..+++||+.|||||++....|+.|+||||+|++.+||++|.+|+....+. .... .+ ..-..|.+..
T Consensus 168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rvlf-------lI-----pk~~PP~L~~ 233 (467)
T KOG0201|consen 168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RVLF-------LI-----PKSAPPRLDG 233 (467)
T ss_pred -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eEEE-------ec-----cCCCCCcccc
Confidence 35689999999999999989999999999999999999999998543221 0000 00 0111122211
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+...+.+++..|+++||+.||++.++++
T Consensus 234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23334667888899999999999999985
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=271.87 Aligned_cols=235 Identities=27% Similarity=0.416 Sum_probs=182.0
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+.+..+|++.+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34567899999999999999999998778899999986543 23567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++.... ...+++.....++.+++.|+.|||+ |||+++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999999997643 2357899999999999999999996 8888876643221
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||..... .. ....+...... ..+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~----~~~~~~~~~~~--~~~-- 226 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AE----VLQQVDQGYRM--PCP-- 226 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HH----HHHHHHcCCCC--CCC--
Confidence 11112233457999999988889999999999999999999 8888743211 11 11112111100 000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
......+.+++.+||+.+|++||++.++.+.|+++
T Consensus 227 -----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 -----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11223577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=266.25 Aligned_cols=177 Identities=26% Similarity=0.386 Sum_probs=153.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.++||+|+||+||.++.. +++.+|+|.+++... ...+....|..+|.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999854 588999999976542 3456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
+||+.||.|..+|.+.. .+++....-++.+++.||.|||+ |||+++.....+
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999997643 36777777789999999999996 999998644332
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
......|||+.|||||++.+..|+..+|.||+||++|||++|.+||...
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 2334589999999999999999999999999999999999999998643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=275.32 Aligned_cols=235 Identities=26% Similarity=0.468 Sum_probs=180.6
Q ss_pred ccCcceeeeecccCcceEEEEEcCC------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+|++.+.||+|+||.||+|.... .+.||+|.+..... .....|.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4578889999999999999998532 25799999865432 2345789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCC------------CCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNATGS------------HEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
+++|||+++|+|.+++...... ...+++.....++.+++.||+|||+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 9999999999999999754211 1357888899999999999999995
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++....... .......+++.|+|||+.....++.++|||||||++|||+| |..||..... .++.
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~--- 236 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVI--- 236 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH---
Confidence 8998876533221 22233457889999999888889999999999999999998 9888754221 1121
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
..+........ ......++.+++.+||+.||++||++.||++.|+++
T Consensus 237 -~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 -EMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 22222111110 112234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=268.70 Aligned_cols=236 Identities=22% Similarity=0.364 Sum_probs=182.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.++... ......|.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999864 68899999875422 223456899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++.........++......++.++++||+|||+ |||+++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999999886543334557888889999999999999996 888877654321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......|++.|+|||...+..++.++||||||+++|||+||+.|+..... +...+. ..+.... .+...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~-~~~~~~~-----~~~~~ 229 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLC-QKIEQCD-----YPPLP 229 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHH-HHHhcCC-----CCCCC
Confidence 112235688999999998888889999999999999999999999854221 112211 1111111 11110
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 230 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 ---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 112234577889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=286.74 Aligned_cols=242 Identities=25% Similarity=0.366 Sum_probs=183.0
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccc-cHHHHHHHHHHhccCC-CCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVK-HQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~ 248 (435)
.|..+..++.+.+.||+|+||.||+|++. .++.||||+++..... ..+.+.+|++++.++. |||||+++|+|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 36677788999999999999999999853 2467999999754322 3457899999999997 99999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC-----------------------------------------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG----------------------------------------------------- 275 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~----------------------------------------------------- 275 (435)
...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 276 -----------------------------------------SHEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 276 -----------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
....+++.....++.++++||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 11246777888999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++....... .......++..|||||......++.++|||||||++|||++ |+.||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 8999876532211 11223457889999999988889999999999999999998 7888743211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.......+..... ...|. .....+.+++.+||..+|++||+|.||++.|++++
T Consensus 348 ----~~~~~~~~~~~~~--~~~p~-------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ----NEQFYNAIKRGYR--MAKPA-------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----hHHHHHHHHcCCC--CCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111110 01111 11235778889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.23 Aligned_cols=235 Identities=24% Similarity=0.380 Sum_probs=180.6
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.....|++.+.||+|+||.||+|... .++.||+|.+.... ....++.+|++++++++||||++++++|...+..++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 34456888999999999999999865 47889999986432 33567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++.... ...+++..+..++.|+++||+|||+ |||+++.......
T Consensus 82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999999987532 2357889999999999999999995 8888876543222
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+..+..++.++|||||||++|||+| |..|+.... ... .......... +..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~-~~~~~~~~~~-----~~~ 226 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQ-VYELLEKGYR-----MER 226 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHH-HHHHHHCCCC-----CCC
Confidence 22222334678999999988889999999999999999998 888874321 111 1122211100 010
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .....+.+++.+||+.+|++|||+.+++++|+.+.
T Consensus 227 ~~----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 227 PE----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 01 11235778899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=269.82 Aligned_cols=234 Identities=28% Similarity=0.453 Sum_probs=184.0
Q ss_pred ccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+..+|++.+.||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45567899999999999999999988889999999976655556789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++++.. ...+++.....++.++++|++|||+ |||+++...... .
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-Y 159 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-c
Confidence 999999999997643 2357899999999999999999996 788876654321 1
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......++..|+|||......++.++||||||+++|||++ |+.||.... ....... ..... .+..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~~----~~~~~-----~~~~- 225 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYDQ----ITAGY-----RMPC- 225 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHH----HHhCC-----cCCC-
Confidence 1223456778999999888889999999999999999999 788874321 1112111 11110 0000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=265.67 Aligned_cols=228 Identities=25% Similarity=0.386 Sum_probs=176.0
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||.||+|.+.++..||+|.+.... ....+|.+|+.++++++||||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999988777789999987433 234679999999999999999999999999899999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.+++.... ..+++...+.++.+++.|++|||+ |||.++...........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999987532 247899999999999999999995 88887765432222222
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...++..|+|||+..+..++.++|||||||++|||+| |+.||..... ...... ....... ..+. .
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~----~~~~~~~--~~~~---~- 225 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEK----VSQGLRL--YRPH---L- 225 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH----HhcCCCC--CCCC---C-
Confidence 2345678999999988889999999999999999999 8888743211 111111 1111100 0011 1
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
....+.+++.+||+.+|++||++.+|++.|+
T Consensus 226 ---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1245778999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=274.00 Aligned_cols=174 Identities=26% Similarity=0.349 Sum_probs=148.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|++++++++|||||++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467889999999999999999865 57889999886542 2234679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
|+++|+|.+++.... .+++.....++.+++.||.|||+ |||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999987532 37888888999999999999984 88888755321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||+.|+|||+..+..++.++|||||||++|||+||+.||..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12345799999999999988899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.36 Aligned_cols=241 Identities=29% Similarity=0.439 Sum_probs=181.4
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 249 (435)
|+.+..+|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 5667788999999999999999999642 247899999875432 2345688899999999 8999999999886
Q ss_pred eC-CeeEEEEecccCCCHHHHHHhhCCC----------------------------------------------------
Q 040641 250 FD-EEKLLVYEYMVNGSLDLWLRNATGS---------------------------------------------------- 276 (435)
Q Consensus 250 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~---------------------------------------------------- 276 (435)
.. ...++||||+++|+|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5678999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc-cccccccCCC
Q 040641 277 -----HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV-STDIAGTLGY 326 (435)
Q Consensus 277 -----~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~-~~~~~gt~~y 326 (435)
...+++.....++.+++.||+|||+ |||+++.+....... .....++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1257889999999999999999996 899988764322211 2234567789
Q ss_pred cCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHH
Q 040641 327 IPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKM 405 (435)
Q Consensus 327 ~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (435)
+|||++.+..++.++|||||||++|||++ |..||...... .. ....+...... ..+ .....++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~---~~~~~~~~~~~--~~~-------~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EE---FCRRLKEGTRM--RAP-------EYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HH---HHHHHhccCCC--CCC-------ccCCHHH
Confidence 99999999999999999999999999998 88887432110 11 11111111100 011 1122357
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 406 LRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 406 ~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+++.+||+.+|++||++.||++.|++++
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 78999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=265.85 Aligned_cols=232 Identities=23% Similarity=0.407 Sum_probs=178.9
Q ss_pred cCcceeeeecccCcceEEEEEcCC----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.+|++.+.||+|+||.||+|.+.. ...||||.++.... ....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998642 35799999865433 2346799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.+++.|++|||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999987643 257899999999999999999996 888887764211
Q ss_pred -ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 314 -THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 314 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
........+++.|+|||......++.++||||||+++|||++ |..||..... ..+. ..+..... .+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~----~~~~~~~~----~~ 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVI----KAVEDGYR----LP 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHH----HHHHcCCC----CC
Confidence 111222345678999999988889999999999999999998 8888743211 1111 11111100 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. ......+.+++.+||+.+|++||++.||++.|++++
T Consensus 229 ~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 PP-----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00 011235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=270.61 Aligned_cols=234 Identities=26% Similarity=0.440 Sum_probs=179.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCC------CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998633 478999998754433 456899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCC----------CCCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNATG----------SHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
++||||+++|+|.++++.... ....+++.....++.+++.|++|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 999999999999999976421 22457888899999999999999995
Q ss_pred -cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHH
Q 040641 302 -DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 -DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+++.+..... .......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~--- 236 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIEC--- 236 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH---
Confidence 8888875432221 11223456788999999999999999999999999999999 9998753221 111111
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
........ .+ ......+.+++.+||+.||++||++.||++.|++
T Consensus 237 -~~~~~~~~--~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 -ITQGRLLQ--RP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHcCCcCC--CC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111110 01 1122356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=272.81 Aligned_cols=236 Identities=28% Similarity=0.453 Sum_probs=182.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|.+.+.||+|+||.||+|... ++..+|+|.+........+.|.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 456888999999999999999742 34579999987655555577999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
+||||+++|+|.+++..... ....+++..+..++.+++.|++|||+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999975421 12347899999999999999999996
Q ss_pred --cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHH
Q 040641 302 --DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 302 --DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~ 377 (435)
|||+++....... .......++..|+|||+..+..++.++|||||||++|||+| |+.||..... ....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~---- 235 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI---- 235 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----
Confidence 8998876543221 12233456788999999988889999999999999999999 8888753221 1111
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+........ + ......+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 236 ~~~~~~~~~~~--~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 ECITQGRVLER--P-------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHhCCCCCCC--C-------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11222111110 0 112235778999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=263.98 Aligned_cols=234 Identities=28% Similarity=0.407 Sum_probs=181.2
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|+.+...|++.+.||+|+||.||+|...+++.||+|.+..... ...+|.+|+.++++++||||+++++++ ..+..++|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEE
Confidence 3456678999999999999999999988889999999875433 346799999999999999999999986 45678999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ...+++.....++.+++.||+|||+ |||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 79 TEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999987543 2357889999999999999999996 888887654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........++..|+|||+.....++.++||||||+++||+++ |+.||..... .... ..+...... .
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~----~~~~~~~~~-----~ 223 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVI----QNLERGYRM-----P 223 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHH----HHHHcCCCC-----C
Confidence 222233456788999999988889999999999999999999 8988753221 1111 111111000 0
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
... ....++.+++.+||+.+|++||++.++.+.|++
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001 112357789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.01 Aligned_cols=235 Identities=26% Similarity=0.397 Sum_probs=179.8
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
..+..+|++.+.||+|+||.||+|...+...||+|+++.... ..+.|.+|++++++++||||+++++++. .+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 345677999999999999999999887777899999975332 3467899999999999999999999874 45689999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.++++... ...+++.....++.++++||+|||+ |||.++.......
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 80 EYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999997532 2347889999999999999999996 8888876543322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+..+..++.++|||||||++|||+| |..||..... ... ......... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~~----~~~~~~~~~-----~-- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REV----LDQVERGYR-----M-- 222 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HHH----HHHHhcCCC-----C--
Confidence 22223456778999999888889999999999999999999 7777643211 011 111111100 0
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+........+.+++.+||+.+|++||++.++++.|++..
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 001123346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=287.17 Aligned_cols=229 Identities=23% Similarity=0.292 Sum_probs=177.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-C-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-D-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++|||||+++++|..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999743 3 578889887554444455688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-c
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-H 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~ 315 (435)
+++|+|.++++........+++.....++.|++.||+|||+ |||+++....... .
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99999999887643334457888889999999999999996 9999987643221 2
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
.....+||++|+|||++.+..++.++|||||||++|||+||+.||.... .......... .... + ..
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~-~~~~----~-~~- 292 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLY-GKYD----P-FP- 292 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-CCCC----C-CC-
Confidence 2344679999999999998899999999999999999999999985321 1111111111 1110 1 00
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++..||+.+|++||++.+++.
T Consensus 293 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 ---CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011235678889999999999999999864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=277.63 Aligned_cols=228 Identities=21% Similarity=0.272 Sum_probs=175.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788999999999999999875 48899999997542 2234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++....
T Consensus 82 ~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 99999999999753 247888888999999999999996 8999876533
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. .... ...|....
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~~-~~~~----~~~~~~~~ 224 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN----ETWENLKY-WKET----LQRPVYDD 224 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH----HHHHHHHh-cccc----ccCCCCCc
Confidence 223467999999999998889999999999999999999999998543211 11111110 0000 00111100
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
........+.+++.+||..+|++||++.++++.
T Consensus 225 -~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 -PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001123356778889999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=267.77 Aligned_cols=236 Identities=26% Similarity=0.435 Sum_probs=181.3
Q ss_pred ccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457889999999999999999742 34569999987655555667999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC---------CCCCCCHHHHHHHHHHhhhccceeec------------------------c
Q 040641 256 LVYEYMVNGSLDLWLRNATG---------SHEVLDRAKRYKIACSSARGLAFLHQ------------------------D 302 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------D 302 (435)
+||||+++|+|.++++.... ....+++.....++.+++.||+|||+ |
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 99999999999999975431 12348999999999999999999996 8
Q ss_pred ccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHh
Q 040641 303 FGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 303 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
||+++....... .......++..|+|||+..+..++.++|||||||++|||+| |..||..... ... ....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~----~~~i 235 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEV----IECI 235 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHH----HHHH
Confidence 998876533221 11223345778999999988889999999999999999999 8888743211 111 1111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
....... .+ . .....+.+++.+||+.+|.+|||+.+|.+.|+++.
T Consensus 236 ~~~~~~~--~~---~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQGRVLQ--RP---R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcCCcCC--CC---C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111110 01 1 11235788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=267.15 Aligned_cols=233 Identities=27% Similarity=0.437 Sum_probs=178.8
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+.+.++|++.+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++||||+++++++. ....++||
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 445668899999999999999999988888899999875433 3467999999999999999999999875 56689999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.++++... ...+++..+..++.+++.|++|||+ |||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 80 EYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999987532 2347899999999999999999996 8888876543222
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+.....++.++||||||+++|||++ |..||.... ...... .+..... +..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~----~~~~~~~-----~~~ 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLE----QVERGYR-----MPC 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHH----HHHcCCC-----CCC
Confidence 22223345678999999888889999999999999999999 778874321 111111 1111100 000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.......+.+++.+||..+|++|||+.++.+.|++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=270.04 Aligned_cols=226 Identities=24% Similarity=0.309 Sum_probs=173.0
Q ss_pred cceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56788999999999999986 4689999999864332 2234678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|..++.... ...+++.....++.|++.|++|||+ |||+++...... .
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 99999998886532 2347888999999999999999996 999987654321 2
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+......... . .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~-~-----~--- 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER----VKREEVDRRVKEDQE-E-----Y--- 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHHhhcccc-c-----C---
Confidence 23457999999999999999999999999999999999999998643211 111111111111100 0 0
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
.......+.+++.+||+.||++||+ +.++++
T Consensus 225 -~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 -SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0112235667889999999999997 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=274.53 Aligned_cols=227 Identities=22% Similarity=0.335 Sum_probs=183.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-eEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE-KLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 258 (435)
.+|...+++|+|+||.++..+++ +++.+++|++.... ....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998765 47799999987543 2334568899999999999999999999998888 89999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
+||+||++.+.+.... ...+++.+...+..|++.|++|||+ |||+||.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999998765 2457888999999999999999995 999999987643
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.....++||+.||.||.+.+.+|+.|+||||+||++|||++-+++|.+. +...++ .+..+.. .
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li---~ki~~~~----------~ 223 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELI---LKINRGL----------Y 223 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc----chHHHH---HHHhhcc----------C
Confidence 2345689999999999999999999999999999999999999998543 212222 2222111 1
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.+-+.....++..++..|+..+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122233456778889999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=270.90 Aligned_cols=239 Identities=25% Similarity=0.301 Sum_probs=180.5
Q ss_pred ccCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 256 (435)
...|+..++||+|.||.||+|+ ..+|+.||+|+++... .....-..+||.||++|.|||||++.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568889999999999999998 4579999999997544 33445678999999999999999999988776 78999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|+|||+. +|.-++... .-.++..+...++.|++.||+|+|. |||+|++....
T Consensus 196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999975 677766543 2348889999999999999999996 99999988776
Q ss_pred CccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc----
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD---- 387 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 387 (435)
.....|..+-|+.|.|||.+.+ ..|+.++|+||.|||+.||++|++.+.. ..+.+....++..........
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G----~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG----RTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC----ccHHHHHHHHHHHhCCCChhccccc
Confidence 6666778889999999998765 5899999999999999999999987643 233334444444433221111
Q ss_pred ------ccccccc-C----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 ------VLDPTVL-N----AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ------~~~~~~~-~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.|... . +.........++++...+..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111100 0 001112234566777778889999999998874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.16 Aligned_cols=241 Identities=21% Similarity=0.228 Sum_probs=174.0
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5788999999999999999875 57899999986532 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++++.+..+... ...+++.....++.|++.||+|||+ |||+++.........
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999887655432 2347888889999999999999995 899988764332222
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHH--------HHHHHhccCCCCcc
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVG--------WVFQKMKKQQADDV 388 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 388 (435)
.....||+.|+|||+..+..++.++|||||||++|||++|+.||...........+.. +.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 3345789999999999888899999999999999999999999854321110000000 00000000000000
Q ss_pred ccccccCCC------CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAG------SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~------~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+...... .......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0012235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=266.81 Aligned_cols=237 Identities=26% Similarity=0.384 Sum_probs=177.0
Q ss_pred cccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
.....+|++.+.||+|+||.||+|.+. .+..||||++.... .....+|.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344567999999999999999998753 24679999986432 22345789999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCC------CCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGS------HEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
...++||||+++|+|.++++..... ...+++.....++.++++|++|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999999764221 2246778889999999999999996
Q ss_pred cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++....... .......+++.|||||+..+..++.++|||||||++|||++ |..||..... ..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~----~ 233 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLR----F 233 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----H
Confidence 8998875433221 11122345788999999988889999999999999999999 6777643211 11111 1
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
......... + . .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~~--~---~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK--P---D----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC--C---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111110 0 0 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=269.48 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=175.3
Q ss_pred cceeeeecccCcceEEEEEc-----CCCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEE
Q 040641 185 LTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLL 256 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 256 (435)
+.+.+.||+|+||+||++.+ .+++.||+|.++.... .....|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 3577899999875432 3456788999999999999999999998654 35789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++... .+++..+..++.++++|++|||+ |||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998653 38999999999999999999996 89988765432
Q ss_pred Cc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.. .......++..|+|||......++.++||||||+++|||+||..|+....... .................+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhhhh
Confidence 21 11122345677999999888889999999999999999999999974321100 000000000000000000011
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
.....+........+.+++.+||+.+|++|||+.+|++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 100001111223467789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=261.68 Aligned_cols=237 Identities=22% Similarity=0.376 Sum_probs=183.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888999999999999999876 78999999886422 223567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|..++.........+++.+...++.++++|++|||+ |||+++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 9999999999987643334558889999999999999999996 788876543221
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......|++.|+|||...+..++.++|||||||++|||++|+.|+.... ....... ........ .+ ..
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~~~~----~~-~~ 229 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLC-KKIEKCDY----PP-LP 229 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHH-hhhhcCCC----CC-CC
Confidence 11233568899999999888889999999999999999999999974321 1121111 11111111 01 10
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.......+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1122335678899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=266.66 Aligned_cols=241 Identities=30% Similarity=0.459 Sum_probs=183.1
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 249 (435)
+.....+|++.+.||+|+||.||++... ....+|+|.+.... .....++.+|++++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4556678899999999999999999853 23579999987532 23345688999999999 8999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhC------------CCCCCCCHHHHHHHHHHhhhccceeec----------------
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNAT------------GSHEVLDRAKRYKIACSSARGLAFLHQ---------------- 301 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------- 301 (435)
.++..++||||+++|+|..+++... .....+++...+.++.|++.|++|||+
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 9999999999999999999987532 123458889999999999999999995
Q ss_pred --------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCc
Q 040641 302 --------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGAN 371 (435)
Q Consensus 302 --------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~ 371 (435)
|||+++.+...... ......++..|+|||+..+..++.++|||||||++|||++ |..|+..... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~ 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----EE 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----HH
Confidence 89998865432211 1122345678999999888889999999999999999998 8888643211 11
Q ss_pred HHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
....+....... . .......+.+++.+||..+|++|||+.|+++.|+++++
T Consensus 243 ----~~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~ 293 (293)
T cd05053 243 ----LFKLLKEGYRME-----K----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293 (293)
T ss_pred ----HHHHHHcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence 122221111100 0 01122357789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=266.21 Aligned_cols=237 Identities=21% Similarity=0.348 Sum_probs=182.3
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|.. .+++.||||.+.... .....+|.+|+++++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677889999999999999985 478999999886432 223457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++.........+++.....++.++++|++|||+ |||+++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 9999999999987543334568999999999999999999996 888877654322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......|+..|+|||+..+..++.++||||||+++|||++|..||..... ..... ....... ..+...
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~-~~~~~~~-----~~~~~~ 229 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSL-CKKIEQC-----DYPPLP 229 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHH-hhhhhcC-----CCCCCC
Confidence 112235688999999999888899999999999999999999999853211 11111 1111111 011111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ......+.+++.+||+.+|++||||.+|++.++++.
T Consensus 230 ~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 S---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred c---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 122335678888999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=268.83 Aligned_cols=234 Identities=24% Similarity=0.425 Sum_probs=177.2
Q ss_pred ccCcceeeeecccCcceEEEEEc-----CCCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
...|++.+.||+|+||.||+|.. .+++.||+|.+..... .....|.+|++++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45688899999999999999974 2457899999974332 33467899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC-------------CCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATG-------------SHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
+||||+++|+|.+++..... ....+++...+.++.+++.||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 99999999999999864321 12347888899999999999999996
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++....... .......++..|+|||+..+..++.++|||||||++|||+| |..||.... ...+.
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~~~~--- 236 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQEVI--- 236 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHH---
Confidence 8998876533221 12233456778999999988889999999999999999999 888874321 11111
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.......... ... ....++.+++.+||+.+|++||++.+|.+.|++
T Consensus 237 -~~~~~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 -EMVRKRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111100 001 112356778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=265.76 Aligned_cols=228 Identities=26% Similarity=0.408 Sum_probs=175.0
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46788999999999999999987777899999864322 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+++|.++++... ..+++.....++.++++|++|||+ |||+++...........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999987542 257899999999999999999996 88888765432211112
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...++..|+|||...+..++.++|||||||++|||+| |+.||..... .... ....... ....+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~----~~~~~~~--~~~~~~----- 224 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVV----ESVSAGY--RLYRPK----- 224 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHH----HHHHcCC--cCCCCC-----
Confidence 2234567999999988889999999999999999999 7888743211 1111 1111110 001111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
....++.+++.+||..+|++||||.|+++.|.
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 12235778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=263.88 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=180.8
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-----CCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-----GKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 253 (435)
...+|++.++||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678899999999999999998755 6789999886432 2335678899999999999999999999876 467
Q ss_pred eEEEEecccCCCHHHHHHhhCCC----CCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGS----HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
.++++||+++|+|..++...... ...+++.....++.+++.||+|||+ |||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998764321 1458899999999999999999996 8999
Q ss_pred cccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 306 ARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 306 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
++.+...... ......++..|+|||+.....++.++|||||||++||+++ |+.||..... ..+..+ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~----~~~~ 235 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAY----LKDG 235 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHH----HHcC
Confidence 8765432222 1123456778999999988889999999999999999999 8988753211 112111 1111
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. .+.... .....+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 236 ~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 236 Y-----RLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C-----CCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000000 11235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=271.47 Aligned_cols=224 Identities=25% Similarity=0.370 Sum_probs=177.2
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccc----cc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQA----KT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 254 (435)
...|.+.+.||+|+||+|+.|.. .+++.||+|.++.. .. ...+...+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45788999999999999999975 46899999977653 12 22345678999999999 99999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLI 309 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~ 309 (435)
++|||||.+|+|.+++.+.. .+.+.....++.|++.|++|+|+ |||+++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999998732 36778888999999999999996 99999887
Q ss_pred cccCccccccccccCCCcCCcCCCCCC-CC-CcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRM-ST-TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .. .++..+....
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~-~l~~ki~~~~--- 239 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VP-NLYRKIRKGE--- 239 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HH-HHHHHHhcCC---
Confidence 4 2234456789999999999998876 74 78999999999999999999996421 11 1222222221
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
..-|.... ..++..++.+|+..||.+|+|+.+|+
T Consensus 240 ~~~p~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 FKIPSYLL------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ccCCCCcC------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11222221 23456788889999999999999998
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=270.68 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=147.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++|||||+++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467899999999999999999865 57889999886542 2334678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
|+++|+|.+++... ..+++.....++.++++||.|||+ |||+++.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999998753 247788888999999999999984 78887654321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235789999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=268.83 Aligned_cols=231 Identities=23% Similarity=0.403 Sum_probs=175.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCC----EEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|++.+.||+|+||.||+|++. +++ .||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999854 333 48999986543 23456799999999999999999999999764 5789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|+||+++|+|.++++... ..+++...+.++.|+++||+|||+ |||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999987642 347888899999999999999996 99999876533
Q ss_pred Cccc-cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ETHV-STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... .....++..|+|||+.....++.++|||||||++|||+| |+.|+..... ..+. ....... ....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~----~~~~~~~--~~~~ 232 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEIS----SILEKGE--RLPQ 232 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHH----HHHhCCC--CCCC
Confidence 2211 122334678999999988899999999999999999998 8888753211 1111 1111110 0011
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+. .+...+.+++.+||+.+|++||+|.+++..|.++.
T Consensus 233 ~~-------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 233 PP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11235678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=264.36 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=180.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcCC------CCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
+....+|++.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4556789999999999999999997642 3689999986443 23345789999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCC------CCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGS------HEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
...++||||+++|+|.+++...... ...+++.....++.+++.|+.|||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999999754321 2347888999999999999999996
Q ss_pred cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++.+..... .......+|..|+|||......++.++|||||||++||++| |..||.... ...... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~~~~----~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS----NEEVLK----F 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC----HHHHHH----H
Confidence 8998876543221 12233456889999999888889999999999999999998 888874321 111211 1
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
......... | .. ....+.+++.+||+.+|++|||+.+++..|++
T Consensus 234 ~~~~~~~~~--~---~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDL--P---EN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCC--C---CC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111110 1 11 12467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=266.99 Aligned_cols=231 Identities=23% Similarity=0.376 Sum_probs=173.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCC----EEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|.+.+.||+|+||.||+|.+. +++ .||+|.+..... ....++..|+.++++++|||||+++|++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999864 344 478888754322 23457888999999999999999999875 456789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|+||+++|+|.+++.... ..+++.....++.|++.||+|||+ |||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999997542 348899999999999999999996 99998865432
Q ss_pred Cc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.. .......++..|+|||+..+..++.++|||||||++||++| |+.||..... ..+.. .+.... ....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~----~~~~~~--~~~~ 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPD----LLEKGE--RLAQ 232 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----HHHCCC--cCCC
Confidence 22 12233457789999999988889999999999999999998 8888753211 11111 111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+.. +...+.+++.+||..+|++|||+.|+++.|..+.
T Consensus 233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 1124567888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=273.08 Aligned_cols=242 Identities=29% Similarity=0.439 Sum_probs=178.8
Q ss_pred ccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 249 (435)
|..+..+|.+.+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++.++ +|||||+++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 456677899999999999999999973 3467899999975332 2345788999999999 6899999999886
Q ss_pred eC-CeeEEEEecccCCCHHHHHHhhCCC----------------------------------------------------
Q 040641 250 FD-EEKLLVYEYMVNGSLDLWLRNATGS---------------------------------------------------- 276 (435)
Q Consensus 250 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~---------------------------------------------------- 276 (435)
.. ...++||||+++|+|.++++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4578999999999999998753210
Q ss_pred -----------CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-cccccc
Q 040641 277 -----------HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-HVSTDI 320 (435)
Q Consensus 277 -----------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~~~~~~ 320 (435)
...+++.....++.|+++||+|||+ |||+++....... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 1236788888999999999999996 8998876532221 111223
Q ss_pred cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.++..|+|||...+..++.++|||||||++|||++ |..|+...... .. ....+...... ..|..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--~~~~~------ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EE----FCRRLKEGTRM--RAPDY------ 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HH----HHHHHhccCCC--CCCCC------
Confidence 45678999999888889999999999999999997 88887432110 01 11112111110 01111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
...++.+++.+||+.+|++|||+.||++.|+.+++
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11256788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=262.37 Aligned_cols=233 Identities=27% Similarity=0.395 Sum_probs=177.9
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+.+..++.+.+.||+|+||.||+|....+..||+|.+.... ...+.|.+|++++++++|||++++++++. .+..++||
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 34456788999999999999999998777789999886433 23467899999999999999999999875 56689999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.++++... ...+++..+..++.+++.|++|||+ |||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 80 EFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999999997532 2347889999999999999999996 8998876543222
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||..... .... ........ +..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~----~~~~~~~~-----~~~ 224 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVL----EQVERGYR-----MPC 224 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHHcCCC-----CCC
Confidence 22223346778999999888889999999999999999999 8888753211 1111 11111100 000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.......+.+++.+||+.+|++||++.+|++.|++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 ----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123456788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=266.14 Aligned_cols=240 Identities=29% Similarity=0.417 Sum_probs=180.1
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGY 247 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 247 (435)
++.+..+|.+.+.||+|+||.||+|... +...+|+|.++... .....++.+|++++.++ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4555678999999999999999999742 23579999997542 23345788899999999 79999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 248 CSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 248 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
|...+..++||||+++|+|.+++..... ....+++...+.++.+++.||+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 9999999999999999999999976432 12358889999999999999999996
Q ss_pred ----------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccC
Q 040641 302 ----------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEG 369 (435)
Q Consensus 302 ----------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~ 369 (435)
|||+++........ ......+++.|+|||+..+..++.++|||||||++|||++ |..|+....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----- 247 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 247 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence 88887654321111 1112234568999999888889999999999999999999 777763211
Q ss_pred CcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .+...+......+ . .......+.+++.+||..+|++|||+.+|++.|++++
T Consensus 248 --~~-~~~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 248 --VE-ELFKLLKEGHRMD-----K----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --HH-HHHHHHHcCCCCC-----C----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 1122222211111 0 0112235677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=268.84 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=180.8
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 249 (435)
+.....+|.+.+.||+|+||.||+|... .+..||||.++... ....+.+.+|+++++++ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3455568899999999999999999741 24579999987543 23346789999999999 7999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
..+..++||||+++|+|.++++.... ..+++.+...++.+++.|++|||+ |||+
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999975432 337899999999999999999996 8998
Q ss_pred cccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 306 ARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 306 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
++....... .......++..|+|||...+..++.++|||||||++|||+| |..||...... ..+ .......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~----~~~~~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKF----YKLIKEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHH----HHHHHcC
Confidence 876543221 11122346778999999988889999999999999999998 88887532211 011 1111111
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. ...+. ....++.+++.+||+.+|++|||+.||++.|++.+
T Consensus 261 ~~--~~~~~-------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 261 YR--MAQPE-------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred Cc--CCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 00 00010 11235778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=264.58 Aligned_cols=242 Identities=22% Similarity=0.336 Sum_probs=176.9
Q ss_pred cccCcceeeeecccCcceEEEEEcC-----------------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCce
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-----------------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLV 242 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv 242 (435)
|..+|++.+.||+|+||.||++... ++..||+|.+..... ....+|.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 5567999999999999999998532 234699999875432 3346799999999999999999
Q ss_pred eEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCC-------CCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS-------HEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 243 ~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
++++++...+..++||||+++|+|.+++...... ...+++.....++.+++.|++|||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999999999999999999999999999764321 1347788899999999999999996
Q ss_pred ----------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh--CCCCCCCCccccc
Q 040641 302 ----------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT--AKEPTGPEFQEKE 368 (435)
Q Consensus 302 ----------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t--g~~p~~~~~~~~~ 368 (435)
|||+++.+...... ......+++.|+|||+.....++.++|||||||++|||+| |..|+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--- 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---
Confidence 89988765332211 1122344678999998887889999999999999999998 6667643211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.................. ..+. ...+...+.+++.+||+.||++||+|.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -EQVIENTGEFFRDQGRQV-YLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHHhhccccc-cCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111110000 0110 01112457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=259.83 Aligned_cols=232 Identities=23% Similarity=0.414 Sum_probs=177.0
Q ss_pred cCcceeeeecccCcceEEEEEcCC-C---CEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-G---KTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.+|+..+.||+|+||.||+|+... + ..+|+|.++... ....+.+.+|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999998642 3 379999986543 23356789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.+++.|++|||+ |||+++......
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999999987532 347889999999999999999996 888887654322
Q ss_pred ccccc--cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 THVST--DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 ~~~~~--~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..... ....+..|+|||+.....++.++|||||||++|||+| |+.||..... ..+. ..+.... ..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~----~~i~~~~----~~ 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVM----KAINDGF----RL 229 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHH----HHHhcCC----CC
Confidence 11111 1223457999999888889999999999999999998 9999753211 1111 1111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
|. .......+.+++.+||+.+|++||++.+|++.|++++
T Consensus 230 ~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 PA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 10 0112235778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.61 Aligned_cols=240 Identities=29% Similarity=0.434 Sum_probs=181.4
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGY 247 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 247 (435)
|.....+|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 4455678889999999999999999741 24579999986432 23456789999999999 89999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 248 CSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 248 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
+...+..++||||+++|+|.+++..... ....+++.....++.|+++||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 9999999999999999999999976422 12357888899999999999999996
Q ss_pred ----------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccC
Q 040641 302 ----------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEG 369 (435)
Q Consensus 302 ----------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~ 369 (435)
|||+++........ ......+++.|+|||+..+..++.++||||||+++|||+| |..|+...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------ 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------ 243 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC------
Confidence 88988765432211 1222346678999999988889999999999999999999 66776322
Q ss_pred CcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... ....+....... .+ ......+.+++.+||+.+|++||||.||++.|++++
T Consensus 244 -~~~~-~~~~~~~~~~~~--~~-------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 244 -PVEE-LFKLLKEGHRMD--KP-------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred -CHHH-HHHHHHcCCcCC--CC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1111 122222111110 01 112345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=265.73 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=175.5
Q ss_pred cccCcceeeeecccCcceEEEEEcCC---------------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD---------------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLL 244 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 244 (435)
+..+|.+.+.||+|+||.||+|+..+ ...||+|.++.... .....|.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45688999999999999999987532 23589999865422 234579999999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHHhhCC--------CCCCCCHHHHHHHHHHhhhccceeec---------------
Q 040641 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATG--------SHEVLDRAKRYKIACSSARGLAFLHQ--------------- 301 (435)
Q Consensus 245 ~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~--------------- 301 (435)
++++...+..++||||+++++|.+++..... ....+++.....++.++++|++|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9999999999999999999999999865321 11236888899999999999999996
Q ss_pred ---------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh--CCCCCCCCcccccC
Q 040641 302 ---------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT--AKEPTGPEFQEKEG 369 (435)
Q Consensus 302 ---------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t--g~~p~~~~~~~~~~ 369 (435)
|||+++....... .......++..|+|||+.....++.++|||||||++|||++ +..||.... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~----~ 238 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS----D 238 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC----h
Confidence 8888876533221 11222345778999999888889999999999999999998 445654321 1
Q ss_pred CcHHHHHHHHhccCCC-CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 370 ANLVGWVFQKMKKQQA-DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
................ .....+. .....+.+++.+||+.+|++||||.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1122111111111000 0000010 112367889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=269.39 Aligned_cols=211 Identities=22% Similarity=0.258 Sum_probs=163.3
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|||||++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 57899999986532 23345688999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
.+++... ..+++.....++.|+++||+|||+ |||+++...... ......+|
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 9998753 247888899999999999999996 899987643221 22334679
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
|+.|+|||++.+..++.++|||||||++|||+||+.||.... .... ......... .-| . ...
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~-~~~~~~~~~---~~~----~---~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEM-YRKILQEPL---RFP----D---GFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHH-HHHHHcCCC---CCC----C---cCC
Confidence 999999999999899999999999999999999999985321 1111 111111110 001 0 111
Q ss_pred HHHHHHHhcccCCCCCCCCCHH
Q 040641 403 LKMLRIAADCVADNPATRPTML 424 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs~~ 424 (435)
..+.+++.+||+.||++||++.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCC
Confidence 3456788899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=264.42 Aligned_cols=239 Identities=27% Similarity=0.416 Sum_probs=176.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-----CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 255 (435)
.++++.+.||+|+||.||+|... +++.||+|++........+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 4789999998766555567899999999999999999999987543 4678
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 9999999999999986532 247899999999999999999996 8999886543
Q ss_pred cCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc--------cCCcHHHHHHHHhc
Q 040641 312 CETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK--------EGANLVGWVFQKMK 381 (435)
Q Consensus 312 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~ 381 (435)
.... ......++..|+|||+..+..++.++|||||||++|||++|..|+....... ............+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 2211 1112234456999999988889999999999999999999887653221100 00000000111111
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
... ..+........+.+++.+||+.+|++|||+.||++.|+++
T Consensus 241 ~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 100 0000111223577899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=270.27 Aligned_cols=220 Identities=20% Similarity=0.283 Sum_probs=172.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|||||++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999875 58899999986532 22345688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... .+++.....++.|++.||+|||+ |||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 99999999999987542 36777888899999999999996 89998765432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .. ....+..... .-|..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~-~~~~i~~~~~---~~p~~ 237 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FR-IYEKILAGRL---KFPNW 237 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HH-HHHHHhcCCc---CCCCC
Confidence 1235799999999999988899999999999999999999999853211 11 1122221111 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVL 427 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl 427 (435)
...++.+++.+||+.||++||+ +.+++
T Consensus 238 -------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 238 -------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred -------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1124567888999999999997 67765
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=261.41 Aligned_cols=234 Identities=27% Similarity=0.401 Sum_probs=180.0
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|+.+..++.+.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++|+||+++++++.. ...++|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 345677899999999999999999997777889999886432 234678999999999999999999999877 778999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ...+++..+..++.+++.|++|||+ |||.++......
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999997643 2357888899999999999999996 888887654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........++..|+|||+.....++.++|||||||++||++| |+.||..... ..+.. ........ +
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~----~~~~~~~~----~- 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIR----ALERGYRM----P- 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHH----HHhCCCCC----C-
Confidence 222223345678999999988889999999999999999999 8888743211 11111 11111100 0
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 R----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 01122357788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=255.83 Aligned_cols=223 Identities=26% Similarity=0.375 Sum_probs=171.2
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHH
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLD 267 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~ 267 (435)
++||+|+||.||+|...+++.||+|.+...... ....|.+|++++++++||||++++++|...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888899999998754332 3346889999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccccccc
Q 040641 268 LWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGT 323 (435)
Q Consensus 268 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~gt 323 (435)
+++.... ..+++.....++.+++.||.|+|+ |||+++..............++
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9886532 247889999999999999999995 8888865433221112223456
Q ss_pred CCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 324 LGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 324 ~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
..|+|||+..+..++.++||||||+++||+++ |..||..... ... ........... .+ ....
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~~----~~~~~~~~~~~--~~-------~~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQA----REQVEKGYRMS--CP-------QKCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HHH----HHHHHcCCCCC--CC-------CCCC
Confidence 78999999988889999999999999999999 8888743211 111 11111111000 01 0122
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 403 LKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 46778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.67 Aligned_cols=215 Identities=22% Similarity=0.361 Sum_probs=159.3
Q ss_pred eecccCcceEEEEEcCC-------------------------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeE
Q 040641 190 ILEDGGFGTVYKATLPD-------------------------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 244 (435)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876554455678999999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 245 ~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
+|+|......++||||+++|+|+.+++... ..+++..+..++.|+++||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999987532 347888899999999999999996
Q ss_pred --------cccccccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHH-hCCCCCCCCcccccCCc
Q 040641 302 --------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELV-TAKEPTGPEFQEKEGAN 371 (435)
Q Consensus 302 --------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~-tg~~p~~~~~~~~~~~~ 371 (435)
|||+++... ......++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+..... ..
T Consensus 159 ~~~~~kl~d~g~~~~~~-----~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~ 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-----SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----SE 229 (274)
T ss_pred ccceeeecCCccccccc-----cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh----HH
Confidence 222221110 1112357888999998765 56899999999999999995 68888743211 11
Q ss_pred HHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
... ... ... . .+ .+ ....+.+++.+||+.+|++||||.+|++.|.
T Consensus 230 ~~~-~~~---~~~--~--~~---~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KER-FYE---KKH--R--LP---EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH-HHH---hcc--C--CC---CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 111 100 0 01 11 1125678899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=265.52 Aligned_cols=235 Identities=27% Similarity=0.396 Sum_probs=176.1
Q ss_pred cccCcceeeeecccCcceEEEEEcCC------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
...+|.+.+.||+|+||.||+|.+.+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998643 56799998864432 234579999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCC---CCCCCCHHHHHHHHHHhhhccceeec---------------------------cc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATG---SHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DF 303 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------Df 303 (435)
.++||||+++|+|.+++..... ....+++...+.++.++++|++|||+ ||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999999976532 12358899999999999999999995 77
Q ss_pred cccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 304 GLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 304 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
|+++.+...... .......+..|+|||+..+..++.++|||||||++|||++ |..||..... ..+.. .+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~----~~~ 235 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVME----FVT 235 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH----HHH
Confidence 777655321111 1112233567999999988889999999999999999997 8888753211 11111 111
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
...... .| ......+.+++.+||+.+|++||++.+|++.|++
T Consensus 236 ~~~~~~--~~-------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRLD--PP-------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcCC--CC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 110000 01 1112356788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=269.20 Aligned_cols=217 Identities=20% Similarity=0.278 Sum_probs=168.2
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
++||+|+||.||+|+.. +|+.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 68899999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDI 320 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~ 320 (435)
+|..++... ..+++.....++.|++.||+|||+ |||+++..... .......
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 999888753 247888889999999999999996 99998753221 1222346
Q ss_pred cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHH
Q 040641 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (435)
+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+ ...+..... .-| . .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~----~~~~~~~~~---~~p---~----~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL----FELILMEEI---RFP---R----T 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHH----HHHHHcCCC---CCC---C----C
Confidence 799999999999988999999999999999999999999854211 111 111111110 001 1 1
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 401 MMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 401 ~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
...++.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123466788899999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=288.14 Aligned_cols=242 Identities=27% Similarity=0.426 Sum_probs=186.8
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC----C----CCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP----D----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.|+.+..++.+.+.+|+|+||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|||||.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 67888888888899999999999999742 1 35799999976443 3567899999999998 5999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhC----------CCC--CCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNAT----------GSH--EVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~----------~~~--~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|..++..++|+||++.|+|..+|+..+ ... ..+.....+.++.|||.||+||++
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998765 001 238888999999999999999975
Q ss_pred -----------cccccccccccCccccccccc--cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACETHVSTDIAG--TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~ 368 (435)
|||+||.....+........| ...|||||.+....|+.|+|||||||+|||++|...++++....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 999999766544443333333 34599999999999999999999999999999965544332110
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
..++ .+.++.+...+ .+..+..++.++|..||+.+|++||+|.++.+.++..
T Consensus 528 ~~~l----~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEEL----LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHH----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1112 22333322111 1112344788999999999999999999999998874
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=260.22 Aligned_cols=233 Identities=24% Similarity=0.396 Sum_probs=174.7
Q ss_pred cceeeeecccCcceEEEEEcCC----CCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-----
Q 040641 185 LTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE----- 253 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 253 (435)
|.+.+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4577899999999999998642 3679999986532 2234678999999999999999999999876554
Q ss_pred -eEEEEecccCCCHHHHHHhhC--CCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 254 -KLLVYEYMVNGSLDLWLRNAT--GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 254 -~~lv~ey~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
.++||||+++|+|..++.... .....+++.....++.|++.||+|||+ |||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 789999999999999886542 122458888999999999999999996 89998
Q ss_pred ccccccCccc-cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 307 RLISACETHV-STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 307 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
+......... .....++..|+|||+.....++.++|||||||++|||++ |..||... ....+... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~----~~~~~~~~----~~~~~ 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV----ENHEIYDY----LRHGN 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----CHHHHHHH----HHcCC
Confidence 7654322211 112345678999999988889999999999999999999 77776432 11112221 11111
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... .. ......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 233 ~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 233 RLK-----QP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCC-----CC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 110 10 112346788899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=270.11 Aligned_cols=236 Identities=23% Similarity=0.309 Sum_probs=179.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHH--HHHHHHHhccCC-CCCceeEEEEEEeCC-eeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQ--FTAEMETLGKVK-HQNLVLLLGYCSFDE-EKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 256 (435)
..+|.+.+.||.|.||.||+|+- .+|+.||||+++..... .++ -.+|++.|+++. |||||++..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 35788999999999999999984 56889999999764433 333 367999999999 999999999998888 9999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|||||+ -+|.++++++ ...+++.....|+.||.+||+|+|. |||+||.+...
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 999996 5899988875 4568999999999999999999996 99999987643
Q ss_pred CccccccccccCCCcCCcCC-CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc--
Q 040641 313 ETHVSTDIAGTLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL-- 389 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 389 (435)
..-|+.+.|..|.|||++ +...|+.+.||||+|||++|+.+-++-|... .+.+.+.-+.+.+.........
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~----sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA----SEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC----cHHHHHHHHHHHhCCCccccchhH
Confidence 345678999999999974 6678999999999999999999998766332 2222222233333222111110
Q ss_pred ----------cccccCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 ----------DPTVLNA----GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ----------~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
-|..... -......+..+++.+|++.||.+|||+.+.++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0111000 01123446678888999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=266.15 Aligned_cols=219 Identities=20% Similarity=0.266 Sum_probs=171.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5788999999999999999865 58899999986432 1234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.++++.. ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999998754 247888888999999999999996 89998765432
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+ ...+...... -|..
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~----~~~i~~~~~~---~~~~-- 220 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGI----YEKILAGKLE---FPRH-- 220 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCcC---CCcc--
Confidence 1235799999999999888899999999999999999999999854211 111 1111111100 0110
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
....+.+++.+||+.||.+||+ +.|+++
T Consensus 221 -----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 221 -----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1124567888999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=258.86 Aligned_cols=234 Identities=28% Similarity=0.434 Sum_probs=180.9
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+.+..+|++.+.||+|+||.||+|...+++.||||.+.... ....++.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45667899999999999999999998778899999987533 33567999999999999999999999999889999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++.... ...+++.....++.+++.|++|||+ |||+++.......
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999997642 2358899999999999999999996 8888766543211
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||...+..++.++|||||||++||++| |+.||.... ...... ...... ....+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~----~~~~~~--~~~~~~- 227 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NREVLE----QVERGY--RMPRPP- 227 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcCC--CCCCCC-
Confidence 11222335678999999988889999999999999999999 888874321 111111 111110 000010
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 ------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 112357788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=263.84 Aligned_cols=234 Identities=29% Similarity=0.415 Sum_probs=176.5
Q ss_pred CcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
+|++.+.||+|+||.||+|+.. ....+|+|.+..... ....++.+|+.+++.++|||||++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999752 235789998864332 234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCC--------------------CCCCCCHHHHHHHHHHhhhccceeec---------------
Q 040641 257 VYEYMVNGSLDLWLRNATG--------------------SHEVLDRAKRYKIACSSARGLAFLHQ--------------- 301 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~--------------- 301 (435)
||||+++|+|.+++..... ....+++...+.++.+++.|++|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 9999999999999865311 11347888999999999999999996
Q ss_pred ---------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCC
Q 040641 302 ---------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 ---------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~ 370 (435)
|||+++........ ......++..|+|||+..+..++.++||||||+++|||+| |+.||..... .
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~ 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----E 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----H
Confidence 89988765332211 1122346778999999888889999999999999999999 8888743211 1
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+ ......... +... ......+.+++.+||+.+|++||++.++++.|++++
T Consensus 237 ~~----~~~~~~~~~-----~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 RL----FNLLKTGYR-----MERP----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH----HHHHhCCCC-----CCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 122211110 0001 112235778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=264.42 Aligned_cols=223 Identities=24% Similarity=0.307 Sum_probs=168.4
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||+||++... +++.||+|++...... ..+.+..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 6889999998653322 235678899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
..++.........+++.....++.|++.||+|||+ |||+++.+.... .......|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCC
Confidence 98886543334568899999999999999999996 899887654322 12234579
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
|+.|+|||+..+..++.++|||||||++|||++|+.||........ ... ......... . .. .....
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~-~~~~~~~~~---~---~~----~~~~~ 225 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKE-LKQRILNDS---V---TY----PDKFS 225 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHH-HHHhhcccC---C---CC----cccCC
Confidence 9999999999999999999999999999999999999854221110 111 111111100 0 00 01122
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 403 LKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
..+.+++.+||+.||++|| ++.++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3566788899999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.04 Aligned_cols=234 Identities=28% Similarity=0.420 Sum_probs=177.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..++.+.+.||+|+||.||++... ++..+|+|.+..........|.+|+++++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788999999999999999632 35689999987665555678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC-----------CCCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATG-----------SHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
+||||+++|+|.++++.... ....+++.....++.|++.|++|||+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 99999999999999876431 11347889999999999999999995
Q ss_pred -cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHH
Q 040641 302 -DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 -DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+++....... .......+++.|+|||+..+..++.++|||||||++|||++ |+.||..... .... .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~----~ 235 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----TEAI----E 235 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----HHHH----H
Confidence 8888875432221 11122345788999999988889999999999999999999 8888743211 1111 1
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
........ ..+. .....+.+++.+||+.||++||++.||.+.|++
T Consensus 236 ~~~~~~~~--~~~~-------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGREL--ERPR-------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccC--CCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111100 0111 112346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.81 Aligned_cols=232 Identities=24% Similarity=0.339 Sum_probs=175.2
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+..+|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 446789999999999999999986 4688999999875544455678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.++++.. ..+++.....++.|+++|+.|||+ |||+++..... ..
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06646 87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IA 161 (267)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-cc
Confidence 99999999988653 247888999999999999999996 88888755321 11
Q ss_pred ccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......|+..|+|||... ...++.++|||||||++|||++|+.|+........ .. .+... ....+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~-~~~~~---~~~~~~ 230 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LF-LMSKS---NFQPPK 230 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------he-eeecC---CCCCCC
Confidence 123356889999999864 34578899999999999999999999743211100 00 00000 000111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
... .......+.+++.+||+.+|++|||+.+|++.|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 111234677889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=244.97 Aligned_cols=237 Identities=26% Similarity=0.353 Sum_probs=181.9
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|...+.+|+|.||+||+|+. .+|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 567788999999999999985 56999999999754322 245678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
|+ -+|...+++. ...+..++...++.++.+|++|||+ |||+|+...... ..
T Consensus 83 m~-tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-RI 157 (318)
T ss_pred cc-ccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC-cc
Confidence 97 5899999875 3468899999999999999999996 999999876533 33
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc---
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT--- 392 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 392 (435)
.+..+-|..|.|||.+.+ +.|+..+||||.|||+.||+-|.+-+ ....+.+....++..+......+..+-.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f----pG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF----PGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC----CCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 344478999999997654 68999999999999999999877443 2334445555566665443322221110
Q ss_pred -----------ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 393 -----------VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 393 -----------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
....-........++++...|..||.+|+|+.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000111223345788899999999999999998753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=280.90 Aligned_cols=232 Identities=23% Similarity=0.333 Sum_probs=177.7
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC----
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE---- 252 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 252 (435)
....+|.+.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3446899999999999999999985 468999999986432 233456889999999999999999988765432
Q ss_pred ----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 253 ----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 253 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
..++||||+++|+|.++++........+++.....++.|++.||+|||+ |||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999997654444568888999999999999999995 999
Q ss_pred ccccccccC-ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 305 LARLISACE-THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 305 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......... .
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-------~~~~~~~~~~~-~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-------NMEEVMHKTLA-G 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHhc-C
Confidence 998654321 12233467999999999999989999999999999999999999998532 11122221111 1
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... .+.+ .....+.+++..||+.||++||++.++++
T Consensus 261 ~~~-~~~~--------~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 261 RYD-PLPP--------SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCC-CCCC--------CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111 0111 11235678889999999999999999875
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=261.06 Aligned_cols=229 Identities=20% Similarity=0.342 Sum_probs=178.3
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+..+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 34556889999999999999999985 46889999998765555567789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.+. .+++.+...++.+++.|++|||+ |||+++......
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999998642 36888899999999999999996 888877543321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......|++.|+|||...+..++.++|||||||++|||++|+.||..... ........... ......
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~~~~~~-~~~~~~--- 238 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNG-TPELQN--- 238 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHHHhcCC-CCCCCC---
Confidence 112335788999999998888889999999999999999999999854321 11111111111 000001
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||..+|++|||+.+|++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1112235667889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=259.18 Aligned_cols=232 Identities=22% Similarity=0.399 Sum_probs=176.6
Q ss_pred cCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788999999999999999753 23479999986543 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.+++.|++|||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999997542 347888999999999999999995 899887664332
Q ss_pred cccc--ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 THVS--TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 ~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... ....++..|+|||+..+..++.++|||||||++||+++ |+.||..... ...... +.... ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~~----~~~~~--~~-- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIKA----IEEGY--RL-- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHHH----HhCCC--cC--
Confidence 2111 11233568999999988889999999999999999887 9988743211 111111 11110 00
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+. . ......+.+++.+||+.+|++||+|.++++.|++++
T Consensus 229 ~~-~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 229 PA-P----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CC-C----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 10 0 011235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=262.09 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=178.7
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-----------------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCce
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-----------------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLV 242 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv 242 (435)
+..+|++.+.||+|+||.||+|...+ +..||+|.+..... .....|.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34678899999999999999987542 24589999875432 3456789999999999999999
Q ss_pred eEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCC-------CCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS-------HEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 243 ~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
+++++|..++..++||||+++++|..++...... ...+++.....++.+++.||+|||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 9999999999999999999999999999764311 1258899999999999999999996
Q ss_pred ----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh--CCCCCCCCccccc
Q 040641 302 ----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT--AKEPTGPEFQEKE 368 (435)
Q Consensus 302 ----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t--g~~p~~~~~~~~~ 368 (435)
|||+++....... .......+|+.|+|||+.....++.++|||||||++|||++ +..|+....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---- 238 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---- 238 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC----
Confidence 8998876543221 12233456789999999888889999999999999999998 556653211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.....................+ .......++.+++.+||+.||++|||+.||++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1112221111111111110000 001122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=261.31 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=164.1
Q ss_pred eecccCcceEEEEEcCC---CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCC
Q 040641 190 ILEDGGFGTVYKATLPD---GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~ 265 (435)
.||+|+||.||+|.+.+ +..+|+|+++.... .....|.+|+.++++++||||++++|++......++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997543 45799999865432 234578999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCC-CCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc-cccc
Q 040641 266 LDLWLRNATG-SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-VSTD 319 (435)
Q Consensus 266 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~-~~~~ 319 (435)
|.++++.... .....++.....++.|+++|++|||+ |||+++........ ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ 161 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence 9999976432 12245677778899999999999995 89988754322211 1223
Q ss_pred ccccCCCcCCcCCCCC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 320 IAGTLGYIPPEYGQSR-------MSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~-------~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..|+..|+|||+.... .++.++|||||||++|||++ |+.||..... ...... .... ......+|
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~---~~~~-~~~~~~~~ 233 (269)
T cd05087 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTY---TVRE-QQLKLPKP 233 (269)
T ss_pred cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHH---Hhhc-ccCCCCCC
Confidence 4578889999987532 35789999999999999996 9888843211 111111 1111 11111222
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
...... ...+.+++..|| .+|++|||+.||++.|+
T Consensus 234 ~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 221111 123556778899 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.48 Aligned_cols=225 Identities=26% Similarity=0.392 Sum_probs=167.2
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
...+|+..+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+++++.++|+|||++++++...+..++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3456788899999999999999864 589999999864332 23467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.... ...+.....++.|+++||+|||+ |||+++.+....
T Consensus 152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999999985421 24556677899999999999996 899988764321
Q ss_pred cccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... .............. .
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~-~---- 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCAICMSQ-P---- 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhccC-C----
Confidence 12234579999999998643 3345689999999999999999999862211 11111111111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+... .....++.+++.+||+.||++|||+.||++
T Consensus 294 -~~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAP----ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCC----CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 112235678889999999999999999985
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=266.20 Aligned_cols=233 Identities=26% Similarity=0.413 Sum_probs=174.0
Q ss_pred cCcceeeeecccCcceEEEEEcCC-C--CEEEEEEcccc-ccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-G--KTVAVKKFSQA-KTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 257 (435)
.+|++.+.||+|+||.||+|...+ + ..+|+|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468899999999999999998653 3 34788888643 223446789999999999 799999999999999999999
Q ss_pred EecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 258 YEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
|||+++|+|.++++.... ....+++.....++.|++.|++|||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999999999999975321 11347888999999999999999996
Q ss_pred cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHh
Q 040641 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 302 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++..... ........+..|+|||+.....++.++|||||||++|||+| |+.||..... .+. ....
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~----~~~~ 231 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AEL----YEKL 231 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH----HHHH
Confidence 88887542211 01111223557999999988889999999999999999998 9888853221 111 1111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... .+... ......+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 232 ~~~~-----~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 232 PQGY-----RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred hcCC-----CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1110 00000 111235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=259.01 Aligned_cols=228 Identities=29% Similarity=0.423 Sum_probs=179.0
Q ss_pred cccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
...+|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4567888999999999999999875 78999999976544 457799999999999999999999999989999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.++++... ...+++.....++.+++.|+.|||+ |||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999997643 2358899999999999999999996 888877653211
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
....++..|+|||+.....++.++||||||+++||+++ |+.||..... .. ............ .+
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~----~~~~~~~~~~~~--~~---- 221 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KD----VVPHVEKGYRME--AP---- 221 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HH----HHHHHhcCCCCC--Cc----
Confidence 12345678999999988889999999999999999998 8888743211 11 111111111000 01
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
......+.+++.+||..+|++|||+.|++++|+.+
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 ---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11224577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=257.13 Aligned_cols=232 Identities=23% Similarity=0.333 Sum_probs=176.4
Q ss_pred ccCcceeeeecccCcceEEEEEcCC----CCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
..++++.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998643 2468999886544 3345679999999999999999999999865 56789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... ..+++..+..++.++++|++|||+ |||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999997532 247899999999999999999996 88888765443
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.....+...++..|+|||......++.++|||||||++||+++ |..||..... ...... +...... ..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~----~~~~~~~--~~~ 230 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGR----IENGERL--PMP 230 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH----HHcCCcC--CCC
Confidence 2222223345578999999888889999999999999999996 9999854321 111111 1111100 011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. .....+.+++.+||..+|++|||+.++++.|+++.
T Consensus 231 ----~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 231 ----P---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11235677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=259.52 Aligned_cols=224 Identities=22% Similarity=0.339 Sum_probs=168.4
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
+.||+|+||.||+|+.. +++.||+|.+.... ......|.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999864 68899999886433 23346799999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc-ccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV-STDIA 321 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~-~~~~~ 321 (435)
.++++... ..+++.....++.|++.||+|||+ |||+++......... .....
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99987532 347889999999999999999995 788876543211110 01112
Q ss_pred ccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHH
Q 040641 322 GTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400 (435)
Q Consensus 322 gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (435)
++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ... ......... +.. ...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~----~~~~~~~~~-----~~~----~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQT----REAIEQGVR-----LPC----PEL 220 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHH----HHHHHcCCC-----CCC----ccc
Confidence 3456999999988889999999999999999998 7777643211 011 111111100 000 011
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 401 MMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 401 ~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
....+.+++.+||+.+|++|||+.+|.++|++
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 22357789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=256.97 Aligned_cols=216 Identities=22% Similarity=0.390 Sum_probs=160.9
Q ss_pred eeecccCcceEEEEEcCC-------------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 189 DILEDGGFGTVYKATLPD-------------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
+.||+|+||.||+|.+.+ ...||+|.+..........|.+|+.+++.++|||||++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------------ccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------DFG 304 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------DfG 304 (435)
+||||+++|+|+.+++... ..+++.....++.|+++||+|||+ |||
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999999886532 348888999999999999999995 344
Q ss_pred ccccccccCccccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHH-hCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELV-TAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
++..... .....|+..|+|||+.. +..++.++|||||||++|||+ +|..|+..... .... . ...
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~----~-~~~ 223 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AEKE----R-FYE 223 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hHHH----H-HHh
Confidence 4332211 12345788999999876 567899999999999999998 47777542110 0010 0 101
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
... .. ..+ ....+.+++.+||+.||++||++.+|++.++
T Consensus 224 ~~~-~~-----~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-ML-----VTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-cC-----CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 100 00 111 1235678899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=255.29 Aligned_cols=225 Identities=23% Similarity=0.391 Sum_probs=175.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|... +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677899999999999999865 5889999998643 233456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.++++... ...+++.....++.+++.|+.|||+ |||+++...... ..
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99999999998642 2358888899999999999999996 888877654322 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|++.|+|||+..+..++.++|||||||++|||+||+.||..... ... ........... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~----~~~~~~~~~~~-----~~-- 222 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GAL----ILKIIRGVFPP-----VS-- 222 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHcCCCCC-----Cc--
Confidence 2335688999999999888899999999999999999999999854321 111 11111111111 00
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|++||++.++++
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 --QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 112235778999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=259.55 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=177.6
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
|+....+|++.+.||+|+||.||+|... .+..||+|.++.... .....+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3455678999999999999999999653 245799998864432 233568899999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCC------CCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGS------HEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
.+..++||||+++|+|.++++..... ....++.....++.+++.||.|||+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999999753211 1335667788899999999999996
Q ss_pred -cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHH
Q 040641 302 -DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 -DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+++........ ......++..|+|||...+..++.++|||||||++|||++ |..||..... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~---- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLK---- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----
Confidence 89988765432211 1122345678999999988889999999999999999999 6777643211 11111
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.......... + ......+.+++.+||+.+|++|||+.++++.|++.
T Consensus 233 ~~~~~~~~~~--~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGYLDQ--P-------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCCCCC--C-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111000 0 01123577899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=265.61 Aligned_cols=217 Identities=20% Similarity=0.283 Sum_probs=166.8
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
++||+|+||.||+++.. +|+.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999864 68999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDI 320 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~ 320 (435)
+|..++... ..+++.....++.|++.||+|||+ |||+++...... ......
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 999888653 247888899999999999999996 899887532211 122345
Q ss_pred cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHH
Q 040641 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (435)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........ ..-|. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~----~~~~~~~~---~~~p~-------~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERL----FELILMEE---IRFPR-------T 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHH----HHHHhcCC---CCCCC-------C
Confidence 799999999999888999999999999999999999999853211 111 11111110 00011 1
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 401 MMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 401 ~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123456788899999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=270.02 Aligned_cols=230 Identities=20% Similarity=0.237 Sum_probs=173.0
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
....+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568899999999999999999865 58899999986432 223345788999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|..+++.. .++......++.+++.||+|||+ |||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998653 26677778889999999999996 9999876543
Q ss_pred cCccccccccccCCCcCCcCCCCC----CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSR----MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..........||+.|||||++... .++.++|||||||++|||+||+.||..... ... +..+..... .
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~-~~~i~~~~~-~ 265 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGT-YSKIMDHKN-S 265 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHH-HHHHHcCCC-c
Confidence 322223346799999999987543 478999999999999999999999854321 111 111111110 0
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPAT--RPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 428 (435)
...|. .......+.+++.+|++.+|++ ||++.|+++
T Consensus 266 ~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 LTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00111 0011234567888899999987 999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=247.60 Aligned_cols=209 Identities=25% Similarity=0.372 Sum_probs=168.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|+....||.|+||.|..++.+ +|.-+|+|+++.... ...+...+|-.+|+.+.||.+|++.+.|.+....||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3467888999999999999999865 478899999976543 334567889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||++||.|..+++... .++.....-+|.+|+.|++|||+ |||+|+.+...
T Consensus 122 vmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999998753 37778888899999999999996 99999987642
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
....||||.|+|||.+.+..|+.++|.|||||++|||+.|.+||..... . .+++.+-.. ++.=|.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~----~iY~KI~~~---~v~fP~ 262 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----I----QIYEKILEG---KVKFPS 262 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----H----HHHHHHHhC---cccCCc
Confidence 3468999999999999999999999999999999999999999975432 1 123333222 223344
Q ss_pred ccCCCCHHHHHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRI 408 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l 408 (435)
..++..++.+.+++++
T Consensus 263 ~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQV 278 (355)
T ss_pred ccCHHHHHHHHHHHhh
Confidence 4555555555555543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=254.52 Aligned_cols=228 Identities=24% Similarity=0.436 Sum_probs=175.5
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788999999999999999887788999999864332 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.++++... ..+++.....++.+++.|++|||+ |||+++...........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 999999987542 247888889999999999999995 78877654322111122
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...++.+|+|||+..+..++.++|||||||++|||++ |+.||..... ..+ ...+.... ....+..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~----~~~~~~~~--~~~~~~~---- 225 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEV----VETINAGF--RLYKPRL---- 225 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHH----HHHHhCCC--CCCCCCC----
Confidence 2345678999999988889999999999999999998 8888753221 111 11221110 1111211
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
....+.+++.+||+.+|++|||+.||++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1235778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=267.15 Aligned_cols=223 Identities=21% Similarity=0.291 Sum_probs=173.9
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC--CCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD--GKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
....+|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+++++.++|||||++++++...+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 345678999999999999999998543 3689999986432 22345788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++.... .+++.....++.|++.||+|||+ |||+++...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999987542 47888889999999999999996 999987654
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||..... . .....+..... .-
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~----~~~~~i~~~~~---~~ 247 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L----LIYQKILEGII---YF 247 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H----HHHHHHhcCCC---CC
Confidence 32 2346799999999999888899999999999999999999999854211 0 11222221111 01
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
|... ...+.+++.+|++.||++|+ ++.++++
T Consensus 248 p~~~-------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 248 PKFL-------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCC-------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111 12356788899999999995 8888864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=258.19 Aligned_cols=233 Identities=24% Similarity=0.373 Sum_probs=172.3
Q ss_pred cceeeeecccCcceEEEEEcCC-CC--EEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC------Ce
Q 040641 185 LTLVDILEDGGFGTVYKATLPD-GK--TVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------EE 253 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 253 (435)
+.+.+.||+|+||.||+|...+ +. .||+|.++... ....+.|.+|+++++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998754 32 58999886532 33456789999999999999999999988542 24
Q ss_pred eEEEEecccCCCHHHHHHhhC--CCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNAT--GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
.++||||+++|+|..++.... .....+++.....++.|++.|++|||+ |||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 689999999999998875322 123458899999999999999999996 999988
Q ss_pred cccccCccc-cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 308 LISACETHV-STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 308 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
......... .....+++.|+|||+.....++.++|||||||++|||++ |+.||.... ...+ ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~----~~~~~~~~~ 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----NSEI----YDYLRQGNR 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHH----HHHHHcCCC
Confidence 764322111 122346678999999988889999999999999999999 777774321 1111 122222111
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ..+ + .....+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 233 ~--~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 233 L--KQP----P---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred C--CCC----C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0 001 0 12234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=270.16 Aligned_cols=236 Identities=16% Similarity=0.215 Sum_probs=171.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++|||||++++++..+...++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999864 58899999753 23467899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+. ++|..++... ..+++...+.++.|+++||+|||+ |||+|+.........
T Consensus 165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 7888887653 247888899999999999999996 999987543322223
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC---CcHHHHHHHHhccCCCC-------
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG---ANLVGWVFQKMKKQQAD------- 386 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~------- 386 (435)
.....||+.|+|||++.+..++.++|||||||++|||+||+.|+......... ......+..........
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 33467999999999998889999999999999999999999886432111000 01111111111000000
Q ss_pred ------------ccccccccC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 ------------DVLDPTVLN--AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ------------~~~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000112345778899999999999999999984
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=257.00 Aligned_cols=232 Identities=21% Similarity=0.417 Sum_probs=175.1
Q ss_pred cCcceeeeecccCcceEEEEEcCC-C---CEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-G---KTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+.+.+.||+|+||.||+|.... + ..||||.+.... .....+|..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357789999999999999998643 3 369999987542 33456899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.++++... ..+++.....++.+++.|++|||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999987542 247889999999999999999996 888877654321
Q ss_pred ccc--ccccc--ccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 314 THV--STDIA--GTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 314 ~~~--~~~~~--gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... ..... .+..|+|||+.....++.++|||||||++||+++ |..||.... ..+...++ .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~----~~~~~~~i----~~~~--~~ 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVINAI----EQDY--RL 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC----HHHHHHHH----HcCC--cC
Confidence 110 11111 2457999999988889999999999999999887 888875321 11122221 1110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+ ......+.+++.+||+.+|++||++.+|+..|++++
T Consensus 231 ~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 231 PPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred CCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 000 112234678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=262.10 Aligned_cols=226 Identities=25% Similarity=0.308 Sum_probs=172.5
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
|++.+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 677899999999999999864 688999999865322 2234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++.... ...+++.....++.|+++|+.|||+ |||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--T 157 (285)
T ss_pred cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--c
Confidence 99999998886532 2348889999999999999999995 899887654221 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...+.... +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~------~~---- 223 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKEDQ------EE---- 223 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhcc------cc----
Confidence 2235789999999999888899999999999999999999999854211 111111111111110 00
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
........+.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111233567889999999999999 7878754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=262.20 Aligned_cols=241 Identities=26% Similarity=0.419 Sum_probs=180.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.|..+..+|.+.+.||+|+||.||+|+.. ....||+|.++... ......+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 35667788999999999999999999742 24579999987533 23346788999999999 6999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|...+..++||||+++|+|.+++..... ....+++.....++.|++.||.|||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 99999999999999999999999976421 12358888999999999999999996
Q ss_pred -----------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++........ ......++..|||||+..+..++.++|||||||++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 89998765432111 1112234567999999888889999999999999999999 7777743211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. ...........+. .. .....+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 243 -~~----~~~~~~~~~~~~~-----~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 -EE----LFKLLREGHRMDK-----PS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -HH----HHHHHHcCCCCCC-----CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 1222221111110 01 11235668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=271.75 Aligned_cols=225 Identities=26% Similarity=0.387 Sum_probs=174.9
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..|...|.-.+.||.|+||.||.|+. .+.+.||||+++-...+ .+.++.+|++.|.+++|||+|.+.|+|......
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 45556677888999999999999985 46789999999755443 456788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|||||||- |+-.+++.-.. ..+....+..|+.+++.||+|||+ |||.|.+..
T Consensus 102 WLVMEYCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 99999995 56666665432 247777888999999999999997 899887765
Q ss_pred ccCccccccccccCCCcCCcCC---CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYG---QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. .+++|||.|||||++ ..+.|+-|+||||+||++.|+..+++|...+ +.....+. +...
T Consensus 178 PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-------NAMSALYH-IAQN---- 240 (948)
T KOG0577|consen 178 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYH-IAQN---- 240 (948)
T ss_pred ch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-------hHHHHHHH-HHhc----
Confidence 43 357899999999975 3578999999999999999999999997432 22222222 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
-.|.+....+.+ .+..++-.|+++-|.+|||..++++
T Consensus 241 -esPtLqs~eWS~---~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 -ESPTLQSNEWSD---YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCCCCCchhHH---HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 123444444444 4455667899999999999998874
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=257.16 Aligned_cols=226 Identities=23% Similarity=0.360 Sum_probs=171.1
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.++||+|+||.||+|.. .+++.||+|.+.... ....++|.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567889999999999999985 468899999986432 233467999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++|+|..+. .+++.....++.+++.||+|||+ |||+++..... ..
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999996542 25677788899999999999996 89988765322 22
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
....||..|+|||+..+..++.++|||||||++|||+||+.||................ ....... .+.....
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~- 223 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDED-----PPVLPVG- 223 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccC-----CCCCCCC-
Confidence 34578999999999988889999999999999999999999986533221111111111 1111111 0111111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
....++.+++.+||+.+|++||++.|+++.
T Consensus 224 --~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 --QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112346788899999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=256.52 Aligned_cols=228 Identities=28% Similarity=0.446 Sum_probs=169.9
Q ss_pred eeecccCcceEEEEEcCC-CC--EEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLPD-GK--TVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 43 57888886433 33446789999999999 899999999999999999999999999
Q ss_pred CCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 264 GSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 264 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
|+|.++++.... ....+++.....++.+++.|++|||+ |||+++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999975421 12347888999999999999999996 888875
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..... ........+..|+|||+.....++.++|||||||++|||+| |+.||..... ... ...+......
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~----~~~~~~~~~~ 230 (270)
T cd05047 161 GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AEL----YEKLPQGYRL 230 (270)
T ss_pred ccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHH----HHHHhCCCCC
Confidence 32211 11111234567999999988889999999999999999997 8888743211 111 1111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
+ ... .....+.+++.+||+.+|.+|||+.+++..|+++++
T Consensus 231 ~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 231 E-----KPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred C-----CCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 0 001 112356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=261.28 Aligned_cols=233 Identities=21% Similarity=0.328 Sum_probs=175.4
Q ss_pred cCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.|.+|+.++++++|||||++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35778889999999999999853 2478999999754332 2456889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
+++||+++++|.+++..... ....+++.....++.|+++||+|+|+
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999853211 12347888889999999999999995
Q ss_pred --cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHH
Q 040641 302 --DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 302 --DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~ 377 (435)
|||+++....... .......+++.|+|||......++.++|||||||++|||+| |..|+.... ...+ .
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~-~ 236 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQDV-I 236 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHH-H
Confidence 8998876543221 11223456789999999888889999999999999999998 777764321 1111 2
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
..+........ . ..+...+.+++.+||+.+|++||++.+|+..|+.
T Consensus 237 ~~i~~~~~~~~-----~----~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLPC-----P----DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCCC-----C----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222211110 0 1122346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=256.40 Aligned_cols=227 Identities=28% Similarity=0.444 Sum_probs=166.4
Q ss_pred eeecccCcceEEEEEcC----CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEEEEeccc
Q 040641 189 DILEDGGFGTVYKATLP----DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLLVYEYMV 262 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~~ 262 (435)
+.||+|+||.||+|.+. +...||+|++.... ....+.+.+|+.+++.++||||++++++|.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23579999985432 2345678899999999999999999998764 556889999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc---c
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET---H 315 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~---~ 315 (435)
+|+|.+++.... ....+.....++.++++|++|||+ |||+++....... .
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997542 235677788899999999999996 8998875432211 1
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......++..|+|||+.....++.++|||||||++|||++|+.|+.... ...++... ...... ...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~---~~~~~~---~~~~~--- 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVY---LLQGRR---LLQPE--- 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH---HhcCCC---CCCCC---
Confidence 1123456778999999888889999999999999999999665532211 11112111 111100 00010
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.....+.+++.+||+.+|++||++.||++.|+++.
T Consensus 226 ----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 ----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11235778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=256.56 Aligned_cols=230 Identities=19% Similarity=0.357 Sum_probs=174.1
Q ss_pred cceeeeecccCcceEEEEEcCC--CCEEEEEEccccc----------cccHHHHHHHHHHhcc-CCCCCceeEEEEEEeC
Q 040641 185 LTLVDILEDGGFGTVYKATLPD--GKTVAVKKFSQAK----------TQGHRQFTAEMETLGK-VKHQNLVLLLGYCSFD 251 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~ 251 (435)
|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6778899999999999998754 6789999875321 1123457789998865 7999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLA 306 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla 306 (435)
+..++||||+++++|.+++.........+++...+.++.+++.||.|||+ |||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999999886533334458888999999999999999994 78877
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
....... ......|+..|+|||+..+..++.++||||||+++|||++|+.|+.... ...... .......
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~- 230 (269)
T cd08528 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLAT-KIVEAVY- 230 (269)
T ss_pred eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHHH-HHhhccC-
Confidence 6544322 2334578999999999988889999999999999999999999974321 111111 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.+.. . ......+.+++.+||+.||++||++.||..++.+
T Consensus 231 ---~~~~-~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 ---EPLP-E---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---CcCC-c---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0100 0 0112356788889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.00 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=177.0
Q ss_pred CcceeeeecccCcceEEEEEc-----CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeE
Q 040641 184 KLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 255 (435)
.|++.+.||+|+||.||++.+ .+++.||+|.++... ......+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 247789999986543 33346799999999999999999999998775 5688
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ..+++..+..++.+++.||+|||+ |||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999986532 247899999999999999999996 8998876543
Q ss_pred cCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-------cCCcHHHHHHHHhcc
Q 040641 312 CET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-------EGANLVGWVFQKMKK 382 (435)
Q Consensus 312 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 382 (435)
... .......|+..|+|||+..+..++.++|||||||++|||+|++.|........ ...............
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 221 11223557778999999888889999999999999999999887643211100 000001111111111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... + ........+.+++.+||+.+|++|||+.++++.|++++
T Consensus 242 ~~~~----~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 242 GKRL----P-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred CccC----C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1100 0 01112346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=255.50 Aligned_cols=222 Identities=21% Similarity=0.345 Sum_probs=167.4
Q ss_pred ecccCcceEEEEEcC---CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP---DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||+|.+. ++..||+|.+..... ...+.|.+|+.++++++||||++++++|. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 799999999999753 355799999865432 23467999999999999999999999885 4578999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc--cccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV--STDI 320 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~--~~~~ 320 (435)
.+++.... ..+++.....++.++++||+|||+ |||+++......... .+..
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 99987532 358899999999999999999996 899887654322211 1122
Q ss_pred cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.++..|+|||+.....++.++|||||||++||+++ |..||..... .... ..+....... .+ .
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~----~~~~~~~~~~-~~----~---- 221 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVM----SFIEQGKRLD-CP----A---- 221 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHH----HHHHCCCCCC-CC----C----
Confidence 34578999999888889999999999999999996 8888753211 1111 1111111100 01 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
....++.+++.+||..+|++||++.+|.+.|+++
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=264.36 Aligned_cols=217 Identities=20% Similarity=0.280 Sum_probs=167.9
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
++||+|+||.||+++.. +++.||||.+.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 58899999996532 223457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDI 320 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~ 320 (435)
+|..++... ..+++.....++.|++.||+|||+ |||+++..... .......
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF 155 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence 999888653 247888999999999999999996 99998754321 1122346
Q ss_pred cccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHH
Q 040641 321 AGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (435)
+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+... ...-|. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~-~~~~~~~---~~~~p~-------~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKL-FELILME---DIKFPR-------T 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHH-HHHhccC---CccCCC-------C
Confidence 799999999999888899999999999999999999999853211 111 1111111 000111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 401 MMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 401 ~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 123466788899999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.45 Aligned_cols=227 Identities=19% Similarity=0.174 Sum_probs=172.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788999999999999999864 588999999975432 234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++.... ..+++.....++.|++.||+|||+ |||+++.+......
T Consensus 82 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999997642 347888888899999999999996 99999876543333
Q ss_pred ccccccccCCCcCCcCCC------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 316 VSTDIAGTLGYIPPEYGQ------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
......||+.|+|||++. ...++.++|||||||++|||+||+.||..... .......+.........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCccCCC
Confidence 333457999999999875 45678999999999999999999999854321 11111111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+. + .....+.+++..|+. +|++|||+.+++.
T Consensus 232 ~~----~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 ED----P---KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC----C---CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 10 0 112245567778887 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=261.18 Aligned_cols=234 Identities=28% Similarity=0.436 Sum_probs=174.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCC--EEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGK--TVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 256 (435)
..+|++.+.||+|+||.||+|.+. ++. .+|+|.++... ......|.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457889999999999999999864 344 46888776432 23346788999999999 89999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec-----------------------
Q 040641 257 VYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------- 301 (435)
||||+++|+|.++++.... ....+++...+.++.|+++|++|||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 9999999999999975421 12357888999999999999999996
Q ss_pred -cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 -DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++..... .......++..|+|||+.....++.++|||||||++|||+| |..||..... ... ...
T Consensus 166 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~----~~~ 235 (303)
T cd05088 166 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AEL----YEK 235 (303)
T ss_pred CccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHH----HHH
Confidence 88887642211 11111234668999999888889999999999999999998 8888743211 111 111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..... .+.... .....+.+++.+||+.+|++||++.+++..|++++
T Consensus 236 ~~~~~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 236 LPQGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HhcCC-----cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 000000 11235678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=268.22 Aligned_cols=236 Identities=22% Similarity=0.295 Sum_probs=167.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-----eeE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-----EKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 255 (435)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999864 68999999986432 223456889999999999999999999886432 479
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||. ++|.+++... ..+++.....++.|+++||+|||+ |||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6898888643 247889999999999999999996 8999876432
Q ss_pred cC--ccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-----
Q 040641 312 CE--THVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK----- 382 (435)
Q Consensus 312 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 382 (435)
.. ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCCHHH
Confidence 21 112234679999999998765 6789999999999999999999999853211 0111111100000
Q ss_pred ------CCCCcc---c---cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 ------QQADDV---L---DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ------~~~~~~---~---~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... . .+.............+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0 000000000001234568899999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=260.20 Aligned_cols=235 Identities=27% Similarity=0.444 Sum_probs=177.1
Q ss_pred cccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
+..+|++.+.||+|+||.||+|... ++..||+|.+..... ...++|.+|+.++++++||||++++++|..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999853 467899999865432 334679999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCC------------------CCCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 254 KLLVYEYMVNGSLDLWLRNATG------------------SHEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
.++||||+++|+|.+++..... ....+++..++.++.+++.||+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 9999999999999999975321 11236788889999999999999996
Q ss_pred ----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccC
Q 040641 302 ----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEG 369 (435)
Q Consensus 302 ----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~ 369 (435)
|||+++.+..... .......++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---- 238 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---- 238 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 8888875432211 11222345678999999888889999999999999999998 7777743211
Q ss_pred CcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
... ............ + .....++.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ---~~~-~~~~~~~~~~~~--~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEV-IYYVRDGNVLSC--P-------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHH-HHHHhcCCCCCC--C-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 112221111000 0 1122467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=260.27 Aligned_cols=236 Identities=24% Similarity=0.311 Sum_probs=167.2
Q ss_pred CcceeeeecccCcceEEEEEcC--CCCEEEEEEcccccc--ccHHHHHHHHHHhccC---CCCCceeEEEEEEe-----C
Q 040641 184 KLTLVDILEDGGFGTVYKATLP--DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKV---KHQNLVLLLGYCSF-----D 251 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~ 251 (435)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788999999999999999863 467899998864332 2234566777776655 79999999999853 4
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
...++||||++ |+|.+++.... ...+++.....++.|+++||+|||+ |||+++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 55899999996 68988887542 2347888999999999999999996 999987
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... .......||+.|+|||......++.++|||||||++|||++|++||..... ......+..........+
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGEED 232 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCChhh
Confidence 65432 223345789999999998888899999999999999999999999864321 112222221111000000
Q ss_pred ----------cccccccCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 ----------VLDPTVLNA---GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ----------~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+....+ ........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 00011224567899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=269.93 Aligned_cols=175 Identities=22% Similarity=0.271 Sum_probs=145.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4778899999999999999854 57899999996532 2234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC--
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-- 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-- 313 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998753 247778888889999999999996 899875431100
Q ss_pred --------------------------------------------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHH
Q 040641 314 --------------------------------------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVI 349 (435)
Q Consensus 314 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvi 349 (435)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123579999999999988889999999999999
Q ss_pred HHHHHhCCCCCCC
Q 040641 350 LLELVTAKEPTGP 362 (435)
Q Consensus 350 l~El~tg~~p~~~ 362 (435)
+|||+||+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (381)
T cd05626 238 LFEMLVGQPPFLA 250 (381)
T ss_pred HHHHHhCCCCCcC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=256.66 Aligned_cols=229 Identities=22% Similarity=0.323 Sum_probs=162.1
Q ss_pred eecccCcceEEEEEcCCC---CEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCC
Q 040641 190 ILEDGGFGTVYKATLPDG---KTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~ 265 (435)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677665432 2345689999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-ccccccc
Q 040641 266 LDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-THVSTDI 320 (435)
Q Consensus 266 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-~~~~~~~ 320 (435)
|.++++.........++.....++.|+++||+|||+ |||+++...... .......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 999998653333346667778899999999999996 888875432211 1112345
Q ss_pred cccCCCcCCcCCCC-------CCCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 321 AGTLGYIPPEYGQS-------RMSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 321 ~gt~~y~aPE~~~~-------~~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.|+..|+|||+... ..++.++|||||||++|||+++ ..|+... . . .......... ......+|.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~---~---~~~~~~~~~~-~~~~~~~~~ 233 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-S---D---REVLNHVIKD-QQVKLFKPQ 233 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-C---H---HHHHHHHHhh-cccccCCCc
Confidence 68899999998643 2457899999999999999985 4455321 1 1 1111111111 112233333
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
..... ...+.+++..|| .+|++||++.+|++.|.
T Consensus 234 ~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 32221 224556777899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=270.12 Aligned_cols=226 Identities=20% Similarity=0.272 Sum_probs=174.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788999999999999999865 68999999997542 2334678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC--
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-- 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-- 313 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 82 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999998754 347888889999999999999996 899987654322
Q ss_pred --------------------------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc
Q 040641 314 --------------------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367 (435)
Q Consensus 314 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~ 367 (435)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-- 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--
Confidence 0122345799999999999988999999999999999999999999854321
Q ss_pred cCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 040641 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT-MLHVLK 428 (435)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl~ 428 (435)
............ ....|... .....+.+++.+|+. +|++||+ +.++++
T Consensus 236 -----~~~~~~i~~~~~--~~~~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 -----QETYNKIINWKE--SLRFPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred -----HHHHHHHhccCC--cccCCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 111111111000 00011100 012346677888997 9999999 999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=257.70 Aligned_cols=229 Identities=22% Similarity=0.365 Sum_probs=178.0
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+..+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 34556799999999999999999985 46889999999765555567789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|..++... .+++.++..++.+++.|++|||+ |||+++......
T Consensus 95 ~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 95 MEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999988642 37889999999999999999995 888877654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
. ......|+..|+|||...+..++.++|||||||++|||+||+.||..... ......... ........+
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~-~~~~~~~~~-- 238 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIAT-NGTPELQNP-- 238 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-cCCcccCCc--
Confidence 1 12335688999999999888899999999999999999999999854321 111111111 111011111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||..+|++||++.+|+.
T Consensus 239 -----~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 -----EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111234667888999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.44 Aligned_cols=222 Identities=23% Similarity=0.371 Sum_probs=174.4
Q ss_pred eecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHH
Q 040641 190 ILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~ 268 (435)
+||+|.||+||-|+..+ ...+|||.+.....+..+....|+.+.+.++|.|||+++|.|.+++.+-|.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 68999999999999765 45799999987777777788999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcccccccccc
Q 040641 269 WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHVSTDIAGT 323 (435)
Q Consensus 269 ~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~~~~~~gt 323 (435)
+|+.+-++-. -.+...--+..||++||.|||. |||.++.+..- ......+.||
T Consensus 662 LLrskWGPlK-DNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRSKWGPLK-DNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGT 739 (1226)
T ss_pred HHHhccCCCc-cchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccccc
Confidence 9997654311 1445555678999999999996 99998876532 2234457899
Q ss_pred CCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHH
Q 040641 324 LGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPM 401 (435)
Q Consensus 324 ~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (435)
..|||||++.. +.|+.++|||||||++.||.||++||...... ...+++.-. -...|. -+.+.
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGm-----yKvHP~----iPeel 804 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGM-----YKVHPP----IPEEL 804 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcc-----eecCCC----CcHHH
Confidence 99999999865 46899999999999999999999998542211 111222110 011222 23455
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 402 MLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 402 ~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+...++++|+..||.+||++.+++.
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 667788999999999999999999874
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=265.57 Aligned_cols=227 Identities=21% Similarity=0.294 Sum_probs=170.4
Q ss_pred CcceeeeecccCcceEEEEEc----CCCCEEEEEEccccc----cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 184 KLTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367889999999999999875 357899999986432 12335678899999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999988753 247888888999999999999996 999987654
Q ss_pred ccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..........+||+.|||||++.+. .++.++|||||||++|||+||+.||....... ....+...+...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~------ 226 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKC------ 226 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcC------
Confidence 3333333456799999999988764 47889999999999999999999985322111 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
++..... ....+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111 112456788899999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=262.70 Aligned_cols=217 Identities=24% Similarity=0.349 Sum_probs=165.7
Q ss_pred eeecccCcceEEEEEc----CCCCEEEEEEccccc----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 189 DILEDGGFGTVYKATL----PDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+.||+|+||.||+++. .+++.||||.++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999986532 12234678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++... ..+.+.....++.|++.||+|||+ |||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV 156 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence 9999999988653 236777778889999999999996 899987543221 22
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..... . +.+.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~-~~~~~~~~-~-~~~~---- 222 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTI-DKILKGKL-N-LPPY---- 222 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHH-HHHHcCCC-C-CCCC----
Confidence 2345799999999999888899999999999999999999999854211 1111 11111110 0 1110
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+||+.+|++|| ++.++++
T Consensus 223 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 ----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112466888999999999999 7777754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=268.91 Aligned_cols=226 Identities=17% Similarity=0.243 Sum_probs=168.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6788999999999999999865 58899999996532 2234568889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++.+......
T Consensus 82 ~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999998753 247888899999999999999996 89998754321100
Q ss_pred -------------------------------------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCC
Q 040641 316 -------------------------------------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKE 358 (435)
Q Consensus 316 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~ 358 (435)
.....+||+.|+|||++....++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999988899999999999999999999999
Q ss_pred CCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC---HHHHHH
Q 040641 359 PTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT---MLHVLK 428 (435)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~evl~ 428 (435)
||..... ............ ....|.. . .....+.+++.+|+. +|.+|++ +.|++.
T Consensus 238 Pf~~~~~-------~~~~~~i~~~~~--~~~~~~~--~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNP-------QETYRKIINWKE--TLQFPDE--V---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCH-------HHHHHHHHcCCC--ccCCCCC--C---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9854321 111111111110 0000110 0 111234566667775 8999998 888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=261.66 Aligned_cols=172 Identities=27% Similarity=0.358 Sum_probs=145.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||++++++|..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5788999999999999999864 57889999886432 223456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~ 316 (435)
++|+|.++++.. ..+++.....++.++++||.|||+ |||+++..... .
T Consensus 82 ~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 82 DGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 999999999754 247888889999999999999994 67776544221 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.....|+..|+|||+..+..++.++|||||||++|||+||+.|+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2345789999999998888899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=254.05 Aligned_cols=225 Identities=28% Similarity=0.386 Sum_probs=172.5
Q ss_pred eeecccCcceEEEEEcCC--C--CEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLPD--G--KTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|.+.+ + ..||+|.+..... ...+.|.+|++++++++|||||++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999976555 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc--cc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH--VS 317 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~--~~ 317 (435)
|+|.+++.+... ..+++.....++.|++.||+|||+ |||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999976432 458899999999999999999996 89988776432211 11
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
....++..|+|||+.....++.++|||||||++|||+| |+.||..... .+....+. .... ....+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~---~~~~--~~~~~----- 223 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKID---KEGE--RLERP----- 223 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH---hcCC--cCCCC-----
Confidence 23457889999999988889999999999999999999 9998743211 11111111 1110 00011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
......+.+++.+||+.+|++||++.+|++.|.+
T Consensus 224 --~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 224 --EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred --ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 1122357788999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=266.94 Aligned_cols=175 Identities=21% Similarity=0.289 Sum_probs=148.0
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++.+++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6788999999999999999854 58899999996532 2233568889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET- 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~- 314 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999998753 247888899999999999999996 9999875432100
Q ss_pred ---------------------------------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 315 ---------------------------------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 315 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01123579999999999988899999999999999999999999985
Q ss_pred C
Q 040641 362 P 362 (435)
Q Consensus 362 ~ 362 (435)
.
T Consensus 238 ~ 238 (363)
T cd05628 238 S 238 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=261.90 Aligned_cols=220 Identities=21% Similarity=0.348 Sum_probs=165.5
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHH---hccCCCCCceeEEEEEEeCCeeEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMET---LGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|++.+.||+|+||.||+|... +++.||||.++... ....+.+.+|+++ ++.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 467889999999999999864 58899999997532 2223456666655 4678899999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|..+++. ..+++.....++.+++.||+|||+ |||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999888753 248889999999999999999996 899887533211
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|||||.+.+..++.++|||||||++|||++|+.||..... ... ...+..... .-|.
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~----~~~i~~~~~---~~p~- 222 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEV----FDSIVNDEV---RYPR- 222 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCC---CCCC-
Confidence 222346799999999999988999999999999999999999999853211 111 111111110 0111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
.....+.+++.+||+.||++||+ +.++++
T Consensus 223 ------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 ------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11234567888999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=240.25 Aligned_cols=225 Identities=24% Similarity=0.379 Sum_probs=182.0
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
..++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+-..++.+|++|-+.|+||||.++||++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468899999999999999999865 46789999986543 2334679999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
++||.++|++...|+... ...++......++.|+|.|+.|+|. |||-+-...
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999998643 2346777777899999999999995 899875433
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......|||.-|.+||...+..++.++|+|++||+.||++.|.+||..... +-.++.+.+. +..+|.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k~---~~~~p~ 243 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRKV---DLKFPS 243 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHHc---cccCCc
Confidence 2344568999999999999999999999999999999999999999865432 2233444332 233443
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ...+++.+|+..+|.+|.+..||+.
T Consensus 244 ~is~-------~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 TISG-------GAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccCh-------hHHHHHHHHhccCccccccHHHHhh
Confidence 3332 4567888999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=257.10 Aligned_cols=236 Identities=21% Similarity=0.337 Sum_probs=174.2
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEE-----
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCS----- 249 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----- 249 (435)
.+.....+|++.+.||+|+||.||+|... +++.+|+|.++... ....++.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456778999999999999999999864 57899999876432 2235688899999999 6999999999884
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
.++..++||||+++|+|.++++........+++.....++.++++|+.|||+ |||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 3456899999999999999887543334457888889999999999999995 8888
Q ss_pred cccccccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
++...... .......|++.|+|||++. ...++.++|||||||++|||++|+.|+..... ...... .
T Consensus 171 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~~~~~-~ 241 (286)
T cd06638 171 SAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALFK-I 241 (286)
T ss_pred eeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hHHHhh-c
Confidence 87654321 1223356899999999864 34578899999999999999999999853211 000111 1
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.........++.. ....+.+++.+||+.+|++|||+.||++.
T Consensus 242 ~~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRNPPPTLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCCcccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111111111 12246788999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=260.85 Aligned_cols=238 Identities=22% Similarity=0.275 Sum_probs=172.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 356889999999999999999865 588999999865432 234567899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|++ |+|.+++.... ..+++.....++.|++.||+|||+ |||+++...... .
T Consensus 84 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 997 58988886532 246788888999999999999996 999987643221 1
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC---------
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA--------- 385 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 385 (435)
......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...... .....+.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhccccc
Confidence 2234578999999998765 56899999999999999999999998543211 111111111111000
Q ss_pred ---CccccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 ---DDVLDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ---~~~~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....|...... ......+..+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000011100000 0011234568889999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=261.65 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=170.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999865 688999999875432 233467889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|++ ++|.+++.... ..++......++.|++.||+|||+ |||+++..... ..
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SH 158 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Cc
Confidence 996 67777776432 347778888999999999999996 89988754321 12
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC--------
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD-------- 386 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 386 (435)
......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...... ......+..........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCCCChhhccchhhc
Confidence 2234578999999998754 45788999999999999999999998643211 11111111111100000
Q ss_pred ccccccc---cCCCC-H------HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DVLDPTV---LNAGS-K------PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~---~~~~~-~------~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...++.. ..+.. . .....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00000 0 01134567888999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=242.13 Aligned_cols=240 Identities=22% Similarity=0.280 Sum_probs=187.7
Q ss_pred cccCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----Cee
Q 040641 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EEK 254 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 254 (435)
...+|.+.+.+|+|||+.||.++ ..+++.+|+|++.....++.+..++|++..++++||||+++++++..+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999997 567899999999877767778899999999999999999999887543 458
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------ccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARL 308 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~ 308 (435)
|+++.|...|+|.+.+.........+++.+.+.|+.++.+||.+||. |||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999998766666679999999999999999999996 7887754
Q ss_pred cccc--Cc------cccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHH
Q 040641 309 ISAC--ET------HVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 309 ~~~~--~~------~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~ 377 (435)
.... .. .......-|..|.|||.+. +...++++|||||||++|+|+.|..||+..+.. +..+.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--GgSla---- 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--GGSLA---- 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--CCeEE----
Confidence 3211 00 0112234688999999764 456789999999999999999999999765542 21110
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+..+...-+...+....+.+++..|++.||.+||++.+++..+++++
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111222222222335567889999999999999999999999998865
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.80 Aligned_cols=241 Identities=29% Similarity=0.408 Sum_probs=180.4
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.|+....+|++.+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34555567899999999999999999742 12368999886433 23456799999999999 8999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|...+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 99999999999999999999999875321 12357888999999999999999995
Q ss_pred -----------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 88888765432111 1122334567999999988889999999999999999999 777764321
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... ...+......+. .. .....+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 242 ---~~~~-~~~~~~~~~~~~-----~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 ---VEEL-FKLLKEGHRMDK-----PA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHHH-HHHHHcCCCCCC-----CC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111 111211111110 01 12235778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=255.38 Aligned_cols=226 Identities=21% Similarity=0.395 Sum_probs=176.2
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||.||+|...+ ++.||+|.++.... .+++.+|++++++++||||+++++++..+...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4578889999999999999998765 78999999865433 57899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++.... ..+++.....++.++++|+.|||+ |||++....... ..
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AK 155 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-cc
Confidence 99999999987532 358899999999999999999995 888877654322 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||+..+..++.++|||||||++|||+||+.|+....... ..... ..... +.. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~~-~~~~~-----~~~--~ 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFMI-PNKPP-----PTL--S 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhhh-ccCCC-----CCC--C
Confidence 233458899999999988889999999999999999999999985422110 00000 00000 000 0
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
........+.+++.+||+.+|++|||+.||+.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112235678889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.42 Aligned_cols=237 Identities=21% Similarity=0.267 Sum_probs=167.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC--------
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-------- 251 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 251 (435)
+..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4467999999999999999999864 58899999885422 2345799999999999999999886432
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLA 306 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla 306 (435)
...++||||+++ +|.+++.........+++.....++.|+++||+|||+ |||+|
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 246799999985 6777665433334568888999999999999999996 99999
Q ss_pred ccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC-
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ- 384 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 384 (435)
+.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||.+||...... .....+.+.+....
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQVLGTPTE 292 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCH
Confidence 8664322 2234578999999998765 46899999999999999999999998543221 11111111111000
Q ss_pred ---------CCccccccccCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ---------ADDVLDPTVLNAG-----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ---------~~~~~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+..-|...... ......++.+++.+||..||++|||+.|++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000000000 0011235778999999999999999999873
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=257.15 Aligned_cols=217 Identities=20% Similarity=0.382 Sum_probs=160.9
Q ss_pred eeecccCcceEEEEEcCC--------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 189 DILEDGGFGTVYKATLPD--------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+.||+|+||.||+|.... ...||+|.+........+.|.+|+.+++.++|||||++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999997532 234888888655444556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------ccccccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------DFGLARL 308 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------DfGla~~ 308 (435)
+++|+|..+++... ..+++..+..++.|++.|++|||+ |||++..
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999997543 257888999999999999999996 3333322
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|..++..... ..... ...... ..
T Consensus 158 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~------~~~~~-~~~~~~--~~ 223 (258)
T cd05078 158 VL-----PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD------SQKKL-QFYEDR--HQ 223 (258)
T ss_pred cC-----CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc------HHHHH-HHHHcc--cc
Confidence 11 1123467889999998876 4578999999999999999999644322111 00000 011110 00
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
.... ...++.+++.+||+.+|++|||+.+|++.|+
T Consensus 224 -----~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----LPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----CCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111 1135678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=253.04 Aligned_cols=225 Identities=26% Similarity=0.396 Sum_probs=170.6
Q ss_pred eeecccCcceEEEEEcCC----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLPD----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++++.|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 468999999999997532 26899999875543 24467999999999999999999999876 4568999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc--
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS-- 317 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~-- 317 (435)
|+|.+++.... .+++..+..++.+++.|++|||. |||+++..........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997542 47889999999999999999996 8888876543222111
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
....++..|+|||...+..++.++|||||||++|||++ |+.||.... ...+..++ ...... ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~----~~~~~~--~~~----- 220 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAML----ESGERL--PRP----- 220 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHH----HcCCcC--CCC-----
Confidence 11234568999999988889999999999999999998 888875321 11222221 111110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
......+.+++.+||..+|++||++.+|++.|+++-+
T Consensus 221 --~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 221 --EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 1112357789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=262.42 Aligned_cols=226 Identities=26% Similarity=0.303 Sum_probs=184.0
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc---cHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 256 (435)
...|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999998765 999999999765443 3468899999999998 9999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARL 308 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~ 308 (435)
|||+|.||.|.+.+... + +++.....++.+++.++.|||+ |||+|..
T Consensus 114 vmEL~~GGeLfd~i~~~---~--~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---H--YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc---c--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999988765 1 7888899999999999999996 9999988
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... .......+||+.|+|||+.....|+..+||||.||++|.|++|.+||....... .+..+..... +.
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~~i~~~~~-~f 257 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFLAILRGDF-DF 257 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHHHHHcCCC-CC
Confidence 765 344567899999999999999999999999999999999999999986543211 1112222211 11
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.+........+++..++..||.+|+|+.++++
T Consensus 258 -----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 -----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 12222333345567788899999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=262.84 Aligned_cols=224 Identities=18% Similarity=0.283 Sum_probs=168.7
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|+.. +++.||||.++... ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999865 58899999997532 22345688899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++..+..++.|++.||+|||+ |||+++..... ......
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST 155 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence 9999888643 248889999999999999999996 89988753221 122234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-cCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-EGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
.+||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......+..+.+...... -|. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~---~-- 227 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IPR---S-- 227 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---CCC---C--
Confidence 679999999999999899999999999999999999999985321111 1112223333333222111 011 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCC------HHHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPT------MLHVL 427 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs------~~evl 427 (435)
...++.+++.+|++.||++||+ +.+++
T Consensus 228 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 228 --LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 1234677888999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=253.67 Aligned_cols=221 Identities=23% Similarity=0.331 Sum_probs=167.7
Q ss_pred eecccCcceEEEEEcC---CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 190 ILEDGGFGTVYKATLP---DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
.||+|+||.||+|.+. +++.||+|.++.... ...++|.+|+.+++.++||||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899999864332 23467999999999999999999999985 45678999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc--cc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV--ST 318 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~--~~ 318 (435)
+|.+++... ..+++.....++.|++.|++|||+ |||+++......... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998653 247888999999999999999996 899887654332211 12
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...++..|+|||......++.++|||||||++|||+| |+.||..... ..+ ...+....... ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~----~~~i~~~~~~~-----~~~~- 222 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEV----TQMIESGERME-----CPQR- 222 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHH----HHHHHCCCCCC-----CCCC-
Confidence 2344678999999888888999999999999999998 8888853211 112 12222211111 1111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
...++.+++.+||+.||++||+|.+|.+.|++
T Consensus 223 ---~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 ---CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=258.57 Aligned_cols=231 Identities=22% Similarity=0.329 Sum_probs=176.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999864 58899999876433 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
+++|+|..+++.. ..+++.....++.+++.|+.|||+ |||+++.....
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999988753 247888899999999999999984 77776543221
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccc----CCcHHHHHHHHhccCCCCccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE----GANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
......||..|+|||+..+..++.++|||||||++||++||+.||........ ...+..+........ .+
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 11235789999999998888899999999999999999999999875433211 111222222221111 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.. ........+.+++.+||+.||++|||+.||++.
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 011133457788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=284.58 Aligned_cols=230 Identities=19% Similarity=0.307 Sum_probs=172.2
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 254 (435)
....+|++.+.||+|+||.||+|... +++.||+|.+.... ......|..|+.++++++|||||++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34468999999999999999999865 46789999886432 2334678999999999999999999998854 3568
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------- 301 (435)
+|||||+++|+|..+|.........+++...+.|+.|++.||+|||+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997644334568999999999999999999994
Q ss_pred ---------------cccccccccccCccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 040641 302 ---------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEF 364 (435)
Q Consensus 302 ---------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~ 364 (435)
|||+++.+... .......||+.|+|||++.+ ..++.++||||||||+|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 56665543221 11234579999999998743 458899999999999999999999985321
Q ss_pred ccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... +...+.... ...... ....+.+++..||+.+|.+||++.|++.
T Consensus 248 ------~~~q-li~~lk~~p-------~lpi~~---~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 ------NFSQ-LISELKRGP-------DLPIKG---KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ------cHHH-HHHHHhcCC-------CCCcCC---CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1111 122222111 110011 1235678889999999999999999983
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=257.05 Aligned_cols=226 Identities=21% Similarity=0.359 Sum_probs=171.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3577888999999999999865 477889999865554556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|..++.... ..+++..+..++.++++||+|||+ |||+++..... .....
T Consensus 86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRD 161 (282)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-ccccc
Confidence 999998876532 348899999999999999999996 88887654321 11223
Q ss_pred cccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 319 DIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
...||..|+|||+.. ...++.++|||||||++|||++|+.||..... ........... ......+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~- 232 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE-PPTLAQPS- 232 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcC-CCCCCCcc-
Confidence 456899999999873 34577899999999999999999999753211 11111111111 11111111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.+|++||++.++++
T Consensus 233 ------~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 233 ------RWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12235678889999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=258.19 Aligned_cols=221 Identities=23% Similarity=0.277 Sum_probs=165.4
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||+++.. +|+.||+|.+..... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 589999999864322 1234566799999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
..++.... ...+++.....++.|++.|++|||+ |||++...... .......|
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 98886532 2347888889999999999999996 89988765432 12234578
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
|..|+|||+..+..++.++||||+||++|||++|+.||...... ..... +........ ... .. ....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~---~~~~~-~~~~~~~~~----~~~--~~---~~~~ 223 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEE-LKRRTLEDE----VKF--EH---QNFT 223 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch---hhHHH-HHHHhhccc----ccc--cc---ccCC
Confidence 99999999998888999999999999999999999998532111 01111 111111110 000 00 0122
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 403 LKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.++.+++..||+.||++||++.|+++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchh
Confidence 34678889999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=261.69 Aligned_cols=240 Identities=23% Similarity=0.400 Sum_probs=178.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-----CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEe--CCee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 254 (435)
..|++.+.||+|+||.||+|++. +++.||||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999853 3678999999755443 45689999999999999999999999877 5578
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++.... ..+++.....++.+++.||+|||+ |||+++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997542 248899999999999999999996 888887654
Q ss_pred ccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC-------CcHHHHHHHHhc
Q 040641 311 ACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG-------ANLVGWVFQKMK 381 (435)
Q Consensus 311 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~ 381 (435)
..... ......++..|+|||......++.++||||||+++|||+||+.|+......... ..........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 22111 111234556799999988888999999999999999999999987543211100 001111111111
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... . +....+..++.+++.+||+.+|++||||.||+++|++|.
T Consensus 241 ~~~~--~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 241 EGER--L-------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cCCc--C-------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1100 0 001112246788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=255.94 Aligned_cols=230 Identities=22% Similarity=0.367 Sum_probs=175.2
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+...|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++..++..++||
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 34567889999999999999999865 48899999997665555678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|..++.+.. ..+++.....++.|++.|++|||+ |||+++..... .
T Consensus 89 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~ 164 (292)
T cd06644 89 EFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-L 164 (292)
T ss_pred ecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-c
Confidence 9999999988876532 247889999999999999999996 78877653221 1
Q ss_pred cccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.......++..|+|||++. ...++.++|||||||++|||++|+.|+..... ...... ..........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~ 236 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK-IAKSEPPTLS 236 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHH-HhcCCCccCC
Confidence 1123456889999999874 34568899999999999999999999743211 111111 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+ ......+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QP-------SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CC-------cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 112235678899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=250.72 Aligned_cols=227 Identities=27% Similarity=0.394 Sum_probs=174.1
Q ss_pred cccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEE-eCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS-FDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e 259 (435)
...+|++.+.||+|+||.||+|... +..||+|.++... ..+.|.+|+.++++++|+||+++++++. .++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4457889999999999999999865 7889999886432 3467899999999999999999999765 4567899999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.++++... ...+++.....++.+++.|++|||+ |||+++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999999987643 2347888999999999999999996 888876543211
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
....++..|+|||+.....++.++|||||||++|||++ |+.|+... ..... ...+....... ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-------~~~~~-~~~~~~~~~~~-----~~ 221 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDV-VPRVEKGYKMD-----AP 221 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHH-HHHHhcCCCCC-----CC
Confidence 22345678999999988889999999999999999998 88886421 11111 11111111111 00
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=256.90 Aligned_cols=229 Identities=23% Similarity=0.364 Sum_probs=175.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
|.++|++.+.||+|+||.||+|... +++.||+|.+........+.|.+|++++++++||||+++++++..++..++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5567899999999999999999864 588999999876555556789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|..++.... ..+++.....++.+++.|+.|||+ |||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 999999999987542 248888999999999999999995 788776543221 1
Q ss_pred ccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 316 VSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
......||+.|+|||... ...++.++|||||||++|||++|+.||..... ...... +..........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLK-ILKSEPPTLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHH-HhcCCCCCcCC
Confidence 223356899999999864 34577899999999999999999999853211 111111 11111111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ ......+.+++..||+.+|++||++.+|++
T Consensus 231 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 231 P-------SKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c-------ccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1 112235667888999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=252.91 Aligned_cols=231 Identities=21% Similarity=0.293 Sum_probs=170.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
....+.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3445555678999999999999854 577899999876655566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
|+++++|.++++..... ...++.....++.|+++|++|||+ |||+++......
T Consensus 86 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred cCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 99999999999764221 112677788899999999999996 677766543211
Q ss_pred cccccccccCCCcCCcCCCCC--CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSR--MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......|+..|+|||+.... .++.++|||||||++|||++|+.|+..... .....+....... .+.
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-------~~~ 232 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE----PQAAMFKVGMFKI-------HPE 232 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC----hhhhHhhhhhhcc-------CCC
Confidence 112234588999999987653 478899999999999999999999753211 0011110000000 111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. .....++.+++.+||+.+|++|||+.|++.
T Consensus 233 ~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 IP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CC----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11 112235677889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=284.15 Aligned_cols=236 Identities=22% Similarity=0.331 Sum_probs=175.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.|.+|++++++++|||||++++++..++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46889999999999999999865 588999999865322 22457999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCC-------CCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 259 EYMVNGSLDLWLRNATG-------SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
||+++|+|.+++..... .....++...+.++.++++||+|||+ |||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999999875311 11235667788999999999999996 899998
Q ss_pred cccccC-----------------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 308 LISACE-----------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 308 ~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
...... .......+||+.|||||+..+..++.++|||||||++|||+||+.||.... ..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~----~~ 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK----GR 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc----hh
Confidence 652110 001123569999999999999899999999999999999999999985421 11
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRP-TMLHVLKLLHEI 433 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i 433 (435)
... ... ...+|....+ .......+.+++.+|++.||++|| ++.++.+.|+..
T Consensus 238 ki~---~~~-------~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 KIS---YRD-------VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh---hhh-------hccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 110 000 0011110000 011223466788999999999996 566677777654
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=254.80 Aligned_cols=235 Identities=24% Similarity=0.379 Sum_probs=175.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+|+..+.||+|+||.||+|+.. +.+.||+|.+...... ....|.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 357888999999999999999853 2467999988654433 356799999999999999999999999998999
Q ss_pred EEEEecccCCCHHHHHHhhCCC-----CCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGS-----HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
++||||+++|+|.+++...... ...+++..+..++.+++.|++|||+ |||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999999999754321 1258999999999999999999996 5666
Q ss_pred cccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
++..............++..|+|||...+...+.++|||||||++|||++ |..||.... ..... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~----~~~~~----~~~~~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS----DEEVL----NRLQAGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc----hHHHH----HHHHcCC
Confidence 55432222222223456778999999888888999999999999999999 667764211 11111 1111111
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
... ..+ . .....+.+++.+||+.+|++||++.|++..|.+
T Consensus 236 ~~~-~~~---~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 LEL-PVP---E----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCC-CCC---C----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 110 000 1 122357789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.09 Aligned_cols=216 Identities=24% Similarity=0.344 Sum_probs=162.4
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhcc-CCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGK-VKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 57889999987532 2233456667777764 4899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|++.||+|||+ |||+++...... .....
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999888653 247888888999999999999996 999987543222 22334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. +...+.... +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~----~~~~i~~~~------~~~~~~--- 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DE----LFDSILNDR------PHFPRW--- 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HH----HHHHHHcCC------CCCCCC---
Confidence 6799999999999888899999999999999999999999853211 11 111111110 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTML-HVL 427 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~-evl 427 (435)
....+.+++.+||+.||++||++. +++
T Consensus 219 -~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 219 -ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112456788899999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=252.07 Aligned_cols=226 Identities=23% Similarity=0.352 Sum_probs=174.3
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4678899999999999999864 58899999886432 234567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++|+|.+++.... ...++......++.++++||.|||+ |||.++...... ...
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccc
Confidence 9999999886532 2347888889999999999999996 888886654321 122
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
....|++.|+|||+..+..++.++||||||+++|||++|+.||.... ...... ......... + +
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~~~-~-~------ 221 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLIL-KVCQGSYKP-L-P------ 221 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHH-HHhcCCCCC-C-C------
Confidence 34578899999999988889999999999999999999999985321 111111 111111110 0 0
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
......+.+++.+||+.||++|||+.+|+..
T Consensus 222 -~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 -SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112346678899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=251.86 Aligned_cols=225 Identities=25% Similarity=0.409 Sum_probs=171.6
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEcccccc------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+++.+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||++++++|...+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 567889999999999999887889999998864321 12356889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE- 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~- 313 (435)
||+++|+|.+++... ..+++.....++.+++.|++|||+ |||+++......
T Consensus 82 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 82 EFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999753 236788888999999999999996 888876542211
Q ss_pred ----ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 314 ----THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 314 ----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
........|+..|+|||+..+..++.++|||||||++|||+||+.||..... . ........... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~-~~~~~~~~~~~----~ 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------L-AAMFYIGAHRG----L 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------H-HHHHHhhhccC----C
Confidence 1112235689999999999888899999999999999999999999853211 1 11111111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.... .....+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 12235678889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=261.66 Aligned_cols=220 Identities=18% Similarity=0.289 Sum_probs=165.0
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++.++ +|||||++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999865 57899999987542 22345577899888776 899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.+++.||+|||+ |||+++..... ......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST 155 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence 9999888653 247888899999999999999996 99998753221 112234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-cCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-EGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......++...+...... -|.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p~------ 226 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IPR------ 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---CCC------
Confidence 679999999999999899999999999999999999999985321111 1112223333333222110 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
.....+.+++.+||+.||++||++
T Consensus 227 -~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 -SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112346678889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=257.77 Aligned_cols=227 Identities=29% Similarity=0.485 Sum_probs=168.8
Q ss_pred eeecccCcceEEEEEcCC-------CCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 189 DILEDGGFGTVYKATLPD-------GKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+.||+|+||.||+|+..+ ++.||+|.+.... ......|.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886433 23456799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCC---CCCCCCHHHHHHHHHHhhhccceeec-----------------------------ccccccc
Q 040641 261 MVNGSLDLWLRNATG---SHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARL 308 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~ 308 (435)
+++|+|.++++.... ....+++.....++.++++|++|||+ |||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 999999999976432 12347889999999999999999996 6666654
Q ss_pred ccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 309 ISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 309 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
...... .......++..|+|||+..+..++.++|||||||++|||+| |+.||..... .+.. ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~----~~~~~~~-- 230 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVL----QHVTAGG-- 230 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHH----HHHhcCC--
Confidence 322111 11112345678999999988889999999999999999998 8888743211 1111 1111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
....+ ......+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQKP-------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccCCc-------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00001 1122356789999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=256.86 Aligned_cols=228 Identities=23% Similarity=0.371 Sum_probs=171.1
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeC------C
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFD------E 252 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~ 252 (435)
+...|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4457888899999999999999864 57899999986433 3346788999999998 799999999998753 4
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++.... ...+++.....++.|++.|++|||+ |||+++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 5789999999999999987632 2357888899999999999999996 8999876
Q ss_pred ccccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
..... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+..... .... .... ..
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~-~~~~-~~ 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRAL-FLIP-RN 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHH-HHHh-cC
Confidence 54321 1223457899999999875 34578899999999999999999999853211 1111 1111 11
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. +..... .....+.+++.+||..+|.+|||+.+|++
T Consensus 232 ~~-----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PA-----PRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 111111 12235678899999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=251.39 Aligned_cols=227 Identities=22% Similarity=0.333 Sum_probs=172.7
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-----ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-----QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
..|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 35788899999999999999854 588999998864321 123568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++++|.+++... ..+++.....++.+++.|++|||+ |||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988754 247788888999999999999995 88888754322
Q ss_pred Ccccc--ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ETHVS--TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..... ....|+..|+|||+..+..++.++||||||+++|||++|+.||..... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~---- 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPT-N---- 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCC-C----
Confidence 11111 235688899999999888899999999999999999999999753211 111111111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
+.... .....+.+++.+||..+|++|||+.++++.
T Consensus 226 ~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPS----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCc----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111 122346678889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=259.35 Aligned_cols=216 Identities=24% Similarity=0.343 Sum_probs=164.0
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhcc-CCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGK-VKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||||.++... ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999865 47899999987542 2234556778888875 5999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|+++||+|||+ |||+++...... .....
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 9999998753 247888888999999999999996 899887532211 12234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+.... ...|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~----~~~i~~~~---~~~~~~------ 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EEL----FQSIRMDN---PCYPRW------ 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCC---CCCCcc------
Confidence 6799999999999888899999999999999999999999854211 111 11111111 001111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTML-HVL 427 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~-evl 427 (435)
....+.+++.+||+.||++||++. ++.
T Consensus 219 -~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 -LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 112456788899999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=259.72 Aligned_cols=223 Identities=22% Similarity=0.337 Sum_probs=172.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999864 57889999886433 23345789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++.. ..+++.....++.++++|++|||+ |||+++.+.... ..
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 999999998854 247888889999999999999995 888887654322 11
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||+..+..++.++|||||||++|||+||+.|+..... .... ....... .+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~----~~~~~~~-----~~~~~-- 222 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVL----FLIPKNS-----PPTLE-- 222 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch----hhHH----hhhhcCC-----CCCCC--
Confidence 2234688899999999888899999999999999999999999753211 1111 1111110 11111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|++||+|.+|++
T Consensus 223 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 --GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112235678889999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=253.12 Aligned_cols=235 Identities=24% Similarity=0.342 Sum_probs=174.5
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 259 (435)
+|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||++++++|... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5778899999999999999874 578999998865432 3456789999999999999999999998653 46899999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++.........++......++.++++||+|||+ |||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 159 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-- 159 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence 999999998876543334457888889999999999999995 888876543211
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-cCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-EGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.....++..|+|||...+..++.++||||+||++|||+||+.|+....... ...+...+.. ........+.
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~--- 231 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDE--- 231 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhccC---
Confidence 123467889999999988889999999999999999999999986542210 1111222211 1111111000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..........+.+++.+||+.+|++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0001122345778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=248.93 Aligned_cols=231 Identities=23% Similarity=0.356 Sum_probs=177.6
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
|..+|++.+.+|+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 3467889999999999999999864 578899999876555566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++++|..++.... ..++......++.+++.|++|||+ |||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 999999999887542 347888899999999999999996 788876543211 1
Q ss_pred ccccccccCCCcCCcCCCCC---CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSR---MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......++..|+|||..... .++.++|||||||++|||+||+.|+...... ....... ... ...+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~~~~-~~~---~~~~~ 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALFLIS-KSN---FPPPK 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH-hcc---CCCcc
Confidence 22345688899999998766 7889999999999999999999998532211 1111111 110 00011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .........+.+++.+||..+|.+|||+.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 011223346778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=257.44 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=174.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCC----EEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|++.+.||+|+||.||+|++. +++ .||+|.++.... ...+++.+|+.+++.++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888999999999999999853 444 489999865332 235678899999999999999999999875 45789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
+|||+++|+|.++++... ..+++...+.++.|+++||+|||+ |||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 999999999999987532 347888999999999999999996 89998876432
Q ss_pred Cccc-cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ETHV-STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.... .....+++.|+|||...+..++.++|||||||++|||+| |..||..... ..+..+ +....... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~----~~~~~~~~--~ 232 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDL----LEKGERLP--Q 232 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHCCCcCC--C
Confidence 2211 112345678999999988889999999999999999999 7888743211 111111 11111000 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+ ......+.+++.+||+.||++||++.++++.|+++.
T Consensus 233 ~-------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 P-------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 112235678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=264.93 Aligned_cols=214 Identities=23% Similarity=0.319 Sum_probs=164.7
Q ss_pred eeecccCcceEEEEEc----CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 189 DILEDGGFGTVYKATL----PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
+.||+|+||.||+++. .+|+.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975432 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.+++... ..+++.....++.|+++||+|||+ |||+++...... ....
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999988653 347889999999999999999996 899987654321 2223
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
...||+.|+|||...+..++.++|||||||++|||+||+.||..... .... ..+..... . + |.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~----~~i~~~~~-~-~-p~------ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETM----TMILKAKL-G-M-PQ------ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHH----HHHHcCCC-C-C-CC------
Confidence 46799999999999888889999999999999999999999853211 1111 11111110 0 0 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTMLH 425 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~~e 425 (435)
.....+.+++.+||+.||++||++.+
T Consensus 220 -~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 -FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01124567888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=267.86 Aligned_cols=169 Identities=22% Similarity=0.250 Sum_probs=142.3
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
..|.+.+.||+|+||.||+|.... ++.||||... ...+.+|++++++++|||||++++++...+..++||||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 368899999999999999998754 7889999642 234678999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-cc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-HV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~~ 316 (435)
. |+|..++.... ..+++..+..++.|+++||+|||+ |||+++....... ..
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 78888876532 258999999999999999999996 9999986543221 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
.....||+.|||||++.+..++.++|||||||++|||++|..|+.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 234679999999999999899999999999999999999987654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=260.02 Aligned_cols=217 Identities=24% Similarity=0.328 Sum_probs=166.5
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||||.++... ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 47899999997542 23345677899998877 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|++.||+|||+ |||+++...... .....
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 9999888653 248899999999999999999996 899886532211 22234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+..... ..|.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~----~~~i~~~~~---~~~~------- 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DEL----FQSILEDEV---RYPR------- 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHH----HHHHHcCCC---CCCC-------
Confidence 5799999999999999999999999999999999999999853211 111 111111110 1111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTM-----LHVLK 428 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~-----~evl~ 428 (435)
.....+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112356788899999999999999 77753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.69 Aligned_cols=217 Identities=24% Similarity=0.340 Sum_probs=165.9
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 47899999986532 23345677899998865 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.+++.||.|||+ |||+++...... .....
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 9999888653 247888889999999999999996 899887543221 22334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+.... ...|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~----~~~i~~~~---~~~p~~------ 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDL----FESILHDD---VLYPVW------ 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHH----HHHHHcCC---CCCCCC------
Confidence 6799999999999888999999999999999999999999854321 111 11111111 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-------CHHHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRP-------TMLHVLK 428 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RP-------s~~evl~ 428 (435)
....+.+++..|++.||++|| ++.++++
T Consensus 219 -~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 -LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 113466788899999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=265.08 Aligned_cols=221 Identities=24% Similarity=0.334 Sum_probs=173.2
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
-+.+++.||+|+-|.|..|++ .+|+.+|||.+.+... .......+|+.+|+-+.||||+++++++....++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356789999999999999986 4699999999976522 123457899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|.|.+++..++ .+......++..||..|+.|+|. |||+|.+-.. ..
T Consensus 93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GK 166 (786)
T ss_pred ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC--Cc
Confidence 999999999997653 47778888899999999999985 9999976432 23
Q ss_pred ccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
...+.||++.|.|||++.+.+| +.++||||.|||||.|+||+.||+++ ++. .....++.+... -|...
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir-~LLlKV~~G~f~---MPs~I 235 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIR-VLLLKVQRGVFE---MPSNI 235 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHH-HHHHHHHcCccc---CCCcC
Confidence 3455799999999999999877 67899999999999999999999632 222 223333333221 12333
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.+...+. +++..||++|.|+.||++
T Consensus 236 s~eaQdLLr-------~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 236 SSEAQDLLR-------RMLDVDPSTRITTEEILK 262 (786)
T ss_pred CHHHHHHHH-------HHhccCccccccHHHHhh
Confidence 343444444 455569999999999986
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.54 Aligned_cols=212 Identities=25% Similarity=0.374 Sum_probs=163.2
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 57899999986532 23345678898888876 699999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|++.||+|||+ |||+++..... ......
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST 155 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence 9999888653 247888899999999999999996 89998753221 122334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+ ...+.... ...|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~----~~~i~~~~---~~~~~~------ 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDL----FEAILNDE---VVYPTW------ 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHH----HHHHhcCC---CCCCCC------
Confidence 6799999999999888999999999999999999999999854211 111 11121111 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
....+.+++.+|++.||++||++
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 -LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCC
Confidence 11245678889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=256.90 Aligned_cols=229 Identities=21% Similarity=0.357 Sum_probs=177.5
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 34457889999999999999999985 46899999999765555556788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++++|.+++... .+++.....++.+++.||.|||+ |||+++......
T Consensus 95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 95 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999998642 36888899999999999999995 899887654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......|++.|+|||...+..++.++|||||||++|||+||+.||........ ........ ......+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~~~~~~-~~~~~~~-- 238 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNG-TPELQNP-- 238 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eeeeccCC-CCCCCCc--
Confidence 122335688999999999888889999999999999999999999854221100 00000000 0000011
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|++||++.+|++
T Consensus 239 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 -----ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234567888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=264.19 Aligned_cols=178 Identities=22% Similarity=0.253 Sum_probs=148.7
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
....+|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567999999999999999999865 57899999986432 223456889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++... .+++.....++.|++.||+|||+ |||+++....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999998643 36778888899999999999996 9999987643
Q ss_pred cCccccccccccCCCcCCcCCCCC----CCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSR----MSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.........+||+.|||||++... .++.++||||+||++|||+||+.||..
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 322223356799999999987653 378899999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=246.41 Aligned_cols=226 Identities=23% Similarity=0.295 Sum_probs=177.3
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+.|++.+.||+|.|+.||++.. ++|+.+|+|.++... ..+.++..+|++|.+.++|||||++...+......|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4688899999999999999964 568999999886433 3356788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
+|.||+|..-+-.. ...++...-..+.|++++++|+|. |||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999996544432 356777778889999999999995 999998877
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........+|||+|||||+....+|+..+|||+.|||||-++.|..||..+.+ ..+++.+..... ++..|.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I~~g~y-d~~~~~ 235 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQIKAGAY-DYPSPE 235 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHHhcccc-CCCCcc
Confidence 34455678999999999999999999999999999999999999999865322 123444443322 222222
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ .....+..+++.+++..||++|.|+.|.++
T Consensus 236 w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 236 W-----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred c-----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2 111123345555667779999999998864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=252.21 Aligned_cols=232 Identities=24% Similarity=0.417 Sum_probs=176.2
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-CC----EEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-GK----TVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|.+.+ |+ .||+|.+..... ....++.+|+.++++++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578889999999999999998642 32 589998865443 344678999999999999999999999987 7889
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ..+++.....++.|+++|++|||+ |||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999987642 238899999999999999999996 8998876543
Q ss_pred cCcccc-ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 312 CETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 312 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
...... ....++..|+|||......++.++|||||||++||++| |+.||..... .++. ..+..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~----~~~~~~~~--~~ 231 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIP----DLLEKGER--LP 231 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHH----HHHhCCCC--CC
Confidence 222111 12234578999999888889999999999999999999 9998753211 1111 11211110 01
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+.. +...+.+++.+||..+|++||++.++++.|+++.
T Consensus 232 ~~~~-------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 232 QPPI-------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 1124678889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=248.43 Aligned_cols=227 Identities=19% Similarity=0.310 Sum_probs=175.9
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999875 458899999886432 33456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++.... ...+++.....++.++++|++|||+ |||+++....... .
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99999999987642 2357888999999999999999995 8888776543221 2
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|++.|+|||...+..++.++||||||+++|||++|+.||.... ......... .......
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHH-cCCCCCC--------
Confidence 234568999999999888888999999999999999999999975321 111111111 1111100
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
......++.+++.+||..+|++||++.++++.+
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011223567888999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=254.48 Aligned_cols=224 Identities=21% Similarity=0.339 Sum_probs=173.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999865 57899999886443 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.++++.. .+++.....++.+++.|++|||+ |||+++...... ..
T Consensus 84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999988642 36778888999999999999996 888887654322 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....++..|+|||+..+..++.++|||||||++|||+||+.|+...... .. . ....... .+.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~---~-~~~~~~~-----~~~---- 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RV---L-FLIPKNN-----PPT---- 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hH---h-hhhhcCC-----CCC----
Confidence 23346888999999988888999999999999999999999998543211 01 1 1111000 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
........+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112334567789999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.72 Aligned_cols=228 Identities=21% Similarity=0.357 Sum_probs=182.3
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.|.+-|.+.+.||+|+||.||+|.++ .|+.||+|++... .+.++..+|+.+|.+...|+||++||.+.....+|+||
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 45567889999999999999999875 5899999998643 35678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||-.|+..+.++-+. ..+.+.....+..+.++||+|||. |||.|..+.+. .
T Consensus 108 EYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-M 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-M 183 (502)
T ss_pred hhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-H
Confidence 9999999999998643 458888889999999999999995 89998766542 2
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.....+.||+.|||||++..-.|+.++||||+|++..||..|++||...-. ...++ .+. ....|..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-------MRAIF-MIP-----T~PPPTF- 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-------MRAIF-MIP-----TKPPPTF- 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-------cceeE-ecc-----CCCCCCC-
Confidence 233457899999999999999999999999999999999999999853211 00000 000 0111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.....+.-+++.+|+-++|++|-|+.++++
T Consensus 250 -~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 -KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 122344556778899999999999999988765
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=253.25 Aligned_cols=229 Identities=21% Similarity=0.314 Sum_probs=172.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 5889999998755444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++... ..+++.+...++.+++.|+.|||+ |||++...... ...
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999999988653 247888999999999999999995 88887655321 122
Q ss_pred cccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 317 STDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.....||..|+|||++. ...++.++|||||||++|||++|+.|+....... . ........ ...+..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~---~~~~~~~~----~~~~~~ 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----A---LFLMTKSN----FQPPKL 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----h---HHhhhccC----CCCCcc
Confidence 23457899999999864 4568899999999999999999999975322110 0 11111110 000111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ......+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 011224667889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=263.11 Aligned_cols=231 Identities=20% Similarity=0.237 Sum_probs=170.9
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.....+|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344578999999999999999999865 57899999986432 22335678899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|..+++.. .++......++.+++.||+|||+ |||+++...
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999998653 26777788899999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCCCC----CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC-CC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSR----MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ-QA 385 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 385 (435)
..........+||+.|||||++... .++.++|||||||++|||++|+.||.... ... .+..+... ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~-~~~~i~~~~~~ 265 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVG-TYSKIMNHKNS 265 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHH-HHHHHHcCCCc
Confidence 4332233456799999999987643 37899999999999999999999985421 111 11222111 11
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPAT--RPTMLHVLKL 429 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~~ 429 (435)
....++ ......+.+++..|+..++.+ ||++.||++.
T Consensus 266 ~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111 112224556777888744433 7899888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=249.18 Aligned_cols=225 Identities=21% Similarity=0.350 Sum_probs=173.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778999999999999999854 58899999986432 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++.... ...+++.+...++.+++.|++|||+ |||+++...... ..
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 99999999887532 2347888889999999999999995 788876543321 11
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|++.|+|||+..+..++.++|||||||++|||+||+.|+.... ....+....... .. ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~-~~-----~~--- 221 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKIIRGS-YP-----PV--- 221 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHHhcCC-CC-----CC---
Confidence 223468899999999988889999999999999999999999975321 111121211111 10 00
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.+|++||+|.+|++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1112235778899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=250.82 Aligned_cols=224 Identities=26% Similarity=0.396 Sum_probs=170.8
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHH
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLD 267 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~ 267 (435)
++||+|+||.||+|...+++.||+|.+...... ....|.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877899999998764433 4567999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc-ccccc
Q 040641 268 LWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS-TDIAG 322 (435)
Q Consensus 268 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~-~~~~g 322 (435)
++++... ..+++.....++.+++.|++|||+ |||+++.......... ....+
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997542 247788889999999999999995 7888765432111111 11234
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPM 401 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (435)
+..|+|||...+..++.++|||||||++|||+| |..||..... ... ........ ....+ ...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~----~~~~~~~~--~~~~~-------~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQT----RERIESGY--RMPAP-------QLC 220 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHH----HHHHhcCC--CCCCC-------ccC
Confidence 567999999888889999999999999999999 7777643211 111 11111110 00011 112
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 402 MLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 402 ~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
...+.+++.+||..+|++|||+.||++.|++
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 2367789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=259.63 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=171.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5778899999999999999975 4889999998643322 345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|..+.... ..+++.....++.++++||+|||+ |||+++...... ..
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 82 VDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred CCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999998876542 237899999999999999999996 888887654322 22
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHH-------HHHhccCC-CCc
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWV-------FQKMKKQQ-ADD 387 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~ 387 (435)
.....++..|+|||+..+ ..++.++|||||||++|||++|++||...........+..+. ........ ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 234568899999998765 457889999999999999999998875321100000000000 00000000 000
Q ss_pred cccccccCC-----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNA-----GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+..... ........+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 001110000 00112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=252.21 Aligned_cols=223 Identities=22% Similarity=0.346 Sum_probs=173.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677889999999999999865 58899999986543 334467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++++|.+++... .+++.....++.|++.|+.|||+ |||+++...... ...
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 999999998753 57889999999999999999996 888887664321 222
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
....|++.|+|||+..+..++.++|||||||++|||+||+.||..... ... ...+.... .+......
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~~----~~~~~~~~-----~~~~~~~~ 222 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MRV----LFLIPKNN-----PPSLEGNK 222 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HHH----HHHhhhcC-----CCCCcccc
Confidence 345688899999999888899999999999999999999999853211 111 11111111 11111110
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.+++.+||..+|++|||+.++++
T Consensus 223 ---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 ---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2234667888999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=257.51 Aligned_cols=217 Identities=22% Similarity=0.305 Sum_probs=165.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCC-CceeEEEEEEeCCeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQ-NLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 258 (435)
+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 47899999986532 23445688899999999765 5888999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|..++... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 999999999988653 247888889999999999999996 899886432211
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+..... ...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~----~~~i~~~~~------~~~ 221 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DEL----FQSIMEHNV------SYP 221 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH----HHHHHcCCC------CCC
Confidence 122345799999999999998899999999999999999999999854321 111 111111110 000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
.. ...++.+++.+||+.||++||+.
T Consensus 222 ~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 11 12346678889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=262.34 Aligned_cols=217 Identities=19% Similarity=0.272 Sum_probs=166.4
Q ss_pred eeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 189 DILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 468899999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcccccc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~~~~ 319 (435)
+|..++... ..+++.....++.|++.||+|||+ |||+++...... .....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 999888653 247888999999999999999994 899887533211 12234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ......... .-|. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~----~~~i~~~~~---~~p~---~--- 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL----FELILMEEI---RFPR---T--- 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHH----HHHHhcCCC---CCCC---C---
Confidence 5799999999999888899999999999999999999999853211 111 111111100 0011 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+||+.||++|+ ++.++++
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 -LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 112456788899999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.81 Aligned_cols=228 Identities=25% Similarity=0.412 Sum_probs=177.6
Q ss_pred cceeeeecccCcceEEEEEc-CCCC----EEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGK----TVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+....+||+|+||+||||.| ++|+ +||+|++.... .+...++..|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34456899999999999975 4543 68999886543 345688999999999999999999999998765 88999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
+|||.|+|.+|++..+ ..+.....+.+..|||+||.|||. |||+|+.+..++.
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999998754 347777889999999999999985 9999999876554
Q ss_pred cccc-cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 315 HVST-DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 315 ~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
...+ ...-.+.|||=|.+....|+.++|||||||++||++| |..|++....+ + +...++.+. ..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----e----I~dlle~ge--RL---- 919 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----E----IPDLLEKGE--RL---- 919 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----H----hhHHHhccc--cC----
Confidence 3322 2334578999999999999999999999999999998 77787543221 1 122222211 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
+.+.-+...++.++.+||..|+..||+|+++...+.++
T Consensus 920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 11223445688899999999999999999998877664
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=267.14 Aligned_cols=236 Identities=23% Similarity=0.261 Sum_probs=170.0
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-----eeE
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-----EKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 255 (435)
+|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999986 468999999986432 223467889999999999999999999998776 789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+. ++|..++... ..+++.....++.|+++||+|||+ |||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 5787777542 347888999999999999999996 8999986543
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC----
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---- 386 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 386 (435)
......+...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI----QQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHHcCCCCHHHHHH
Confidence 33333344578999999998776 45789999999999999999999998643211 1111111100000000
Q ss_pred -----------ccccccc---cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 -----------DVLDPTV---LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 -----------~~~~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.. ..........++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000 00000011235678899999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=251.55 Aligned_cols=236 Identities=30% Similarity=0.451 Sum_probs=178.6
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhc--cCCCCCceeEEEEEEeCC----eeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLG--KVKHQNLVLLLGYCSFDE----EKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l 256 (435)
.++++.+.||+|.||.||+|.|+ |+.||||.+...+ .+.|.+|.+|.. .|+|+||..+++.-..+. ++||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 57889999999999999999996 8899999996433 356788888765 469999999998754432 5799
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------ccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------DFG 304 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------DfG 304 (435)
|+||-+.|||.+||.. ..++....++++..+|.||++||. |+|
T Consensus 287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999975 358888999999999999999994 999
Q ss_pred ccccccccCc---cccccccccCCCcCCcCCCCCCC------CCcccchhHHHHHHHHHhC----------CCCCCCCcc
Q 040641 305 LARLISACET---HVSTDIAGTLGYIPPEYGQSRMS------TTRGDVYSFGVILLELVTA----------KEPTGPEFQ 365 (435)
Q Consensus 305 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~k~DV~SfGvil~El~tg----------~~p~~~~~~ 365 (435)
+|-....+.. ......+||-+|||||++....- -..+||||||.|+||++-+ +.||++..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9855433211 12234689999999998765321 1359999999999999864 345543322
Q ss_pred cccCCcHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+- . +..+++.-..+.+.|.+.+ ....+.+..|.++|..||..+|..|-|+-.|-+.|.++.
T Consensus 442 ~DP--s-----~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 SDP--S-----FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCC--C-----HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111 1 2333333344444554432 345678899999999999999999999999999888764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=249.16 Aligned_cols=214 Identities=23% Similarity=0.413 Sum_probs=160.1
Q ss_pred eeecccCcceEEEEEcCCCC-----------EEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 189 DILEDGGFGTVYKATLPDGK-----------TVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||++++|++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999875422 5788877644333 5789999999999999999999999988 788999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------------ccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------DFGLA 306 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------DfGla 306 (435)
|||+++|+|.++++.... .+++..+..++.|++.||+|||+ |||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999976432 57888999999999999999996 44544
Q ss_pred ccccccCccccccccccCCCcCCcCCCCC--CCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSR--MSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+.... .....++..|+|||++... .++.++|||||||++|||++| ..|+..... .....+ ....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~----~~~~~~----~~~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS----SEKERF----YQDQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc----hhHHHH----HhcC
Confidence 43221 1123567889999998776 789999999999999999995 555532211 111111 1000
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
. ....+ . ...+.+++.+||..+|++|||+.+|++.|+
T Consensus 223 ~--~~~~~-----~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--RLPMP-----D----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CCCCC-----C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00001 0 146778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=246.60 Aligned_cols=224 Identities=20% Similarity=0.353 Sum_probs=172.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|+..+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 57899999986532 23356789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
+++++|.+++.... ...+++.....++.++++|++|||+ |||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 99999999997643 2347888899999999999999995 677766543211
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......|+..|+|||...+..++.++||||||+++|||++|+.|+.... ........... ...... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~-----~ 223 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSG-TFAPIS-----D 223 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhc-CCCCCC-----C
Confidence 1223568899999999988888999999999999999999999975321 11111111111 111110 0
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.+|++|||+.|++.
T Consensus 224 ----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12235678889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=264.51 Aligned_cols=175 Identities=21% Similarity=0.252 Sum_probs=145.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|||||++++++..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4788999999999999999864 57899999986543 2234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC--
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-- 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-- 313 (435)
||++|+|.+++... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999988653 246777788899999999999996 999975321000
Q ss_pred --------------------------------------------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHH
Q 040641 314 --------------------------------------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVI 349 (435)
Q Consensus 314 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvi 349 (435)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123479999999999988899999999999999
Q ss_pred HHHHHhCCCCCCC
Q 040641 350 LLELVTAKEPTGP 362 (435)
Q Consensus 350 l~El~tg~~p~~~ 362 (435)
+|||+||+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (382)
T cd05625 238 LYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=253.19 Aligned_cols=226 Identities=23% Similarity=0.293 Sum_probs=170.7
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 567788999999999999865 5889999998653322 234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|.+++.... ...+++.....++.|++.||.|||+ |||++....... .
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 157 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--c
Confidence 99999999886532 2347888899999999999999996 899887653322 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....||..|+|||+..+..++.++|||||||++|||++|+.||....... ............. ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~~~~~~~~~~~~~------~~~~-- 225 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVQ------EEYS-- 225 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----hHHHHHhhhhhhh------hhcC--
Confidence 123578999999999988889999999999999999999999986432110 0000111111000 0000
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
......+.+++.+||+.||++||| +.|+++
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 --EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011224567888999999999999 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=250.50 Aligned_cols=226 Identities=23% Similarity=0.304 Sum_probs=170.5
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999864 688999999864322 2234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|..++.... ...+++.....++.|++.||.|||+ |||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--S 157 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--c
Confidence 99999998886542 2348999999999999999999996 899886543221 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||+..+..++.++|||||||++|||+||+.||...... .....+........ ....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~~--~~~~------ 225 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLETE--EVYS------ 225 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhccc--cccC------
Confidence 23457899999999998888999999999999999999999998532110 01111111111110 0000
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
......+.+++..||+.||++||+ +.+++.
T Consensus 226 --~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 --AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111224567888999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=246.97 Aligned_cols=226 Identities=28% Similarity=0.456 Sum_probs=175.0
Q ss_pred eeecccCcceEEEEEcCC----CCEEEEEEcccccccc-HHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLPD----GKTVAVKKFSQAKTQG-HRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998653 7889999997654333 57899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCC-----CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 264 GSLDLWLRNATGS-----HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 264 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|+|.+++...... ...+++.....++.++++|++|||+ |||.++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999865211 2458999999999999999999996 8888876543221
Q ss_pred -cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 315 -HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 315 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......++..|+|||......++.++||||+||++|||++ |..||.... ...+ ...+.... ....+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~----~~~~~~~~--~~~~~~ 230 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEV----LEYLRKGY--RLPKPE 230 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHH----HHHHHcCC--CCCCCc
Confidence 22234567889999999888889999999999999999999 588875431 1111 22222111 111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
.....+.+++.+||..+|++|||+.|+++.|+
T Consensus 231 -------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 -------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11235778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=258.87 Aligned_cols=223 Identities=21% Similarity=0.283 Sum_probs=167.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++..+||+|+||.||.|+- .+|..+|+|++++..- ...+....|=.+|....+|.||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 456889999999999999999985 4599999999987643 345678889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhh------hccceeec------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA------RGLAFLHQ------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia------~gl~yLH~------------------DfGla~~~~~~ 312 (435)
||||+|||++..+|... ..|+.......+.+.+ +-+.|+|+ ||||++-+...
T Consensus 219 iMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999998764 3455555444444444 44556665 99998532210
Q ss_pred ----------------------Ccc-----c-------------------cccccccCCCcCCcCCCCCCCCCcccchhH
Q 040641 313 ----------------------ETH-----V-------------------STDIAGTLGYIPPEYGQSRMSTTRGDVYSF 346 (435)
Q Consensus 313 ----------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~DV~Sf 346 (435)
+.. . ....+|||-|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0 012579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC
Q 040641 347 GVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT 422 (435)
Q Consensus 347 Gvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs 422 (435)
|||+|||+.|-+||..+........++.|......... .+...+..++|.+|+. ||+.|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999876655444555555432211110 0111355677778877 9999964
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=258.14 Aligned_cols=217 Identities=23% Similarity=0.294 Sum_probs=165.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+|++.+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4678899999999999999865 47899999987532 22334567788888777 5899999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|..++... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 999999999888653 247888899999999999999996 999987543211
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+. ..+..... .-|.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~----~~i~~~~~---~~p~-- 222 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELF----QSIMEHNV---AYPK-- 222 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHH----HHHHhCCC---CCCC--
Confidence 222346799999999999999999999999999999999999999854211 1111 11111111 0011
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
....++.+++.+|++.+|++|++.
T Consensus 223 -----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 -----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 112356778899999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=263.65 Aligned_cols=175 Identities=21% Similarity=0.268 Sum_probs=145.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5788999999999999999854 68899999986432 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET- 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~- 314 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++.......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999998753 247777888899999999999996 9999863211000
Q ss_pred ------------c---------------------------------ccccccccCCCcCCcCCCCCCCCCcccchhHHHH
Q 040641 315 ------------H---------------------------------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVI 349 (435)
Q Consensus 315 ------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvi 349 (435)
. .....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012469999999999988899999999999999
Q ss_pred HHHHHhCCCCCCC
Q 040641 350 LLELVTAKEPTGP 362 (435)
Q Consensus 350 l~El~tg~~p~~~ 362 (435)
+|||+||+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (377)
T cd05629 238 MFECLIGWPPFCS 250 (377)
T ss_pred hhhhhcCCCCCCC
Confidence 9999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=253.06 Aligned_cols=229 Identities=22% Similarity=0.354 Sum_probs=175.8
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+..+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||++++++|...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3456888999999999999999975 467899999986555445567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++... .+++..+..++.+++.|++|||+ |||++.......
T Consensus 96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 999999999998653 36788889999999999999996 788776543322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......|++.|+|||......++.++|||||||++||+++|+.||....... .+........ +..
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~~~~~~~------~~~- 235 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGT------PEL- 235 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heeehhcCCC------CCC-
Confidence 12233468899999999888888999999999999999999999985432110 0000000000 000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111122346678899999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=255.98 Aligned_cols=216 Identities=24% Similarity=0.339 Sum_probs=164.0
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhcc-CCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGK-VKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999865 58899999987532 2234556778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|+++||+|||+ |||+++..... ......
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 9999888653 247888888999999999999996 89988643221 122345
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+.... +.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~----~~~~~~~~------~~~~~~--- 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DEL----FESIRVDT------PHYPRW--- 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCC------CCCCCC---
Confidence 6799999999999988999999999999999999999999854221 111 11121111 111111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTML-HVL 427 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~-evl 427 (435)
...++.+++.+||+.||++||++. ++.
T Consensus 219 -~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 -ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 122456788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=249.49 Aligned_cols=229 Identities=27% Similarity=0.381 Sum_probs=161.8
Q ss_pred eecccCcceEEEEEcCC---CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCC
Q 040641 190 ILEDGGFGTVYKATLPD---GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~ 265 (435)
.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++||||++++|+|...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34688888764332 234578899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCC-CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-ccccc
Q 040641 266 LDLWLRNATGS-HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-HVSTD 319 (435)
Q Consensus 266 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~~~~~ 319 (435)
|.+++...... ....++.....++.|+++|++|||+ |||+++....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 99999765322 2335677788899999999999996 8998865432211 11123
Q ss_pred ccccCCCcCCcCCC-------CCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 320 IAGTLGYIPPEYGQ-------SRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 320 ~~gt~~y~aPE~~~-------~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..+++.|+|||+.. ...++.++|||||||++|||++ |..||..... .+.. ....... ......+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~---~~~~~~~-~~~~~~~ 233 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVL---KQVVREQ-DIKLPKP 233 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHH---HHHhhcc-CccCCCC
Confidence 34677899999753 3456889999999999999999 6667642211 1111 1111111 1112222
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
..... ....+.+++..|| .||++|||+.+|++.|.
T Consensus 234 ~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22111 2234456777899 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=265.20 Aligned_cols=175 Identities=21% Similarity=0.265 Sum_probs=145.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788999999999999999854 58899999986532 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc---
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC--- 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~--- 312 (435)
|+++|+|.+++... ..++......++.|++.||+|||+ |||+|+.....
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999998753 246777778889999999999996 99987532100
Q ss_pred ---------------------------------------CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHH
Q 040641 313 ---------------------------------------ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLEL 353 (435)
Q Consensus 313 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El 353 (435)
........+||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001235799999999999988999999999999999999
Q ss_pred HhCCCCCCC
Q 040641 354 VTAKEPTGP 362 (435)
Q Consensus 354 ~tg~~p~~~ 362 (435)
+||+.||..
T Consensus 238 l~G~~Pf~~ 246 (376)
T cd05598 238 LVGQPPFLA 246 (376)
T ss_pred hhCCCCCCC
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=255.42 Aligned_cols=176 Identities=23% Similarity=0.268 Sum_probs=146.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.|.+|..++..++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6788999999999999999865 58899999986422 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++.... ..+++.....++.|++.||+|||+ |||+++........
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999997532 247788888899999999999996 89998765443322
Q ss_pred ccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 VSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||+.|||||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 2233569999999998752 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=266.74 Aligned_cols=219 Identities=25% Similarity=0.384 Sum_probs=172.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|.+..+||+|.||+|+++..+ +++.+|||.+++.. .++.+..+.|-+|+... +||.+++++.++++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467899999999999999999875 57899999998754 34567788898888766 5999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
.||||+.||++..+.+ ...+++.+..-+|..|+.||.|||+ |||++|....
T Consensus 446 fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999544443 2358888888999999999999996 9999987542
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ....++.||||.|||||++.+..|+..+|.|||||++|||+.|+.||..+..+ + ++..+.. +++.-|
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----e----~FdsI~~---d~~~yP 588 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----E----VFDSIVN---DEVRYP 588 (694)
T ss_pred C-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----H----HHHHHhc---CCCCCC
Confidence 2 23456789999999999999999999999999999999999999998644321 1 2222221 222223
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
... ..+.+.|+.+-+.++|++|--+
T Consensus 589 ~~l-------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RFL-------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred Ccc-------cHHHHHHHHHHhccCcccccCC
Confidence 222 2345567777788999999765
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=258.31 Aligned_cols=231 Identities=24% Similarity=0.398 Sum_probs=172.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCC----EEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+..... ....++.+|+.++++++||||++++|+|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 46778889999999999999853 343 478888865432 223478899999999999999999999875 45679
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|+||+++|+|.+++.... ..+++.....++.|++.||+|||+ |||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 999999999999987532 247888899999999999999996 89998865432
Q ss_pred Ccc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
... ......++..|+|||+..+..++.++|||||||++|||++ |+.||..... .....+ +..... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~----~~~~~~--~~~ 232 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDL----LEKGER--LPQ 232 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH----HHCCCC--CCC
Confidence 221 1122345778999999988889999999999999999998 8888743211 111111 111110 001
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+. .....+.+++..||..+|++||++.++++.|+++.
T Consensus 233 ~~-------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 233 PP-------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11235678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=255.68 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=173.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788999999999999999875 47899999986532 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++++.+..+.... ..+++.....++.++++|++|||+ |||+++.........
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9998877665432 237888999999999999999996 888887665433223
Q ss_pred cccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc------------C
Q 040641 317 STDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK------------Q 383 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~ 383 (435)
.....++..|+|||+..+. .++.++||||||+++|||++|+.||..... .+........... .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 3446788999999998877 889999999999999999999998753211 0111000000000 0
Q ss_pred CCC--cccc---cccc-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QAD--DVLD---PTVL-NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~--~~~~---~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ...+ +... .........++.+++.+||..+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000 0000 0000112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=258.39 Aligned_cols=213 Identities=22% Similarity=0.322 Sum_probs=160.9
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHH-HhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEME-TLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|+.. +|+.||+|.+..... .....+.+|.. +++.++|||||++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999865 689999999865321 22344555555 56889999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|+++||+|||+ |||+++..... ......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 9999988653 247888888999999999999996 89998753221 122334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ...+...... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~-~~~i~~~~~~--~~~~------- 218 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEM-YDNILNKPLR--LKPN------- 218 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHH-HHHHHcCCCC--CCCC-------
Confidence 679999999999998899999999999999999999999985321 1111 1111111110 1111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTML 424 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~ 424 (435)
....+.+++.+|++.||++||++.
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 -ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 123466788899999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=256.24 Aligned_cols=219 Identities=19% Similarity=0.288 Sum_probs=165.7
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999864 578999999975422 2345688899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++..+..++.|++.||+|||+ |||+++..... ......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 9999888643 248889999999999999999996 89988753221 122234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|+|||+..+..++.++|||||||++|||+||+.||...... .......+........... .|..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~---~p~~------ 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-PDMNTEDYLFQVILEKPIR---IPRF------ 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-cccccHHHHHHHHHhCCCC---CCCC------
Confidence 67999999999998889999999999999999999999998542211 1112223333333222110 1111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
....+.+++.+||+.||++||++
T Consensus 226 -~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 -LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCC
Confidence 11245678889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=247.12 Aligned_cols=232 Identities=24% Similarity=0.379 Sum_probs=176.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 5788999999999999999854 57899999986433 224567999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc--
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-- 315 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~-- 315 (435)
++++|.++++.... ...+++.....++.+++.|++|||+ |||++.........
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999976432 2357888999999999999999996 78887665432221
Q ss_pred -ccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 316 -VSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 316 -~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......|+..|+|||++... .++.++|||||||++|||++|+.||......+ .. ....... .. .....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~----~~~~~~~-~~-~~~~~- 230 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VL----MLTLQND-PP-SLETG- 230 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hH----HHHhcCC-CC-CcCCc-
Confidence 12334689999999987766 78999999999999999999999985432211 11 1111111 00 00000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.........+.+++.+||+.||++||++.+|++
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 --ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001123345678899999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=246.60 Aligned_cols=225 Identities=23% Similarity=0.388 Sum_probs=172.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4678899999999999999865 47899999986532 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
+++++|.+++.... ...+++.....++.++++|++|||+ |||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99999999987542 2357899999999999999999996 666665543211 1
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......|++.|+|||+.....++.++|||||||++|||++|+.|+.... ...++....... ..+. .
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-----~~~~-~- 223 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGY-----FAPI-S- 223 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhccc-----CCCC-C-
Confidence 1223468899999999888889999999999999999999999975321 122222221111 1110 0
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ .....+.+++.+||..+|++|||+.||++
T Consensus 224 ~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 P---NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred C---CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1 11235677889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=245.63 Aligned_cols=227 Identities=30% Similarity=0.486 Sum_probs=173.6
Q ss_pred cceeeeecccCcceEEEEEcCC-----CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLPD-----GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+++.+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|++++..++|+||+++++++...+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998653 378999999755433 4578999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++..... ..+++.....++.+++.|++|||+ |||+++.......
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999876432 127899999999999999999996 8888876554322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+++.|+|||......++.++||||+|+++|||++ |..|+... ....+. .......... .+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~----~~~~~~~~~~--~~-- 226 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVL----EYLKKGYRLP--KP-- 226 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHH----HHHhcCCCCC--CC--
Confidence 22212347789999999888889999999999999999999 66776431 111111 1111111100 01
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
.. ....+.+++.+||..+|++|||+.|+++.|
T Consensus 227 -~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 -EN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -Cc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 223577889999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.37 Aligned_cols=222 Identities=19% Similarity=0.303 Sum_probs=177.9
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++.... +.-.+.+|++||+.|+||||++++.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35789999999999999999974 67999999999876543 344578999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||..+|.|.+|+.... .+++.....+..||..|+.|+|. |||++..+...
T Consensus 132 MEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 99999999999998653 48888999999999999999996 99999887643
Q ss_pred ccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
...+.+||++-|.+||...+.+| ++.+|.||+||+||-++.|..||+.. +.... ...+..+.. ..|.
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~l-vrQIs~GaY---rEP~ 274 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRL-VRQISRGAY---REPE 274 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-------hHHHH-HHHhhcccc---cCCC
Confidence 34567899999999999999877 67899999999999999999999642 22221 222332222 2222
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+ ....++..++..||++|-|+.+|..
T Consensus 275 ~PS--------dA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 275 TPS--------DASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred CCc--------hHHHHHHHHHhcCcccchhHHHHhh
Confidence 211 1223455566679999999999875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=248.88 Aligned_cols=233 Identities=24% Similarity=0.363 Sum_probs=172.9
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeC-----
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFD----- 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----- 251 (435)
..+..+|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 345678999999999999999999864 58899999986432 2245678899999998 899999999998754
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+..++||||+++|+|.++++........+++.....++.+++.||+|||+ |||+++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 35799999999999999887543333458889999999999999999996 888877
Q ss_pred cccccCccccccccccCCCcCCcCCCCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSR-----MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
....... ......|+..|+|||+.... .++.++|||||||++|||++|+.|+..... ...+.. ...
T Consensus 177 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~~~~~-~~~ 247 (291)
T cd06639 177 QLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFK-IPR 247 (291)
T ss_pred hcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HHHHHH-Hhc
Confidence 6543221 12235688999999986543 368899999999999999999999853211 111111 111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......++ ......+.+++.+||+.+|++||++.|++.
T Consensus 248 ~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 112235778999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=256.47 Aligned_cols=174 Identities=19% Similarity=0.241 Sum_probs=135.9
Q ss_pred eeeeeccc--CcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 187 LVDILEDG--GFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 187 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+.++||+| +|++||+++. .+|+.||+|+++.... ...+.+.+|+++++.++|||||+++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7889999986 4689999999865432 23356778999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc--
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-- 315 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~-- 315 (435)
++|+|.+++.... ...+++.....++.|++.||+|||+ |||...........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999986532 2247888999999999999999996 33322111100000
Q ss_pred ----ccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 ----VSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ----~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0112346778999998865 4688999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=246.72 Aligned_cols=223 Identities=22% Similarity=0.376 Sum_probs=170.3
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc---------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
+.+...||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999864 5789999988543221 124688899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++++|..++... ..+++.....++.+++.|++|||+ |||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999753 247788888999999999999995 888887654
Q ss_pred ccCc-----cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 311 ACET-----HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 311 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.... .......|+..|+|||...+..++.++|||||||++|||+||+.||..... ...+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~-- 227 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKIGE-N-- 227 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHHHHHhc-c--
Confidence 2111 111234688999999999888899999999999999999999999853211 111111111 1
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.... .....+.+++.+||+.+|.+||++.+|++
T Consensus 228 ---~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---ASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 12235677888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=258.78 Aligned_cols=166 Identities=22% Similarity=0.291 Sum_probs=139.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
..|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|||||++++++...+..++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 46899999999999999999865 4678999975322 2356999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
. |+|.+++.... ..+++..+..++.|++.||+|||+ |||+++..... ...
T Consensus 140 ~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred C-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 5 68888876532 358899999999999999999996 89998754321 122
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3457999999999999889999999999999999999976664
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=248.77 Aligned_cols=229 Identities=25% Similarity=0.401 Sum_probs=169.5
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---c-------cHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---Q-------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
+|.+.+.||+|+||.||+|... +++.||+|.++.... . ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999754 588999998753211 0 1246788999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.++++.. ..+++..+..++.+++.|+.|||+ |||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998764 347888888999999999999996 7888765
Q ss_pred ccccCc-cccccccccCCCcCCcCCCCCC--CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 309 ISACET-HVSTDIAGTLGYIPPEYGQSRM--STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 309 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
...... .......|+..|+|||...... ++.++||||||+++||+++|+.|+.... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~ 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-------AIAAMFKLGNKR-S 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-------hHHHHHHhhccc-c
Confidence 432111 1123356889999999876544 7899999999999999999999984321 111111111111 0
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....++. ........+.+++.+||+.+|++|||+.+|++
T Consensus 230 ~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0011111 11122345677889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=268.50 Aligned_cols=236 Identities=22% Similarity=0.292 Sum_probs=183.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCC-CEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEE-Ee---
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDG-KTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYC-SF--- 250 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~--- 250 (435)
.+.....++++.+.|.+|||+.||.|....+ ..||+|++-..+....+...+||++|++|+ |+|||.+++.+ ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3455567889999999999999999997665 999999997767777888999999999997 99999999932 11
Q ss_pred ---CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------
Q 040641 251 ---DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------- 301 (435)
Q Consensus 251 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------- 301 (435)
.-+.+|.||||+||.|-+++...... .|.+...++|+.++++|+++||.
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 13578999999999999999865432 38999999999999999999995
Q ss_pred cccccccccccC--cc------ccccccccCCCcCCcC---CCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 302 DFGLARLISACE--TH------VSTDIAGTLGYIPPEY---GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 DfGla~~~~~~~--~~------~~~~~~gt~~y~aPE~---~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
|||-|....... .. ......-|+.|.|||. ..+...++|+|||++||+||-|+....||+.... .
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----l 264 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----L 264 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----e
Confidence 999875321111 00 0012357899999996 4677899999999999999999999999854211 0
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.++.....-+........+.+||..|++.||.+||++.+|+..+-++.
T Consensus 265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 111111112222455667889999999999999999999999887764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=246.37 Aligned_cols=225 Identities=20% Similarity=0.339 Sum_probs=165.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 254 (435)
.+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 35788899999999999999864 58899999885332 1223568889999999999999999998865 3567
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
+++|||+++++|.+++.... .+++.....++.+++.||+|||+ |||+++.+.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999987532 37888888999999999999996 889887543
Q ss_pred ccC--ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACE--THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... ........++..|+|||+..+..++.++|||||||++|||+||+.||..... ...+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~----- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQP----- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCC-----
Confidence 211 1111234688999999999888899999999999999999999999853211 11111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.... .....+..++ +||..+|++||+|.||++
T Consensus 226 ~~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0111111 1111223333 799999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=253.31 Aligned_cols=236 Identities=22% Similarity=0.299 Sum_probs=171.5
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5788899999999999999876 588999998864332 2335688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|..++... ..+++..+..++.|+++||+|||+ |||+++....... .
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 82 CDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred cCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999988876542 247899999999999999999996 8888876543221 1
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-----------CC
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK-----------QQ 384 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 384 (435)
.....++..|+|||+..+ ..++.++|||||||++|||+||+.||....... ....+...... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHhhhccccc
Confidence 223467889999998765 567899999999999999999999985432111 11111110000 00
Q ss_pred C-CccccccccCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 A-DDVLDPTVLNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ~-~~~~~~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+....... ......+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000000000 011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=244.00 Aligned_cols=227 Identities=26% Similarity=0.404 Sum_probs=172.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999864 6889999998755432 567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++... ..+++.....++.++++|+.|||+ |||++..........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998753 236788888999999999999996 888877654322211
Q ss_pred c---ccccccCCCcCCcCCCCCC---CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 317 S---TDIAGTLGYIPPEYGQSRM---STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 317 ~---~~~~gt~~y~aPE~~~~~~---~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. ....++..|+|||+..... ++.++||||||+++||+++|+.||..... .......... .. .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~------~~~~~~~~~~-~~-----~ 224 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIMFHVGA-GH-----K 224 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc------hHHHHHHHhc-CC-----C
Confidence 1 1356788999999987765 88999999999999999999999853211 1111111111 10 1
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.... .......+.+++.+||+.+|++|||+.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 1111234567888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=246.21 Aligned_cols=222 Identities=25% Similarity=0.380 Sum_probs=170.4
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|++++++++||||+++++++......++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999876 68999999886433 123467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.++++.. ..+++.....++.++++|++|||+ |||+++......
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999998753 247888889999999999999995 788776543321
Q ss_pred cccccccccCCCcCCcCCCCCC-CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRM-STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......|+..|+|||...... ++.++|||||||++|||++|+.||..... ............... +.
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~-~~--- 224 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPP-IP--- 224 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCC-cC---
Confidence 223456889999999877665 88999999999999999999999854221 111111111111111 00
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+.+++.+||+.+|++||++.+++.
T Consensus 225 --~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 --D---HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --C---CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 11234567888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=247.71 Aligned_cols=232 Identities=25% Similarity=0.389 Sum_probs=173.4
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCC-----
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDE----- 252 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 252 (435)
.+..+|++.+.||+|+||.||+|... +++.+|+|.+..... ....|.+|+.+++++ .||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35578999999999999999999875 578899999865433 346789999999999 7999999999997644
Q ss_pred -eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 253 -EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 253 -~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
..++||||+++++|.+++.........+++.....++.|+++||.|||+ |||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 4899999999999999887643233468889999999999999999996 788776
Q ss_pred cccccCccccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
..... ........|+..|+|||++.. ..++.++|||||||++|||+||+.||..... ...... +..
T Consensus 162 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~-~~~ 232 (275)
T cd06608 162 QLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFK-IPR 232 (275)
T ss_pred ecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHH-hhc
Confidence 54321 122234568999999997643 3567899999999999999999999853211 111111 111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... +.... .......+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~-----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPP-----PTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCC-----CCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 11111 1113345678899999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=252.40 Aligned_cols=226 Identities=21% Similarity=0.298 Sum_probs=173.1
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+..|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 345555668999999999999864 6889999998655444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|..++... .+++.....++.|++.|++|||+ |||+++...... ..
T Consensus 100 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 100 LQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 9999999877542 37888999999999999999995 888886544321 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||+..+..++.++|||||||++|||++|+.||..... ... . ..+..........+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~---~-~~~~~~~~~~~~~~----- 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQA---M-KRLRDSPPPKLKNA----- 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH---H-HHHhccCCCCcccc-----
Confidence 2345789999999999888899999999999999999999999853211 111 1 11111111000000
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|++||++.++++
T Consensus 241 --~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 241 --HKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred --CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011224567888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=244.08 Aligned_cols=225 Identities=21% Similarity=0.359 Sum_probs=172.3
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 259 (435)
.|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778999999999999999864 47889999986432 2334568899999999999999999998764 446789999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++++|.+++.... ...+++.+...++.+++.|++|||+ |||+++...... .
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-D 157 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-C
Confidence 999999999997642 2357899999999999999999996 788887654322 2
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... .......... ... +..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~~~-~~~-----~~~-- 222 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRIIE-GKL-----PPM-- 222 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHh-cCC-----CCC--
Confidence 2234568999999999988889999999999999999999999975321 1111121111 111 001
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.+|++|||+.++++
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112235778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=256.73 Aligned_cols=225 Identities=23% Similarity=0.343 Sum_probs=174.9
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 256 (435)
..+|.+.++||+|+|++|++|+. .+++++|||++.+.. ....+-..+|-.+|.+| .||.||+|+-.|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 45789999999999999999985 458999999996532 22234466788889998 89999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|+||+++|+|-++|+..+ .+++.....++.+|..|++|||+ |||-|+.+...
T Consensus 152 vLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999998653 48888888899999999999996 99999987542
Q ss_pred Ccc----------c--cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 313 ETH----------V--STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 313 ~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
... . ...++||..|.+||++.....+..+|+|+||||+|+|+.|++||....+ . .+++.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----y----liFqkI 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----Y----LIFQKI 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----H----HHHHHH
Confidence 211 1 1458999999999999999999999999999999999999999865322 1 133333
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... + |.... ..+.+|+.+-+..||.+|+|..+|-+
T Consensus 300 ~~l~y~--f-p~~fp-------~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 QALDYE--F-PEGFP-------EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHhccc--C-CCCCC-------HHHHHHHHHHHccCccccccHHHHhh
Confidence 322111 1 11111 12344555566779999999988754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=251.12 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=169.3
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4678899999999999999865 58899999986432 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++ |+|.+++..... ...+++.....++.|+++||+|||+ |||+++..... ...
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRV 157 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-ccc
Confidence 97 688888765322 2458889999999999999999996 88887654321 122
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC-----------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ----------- 384 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 384 (435)
.....+++.|+|||+..+ ..++.++|||||||++|||+||+.||....... .... .........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID---QLFR-IFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-HHHHhCCCChhhhhcchhhH
Confidence 233467889999998765 457889999999999999999999985432110 0000 000000000
Q ss_pred -----CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 -----ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 -----~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......... .........++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000012235568899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=257.58 Aligned_cols=214 Identities=25% Similarity=0.344 Sum_probs=161.2
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHH-HhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEME-TLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +|+.||+|.+.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999854 68899999986532 123345566655 46789999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|+++||+|||+ |||+++..... ......
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 9998888643 247888889999999999999996 89998753221 122334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|||||++.+..++.++|||||||++|||++|+.||.... ... +...+..... ...+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~-~~~~~~~~~~--~~~~-----~-- 218 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAE-MYDNILHKPL--VLRP-----G-- 218 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHH-HHHHHHcCCc--cCCC-----C--
Confidence 679999999999999899999999999999999999999985321 111 1111111111 1111 1
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLH 425 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~e 425 (435)
....+.+++.+|++.+|++||++.+
T Consensus 219 -~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 -ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1124567888999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=250.28 Aligned_cols=227 Identities=26% Similarity=0.419 Sum_probs=171.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999875 68899999886432 233467899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~ 316 (435)
++++|..++.... ....+++.....++.+++.||.|||+ |||+++..... .
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---L 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---c
Confidence 9999999887532 12358899999999999999999984 78877654321 1
Q ss_pred cccccccCCCcCCcCCCCC------CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 317 STDIAGTLGYIPPEYGQSR------MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~------~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.....|+..|+|||...+. .++.++|||||||++|||+||+.||..... ...... .........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~-~~~~~~~~~----- 227 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQ-LSAIVDGDP----- 227 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHH-HHHHhhcCC-----
Confidence 2234688899999987543 358899999999999999999999854211 111111 111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+... ......+.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTLP----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCC----cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 113345678889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=254.04 Aligned_cols=239 Identities=28% Similarity=0.408 Sum_probs=172.4
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhc--cCCCCCceeEEEEEEeCC----eeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLG--KVKHQNLVLLLGYCSFDE----EKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~ 255 (435)
...+++.+++|+|.||.||||.+. ++.||||++... +.+.|.+|-+|.+ .++|+||++++++-.... +.+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 456778899999999999999986 589999999753 3456777777655 568999999999876555 789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------------c
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------------D 302 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------------D 302 (435)
||+||-++|+|.+||... +++|....+|+..+|+||+|||+ |
T Consensus 285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 999999999999999753 59999999999999999999996 9
Q ss_pred ccccccccccCc-cccccccccCCCcCCcCCCCCCC-C-----CcccchhHHHHHHHHHhCCCCCC--------CCcccc
Q 040641 303 FGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMS-T-----TRGDVYSFGVILLELVTAKEPTG--------PEFQEK 367 (435)
Q Consensus 303 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~-----~k~DV~SfGvil~El~tg~~p~~--------~~~~~~ 367 (435)
||+|..+..+.. ......+||.+|||||++.+..- . .+.||||.|.|+|||+++-.-.+ ..|..+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999987764322 22334789999999999876422 1 36999999999999999754432 112211
Q ss_pred cCC-cHHHHHHHHhccCCCCccccccccCC-CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 368 EGA-NLVGWVFQKMKKQQADDVLDPTVLNA-GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 368 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
-+. --.+.+...+-.. ...|.+... .....+..+.+.+..||+.||+.|-|+.=|.+++.++
T Consensus 440 vG~hPt~e~mq~~VV~k----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRK----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred hcCCCCHHHHHHHHHhh----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 111 0111111111111 111211110 0013345567788899999999999999888887765
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=247.46 Aligned_cols=227 Identities=21% Similarity=0.351 Sum_probs=174.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 258 (435)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3677889999999999999854 57899999886432 2334578899999999999999999998764 45578999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee-----c------------------------cccccccc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH-----Q------------------------DFGLARLI 309 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-----~------------------------DfGla~~~ 309 (435)
||+++++|.+++.........+++.....++.+++.|++||| + |||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444456899999999999999999999 4 78888765
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..... ......|+..|+|||......++.++||||||+++|||++|+.|+..... .. ............
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~----~~~~~~~~~~~~-- 229 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQ----LASKIKEGKFRR-- 229 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HH----HHHHHhcCCCCC--
Confidence 43221 12345689999999999888899999999999999999999999854211 11 112222211111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .......+.+++.+||+.+|++||++.+|++
T Consensus 230 ---~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 ---I----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---C----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 1122345778899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=250.33 Aligned_cols=230 Identities=18% Similarity=0.253 Sum_probs=172.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||++... +++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999865 478999999865432 234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC--
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-- 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-- 313 (435)
|+++|+|.+++... ..+++.....++.++++|++|||+ |||+++......
T Consensus 82 ~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999753 247888888999999999999996 888876421100
Q ss_pred ------------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 314 ------------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 314 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
........|+..|+|||+.....++.++|||||||++|||++|+.||.... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-------~~~~-~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-------PEEL-FGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHH-HHHHH
Confidence 001122467889999999888889999999999999999999999985321 1111 11111
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
... ...|.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 11111100 122346788999999999999997766666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=243.83 Aligned_cols=224 Identities=27% Similarity=0.427 Sum_probs=170.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
..+|++.+.||+|+||.||+|.. +++.||+|.++... ....|.+|+.++++++||||+++++++..+ ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 45788999999999999999975 57889999986432 345789999999999999999999998654 579999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++|+|.+++.... ...+++..+..++.++++|++|||+ |||+++..... .
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~ 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence 9999999997643 2347888899999999999999996 78877653321 1
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....+..|+|||+..+..++.++|||||||++|||++ |+.||.... .... ......... .++ .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~-~~~~~~~~~---~~~--~-- 219 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-------LKEV-KECVEKGYR---MEP--P-- 219 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-------HHHH-HHHHhCCCC---CCC--C--
Confidence 12234567999999888889999999999999999998 888874321 1111 111111110 111 0
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
......+.+++.+||+.+|++||++.+++..|++
T Consensus 220 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 --EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=257.04 Aligned_cols=172 Identities=27% Similarity=0.268 Sum_probs=141.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467899999999999999999864 58899999986432 233467889999999999999999999986543
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++ +|...++. .+++.....++.|+++||+|||+ |||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46999999975 55555532 26777888899999999999996 9999876
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 4321 223346789999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=252.24 Aligned_cols=237 Identities=20% Similarity=0.281 Sum_probs=170.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999865 578899999865432 2335678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++ +|..++.... ..+++.....++.|+++||+|||+ |||+++...... ..
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 975 8888776532 347888888899999999999996 899887543221 12
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC----------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA---------- 385 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 385 (435)
.....+|+.|+|||...+ ..++.++|||||||++|||+||+.||...... +....+...+.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE----DELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhhcchh
Confidence 233568899999998754 56889999999999999999999998543211 111111111110000
Q ss_pred --CccccccccC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 --DDVLDPTVLN----AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 --~~~~~~~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...-.+.... ...........+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000011234568899999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=253.65 Aligned_cols=216 Identities=21% Similarity=0.307 Sum_probs=165.3
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEe
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 259 (435)
|++.+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 677899999999999999864 58899999987532 223456788999988885 5778889999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|..++... ..+++.....++.|++.||+|||+ |||+++...... .
T Consensus 82 y~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 99999999988653 248889999999999999999996 899987543221 1
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+..... ..|.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~----~~~i~~~~~---~~p~--- 222 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DEL----FQSIMEHNV---SYPK--- 222 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCC---CCCc---
Confidence 22345799999999999888899999999999999999999999854321 111 111111111 0111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
.....+.+++.+||+.+|++|++.
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 ----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 112346678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=248.88 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=173.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4678899999999999999864 68899999986543 22346799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+ +++|.+++.... ..+++..+..++.++++||+|||+ |||+++.........
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999987543 358899999999999999999996 788877654332222
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC----------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA---------- 385 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 385 (435)
.....|+..|+|||+..+ ..++.++||||+||++|||+||++|+..... ......+.........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 334568999999998765 4468999999999999999999777643211 1111111111111000
Q ss_pred --Ccccccccc----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 --DDVLDPTVL----NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 --~~~~~~~~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+... ..........+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0000011256778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=253.53 Aligned_cols=227 Identities=22% Similarity=0.319 Sum_probs=172.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+.+.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344555678999999999999864 5889999998665545566789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++... .+++.....++.+++.||+|||+ |||+++...... ..
T Consensus 101 ~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 174 (292)
T cd06658 101 LEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PK 174 (292)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-cc
Confidence 9999999988542 37888899999999999999995 888876543221 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||...+..++.++|||||||++|||++|+.||..... .... ..+... ..+.....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~----~~~~~~-----~~~~~~~~ 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAM----RRIRDN-----LPPRVKDS 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHHhc-----CCCccccc
Confidence 2335689999999999888899999999999999999999999853211 1111 111111 01111000
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
......+.+++..||..||++|||+.++++.
T Consensus 242 --~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 --HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0112245677888999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=248.87 Aligned_cols=223 Identities=22% Similarity=0.355 Sum_probs=171.6
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.-|+..+.||+|+||.||+|.. .+++.||+|.+.... ......|.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3466788899999999999985 467899999886433 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++|+|..++... .+++.....++.+++.|+.|||+ |||+++.+.... ..
T Consensus 84 ~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 84 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 9999999988642 37888999999999999999996 888876554321 11
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||.......+.++|||||||++|||++|..|+..... .... ........ +....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~-~~~~~~~~-----~~~~~- 223 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVL-FLIPKNNP-----PTLEG- 223 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHH-HHHhcCCC-----CCCCc-
Confidence 2234688899999998888889999999999999999999999743211 1111 11111111 11111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 ---NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ---ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12234667889999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.03 Aligned_cols=228 Identities=25% Similarity=0.377 Sum_probs=173.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4677889999999999999875 58899999986543 234567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~ 316 (435)
++++|.+++.... ..++......++.++++|++|||+ |||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 9999999987642 357888888999999999999997 555554332111
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||+..+..++.++||||||+++|||++|+.|+...... ............... . +....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-~-----~~~~~- 226 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP-P-----PRLPS- 226 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC-C-----CCCCh-
Confidence 11256888999999998889999999999999999999999998643211 111222221111111 0 11100
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||..+|++|||+.+++.
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 012335678889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=254.17 Aligned_cols=213 Identities=22% Similarity=0.319 Sum_probs=159.6
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHH-HhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEME-TLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++||+|+||.||+|+.. +++.||+|.+.... ......+.+|.. +++.++|||||++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999865 58899999986432 122344556654 67889999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+.......++.|+++||+|||+ |||+++...... .....
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9998888643 236777788899999999999996 899887532211 22234
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ... ....+..... . + | ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~-~~~~i~~~~~-~-~-~----~~-- 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQ-MYDNILHKPL-Q-L-P----GG-- 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHH-HHHHHhcCCC-C-C-C----CC--
Confidence 679999999999988889999999999999999999999985421 111 1111111110 0 0 1 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTML 424 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~ 424 (435)
....+.+++.+|++.+|++||+..
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 -KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCHHHHHHHHHHccCCHhhcCCCC
Confidence 122466788899999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=249.59 Aligned_cols=224 Identities=26% Similarity=0.369 Sum_probs=169.5
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+...|...+.||+|+||.||+|... +++.||+|.+..... ...+++.+|+++++.++||||++++++|...+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 44567888999999999999999864 588999998864322 23457889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||++ |++.+++.... ..+++.....++.|++.||.|||+ |||+++....
T Consensus 92 lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9999997 57766665432 248899999999999999999996 7777765432
Q ss_pred cCccccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
. ....|+..|+|||+.. ...++.++||||||+++|||+||+.|+.... ......... ...
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-------~~~~~~~~~-~~~---- 230 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIA-QND---- 230 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-------HHHHHHHHh-cCC----
Confidence 1 2346888999999863 4568899999999999999999999974321 111111111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+... .......+.+++.+||+.+|++||+|.+|+.
T Consensus 231 -~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 231 -SPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -CCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01111 1123345778899999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.63 Aligned_cols=230 Identities=24% Similarity=0.384 Sum_probs=170.2
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEe------
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSF------ 250 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------ 250 (435)
..+...|++.+.+|+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 345578889999999999999999864 57899999885433 2345688899999998 69999999999853
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
.+..++||||+++|+|.+++.... ...+++.....++.|+++|++|||+ |||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 456899999999999999987643 2347788888899999999999996 88887
Q ss_pred ccccccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
+...... .......|++.|+|||.+. ...++.++|||||||++|||+||+.||....... ......
T Consensus 169 ~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~- 239 (282)
T cd06636 169 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIP- 239 (282)
T ss_pred hhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-------hhhhHh-
Confidence 6543211 1122356899999999865 3467889999999999999999999985321110 011110
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... .+... .......+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 01111 1112235778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=246.56 Aligned_cols=227 Identities=22% Similarity=0.334 Sum_probs=167.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHH-hccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMET-LGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.+ ++..+|||||++++++..++..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5788899999999999999865 589999999865432 233456667665 6677999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
++ |+|.+++.........+++.....++.|++.||+|||+ |||+++..... .
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--V 158 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--c
Confidence 96 78888887644334568999999999999999999995 78877654321 1
Q ss_pred ccccccccCCCcCCcCCCC----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQS----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..+...|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+..... . . .......... .+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~--~-~~~~~~~~~~------~~ 226 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---P--F-QQLKQVVEEP------SP 226 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---C--H-HHHHHHHhcC------CC
Confidence 2233568899999998754 4568899999999999999999999853111 0 1 1111111110 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... .....+.+++.+||+.+|++||++.+|++
T Consensus 227 ~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 12235678899999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=254.53 Aligned_cols=216 Identities=21% Similarity=0.288 Sum_probs=160.3
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHH-HhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEME-TLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 57789999986532 122234455544 56889999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++.... .+.......++.|+++||+|||+ |||+++..... ......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 99999887532 36667777899999999999996 99998754321 122334
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~----~~i~~~~~--~~~~~------- 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMY----DNILNKPL--QLKPN------- 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHH----HHHHhCCc--CCCCC-------
Confidence 6799999999999998999999999999999999999999853211 1111 11111110 01111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
....+.+++.+|++.+|.+||++.+.+
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 219 -ITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112456788899999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=244.85 Aligned_cols=233 Identities=22% Similarity=0.361 Sum_probs=171.5
Q ss_pred cceeeeecccCcceEEEEEcC----CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 185 LTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
|.+.++||+|+||.||+|.+. +++.||||.+.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999753 36789999986532 233567889999999999999999999886532
Q ss_pred eeEEEEecccCCCHHHHHHhhC--CCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNAT--GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
..++++||+++|+|..++.... .....+++.....++.+++.|++|||+ |||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999999998875432 122357888899999999999999996 89988
Q ss_pred ccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 307 RLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 307 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
+........ ......+++.|++||......++.++|||||||++|||++ |+.|+..... .++..+ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~----~~~~~ 232 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNY----LIKGN 232 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHH----HHcCC
Confidence 765432211 1122345678999999988889999999999999999999 7777643211 112111 11111
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ...+ ......+.+++.+||+.+|++||++.+++..|+++.
T Consensus 233 ~--~~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 233 R--LKQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred c--CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 0 0000 012236788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=245.99 Aligned_cols=230 Identities=23% Similarity=0.361 Sum_probs=176.5
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+...|+..+.+|+|+||.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345567888899999999999999876 588999999875443 456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
+||+++++|.+++.... ..+++..+..++.+++.||+|||+ |||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999998643 358899999999999999999996 666655433211
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......++..|+|||+..+..++.++|||||||++|||++|+.|+..... ........ .........+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~~~-~~~~~~~~~~-- 239 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFLIT-TKGIPPLKNP-- 239 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHH-hcCCCCCcch--
Confidence 112234578899999998888899999999999999999999999753211 11111111 1111111111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|.+||++.+|++
T Consensus 240 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112235678899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=249.91 Aligned_cols=236 Identities=25% Similarity=0.314 Sum_probs=166.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccC---CCCCceeEEEEEEe-----CC
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKV---KHQNLVLLLGYCSF-----DE 252 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 252 (435)
+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 588999998865322 2234566777777665 79999999998864 24
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||++ ++|..++.... ...+++.....++.|++.||+|||+ |||+++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 5789999998 58888886532 2347888999999999999999995 8998876
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC---C
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ---A 385 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 385 (435)
.... .......||..|+|||++.+..++.++|||||||++|||++|++||...... .....+........ .
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 158 YSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHHHhCCCChhhC
Confidence 5432 2223457899999999998888999999999999999999999998543211 11111111110000 0
Q ss_pred C-------cccccccc---CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 D-------DVLDPTVL---NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~-------~~~~~~~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+... ..........+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0000112234668889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=263.41 Aligned_cols=229 Identities=24% Similarity=0.403 Sum_probs=177.7
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
|.....++..||.|+||.||+|..++ +...|.|.+........++|.-|++||+.+.||+||++++.|...+.++|..|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45566778889999999999998765 34567788877667778899999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||.||-.+.++-... .++...+...++.+++.||.|||+ |||.+...... ..
T Consensus 110 FC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred ecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 999999998876542 358889999999999999999996 89987654321 22
Q ss_pred ccccccccCCCcCCcCC-----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 316 VSTDIAGTLGYIPPEYG-----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~-----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
....+.|||+|||||+. ...+|+.++|||||||+|.||..+.+|... .+... +.-.+.+......+.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-------lnpMR-VllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-------LNPMR-VLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-------cchHH-HHHHHhhcCCCcccC
Confidence 33467899999999964 457899999999999999999999988532 22222 122222222222333
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
|.. ....+.++...|+.+||..||++.++++
T Consensus 258 PS~-------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PSH-------WSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cch-------hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 322 2334566777899999999999999874
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.46 Aligned_cols=238 Identities=22% Similarity=0.275 Sum_probs=170.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999865 578999999864432 234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|++ ++|..++.... ..+++.....++.++++||+|||+ |||+++...... .
T Consensus 85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 997 68988886532 247788888999999999999996 889887543221 1
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC---CCCccc--
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ---QADDVL-- 389 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 389 (435)
......+++.|+|||...+ ..++.++|||||||++|||+||+.||...... .....+...+... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE----EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhchhhhcc
Confidence 1223467889999998754 45788999999999999999999998543211 1111111111100 000000
Q ss_pred -------cccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 -------DPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 -------~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+...... .......+.+++.+|+..||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0011224567899999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=245.21 Aligned_cols=227 Identities=24% Similarity=0.410 Sum_probs=171.5
Q ss_pred cceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56678999999999999985 5688999999864321 1245789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISAC 312 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~ 312 (435)
|||+++++|.+++... ..+++.....++.|++.||+|||+ |||+++.....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 82 VEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999998753 247888889999999999999996 77777654322
Q ss_pred Cc---cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 313 ET---HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 313 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.. .......||..|+|||...+..++.++||||+|+++|||++|..||..... ...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATT----- 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCC-----
Confidence 11 111234688899999998888889999999999999999999999853211 111111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.. .......+.+++.+||..+|++||++.++++
T Consensus 229 ~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSI----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCC----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111 1112245677889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=238.01 Aligned_cols=239 Identities=22% Similarity=0.278 Sum_probs=176.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccccc--HHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 255 (435)
....|+..+.|++|.||.||+|+.. +++.||+|+++...... --.-.+||.+|.+++|||||.+..+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3456888899999999999999865 58899999997654321 2346799999999999999999887654 46799
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
||||||+. +|..++..-. +.+.......+..|+++|++|||+ |||+||.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999975 7888887543 457778888899999999999996 9999998764
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC---c
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---D 387 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 387 (435)
. ....|..+-|..|.|||.+.+ ..|++.+|+||+|||+.||+++++-|. .+.+.+.+..++..+...... .
T Consensus 230 p-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~----G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 P-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP----GKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred C-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC----CCchHHHHHHHHHHhCCCccccCCC
Confidence 3 344577889999999997665 579999999999999999999997653 334455556666655432211 1
Q ss_pred ccccccc-----CCCC----------HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVL-----NAGS----------KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~-----~~~~----------~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....... .... ......-+++...-+..||.+|-|+.|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111100 0000 001123345666677889999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=249.67 Aligned_cols=228 Identities=29% Similarity=0.445 Sum_probs=172.6
Q ss_pred cceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccH--HHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGH--RQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
|++.+.||+|+||.||+++... ++.||+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999998654 66899999976543322 23456999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++++|.+++... ..+++..+..++.++++||+|||+ |||.+..... .....
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999832 347889999999999999999996 8998875421 22333
Q ss_pred ccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 318 TDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
....+|..|+|||+.. +..++.++||||+|+++|||++|+.|+..... .+............ ...+.....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~ 227 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS----DDQLEIIEKILKRP----LPSSSQQSR 227 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH----HHHHHHHHHHHHTH----HHHHTTSHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc----hhhhhhhhhccccc----ccccccccc
Confidence 4567899999999988 88899999999999999999999999864310 01111111111100 000000000
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++..||+.||++||++.++++
T Consensus 228 ---~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 ---EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00146778899999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=257.46 Aligned_cols=236 Identities=19% Similarity=0.233 Sum_probs=170.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC---CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP---DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
..+|.+.+.||+|+||.||+|... .++.||||.+... +.+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357899999999999999999743 3578999988542 23568999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+. ++|..++.. ...+++..+..++.|++.||+|||+ |||+++.......
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 688888743 2358899999999999999999996 9999876543222
Q ss_pred -cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC-------
Q 040641 315 -HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD------- 386 (435)
Q Consensus 315 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 386 (435)
.......||+.|+|||++....++.++|||||||++|||++|+.||......... .....+...+......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHHHHHHhccCccccCCccch
Confidence 1223457999999999999889999999999999999999999998543221111 1111111111100000
Q ss_pred ----------ccccccccCCCC---HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 ----------DVLDPTVLNAGS---KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ----------~~~~~~~~~~~~---~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+....+.. ......+.+++.+|+..||++|||+.|++.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 001224567788999999999999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=250.68 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=168.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4678899999999999999865 588999999864322 2235678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++ ++|.+++.... ..+++.....++.|+++||.|||+ |||+++...... ..
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 97 57877776432 248899999999999999999996 899887553221 11
Q ss_pred cccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC------Cccc
Q 040641 317 STDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA------DDVL 389 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 389 (435)
.....++..|+|||++.+. .++.++|||||||++|||+||+.|+....... .....+......... ....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH---HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 2334678899999987654 57899999999999999999999865432211 111111111110000 0000
Q ss_pred c----ccccC-----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 D----PTVLN-----AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~----~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ +.... .........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00000 000112345668899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=253.62 Aligned_cols=176 Identities=22% Similarity=0.254 Sum_probs=146.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++...+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6788999999999999999865 57889999986432 2233458889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|..++.... ..+++.....++.|++.||+|||+ |||+++........
T Consensus 82 y~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999997532 247788888899999999999995 99998766543322
Q ss_pred ccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 VSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 2234579999999998765 4678899999999999999999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=251.00 Aligned_cols=176 Identities=23% Similarity=0.267 Sum_probs=146.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ......|.+|+.++..++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6788999999999999999865 47789999986422 2233458889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.++++... ..+++.....++.|++.||+|||+ |||+++.+......
T Consensus 82 y~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999997532 247888888899999999999986 89998765433322
Q ss_pred ccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 VSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 233457999999999875 34678999999999999999999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=246.83 Aligned_cols=223 Identities=20% Similarity=0.358 Sum_probs=170.9
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCC---CCCceeEEEEEEeCCeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVK---HQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 258 (435)
.|+..+.||+|+||.||+|.. .+++.||+|.++... .....++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366778899999999999986 468899999986532 334567889999999987 999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.++++.. .+++.....++.++++|+.|||+ |||++.......
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999988642 47889999999999999999996 888887654322
Q ss_pred cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......|+..|+|||...+ ..++.++|||||||++|||++|+.||..... ..... ..... ..+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~-~~~~~-----~~~~~ 222 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMM-LIPKS-----KPPRL 222 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhh-ccccC-----CCCCC
Confidence 22234568999999998764 4568899999999999999999999854211 11111 11110 11111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... .....+.+++.+||+.||++||++.++++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 12345778889999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=242.26 Aligned_cols=227 Identities=26% Similarity=0.390 Sum_probs=175.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|++.+.||+|++|.||+|+.. +++.||||++..... .....+.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999876 489999999875543 34577999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHV 316 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~ 316 (435)
++++|.+++... ..+++.....++.++++|++|||+ |||+++....... .
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 999999999754 347889999999999999999996 6776665433221 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....++..|+|||......++.++||||||+++|||+||+.|+..... ......... +..... +.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~-~~~~~~-----~~~~~~ 226 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQA-ICDGPP-----PSLPAE 226 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHH-HhcCCC-----CCCCcc
Confidence 1234678899999999888899999999999999999999999854321 111111111 111111 111110
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 ---EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 02245778888999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=241.06 Aligned_cols=225 Identities=20% Similarity=0.299 Sum_probs=166.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--Cee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 254 (435)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788999999999999999864 58899999875321 12235788899999999999999999988663 467
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... ..+++.....++.+++.||+|||+ |||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998753 236778888999999999999996 899887543
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... .......|+..|+|||+..+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~-~--- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQP-T--- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHHHHhcCC-C---
Confidence 2111 11223568899999999888888999999999999999999999985321 111111111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.. .......+.+++.+||. +|++||++.||++
T Consensus 227 -~~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 -NPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111 11222345667778884 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=251.00 Aligned_cols=237 Identities=24% Similarity=0.300 Sum_probs=170.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-----cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-----GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
+|++.+.||+|+||.||+|... +++.||||+++..... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999865 5889999999754322 234577899999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+ +|+|.+++.... ..+++.....++.|+++||+|||+ |||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 999999997542 258899999999999999999996 788887654322
Q ss_pred ccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC-------
Q 040641 314 THVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA------- 385 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 385 (435)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..... ................
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHHHcCCCchhhhhhcc
Confidence 11223456788999998754 4678999999999999999999776643211 1111111111110000
Q ss_pred --CccccccccCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 386 --DDVLDPTVLNAG-----SKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 386 --~~~~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
..........+. .......+.+++.+||+.+|++|||+.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 01123467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=255.52 Aligned_cols=172 Identities=26% Similarity=0.265 Sum_probs=141.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467899999999999999999854 58899999986532 223457889999999999999999999886433
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++ +|..++.. .+++.....++.|+++||+|||+ |||+++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 46999999975 56665542 26778888899999999999996 9999876
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .......||..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5432 222345789999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=244.40 Aligned_cols=225 Identities=22% Similarity=0.331 Sum_probs=172.8
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
..|...+.||+|++|.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3456668999999999999985 468899999986554445567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++++|.+++... .+++.....++.+++.|++|||+ |||+++..... ....
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-~~~~ 172 (285)
T cd06648 99 EGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRR 172 (285)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-Cccc
Confidence 999999998752 37888889999999999999996 77776654322 1122
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
....|+..|+|||...+..++.++|||||||++|||++|+.||.... ..... ........ +.....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~-~~~~~~~~-----~~~~~~- 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAM-KRIRDNLP-----PKLKNL- 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHH-HHHHhcCC-----CCCccc-
Confidence 23568999999999888889999999999999999999999985321 11111 11111111 111000
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.+|++||++.++++
T Consensus 239 -~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 -HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 012235778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=248.34 Aligned_cols=238 Identities=23% Similarity=0.287 Sum_probs=169.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999865 578999999865332 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++ ++|.+++.... ..+++.....++.++++||.|||+ |||+++..... ...
T Consensus 85 ~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~ 159 (291)
T cd07844 85 LD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SKT 159 (291)
T ss_pred CC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC-Ccc
Confidence 98 49998887542 247888889999999999999996 88887653221 111
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc--------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD-------- 387 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 387 (435)
.....++..|+|||+..+ ..++.++|||||||++|||++|+.||...... .+....+...+.......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 223457889999998765 45789999999999999999999998543210 011111111111000000
Q ss_pred --------cccccccCC--CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 --------VLDPTVLNA--GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 --------~~~~~~~~~--~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+..... ........+.+++.+|++.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 00001145678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=248.93 Aligned_cols=172 Identities=24% Similarity=0.284 Sum_probs=136.0
Q ss_pred eeeecccCcceEEEEEcC---CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEEEEeccc
Q 040641 188 VDILEDGGFGTVYKATLP---DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLLVYEYMV 262 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~ 262 (435)
...||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++|||||++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999854 46789999986432 23457899999999999999999998854 456789999986
Q ss_pred CCCHHHHHHhhCC-----CCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccccc
Q 040641 263 NGSLDLWLRNATG-----SHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLI 309 (435)
Q Consensus 263 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~ 309 (435)
++|..++..... ....+++.....++.|++.||+|||+ |||+++..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 578777753221 12347888889999999999999996 89998765
Q ss_pred cccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 310 SACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 310 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
..... .......||+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 43211 12234678999999998866 4689999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=256.69 Aligned_cols=175 Identities=21% Similarity=0.294 Sum_probs=147.1
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999999865 58899999986432 2234568889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET- 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~- 314 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999998753 247888888999999999999996 9999875422100
Q ss_pred ---------------------------------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 315 ---------------------------------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 315 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999985
Q ss_pred C
Q 040641 362 P 362 (435)
Q Consensus 362 ~ 362 (435)
.
T Consensus 238 ~ 238 (360)
T cd05627 238 S 238 (360)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=248.84 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=167.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3678899999999999999864 588999999864332 2335788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+. ++|..++.... ...+++.....++.++++||+|||+ |||+++...... ..
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 156 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cc
Confidence 96 68988886532 2358889999999999999999996 788876543221 11
Q ss_pred cccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC------Ccc-
Q 040641 317 STDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA------DDV- 388 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 388 (435)
.....++..|+|||+..+. .++.++|||||||++|||+||+.||....... .... .......... ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFR-IFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-HHHHhCCCChhhhhhhhHHH
Confidence 2234578899999987654 46889999999999999999999985322110 0111 1111100000 000
Q ss_pred ----ccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 ----LDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ----~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.-+...... .......+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 0011234567899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=253.14 Aligned_cols=172 Identities=24% Similarity=0.253 Sum_probs=141.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC------C
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------E 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 252 (435)
..+|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 457899999999999999999854 57899999986532 23346788999999999999999999987543 3
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++ +|..++.. .+++.....++.|+++||+|||+ |||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 47999999975 67666643 26778888999999999999996 9999986
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .......||..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 176 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred cCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 5432 222345789999999999988999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=249.38 Aligned_cols=171 Identities=25% Similarity=0.295 Sum_probs=134.9
Q ss_pred eeecccCcceEEEEEcC---CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP---DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~~ 263 (435)
..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++|||||++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 35789999986433 23467899999999999999999998854 5667899999875
Q ss_pred CCHHHHHHhhC-----CCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccccccc
Q 040641 264 GSLDLWLRNAT-----GSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLIS 310 (435)
Q Consensus 264 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~~ 310 (435)
+|.+++.... .....+++.....++.|++.||.|||+ |||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 6777664321 112347888889999999999999996 899987654
Q ss_pred ccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 3211 12234578999999998766 4578999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.64 Aligned_cols=222 Identities=22% Similarity=0.283 Sum_probs=178.3
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
-|.+.+.||+|.|++|-.|++ -+|+.||||++.+.+.+ ....+.+|++.|+-++|||||++|.+......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 467889999999999999974 57999999999875543 345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
-.+|+|.+||-+.. .-+.+....++..||.+|+.|+|+ |||++...... .
T Consensus 99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 99999999997653 237778888999999999999996 99998766542 3
Q ss_pred ccccccccCCCcCCcCCCCCCCC-CcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMST-TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
..+..||++.|-|||++.+..|+ +++||||+|||||-++.|++||......+. ... ++|-...
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----LTm------------ImDCKYt 237 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----LTM------------IMDCKYT 237 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----hhh------------hhccccc
Confidence 44568999999999999887774 689999999999999999999865433211 111 1111110
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
-+.....++.+++..++..||.+|.+.+||+.
T Consensus 238 --vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 --VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11223456778889999999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=235.42 Aligned_cols=225 Identities=26% Similarity=0.443 Sum_probs=175.5
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999875 688999999976555456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+++|.+++.... ..+++.....++.++++|++|||+ |||.+........ ..
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999999987542 358899999999999999999996 7787766543221 23
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
...|+..|+|||+..+..++.++||||||+++|||++|+.|+.... .......... ........+
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~------- 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIAT-NGPPGLRNP------- 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHh-cCCCCcCcc-------
Confidence 4568899999999888888999999999999999999999975321 1111111111 111111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001235678889999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=257.92 Aligned_cols=221 Identities=24% Similarity=0.376 Sum_probs=168.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEc--cc--cccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe--eEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKF--SQ--AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE--KLL 256 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~l 256 (435)
-+.+.++||+|+|=+||||... +|.+||=-.+ +. ......+.|..|+.+|+.|+|||||+++.+..+... .-+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 3467789999999999999864 4777763222 11 122345789999999999999999999999877655 678
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~ 309 (435)
|+|.|..|+|..|++..+ .++......++.||++||.|||+ |+|+|...
T Consensus 121 iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999998653 36666788999999999999996 99999887
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.... ...+.|||-|||||.+. ..|++.+||||||++++||+|+..||.... ....+...+...++......+-
T Consensus 197 r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 197 RKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred hccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCHHHhhccC
Confidence 6432 23478999999999887 789999999999999999999999985321 2222333333333322222333
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
|| ++.++|.+|+.. .++|||+.|+++
T Consensus 270 dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 DP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 33 356788899999 899999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=242.71 Aligned_cols=218 Identities=22% Similarity=0.301 Sum_probs=170.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788999999999999999865 58899999986533 2234568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++... ..++...+..++.++++||.|||+ |||+++.....
T Consensus 82 ~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999998754 347888899999999999999996 88888765432
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
.....|++.|+|||...+...+.++||||||+++|||++|+.||..... ............ ....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~------~~~~ 219 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKV------RFPS 219 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCc------cCCc
Confidence 2345689999999998888889999999999999999999999853221 111111111110 0101
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRP-----TMLHVL 427 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl 427 (435)
. ....+.+++.+||+.+|.+|| ++.|++
T Consensus 220 ~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 220 F----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred c----CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1 123556788899999999999 677765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=247.33 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=167.6
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
|++.+.||+|++|.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999864 689999999864332 23356889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
+ ++|.+++..... ..+++..+..++.++++||+|||+ |||+++..... ....
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRTY 156 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-cccc
Confidence 5 689988865432 358899999999999999999996 78887654321 1112
Q ss_pred ccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC------------
Q 040641 318 TDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ------------ 384 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------ 384 (435)
....++..|+|||+..+. .++.++|||||||++|||+||+.||....... .... +........
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFR-IFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHhCCCChHHhhhhhhchh
Confidence 233568899999987654 57889999999999999999999985321110 0111 000000000
Q ss_pred ----CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ----ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.. ..........+.+++.+||+.+|++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0000111235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=246.47 Aligned_cols=227 Identities=21% Similarity=0.294 Sum_probs=171.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999865 4899999998654322 34578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++++|.+++.... ...+++.....++.|+++||+|||+ |||++.........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999987532 2458888899999999999999996 78877643221100
Q ss_pred ----------------------------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc
Q 040641 316 ----------------------------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367 (435)
Q Consensus 316 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~ 367 (435)
......||..|+|||+..+..++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~- 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD- 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence 011246889999999998888999999999999999999999998532211
Q ss_pred cCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC----HHHHHH
Q 040641 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT----MLHVLK 428 (435)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs----~~evl~ 428 (435)
....... ..... .+ ........+.+++.+||+.+|++||| +.|++.
T Consensus 239 ------~~~~~~~-~~~~~---~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ------ETFSNIL-KKEVT---FP-----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------HHHHHHh-cCCcc---CC-----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1011111 11000 00 01112346778899999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=245.56 Aligned_cols=226 Identities=26% Similarity=0.368 Sum_probs=169.6
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+...|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|||+|++++++..++..+
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 44456888899999999999999864 588999999864322 23357889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||++ |+|.+++.... ..+++..+..++.+++.|+.|||+ |||+++....
T Consensus 102 lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9999997 57777765432 348899999999999999999996 7887654332
Q ss_pred cCccccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.....|++.|+|||++. ...++.++|||||||++|||++|+.|+.... .............
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~---- 241 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES---- 241 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccC----
Confidence 12346889999999863 4568899999999999999999999975321 1111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
+.... ......+.+++.+||+.+|++||++.+|++.+
T Consensus 242 --~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 --PTLQS---NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred --CCCCC---ccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00001 11223467888899999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=260.32 Aligned_cols=179 Identities=30% Similarity=0.416 Sum_probs=152.7
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC------CeeEE
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------EEKLL 256 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 256 (435)
....+.||+|+||.||+|+.+ +|+.||||.++... ....+.+.+|+++|++++|||||++.+.=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345788999999999999954 69999999997643 34556789999999999999999999875443 35689
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARL 308 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~ 308 (435)
|||||++|||+..+.+.. ...-+++...+.+..+++.||.|||. |||.||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999998764 34569999999999999999999985 9999999
Q ss_pred ccccCccccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCccc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQE 366 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~ 366 (435)
+.++. ..++.+||..|.|||.+. .+.|+..+|.|||||++||++||..||.+.-..
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 87643 556789999999999988 488999999999999999999999999765443
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.57 Aligned_cols=236 Identities=24% Similarity=0.273 Sum_probs=170.7
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEEEEe
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLLVYE 259 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 259 (435)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 467889999999999999865 47899999997653 33346788999999999999999999999887 88999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++ +|..++.... ..+++.....++.++++|++|||+ |||+++........
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9974 8888876532 358889999999999999999996 88888765443222
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc------
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV------ 388 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 388 (435)
..+...++..|+|||...+ ..++.++||||||+++|||+||+.||..... ......+............
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE----LEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCchhhccccccc
Confidence 2234467889999997654 4678999999999999999999999854321 1111111111111000000
Q ss_pred -----ccccccCC-----CCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 -----LDPTVLNA-----GSKP-MMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 -----~~~~~~~~-----~~~~-~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+..... .... +...+.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 0000 1346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=241.08 Aligned_cols=227 Identities=22% Similarity=0.341 Sum_probs=170.1
Q ss_pred CcceeeeecccCcceEEEEEcCC-CCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
+|.+.+.||+|+||.||+++... +..+++|.++... .....++..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46788999999999999998643 4445555554321 22334677899999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccccCc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACET 314 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~~~~ 314 (435)
|||+++++|..+++........+++.....++.++++|+.|||+ |||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~- 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSC- 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCc-
Confidence 99999999999987643344568999999999999999999996 788776653321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......|+..|+|||......++.++||||||+++|||++|+.|+... ........... .. .+..
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~~~-~~-----~~~~- 225 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-------NFLSVVLRIVE-GP-----TPSL- 225 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHHc-CC-----CCCC-
Confidence 1222356888999999988888899999999999999999999997432 11111111111 11 1111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||..+|++||++.|+++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 ---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1122345678899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.79 Aligned_cols=225 Identities=20% Similarity=0.332 Sum_probs=175.3
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4678899999999999999754 67899999986533 23345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|..++.........+++.....++.++++|++|||+ |||+++..... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 99999999987644334568889999999999999999996 78877665432 2
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||...+..++.++|+||||+++|||++|+.|+..... ..+. ..........
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~----~~~~~~~~~~--------- 220 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLR----YKVQRGKYPP--------- 220 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHhcCCCCC---------
Confidence 2234688999999999888899999999999999999999999853211 1111 1111111110
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
........+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01123345788999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=244.30 Aligned_cols=231 Identities=22% Similarity=0.320 Sum_probs=167.7
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |||||++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667788999999999999864 588999999865432 34457889999999996 9999999999999999999999
Q ss_pred cccCCCHHHHHHhh-CCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccC
Q 040641 260 YMVNGSLDLWLRNA-TGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~ 313 (435)
|+.. ++.++.... ......+++.....++.+++.||+|||+ |||+++......
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9864 554433211 1112458888999999999999999984 788876543221
Q ss_pred ccccccccccCCCcCCcCCCCC---CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSR---MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
......|++.|+|||++... .++.++|||||||++|||++|+.||.... .....+....... .
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~------~ 228 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGD------P 228 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCC------C
Confidence 12234688999999988765 68899999999999999999999985321 1111111111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.............+.+++.+||+.+|++|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111223346778999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=236.45 Aligned_cols=227 Identities=22% Similarity=0.390 Sum_probs=176.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4678899999999999999865 588999999875433 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++.........+++.....++.+++.|++|||+ |||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 99999999998754333568999999999999999999996 788776543322 12
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|++.|+|||......++.++||||+|+++|||++|+.|+.... .... ........... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~-~~~~~~~~~~~-----~~~- 225 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLEL-ALKILKGQYPP-----IPS- 225 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHH-HHHHhcCCCCC-----CCC-
Confidence 233568899999999888889999999999999999999999975321 1111 11111111111 111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||..+|++|||+.++++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11235678889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=249.40 Aligned_cols=229 Identities=24% Similarity=0.326 Sum_probs=170.1
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccc--cccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQ--AKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 258 (435)
-..|++.+.||+||.+.||++...+.+.+|+|++.. .+.+....|.+|+..|.+++ |.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 346788899999999999999988888999998753 33445677999999999994 999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccccCc-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACET- 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~~~~- 314 (435)
||- .-+|..+|++... ...+| .+..+-.|++.++.++|. |||+|+.+..+.+
T Consensus 440 E~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccc
Confidence 986 5689999987643 23445 445577888888988885 9999998865543
Q ss_pred cccccccccCCCcCCcCCCCC-----------CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 315 HVSTDIAGTLGYIPPEYGQSR-----------MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
......+||+.||+||.+... ..+.++||||+|||||+|+.|+.||... .+....+ ..+...
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl-~aI~~P 588 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKL-HAITDP 588 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHH-HhhcCC
Confidence 334567999999999965322 2568999999999999999999998531 1111111 111111
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .++.-|.+.. . .+++++|..|++.||.+|||+.|+++
T Consensus 589 ~-~~Iefp~~~~--~----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 589 N-HEIEFPDIPE--N----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred C-ccccccCCCC--c----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 0 0111111111 1 12778999999999999999999974
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=239.66 Aligned_cols=223 Identities=22% Similarity=0.304 Sum_probs=172.6
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3678899999999999999875 588999999965432 335679999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++++|..++... ..+++.....++.++++||.|||+ |||++.......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998754 347888899999999999999996 788776543321
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......|+..|+|||+.....++.++||||||+++|||++|+.|+...... ...+........ . ...|.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--~-~~~~~--- 223 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETA--D-VLYPA--- 223 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccc--c-ccCcc---
Confidence 223456888999999988888999999999999999999999998643221 111122211110 0 00111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH--HHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTM--LHVL 427 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~--~evl 427 (435)
.....+.+++.+||+.||.+||++ .|++
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 ----TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112456788899999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=246.87 Aligned_cols=179 Identities=27% Similarity=0.347 Sum_probs=141.8
Q ss_pred CcceeeeecccCcceEEEEEcC---CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP---DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 255 (435)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4678889999999999999864 47899999997633 33346788999999999999999999999988 7899
Q ss_pred EEEecccCCCHHHHHHhhCCC-CCCCCHHHHHHHHHHhhhccceeec----------------------------ccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGS-HEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLA 306 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla 306 (435)
+||||+++ +|.+++...... ...++......++.|++.||+|||+ |||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 666666543322 2357888889999999999999985 78877
Q ss_pred ccccccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 307 RLISACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 307 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
+....... .......+|+.|+|||+..+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 65432211 11223467899999997665 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=243.95 Aligned_cols=239 Identities=22% Similarity=0.242 Sum_probs=167.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCe-----e
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEE-----K 254 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~ 254 (435)
+|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5788899999999999999865 588999998864332 23457889999999995 6999999999987665 8
Q ss_pred EEEEecccCCCHHHHHHhhCCC-CCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGS-HEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARL 308 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~ 308 (435)
++||||+++ +|..++...... ...+++.....++.|+++||+|||+ |||+++.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999985 788887654322 3457899999999999999999996 7777765
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... ........+++.|+|||+..+ ..++.++|||||||++|||+||..||...... .....+...........
T Consensus 161 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 161 FSIP-VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL----QQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cCCC-ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHHhCCCChhh
Confidence 4321 111122356888999998754 46789999999999999999999998542111 11101111111000000
Q ss_pred ---c---c----ccc----ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 ---V---L----DPT----VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ---~---~----~~~----~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. . -+. ...........++.+++.+||..||++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 000 000000112345678899999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=234.18 Aligned_cols=226 Identities=24% Similarity=0.359 Sum_probs=174.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 258 (435)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667889999999999999876 688999999865442 3456789999999999999999999999988 8899999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++.... .+++..+..++.++++|++|||+ |||.+........
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987642 58899999999999999999996 7777766543221
Q ss_pred c-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 H-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
. ......++..|+|||.......+.++||||||+++|||++|+.||.... +................ .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~-----~ 225 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPE-----I 225 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcC-----C
Confidence 0 1234568889999999888889999999999999999999999985432 11111111111011111 1
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ......+.+++.+|++.+|++||++.+++.
T Consensus 226 ~----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 P----EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred C----cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 111245778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=250.14 Aligned_cols=170 Identities=27% Similarity=0.315 Sum_probs=140.5
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeC------Ce
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------EE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 253 (435)
.+|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 5788899999999999999985 4678999999865322 2345678999999999999999999987543 34
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.+++|||+ +++|..++.. ..+++.....++.|+++||+|||+ |||+++..
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 68999998 7899887753 247888999999999999999996 89998765
Q ss_pred cccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 431 234578999999998766 5688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=244.84 Aligned_cols=237 Identities=22% Similarity=0.241 Sum_probs=169.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 257 (435)
..|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999875 578999999864332 2234577899999999999999999999877 889999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||++ ++|.+++.... ..+++.....++.|++.||+|||+ |||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 58988886532 258899999999999999999996 888887654321
Q ss_pred ccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc----------
Q 040641 314 THVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK---------- 382 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
.......+++.|+|||...+. .++.++||||||+++|||++|+.||...... .....+......
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI----DQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchHHHHHhh
Confidence 112334678899999987654 4688999999999999999999998543211 111111111000
Q ss_pred -------CCCCccccccccCCCCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 -------QQADDVLDPTVLNAGSKP-MMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 -------~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.................. ....+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000 1334667889999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=237.33 Aligned_cols=218 Identities=22% Similarity=0.305 Sum_probs=166.8
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||.|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 488999999865332 2346799999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
.+++... ..+++.....++.++++||+|||+ |||+++...... ......|
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999753 237888889999999999999996 888887654321 2233568
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
+..|+|||......++.++|+||||+++|||++|..|+..... +............. ....|. ...
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~--~~~~~~-------~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNG--KLEFPN-------YID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCC--CCCCCc-------ccC
Confidence 8999999998888889999999999999999999999864321 11111111111010 000010 012
Q ss_pred HHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 403 LKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
..+.+++.+||+.+|++||+ +.|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 35778999999999999999 677664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=241.15 Aligned_cols=223 Identities=22% Similarity=0.324 Sum_probs=169.1
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
++....||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 333467899999999999864 6889999998654444556789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
++|.+++... .+++.....++.+++.|++|||+ |||++....... .....
T Consensus 102 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 102 GALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9999887532 36888889999999999999996 788776543221 12233
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..|++.|+|||+..+..++.++|||||||++|||++|+.||..... ..... ....... +..... .
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~----~~~~~~~-----~~~~~~--~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMK----MIRDNLP-----PKLKNL--H 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH----HHHhhCC-----cccCCc--c
Confidence 5688999999998888889999999999999999999999753211 11111 1111100 000000 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11224567888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.45 Aligned_cols=238 Identities=23% Similarity=0.300 Sum_probs=169.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
+|+..+.||+|++|.||+|+.. +|+.||||.++..... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4678899999999999999975 5889999998754322 3456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++ +|.+++.... ....+++.....++.++++||+|||+ |||+++...... ...
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTF 157 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-ccc
Confidence 85 8888886543 23458999999999999999999996 777776443211 112
Q ss_pred ccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC---C-----cc
Q 040641 318 TDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA---D-----DV 388 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~ 388 (435)
....+|..|+|||+..+ ..++.++|||||||++|||++|+.||....... .............. . ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED----QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhHHHHhcCch
Confidence 23457889999998755 457889999999999999999999986432211 11111111100000 0 00
Q ss_pred ccccccCC-------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNA-------GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~-------~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
........ ........+.+++..||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00011234668889999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=239.26 Aligned_cols=234 Identities=18% Similarity=0.205 Sum_probs=166.3
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeC--CeeEEEEe
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFD--EEKLLVYE 259 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 259 (435)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. ||||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 467889999999999999854 588999999865422 22334567999999885 99999999999887 88999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccccCccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACETHV 316 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~~~~~~ 316 (435)
|++ |+|.+++.... ..+++.....++.+++.||+|||+ |||+++.+.... .
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~--~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKP--P 154 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCC--C
Confidence 997 57877776532 358899999999999999999996 788776553321 1
Q ss_pred cccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh-----------ccCC
Q 040641 317 STDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM-----------KKQQ 384 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~ 384 (435)
.....++..|+|||+.. +..++.++|||||||++|||++|..||..... .+...+..... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12346789999999754 45678899999999999999999999854221 11111111111 0000
Q ss_pred CCccccccccCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ADDVLDPTVLNA----GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ~~~~~~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+..... ........+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001001110000 00122456788999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=250.54 Aligned_cols=216 Identities=20% Similarity=0.274 Sum_probs=158.7
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccC---CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKV---KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
||+|+||.||+|+.. +++.||||.+..... .....+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 588999999864322 1233456677777655 699999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|..++... ..+++.....++.|+++||+|||+ |||+++...... .....
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 9999888653 247888899999999999999996 999987543221 22234
Q ss_pred ccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 320 IAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
.+||+.|+|||++.+. .++.++|||||||++|||+||+.||..... .. ....+..... .. + ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~-~~~~i~~~~~-~~--~---~~-- 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQ-MYRNIAFGKV-RF--P---KN-- 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HH-HHHHHHcCCC-CC--C---Cc--
Confidence 6799999999987654 578999999999999999999999854211 11 1122211111 00 1 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC----CHHHHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRP----TMLHVLK 428 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RP----s~~evl~ 428 (435)
.....+.+++.+||+.||++|| ++.++++
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112456788899999999998 4555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=242.56 Aligned_cols=230 Identities=22% Similarity=0.284 Sum_probs=170.9
Q ss_pred cceeeeecccCcceEEEEEc----CCCCEEEEEEccccc----cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 185 LTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
|++.+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 67789999999999999974 256889999986432 22345688999999999 5999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++... ..+++.....++.|+++||+|||+ |||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999988653 247788888899999999999995 8888876543
Q ss_pred cCccccccccccCCCcCCcCCCCCC--CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRM--STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
..........|+..|+|||...+.. .+.++||||||+++|||+||..||..... ..............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSEISRRILKS------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHHHHHHHHcc-------
Confidence 3222223356899999999876654 78899999999999999999999853211 11111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.+.... .....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011101 112346678889999999999999988777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=240.44 Aligned_cols=232 Identities=20% Similarity=0.333 Sum_probs=169.1
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCC-CCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCee
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 254 (435)
+.....+|++.+.||+|+||.||+|...+ ++.||||.++.... ....++.+|+.++.+.. ||||++++++|......
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 34456788999999999999999999765 88999999865432 23456777887776665 99999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLI 309 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~ 309 (435)
++||||++ +++..++.... ..+++..+..++.++++||+|||+ |||+++.+
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEeeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999985 57777665432 258889999999999999999995 78877654
Q ss_pred cccCccccccccccCCCcCCcCCCCCC----CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRM----STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.... ......++..|+|||++.+.. ++.++||||||+++|||++|+.||..... . ........... .
T Consensus 166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~~~~~~~~~~-~ 236 (296)
T cd06618 166 VDSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E---FEVLTKILQEE-P 236 (296)
T ss_pred cCCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H---HHHHHHHhcCC-C
Confidence 3221 112345788999999886543 78899999999999999999999853211 0 11111111111 0
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
..... . .....++.+++.+||+.||++||++.++++.
T Consensus 237 ~~~~~-----~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP-----N--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-----C--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 0 0122356788899999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=242.72 Aligned_cols=239 Identities=26% Similarity=0.283 Sum_probs=168.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 357888999999999999999875 588999999864332 23356788999999999999999999987654
Q ss_pred ----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 253 ----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 253 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
..++||||+++ ++...+... ...+++.....++.+++.||+|||+ |||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 666666543 2358899999999999999999995 888
Q ss_pred ccccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++..............++..|+|||...+ ..++.++|||||||++|||++|+.||.... .......+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~----~~~~~~~~~~~~~~~ 237 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ----ELAQLELISRLCGSP 237 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Confidence 887654332222223456788999997754 457889999999999999999999885321 111111111111111
Q ss_pred CCC---cc--------ccccc-c----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QAD---DV--------LDPTV-L----NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~---~~--------~~~~~-~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ++ .++.. . ..........+.+++.+||+.+|++||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00 00000 0 0000012345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=241.44 Aligned_cols=176 Identities=27% Similarity=0.336 Sum_probs=141.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 457889999999999999999854 5889999998654322 23467899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+. ++|..++.... ..+.+.....++.|+++||+|||+ |||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-Q 158 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-C
Confidence 996 67776665432 236777788899999999999996 899887543211 1
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......+++.|+|||+..+ ..++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1233457899999998765 3578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=244.28 Aligned_cols=237 Identities=22% Similarity=0.256 Sum_probs=167.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 688999999864332 234578899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
|++ ++|..++.... ....++.....++.+++.||+|||+ |||+++..... .
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-V 157 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-c
Confidence 996 57877775432 2235677778899999999999996 77777654321 1
Q ss_pred cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc----
Q 040641 315 HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL---- 389 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 389 (435)
...+...+++.|+|||+..+ ..++.++|||||||++|||+||+.||...... +....+....... .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~ 232 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFRILGTP-NEETWPGVT 232 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCC-Chhhccccc
Confidence 11223467889999998765 45789999999999999999999998542211 1111111111000 00000
Q ss_pred --------cccccCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 --------DPTVLNA----GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 --------~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+..... .......++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00111234677889999999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=241.42 Aligned_cols=228 Identities=21% Similarity=0.304 Sum_probs=168.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--------------cHHHHHHHHHHhccCCCCCceeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--------------GHRQFTAEMETLGKVKHQNLVLLL 245 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~niv~l~ 245 (435)
...+|++.+.||+|.||.|-+|+. .+++.||||.+.+.... ..+...+||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 456899999999999999999985 46899999999653211 124788999999999999999999
Q ss_pred EEEEeC--CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 246 GYCSFD--EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 246 g~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
.+..+. +.+|||+|||..|.+... ......++..+..++..++..||+|||.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 998664 568999999999986321 1122238899999999999999999995
Q ss_pred --cccccccccccC----ccccccccccCCCcCCcCCCCC----CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCc
Q 040641 302 --DFGLARLISACE----THVSTDIAGTLGYIPPEYGQSR----MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371 (435)
Q Consensus 302 --DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~ 371 (435)
|||.+....... .......+|||.|||||...++ ..+.+.||||+||+||.|+.|+.||..++.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------ 324 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------ 324 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------
Confidence 999887553211 1112236899999999976652 346789999999999999999999865432
Q ss_pred HHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
--.+..+...... -+...+.-..+-+++.+.+.+||+.|.+..+|..
T Consensus 325 --~~l~~KIvn~pL~--------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 --LELFDKIVNDPLE--------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --HHHHHHHhcCccc--------CCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 1123333222111 1111122334557788888999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=233.34 Aligned_cols=242 Identities=25% Similarity=0.296 Sum_probs=178.7
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCC-ceeEEEEEEeCC-----
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQN-LVLLLGYCSFDE----- 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~----- 252 (435)
...|+..++||+|+||+||+|+. .+|+.||+|+++....+ ......+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788899999999999985 46899999999755432 2345689999999999999 999999998877
Q ss_pred -eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 253 -EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 253 -~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
..++|+||+. -+|..++.........++......++.|+.+||+|||+ |||+|+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 7899999995 58999987654322346667788899999999999996 999999
Q ss_pred cccccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
.... .....+..++|..|.|||++.+. .|++..||||+|||+.||+++++-|.... +.+....++..+......
T Consensus 169 a~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s----e~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 169 AFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS----EIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHHHcCCCCcc
Confidence 6543 22334567899999999987765 79999999999999999999887664332 233444455555433211
Q ss_pred cc---c---c--ccccCCC-CHHH-------HHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 387 DV---L---D--PTVLNAG-SKPM-------MLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 387 ~~---~---~--~~~~~~~-~~~~-------~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.. . + +...... .... .....+++..|++.+|.+|.|+..++..
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 0 0 0000000 1111 1246678889999999999999998864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=237.49 Aligned_cols=219 Identities=24% Similarity=0.297 Sum_probs=163.4
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||+|... +|+.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 58899999986432 22344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
.+++..... ..+++.....++.+++.|+.|||+ |||+++..... .......+
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 999876432 357888999999999999999996 88887665431 11223467
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
+..|+|||+..+..++.++|||||||++|||++|+.||........ . ..+....... ..... . ...
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-~~~~~~~~~~------~~~~~-~---~~~ 222 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---K-EELKRRTLEM------AVEYP-D---KFS 222 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---H-HHHHhccccc------cccCC-c---cCC
Confidence 8899999998888899999999999999999999999854322111 0 0111111100 00000 0 112
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHH
Q 040641 403 LKMLRIAADCVADNPATRP-----TMLHVL 427 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RP-----s~~evl 427 (435)
..+.+++.+||+.+|++|| ++.+++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 3466788899999999999 555564
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=232.19 Aligned_cols=173 Identities=28% Similarity=0.396 Sum_probs=143.1
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEe-----CCeeE
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-----DEEKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~ 255 (435)
.|...+.||+|+||.|..+.. .+|+.||||++... .....+.-.+|+++|+.++|+|||.+.+.+.. -...|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 344478899999999999985 46899999999743 23345678899999999999999999998865 35689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|+|+| .-+|...++.. ..+...+..-+..|+++||.|+|+ |||+||....
T Consensus 103 iV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 999999 56888888753 347888888899999999999997 9999998753
Q ss_pred c-CccccccccccCCCcCCcCC-CCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 312 C-ETHVSTDIAGTLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 312 ~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
. .....|..+.|..|.|||.. ....|+.+.||||.|||+.||++|++-|.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 2 22345778899999999965 55789999999999999999999997763
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=236.77 Aligned_cols=235 Identities=25% Similarity=0.302 Sum_probs=167.3
Q ss_pred cceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc--cHHHHHHHHHHhccC---CCCCceeEEEEEEeCCe-----
Q 040641 185 LTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ--GHRQFTAEMETLGKV---KHQNLVLLLGYCSFDEE----- 253 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 253 (435)
|++.+.||+|+||.||+|+... ++.||+|.++..... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4678899999999999999764 889999998643222 234566788776655 69999999999988776
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.+++|||++ ++|.+++..... ..+++.....++.++++||+|||+ |||+++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 899999997 589888865422 348899999999999999999996 88887665
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC---
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD--- 386 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 386 (435)
.... ......++..|+|||+..+..++.++|||||||++|||+||..||..... .+....+..........
T Consensus 158 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred cCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHHHcCCCChHhcC
Confidence 3321 11234578899999999888899999999999999999999888754321 11111111111100000
Q ss_pred -------ccccccc---cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 -------DVLDPTV---LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 -------~~~~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....... ...........+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 00001122345678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=248.27 Aligned_cols=236 Identities=27% Similarity=0.318 Sum_probs=167.7
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--ccccHHHHHHHHHHhccC-CCCCceeEEEEEEeC--CeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFD--EEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~l 256 (435)
.+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||++++++|... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 57888999999999999999865 5789999988542 222345677899999999 999999999998653 36799
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||++ ++|..++... .+++..+..++.+++.||+|||+ |||+++.....
T Consensus 87 v~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred Eecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 999997 5898887642 47888889999999999999996 89988765432
Q ss_pred Cc----cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-----
Q 040641 313 ET----HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK----- 382 (435)
Q Consensus 313 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 382 (435)
.. .......||..|+|||.+.+ ..++.++|||||||++|||+||+.||....... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN----QLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHH
Confidence 21 12234568999999997654 567889999999999999999999985322111 00000000000
Q ss_pred ------CCCCcccc----ccc--cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 ------QQADDVLD----PTV--LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ------~~~~~~~~----~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+ ... ...........+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000000 000 00000012345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=241.01 Aligned_cols=236 Identities=19% Similarity=0.211 Sum_probs=162.5
Q ss_pred eeeeecccCcceEEEEEcCCCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 187 LVDILEDGGFGTVYKATLPDGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 187 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455566666666655 6899999998654 2334567999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc------
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET------ 314 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~------ 314 (435)
+|.+++..... ..+++.....++.++++||+|||+ |||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999986432 247788888999999999999996 6666654321111
Q ss_pred cccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc----cCC----
Q 040641 315 HVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK----KQQ---- 384 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~---- 384 (435)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ............ ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccccCchhhh
Confidence 01123457788999998765 35789999999999999999999998532110 001110000000 000
Q ss_pred ---CCc----cccccc----cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ---ADD----VLDPTV----LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ---~~~----~~~~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..++.. ...........+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000000 01111223346778999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=231.52 Aligned_cols=225 Identities=21% Similarity=0.316 Sum_probs=167.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc-----ccccHHHHHHHHHHhccCCCCCceeEEEEEEeC--Cee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA-----KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 254 (435)
.+|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46788999999999999999864 5889999987432 122345788999999999999999999998664 457
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++++|.+++... ..+++.....++.+++.|+.|||+ |||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999988753 236788888999999999999996 899887543
Q ss_pred ccC--ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACE--THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... ........|+..|+|||+..+..++.++|||||||++|||++|+.||.... ....+.+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~~-- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQP-TK-- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCC-CC--
Confidence 211 111223568999999999988888999999999999999999999985321 111111111111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+... ......+.+++.+||. +|..||+..+++.
T Consensus 228 --~~~p----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 --PMLP----DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCC----cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 1122356678889999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=245.40 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=167.1
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-----eeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-----EKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 255 (435)
.+|++.+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 5788999999999999999985 468899999986432 233456889999999999999999999876543 479
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||++ ++|..++... .+++.....++.|+++||+|||+ |||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 85 IVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9999997 4787776532 47888899999999999999996 8998876543
Q ss_pred cCcc--ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc-
Q 040641 312 CETH--VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD- 387 (435)
Q Consensus 312 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 387 (435)
.... ......||..|+|||...+ ..++.++|||||||++|||+||+.||..... ......+...+......+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~----~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY----LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCHHHH
Confidence 2211 1233578999999997644 5688999999999999999999999843211 111111111111100000
Q ss_pred --ccc----------ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 388 --VLD----------PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 388 --~~~----------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
..+ +...... ......++.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000 00112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=252.86 Aligned_cols=172 Identities=22% Similarity=0.256 Sum_probs=133.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCC------CCceeEEEEEEeC-C
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH------QNLVLLLGYCSFD-E 252 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~-~ 252 (435)
...+|++.+.||+|+||.||+|... .++.||||+++... ...+++..|++++.+++| ++++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3567999999999999999999864 57889999986432 223445567766666554 5588999988764 5
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeecc------------------------------
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQD------------------------------ 302 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~D------------------------------ 302 (435)
..++|||++ +++|.+++... ..+++.....|+.|++.||+|||+.
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 688999988 77888888653 3488889999999999999999953
Q ss_pred -----------ccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 303 -----------FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 303 -----------fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
||.+... ....+..+||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 281 ~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred CCCCceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2222110 1122346799999999999999999999999999999999999999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=232.73 Aligned_cols=219 Identities=20% Similarity=0.249 Sum_probs=160.1
Q ss_pred eeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHH-hccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMET-LGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+|+||.||+|... +++.||||.++.... .....+..|..+ ....+||||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 588999999865432 122334555544 4556899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~ 319 (435)
|+|.+++... ..+++.....++.|+++||.|||+ |||+++.... ...
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999998753 247788888999999999999996 7777764322 223
Q ss_pred ccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCH
Q 040641 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399 (435)
Q Consensus 320 ~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (435)
..|+..|+|||...+..++.++||||||+++|||+||..||..... . . .+......... ..+... .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~-~~~~~~~~~~~--~~~~~~----~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----D---A-VFDNILSRRIN--WPEEVK----E 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----H---H-HHHHHHhcccC--CCCccc----c
Confidence 4688999999998888889999999999999999999999853211 1 1 11111111110 000000 0
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 400 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
.....+.+++.+||+.+|++||++.++.+.|
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1223567889999999999999776555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=243.20 Aligned_cols=231 Identities=19% Similarity=0.271 Sum_probs=160.9
Q ss_pred eeeccc--CcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 189 DILEDG--GFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 189 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+.||+| +||+||++... +|+.||+|.+.... ....+.+.+|+.+++.++|||||+++++|..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999864 68999999986432 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc---
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV--- 316 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~--- 316 (435)
|+|.+++..... ..+++.....++.|++.||+|||+ ||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999876432 347888888999999999999996 222111110000000
Q ss_pred ---cccccccCCCcCCcCCCCC--CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC-------
Q 040641 317 ---STDIAGTLGYIPPEYGQSR--MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ------- 384 (435)
Q Consensus 317 ---~~~~~gt~~y~aPE~~~~~--~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 384 (435)
.....++..|+|||+..+. .++.++|||||||++|||++|+.||........ . ........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~----~~~~~~~~~~~~~~~ 234 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---L----LQKLKGPPYSPLDIT 234 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---H----HHHhcCCCCCCcccc
Confidence 0012345679999998663 478999999999999999999999854321100 0 00000000
Q ss_pred -----------------------------CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 -----------------------------ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.....+........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000111111122334557889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=230.15 Aligned_cols=223 Identities=26% Similarity=0.434 Sum_probs=172.9
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 578999999976543 3456799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++++|.+++... ..+++..+..++.+++.|+.|||+ |||+++....... .
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D 155 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence 9999999998754 348899999999999999999996 7887766543221 1
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (435)
.....|+..|+|||...+..++.++||||+|+++|||++|+.|+.... . ......... ... +....
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~-~~~~~~~~~-~~~-----~~~~~- 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------P-MAALFRIVQ-DDH-----PPLPE- 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------H-HHHHHHHhc-cCC-----CCCCC-
Confidence 233568899999999887778999999999999999999999975321 1 111111111 111 01101
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 397 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||..+|++|||+.+++.
T Consensus 222 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 ---GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11235667888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=246.33 Aligned_cols=172 Identities=25% Similarity=0.290 Sum_probs=141.0
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEeC------C
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------E 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 252 (435)
..+|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 367889999999999999999854 6889999998643 223345678899999999999999999988644 3
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+. ++|...+... ++......++.|++.||+|||+ |||+++.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 4699999996 5787776532 6778888899999999999996 8999876
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .......||..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 168 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 5432 122335688999999999888999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=235.43 Aligned_cols=221 Identities=23% Similarity=0.303 Sum_probs=167.9
Q ss_pred ecccCcceEEEEEcCC-CCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLPD-GKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||+++..+ ++.||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999764 89999999865433 3446788999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-------c
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-------H 315 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-------~ 315 (435)
.+++.... .+++..+..++.|+++||+|||+ |||++........ .
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99987642 47889999999999999999996 8888765432211 1
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......++..|+|||.......+.++||||||+++||++||+.||..... ... .......... .+..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~-~~~~~~~~~~---~~~~-- 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEI-FQNILNGKIE---WPED-- 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHhcCCcC---CCcc--
Confidence 22335678899999998888889999999999999999999999854321 111 1111111100 0100
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
......+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 224 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 224 ---VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 001245678899999999999999965555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=237.90 Aligned_cols=227 Identities=22% Similarity=0.299 Sum_probs=167.5
Q ss_pred CcceeeeecccCcceEEEEEc----CCCCEEEEEEcccccc----ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 184 KLTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQAKT----QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
.|++.+.||+|+||.||+|+. .+|+.||+|.++.... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367889999999999999975 3688999999865322 2345688899999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... ..+++.....++.++++||+|||+ |||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998753 236778888888999999999996 899887654
Q ss_pred ccCccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
...........|+..|+|||.... ..++.++||||||+++|||+||+.|+..... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSE----- 228 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccC-----
Confidence 332222234568999999998764 3467899999999999999999999853211 111111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
+... ......+.+++.+||+.+|++|| +..+++.
T Consensus 229 --~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --PPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 11123456788899999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=238.98 Aligned_cols=225 Identities=24% Similarity=0.364 Sum_probs=167.7
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+...|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++|+|++++++++...+..+
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34556778889999999999999864 57889999886422 223456889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+. |++.+++.... ..+++.....++.+++.|+.|||+ |||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9999996 68877765432 247888889999999999999996 7887765432
Q ss_pred cCccccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.....|++.|+|||+.. ...++.++|||||||++|||++|+.|+..... ......... ...
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~~~--- 231 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NES--- 231 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhh-cCC---
Confidence 12346889999999863 35678899999999999999999999743211 111111111 100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
+.... ......+.+++.+||+.+|++||++.+|++.
T Consensus 232 --~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 --PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --CCcCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11111 1122346778899999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=238.80 Aligned_cols=239 Identities=24% Similarity=0.263 Sum_probs=168.9
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeC--CeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 255 (435)
+..+|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3467899999999999999999864 5899999998643322 233567899999999999999999998754 5689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+. ++|.+++.... ..+++.....++.|+++|++|||+ |||+++....
T Consensus 85 lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999997 47888876532 358899999999999999999996 8888876543
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC----
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---- 386 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 386 (435)
.. ...+...+++.|+|||...+ ..++.++||||+||++|||++|+.||..... ......+..........
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCChhhchh
Confidence 21 12223346788999998765 5678999999999999999999999853221 11111111111100000
Q ss_pred --------ccccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 --------DVLDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 --------~~~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+...... .........+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 0011345668899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=238.09 Aligned_cols=241 Identities=24% Similarity=0.237 Sum_probs=166.9
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe---
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE--- 253 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 253 (435)
....+|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||++++++|...+.
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34457899999999999999999864 588999998864322 223456789999999999999999999876543
Q ss_pred -----eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 254 -----KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 254 -----~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
.++||||+. ++|..++.... ..+++.....++.|++.||+|||+ |||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 499999997 47877776432 347889999999999999999996 888
Q ss_pred ccccccccCcc---ccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 305 LARLISACETH---VSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 305 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
+++........ ......++..|+|||...+. .++.++||||||+++|||+||+.|+..... ......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~----~~~~~~~~~~~ 240 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE----QHQLTLISQLC 240 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHh
Confidence 88765432211 11234578899999987654 478899999999999999999988754321 11111111110
Q ss_pred cc---CCCCcc---------ccccccCCCCH------HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KK---QQADDV---------LDPTVLNAGSK------PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~---~~~~~~---------~~~~~~~~~~~------~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. ...... ..+........ .....+.+++.+||..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 000000 00000000000 01124568999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=237.38 Aligned_cols=234 Identities=25% Similarity=0.324 Sum_probs=167.7
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
|++.+.||+|+||.||+|... +++.||+|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 467789999999999999975 478899999865432 22234567999999999 999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
+|+|.+++.... ...+++.....++.++++||.|||+ |||+++...... ..
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 889988887643 2357999999999999999999996 888877554321 12
Q ss_pred ccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-------------C
Q 040641 318 TDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK-------------Q 383 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~ 383 (435)
....|+..|+|||+.. ...++.++||||||+++|||++|+.||....... ........+.. .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID----QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH----HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 3356888999999764 4567899999999999999999998874322110 11000000000 0
Q ss_pred CCCccccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... +...... .......+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRF-PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccc-cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 0000000 0011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=242.26 Aligned_cols=234 Identities=25% Similarity=0.258 Sum_probs=166.0
Q ss_pred ceeeeecccCcceEEEEEcC-CCCEEEEEEcccccccc--------------HHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 186 TLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQG--------------HRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
.+.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 35678999999999999864 58899999886432211 1257889999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
.+..++||||++ |+|.+++... ..+++.....++.|+++||+|||+ |||++
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 999999999997 6898888643 247888899999999999999996 88888
Q ss_pred ccccccC-------------ccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcH
Q 040641 307 RLISACE-------------THVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL 372 (435)
Q Consensus 307 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~ 372 (435)
+...... ........+++.|+|||++.+. .++.++|||||||++|||+||+.||..... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~----~~~ 242 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE----IDQ 242 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 7543100 1111233568899999987654 468999999999999999999999854321 112
Q ss_pred HHHHHHHhccCCCCccc-----------c---ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 373 VGWVFQKMKKQQADDVL-----------D---PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+............. . +.............+.+++.+||+.+|++|||+.|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 22222211111100000 0 00000000111345678899999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=239.26 Aligned_cols=235 Identities=23% Similarity=0.279 Sum_probs=170.7
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
|++.+.||+|++|.||+|... +++.+|+|+++..... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 356788999999999999865 5889999998654332 3467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
++ +|..++.... ..+++..+..++.++++|++|||+ |||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 8888876532 358889999999999999999996 788776654322 122
Q ss_pred ccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC---Ccccc---
Q 040641 318 TDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA---DDVLD--- 390 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 390 (435)
....++..|+|||...+. .++.++||||||+++|||+||+.||..... .+....+......... ....+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCchHhcccchhhhh
Confidence 234678899999987766 789999999999999999999988743221 1111111111110000 00000
Q ss_pred ------ccc----cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 ------PTV----LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ------~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.. ..........++.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00011123456788999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=231.60 Aligned_cols=217 Identities=23% Similarity=0.247 Sum_probs=157.3
Q ss_pred Ccceeeee--cccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhcc-CCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDIL--EDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGK-VKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+++.+.+ |+|+||.||+++.. +++.+|+|.+........ |+..... .+||||+++++++..++..++|||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 44555554 99999999999864 578899999864322211 2222221 279999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
|+++|+|.+++.... .+++.....++.|+++|+.|||+ |||+++.....
T Consensus 90 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 999999999987542 58899999999999999999996 67766544321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
....|+..|+|||+..+..++.++|||||||++|||++|+.||..... .......+.... . . ....+
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~-~---~~~~~--- 230 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQ-Q-K---KLPFI--- 230 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhh-c-c---cCCcc---
Confidence 224688999999999888899999999999999999999999863322 111122221111 1 0 00000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPT-MLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl~ 428 (435)
......+.+++.+||+.+|.+||+ +.++++
T Consensus 231 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 ----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 112235677888999999999996 688874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=233.50 Aligned_cols=235 Identities=25% Similarity=0.325 Sum_probs=168.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-----eEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE-----KLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~l 256 (435)
..+.-.+++|.|+||.||+|... +++.||||+.-....- -.+|+++|+++.|||||++.-+|..... ..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677899999999999999865 4689999998544322 2379999999999999999988865332 348
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
||||||. +|..+++.-......++.....-+.-|+.+||+|||+ |||-|+.+..
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999985 7888887533333446666667788999999999996 9999999876
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC----
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---- 386 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 386 (435)
.+.. ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|..+ ...+....+...+......
T Consensus 179 ~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~----s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 179 GEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD----SSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred CCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC----CHHHHHHHHHHHhCCCCHHHHhh
Confidence 5433 34556789999997655 68999999999999999999999876432 2333333333333222111
Q ss_pred ------ccccccccCC-----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 ------DVLDPTVLNA-----GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ------~~~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+...|.+... .......+.++++.+++..+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111222111 11222345778899999999999999998873
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=236.14 Aligned_cols=220 Identities=26% Similarity=0.360 Sum_probs=164.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 4566678999999999999864 588999999864322 233568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+. |++.+++.... ..+++.....++.+++.|++|||+ |||++.....
T Consensus 102 ~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 996 57777775432 348889999999999999999996 7777643221
Q ss_pred ccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+.... ............ . +.
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~-~-----~~ 239 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQND-S-----PT 239 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-C-----CC
Confidence 12356889999999874 4568889999999999999999999975321 111111111111 1 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... .....+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~---~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11124667888999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=256.44 Aligned_cols=178 Identities=18% Similarity=0.250 Sum_probs=134.3
Q ss_pred ccCcceeeeecccCcceEEEEEcCC--CCEEEEEEc--------------c---ccccccHHHHHHHHHHhccCCCCCce
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD--GKTVAVKKF--------------S---QAKTQGHRQFTAEMETLGKVKHQNLV 242 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~niv 242 (435)
..+|++.+.||+|+||.||+|..+. +..++.|.+ . .........+.+|+.++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999987532 222222211 0 01112235688999999999999999
Q ss_pred eEEEEEEeCCeeEEEEecccCCCHHHHHHhhCC-CCCCCCHHHHHHHHHHhhhccceeec--------------------
Q 040641 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG-SHEVLDRAKRYKIACSSARGLAFLHQ-------------------- 301 (435)
Q Consensus 243 ~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------- 301 (435)
++++++...+..++|+|++. ++|..++..... ............++.|++.||+|||+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999985 567666654221 11122344566799999999999996
Q ss_pred ----cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 302 ----DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 302 ----DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999876543333334467999999999999889999999999999999999998654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=241.65 Aligned_cols=236 Identities=22% Similarity=0.235 Sum_probs=165.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC----------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD---------- 251 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 251 (435)
.+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57889999999999999999864 5889999998766555667789999999999999999999776543
Q ss_pred ----CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------c
Q 040641 252 ----EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------D 302 (435)
Q Consensus 252 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------D 302 (435)
...++||||++ ++|..++... .+++.....++.|+++||.|||+ |
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 5888877532 37888899999999999999996 7
Q ss_pred ccccccccccCcc--ccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHH
Q 040641 303 FGLARLISACETH--VSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 303 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
||+++........ ......|+..|+|||... ...++.++|||||||++|||++|+.||........ .......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ----MQLILES 234 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHh
Confidence 8877654321111 112235788999999754 35688899999999999999999999854321100 0000000
Q ss_pred hccCC----------C-Cccc-cccccCCCC----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 380 MKKQQ----------A-DDVL-DPTVLNAGS----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 380 ~~~~~----------~-~~~~-~~~~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... . .... ......... .....++.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0 0000 000000000 012235678999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=232.46 Aligned_cols=229 Identities=21% Similarity=0.255 Sum_probs=170.9
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|.-|+||.++..+ +..+|+|++.+.... .......|-+||+.+.||.++.+|+.+..+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34578889999999999999999765 588999999765433 33456779999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc--
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS-- 310 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~-- 310 (435)
|||||+||+|....+.+.+ ..++.....-++.+|.-||+|||- ||-++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999998876543 457777777789999999999994 665442110
Q ss_pred --------------------------------ccC---------------------ccccccccccCCCcCCcCCCCCCC
Q 040641 311 --------------------------------ACE---------------------THVSTDIAGTLGYIPPEYGQSRMS 337 (435)
Q Consensus 311 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 337 (435)
... ...+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011123579999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCC
Q 040641 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNP 417 (435)
Q Consensus 338 ~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P 417 (435)
+.++|.|+|||++|||+.|+.||......+. +.. .+.+. . .-+........+.+||..-+.+||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---l~N----Iv~~~-l--------~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---LRN----IVGQP-L--------KFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---HHH----HhcCC-C--------cCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999965433221 111 11111 0 011111233455677778889999
Q ss_pred CCCCC----HHHHH
Q 040641 418 ATRPT----MLHVL 427 (435)
Q Consensus 418 ~~RPs----~~evl 427 (435)
++|-- +.||-
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99987 66653
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=232.70 Aligned_cols=217 Identities=20% Similarity=0.267 Sum_probs=158.0
Q ss_pred eecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHH---hccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 190 ILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMET---LGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
+||+|+||.||++... +++.||+|.+..... .....+.+|..+ +...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4799999999999864 588999998864322 112234445433 344579999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|..++... ..+++.....++.|++.|++|||+ |||+++...... ..
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999988753 248999999999999999999995 899886543221 12
Q ss_pred cccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...||..|+|||... +..++.++|||||||++|||+||..||...... ... ........ ..+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~-~~~~~~~~------~~~~~~--- 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKH-EIDRMTLT------VNVELP--- 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----CHH-HHHHHhhc------CCcCCc---
Confidence 346899999999875 456889999999999999999999998543211 111 11111100 001111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
.....++.+++.+||..||++|| ++.|+++
T Consensus 220 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 220 -DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred -cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 11223566788899999999999 5988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=241.48 Aligned_cols=236 Identities=22% Similarity=0.244 Sum_probs=168.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----Cee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 254 (435)
.+|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46888999999999999999854 5889999998643 222345678899999999999999999988654 347
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+. ++|.+++... ..+++.....++.|++.||.|||+ |||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999996 7888887643 248888999999999999999996 899887654
Q ss_pred ccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC-----
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ----- 384 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 384 (435)
... .......+|..|+|||.... ..++.++|||||||++|||++|+.||..... ...............
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY----VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHHhCCCChHHhh
Confidence 322 22234568889999997654 4688999999999999999999999853211 111111111100000
Q ss_pred -------------CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 385 -------------ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 385 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
.....++... .........+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0001123456789999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=240.33 Aligned_cols=236 Identities=23% Similarity=0.274 Sum_probs=171.7
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-----eeE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-----EKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 255 (435)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999865 48899999987543 334567899999999999999999999988765 789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||++ ++|..++... ..+++.....++.++++||+|||+ |||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 5788888643 258899999999999999999996 8888876543
Q ss_pred cCc--cccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC---
Q 040641 312 CET--HVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA--- 385 (435)
Q Consensus 312 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 385 (435)
... .......+|..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCCCChhHh
Confidence 221 122345688899999998877 8899999999999999999999998543211 111111111100000
Q ss_pred --------Ccccc---ccc---cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 --------DDVLD---PTV---LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 --------~~~~~---~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+.+. ... ...........+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000 000 00000012345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=237.48 Aligned_cols=239 Identities=24% Similarity=0.273 Sum_probs=166.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999865 5889999988643322 2346788999999999999999999875433
Q ss_pred --eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 253 --EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 253 --~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
..++||||+.+ ++...+... ...+++.....++.++++||+|||+ |||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999975 666666542 2358899999999999999999996 88888
Q ss_pred ccccccCc----------cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHH
Q 040641 307 RLISACET----------HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGW 375 (435)
Q Consensus 307 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~ 375 (435)
+....... ...+...|++.|+|||...+ ..++.++|||||||++|||++|++||...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~----~~~~~ 238 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI----DQLHL 238 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 76532211 11123467889999997654 45789999999999999999999998543221 11111
Q ss_pred HHHHhccCCC---------Cccc----ccccc---CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 376 VFQKMKKQQA---------DDVL----DPTVL---NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 376 ~~~~~~~~~~---------~~~~----~~~~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+......... .... .+... ..........+.+++.+|++.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111110000 0000 00000 0000111245778999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=233.78 Aligned_cols=223 Identities=22% Similarity=0.321 Sum_probs=171.8
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 258 (435)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++ ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788899999999999999865 68999999986532 223457889999999998 999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++++|.+++.... .+++.....++.+++.||+|||+ |||++........
T Consensus 82 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999997542 58999999999999999999996 8888876543211
Q ss_pred -------------------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHH
Q 040641 315 -------------------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGW 375 (435)
Q Consensus 315 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~ 375 (435)
.......|+..|+|||......++.++||||||+++||+++|+.|+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~---- 229 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YL---- 229 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HH----
Confidence 111234578899999998888899999999999999999999999853211 00
Q ss_pred HHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCH----HHHHH
Q 040641 376 VFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM----LHVLK 428 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~----~evl~ 428 (435)
.+........ ..+. .....+.+++.+||+.+|++||++ .++++
T Consensus 230 ~~~~~~~~~~---~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKILKLEY---SFPP-------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHhcCC---CCCC-------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111100 0010 112356788999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=242.36 Aligned_cols=237 Identities=21% Similarity=0.276 Sum_probs=168.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 255 (435)
.+|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999864 589999999865322 234667889999999999999999998753 34679
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+. |+|..++... ..+++.....++.++++||+|||+ |||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999995 6888887643 238889999999999999999996 8998876543
Q ss_pred cCc---cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC----
Q 040641 312 CET---HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ---- 383 (435)
Q Consensus 312 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 383 (435)
... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHHHHhCCChhHh
Confidence 211 11234578999999998655 5688999999999999999999999854321 11111111110000
Q ss_pred -------CCCcccc--ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 -------QADDVLD--PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 -------~~~~~~~--~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+ +...... .......+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 0000000 0112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=222.39 Aligned_cols=227 Identities=21% Similarity=0.270 Sum_probs=178.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--------cHHHHHHHHHHhccC-CCCCceeEEEEEEeC
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--------GHRQFTAEMETLGKV-KHQNLVLLLGYCSFD 251 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 251 (435)
..+|.-.+++|.|..++|.++..+ +|+++|+|++...... -.+.-.+|+.||+++ .||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777899999999999999764 5889999998543211 123456799999998 699999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
...++|+|.|+.|.|.++|... ..+++....+|+.++.+|++|||. |||+|.
T Consensus 96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999764 358888899999999999999995 999998
Q ss_pred cccccCccccccccccCCCcCCcCCC------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQ------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
.+... ......||||+|+|||.+. ...|+..+|.||.|||+|.++.|.+||...- .+ .+...+.
T Consensus 172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qm--lMLR~Im 241 (411)
T KOG0599|consen 172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QM--LMLRMIM 241 (411)
T ss_pred ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HH--HHHHHHH
Confidence 87653 3456789999999999754 3468889999999999999999999984311 01 1222232
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
++.. ...++.+.+......+++.+|++.||++|.|.+|++.
T Consensus 242 eGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2221 1223444555566778999999999999999999874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=232.11 Aligned_cols=235 Identities=26% Similarity=0.295 Sum_probs=169.8
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999875 48999999987643 233467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~ 317 (435)
+ ++|.+++.... ..+++..+..++.++++|++|||+ |||+++....... ..
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 58999987642 348899999999999999999996 7887765433211 12
Q ss_pred ccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC-----------
Q 040641 318 TDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA----------- 385 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 385 (435)
....++..|+|||..... .++.++|||||||++|||++|+.||..... ......+.........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 234567789999987665 789999999999999999999988754321 1111111111100000
Q ss_pred CccccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDVLDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+..-+...... .......+.+++.+||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 0011345788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=234.29 Aligned_cols=233 Identities=20% Similarity=0.225 Sum_probs=164.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.. ....++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 457889999999999999999854 68999999885422 2234678899999999999999999998865 5678999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+ +++|..+++.. .+++.....++.++++||+|||+ |||+++.....
T Consensus 89 ~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 89 TELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred eehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 9998 56898887632 36777778899999999999996 78877654221
Q ss_pred ccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc----------
Q 040641 314 THVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK---------- 382 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 382 (435)
.....++..|+|||+..+ ..++.++|||||||++|||+||+.||...... .....+......
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV----NQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHHHhcc
Confidence 123467889999998755 56899999999999999999999998532210 000000000000
Q ss_pred -CCCCcccc-ccccCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 -QQADDVLD-PTVLNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 -~~~~~~~~-~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+... ........ ......+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000000 011246778899999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=229.67 Aligned_cols=231 Identities=16% Similarity=0.204 Sum_probs=157.3
Q ss_pred ccCcceeeeecccCcceEEEEEcCC----CCEEEEEEcccccccc-----------HHHHHHHHHHhccCCCCCceeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKTQG-----------HRQFTAEMETLGKVKHQNLVLLLG 246 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g 246 (435)
..+|.+.++||+|+||.||+|...+ +..+|+|......... ......+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578999999999999999998654 3456666533221110 012233445667889999999999
Q ss_pred EEEeCC----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 247 YCSFDE----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 247 ~~~~~~----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
++.... ..++++|++.. ++.+.+... ...++.....++.|+++||+|||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 776543 34678887743 555555432 124567788899999999999996
Q ss_pred ---cccccccccccCc------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcH
Q 040641 302 ---DFGLARLISACET------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL 372 (435)
Q Consensus 302 ---DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~ 372 (435)
|||+|+....... .......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~---~~ 242 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG---NL 242 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch---HH
Confidence 9999986542211 11123469999999999999999999999999999999999999986432111 11
Q ss_pred HHHH----HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 373 VGWV----FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 373 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
.... ...+.... .. .+. ....+.+++..||+.+|++||++.++.+.|+
T Consensus 243 ~~~~~~~~~~~~~~~~----~~----~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK----IK----IKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhhhh----hc----cCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111 11111110 00 011 1235678888999999999999999998763
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=226.29 Aligned_cols=217 Identities=20% Similarity=0.275 Sum_probs=158.6
Q ss_pred eecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHH---HHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 190 ILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEM---ETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
+||+|+||.||+|... +++.||+|.+...... ....+..|. +.++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999864 5889999998653221 122244443 34555689999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|..++... ..+++..+..++.|+++|++|||+ |||+++...... ..
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 99999888643 358999999999999999999995 899887543221 22
Q ss_pred cccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...|+..|+|||+..+. .++.++|||||||++|||++|+.||...... .... ....... ..+.....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~----~~~~-~~~~~~~------~~~~~~~~- 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHE-IDRMTLT------MAVELPDS- 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc----chHH-HHHHhhc------cCCCCCCc-
Confidence 35789999999988644 6889999999999999999999998643111 1111 1111110 01111111
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+|+..+|++|| ++.++++
T Consensus 222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 123567788899999999999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=235.99 Aligned_cols=231 Identities=22% Similarity=0.256 Sum_probs=162.4
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------e
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------E 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 253 (435)
.+|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 47888999999999999999864 68999999986432 222356889999999999999999999986543 4
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++|+||+.. +|..+.. ..+++.....++.++++||+|||+ |||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 5899999964 6766542 137888888999999999999996 88887654
Q ss_pred cccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc-------
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK------- 381 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 381 (435)
.. ......+|..|+|||...+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 32 1223567889999998765 4688999999999999999999999864211 111111111000
Q ss_pred ----cCCCCcccc--ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 ----KQQADDVLD--PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ----~~~~~~~~~--~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......... +...... .......+.+++.+||+.||++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 0000000 0011234678899999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.64 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=184.1
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEe-
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSF- 250 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 250 (435)
.+..+..|...+++.+++|+|.+|.||+++. ++++.+|||.+....+. .++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445567778899999999999999999984 46888899888654433 35677888888877 69999999999864
Q ss_pred ----CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------c
Q 040641 251 ----DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------D 302 (435)
Q Consensus 251 ----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------D 302 (435)
++++|||||||.+||..+++++.. ...++|.....|+..+++|+.+||. |
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEee
Confidence 578999999999999999998765 4568999999999999999999996 9
Q ss_pred ccccccccccCccccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHH
Q 040641 303 FGLARLISACETHVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 303 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~ 377 (435)
||++..+.... .......||+.|||||++.. ..|+..+|+||+||+..||.-|.+|+..+-. ...++
T Consensus 167 FGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF 238 (953)
T KOG0587|consen 167 FGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF 238 (953)
T ss_pred eeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhc
Confidence 99998775432 33345689999999998643 3577899999999999999999999754321 11122
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+ ...|.+ ..++....++.+.+..|+.+|-++||++.++++
T Consensus 239 ~IpR------NPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPR------NPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCC------CCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111 112222 234566778889999999999999999998864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=232.06 Aligned_cols=171 Identities=27% Similarity=0.327 Sum_probs=139.9
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 45788999999999999999985 468899999985432 222356889999999999999999999987654
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+ +++|..++.. ..+++.....++.|+++||+|||+ |||+++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 7799888753 247888999999999999999996 8888875
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .....+++.|+|||...+ ..++.++|||||||++||+++|+.||..
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4321 123467899999998765 4588999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=231.44 Aligned_cols=232 Identities=21% Similarity=0.241 Sum_probs=164.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC------C
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------E 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 252 (435)
..+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 46799999999999999999985 468899999986532 22345688899999999999999999988643 3
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++++|++ +++|..++... .+++.....++.|+++|++|||+ |||+++.
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 467888887 78998877532 37888999999999999999996 8888765
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
... ......||..|+|||...+ ..++.++|||||||++|||++|+.||...... .....+....... ...
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~-~~~ 240 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRLVGTP-GAE 240 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCC-CHH
Confidence 432 1233568899999998755 56788999999999999999999998432111 1111000000000 000
Q ss_pred cc----c----------ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VL----D----------PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~----~----------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. + +...... .......+.+++.+|++.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 0 0000000 0001234678999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=235.84 Aligned_cols=233 Identities=21% Similarity=0.264 Sum_probs=166.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-----
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE----- 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 253 (435)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 357889999999999999999875 57899999986432 2234567889999999999999999998766554
Q ss_pred -eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 254 -KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 254 -~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
.++|+||+ +++|.+++.. ..+++.....++.++++|++|||+ |||+++.
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799888864 248889999999999999999996 7888765
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC---
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ--- 384 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 384 (435)
.... .....+|..|+|||...+ ..++.++|||||||++|||+||+.||..... ......+........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHHH
Confidence 4321 233567889999998654 4678999999999999999999999853211 111111111100000
Q ss_pred --------CCcccc--ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 --------ADDVLD--PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 --------~~~~~~--~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... +...... .......+.+++.+||+.+|++|||+.||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 0000000 0011346778999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=225.85 Aligned_cols=237 Identities=23% Similarity=0.285 Sum_probs=173.7
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC-
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD- 251 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 251 (435)
....++++..++-+|.||.||+|.|.+ .+.|-||.++.... -....|.+|.-.+..+.|||+.++.|++.++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 345567888899999999999996543 34577777754332 3456789999999999999999999998764
Q ss_pred CeeEEEEecccCCCHHHHHHhhC----CCCCCCCHHHHHHHHHHhhhccceeec------------------------cc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNAT----GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DF 303 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------Df 303 (435)
...+++|.|+.-|+|..||+..+ ...+.+.-.+...++.|++.||+|||+ |-
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 56788899999999999998322 123456777888999999999999996 55
Q ss_pred cccccccccCccccc-cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 304 GLARLISACETHVST-DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 304 Gla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
.++|.+-..+.+... ....+..||+||.+....|+.++|||||||++|||+| |+.|+....+ .++ ...++
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----fEm----~~ylk 512 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----FEM----EHYLK 512 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----HHH----HHHHh
Confidence 555555443333222 2234678999999999999999999999999999998 6777643211 111 12222
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
++. .. ..+..+..+++.+|.-||+..|++||+|++++.-|.+.
T Consensus 513 dGy--Rl-------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 DGY--RL-------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ccc--ee-------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 211 00 11122345788999999999999999999999888764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-30 Score=262.11 Aligned_cols=224 Identities=25% Similarity=0.353 Sum_probs=166.5
Q ss_pred cceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
......||.|.||.||-|.. .+|+..|||.++.... .....+.+|+.++..++|||+|+++|+-.+++..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 34466799999999999984 5688999998865433 34467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc---
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET--- 314 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~--- 314 (435)
++|+|.+.+.... ..++.....+..|++.|++|||+ |||.|..+.....
T Consensus 1317 ~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred ccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999887542 35555556678899999999996 9999987754321
Q ss_pred cccccccccCCCcCCcCCCCC---CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSR---MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.......||+.|||||++.+. ....++||||+|||+.||+||++||..... -.+.++..- -+. .|
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~-~gh-----~P 1460 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVA-AGH-----KP 1460 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHh-ccC-----CC
Confidence 112356899999999988653 456789999999999999999999853211 111111111 111 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+. ....+-.+++..|+..||++|.++.|+++
T Consensus 1461 q~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 QIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1111 12223346777899999999999888765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=221.10 Aligned_cols=212 Identities=25% Similarity=0.317 Sum_probs=163.1
Q ss_pred ecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
||+|+||.||++... +++.||+|.+...... ....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 4889999998654322 345788999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccc
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~g 322 (435)
.+++.... .+++.....++.++++|+.|+|+ |||++....... .......+
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99987542 47889999999999999999996 777776543321 12234568
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
+..|+|||...+...+.++|+||||+++||+++|+.||..... ... ........ . ..... ..
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~----~~~~~~~~---~---~~~~~----~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEI----YEKILKDP---L---RFPEF----LS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHH----HHHHhcCC---C---CCCCC----CC
Confidence 8899999998888889999999999999999999999853211 111 11111110 0 00001 12
Q ss_pred HHHHHHHhcccCCCCCCCCCHHH
Q 040641 403 LKMLRIAADCVADNPATRPTMLH 425 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs~~e 425 (435)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 35678889999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=232.56 Aligned_cols=224 Identities=18% Similarity=0.288 Sum_probs=170.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
....|.+...||+|.|++|..|++. ++..||+|.+++.... ..+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3456788999999999999999864 5899999999765432 345689999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+.+|.+.+++..... ........+..|+.++++|||+ |||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999999987543 3345666788999999999996 8999987763
Q ss_pred ccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.....+.+|++.|.|||+..+..| ++++|+||+||++|-|+.|..||+...-. ..-...+. ...--|.
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------~Lr~rvl~----gk~rIp~ 276 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------ELRPRVLR----GKYRIPF 276 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------cccchhee----eeecccc
Confidence 334456899999999999888655 68999999999999999999999643211 10000010 0111122
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+ +++.+.+..+|.+|+++.+|.+
T Consensus 277 ~ms~dce-------~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 277 YMSCDCE-------DLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeechhH-------HHHHHhhccCccccCCHHHhhh
Confidence 2333333 3444445569999999998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=227.02 Aligned_cols=232 Identities=24% Similarity=0.245 Sum_probs=162.6
Q ss_pred CcceeeeecccCcceEEEEEcC-C--CCEEEEEEcccccc--ccHHHHHHHHHHhccC-CCCCceeEEEEEEeC----Ce
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-D--GKTVAVKKFSQAKT--QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFD----EE 253 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 253 (435)
+|++.+.||+|+||.||+++.. . +..||+|++..... ...+.+.+|+++++++ .|||||++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3678899999999999999864 3 67899999864322 2345688999999999 599999999976432 45
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++++||+. ++|.+++... ..+++.....++.|++.||+|||+ |||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999986 6898888643 347889999999999999999996 89988765
Q ss_pred cccCc---cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc---
Q 040641 310 SACET---HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK--- 382 (435)
Q Consensus 310 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 382 (435)
..... .......||..|+|||+..+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY----VDQLNQILQVLGTPDE 231 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 43211 11223578999999997655 5688999999999999999999998754211 0111111110000
Q ss_pred --------CC---------CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 383 --------QQ---------ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 383 --------~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
.. ...........+. ....+.+++.+|++.+|++|||+.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN---ANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCC---CCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00 0000000000001 123567889999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=244.24 Aligned_cols=115 Identities=26% Similarity=0.320 Sum_probs=100.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++|||||++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999875 588999999865432 22356889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
||+++|+|.+++... ..+++...+.++.|++.||+|||.
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~ 122 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHR 122 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999998753 247788889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=230.59 Aligned_cols=169 Identities=30% Similarity=0.346 Sum_probs=142.8
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-C-----CCceeEEEEEEeCCeeEE
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-H-----QNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 256 (435)
+|++.++||+|+||.|-||.. .+++.||||.++.... -..+-..|+.+|..++ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 678899999999999999985 4689999999975432 3456678999999997 4 389999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------ccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLIS 310 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~ 310 (435)
|+|.+. -+|.++|+... ...++......++.||+.||.+||. |||.|....
T Consensus 266 VfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999884 68999998754 2347888888999999999999986 999987654
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
.. .....-+..|.|||++.+.+|+.+.||||||||+.||+||.+-|
T Consensus 343 q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 343 QR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred Cc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 32 12456678999999999999999999999999999999996544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=212.56 Aligned_cols=214 Identities=29% Similarity=0.369 Sum_probs=164.9
Q ss_pred CcceEEEEEcCC-CCEEEEEEcccccccc-HHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHHHHHh
Q 040641 195 GFGTVYKATLPD-GKTVAVKKFSQAKTQG-HRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN 272 (435)
Q Consensus 195 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~ 272 (435)
+||.||+|...+ ++.+|+|.+....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999997655444 67899999999999999999999999999999999999999999999875
Q ss_pred hCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccccCCCcC
Q 040641 273 ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP 328 (435)
Q Consensus 273 ~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~gt~~y~a 328 (435)
.. .+++.....++.+++++++|||+ |||.+....... ......++..|++
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 42 27888999999999999999986 777776554321 2234568889999
Q ss_pred CcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHH
Q 040641 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRI 408 (435)
Q Consensus 329 PE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 408 (435)
||......++.++||||||+++||+++|..|+.... .... ............ . ........++.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~----~~~~~~~~~~~~----~---~~~~~~~~~~~~~ 220 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLE----LFKKIGKPKPPF----P---PPEWKISPEAKDL 220 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHH----HHHHHhccCCCC----c---cccccCCHHHHHH
Confidence 999888888999999999999999999999975321 1111 122222111110 0 0000022367789
Q ss_pred HhcccCCCCCCCCCHHHHHH
Q 040641 409 AADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 409 ~~~C~~~~P~~RPs~~evl~ 428 (435)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=246.55 Aligned_cols=228 Identities=23% Similarity=0.370 Sum_probs=161.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEe---------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--------- 250 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 250 (435)
..+|+..++||+||||.||+++.+ ||+.+|||++.... ........+|+..+++|+|||||+++....+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356788889999999999999854 79999999997543 3334568899999999999999998731100
Q ss_pred --------------------------------------------------------------------------------
Q 040641 251 -------------------------------------------------------------------------------- 250 (435)
Q Consensus 251 -------------------------------------------------------------------------------- 250 (435)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee
Q 040641 251 ----------------------D--------EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300 (435)
Q Consensus 251 ----------------------~--------~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 300 (435)
. ..+||-||||+.-.++++++...... .....+++..+|++|++|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 0 12467889999988888887543211 34566789999999999999
Q ss_pred c------------------------ccccccccc-----------------ccCccccccccccCCCcCCcCCCCC---C
Q 040641 301 Q------------------------DFGLARLIS-----------------ACETHVSTDIAGTLGYIPPEYGQSR---M 336 (435)
Q Consensus 301 ~------------------------DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~ 336 (435)
+ |||+|.... ..+....|..+||.-|+|||...+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 6 999998722 0111234567899999999987664 4
Q ss_pred CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCC
Q 040641 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADN 416 (435)
Q Consensus 337 ~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 416 (435)
|+.|+|+||+|||++||+. ||..... -+ .+...++....... +.. ..+....-..++...++.|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra-~iL~~LR~g~iP~~--~~f----~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSME------RA-SILTNLRKGSIPEP--ADF----FDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHH------HH-HHHHhcccCCCCCC--ccc----ccccchHHHHHHHHHhcCC
Confidence 9999999999999999996 4543221 11 12333333332221 111 1122223345677788999
Q ss_pred CCCCCCHHHHHH
Q 040641 417 PATRPTMLHVLK 428 (435)
Q Consensus 417 P~~RPs~~evl~ 428 (435)
|++|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-28 Score=223.98 Aligned_cols=176 Identities=28% Similarity=0.455 Sum_probs=143.3
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-------cccHHHHHHHHHHhccCCCCCceeEEEEEE-eCCee
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-------TQGHRQFTAEMETLGKVKHQNLVLLLGYCS-FDEEK 254 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~ 254 (435)
+|-+..+||+|||+.||+|.. ...+-||||.-...+ ....+...+|-+|.+.|.||.||++|+|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 466677899999999999974 456789998653211 112356788999999999999999999985 45678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGL 305 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGl 305 (435)
+-|+|||+|.+|+-||+.. ..+++.....|++||..||.||.. |||+
T Consensus 544 CTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 8999999999999999864 357888899999999999999964 9999
Q ss_pred cccccccCc------cccccccccCCCcCCcCCCC----CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 306 ARLISACET------HVSTDIAGTLGYIPPEYGQS----RMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 306 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
++++.++.. ......+||.+|++||.+.- ...+.|+||||.|||+|.++.|+.||+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 999865432 22345689999999996532 35789999999999999999999999753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=212.80 Aligned_cols=196 Identities=19% Similarity=0.153 Sum_probs=147.3
Q ss_pred cCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHHHHHh
Q 040641 194 GGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN 272 (435)
Q Consensus 194 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~ 272 (435)
|.||.||+++.. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 58899999986532 234555556667799999999999999999999999999999999875
Q ss_pred hCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccccCCCcC
Q 040641 273 ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP 328 (435)
Q Consensus 273 ~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~gt~~y~a 328 (435)
.. .+++.....++.++++||+|||+ |||.++..... .....++..|+|
T Consensus 79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 79 FL----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 42 37889999999999999999996 67765543321 123456778999
Q ss_pred CcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHH
Q 040641 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRI 408 (435)
Q Consensus 329 PE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 408 (435)
||......++.++||||+|+++|||++|+.|+...... .... .....|. .....+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~--~~~~~~~-------~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTH--TTLNIPE-------WVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccc--cccCCcc-------cCCHHHHHH
Confidence 99998888899999999999999999999876421110 0000 0000011 112346678
Q ss_pred HhcccCCCCCCCCCHH
Q 040641 409 AADCVADNPATRPTML 424 (435)
Q Consensus 409 ~~~C~~~~P~~RPs~~ 424 (435)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=216.75 Aligned_cols=178 Identities=24% Similarity=0.302 Sum_probs=145.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|.+..+||+|+||+|-.|..+ +.+.+|||.+++.. .++.+--+.|-++|+-. +-|.+|+++.+++.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457888999999999999999755 35789999997643 22333345677777766 5689999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
.||||+.||+|--.+++... +.+....-+|..||-||-|||+ |||+.+.--.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999888876543 5556677789999999999997 8999875322
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
. .......+||+.|+|||.+...+|+..+|.|||||+||||+.|++||+.+
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 1 23344689999999999999999999999999999999999999999754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-28 Score=208.35 Aligned_cols=233 Identities=25% Similarity=0.411 Sum_probs=167.6
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccc--cccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQ--AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.++.+..+|.+...|..|+|+|+. ..+++|.+.. ......++|..|.-.|+-+.||||..++|.|..+....++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 345666778899999999999974 4455666643 2334457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------ccccc-----------ccccccCcccccc---c
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------DFGLA-----------RLISACETHVSTD---I 320 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------DfGla-----------~~~~~~~~~~~~~---~ 320 (435)
|+.|+|..+|+... ..+++..+..+++.++|+||+|||+ .|-+. ..++-.+...+-. .
T Consensus 269 mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~gr 346 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGR 346 (448)
T ss_pred ccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecccc
Confidence 99999999998753 4568888999999999999999997 12211 1111111111111 2
Q ss_pred cccCCCcCCcCCCCCCC---CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 321 AGTLGYIPPEYGQSRMS---TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 321 ~gt~~y~aPE~~~~~~~---~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
.-.+.||+||.++..+- -.++|+|||+|++||+.|+..||..-..-+-++.+ +.+. +.+. ..++
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---aleg---------lrv~-ippg 413 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---ALEG---------LRVH-IPPG 413 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---hhcc---------cccc-CCCC
Confidence 23578999998876543 34799999999999999999998643322212111 1111 1111 1122
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... .+.+++.-|+..||.+||.|..|+-.|+++.
T Consensus 414 is~---hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ISR---HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccH---HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 223 4556666799999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=225.57 Aligned_cols=180 Identities=21% Similarity=0.254 Sum_probs=129.6
Q ss_pred cccCcceeeeecccCcceEEEEEc-----------------CCCCEEEEEEccccccccHHH--------------HHHH
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-----------------PDGKTVAVKKFSQAKTQGHRQ--------------FTAE 229 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 229 (435)
...+|++.++||+|+||.||+|.. .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999963 235679999986543222223 3457
Q ss_pred HHHhccCCCCCc-----eeEEEEEEe--------CCeeEEEEecccCCCHHHHHHhhCCC--------------------
Q 040641 230 METLGKVKHQNL-----VLLLGYCSF--------DEEKLLVYEYMVNGSLDLWLRNATGS-------------------- 276 (435)
Q Consensus 230 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~ey~~~g~L~~~l~~~~~~-------------------- 276 (435)
+.++.+++|.|+ ++++++|.. .+..++||||+++|+|.++++...+.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777877655 677888753 35689999999999999998753211
Q ss_pred CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccccccccCCCcCCcCC
Q 040641 277 HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYG 332 (435)
Q Consensus 277 ~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 332 (435)
...+++.....++.++++||.|+|+ |||+++..............+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1235677888899999999999996 8999876543221111223457899999976
Q ss_pred CCCC--------------------C--CCcccchhHHHHHHHHHhCCC-CC
Q 040641 333 QSRM--------------------S--TTRGDVYSFGVILLELVTAKE-PT 360 (435)
Q Consensus 333 ~~~~--------------------~--~~k~DV~SfGvil~El~tg~~-p~ 360 (435)
.... + ..+.||||+||+++||+++.. |+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 4321 1 235799999999999999875 44
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=206.21 Aligned_cols=226 Identities=18% Similarity=0.209 Sum_probs=170.5
Q ss_pred Ccce-eeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEe----CCeeEE
Q 040641 184 KLTL-VDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSF----DEEKLL 256 (435)
Q Consensus 184 ~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~l 256 (435)
+|++ .++||-|-.|.|-.+..+ +++.+|+|.+... ....+|++..-.. .|||||++++++.. ..-+.+
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 3443 367999999999999764 5889999998542 3346788875444 69999999998753 445789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~ 309 (435)
|||+|+||.|...+.++. ...+.+.+.-.|+.+|+.|+.|||+ |||+|+.-
T Consensus 137 VmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999998764 4568888999999999999999996 99999875
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.. .......+-|+.|.|||++....|+..+|+||+||++|-|+.|-+||+..- +..+.--+...++.+.. ++
T Consensus 215 ~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h----g~aispgMk~rI~~gqy-~F- 286 (400)
T KOG0604|consen 215 QE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH----GLAISPGMKRRIRTGQY-EF- 286 (400)
T ss_pred CC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC----CccCChhHHhHhhccCc-cC-
Confidence 42 233345678999999999999999999999999999999999999997532 12222222333333222 11
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.+........+++..-+..+|++|-|+.++++
T Consensus 287 ----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 ----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 23344445555566777778889999999999874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=220.29 Aligned_cols=176 Identities=27% Similarity=0.381 Sum_probs=150.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
...|..-++||+|+||.||-++.+ +|+.+|.|++.+.. ........+|-++|.+++.+.||.+--+|.+.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 345778899999999999999765 59999999986532 23345577899999999999999999899999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|..|.||+|.-+|.+... ..+++...+-++.+|+.||++||+ |.|+|-.+....
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999988887643 458888889999999999999996 788887665433
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
..+..+||.||||||++....|+...|.||+||++|||+.|+.||.
T Consensus 342 --~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 342 --PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred --ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 2344589999999999999999999999999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=209.19 Aligned_cols=177 Identities=21% Similarity=0.299 Sum_probs=148.0
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.++||+|.||+|-.++-+ +++.+|+|.+++...- ....-..|-++|...+||.+..+.-.|+..+.++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356888899999999999999854 5899999999765332 234456799999999999999998888999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+.||.|.-+|... ..+++.+..-....|..||.|||+ |||+.+.--. .
T Consensus 247 MeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-Y 321 (516)
T ss_pred EEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-c
Confidence 9999999998877643 356777777788899999999997 8999875221 1
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
.......||||.|+|||++....|+.++|.|..|||+|||+.|+.||+..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 23345689999999999999999999999999999999999999999653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=223.59 Aligned_cols=169 Identities=27% Similarity=0.414 Sum_probs=145.1
Q ss_pred eeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCC
Q 040641 188 VDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
.++||+|.||+||-|.++ +|+.||||.+.+.. .....+..+|+.||.+++||.||.+.-.|...+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999865 69999999997654 234467889999999999999999999999999999999999766
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccCcccc
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~~~~~ 317 (435)
-|.-+|....+ .++.....-++.||+.||.|||. |||+||++.. ....
T Consensus 649 MLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFR 723 (888)
T ss_pred HHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhh
Confidence 66666665433 36666666688999999999995 9999999875 3445
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
..++||+.|+|||++..+.|+..-|+||.|||+|--++|..||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 67899999999999999999999999999999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-28 Score=208.26 Aligned_cols=234 Identities=23% Similarity=0.320 Sum_probs=166.8
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHh-ccCCCCCceeEEEEEEeCCeeE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETL-GKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+...+++-...||.|+||+|+|-.++ .|+..|||+++.... ...+++..|.++. +.-+.||||+++|.+..++..|
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 344556777788999999999999865 599999999976544 4556788888864 5557899999999999999999
Q ss_pred EEEecccCCCHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhcccee-------ec------------------cccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNAT-GSHEVLDRAKRYKIACSSARGLAFL-------HQ------------------DFGLARLI 309 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~yL-------H~------------------DfGla~~~ 309 (435)
+.||.|. -||+.+-.... -....+++...-.|.....+||.|| |+ |||+...+
T Consensus 140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9999995 56665433211 0122356655556666667788777 33 89988765
Q ss_pred cccCccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. +...+..+|...|||||.+.. ..|+.+|||||+|++|+|+.||+.|+.. ..++.+.+.+.+..
T Consensus 219 v~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~------w~svfeql~~Vv~g----- 285 (361)
T KOG1006|consen 219 VD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK------WDSVFEQLCQVVIG----- 285 (361)
T ss_pred HH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch------HHHHHHHHHHHHcC-----
Confidence 43 334455678899999997653 3589999999999999999999999742 22333333333322
Q ss_pred ccccccc--CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVL--NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
||... ..........+.+.+..|+.+|-++||...++.+
T Consensus 286 --dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 --DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22211 1112234456778888999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=202.74 Aligned_cols=231 Identities=21% Similarity=0.311 Sum_probs=168.9
Q ss_pred eeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccCCC
Q 040641 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~g~ 265 (435)
.++||+|+||.|.-++ ..+|.++|||.+.+..........+|++++... .|+||++++.+|.++..+|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5789999999999986 678999999999888766778899999999988 59999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccc--cC---
Q 040641 266 LDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISA--CE--- 313 (435)
Q Consensus 266 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~--~~--- 313 (435)
|-.+|++.. .+.+...-+++.+||.||.|||. ||-+..-+.. +-
T Consensus 163 lLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKRK----HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999988653 36777888899999999999996 5554432211 11
Q ss_pred -ccccccccccCCCcCCcCC-----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccc------CCcH-HHHHHHHh
Q 040641 314 -THVSTDIAGTLGYIPPEYG-----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE------GANL-VGWVFQKM 380 (435)
Q Consensus 314 -~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~------~~~~-~~~~~~~~ 380 (435)
+......+|+..|||||+. ....|+.++|.||+|||+|-|++|.+||.....+.- .... ....+..+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1112345788999999953 345789999999999999999999999965432211 1111 12234444
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+++.. +..|..+ .....+..+++..-+..++..|-++.++++
T Consensus 319 QEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 QEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 44332 2222221 122223344555556679999988887764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=204.06 Aligned_cols=179 Identities=27% Similarity=0.344 Sum_probs=142.5
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-----CCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEe-CCe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-----GKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 253 (435)
...|+....||+|.||.||+|.-.+ .+.+|+|+++..+.. -.....+|+.+++.++|||||.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999996432 347999999765432 23567899999999999999999998877 788
Q ss_pred eEEEEecccCCCHHHHHHhhCC-CCCCCCHHHHHHHHHHhhhccceeec----------------------------ccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATG-SHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFG 304 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfG 304 (435)
.++++||.+. +|..+|+-... ....++......|.-|++.|+.|||+ |||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999976 67666664332 22457888888999999999999996 899
Q ss_pred ccccccccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 305 LARLISACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 305 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
+||+....-. .....++-|+.|.|||.+.+ ..||.+.||||.|||+.||+|-++-|.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9998653211 12334678999999998766 578999999999999999999887664
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=198.05 Aligned_cols=228 Identities=20% Similarity=0.346 Sum_probs=164.9
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 257 (435)
...+++....||.|..|.|+++++. +|...|||.+.+... +..+.....+.++.+-+ .|.||+.+|||..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3456777888999999999999876 488999999976543 34566777777766654 89999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee-------c------------------ccccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH-------Q------------------DFGLARLISAC 312 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-------~------------------DfGla~~~~~~ 312 (435)
||.|. -.++.+++.-. ..+++...=++...+.+||.||- + |||++..+.+.
T Consensus 170 MelMs-~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHH-HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99985 35566665432 23666666677788889999983 2 99999776543
Q ss_pred CccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
...+..+|.+.|||||.+.- ..|+.++|||||||.++|++||+.||.....+ .+... ..+...
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~lt---kvln~e------ 311 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLT---KVLNEE------ 311 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHH---HHHhcC------
Confidence 33345689999999998753 47899999999999999999999998542211 11111 111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.|.+... ..+.....++...|+.+|+.+||.-.++++
T Consensus 312 PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1222111 113345567778899999999999988764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=223.58 Aligned_cols=238 Identities=17% Similarity=0.140 Sum_probs=144.5
Q ss_pred cccCcceeeeecccCcceEEEEEcC-C----CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEE------EE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-D----GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGY------CS 249 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 249 (435)
...+|++.+.||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999865 4 68999998764321 1222222 1122222333322211 24
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhCCCC----------------CCCCHHHHHHHHHHhhhccceeec------------
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNATGSH----------------EVLDRAKRYKIACSSARGLAFLHQ------------ 301 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~------------ 301 (435)
.....++||||+++|+|.+++....... ..........++.|+++||+|||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 5677899999999999999887532110 001122345689999999999996
Q ss_pred -------------cccccccccccCccccccccccCCCcCCcCCCCC----------------------CCCCcccchhH
Q 040641 302 -------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR----------------------MSTTRGDVYSF 346 (435)
Q Consensus 302 -------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~DV~Sf 346 (435)
|||+|+.+............||+.|||||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9999987654333444567899999999954221 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCcc------cccCCcHHHHHHHHhccCCCCccccccccC--CCCHHHHHHHHHHHhcccCCCCC
Q 040641 347 GVILLELVTAKEPTGPEFQ------EKEGANLVGWVFQKMKKQQADDVLDPTVLN--AGSKPMMLKMLRIAADCVADNPA 418 (435)
Q Consensus 347 Gvil~El~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~ 418 (435)
||++|||+++..|++.... ...+.+...|..... .. ..+.... ...........+++.+|++.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-PR-----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-cc-----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999997766432110 000111111111000 00 0000000 00000011234788899999999
Q ss_pred CCCCHHHHHH
Q 040641 419 TRPTMLHVLK 428 (435)
Q Consensus 419 ~RPs~~evl~ 428 (435)
+|||+.|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=231.60 Aligned_cols=183 Identities=23% Similarity=0.267 Sum_probs=148.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccc---cccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQ---AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.-...+|.+.++||+|+||.|..++++ +++.+|+|++++ .+.....-|..|-.+|..-..+=||+++-.|.++..+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 345578999999999999999999975 478999999976 3344556789999999998999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHH----HHHHHHhhhccceeec------------------ccccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKR----YKIACSSARGLAFLHQ------------------DFGLARLISAC 312 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~----~~i~~~ia~gl~yLH~------------------DfGla~~~~~~ 312 (435)
|+|||||+||+|-.++.+.. .-+-+|+.- +-+|++..+-|.|+|+ |||-.-.+..+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999887642 122234322 2346666777888887 89987666665
Q ss_pred CccccccccccCCCcCCcCCC----C-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQ----S-RMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
....+...+|||-|++||++. + +.|+..+|.||+||++|||+.|..||+.+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 555666789999999999753 3 67999999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=219.95 Aligned_cols=229 Identities=22% Similarity=0.324 Sum_probs=175.7
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.|..+|++...+|.|.||.|||++. .+++..|||.++.....+..-.++|+-+++..+|||||.++|.+...+..+++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 5677899999999999999999985 468899999998776667777889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||.+|+|++.-+.. ..+++.+...++....+|++|||+ |||.+..+... .
T Consensus 92 EycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I 166 (829)
T ss_pred EecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-h
Confidence 999999998865532 358888888899999999999996 89988765432 2
Q ss_pred cccccccccCCCcCCcCC---CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 315 HVSTDIAGTLGYIPPEYG---QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
....++.||+.|||||+. ....|..++|||+.|+...|+..-++|-..- .. . .+...+.+. ..+|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hp---m-r~l~LmTkS----~~qp 234 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HP---M-RALFLMTKS----GFQP 234 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----ch---H-HHHHHhhcc----CCCC
Confidence 334568899999999964 4567899999999999999999888773211 00 0 111112111 1122
Q ss_pred c-ccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 T-VLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~-~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. +.. ..+.+ .+.+++..|+.++|++||+++.++.
T Consensus 235 p~lkDk~kws~---~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccchH---HHHHHHHHHhcCCCccCCChhhhee
Confidence 2 211 12223 3456677799999999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=214.80 Aligned_cols=215 Identities=20% Similarity=0.205 Sum_probs=161.2
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 259 (435)
...|.+...+|.|+|+.|-++.. .+++..+||.+.+... +-.+|+.++... .||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45677888899999999999985 4688999999976522 234677665554 79999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
++.+|-+.+.+.... .....+..|+.+++.++.|||+ |||.++.....
T Consensus 397 ~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999998877666432 1225666799999999999996 67776655432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
....+=|..|.|||+.....|++++|+||+|++||||++|+.|+...... .+ +...+......+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e----i~~~i~~~~~s~------- 533 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE----IHTRIQMPKFSE------- 533 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH----HHHhhcCCcccc-------
Confidence 11235678999999999999999999999999999999999998643221 11 223333222211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+++..|++.||.+||+|.++..
T Consensus 534 -----~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 -----CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11123456777899999999999999863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=178.59 Aligned_cols=174 Identities=29% Similarity=0.376 Sum_probs=140.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+|.-.+.||+|.||+||+|+.. +++.||+|+++..+.+ -.....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455688999999999999854 5889999988654332 235678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
|. .+|..+..... ..++......++.|+.+|+.|+|+ |||+||..... ...
T Consensus 83 cd-qdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-vrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRC 157 (292)
T ss_pred hh-HHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEe
Confidence 95 46777765433 347888888999999999999996 99999875431 112
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
....+-|..|.+|.++.+ .-|++..|+||-|||+.|+.....|..+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 233467899999998766 4689999999999999999987777543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=205.70 Aligned_cols=238 Identities=21% Similarity=0.272 Sum_probs=172.7
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCC--CC----ceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH--QN----LVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~g~~~~~~~~ 254 (435)
..+|.+.+.+|+|.||.|-++.... +..||||.++... ...+...-|++++.++.+ |+ +|++.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5688999999999999999997543 6889999997543 234556779999999843 32 68888999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------- 301 (435)
++|+|.+ |-|+.+++.... ...++..+...|+.|+.++++|||+
T Consensus 167 Civfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 9999988 568999997643 3457778889999999999999996
Q ss_pred -----------cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 302 -----------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
|||-|+..... .+.++.|..|.|||++.+-..+.++||||+||||.|+.||..-|..... .+..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen-~EHL 318 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN-LEHL 318 (415)
T ss_pred ccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc-HHHH
Confidence 88888764322 2457889999999999999999999999999999999999987753221 1111
Q ss_pred cHHHHHHH--------Hh------ccCCC-----------Cccccccc----cCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 040641 371 NLVGWVFQ--------KM------KKQQA-----------DDVLDPTV----LNAGSKPMMLKMLRIAADCVADNPATRP 421 (435)
Q Consensus 371 ~~~~~~~~--------~~------~~~~~-----------~~~~~~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RP 421 (435)
.+.+.+.. .. ..... ..+.++.. .-.....+..++++++...+..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 11111110 00 00000 00011100 0112234556789999999999999999
Q ss_pred CHHHHHH
Q 040641 422 TMLHVLK 428 (435)
Q Consensus 422 s~~evl~ 428 (435)
|+.|++.
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-26 Score=212.10 Aligned_cols=177 Identities=22% Similarity=0.311 Sum_probs=149.9
Q ss_pred cccCcceeeeecccCcceEEEEEcCCC-CEEEEEEcccc---ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDG-KTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...++.....||-|+||.|-.+..... ..+|+|.+++. ++...+....|-.||...+.|.||++|-.|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 455677788899999999999886543 34888888654 34445668889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
.||-|-||.|...|+++. .++.....-++..+.+|++|||+ |||+|+.+...
T Consensus 498 LmEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999998764 35556666678889999999997 99999988753
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
...-.+|||+.|.|||++.....+.++|.||+||++||++||.+||...
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 3334689999999999999999999999999999999999999998643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=192.61 Aligned_cols=229 Identities=19% Similarity=0.288 Sum_probs=166.0
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCC
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDE 252 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 252 (435)
+.....+|.+..+||+|+|++|..+++. +.+.+|+|.+++.- .++..=.+.|-.+..+. +||.+|.++.++....
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3445678999999999999999999875 47789999987532 22222234455555444 7999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
.++.|.||++||+|--+.+... .+++.+..-+...|.-||.|||+ |+|+.+.
T Consensus 325 rlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred eEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999999976665432 47777777788899999999996 7777654
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
--. ........+||+.|+|||.+.+..|+..+|.|++||+++||..|+.||+--.......+..++.++.+.+.++.
T Consensus 401 ~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-- 477 (593)
T KOG0695|consen 401 GLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-- 477 (593)
T ss_pred CCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--
Confidence 221 12234568999999999999999999999999999999999999999964222222344555666665443321
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRP 421 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP 421 (435)
-|...+. +...+...-+++||.+|-
T Consensus 478 -iprslsv-------kas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -IPRSLSV-------KASHVLKGFLNKDPKERL 502 (593)
T ss_pred -ccceeeh-------hhHHHHHHhhcCCcHHhc
Confidence 2222222 223344455678998884
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-26 Score=196.10 Aligned_cols=175 Identities=30% Similarity=0.375 Sum_probs=137.6
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEe--------C
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--------D 251 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 251 (435)
..|+-...+|+|.||.||+|+..+ |+.||+|+.-.. +..--....+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667789999999999998764 778999876432 22223456899999999999999999988754 2
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
..+|+||++|+. +|.-+|.+. ...++.....+++.++..||.|+|+ |||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 347999999975 777777654 2347778888999999999999996 999998
Q ss_pred cccccCccc---cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 308 LISACETHV---STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 308 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
......... -+..+-|..|.+||.+.+ +.|+++.|||.-|||+.||.||.+-+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 765433221 244567999999997655 679999999999999999999987654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=184.51 Aligned_cols=186 Identities=32% Similarity=0.537 Sum_probs=152.1
Q ss_pred ecccCcceEEEEEcCC-CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHH
Q 040641 191 LEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL 268 (435)
Q Consensus 191 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~ 268 (435)
||+|++|.||++...+ ++.+++|.+...... ....+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999999755432 34678999999999999999999999999899999999999999999
Q ss_pred HHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcccccccccc
Q 040641 269 WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETHVSTDIAGT 323 (435)
Q Consensus 269 ~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~~~~~~~gt 323 (435)
++.... ..+++..+..++.+++++++|||+ |||.+........ ......+.
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 987542 347888999999999999999986 4444433221110 12234577
Q ss_pred CCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH
Q 040641 324 LGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402 (435)
Q Consensus 324 ~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (435)
..|++||..... .++.++|+|++|++++|+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 889999988776 788999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 403 LKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 403 ~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 245678888999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=216.48 Aligned_cols=222 Identities=22% Similarity=0.318 Sum_probs=162.5
Q ss_pred cceeeeecccCcce-EEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 185 LTLVDILEDGGFGT-VYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 185 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
|.-.+++|.|+-|+ ||+|.+. |+.||||++-... ..-..+|++.|..- .|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44567889999884 7999984 7899999985422 23456899999887 69999999999888999999999994
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccccccccC
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARLISACE 313 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~~~~~~ 313 (435)
.+|++++...........-...+.+..|++.|+++||+ |||+++.+..+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 69999997641111111113345678899999999995 999999886544
Q ss_pred ccc--cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 THV--STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
... .....||-||+|||.+....-+.++||+|+|||+|..+|| ..||+.....+ .+++. .......+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~-------~~~~L~~L~ 736 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT-------GNYTLVHLE 736 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc-------Cccceeeec
Confidence 322 3457899999999999988888899999999999999997 88997654322 11111 000001111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.... +..+++.++++.+|..||++.+|+.
T Consensus 737 -----~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -----PLPDC---EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----cCchH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111 4567888999999999999999973
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=186.75 Aligned_cols=175 Identities=35% Similarity=0.460 Sum_probs=145.6
Q ss_pred cceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 185 LTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998765 889999999765544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+++|.+++..... .+++.....++.++++++.|||+ |||.+............
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999875421 17888899999999999999986 78877665432111223
Q ss_pred cccccCCCcCCcCC-CCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 319 DIAGTLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 319 ~~~gt~~y~aPE~~-~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
...++..|++||.. ....++.++||||||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 35678899999988 667788899999999999999999999843
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=178.39 Aligned_cols=182 Identities=25% Similarity=0.371 Sum_probs=148.6
Q ss_pred ccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHh-ccCCCCCceeEEEEEEeCCee
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETL-GKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~ 254 (435)
++.+...+.-.+.||+|+||.|-+-++ .+|+..|||++...- .+..+...+|+.+. +....|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 556667777888999999999988875 579999999997543 33456677888864 556899999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLI 309 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~ 309 (435)
++.||.|. -||+.+-+........+++...=+||..+.+||.|||+ |||++..+
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999995 58888877665556678888888999999999999996 99999877
Q ss_pred cccCccccccccccCCCcCCcCCC----CCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQ----SRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.+ +...+-..|.-.|||||.+. ...|+-|+||||+|+.+.||.+++.|++.
T Consensus 200 ~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 54 23334357888999999754 34789999999999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=195.91 Aligned_cols=188 Identities=21% Similarity=0.318 Sum_probs=141.4
Q ss_pred CcceeeeecccCcceEEEEE-cCCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
-|...+.||-|+||+|.+++ .++...+|+|.+++.+. ........|-.||....++=||+||-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36667889999999999996 45567899999976543 234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhc------cceeec------------------ccccccccc-----
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG------LAFLHQ------------------DFGLARLIS----- 310 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~g------l~yLH~------------------DfGla~~~~----- 310 (435)
|++||++-.+|-... ++.+....-++.+++.| |.|+|+ ||||..-+.
T Consensus 710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999988775432 34444333344444444 555554 899864210
Q ss_pred ---ccCcc---------------------------------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHH
Q 040641 311 ---ACETH---------------------------------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELV 354 (435)
Q Consensus 311 ---~~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~ 354 (435)
....+ .....+||+.|+|||++....|+.-+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 00000 012357999999999999999999999999999999999
Q ss_pred hCCCCCCCCcccccCCcHHHH
Q 040641 355 TAKEPTGPEFQEKEGANLVGW 375 (435)
Q Consensus 355 tg~~p~~~~~~~~~~~~~~~~ 375 (435)
.|+.||......+....++.|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 999999876665555555555
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=177.54 Aligned_cols=151 Identities=19% Similarity=0.224 Sum_probs=107.2
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------cccccccccccCccccccccccCCCc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------DFGLARLISACETHVSTDIAGTLGYI 327 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------DfGla~~~~~~~~~~~~~~~gt~~y~ 327 (435)
|+|.++++... ..+++.....++.|+++||+|||+ .||+++..... ...||+.||
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~fG~~~~~~~~------~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPE------QSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceeeccceEeeccc------cCCCccccc
Confidence 78999997532 348999999999999999999997 26666554321 236899999
Q ss_pred CCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHH--HHH
Q 040641 328 PPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM--LKM 405 (435)
Q Consensus 328 aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 405 (435)
|||++.+..++.++|||||||++|||+||+.||..... ...........+.... +.. ........ ..+
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~ 141 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPADD------PRD-RSNLESVSAARSF 141 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccCC------ccc-cccHHHHHhhhhH
Confidence 99999999999999999999999999999999854221 1111111111111110 000 01111122 257
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 406 LRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 406 ~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.+++.+||+.+|++||++.|+++.+..+
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 8899999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-23 Score=181.10 Aligned_cols=174 Identities=28% Similarity=0.337 Sum_probs=141.2
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-----eeE
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-----EKL 255 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 255 (435)
+++-.+-||-|+||+||.++.+ +|+.||.|++.... -...+.+.+|+++|..++|.|+...++...... +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556778999999999999865 69999999996532 224577899999999999999999988765432 467
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|+|.|. .+|+.++-. .+.++.....-+..||.+||.|||+ |||+||....
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 8889885 467666643 3457777777889999999999996 9999998776
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
++...++..+-|-.|.|||.+.+ +.|+.+.||||.|||+.|++-++.-|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 66556667778999999998876 5789999999999999999988876644
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=189.40 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=140.8
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEcccccc--------ccHHHHHHHHHHhccCC---CCCceeEEEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKT--------QGHRQFTAEMETLGKVK---HQNLVLLLGYCSF 250 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 250 (435)
.+|+..+.+|+|+||.|+.|.++. ...|+||.+.+... ...-..-.|++||..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358889999999999999999764 56899999875431 11123556999999997 9999999999999
Q ss_pred CCeeEEEEecc-cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 251 DEEKLLVYEYM-VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 251 ~~~~~lv~ey~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
++..||+||-- ++-+|.+++.-+ ..+++.....|..||+.|+++||+ |||-
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999954 456888888643 347888889999999999999996 7887
Q ss_pred cccccccCccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCC
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
|...+.... ...+||.+|.|||++.+..| +..-|||++||+||.++....||+
T Consensus 717 aa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 776654332 34689999999999988776 566899999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=171.53 Aligned_cols=115 Identities=22% Similarity=0.239 Sum_probs=92.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCC-----C---CCceeEEEEEEe---
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-----H---QNLVLLLGYCSF--- 250 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 250 (435)
.+|.+.++||-|.|++||+|... +.+-||+|+.+.+. ...+....||++|++++ | ..||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 58999999999999999999854 46789999986543 23456778999999874 3 369999999965
Q ss_pred -CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 251 -DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 251 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+.+.+||+|+. |-+|-.+|... ...-++.....+|+.||+.||.|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ 205 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHR 205 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 45789999998 66787777653 23458888899999999999999995
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=162.74 Aligned_cols=170 Identities=19% Similarity=0.293 Sum_probs=134.8
Q ss_pred cccCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCC--eeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDE--EKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 256 (435)
...+|++.+.+|+|.|+.||.|. ..+++.++||.++..+ .+...+|+.||..++ |||||++++...++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 44678999999999999999997 4567899999997544 356889999999997 999999999887654 4579
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
|+||+.+-+...+-. .++.......+.++++||.|+|+ |+|+|.+...
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999988765432 24445566678899999999996 8999987654
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.... .-.+.+..|.-||.+.. +.|+..-|+|||||++.+|+..+.||..
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 3211 11345667889997654 5678889999999999999999999854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=180.79 Aligned_cols=191 Identities=27% Similarity=0.420 Sum_probs=140.3
Q ss_pred hccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------
Q 040641 233 LGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------- 301 (435)
Q Consensus 233 l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------- 301 (435)
|+.+.|.|+.+++|.+..+...++|.+||+.|+|.+.+... ...++|.....++.++++||+|+|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 56789999999999999999999999999999999999863 3458999999999999999999996
Q ss_pred --------------ccccccccccc-CccccccccccCCCcCCcCCCCC-------CCCCcccchhHHHHHHHHHhCCCC
Q 040641 302 --------------DFGLARLISAC-ETHVSTDIAGTLGYIPPEYGQSR-------MSTTRGDVYSFGVILLELVTAKEP 359 (435)
Q Consensus 302 --------------DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~SfGvil~El~tg~~p 359 (435)
|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++++.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 89988776421 11111112233569999977653 146789999999999999999999
Q ss_pred CCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 360 TGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
|+.........+++.. ++. .....+.|.+.... +....+..++.+||..+|++||++.+|-..++.+
T Consensus 158 ~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCChHHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9765443333233333 222 12223334332221 2233678899999999999999999998887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-21 Score=201.93 Aligned_cols=171 Identities=22% Similarity=0.289 Sum_probs=115.8
Q ss_pred cCCC-CCceeEEEEE-------EeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----
Q 040641 235 KVKH-QNLVLLLGYC-------SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301 (435)
Q Consensus 235 ~l~H-~niv~l~g~~-------~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----- 301 (435)
.++| +||++++++| ...+..+.+|||+ +++|.++|... ...+++.....++.|+++||+|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 4456 6888888887 2334567888987 66999999753 2348899999999999999999996
Q ss_pred --------------------------------------cccccccccccC--------c-------cccccccccCCCcC
Q 040641 302 --------------------------------------DFGLARLISACE--------T-------HVSTDIAGTLGYIP 328 (435)
Q Consensus 302 --------------------------------------DfGla~~~~~~~--------~-------~~~~~~~gt~~y~a 328 (435)
|||+++...... . .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 344443211000 0 00112358889999
Q ss_pred CcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHH
Q 040641 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRI 408 (435)
Q Consensus 329 PE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 408 (435)
||++.+..++.++|||||||++|||+++..|+... .... ..+... ..++... ....+...+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~----~~~~~~----~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTM----SSLRHR----VLPPQIL-----LNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHH----HHHHHh----hcChhhh-----hcCHHHHHH
Confidence 99999999999999999999999999988775321 0011 111100 0111110 112234567
Q ss_pred HhcccCCCCCCCCCHHHHHH
Q 040641 409 AADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 409 ~~~C~~~~P~~RPs~~evl~ 428 (435)
+..||+.+|.+||+|.||++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 78899999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-20 Score=170.15 Aligned_cols=173 Identities=28% Similarity=0.362 Sum_probs=138.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 256 (435)
...|..+++||+|.|++||++.+. ..+.||+|.+..... .....+|+++|..+ .+.||+++.+++..++...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 456788999999999999999753 357899999975443 34578999999998 58999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
|+||++.-...++.+. ++............+||.++|. |||+|.....
T Consensus 113 vlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999998888764 4566677788889999999986 9999872110
Q ss_pred c------Cc-------------------------------------cccccccccCCCcCCcCCCC-CCCCCcccchhHH
Q 040641 312 C------ET-------------------------------------HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFG 347 (435)
Q Consensus 312 ~------~~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfG 347 (435)
. .. ......+||+||.|||++.. ..-++++||||-|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 00 00112469999999998655 4568899999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 040641 348 VILLELVTAKEPTGPE 363 (435)
Q Consensus 348 vil~El~tg~~p~~~~ 363 (435)
||++-+++++.||...
T Consensus 266 VI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeehhhccccccccC
Confidence 9999999999998644
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-19 Score=159.95 Aligned_cols=168 Identities=26% Similarity=0.270 Sum_probs=132.4
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------ee
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------EK 254 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 254 (435)
+|.-...+|.|+- .|..+... .++.||+|++... .....+...+|...+..+.|+||++++.++.... +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444455677776 55555432 4789999998543 2334567789999999999999999999986543 46
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|+|||||. ++|...+... ++-.+...|..|+..|+.|||+ |||+|+...
T Consensus 97 y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 89999994 6888877632 5556777889999999999996 999998654
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
. ....++.+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.
T Consensus 170 ~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 170 T--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred c--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 3 256678899999999999988889999999999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-19 Score=152.84 Aligned_cols=228 Identities=20% Similarity=0.273 Sum_probs=154.3
Q ss_pred cCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEE-EEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLG-YCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g-~~~~~~~~~lv~e 259 (435)
+.|++.+.+|+|.||.+-.++++. .+.+++|.+..... ..++|.+|..---.| .|.|||.-|+ .|+..+..+.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 467888999999999999999764 56788888865432 457899998765555 5899998776 4566778889999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccC
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACE 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~ 313 (435)
|+|.|+|.+-+... -+.+....+++.|++.|+.|+|+ |||+.+.....
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999998766432 26677788899999999999997 78877653221
Q ss_pred ccccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 314 THVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.....-+..|-|||.... -...+.+|||.|||+++.++||..||..... .......|. .+.......
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~--~d~~Y~~~~--~w~~rk~~~- 248 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI--MDKPYWEWE--QWLKRKNPA- 248 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--cCchHHHHH--HHhcccCcc-
Confidence 111234567899996432 2346779999999999999999999974322 112223332 222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
-|....+ ...+..++-.+-+..+|++|-...++.++-
T Consensus 249 -~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 249 -LPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -Cchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1222222 222344455566788888886666655443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.6e-19 Score=165.36 Aligned_cols=173 Identities=25% Similarity=0.222 Sum_probs=134.4
Q ss_pred CcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCC------CCCceeEEEEEEeCCeeEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVK------HQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~l 256 (435)
+|.+....|+|-|+.|.+|.... |..||||.|.....- .+.=.+|+++|++|. --|.++++-.|...++++|
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 56666777999999999998654 789999999764432 344568999999985 2478999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCC-----CCCCHHHHHHHHHHhhhccceeec-------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSH-----EVLDRAKRYKIACSSARGLAFLHQ-------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~-------------------DfGla~~~~~~ 312 (435)
|+|-. .-+|..+|....... .+-..++.+-+|...++-..+||. |||-|..+...
T Consensus 512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence 99977 457888887643221 122345666777788888899996 89988766542
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
+ .+...-+..|.|||++.+-+|+...|+||.||+|||+.||+.-|.
T Consensus 591 e---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 591 E---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred c---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 2 233444567999999999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-16 Score=148.30 Aligned_cols=236 Identities=24% Similarity=0.369 Sum_probs=168.6
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccccc---cHHHHHHHHHHhccCCCC-CceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQ-NLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ey 260 (435)
|.+.+.+|.|+||.||++... ..+|+|.+...... ....|.+|+.+++.+.|+ ||+++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999876 78999998765433 367899999999999988 799999999777778999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
+.++++..++...... ..+.......+..+++.++.|+|+ |||.++........
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999776543211 257778888999999999999995 89998755433221
Q ss_pred -----ccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 316 -----VSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 316 -----~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
......||..|+|||...+ ..++...|+||+|++++++++|..|+...... .........+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTP- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCc-
Confidence 2356789999999998877 57889999999999999999999996432210 0011111212111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.................+.+++..|+..+|..|.+..+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00000000000111234566777888899999999887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-17 Score=153.52 Aligned_cols=139 Identities=21% Similarity=0.178 Sum_probs=101.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC--CCCEEEEEEcccc-----ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP--DGKTVAVKKFSQA-----KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
...|++.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++++|+|||..+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 357999999999999999999864 4777899987532 11234568999999999999999953322 2567
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLI 309 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~ 309 (435)
++||||+++++|... . . . . ...++.++++||.|||+ |||+|+..
T Consensus 94 ~LVmE~~~G~~L~~~-~-~---~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R-P---H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEEEccCCCCHHHh-C-c---c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 999999999999632 1 1 0 0 13567788899999985 89999866
Q ss_pred cccCcc-------ccccccccCCCcCCcCCCC
Q 040641 310 SACETH-------VSTDIAGTLGYIPPEYGQS 334 (435)
Q Consensus 310 ~~~~~~-------~~~~~~gt~~y~aPE~~~~ 334 (435)
...... ..+...+++.|+|||++..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 432211 1135678899999998654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-15 Score=142.37 Aligned_cols=234 Identities=21% Similarity=0.217 Sum_probs=162.4
Q ss_pred CcceeeeecccCcceEEEEEcCCC--CEEEEEEccccccccHHHHHHHHHHhccCCC----CCceeEEEEE-EeCCeeEE
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDG--KTVAVKKFSQAKTQGHRQFTAEMETLGKVKH----QNLVLLLGYC-SFDEEKLL 256 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 256 (435)
+|.+...||+|+||.||.+...+. ..+|+|.-..........+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999986543 4788887655433322367788998888873 5888888888 47778899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLAR 307 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~ 307 (435)
||+.+ |-+|.++..... ...++..+.++|+.|+..+|.++|+ |||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 99987 789998765432 4568889999999999999987775 999998
Q ss_pred --cccccCcc----c---cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 308 --LISACETH----V---STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 308 --~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
........ . .....||..|.++....+...+.+-|+||++-++.|+..|..||........ ......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~~~~~ 251 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KSKFEK 251 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HHHHHH
Confidence 32211110 1 1235699999999999999999999999999999999999999843221111 111111
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
..... .... ...........+. ..+-+.+..++|.-..+...|++.
T Consensus 252 ~~~~~----~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 DPRKL----LTDR--FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred Hhhhh----cccc--ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHH
Confidence 11111 1110 1111223333333 334446889999999988887664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-16 Score=170.91 Aligned_cols=127 Identities=39% Similarity=0.603 Sum_probs=79.8
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
+|.+|..++++++|+.|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..+
T Consensus 153 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 232 (968)
T PLN00113 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232 (968)
T ss_pred cccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence 34556666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
+++++|++|++++|++++.+|..++++++|+.|++++|.+.+.+|..
T Consensus 233 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 279 (968)
T PLN00113 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279 (968)
T ss_pred hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh
Confidence 66666666666666666666666666666666666666666555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.4e-17 Score=162.14 Aligned_cols=229 Identities=22% Similarity=0.235 Sum_probs=153.7
Q ss_pred ceeeeecccCcceEEEEEcC-CCCEEEEEEcccc--cccc----HHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 186 TLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA--KTQG----HRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
....++|.|++|.|+..... ..+..+.|..+.. .... ...+..|.-+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877533 3444555544310 1111 122566888888999999988877777766666669
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc-C
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC-E 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~-~ 313 (435)
|||++ +|..++... ..+....+-.+..|+.+|+.|+|. |||.+...... +
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 998888653 235666777889999999999996 88887654322 1
Q ss_pred --ccccccccccCCCcCCcCCCCCCCCC-cccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 314 --THVSTDIAGTLGYIPPEYGQSRMSTT-RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 314 --~~~~~~~~gt~~y~aPE~~~~~~~~~-k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.......+|+-.|+|||++....|.+ ..||||.||++..|.+|+.||...-..+.. + .......+......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~--~----~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS--F----KTNNYSDQRNIFEG 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc--h----hhhccccccccccC
Confidence 24556789999999999998887765 589999999999999999998644332211 0 00000000000000
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ ..-......+...++.+.++.+|.+|-|+.+|++
T Consensus 550 ~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 P---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred h---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0001122234456777788999999999999985
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-16 Score=128.31 Aligned_cols=110 Identities=28% Similarity=0.402 Sum_probs=60.5
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
.++..++.|-||+|+++ .+|+.+..+.+|+.|++++|++. .+|.+++.+++|++|+++-|++. .+|..||.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34445555555555555 55555555555555555555555 45555555555555555555554 45555555555555
Q ss_pred EeCCCCCCc-ccCCccccCcCCCCcccccCCcce
Q 040641 90 LDLHDNKFT-REIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 90 L~l~~n~~~-~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
||+..|+++ ..+|..|..+..|..|+++.|.|.
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe 140 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE 140 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence 555555543 234555545555555555555443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-14 Score=146.84 Aligned_cols=108 Identities=35% Similarity=0.562 Sum_probs=93.4
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
.++.|+|++|.++|.+|.+++.+++|+.|+|++|.++|.+|..++.+++|+.|||++|.++|.+|..++++++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37788999999999999999999999999999999998899889999999999999999999999989999999999999
Q ss_pred CCCCcccCCccccCc-CCCCcccccCCcc
Q 040641 94 DNKFTREIPQNLGNL-AQLEHLDVLRNML 121 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l-~~L~~l~l~~n~l 121 (435)
+|+++|.+|..++.+ .++..+++.+|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcc
Confidence 999999999888764 3566778877754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.4e-15 Score=141.49 Aligned_cols=162 Identities=27% Similarity=0.347 Sum_probs=124.8
Q ss_pred eecccCcceEEEEE----cCCCCEEEEEEccccccc--cHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEeccc
Q 040641 190 ILEDGGFGTVYKAT----LPDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
++|+|+||.|+.++ ...|..+|+|.+++.... .......|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999764 234778899988654321 1124556888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|...+.+. ...+..........+|-+++++|. |||+++..-..+.
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99987766542 224444444556667778888885 8898887543221
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
.|||.-|||||+.. .....+|.||||++++||+||..||..
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999987 567789999999999999999999865
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-15 Score=121.76 Aligned_cols=123 Identities=29% Similarity=0.477 Sum_probs=112.2
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC-CcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD-GGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~-~~~p~~~~ 82 (435)
.+|+.+..|.+|+.|++++|+++ .+|.++++++.|+.|+++-|++. .+|..|+.++.|+.|||+.|++. ..+|..|.
T Consensus 47 ~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff 124 (264)
T KOG0617|consen 47 VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFF 124 (264)
T ss_pred ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchh
Confidence 37899999999999999999998 89999999999999999999998 79999999999999999999986 45899999
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
.+..|+.|++++|.|. .+|..++++++|+.|.+..|.+- ++|.++.
T Consensus 125 ~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig 170 (264)
T KOG0617|consen 125 YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG 170 (264)
T ss_pred HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHH
Confidence 9999999999999996 79999999999999999999886 5677664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-13 Score=119.96 Aligned_cols=160 Identities=13% Similarity=0.145 Sum_probs=101.5
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHH---------HHHHHHHHhccCCCCCceeEEEEEEeC-
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHR---------QFTAEMETLGKVKHQNLVLLLGYCSFD- 251 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~- 251 (435)
..+|...+++|.|+||.||.+.. ++..+|+|.+........+ .|.+|++.+.++.||+|.....++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 35788999999999999999765 5778999999754332222 268999999999999999998886533
Q ss_pred -------CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhcccee------eccccccccccccCccccc
Q 040641 252 -------EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL------HQDFGLARLISACETHVST 318 (435)
Q Consensus 252 -------~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL------H~DfGla~~~~~~~~~~~~ 318 (435)
+..++||||++|.+|.++.. ++.. ...+++.++..+ |.|.-.+.++-........
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~li 176 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRII 176 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEE
Confidence 35789999999999987632 1111 223444455544 4454444333221111111
Q ss_pred cccccCCCcCCc----CCCCCCCCCcccchhHHHHHHHHH
Q 040641 319 DIAGTLGYIPPE----YGQSRMSTTRGDVYSFGVILLELV 354 (435)
Q Consensus 319 ~~~gt~~y~aPE----~~~~~~~~~k~DV~SfGvil~El~ 354 (435)
+..++..+.-+. +.....++.++|+||||+.+.-..
T Consensus 177 Dfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence 111111111111 334455678999999998876443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-12 Score=116.33 Aligned_cols=174 Identities=17% Similarity=0.258 Sum_probs=136.7
Q ss_pred cCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..|.+.+.||+|+||+.+.|+ +-+++.||||.=..... .-++..|-+..+.| ..++|-.++-+-..+-.-.||||.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368899999999999999997 56799999997543222 23455666666666 458888888776777778899998
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccccccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARLISA 311 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~~~~ 311 (435)
. |-||+++..-.. ..++..+...+|.|+..-++|+|+ |||+|+...+
T Consensus 106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 788888765432 237778888999999999999996 9999998654
Q ss_pred cCcc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 312 CETH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 312 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
..+. ......||..||+=-.-.++.-+.+-|.=|+|-|+...+-|..||..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 3322 23457899999998777777778889999999999999999999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.3e-13 Score=117.30 Aligned_cols=107 Identities=16% Similarity=0.155 Sum_probs=77.5
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccc--c-------HHH-----------------HHHHHHHhccCCCCCc
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ--G-------HRQ-----------------FTAEMETLGKVKHQNL 241 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 241 (435)
.+.||+|+||.||+|...+|+.||||.++..... . ... ..+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998653211 1 111 2349999999988776
Q ss_pred eeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee
Q 040641 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300 (435)
Q Consensus 242 v~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 300 (435)
.....+.. ...+|||||++++++....... ..++......++.+++.+|.|+|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~ 134 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILY 134 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 43332222 2348999999998776443221 24778888999999999999994
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=4e-13 Score=137.47 Aligned_cols=101 Identities=36% Similarity=0.565 Sum_probs=92.9
Q ss_pred CcccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS 80 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 80 (435)
|+|.+|.+++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.|++|+.|+|++|.++|.+|..
T Consensus 430 L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred ccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCC-CCCCEEeCCCCCCcccC
Q 040641 81 LGNL-SYSTYLDLHDNKFTREI 101 (435)
Q Consensus 81 ~~~l-~~L~~L~l~~n~~~~~~ 101 (435)
++.+ .++..+++.+|......
T Consensus 510 l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 510 LGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred HhhccccCceEEecCCccccCC
Confidence 8764 46788999999765433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.8e-13 Score=114.55 Aligned_cols=174 Identities=21% Similarity=0.282 Sum_probs=132.4
Q ss_pred cCcceeeeecccCcceEEEEE-cCCCCEEEEEEccccccccHHHHHHHHHHhccCCC-CCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH-QNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|.+++.||+|+||.+|.|. ..+|+.||+|.=+... ..-+...|.++.+.++| ..|-.+.-|..+.+.-.+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 578899999999999999997 5679999999854322 23457788998888876 4566666677788888999998
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
. |-+|+++..-... .++..+.+-++-|+..-++|+|. |||+|+...+..
T Consensus 93 L-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 7899887754321 25666777888888888888884 999998765432
Q ss_pred cc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 314 TH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 314 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
+. ......||..|.+--...+..-+.+-|+=|.|-+|...--|..||..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 21 22456799999765544444456678999999999999999999964
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-13 Score=128.39 Aligned_cols=102 Identities=26% Similarity=0.395 Sum_probs=83.6
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccce---eec------------------cccccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF---LHQ------------------DFGLARLISA 311 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~y---LH~------------------DfGla~~~~~ 311 (435)
..|+.|++|..++|.+||.... .....++.....++.|++.|+.| +|. |||+......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~ 408 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK 408 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeeccc
Confidence 4789999999999999997543 23456788888999999999975 343 8888765544
Q ss_pred cC-----ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh
Q 040641 312 CE-----THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT 355 (435)
Q Consensus 312 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t 355 (435)
+. ....+..+||..||+||.+.+..|+.|+||||+|+|++|+++
T Consensus 409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 409 DETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred CCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 33 223456789999999999999999999999999999999998
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.9e-14 Score=137.02 Aligned_cols=123 Identities=33% Similarity=0.517 Sum_probs=105.3
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
||.++.++.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+++ .+.-..+...+|+.|+||.|+++ .+|+.++.|
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 7888999999999999999998 88999999999999999999998 56666677788999999999998 689999999
Q ss_pred CCCCEEeCCCCCCc-ccCCccccCcCCCCcccccCCcceecCCccccc
Q 040641 85 SYSTYLDLHDNKFT-REIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 85 ~~L~~L~l~~n~~~-~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~~ 131 (435)
+.|+.|.+.+|+++ ..||+.+|++.+|+.+..++|.+. .+|..+|+
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcR 337 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCR 337 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhh
Confidence 99999999988764 348899999999999998888776 67877765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-13 Score=131.18 Aligned_cols=90 Identities=33% Similarity=0.432 Sum_probs=59.5
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
||+++..+..|+.||||+|++. ..|..+-..+++-.|+||+|++. .||.. |-++.-|-.||||+|++. .+|+.+..
T Consensus 95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR 171 (1255)
T KOG0444|consen 95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR 171 (1255)
T ss_pred CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHH
Confidence 7888888888888888888887 67777777777777777777776 45554 445555666666666665 34545555
Q ss_pred CCCCCEEeCCCCCC
Q 040641 84 LSYSTYLDLHDNKF 97 (435)
Q Consensus 84 l~~L~~L~l~~n~~ 97 (435)
|..|++|+|++|.+
T Consensus 172 L~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 172 LSMLQTLKLSNNPL 185 (1255)
T ss_pred HhhhhhhhcCCChh
Confidence 55555555555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.2e-12 Score=109.25 Aligned_cols=107 Identities=17% Similarity=0.180 Sum_probs=78.9
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccc--c------------------------HHHHHHHHHHhccCCCCCc
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ--G------------------------HRQFTAEMETLGKVKHQNL 241 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 241 (435)
.+.||+|+||.||+|+..+|+.||||.++..... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998753211 0 1123578999999999988
Q ss_pred eeEEEEEEeCCeeEEEEecccCCCHHHH-HHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLW-LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 242 v~l~g~~~~~~~~~lv~ey~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.....+... ..++||||++++++... +.. ..++......++.+++.++.++|+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~ 135 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQ 135 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHH
Confidence 544443332 34899999998865432 332 235667788899999999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-13 Score=124.05 Aligned_cols=117 Identities=36% Similarity=0.477 Sum_probs=101.7
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+.+|..++.+++|+.|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++...-|+.+.
T Consensus 425 sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~ 502 (565)
T KOG0472|consen 425 SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK 502 (565)
T ss_pred ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence 456778888999999999999888 89999999999999999999987 7888877777777777777888755555699
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++.+|.+||+.+|.+. .+|+.++++++|++|++.+|+|.
T Consensus 503 nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 503 NMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999999996 79999999999999999999997
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.1e-12 Score=114.49 Aligned_cols=176 Identities=24% Similarity=0.361 Sum_probs=114.9
Q ss_pred HhccCCCCCceeEEEEEEeC-----CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----
Q 040641 232 TLGKVKHQNLVLLLGYCSFD-----EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301 (435)
Q Consensus 232 ~l~~l~H~niv~l~g~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----- 301 (435)
-+-++-|.|||+++.|..+. ....++.|||+.|++..+|+........+......+++.||..||.|||+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34456799999999887543 34678999999999999998765545556666667899999999999997
Q ss_pred -------------cccccccccc--cCcc---------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCC
Q 040641 302 -------------DFGLARLISA--CETH---------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAK 357 (435)
Q Consensus 302 -------------DfGla~~~~~--~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~ 357 (435)
--|+-++-.. +..+ ......|-++|.|||+......+.++|||+||+..+||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 1122221100 0000 011124668999999998888889999999999999999887
Q ss_pred CCCCC-CcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 358 EPTGP-EFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 358 ~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.-... +.......++. .+.... .+-++ ...+..|++..|..||+|.+++.
T Consensus 280 iq~tnseS~~~~ee~ia-~~i~~l-----en~lq---------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIA-NVIIGL-----ENGLQ---------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhhhh-hheeec-----cCccc---------------cCcCcccccCCCCCCcchhhhhc
Confidence 54221 11100000000 000000 01011 23566799999999999998763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3e-13 Score=123.75 Aligned_cols=113 Identities=30% Similarity=0.438 Sum_probs=56.1
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCcc-CCCCCCeEECcCcccCCcCCCcC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG-NLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
|+||++++.+.+|..|||..|++. .+| +|+++..|..|+++.|+++ .+|.+.. ++++|..|||..|+++ +.|+++
T Consensus 196 ~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 196 ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence 344555555555555555555554 444 4555555555555555554 4444433 4455555555555554 455555
Q ss_pred CCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcc
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l 121 (435)
+-+.+|..||+|+|.++ .+|.++|++ .|..|.+.+|.+
T Consensus 272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCch
Confidence 55555555555555554 344445555 455555555544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-12 Score=131.69 Aligned_cols=223 Identities=21% Similarity=0.230 Sum_probs=140.5
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEccccc-cccHHHHHHHHHH--hccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK-TQGHRQFTAEMET--LGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+...+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+-..+...|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6788899999999999999998887 8899885544 3344555554333 5566999999988777777777888888
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc--cccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI--SACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~--~~~~~ 314 (435)
+.+ +|.+.|.- ...+......-|+.|+..|+.=+|. ||.--|.. ..++.
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 854 66666542 2345566667788899888877774 66544432 11111
Q ss_pred c-----ccccccccCCCcCCcCCCC----------CC-CCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHH
Q 040641 315 H-----VSTDIAGTLGYIPPEYGQS----------RM-STTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 315 ~-----~~~~~~gt~~y~aPE~~~~----------~~-~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~ 377 (435)
. ..|... -.+|+|||.+.. .. .+++.||||.||++.|+++- ++||.- ..+.. +
T Consensus 178 adf~fFFDTSrR-RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~a--Y 247 (1431)
T KOG1240|consen 178 ADFTFFFDTSRR-RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLA--Y 247 (1431)
T ss_pred ccceEEEecCCc-eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHh--H
Confidence 1 111111 236999995433 12 57899999999999999985 555531 01111 1
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 430 (435)
+... ....+.+-..+... .+..+++.+++.||++|-++++.++.=
T Consensus 248 r~~~-~~~~e~~Le~Ied~-------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDV-------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred hccC-ccCHHHHHHhCcCc-------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1110 00000000000111 233556667788999999999998763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.5e-11 Score=106.65 Aligned_cols=108 Identities=12% Similarity=0.179 Sum_probs=79.7
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-----CCCCceeEEEEEEeCC---eeE-
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-----KHQNLVLLLGYCSFDE---EKL- 255 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~- 255 (435)
++-.+.||+|+||.||. +++....+||++........+.+.+|+++++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44567899999999996 544333479988654444557799999999999 5799999999998863 333
Q ss_pred EEEec--ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhcc-ceeec
Q 040641 256 LVYEY--MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL-AFLHQ 301 (435)
Q Consensus 256 lv~ey--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~ 301 (435)
+|||| +++|+|.+++.+.. +++. ..++.++..++ +|||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~ 123 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLD 123 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHH
Confidence 78999 66899999996531 3333 24456666666 78875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-11 Score=108.16 Aligned_cols=104 Identities=13% Similarity=0.210 Sum_probs=83.1
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEccccccc--------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ--------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 5778999976532211 124578899999999999998877777778889999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
++|++|.+++... .+ .+..++.+++.++.++|+
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~ 113 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS 113 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh
Confidence 9999999988642 11 677888889988888875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-11 Score=103.18 Aligned_cols=161 Identities=15% Similarity=0.096 Sum_probs=109.2
Q ss_pred ceeeeecccCcceEEEEEcCCCCEEEEEEccccccc----cHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEec
Q 040641 186 TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ----GHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.....|++|+||+||.+.. .+..++.+.+.....- ....|.+|+++|+++. |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 5778887877654321 1235889999999995 5889999886 456999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCcc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACETH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~~ 315 (435)
++|.+|...+.. . ...+..++++++.++|+ |||+|........-
T Consensus 80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998654321 0 12355666777777774 88888743321100
Q ss_pred ----c--------cccccccCCCcCCcCCCCC-CCC-CcccchhHHHHHHHHHhCCCCCCC
Q 040641 316 ----V--------STDIAGTLGYIPPEYGQSR-MST-TRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 316 ----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
. ..-...++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0012357788888743221 222 456777999999999999998654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=118.44 Aligned_cols=104 Identities=17% Similarity=0.153 Sum_probs=80.1
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEE-ccccc-c------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKK-FSQAK-T------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~-~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
+...+.||+|+||.||+|.+.... +++|+ ..... . ...+.+.+|++++.+++|++++....++......++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred cCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 355789999999999999876543 33433 22111 0 123468899999999999999988888888788899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
||||+++++|.+++. ....++.++++++.|||+
T Consensus 414 v~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~ 446 (535)
T PRK09605 414 VMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK 446 (535)
T ss_pred EEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh
Confidence 999999999998875 235678889999998886
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-11 Score=107.78 Aligned_cols=215 Identities=20% Similarity=0.237 Sum_probs=120.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCC----------CCceeEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKH----------QNLVLLLGY 247 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~ 247 (435)
...+...+.||.|+|+.||.+++. +|+.+|||.+.... ....+++.+|.-....+.+ -.++--++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 346778899999999999999976 48999999874322 2345677777766655433 111111111
Q ss_pred ---------EEeCC--------eeEEEEecccCCCHHHHHH---hhCCCCCCCCHHHHHHHHHHhhhccceeec------
Q 040641 248 ---------CSFDE--------EKLLVYEYMVNGSLDLWLR---NATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301 (435)
Q Consensus 248 ---------~~~~~--------~~~lv~ey~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------ 301 (435)
..... ..+++|.-+ -++|.+++. .....+..+....++.+..|+.+-+++||+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 11111 235666666 568877643 322222234455666777888887777775
Q ss_pred ccccccccccc---------------CccccccccccCCCcCCcCCCC--------CCCCCcccchhHHHHHHHHHhCCC
Q 040641 302 DFGLARLISAC---------------ETHVSTDIAGTLGYIPPEYGQS--------RMSTTRGDVYSFGVILLELVTAKE 358 (435)
Q Consensus 302 DfGla~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~SfGvil~El~tg~~ 358 (435)
|+-...++-.. ...... ...+..|.+||.... -.++.+.|.|++|+++|.|.+++.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 33222221110 011111 234567999996432 357889999999999999999999
Q ss_pred CCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCC
Q 040641 359 PTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR 420 (435)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 420 (435)
||+....+..... ....+ . +....+..++..-++.||++|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFSRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGTTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cchhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 9864422211100 11111 1 344456677778899999887
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.7e-11 Score=105.05 Aligned_cols=108 Identities=16% Similarity=0.227 Sum_probs=78.8
Q ss_pred eecccCcceEEEEEcCCCCEEEEEEccccccc--------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 190 ILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ--------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
.||+|+||.||+|.+ ++..|++|........ ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999985 5678999986432110 1245778999999999988766555666677789999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------cccccccc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------DFGLARLI 309 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------DfGla~~~ 309 (435)
+|++|.+++.... . .++.+++++|.++|+ |+....++
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil 122 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAGIVHGDLTTSNII 122 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCCeecCCCCcceEE
Confidence 9999998875421 0 567777777777764 55554443
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.9e-11 Score=122.07 Aligned_cols=174 Identities=21% Similarity=0.260 Sum_probs=127.9
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCC---CCCceeEEEEEEeCCee
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK---HQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 254 (435)
++.....|.+...+|+|+||.||+|...+|+.||+|.=+.... -+|.-=.+++.+|+ -+-|..+..++...+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3344567888899999999999999988899999998654321 22333334444554 13344555555667888
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------------cc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------DF 303 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------Df 303 (435)
++|+||.+.|+|.+++. ....++|.....+++++++=++.||. ||
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999886 23457777777777777776666664 88
Q ss_pred cccccccccC-ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCC
Q 040641 304 GLARLISACE-THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKE 358 (435)
Q Consensus 304 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~ 358 (435)
|.+-.+.--. .......++|-++-.+|...++..+..+|-|.++.+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 8775443211 123345678889999999999999999999999999999999873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.4e-11 Score=125.56 Aligned_cols=143 Identities=21% Similarity=0.310 Sum_probs=95.9
Q ss_pred ccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|..++++..|+||.||..+++. .+.+|+ ++++... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee------------------
Confidence 3578889999999999999998864 567888 4443221 1111 33333444443
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC---
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE--- 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~--- 313 (435)
|+=...++... .++.. .+.+++|+|+ |||+++......
T Consensus 136 ---gDc~tllk~~g----~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG----PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCC----CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333333221 12111 1557888886 999987532100
Q ss_pred -----------ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 040641 314 -----------THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ 365 (435)
Q Consensus 314 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~ 365 (435)
......++||+.|+|||++..+.|+..+|.|++|+|+||.+-|..||+.+..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 1112346899999999999999999999999999999999999999976543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-12 Score=121.38 Aligned_cols=119 Identities=28% Similarity=0.186 Sum_probs=86.9
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
|-.+.++++|+|+.|+++..--..+.+|+.|+.|+||+|.++..-++++..+++|+.||||+|+++..-+..|..|+.|+
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 45566777888888888766666777888888888888888766677788888888888888888765556676777777
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
.|+|++|.+...--..|..+.+|+.|||++|.+++.|..
T Consensus 345 ~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 345 ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 777777777644444566667777777777777666544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-11 Score=124.46 Aligned_cols=230 Identities=20% Similarity=0.235 Sum_probs=155.2
Q ss_pred ccCcceeeeecccCcceEEEEEcCC--CCEEEEEEccccc--cccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD--GKTVAVKKFSQAK--TQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 256 (435)
...+.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4456677779999999998886532 4467777775543 122234455788777787 9999999999999999999
Q ss_pred EEecccCCCHHHHH-HhhCCCCCCCCHHHHHHHHHHhhhccceee-c-------------------------cccccccc
Q 040641 257 VYEYMVNGSLDLWL-RNATGSHEVLDRAKRYKIACSSARGLAFLH-Q-------------------------DFGLARLI 309 (435)
Q Consensus 257 v~ey~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~-------------------------DfGla~~~ 309 (435)
++||..+|++...+ .... ...+....-....++..|+.|+| . |||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988776 3221 12333344557888999999999 3 89998765
Q ss_pred cc--cCccccccccc-cCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 310 SA--CETHVSTDIAG-TLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 310 ~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.. .........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...... .....|.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~----- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG----- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc-----
Confidence 44 22233345678 999999998877 456778999999999999999999986443322 11122211110
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
.....+ .........++..+++..+|+.|.+.+++.
T Consensus 249 ~~~~~~------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 RFTQLP------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccCc------cccCChhhhhcccccccCCchhcccccccc
Confidence 000000 011112334555567778999999887763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-10 Score=104.91 Aligned_cols=172 Identities=17% Similarity=0.192 Sum_probs=104.9
Q ss_pred CCCCceeEEEEEEe---------------------------CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHH
Q 040641 237 KHQNLVLLLGYCSF---------------------------DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIA 289 (435)
Q Consensus 237 ~H~niv~l~g~~~~---------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 289 (435)
+|||||++.++|.+ +...|+||.-.+ -+|..++-... .+.-.+.-|.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence 69999999987654 123578886553 47777775432 3334455688
Q ss_pred HHhhhccceeec----------------------------cccccccccccC-----ccccccccccCCCcCCcCCCCCC
Q 040641 290 CSSARGLAFLHQ----------------------------DFGLARLISACE-----THVSTDIAGTLGYIPPEYGQSRM 336 (435)
Q Consensus 290 ~~ia~gl~yLH~----------------------------DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~ 336 (435)
.|+.+|+.|||+ |||..---.... .....+..|...-||||+....+
T Consensus 348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 899999999985 888753211100 01112345778899999865422
Q ss_pred ------CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHh
Q 040641 337 ------STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAA 410 (435)
Q Consensus 337 ------~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 410 (435)
.-.|+|.|+.|.+.||+++...||+.. .++.+-...+ ++.+. |.+.+..+ ..+-+++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~r----Gem~L~~r~Y---qe~qL-----Palp~~vp----p~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR----GEMLLDTRTY---QESQL-----PALPSRVP----PVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCccccc----chheechhhh---hhhhC-----CCCcccCC----hHHHHHHH
Confidence 125899999999999999999999752 1111111111 11111 11111111 12335555
Q ss_pred cccCCCCCCCCCHHHHHHHH
Q 040641 411 DCVADNPATRPTMLHVLKLL 430 (435)
Q Consensus 411 ~C~~~~P~~RPs~~evl~~L 430 (435)
.-++.||++||+..-..+.|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 66889999999976555544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-11 Score=118.95 Aligned_cols=121 Identities=24% Similarity=0.209 Sum_probs=68.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCC-----------------------
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLS----------------------- 64 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~----------------------- 64 (435)
++.+|+.|+.|+||+|.|...-++++...+.|+.|+||+|+++..-+.+|..++.|+
T Consensus 288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL 367 (873)
T KOG4194|consen 288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL 367 (873)
T ss_pred cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh
Confidence 455677777777777777766666666667777777777777644444454444444
Q ss_pred -eEECcCcccCCcCCC---cCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 65 -HLDLSSNFFDGGWPR---SLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 65 -~L~l~~n~l~~~~p~---~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
.|||++|.+++.+-+ .|.+|+.|+.|++.+|++...--..|..+..|++|||.+|.+...-|..
T Consensus 368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nA 435 (873)
T KOG4194|consen 368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNA 435 (873)
T ss_pred hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccc
Confidence 455555554433322 2444555555666666554322234556666666666666555444433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-11 Score=118.65 Aligned_cols=121 Identities=33% Similarity=0.500 Sum_probs=90.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+++|..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|.+||.+.|.+. .+|..+++
T Consensus 112 ~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~ 187 (722)
T KOG0532|consen 112 TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGY 187 (722)
T ss_pred ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhh
Confidence 37888899999999999999988 8888888876 888888888887 68888887788888888888876 45555555
Q ss_pred CCC----------------------CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 84 LSY----------------------STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 84 l~~----------------------L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
+.+ |..||+++|+++ .||..|.+|..|++|-|.+|.|. +.|..+|
T Consensus 188 l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 188 LTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred HHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 443 556677777765 57777777777777777777666 3344444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-10 Score=97.31 Aligned_cols=109 Identities=32% Similarity=0.451 Sum_probs=41.4
Q ss_pred ccCCCCCCeeecCCCcccccCCcccC-CCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC-CCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLG-QLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL-GNLSY 86 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~ 86 (435)
+.+..+++.|+|++|.|+ .+. .++ .+.+|+.|+||+|.++ .++ .+..+++|+.|++++|.++. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 556668999999999998 554 566 6899999999999998 454 57889999999999999984 54444 35899
Q ss_pred CCEEeCCCCCCcccC-CccccCcCCCCcccccCCcce
Q 040641 87 STYLDLHDNKFTREI-PQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 87 L~~L~l~~n~~~~~~-p~~~~~l~~L~~l~l~~n~l~ 122 (435)
|++|++++|++...- -..+..+++|+.|++.+|+++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 999999999986321 134677899999999999775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-09 Score=90.73 Aligned_cols=101 Identities=22% Similarity=0.182 Sum_probs=77.6
Q ss_pred eeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCC--CCceeEEEEEEeCCeeEEEEecccCC
Q 040641 187 LVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH--QNLVLLLGYCSFDEEKLLVYEYMVNG 264 (435)
Q Consensus 187 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~ey~~~g 264 (435)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35678999999999999754 7899999865433 4578899999999987 58999999888888899999999988
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.+..+ +......++.+++++++++|.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~ 104 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQ 104 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhC
Confidence 76533 334445566666666665553
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-09 Score=112.78 Aligned_cols=40 Identities=20% Similarity=0.274 Sum_probs=20.3
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
|+.|++++|+++ .+|..++++++|+.+++++|+|+|.+|.
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 334444444443 3455555555555555555555555444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-09 Score=95.62 Aligned_cols=103 Identities=17% Similarity=0.137 Sum_probs=72.6
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccccc----------------------cHHHHHHHHHHhccCCCCC--
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ----------------------GHRQFTAEMETLGKVKHQN-- 240 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n-- 240 (435)
+.+.+.||+|+||.||+|...+|+.||||.++..... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5667899999999999999888999999986532100 0123677899999998874
Q ss_pred ceeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 241 iv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+...++. ...++||||+++++|...... .....++.++++++.++|+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH
Confidence 4444442 455899999999998765321 1233566677777766664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-09 Score=97.31 Aligned_cols=110 Identities=15% Similarity=0.147 Sum_probs=78.8
Q ss_pred CcceeeeecccCcceEEEEE--cCCCCEEEEEEccccccc------------------------cHHHHHHHHHHhccCC
Q 040641 184 KLTLVDILEDGGFGTVYKAT--LPDGKTVAVKKFSQAKTQ------------------------GHRQFTAEMETLGKVK 237 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 237 (435)
.|.+.+.||+|+||.||+|+ ..+|+.||||.++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999998 567999999988643210 0123568999999997
Q ss_pred CCC--ceeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 238 HQN--LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 238 H~n--iv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+.. +.+++++ ...++||||+++++|..+.... ..........++.+++.++.|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh
Confidence 633 3344433 2358999999998886554221 124445567889999999999885
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.8e-10 Score=76.41 Aligned_cols=59 Identities=39% Similarity=0.528 Sum_probs=30.7
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcc
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~ 72 (435)
+|+.|++++|+++..-+..|.++++|++|++++|.++...|..|..+++|++|++++|.
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555553333345555555555555555554333445555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-09 Score=75.38 Aligned_cols=61 Identities=38% Similarity=0.524 Sum_probs=46.3
Q ss_pred CCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCC
Q 040641 37 GGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKF 97 (435)
Q Consensus 37 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 97 (435)
++|+.|++++|+++...+..|..+++|++|++++|.++..-|..|.++++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888744345678888888888888888766666778888888888888764
|
... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8e-11 Score=118.49 Aligned_cols=107 Identities=36% Similarity=0.479 Sum_probs=74.5
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
.+.|+.|+|-+|.|+...-+.+.+..+|+.|+|++|++. .+|.+ +.++..|+.|+||+|+|+ .+|..+.+++.|++|
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 345667777777777666666777777777777777775 45554 566677777777777776 567777777777777
Q ss_pred eCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 91 DLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 91 ~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
...+|++. ..| ++.++++|+.+|+|.|+++
T Consensus 436 ~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 436 RAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred hhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 77777764 566 6667777777777777664
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.84 E-value=1e-08 Score=112.73 Aligned_cols=118 Identities=24% Similarity=0.279 Sum_probs=72.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+ ...+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..++++
T Consensus 604 lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L 680 (1153)
T PLN03210 604 MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYL 680 (1153)
T ss_pred CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhcc
Confidence 44444 3456666777766665 566666667777777776655444555 36666677777777665555667667777
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|+.|++++|.....+|..+ ++++|+.|++++|...+.+|
T Consensus 681 ~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 681 NKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred CCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence 777777777665445666654 56666666666654433333
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.1e-10 Score=99.80 Aligned_cols=114 Identities=29% Similarity=0.278 Sum_probs=88.9
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
|++-.++.....|+.||||+|.++ .+.+++.-++.++.|++|+|.+. .+ .++..+++|+.||||+|.++ .+-.+=-
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHh
Confidence 444444555567899999999998 88999999999999999999997 33 45888999999999999987 3333334
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
.+.+.++|.|++|.+. --+.++++-+|..||+++|++.
T Consensus 350 KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhcCEeeeehhhhhHh--hhhhhHhhhhheeccccccchh
Confidence 5667788899999874 2245778888899999999764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.5e-11 Score=113.68 Aligned_cols=121 Identities=33% Similarity=0.543 Sum_probs=106.5
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+|.+++.+..|..|.|..|.+. .+|..++++..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.
T Consensus 89 elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~ 164 (722)
T KOG0532|consen 89 ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL 164 (722)
T ss_pred cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc
Confidence 47777888888888999999987 89999999999999999999998 7999998888 999999999997 79999998
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
+..|..|+.+.|++. .+|+.++.+.+|+.|.+..|++. .+|.+++
T Consensus 165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~ 209 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC 209 (722)
T ss_pred chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh
Confidence 899999999999985 79999999999988888888876 4555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.3e-09 Score=89.69 Aligned_cols=106 Identities=31% Similarity=0.335 Sum_probs=51.0
Q ss_pred cccc-CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCc-cCCCCCCeEECcCcccCCcC-CCcCCC
Q 040641 7 SEFG-DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSL-GNLKGLSHLDLSSNFFDGGW-PRSLGN 83 (435)
Q Consensus 7 ~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~-p~~~~~ 83 (435)
+.++ .+.+|+.|+|++|.++ .++ .+..+++|+.|++++|+++ .+++.+ ..+++|+.|+|++|++...- -..+..
T Consensus 35 e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~ 111 (175)
T PF14580_consen 35 ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSS 111 (175)
T ss_dssp -S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG
T ss_pred cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHc
Confidence 4566 4789999999999998 565 5888999999999999998 566555 46899999999999997421 135667
Q ss_pred CCCCCEEeCCCCCCcccCCcc----ccCcCCCCcccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQN----LGNLAQLEHLDV 116 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~----~~~l~~L~~l~l 116 (435)
+++|+.|++.+|.++. .+.. +..+++|+.||-
T Consensus 112 l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 112 LPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred CCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 8999999999999863 3332 456778887764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.1e-10 Score=112.84 Aligned_cols=110 Identities=30% Similarity=0.358 Sum_probs=93.5
Q ss_pred ccccCCCCCCeeecCCCcccccCCc-ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+-|-+.+.|+.|+|++|+|. .+|. .+.+|..|+.|+||+|+|+ .+|..+..+..|++|...+|++. ..| ++..++
T Consensus 377 p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~ 452 (1081)
T KOG0618|consen 377 PVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLP 452 (1081)
T ss_pred hhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcC
Confidence 44777889999999999998 6776 5789999999999999998 79999999999999999999997 678 889999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCc
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~ 120 (435)
.|+.+|++.|+++-..-..-...++|++||+++|.
T Consensus 453 qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 453 QLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999999874333333334799999999995
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-08 Score=105.71 Aligned_cols=104 Identities=32% Similarity=0.491 Sum_probs=66.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+. +.|+.|+|++|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|.+. .+|..+.
T Consensus 193 LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~-- 261 (754)
T PRK15370 193 IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP-- 261 (754)
T ss_pred CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--
Confidence 555443 36778888888887 5776554 47778888887777 4665443 35677777777766 5565543
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
.+|+.|++++|+++ .+|..+. .+|+.|++++|+|+
T Consensus 262 s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 262 SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 35667777777665 4565443 35666666666665
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-08 Score=105.74 Aligned_cols=104 Identities=32% Similarity=0.514 Sum_probs=76.5
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
||..+. .+|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|++++|.|+ .+|..+.
T Consensus 214 LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 214 LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 565554 48899999999998 6787654 47888899998887 6777654 47888888888887 4777664
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
.+|++|++++|+++ .+|..+. ++|+.|++++|.++
T Consensus 283 ~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 283 EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc
Confidence 47888888888887 4665442 35666667766665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.8e-08 Score=109.39 Aligned_cols=122 Identities=26% Similarity=0.326 Sum_probs=105.0
Q ss_pred cCCccccCCC-CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.+|..+..++ +|+.|++.+|.+. .+|..+ ...+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls 654 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS 654 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence 4677777764 6999999999887 888877 5789999999999997 7898999999999999998876667884 88
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
.+++|++|++++|.....+|..++++++|+.|++++|.....+|..+
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i 701 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI 701 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC
Confidence 89999999999998778999999999999999999986666777654
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.6e-08 Score=100.96 Aligned_cols=61 Identities=26% Similarity=0.410 Sum_probs=35.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 74 (435)
+||+.+.. +|+.|++++|+|+ .+|.. .++|++|+|++|+|+ .+|..+ ++|+.|+|++|.++
T Consensus 215 sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~lp---~sL~~L~Ls~N~L~ 275 (788)
T PRK15387 215 TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVLP---PGLLELSIFSNPLT 275 (788)
T ss_pred cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCcc---cccceeeccCCchh
Confidence 46766643 6777777777777 56642 466777777777776 455322 23444444444433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.8e-09 Score=93.79 Aligned_cols=115 Identities=27% Similarity=0.309 Sum_probs=94.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
|-++..-++.++.|++|+|.+. .+.. +..+++|+.||||+|.++ .+-..-..+-+...|.|+.|.+.. -+.++.+
T Consensus 299 iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KL 373 (490)
T KOG1259|consen 299 IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKL 373 (490)
T ss_pred hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhh
Confidence 3445566789999999999998 5554 899999999999999998 566666778899999999999873 2467888
Q ss_pred CCCCEEeCCCCCCcccC-CccccCcCCCCcccccCCcceec
Q 040641 85 SYSTYLDLHDNKFTREI-PQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
-+|..||+++|++...- -..+|+++-|+++.+.+|.+.+.
T Consensus 374 YSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 374 YSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 89999999999985211 24589999999999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.8e-08 Score=94.49 Aligned_cols=174 Identities=21% Similarity=0.225 Sum_probs=124.7
Q ss_pred cCcceeeeecc--cCcceEEEEEc---CCCCEEEEEEccc--cccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 183 LKLTLVDILED--GGFGTVYKATL---PDGKTVAVKKFSQ--AKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
..+.....+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+....++ .|+|.|+.+......+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35566778899 99999999986 3578899998432 2222333335677777777 499999988888899999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhh----ccceeec-------------------------cccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR----GLAFLHQ-------------------------DFGL 305 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~-------------------------DfGl 305 (435)
++-+|+|. .+|..+.+... ..++......+..+..+ |+..+|. |||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999985 77777766432 22444445555555556 9999996 7887
Q ss_pred cccccccCcc----ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 306 ARLISACETH----VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 306 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
...+...+.. ......|...|++||...+ .++.+.|+||+|.+..|..++...+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 7766544321 1122356778999998765 46788999999999999999887653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.9e-09 Score=102.09 Aligned_cols=117 Identities=23% Similarity=0.237 Sum_probs=60.5
Q ss_pred CccccCCCCCCeeecCCCcccc------cCCcccCCCCCCcEEECCCCcCccCCCcCccCCCC---CCeEECcCcccCC-
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTG------SIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG---LSHLDLSSNFFDG- 75 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g------~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~---L~~L~l~~n~l~~- 75 (435)
+..+...+.|+.|+++++.+.+ .++..+..+++|+.|++++|.+.+..+..+..+.+ |+.|++++|.+++
T Consensus 44 ~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~ 123 (319)
T cd00116 44 ASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123 (319)
T ss_pred HHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchH
Confidence 3344455556666666665541 22334455566666666666665444444443333 6666666666552
Q ss_pred ---cCCCcCCCC-CCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCcce
Q 040641 76 ---GWPRSLGNL-SYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 76 ---~~p~~~~~l-~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
.+...+..+ ++|+.|++++|.+++. ++..+..+.+|+.|++++|.++
T Consensus 124 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCc
Confidence 122233344 5566666666665522 2223444455666666666555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.3e-09 Score=100.44 Aligned_cols=119 Identities=25% Similarity=0.264 Sum_probs=91.2
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCC---CcEEECCCCcCcc----CCCcCccCC-CCCCeEECcCcccCCc
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGG---LVKLNLTRNKFSG----PVPTSLGNL-KGLSHLDLSSNFFDGG 76 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~---L~~L~ls~n~l~~----~~p~~~~~l-~~L~~L~l~~n~l~~~ 76 (435)
++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|++++|.+++ .+...+..+ ++|+.|++++|.+++.
T Consensus 73 ~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 152 (319)
T cd00116 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA 152 (319)
T ss_pred HHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCch
Confidence 4456777889999999999998767766666665 9999999999873 233455666 8899999999998843
Q ss_pred ----CCCcCCCCCCCCEEeCCCCCCcc----cCCccccCcCCCCcccccCCccee
Q 040641 77 ----WPRSLGNLSYSTYLDLHDNKFTR----EIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 77 ----~p~~~~~l~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++..+..+..|++|++++|.+++ .++..+..+++|+.|++++|.+++
T Consensus 153 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 34456667889999999999874 244445566789999999998764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.6e-08 Score=83.27 Aligned_cols=107 Identities=19% Similarity=0.231 Sum_probs=66.3
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccc--cHHH----------------------HHHHHHHhccCCCCC--c
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ--GHRQ----------------------FTAEMETLGKVKHQN--L 241 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 241 (435)
.+.||+|+||.||+|...+++.||||.+...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4678999999999999888999999988643211 1111 134566666654433 3
Q ss_pred eeEEEEEEeCCeeEEEEecccCCCHHH-HHHhhCCCCCCCCHHHHHHHHHHhhhccceeecccc
Q 040641 242 VLLLGYCSFDEEKLLVYEYMVNGSLDL-WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQDFG 304 (435)
Q Consensus 242 v~l~g~~~~~~~~~lv~ey~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~DfG 304 (435)
.+.+++ ...++||||+++|.+.. .+.... .. .....++.+++.++.++|...|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC
Confidence 444433 34689999999965321 121110 00 3455677888888887776333
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.7e-08 Score=94.03 Aligned_cols=115 Identities=36% Similarity=0.484 Sum_probs=90.5
Q ss_pred cCCccccCCC-CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.||+..+.++ +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|++. .+|..+.
T Consensus 130 ~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~ 206 (394)
T COG4886 130 DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE 206 (394)
T ss_pred cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhh
Confidence 3666677774 8899999999988 78788888999999999999998 67877778888899999999887 6777666
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
.+..|++|.+++|... .++..+.++..+..+.+..|++.
T Consensus 207 ~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 207 LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence 6667888888888543 46666777777777777777654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.3e-08 Score=93.81 Aligned_cols=109 Identities=39% Similarity=0.569 Sum_probs=97.0
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCC-CCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLG-GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~-~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
.+..++.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..+..+++|+.|++++|.++ .+|...+.++.
T Consensus 111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~ 187 (394)
T COG4886 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187 (394)
T ss_pred hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence 3455678999999999999 8998888885 9999999999998 78888999999999999999998 68877778999
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~ 120 (435)
|+.|++++|+++ .+|........|+.+.+++|.
T Consensus 188 L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999999997 788877677789999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=79.22 Aligned_cols=104 Identities=15% Similarity=0.164 Sum_probs=72.9
Q ss_pred eeeec-ccCcceEEEEEcCCCCEEEEEEccccc-------------cccHHHHHHHHHHhccCCCCCc--eeEEEEEEeC
Q 040641 188 VDILE-DGGFGTVYKATLPDGKTVAVKKFSQAK-------------TQGHRQFTAEMETLGKVKHQNL--VLLLGYCSFD 251 (435)
Q Consensus 188 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 251 (435)
..++| .|+.|+||++... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 6789999875311 0122457889999999999885 6677765433
Q ss_pred Ce----eEEEEecccC-CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 252 EE----KLLVYEYMVN-GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 252 ~~----~~lv~ey~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.. .++||||+++ .+|.+++... .++.. ...++++++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~ 160 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD 160 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH
Confidence 22 2599999997 6998887542 23332 24567777887775
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.2e-06 Score=82.83 Aligned_cols=144 Identities=17% Similarity=0.209 Sum_probs=93.5
Q ss_pred cCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHH
Q 040641 204 LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRA 283 (435)
Q Consensus 204 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~ 283 (435)
..++.+|.|...+...........+-++.|+.+|||||++++......+..|||+|-+. .|..++.... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------KE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------HH
Confidence 34678888888866554344556778899999999999999999999999999999874 5666776532 23
Q ss_pred HHHHHHHHhhhccceeecccccccc--------ccccC------ccccccccccC----------CCcCCcCCCCCCCCC
Q 040641 284 KRYKIACSSARGLAFLHQDFGLARL--------ISACE------THVSTDIAGTL----------GYIPPEYGQSRMSTT 339 (435)
Q Consensus 284 ~~~~i~~~ia~gl~yLH~DfGla~~--------~~~~~------~~~~~~~~gt~----------~y~aPE~~~~~~~~~ 339 (435)
...-.+.||+.||.|||+|-++..- +.... ........|+. .|..|+.+.... -
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence 3444678999999999976544321 00000 00000111221 133343322111 2
Q ss_pred cccchhHHHHHHHHHhCCC
Q 040641 340 RGDVYSFGVILLELVTAKE 358 (435)
Q Consensus 340 k~DV~SfGvil~El~tg~~ 358 (435)
..|.|-||+++||++.|..
T Consensus 183 s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred chhhhhHHHHHHHHhCccc
Confidence 3599999999999999943
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2e-08 Score=79.04 Aligned_cols=110 Identities=25% Similarity=0.294 Sum_probs=77.9
Q ss_pred CCCeeecCCCcccccCCccc---CCCCCCcEEECCCCcCccCCCcCccCC-CCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 14 KLQGLYLGNNQLTGSIPRSL---GQLGGLVKLNLTRNKFSGPVPTSLGNL-KGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~---~~l~~L~~L~ls~n~l~~~~p~~~~~l-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
.+..++|+++++- .+++.. ....+|+..+|++|.|. ..|+.|... +-++.|+|++|.++ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3455777877763 555543 34455666688888887 567666543 46788888888887 68888888888888
Q ss_pred EeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 90 LDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 90 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|+++.|.+. ..|.-+..|.+|..|+.-+|... .+|..
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 888888886 56666777778888887777654 44443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-08 Score=92.24 Aligned_cols=116 Identities=24% Similarity=0.281 Sum_probs=92.9
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcC-cccCCcCCCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSS-NFFDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~ 83 (435)
+|.++.. .-+.|+|..|+|+...|..|+.+.+|+.||||+|+++-.-|.+|.++++|..|-+-+ |+|+..--..|++
T Consensus 61 VP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~g 138 (498)
T KOG4237|consen 61 VPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGG 138 (498)
T ss_pred CcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhh
Confidence 4544432 456799999999955556899999999999999999987888999999876655544 8898433357889
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
|..|+-|.+.-|++.-.....|..+++|..|.+.+|.+.
T Consensus 139 L~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q 177 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ 177 (498)
T ss_pred HHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh
Confidence 999999999999988666677888999999999888775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.2e-07 Score=87.67 Aligned_cols=84 Identities=21% Similarity=0.189 Sum_probs=57.5
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEcccccccc----------------------------------------HHHHHH
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG----------------------------------------HRQFTA 228 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 228 (435)
+.||.|++|.||+|++.+|+.||||+.+...... .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999999999999999985421000 012556
Q ss_pred HHHHhccC----CCCCceeEEEEEE-eCCeeEEEEecccCCCHHHHHHh
Q 040641 229 EMETLGKV----KHQNLVLLLGYCS-FDEEKLLVYEYMVNGSLDLWLRN 272 (435)
Q Consensus 229 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~ey~~~g~L~~~l~~ 272 (435)
|++.+.++ +|.+-|.+-.++. .....+|||||++|++|.++...
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~ 251 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL 251 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH
Confidence 66666555 3444444434332 23457999999999999887653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.1e-07 Score=78.94 Aligned_cols=108 Identities=19% Similarity=0.199 Sum_probs=83.1
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCC--CceeEEEEEEeC---CeeEEEEeccc
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQ--NLVLLLGYCSFD---EEKLLVYEYMV 262 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~ey~~ 262 (435)
+.++.|.++.||+++..+|+.+++|....... .....+.+|.+++..+++. ++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56799999999999887778999998764332 1345688999999998763 456777776653 25689999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
++++...+.. ..++...+..++.++++.+++||+
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 9887654321 236777888899999999999997
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.7e-07 Score=86.44 Aligned_cols=100 Identities=26% Similarity=0.250 Sum_probs=73.8
Q ss_pred CcccccCCc-ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccC
Q 040641 23 NQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREI 101 (435)
Q Consensus 23 n~l~g~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 101 (435)
....+..|. .|..|++|+.|+|++|++++.-+.+|.++.+++.|.|..|++...--..|.+++.|++|+|.+|+++-.-
T Consensus 259 d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~ 338 (498)
T KOG4237|consen 259 DFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVA 338 (498)
T ss_pred cCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEe
Confidence 333334443 4677888888888888887666667888888888888888877555556777788888888888888777
Q ss_pred CccccCcCCCCcccccCCcce
Q 040641 102 PQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 102 p~~~~~l~~L~~l~l~~n~l~ 122 (435)
|..|..+..|.++++-.|.+.
T Consensus 339 ~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 339 PGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cccccccceeeeeehccCccc
Confidence 777877888888888777664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.2e-06 Score=85.48 Aligned_cols=116 Identities=17% Similarity=0.151 Sum_probs=69.8
Q ss_pred CcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccc----------------------------------cH-----
Q 040641 184 KLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQ----------------------------------GH----- 223 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~----- 223 (435)
.|+. +.+|+|++|.||+|++++ |+.||||+++..-.. -.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4554 679999999999999887 999999998643100 00
Q ss_pred -HHHHHHHHHhccCC----CCCceeEEEEEEe-CCeeEEEEecccCCCHHHHH--HhhCCCCCCCCHHHHHHHHHHhhhc
Q 040641 224 -RQFTAEMETLGKVK----HQNLVLLLGYCSF-DEEKLLVYEYMVNGSLDLWL--RNATGSHEVLDRAKRYKIACSSARG 295 (435)
Q Consensus 224 -~~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lv~ey~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~ia~g 295 (435)
-+|.+|+..+.+++ +.+.|.+-.++.+ ....+|||||++|+.+.++- .........+.......+..|+.+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~- 278 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR- 278 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-
Confidence 12455665555543 4444554444432 35678999999999997742 221111112333333344555553
Q ss_pred cceeec
Q 040641 296 LAFLHQ 301 (435)
Q Consensus 296 l~yLH~ 301 (435)
-.+.|.
T Consensus 279 ~GffHa 284 (537)
T PRK04750 279 DGFFHA 284 (537)
T ss_pred CCeeeC
Confidence 567775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-07 Score=93.17 Aligned_cols=180 Identities=21% Similarity=0.221 Sum_probs=112.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc---ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
...+.+.+-+-+|.++.++-+.-. .|...+.|..... ...+.+...++-.++-..+||-+++..--+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345566667788999998877532 2433444433221 222223333444444445667777655444556788999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc--
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA-- 311 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~-- 311 (435)
++|..+|+|...++......... .......+..+.+|||. |||..+....
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saep----aRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEP----ARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hHHhccCCchhhhhcCCCccccc----ccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 99999999999988754222111 11223334456677764 5653221100
Q ss_pred ----------------------------cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 312 ----------------------------CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 312 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
++........||+.|.|||...+......+|.|++|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0001122357999999999999999999999999999999999999998654
Q ss_pred cc
Q 040641 364 FQ 365 (435)
Q Consensus 364 ~~ 365 (435)
..
T Consensus 1039 tp 1040 (1205)
T KOG0606|consen 1039 TP 1040 (1205)
T ss_pred ch
Confidence 43
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.23 E-value=8e-07 Score=56.67 Aligned_cols=36 Identities=44% Similarity=0.623 Sum_probs=20.2
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCc
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFS 50 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~ 50 (435)
+|++|+|++|+|+ .+|+.+++|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4566666666665 45555566666666666666555
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.1e-06 Score=82.69 Aligned_cols=172 Identities=19% Similarity=0.178 Sum_probs=118.2
Q ss_pred ccccCcceeeeecccCcceEEEEEc--CCCCEEEEEEccccccccHH--HHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL--PDGKTVAVKKFSQAKTQGHR--QFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
....+|..+..||.|.|+.|++... .++..+++|.+......... .-..|+.+...+ .|.++++....+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999864 35788999988654322211 123455555444 588888887777777788
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLI 309 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~ 309 (435)
|+=-|||+++++...+.- ...++...++++..+++.++.++|+ |||.+.-+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 899999999998765521 2357777888999999999999996 23332211
Q ss_pred cccCccccccccccCCCc--CCcCCCCCCCCCcccchhHHHHHHHHHhCCCC
Q 040641 310 SACETHVSTDIAGTLGYI--PPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p 359 (435)
. .......++-+++ +|+......+..++|+||||.-+.|.+++..-
T Consensus 418 ~----~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 418 A----FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred c----eecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 0 0001112233444 45555666788899999999999999998753
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.8e-08 Score=76.50 Aligned_cols=114 Identities=23% Similarity=0.274 Sum_probs=84.0
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCC-CCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQL-GGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l-~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
.....|+..+|++|.|. ..|+.|... +.++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|.
T Consensus 50 ~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 50 SKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLD 126 (177)
T ss_pred hCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHH
Confidence 34455667799999988 677776654 47889999999998 78988989999999999999987 5777777788888
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
.|+..+|... +||-.+---++....++.++.+.+..|.
T Consensus 127 ~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 127 MLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred HhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 8888888774 6776543333444555666666554443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.1e-07 Score=94.63 Aligned_cols=102 Identities=34% Similarity=0.386 Sum_probs=52.7
Q ss_pred CCCeeecCCCc--ccccCCc-ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 14 KLQGLYLGNNQ--LTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 14 ~L~~L~l~~n~--l~g~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
.|++|-+..|. +. .++. .|..++.|++||||+|.=-+.+|.+++.|-+|++|||+...+. .+|..+++|..|.+|
T Consensus 546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 45555555553 32 2222 2444555555555555444455555555555555555555554 455555555555555
Q ss_pred eCCCCCCcccCCccccCcCCCCccccc
Q 040641 91 DLHDNKFTREIPQNLGNLAQLEHLDVL 117 (435)
Q Consensus 91 ~l~~n~~~~~~p~~~~~l~~L~~l~l~ 117 (435)
|+..+.....+|.-...+.+|++|.+.
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred ccccccccccccchhhhcccccEEEee
Confidence 555554433444444445555555543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.2e-08 Score=95.25 Aligned_cols=101 Identities=35% Similarity=0.443 Sum_probs=49.4
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc-CCCCCCCCEEeCC
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS-LGNLSYSTYLDLH 93 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~l~ 93 (435)
|...+.+.|.+. .+..++.-+++|+.||||+|++. .+- .+..|++|.+|||++|.|. .+|.. -..+ .|..|++.
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 344455555555 45555555555555555555555 222 4555555555555555554 23321 1112 25555555
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcce
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+|.++. + ..+.+|.+|..||++.|-+.
T Consensus 241 nN~l~t-L-~gie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 241 NNALTT-L-RGIENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred ccHHHh-h-hhHHhhhhhhccchhHhhhh
Confidence 555431 1 22445555555555555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.4e-07 Score=88.38 Aligned_cols=167 Identities=20% Similarity=0.130 Sum_probs=114.1
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCC-ceeEEEEEEeCCeeEEEEeccc
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN-LVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+....-.++|+++++||.+-...+...++.+... ....-++++|.+++||| .|..++-+..++..+++|+|+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34444567999999999987543333335554322 33445889999999999 8888888888888999999999
Q ss_pred CC-CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeeccccccc-------------------cccccCccccccccc
Q 040641 263 NG-SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQDFGLAR-------------------LISACETHVSTDIAG 322 (435)
Q Consensus 263 ~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~DfGla~-------------------~~~~~~~~~~~~~~g 322 (435)
+| +-..-. . .....+...+...+...-+++++|+|++.+..+ .+.. ........+
T Consensus 318 ~~rs~~~~~-~--~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~--~~~~~t~~~ 392 (829)
T KOG0576|consen 318 TGRSSALEM-T--VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTR--TMKPRTAIG 392 (829)
T ss_pred CCccccccC-C--hhhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCc--ccccccCCC
Confidence 88 211100 0 011123334445566777899999998543333 1111 112234578
Q ss_pred cCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 323 t~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
|+.|+|||+.....+..+.|+||.|+--.++.-|-+|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999998877887777664
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.3e-06 Score=54.54 Aligned_cols=36 Identities=36% Similarity=0.586 Sum_probs=20.7
Q ss_pred CCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC
Q 040641 38 GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74 (435)
Q Consensus 38 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 74 (435)
+|++|++++|+++ .+|+.+++|++|+.|++++|.++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5566666666665 45555666666666666666655
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.4e-05 Score=76.81 Aligned_cols=161 Identities=24% Similarity=0.278 Sum_probs=101.6
Q ss_pred CcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeEEEEecccC-CCHHH
Q 040641 195 GFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKLLVYEYMVN-GSLDL 268 (435)
Q Consensus 195 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey~~~-g~L~~ 268 (435)
--.+.||+.. .||..|+.|++.............-+++++++.|+|||++..++.. +..+.+||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899974 5799999999954443333334456788999999999999988763 4567899999986 46654
Q ss_pred H-HHhhCC----------CCCCCCHHHHHHHHHHhhhccceeecccccc-------ccccccCccccccccccCCCcC--
Q 040641 269 W-LRNATG----------SHEVLDRAKRYKIACSSARGLAFLHQDFGLA-------RLISACETHVSTDIAGTLGYIP-- 328 (435)
Q Consensus 269 ~-l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~DfGla-------~~~~~~~~~~~~~~~gt~~y~a-- 328 (435)
+ ...... .....++...+.++.|++.||.++|+ =|+| |++...........||-..-+-
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3 222111 12235677888999999999999997 2333 2222211122222222211111
Q ss_pred C-cCCCCCCCCCcccchhHHHHHHHHHhCCCC
Q 040641 329 P-EYGQSRMSTTRGDVYSFGVILLELVTAKEP 359 (435)
Q Consensus 329 P-E~~~~~~~~~k~DV~SfGvil~El~tg~~p 359 (435)
| |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 447 ~~~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PTEPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCcchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 2 21222 2356888999999999999643
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.4e-06 Score=91.90 Aligned_cols=111 Identities=31% Similarity=0.332 Sum_probs=77.5
Q ss_pred CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCc--CccCCCcC-ccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK--FSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~--l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
+....+...+-+|.+. .++.... .+.|++|-+..|. +. .++.. |..++.|+.|||++|.=-+.+|..+++|-+|
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 3356677777777776 5554443 3367788777775 33 44443 6677888888888777666788888888888
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~ 125 (435)
++|++++..++ .+|..++++..|.+|++..+.....+
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~ 634 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI 634 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccc
Confidence 88888888876 68888888888888888766543333
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.7e-07 Score=92.66 Aligned_cols=109 Identities=29% Similarity=0.298 Sum_probs=86.4
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
++.-++.|+.|||++|+++ ... .+..++.|++|||+.|++. .+|.- ...|+ |+.|+|++|.++.. ..+.+|.+
T Consensus 182 SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhh
Confidence 3444678999999999998 333 7889999999999999998 78863 44555 99999999999743 35778999
Q ss_pred CCEEeCCCCCCcccCCc-cccCcCCCCcccccCCcce
Q 040641 87 STYLDLHDNKFTREIPQ-NLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~l~ 122 (435)
|+.||++.|-+.+.--- .++.|..|..|+|.+|.+.
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999999988753321 2456778899999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.8e-06 Score=82.47 Aligned_cols=103 Identities=31% Similarity=0.359 Sum_probs=44.0
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
.+..+++..|.+. .+-..++.+++|..|++.+|++. .+...+..+.+|++|||++|.++... .+..+..|+.|+++
T Consensus 73 ~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheec
Confidence 3344444444444 22233444444555555555544 23322444445555555555544221 22333444445555
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcce
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+|.++ .+ ..+..+..|+.+++++|.+.
T Consensus 149 ~N~i~-~~-~~~~~l~~L~~l~l~~n~i~ 175 (414)
T KOG0531|consen 149 GNLIS-DI-SGLESLKSLKLLDLSYNRIV 175 (414)
T ss_pred cCcch-hc-cCCccchhhhcccCCcchhh
Confidence 55443 12 12233444444555554443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.6e-05 Score=66.34 Aligned_cols=77 Identities=16% Similarity=0.132 Sum_probs=55.9
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCce-eEEEEEEeCCeeEEEEecccCCCH
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV-LLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
.+.++.|.++.||+++.. ++.|++|....... ....+.+|+.++..+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356789999999999875 77899998754332 223567899999988766655 444443 3346899999999887
Q ss_pred HH
Q 040641 267 DL 268 (435)
Q Consensus 267 ~~ 268 (435)
..
T Consensus 79 ~~ 80 (170)
T cd05151 79 LT 80 (170)
T ss_pred cc
Confidence 53
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=9.6e-06 Score=79.66 Aligned_cols=109 Identities=30% Similarity=0.389 Sum_probs=89.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.++.+++|..|+|.+|+|. .+...+..+++|++|+||+|.++. +. .+..+..|+.|++++|.++. + ..+..+..|
T Consensus 90 ~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~-~l~~l~~L~~L~l~~N~i~~-~-~~~~~l~~L 164 (414)
T KOG0531|consen 90 HLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LE-GLSTLTLLKELNLSGNLISD-I-SGLESLKSL 164 (414)
T ss_pred ccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-cc-chhhccchhhheeccCcchh-c-cCCccchhh
Confidence 3778899999999999998 566558889999999999999985 33 46677789999999999973 3 356668999
Q ss_pred CEEeCCCCCCcccCCcc-ccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~n~l~ 122 (435)
+.+++++|.+. .+... ...+..++.+++..|.+.
T Consensus 165 ~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 165 KLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred hcccCCcchhh-hhhhhhhhhccchHHHhccCCchh
Confidence 99999999997 45442 467889999999999764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.53 E-value=1.6e-05 Score=74.68 Aligned_cols=115 Identities=23% Similarity=0.148 Sum_probs=72.7
Q ss_pred cccCCCCCCeeecCCCcccccCC--cccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCc-CCCcCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIP--RSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGG-WPRSLGN 83 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p--~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~-~p~~~~~ 83 (435)
....++.++.||||.|-|...-| .-...|++|+.|+||.|++.-..... -..+++|+.|.|+++.|+-. +-..+-.
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 35568889999999998875433 23456889999999999987433322 12457788888888877611 1112234
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+++|..|+|..|...+.-......+..|+.|||++|++-
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 567777777777422222223334556777777777653
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00016 Score=61.27 Aligned_cols=82 Identities=24% Similarity=0.222 Sum_probs=45.3
Q ss_pred CCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCc--ccCCccccCcCCCCccc
Q 040641 38 GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT--REIPQNLGNLAQLEHLD 115 (435)
Q Consensus 38 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~--~~~p~~~~~l~~L~~l~ 115 (435)
+...+||++|.+. .++ .|..+++|.+|.|++|+++..-|.----+++|..|.|.+|++. |.+ .-+..++.|+.|.
T Consensus 43 ~~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl-~pLa~~p~L~~Lt 119 (233)
T KOG1644|consen 43 QFDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDL-DPLASCPKLEYLT 119 (233)
T ss_pred ccceecccccchh-hcc-cCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhc-chhccCCccceee
Confidence 4556667776664 332 4556666677777777766433332223455666666666653 111 1234556666666
Q ss_pred ccCCcce
Q 040641 116 VLRNMLC 122 (435)
Q Consensus 116 l~~n~l~ 122 (435)
+-+|+.+
T Consensus 120 ll~Npv~ 126 (233)
T KOG1644|consen 120 LLGNPVE 126 (233)
T ss_pred ecCCchh
Confidence 6666543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00012 Score=68.93 Aligned_cols=111 Identities=24% Similarity=0.198 Sum_probs=70.5
Q ss_pred CCCCCCeeecCCCccccc-CCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCC--CcCCCCCCC
Q 040641 11 DSLKLQGLYLGNNQLTGS-IPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP--RSLGNLSYS 87 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p--~~~~~l~~L 87 (435)
.++.|+.|.|+.+.|+-. +-.-+-.+++|..|+|..|..-+.-..+..-+..|+.|||++|++- ..+ ...+.++.|
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccch
Confidence 456777888888887621 2223445778888888888532222223344566888888888875 233 456777888
Q ss_pred CEEeCCCCCCccc-CCcc-----ccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTRE-IPQN-----LGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~-~p~~-----~~~l~~L~~l~l~~n~l~ 122 (435)
..|+++.|.++.. +|.. ...+++|+.|+++.|++.
T Consensus 274 ~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 274 NQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 8888888776521 1221 245678888888888763
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00026 Score=62.45 Aligned_cols=89 Identities=22% Similarity=0.260 Sum_probs=47.6
Q ss_pred CCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCc--ccCCcCCCcCCCCCCCCEEeCCCCCCcccCCcc--
Q 040641 29 IPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN--FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-- 104 (435)
Q Consensus 29 ~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n--~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~-- 104 (435)
+..-.-....|+.|.+.+-.++. + ..+-.|++|+.|++|.| ...+.++.-.-.+++|++|++++|++. ++.+
T Consensus 35 ~~gl~d~~~~le~ls~~n~gltt-~-~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~--~lstl~ 110 (260)
T KOG2739|consen 35 LGGLTDEFVELELLSVINVGLTT-L-TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK--DLSTLR 110 (260)
T ss_pred cccccccccchhhhhhhccceee-c-ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc--cccccc
Confidence 44333444455555555544442 1 12345566777777777 444445444445567777777777664 2333
Q ss_pred -ccCcCCCCcccccCCcc
Q 040641 105 -LGNLAQLEHLDVLRNML 121 (435)
Q Consensus 105 -~~~l~~L~~l~l~~n~l 121 (435)
+..+.+|..|++.+|..
T Consensus 111 pl~~l~nL~~Ldl~n~~~ 128 (260)
T KOG2739|consen 111 PLKELENLKSLDLFNCSV 128 (260)
T ss_pred hhhhhcchhhhhcccCCc
Confidence 23445556666666643
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0012 Score=63.29 Aligned_cols=82 Identities=22% Similarity=0.451 Sum_probs=53.2
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCC-CcCccCCCcCccCCCCCCeEECcCc-ccCCcCCCcCCCCCCC
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDLSSN-FFDGGWPRSLGNLSYS 87 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~-n~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L 87 (435)
..+.+++.|++++|.++ .+|. + -.+|+.|.+++ +.+. .+|..+ .++|+.|++++| .+. .+|.. |
T Consensus 49 ~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nLt-sLP~~L--P~nLe~L~Ls~Cs~L~-sLP~s------L 114 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNLT-TLPGSI--PEGLEKLTVCHCPEIS-GLPES------V 114 (426)
T ss_pred HHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCcc-cCCchh--hhhhhheEccCccccc-ccccc------c
Confidence 34678899999999888 6772 2 23689999876 5554 566544 257889999888 444 56654 4
Q ss_pred CEEeCCCCCC--cccCCccc
Q 040641 88 TYLDLHDNKF--TREIPQNL 105 (435)
Q Consensus 88 ~~L~l~~n~~--~~~~p~~~ 105 (435)
+.|+++.|.. -+.+|..+
T Consensus 115 e~L~L~~n~~~~L~~LPssL 134 (426)
T PRK15386 115 RSLEIKGSATDSIKNVPNGL 134 (426)
T ss_pred ceEEeCCCCCcccccCcchH
Confidence 5555655543 23455543
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00099 Score=56.61 Aligned_cols=56 Identities=27% Similarity=0.388 Sum_probs=23.2
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccC-CCCCCeEECcCccc
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN-LKGLSHLDLSSNFF 73 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~-l~~L~~L~l~~n~l 73 (435)
...+||++|.+. .++ .|..++.|.+|.|++|+++ .|-+.+.. +++|..|.|.+|.+
T Consensus 44 ~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt-~I~p~L~~~~p~l~~L~LtnNsi 100 (233)
T KOG1644|consen 44 FDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRIT-RIDPDLDTFLPNLKTLILTNNSI 100 (233)
T ss_pred cceecccccchh-hcc-cCCCccccceEEecCCcce-eeccchhhhccccceEEecCcch
Confidence 334444444443 222 2334444444444444444 22222222 23344444444444
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0012 Score=55.27 Aligned_cols=84 Identities=20% Similarity=0.227 Sum_probs=61.5
Q ss_pred cccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCcee-EEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL-LLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e 259 (435)
..-.......||+|.+|.||+|.+. |..+|+|.-+... ....+..|+++|..+.-.++.+ ++.| +..++.||
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me 92 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRME 92 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhh
Confidence 3344566778999999999999986 5588888765433 3467889999999888766653 3443 34456699
Q ss_pred cccCCCHHHHHH
Q 040641 260 YMVNGSLDLWLR 271 (435)
Q Consensus 260 y~~~g~L~~~l~ 271 (435)
|+.|-.|.++-.
T Consensus 93 ~i~G~~L~~~~~ 104 (201)
T COG2112 93 YIDGRPLGKLEI 104 (201)
T ss_pred hhcCcchhhhhh
Confidence 999988876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.006 Score=57.90 Aligned_cols=242 Identities=14% Similarity=0.127 Sum_probs=125.6
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEE------EeCCe-eEE
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYC------SFDEE-KLL 256 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~~~-~~l 256 (435)
+....-||+|+-+.+|-.--- +. .+.|+..........+ -+..|.+. .||-+-.=+.+= -.... ..+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 345677899999999964321 11 2345554332222111 12223332 455332211110 01111 445
Q ss_pred EEecccCC-CHHHHHHhh--CCCCCCCCHHHHHHHHHHhhhccceeec----------------cccccccccccCcc--
Q 040641 257 VYEYMVNG-SLDLWLRNA--TGSHEVLDRAKRYKIACSSARGLAFLHQ----------------DFGLARLISACETH-- 315 (435)
Q Consensus 257 v~ey~~~g-~L~~~l~~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------DfGla~~~~~~~~~-- 315 (435)
.|..+++- -...+++.. ..+....+|...++.+..+|.+.+-||. |=|..+++..+...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 66666543 223333211 1233457899999999999999999986 33444444332221
Q ss_pred ----ccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCC-----cHHHHHHHHh
Q 040641 316 ----VSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGA-----NLVGWVFQKM 380 (435)
Q Consensus 316 ----~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~-----~~~~~~~~~~ 380 (435)
.....+|...|.+||.-. +-.-+...|-|.+||++++++.| +.||.......... .+....+..-
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 122346788899999543 33456789999999999999987 88986543221111 1211111111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCC--CCCCCCCHHHHHHHHhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVAD--NPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~--~P~~RPs~~evl~~L~~i 433 (435)
.+........| ......-....+-.+-.+|+.. ++.-|||.+.-+..|.++
T Consensus 248 ~~~~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 248 SDQRRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhccCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11111111111 1111111112233455567765 467899999888777664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0025 Score=68.22 Aligned_cols=108 Identities=19% Similarity=0.244 Sum_probs=77.7
Q ss_pred eeeecccCcceEEEEEcCCC---CEEEEEEccccc-cccHHHHHHHHHHhccCC-CCCc--eeEEEEEEeC---CeeEEE
Q 040641 188 VDILEDGGFGTVYKATLPDG---KTVAVKKFSQAK-TQGHRQFTAEMETLGKVK-HQNL--VLLLGYCSFD---EEKLLV 257 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 257 (435)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |++| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46679999999999876553 367777764432 123356889999999995 6665 7788888664 467899
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
|||++|..+.+ . ....++...+..++.++++.|+.||+
T Consensus 123 ME~v~G~~~~~----~--~~~~~~~~~r~~l~~~l~~~La~LH~ 160 (822)
T PLN02876 123 MEYLEGRIFVD----P--KLPGVAPERRRAIYRATAKVLAALHS 160 (822)
T ss_pred EEecCCcccCC----c--cCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999754321 1 11124566777899999999999998
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00038 Score=62.51 Aligned_cols=116 Identities=20% Similarity=0.181 Sum_probs=66.6
Q ss_pred CCccccCCCCCCeeecCCCcccccCCc--cc-CCCCCCcEEECCCCcCcc--CCCcCccCCCCCCeEECcCcccCCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPR--SL-GQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSNFFDGGWPR 79 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~--~~-~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~ 79 (435)
-|..+..+..+..|-|.+..+- ...+ .| ...+.++.|||.+|+++. .|-.-+.+|++|+.|+|++|.+...|-.
T Consensus 37 s~~~v~s~ra~ellvln~~~id-~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~ 115 (418)
T KOG2982|consen 37 SYLGVSSLRALELLVLNGSIID-NEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKS 115 (418)
T ss_pred ceeeeccccchhhheecCCCCC-cchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcccc
Confidence 3444444454545555444443 2221 12 235677788888888873 2333356778888888888887644322
Q ss_pred cCCCCCCCCEEeCCCCCCccc-CCccccCcCCCCcccccCCcc
Q 040641 80 SLGNLSYSTYLDLHDNKFTRE-IPQNLGNLAQLEHLDVLRNML 121 (435)
Q Consensus 80 ~~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~l~l~~n~l 121 (435)
.-..+.+|++|-|.+..+... .-..+..++.++.|.+|.|.+
T Consensus 116 lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 116 LPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred CcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 112455677777776665432 223455677777787887744
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00031 Score=63.08 Aligned_cols=86 Identities=29% Similarity=0.261 Sum_probs=62.3
Q ss_pred CCCCCeeecCCCccccc--CCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCC-cCCCcCCCCCCCC
Q 040641 12 SLKLQGLYLGNNQLTGS--IPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG-GWPRSLGNLSYST 88 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~--~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~ 88 (435)
.+.++.|||.+|.++.+ +..-+-++++|++|+||+|+++..|-..-..+.+|+.|-|.+..+.= ..-..+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 45788999999999843 33345689999999999999986554333466789998888766541 1223455677788
Q ss_pred EEeCCCCCC
Q 040641 89 YLDLHDNKF 97 (435)
Q Consensus 89 ~L~l~~n~~ 97 (435)
.|++|.|++
T Consensus 150 elHmS~N~~ 158 (418)
T KOG2982|consen 150 ELHMSDNSL 158 (418)
T ss_pred hhhhccchh
Confidence 888888854
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0063 Score=59.38 Aligned_cols=103 Identities=28% Similarity=0.356 Sum_probs=62.8
Q ss_pred HHHHHHHHHhccCCCCCceeEEEEEEeCCe-eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeecc
Q 040641 224 RQFTAEMETLGKVKHQNLVLLLGYCSFDEE-KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQD 302 (435)
Q Consensus 224 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~D 302 (435)
.+..-..++++.+.|+|..+++.+...... ..+|||++ +-||.+.+.... + +.....|.+...+|.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l------~~~s~~~~~~~~~~~- 93 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----L------KDESLLAHGVLHLNI- 93 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----c------chhhhcccccceehh-
Confidence 455566778889999999999988765443 56889998 568888776432 1 111122444443332
Q ss_pred ccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCC
Q 040641 303 FGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359 (435)
Q Consensus 303 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p 359 (435)
....+ +.. | .| |-. ..+|+||||+|.++.|+.-|..-
T Consensus 94 -----~~~td--~~~-----t-~~--~~~-----~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 94 -----IYITD--HFL-----T-KY--PSP-----IGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred -----hhccc--ccc-----c-cC--CCC-----CCcchhhhhHHHHHHHHHHhhHH
Confidence 00000 000 0 01 111 12599999999999999988654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 435 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 8e-98
Identities = 96/270 (35%), Positives = 143/270 (52%), Gaps = 29/270 (10%)
Query: 190 ILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGH-RQFTAEMETLGKVKHQNLVLLLGYC 248
IL GGFG VYK L DG VAVK+ + +TQG QF E+E + H+NL+ L G+C
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
E+LLVY YM NGS+ LR S LD KR +IA SARGLA+LH
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 302 --------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG 341
DFGLA+L+ +THV+T + GT+G+I PEY + S+ +
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216
Query: 342 DVYSFGVILLELVTAKEPTGP-EFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
DV+ +GV+LLEL+T + + L+ WV +K+++ + ++D +
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLKLL 430
+ +++++A C +P RP M V+++L
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-87
Identities = 86/267 (32%), Positives = 130/267 (48%), Gaps = 26/267 (9%)
Query: 194 GGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253
G FG VYK L DG VA+K+ + +QG +F E+ETL +H +LV L+G+C E
Sbjct: 50 GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------ 301
+L+Y+YM NG+L L + + +R +I +ARGL +LH
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSIN 169
Query: 302 ------------DFGLARLISAC-ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGV 348
DFG+++ + +TH+ST + GTLGYI PEY T + DVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 349 ILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRI 408
+L E++ A+ +E NL W + Q + ++DP + + + K
Sbjct: 230 VLFEVLCARSAIVQS-LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 409 AADCVADNPATRPTMLHVLKLLHEIVD 435
A C+A + RP+M VL L +
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 2e-82
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 41/274 (14%)
Query: 194 GGFGTVYKATLPDGKTVAVKKFSQAKT----QGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
GGFG VYK + + TVAVKK + + +QF E++ + K +H+NLV LLG+ S
Sbjct: 42 GGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS 100
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
++ LVY YM NGSL L G+ L R KIA +A G+ FLH+
Sbjct: 101 DGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHHIHRDI 159
Query: 302 ----------------DFGLARLI-SACETHVSTDIAGTLGYIPPEY--GQSRMSTTRGD 342
DFGLAR +T +++ I GT Y+ PE G+ T + D
Sbjct: 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE---ITPKSD 216
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK-KQQADDVLDPTVLNAGSKPM 401
+YSFGV+LLE++T + + L+ + ++ +D +D +N
Sbjct: 217 IYSFGVVLLEIITGLPAVDEHREPQ---LLLDIKEEIEDEEKTIEDYIDKK-MNDADSTS 272
Query: 402 MLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ M +A+ C+ + RP + V +LL E+
Sbjct: 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-64
Identities = 64/313 (20%), Positives = 114/313 (36%), Gaps = 58/313 (18%)
Query: 171 LRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEM 230
+ + + L L+++ G FG V+KA + VAVK F Q Q E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEV 69
Query: 231 ETLGKVKHQNLVLLLGYC----SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY 286
+L +KH+N++ +G S D + L+ + GSL +L+ V+ +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELC 124
Query: 287 KIACSSARGLAFLHQ----------------------------------DFGLARLISAC 312
IA + ARGLA+LH+ DFGLA A
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 313 ETHVSTD-IAGTLGYIPPEYGQSRM-----STTRGDVYSFGVILLELVTAKEPTGPEFQE 366
++ T GT Y+ PE + + + R D+Y+ G++L EL + E
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 367 KEGANLVGWV-----FQKMKKQQADDVLDPTVLNA-GSKPMMLKMLRIAADCVADNPATR 420
+ + M++ P + + M + +C + R
Sbjct: 245 YM-LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 421 PTMLHVLKLLHEI 433
+ V + + ++
Sbjct: 304 LSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 68/313 (21%), Positives = 112/313 (35%), Gaps = 71/313 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEME--TLGKVKHQNL 241
L L++++ G +G VYK +L D + VAVK FS + F E + ++H N+
Sbjct: 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNI 69
Query: 242 VLLLGYC-----SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
+ E LLV EY NGSL +L T D ++A S RGL
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGL 124
Query: 297 AFLHQ---------------------------------DFGLARLISAC-------ETHV 316
A+LH DFGL+ ++ E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 317 STDIAGTLGYIPPEYGQSRMSTT-------RGDVYSFGVILLELVTAKEPTGPEFQEKE- 368
+ GT+ Y+ PE + ++ + D+Y+ G+I E+ P E
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 369 ---GANLVGW--VFQKMKKQQADDVLDPTVLNA--GSKPMMLKMLRIAADCVADNPATRP 421
VG F+ M+ + + P A + + + DC + R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 422 TMLHVLKLLHEIV 434
T + + E++
Sbjct: 305 TAQXAEERMAELM 317
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 45/157 (28%), Positives = 67/157 (42%), Gaps = 16/157 (10%)
Query: 1 LTGSIPSEFGDSLKL-QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
++G+IP +G KL + + N+LTG IP + L L ++L+RN G G+
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS 219
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
K + L+ N +G LDL +N+ +PQ L L L L+V N
Sbjct: 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
LCG+IP+ G Q + A NK
Sbjct: 279 NLCGEIPQ-------------GGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L G IP +L LY+ + ++G+IP L Q+ LV L+ + N SG +P S+ +L
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSY-STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L + N G P S G+ S T + + N+ T +IP NL L +D+ RN
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 120 MLCGKIPEKI--CKS---------RLEGLVSQSGICQNLSKISLAGNK 156
ML G K+ L + + G+ +NL+ + L N+
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 53/168 (31%), Positives = 73/168 (43%), Gaps = 13/168 (7%)
Query: 2 TGSIPSEFGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
IPS + L LY+G N L G IP ++ +L L L +T SG +P L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQL-EHLDVLRN 119
K L LD S N G P S+ +L + N+ + IP + G+ ++L + + RN
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 120 MLCGKIPEKICKS----------RLEGLVSQS-GICQNLSKISLAGNK 156
L GKIP LEG S G +N KI LA N
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 31/131 (23%), Positives = 51/131 (38%), Gaps = 3/131 (2%)
Query: 2 TGSIPSEFGDSLKLQGLYLGNNQLTGS--IPRSLGQLGGLVKLNLT-RNKFSGPVPTSLG 58
G + + ++ L L L IP SL L L L + N GP+P ++
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 59 NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
L L +L ++ G P L + LD N + +P ++ +L L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 119 NMLCGKIPEKI 129
N + G IP+
Sbjct: 159 NRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 38/160 (23%), Positives = 58/160 (36%), Gaps = 19/160 (11%)
Query: 4 SIPSEFGDSLKLQ----GLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSL 57
I + G+ L N G + + Q + L+L+ P+P+SL
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 58 GNLKGLSHLDLSS-NFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
NL L+ L + N G P ++ L+ YL + + IP L + L LD
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N L G +P I NL I+ GN+
Sbjct: 133 SYNALSGTLPPSISS------------LPNLVGITFDGNR 160
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-44
Identities = 52/296 (17%), Positives = 105/296 (35%), Gaps = 74/296 (25%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGH-------RQFTAEMETLGK 235
++ + GGFG V+K + D VA+K ++G ++F E+ +
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 236 VKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
+ H N+V L G +V E++ G L L + + + + ++ A G
Sbjct: 80 LNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALG 134
Query: 296 LAFLHQ-------------------------------DFGLARLISACETHVSTDIAGTL 324
+ ++ DFGL++ H + + G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNF 190
Query: 325 GYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382
++ PE + T + D YSF +IL ++T + P F +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----------------FDEYSY 233
Query: 383 QQADDVLDPTVLNAGSKPMM-----LKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ + + G +P + ++ + C + +P RP +++K L E+
Sbjct: 234 GKIKFINM--IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 54/306 (17%)
Query: 156 KDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKF 215
NLY + + I L + + + G FGTV++A G VAVK
Sbjct: 17 TTENLYFQGAMDGDDMDIPWC-------DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKIL 68
Query: 216 SQAKTQGH--RQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNA 273
+ +F E+ + +++H N+VL +G + +V EY+ GSL L
Sbjct: 69 MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK- 127
Query: 274 TGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLAR 307
+G+ E LD +R +A A+G+ +LH DFGL+R
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367
L ++ S AGT ++ PE + S + DVYSFGVIL EL T ++P +
Sbjct: 188 LKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGNL 242
Query: 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427
A +V V K K+ + + + ++ I C + P RP+ ++
Sbjct: 243 NPAQVVAAVGFKCKR--------LEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
Query: 428 KLLHEI 433
LL +
Sbjct: 291 DLLRPL 296
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 60/304 (19%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEME--TLGKVKH 238
++ +V + G +G V+ G+ VAVK F T + E E ++H
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRH 90
Query: 239 QNLVLLLGYC----SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
+N++ + + L+ +Y NGSL +L++ T LD K+A SS
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVS 145
Query: 295 GLAFLHQ--------------------------------DFGLARLISACETHV---STD 319
GL LH D GLA + V
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 320 IAGTLGYIPPE------YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK---EGA 370
GT Y+PPE S D+YSFG+IL E+ G + +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 371 NLVGWVFQKMKKQQADDVLDPTV-LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
++ M++ L P+ S + +M ++ +C A NPA+R T L V K
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 430 LHEI 433
L ++
Sbjct: 326 LAKM 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 55/287 (19%)
Query: 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK 235
S+ ++ + +++ G FG V KA K VA+K+ + + F E+ L +
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSR 57
Query: 236 VKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
V H N+V L G C LV EY GSL L A A ++G
Sbjct: 58 VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQG 114
Query: 296 LAFLHQ----------------------------DFGLARLISACETHVSTDIAGTLGYI 327
+A+LH DFG A I T+ G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWM 170
Query: 328 PPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL-VGWVFQKMKKQQAD 386
PE + + + DV+S+G+IL E++T ++P F E G + W +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR---- 222
Query: 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
P ++ KP+ M R C + +P+ RP+M ++K++ +
Sbjct: 223 ----PPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMTHL 261
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-42
Identities = 50/156 (32%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
TG IP + +L L+L N L+G+IP SLG L L L L N G +P L +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
K L L L N G P L N + ++ L +N+ T EIP+ +G L L L + N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
G IP ++ C++L + L N
Sbjct: 526 FSGNIPAELGD------------CRSLIWLDLNTNL 549
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-39
Identities = 51/163 (31%), Positives = 72/163 (44%), Gaps = 8/163 (4%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+G+IPS G KL+ L L N L G IP+ L + L L L N +G +P+ L N
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L+ + LS+N G P+ +G L L L +N F+ IP LG+ L LD+ N+
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 121 LCGKIPEKICKSRLE--------GLVSQSGICQNLSKISLAGN 155
G IP + K + + AGN
Sbjct: 550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 59/173 (34%), Positives = 73/173 (42%), Gaps = 17/173 (9%)
Query: 1 LTGSIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLG 58
TG IP + L GL L N G++P G L L L+ N FSG +P +L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 59 NLKGLSHLDLSSNFFDGGWPRSLGNLSYS-TYLDLHDNKFTREIPQNLGN--LAQLEHLD 115
++GL LDLS N F G P SL NLS S LDL N F+ I NL L+ L
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 116 VLRNMLCGKIPEKICKSR-----------LEGLVSQS-GICQNLSKISLAGNK 156
+ N GKIP + L G + S G L + L N
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-38
Identities = 36/169 (21%), Positives = 62/169 (36%), Gaps = 13/169 (7%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNN--QLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG 58
+ G + + + N + G L +L N+T + G +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629
Query: 59 NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
N + LD+S N G P+ +G++ Y L+L N + IP +G+L L LD+
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689
Query: 119 NMLCGKIPEKICKS-----------RLEGLVSQSGICQNLSKISLAGNK 156
N L G+IP+ + L G + + G + N
Sbjct: 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-34
Identities = 47/157 (29%), Positives = 69/157 (43%), Gaps = 15/157 (9%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+ IP GD LQ L + N+L+G R++ L LN++ N+F GP+P L
Sbjct: 212 FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PL 268
Query: 61 KGLSHLDLSSNFFDGGWPRSL-GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
K L +L L+ N F G P L G T LDL N F +P G+ + LE L + N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
G++P + L + L+ N+
Sbjct: 329 NFSGELPM-----------DTLLKMRGLKVLDLSFNE 354
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-34
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 18/171 (10%)
Query: 1 LTGSIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL---GQLGGLVKLNLTRNKFSGPVPTS 56
L G L L+ L L N ++G+ G L L ++ NK SG V
Sbjct: 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-- 195
Query: 57 LGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
+ L LD+SSN F G P LG+ S +LD+ NK + + + + +L+ L++
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254
Query: 117 LRNMLCGKIPEKICKS---------RLEGLVSQS--GICQNLSKISLAGNK 156
N G IP KS + G + G C L+ + L+GN
Sbjct: 255 SSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 15/157 (9%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+G+IP+E GD L L L N G+IP ++ + + N +G + N
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKND 581
Query: 61 KGLSHLDLSSNF--FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
+ N F G L LS ++ + N + LD+
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 119 NMLCGKIPEKICK-SRLEGLVSQSGICQNLSKISLAG 154
NML G IP++I L L NL ++G
Sbjct: 642 NMLSGYIPKEIGSMPYLFIL--------NLGHNDISG 670
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT--SLGNL 60
++ S L+ L+L N+ + GS+ L L+L+RN SGPV T SLG+
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 61 KGLSHLDLSSNFFDGGWPRSLG-NLSYSTYLDLHDNKFTREIPQNL---GNLAQLEHLDV 116
GL L++SSN D S G L+ LDL N + +L+HL +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 117 LRNMLCGKIPEKICKS---------RLEGLVSQSGICQNLSKISLAGNK 156
N + G + C + + G C L + ++GNK
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK 234
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 39/148 (26%), Positives = 56/148 (37%), Gaps = 15/148 (10%)
Query: 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN 71
S+ L L N ++ SL L GL L L+ + +G V L+ LDLS N
Sbjct: 54 SIDLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110
Query: 72 FFDGGWP--RSLGNLSYSTYLDLHDNKFTREIP-QNLGNLAQLEHLDVLRNMLCGKIPEK 128
G SLG+ S +L++ N L LE LD+ N + G
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 129 ICKSRLEGLVSQSGICQNLSKISLAGNK 156
S C L ++++GNK
Sbjct: 171 W---------VLSDGCGELKHLAISGNK 189
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 19/112 (16%)
Query: 63 LSHLDLSSNFFDGGW---PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
++ +DLSS + G+ SL +L+ L L ++ + A L LD+ RN
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110
Query: 120 MLCGKIPEKICKSRLEGLV---------------SQSGICQNLSKISLAGNK 156
L G + GL S +L + L+ N
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-42
Identities = 69/300 (23%), Positives = 113/300 (37%), Gaps = 60/300 (20%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEME--TLGKVKHQNLV 242
+TL++ + G +G V++ + G+ VAVK FS ++ + + E E ++H+N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENIL 65
Query: 243 LLLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+ L+ Y GSL +L+ T LD +I S A GLA
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAH 120
Query: 299 LHQ--------------------------------DFGLARLISACETHV---STDIAGT 323
LH D GLA + S + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 324 LGYIPPE------YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK---EGANLVG 374
Y+ PE S R D+++FG++L E+ G K
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 375 WVFQKMKKQQADDVLDPTVLNA-GSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
F+ M+K D P + N S P + + ++ +C NP+ R T L + K L +I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 71/325 (21%), Positives = 121/325 (37%), Gaps = 70/325 (21%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG 222
S S S PL + ++ + + L + + G FG V++ G+ VAVK F ++
Sbjct: 26 SGSGSGLPLLVQRTIART----IVLQESIGKGRFGEVWRGKW-RGEEVAVKIF---SSRE 77
Query: 223 HRQFTAEME--TLGKVKHQNLVLLLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGS 276
R + E E ++H+N++ + + D LV +Y +GSL +L T
Sbjct: 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-- 135
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ--------------------------------DFG 304
+ K+A S+A GLA LH D G
Sbjct: 136 ---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192
Query: 305 LARLISACETHV---STDIAGTLGYIPPE------YGQSRMSTTRGDVYSFGVILLELVT 355
LA + + GT Y+ PE + S R D+Y+ G++ E+
Sbjct: 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 356 AKEPTGPE------FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA-GSKPMMLKMLRI 408
G + + ++ ++M+K + L P + N S + M +I
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDP---SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 409 AADCVADNPATRPTMLHVLKLLHEI 433
+C N A R T L + K L ++
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQL 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 68/289 (23%), Positives = 105/289 (36%), Gaps = 64/289 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKF----SQAKTQGHRQFTAEMETLGKVKHQ 239
+LTL +I+ GGFG VY+A G VAVK + +Q E + +KH
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N++ L G C + LV E+ G L+ L + + A ARG+ +L
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYL 121
Query: 300 HQ-----------------------------------DFGLARLISACETHVSTDIAGTL 324
H DFGLAR AG
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAY 178
Query: 325 GYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384
++ PE ++ M + DV+S+GV+L EL+T + P F+ +G + V
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAVAYGVAMNKLALP 234
Query: 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
++ DC +P +RP+ ++L L I
Sbjct: 235 IPSTCPE------------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 64/281 (22%), Positives = 113/281 (40%), Gaps = 50/281 (17%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGH--RQFTAEMETLGKVKHQNL 241
++T+ + G FGTVYK VAVK + + F E+ L K +H N+
Sbjct: 25 QITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 242 VLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+L +GY + +L +V ++ SL L + + K IA +ARG+ +LH
Sbjct: 83 LLFMGYST--APQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLH 137
Query: 301 Q------------------------DFGLARLISACE-THVSTDIAGTLGYIPPE---YG 332
DFGLA S +H ++G++ ++ PE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392
S + + DVY+FG++L EL+T + P + + + + + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
P +K R+ A+C+ RP+ +L + E+
Sbjct: 254 C------PKRMK--RLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 63/317 (19%), Positives = 111/317 (35%), Gaps = 63/317 (19%)
Query: 159 NLYLSSSRSKGPLRINISMFQQ----PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKK 214
NL L S+RS S+F Q P +L + +++ G FG VY VA++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRL 62
Query: 215 FSQAKTQGH--RQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN 272
+ + F E+ + +H+N+VL +G C ++ +L +R+
Sbjct: 63 IDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD 122
Query: 273 ATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLI 309
A VLD K +IA +G+ +LH DFGL +
Sbjct: 123 A---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSIS 179
Query: 310 SACE----THVSTDIAGTLGYIPPE---------YGQSRMSTTRGDVYSFGVILLELVTA 356
+ G L ++ PE + DV++ G I EL
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 357 KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADN 416
+ P F+ + ++ + MK + + ++ I C A
Sbjct: 240 EWP----FKTQPAEAIIWQMGTGMKPNLSQIGMGK------------EISDILLFCWAFE 283
Query: 417 PATRPTMLHVLKLLHEI 433
RPT ++ +L ++
Sbjct: 284 QEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 54/292 (18%), Positives = 100/292 (34%), Gaps = 66/292 (22%)
Query: 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L ++L G FG K T G+ + +K+ + + R F E++ + ++H N++
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
+G D+ + EY+ G+L +++ ++R A A G+A+LH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 302 ----------------------DFGLARLISACETH-------------VSTDIAGTLGY 326
DFGLARL+ +T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 327 IPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386
+ PE R + DV+SFG++L E++ + D
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----------------DPDYLPRTMD 231
Query: 387 DVLDPTVLNAGSKPMM-----LKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
L+ + I C +P RP+ + + L +
Sbjct: 232 FGLN---VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 58/283 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNL 241
+L + L + G ++K G + VK T+ R F E L H N+
Sbjct: 11 QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 242 VLLLGYCSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
+ +LG C + +M GSL L T V+D+++ K A ARG+AFL
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFL 127
Query: 300 HQ--------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--- 330
H + + S ++ PE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQ 181
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
+ D++SF V+L ELVT + P F + + V A + L
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIGMKV--------ALEGLR 229
Query: 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
PT+ S + ++ C+ ++PA RP ++ +L ++
Sbjct: 230 PTIPPGISPH----VSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 60/287 (20%), Positives = 98/287 (34%), Gaps = 66/287 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKT-VAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNL 241
L L + + G FG V+ L T VAVK + + F E L + H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V L+G C+ + +V E + G +LR L ++ +A G+ +L
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES 231
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYG 332
DFG++R + S G L +P PE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS----GGLRQVPVKWTAPEAL 287
Query: 333 QSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
++ DV+SFG++L E + P + + QQ +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP-----------------YPNLSNQQ---TRE- 326
Query: 392 TVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ G P + + R+ C A P RP+ + + L I
Sbjct: 327 -FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 28/193 (14%), Positives = 56/193 (29%), Gaps = 41/193 (21%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTG-------------------SIPRSLGQLGGLVKLNL 44
+ KL+ Y+GN+ + L L + +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 45 TRNKFSGPVPTSLGNLKGLSHLDLSSNFF--------DGGWPRSLGNLSYSTYLDLHDNK 96
+PT L L + ++++ N D + + N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 97 FTR-EIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKS-----------RLEGLVSQ-SGI 143
+ +L + +L L+ L N L GK+P ++ + + G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 144 CQNLSKISLAGNK 156
+ + +S A NK
Sbjct: 376 TEQVENLSFAHNK 388
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 32/178 (17%), Positives = 54/178 (30%), Gaps = 26/178 (14%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-------PVPT 55
+ + + + L NNQ++ L +NL N +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSL--GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEH 113
+ N L+ +DL N L Y +DL N F+ + P N + L+
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKL-SDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKG 540
Query: 114 LDVL------RNMLCGKIPEKICK-SRLEGL-VSQ-------SGICQNLSKISLAGNK 156
+ N + PE I L L + I N+S + + N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNP 598
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 19/168 (11%), Positives = 49/168 (29%), Gaps = 14/168 (8%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTG----SIPRSLGQLGGLVKLNLTRNKFSGPVPTS 56
+G +P G +L+ L LG++ P+ + + R +
Sbjct: 93 ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY 152
Query: 57 LGNLK--GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
L ++S+ +S T + N T + + + L +L
Sbjct: 153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQF 211
Query: 115 DVLRNMLCGKIPEKICKSRLEGLVSQSGI-------CQNLSKISLAGN 155
+ + + + ++ Q ++L+ + +
Sbjct: 212 YMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 14/164 (8%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGN 59
L G +P FG +KL L L NQ+T G + L+ NK P +
Sbjct: 342 LEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYS-------TYLDLHDNKFTREIPQNLGNLAQLE 112
+ +S +D S N ++ L + + ++L +N+ ++ + + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 113 HLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
++++ NML IP+ K E L+ I L NK
Sbjct: 461 SINLMGNMLTE-IPKNSLKDENENF----KNTYLLTSIDLRFNK 499
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 27/186 (14%), Positives = 61/186 (32%), Gaps = 31/186 (16%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSL--GQLGGLVKLNLTRNKFSG------- 51
+T + G + +++ L +N+L IP + + ++ + N+
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 52 PVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT-------REIPQN 104
P+ + +S ++LS+N S + ++L N T ++ +N
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 105 LGNLAQLEHLDVLRNMLCGKIPEKICKS-------------RLEGLVSQSGICQNLSKIS 151
N L +D+ N L K+ + + +Q L
Sbjct: 484 FKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542
Query: 152 LAGNKD 157
+ +D
Sbjct: 543 IRNQRD 548
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 28/138 (20%), Positives = 45/138 (32%), Gaps = 13/138 (9%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSL--GQLGGLVKLNLTRNKFSGPVPTSLGNL 60
F ++ L + L N+LT + L LV ++L+ N FS PT N
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 61 KGLSHL------DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
L D N WP + T L + N ++ + + + L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVL 592
Query: 115 DVLRNMLCGKIPEKICKS 132
D+ N +C
Sbjct: 593 DIKDNPNISIDLSYVCPY 610
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 17/161 (10%), Positives = 45/161 (27%), Gaps = 19/161 (11%)
Query: 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP----VPTSL 57
+ ++ GL L +G +P ++GQL L L L + P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYS--TYLDLHDNKFTREIPQNLGNLAQLEHLD 115
+ + +S ++ + + I ++ + +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 116 VLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L N + + + + + L + + +
Sbjct: 190 QLSNNITF-VSKAVMR------------LTKLRQFYMGNSP 217
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 18/124 (14%), Positives = 36/124 (29%), Gaps = 12/124 (9%)
Query: 4 SIPSEFGDS--LKLQGLYLGNNQLTGSIPRSLGQLGGLVKL------NLTRNKFSGPVPT 55
+ +F + L G+ L N + P L + N+ P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLD 115
+ L+ L + SN + N+ + LD+ DN + +
Sbjct: 561 GITLCPSLTQLQIGSNDIRKVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 116 VLRN 119
+ +
Sbjct: 618 LFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 19/115 (16%), Positives = 37/115 (32%), Gaps = 14/115 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGN------NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSL 57
P++ +S L+G + N N+ P + L +L + N V +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE 112
+S LD+ N + + L +K Q++ L+
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK-----TQDIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 8/71 (11%), Positives = 19/71 (26%), Gaps = 3/71 (4%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
P L L +G+N + + + + L++ N + +
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 61 KGLSHLDLSSN 71
L +
Sbjct: 611 IEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 19/132 (14%), Positives = 36/132 (27%), Gaps = 18/132 (13%)
Query: 43 NLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT---- 98
N + + SL + ++ L L G P ++G L+ L L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 99 REIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLV--------------SQSGIC 144
P+ + E +R + + L+ S I
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 145 QNLSKISLAGNK 156
++I N
Sbjct: 183 LKDTQIGQLSNN 194
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/325 (18%), Positives = 110/325 (33%), Gaps = 69/325 (21%)
Query: 142 GICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYK 201
G+ L A ++ S + + + +T+ L G +G VY+
Sbjct: 188 GLITTLHYP--APKRNKPTIYGVSPNYDKWEMERT-------DITMKHKLGGGQYGEVYE 238
Query: 202 ATLPDGKT-VAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260
VAVK + + +F E + ++KH NLV LLG C+ + ++ E+
Sbjct: 239 GVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297
Query: 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------- 301
M G+L +LR + +A + + +L +
Sbjct: 298 MTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH 355
Query: 302 -----DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT- 355
DFGL+RL++ + + PE + + DV++FGV+L E+ T
Sbjct: 356 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415
Query: 356 AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK-------PMMLKMLRI 408
P + + V + +L + P + L
Sbjct: 416 GMSP-----------------YPGIDLS---QVYE--LLEKDYRMERPEGCPEKVYELMR 453
Query: 409 AADCVADNPATRPTMLHVLKLLHEI 433
C NP+ RP+ + + +
Sbjct: 454 --ACWQWNPSDRPSFAEIHQAFETM 476
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 32/172 (18%), Positives = 52/172 (30%), Gaps = 16/172 (9%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L F +LQ L L ++ + L L L LT N + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRN 119
L L +G+L L++ N ++P+ NL LEHLD+ N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 120 MLCGKIPEKICKSR---------------LEGLVSQSGICQNLSKISLAGNK 156
+ + + + + L K++L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 29/168 (17%), Positives = 55/168 (32%), Gaps = 15/168 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
++ S F +L+ L ++ L S L L+ L+++ L
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 63 LSHLDLSSNFFDGGW-PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L L ++ N F + P L T+LDL + + P +L+ L+ L++ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 122 CGKIPEKICKS-----------RLEGLVSQS--GICQNLSKISLAGNK 156
+ Q +L+ ++L N
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 36/154 (23%), Positives = 53/154 (34%), Gaps = 15/154 (9%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
IP S K L L N L S L L+L+R + + +L L
Sbjct: 21 KIPDNLPFSTKN--LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML-C 122
S L L+ N + LS L + +G+L L+ L+V N++
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 123 GKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
K+PE NL + L+ NK
Sbjct: 139 FKLPEYFSN------------LTNLEHLDLSSNK 160
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 34/172 (19%), Positives = 55/172 (31%), Gaps = 17/172 (9%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLT--GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG 58
G D L+ L L N L+ G +S L L+L+ N + ++
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
Query: 59 NLKGLSHLDLSSNFFDGGWPRS-LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVL 117
L+ L HLD + S +L YLD+ L+ LE L +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 118 RNMLCGKIPEKICKS------------RLEGLVSQS-GICQNLSKISLAGNK 156
N I +LE L + +L ++++ N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 2/123 (1%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSI-PRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+ F L+ L + N + P +L L L+L++ + PT+ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLA-QLEHLDVLR 118
L L L++S N F L+ LD N Q L + L L++ +
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 119 NML 121
N
Sbjct: 553 NDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 29/131 (22%), Positives = 41/131 (31%), Gaps = 4/131 (3%)
Query: 1 LTGSIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+ + F + L L L QL P + L L LN++ N F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYS-TYLDLHDNKFTREIPQN--LGNLAQLEHLDV 116
L L LD S N + L + S +L+L N F L + L V
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 117 LRNMLCGKIPE 127
+ P
Sbjct: 577 EVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 29/175 (16%), Positives = 57/175 (32%), Gaps = 24/175 (13%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSG---PVPTS 56
+ P F ++L L L NN + ++ + + L GL L +F
Sbjct: 189 MNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 57 LGNLKGLSHLDLSSN------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQ 110
L+GL +L + ++ L+ + L R ++
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFG 305
Query: 111 LEHLDVLRNMLCGKIPEKICKS---------RLEGLVSQSGICQNLSKISLAGNK 156
+HL+++ G+ P KS + S+ +L + L+ N
Sbjct: 306 WQHLELVNCKF-GQFPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFLDLSRNG 358
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 30/153 (19%), Positives = 45/153 (29%), Gaps = 16/153 (10%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK--FSGPVPTSLGNLKGLS 64
+F L G S L L L+L+RN F G S L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 65 HLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCG 123
+LDLS N + L +LD + + + +L L +LD+
Sbjct: 377 YLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+L + +AGN
Sbjct: 436 AFNGIFNG------------LSSLEVLKMAGNS 456
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 51/219 (23%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQFTAEMETLGKVK 237
+ L L +G FG V+ A + VAVK + F E E L ++
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR------------NATGSHEVLDRAKR 285
H+++V G C + ++V+EYM +G L+ +LR + L ++
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 286 YKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIA 321
IA A G+ +L DFG++R + + + +
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----V 191
Query: 322 GTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
G +P PE R TT DV+SFGVIL E+ T
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 67/282 (23%), Positives = 101/282 (35%), Gaps = 60/282 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L L L G FG V+ T VA+K F E + + K++H+ LV
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 243
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L S +E +V EYM GSL +L+ TG + L + +A A G+A++ +
Sbjct: 244 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN 300
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGLARLI E + + PE T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 340 RGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD-------P 391
+ DV+SFG++L EL T + P + M ++ D ++ P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP-----------------YPGMVNREVLDQVERGYRMPCP 403
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+M C P RPT ++ L +
Sbjct: 404 PECPESLHDLMC-------QCWRKEPEERPTFEYLQAFLEDY 438
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 47/214 (21%), Positives = 81/214 (37%), Gaps = 46/214 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK----TVAVK--KFSQAKTQGHRQFTAEMETLGKVK 237
L L IL +G FG+V + L VAVK K + + +F +E +
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 238 HQNLVLLLGYCSFDE-----EKLLVYEYMVNGSLDLWLRN--ATGSHEVLDRAKRYKIAC 290
H N++ LLG C + +++ +M G L +L + + K
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 291 SSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGY 326
A G+ +L DFGL++ I + + + G +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAK 210
Query: 327 IP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P E R+ T++ DV++FGV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 38/202 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKT-VAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+T+ L G +G VY+ VAVK + + +F E + ++KH NLV
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL--- 299
LLG C+ + ++ E+M G+L +LR + +A + + +L
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK 130
Query: 300 ---HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQ 333
H+D FGL+RL++ T A P PE
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLA 185
Query: 334 SRMSTTRGDVYSFGVILLELVT 355
+ + DV++FGV+L E+ T
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT 207
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 62/293 (21%), Positives = 102/293 (34%), Gaps = 60/293 (20%)
Query: 185 LTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
L + L G FG+V G VAVK+ + R F E++ L +
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSD 84
Query: 240 NLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
+V G + LV EY+ +G L +L+ LD ++ + +G+
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGME 141
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDI--AGTLGYIP--- 328
+L DFGLA+L+ + D G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL-----PLDKDYYVVREPGQSPIFW 196
Query: 329 --PEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385
PE + + + DV+SFGV+L EL T + P E ++G
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP---SAEFLRMMGCERDVPALS-- 251
Query: 386 DDVLDPTVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+L+ +L G P ++ + C A +P RP+ + L +
Sbjct: 252 -RLLE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 56/196 (28%), Positives = 80/196 (40%), Gaps = 28/196 (14%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L L L G FG V+ T VA+K F E + + K++H+ LV
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 326
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L S +E +V EYM GSL +L+ TG + L + +A A G+A++ +
Sbjct: 327 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN 383
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGLARLI E + + PE T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 340 RGDVYSFGVILLELVT 355
+ DV+SFG++L EL T
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 50/214 (23%), Positives = 75/214 (35%), Gaps = 46/214 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQ-AKTQGHRQFTAEMETLGKV 236
+TL+ L G FG VY+ + VAVK + Q F E + K
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHE---VLDRAKRYKIACSSA 293
HQN+V +G + ++ E M G L +LR L +A A
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 294 RGLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
G +L + DFG+AR I + G
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----GGCAM 206
Query: 327 IP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE + T++ D +SFGV+L E+ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 57/208 (27%), Positives = 83/208 (39%), Gaps = 40/208 (19%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVK 237
L + +++ G FG VY TL D AVK ++ G F E +
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 238 HQNLVLLLGYCSFDEEKLL-VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
H N++ LLG C E L V YM +G L ++RN T + A+G+
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGM 141
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
+L DFGLAR + E + + G +P
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK--LPVKWM 199
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVT 355
E Q++ TT+ DV+SFGV+L EL+T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 46/214 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
K+T+ L G FG VY+ VA+K ++A + R F E + +
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNA------TGSHEVLDRAKRYKIAC 290
++V LLG S + L++ E M G L +LR+ +K ++A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 291 SSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGY 326
A G+A+L+ DFG+ R I + + G G
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGL 201
Query: 327 IP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE + + TT DV+SFGV+L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 50/218 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQFTAEMETLGKVK 237
+ L L +G FG V+ A + VAVK +A + F E E L ++
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 101
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR-----------NATGSHEVLDRAKRY 286
HQ++V G C+ L+V+EYM +G L+ +LR + L +
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 287 KIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322
+A A G+ +L DFG++R I + + + G
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VG 217
Query: 323 TLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE R TT DV+SFGV+L E+ T
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 45/215 (20%), Positives = 77/215 (35%), Gaps = 47/215 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK----TVAVK--KFSQAKTQGHRQFTAEMETLGKVK 237
+ TL +L G FG+V +A L VAVK K + +F E + +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 238 HQNLVLLLGYCSFDEEK------LLVYEYMVNGSLDLWLRNATGSHE--VLDRAKRYKIA 289
H ++ L+G K +++ +M +G L +L + L +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 290 CSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLG 325
A G+ +L DFGL+R I + + + G
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCAS 199
Query: 326 YIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P E + T DV++FGV + E++T
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 66/253 (26%), Positives = 91/253 (35%), Gaps = 72/253 (28%)
Query: 169 GPLRINISMFQQPLL--------KLTLVDILEDGGFGTVYKATLPDGK------TVAVKK 214
GPL +++ F+ L L L +G FG V KAT K TVAVK
Sbjct: 1 GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 215 F-SQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN- 272
A R +E L +V H +++ L G CS D LL+ EY GSL +LR
Sbjct: 61 LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 273 -------------------ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------ 301
L A ++G+ +L +
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180
Query: 302 ------------DFGLARLISACETHVSTDI--AGTLGYIP-----PEYGQSRMSTTRGD 342
DFGL+R + D + G IP E + TT+ D
Sbjct: 181 ILVAEGRKMKISDFGLSRDV------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 343 VYSFGVILLELVT 355
V+SFGV+L E+VT
Sbjct: 235 VWSFGVLLWEIVT 247
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 61/201 (30%), Positives = 82/201 (40%), Gaps = 38/201 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L LV+ L G FG V+ VAVK Q F AE + +++HQ LV
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVR 72
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL---- 299
L + E ++ EYM NGSL +L+ +G L K +A A G+AF+
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN 129
Query: 300 --HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQS 334
H+D FGLARLI E P PE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-----AKFPIKWTAPEAINY 184
Query: 335 RMSTTRGDVYSFGVILLELVT 355
T + DV+SFG++L E+VT
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 44/202 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+L L+ + G FG V G VAVK T + F AE + +++H NLV
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 244 LLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LLG ++ L +V EYM GSL +LR+ S L K + + +L
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN 308
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQ 333
DFGL + S+ +P PE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK--LPVKWTAPEALR 359
Query: 334 SRMSTTRGDVYSFGVILLELVT 355
+ +T+ DV+SFG++L E+ +
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 51/208 (24%), Positives = 78/208 (37%), Gaps = 42/208 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH 238
L + L G FG+V G+ VAVKK + + R F E+E L ++H
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 239 QNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
N+V G C + L+ EY+ GSL +L+ +D K + +G+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGM 158
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
+L DFGL +++ + + G P
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK---VKEPGESPIFWY 215
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVT 355
PE + DV+SFGV+L EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 49/208 (23%), Positives = 75/208 (36%), Gaps = 43/208 (20%)
Query: 185 LTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
L + L +G FG V G+ VAVK H E+E L + H
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 239 QNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
+N+V G C+ D L+ E++ +GSL +L ++ ++ K A +G+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGM 139
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
+L DFGL + I + + + P
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWY 196
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVT 355
PE DV+SFGV L EL+T
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 65/294 (22%), Positives = 107/294 (36%), Gaps = 55/294 (18%)
Query: 184 KLTLVDILEDGGFGTVYKAT---LPDGKT--VAVKKFSQAKTQGHRQFTAEMETLGKVKH 238
L + L G FG+V L D VAVKK + + R F E+E L ++H
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 239 QNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
N+V G C + L+ EY+ GSL +L+ +D K + +G+
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGM 127
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
+L DFGL +++ + G P
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK---VKEPGESPIFWY 184
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWV-FQKMKKQQAD 386
PE + DV+SFGV+L EL T E + E ++G +M
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQGQMIVF--- 239
Query: 387 DVLDPTVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+++ +L +P ++ I +C +N RP+ + + +I D
Sbjct: 240 HLIE--LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 60/208 (28%), Positives = 83/208 (39%), Gaps = 40/208 (19%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVK 237
L + +++ G FG VY TL D AVK ++ G F E +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 238 HQNLVLLLGYCSFDEEKLL-VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
H N++ LLG C E L V YM +G L ++RN T + V D A+G+
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGM 205
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
FL DFGLAR + E T +P
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWM 263
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVT 355
E Q++ TT+ DV+SFGV+L EL+T
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 44/202 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+L L+ + G FG V G VAVK T + F AE + +++H NLV
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 244 LLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL--- 299
LLG ++ L +V EYM GSL +LR+ S L K + + +L
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN 136
Query: 300 ---HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQ 333
H+D FGL + G +P PE +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---------SSTQDTGKLPVKWTAPEALR 187
Query: 334 SRMSTTRGDVYSFGVILLELVT 355
+ +T+ DV+SFG++L E+ +
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 43/206 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL-PDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
+ +L G FGTVYK P+G+ VA+K+ +A + + E + V +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++ LLG C L+ + M G L ++R + + A+G+ +
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNY 132
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGLA+L+ A E + G +P
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG----GKVPIKWMAL 188
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R+ T + DV+S+GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 38/201 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
LT + L G FG V VA+K + +F E + + + H+ LV
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 83
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL---- 299
L G C+ ++ EYM NG L +LR + ++ + +L
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 300 --HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQS 334
H+D FGL+R + E S G+ P PE
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSK--FPVRWSPPEVLMY 195
Query: 335 RMSTTRGDVYSFGVILLELVT 355
+++ D+++FGV++ E+ +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 32/156 (20%), Positives = 51/156 (32%), Gaps = 10/156 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L + F +L L +G N ++ P +L L LNL N+ S +
Sbjct: 37 LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L+ L L SN LDL N + L L+ L + N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ E++ +L K+ L+ N+
Sbjct: 157 IQALKSEEL----------DIFANSSLKKLELSSNQ 182
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 34/160 (21%), Positives = 54/160 (33%), Gaps = 9/160 (5%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSGPVPTSLGN 59
++ F L+ L LG N++ + L + ++ L+ NK+ S
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
Query: 60 LKGLSHLDLSSNFFDGGW--PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVL 117
+ L L L P L T LDL +N L L +LE LD+
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 118 RNMLCGKIPEKICKSRLEGLVSQS-GICQNLSKISLAGNK 156
N L ++ K G +L ++L N
Sbjct: 513 HNNL-----ARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 31/167 (18%), Positives = 49/167 (29%), Gaps = 19/167 (11%)
Query: 1 LTGSIPSEFG--DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG 58
L+ + + F L L L N L S L L L N SL
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 59 NLKGLSHLDLSSNFFDGGW---------PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLA 109
L + +L+L +F S L +L++ DN L
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 110 QLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L++L + + + + L L ++L NK
Sbjct: 354 NLKYLSLSNSFTSLRT---LTNETFVSLAHSP-----LHILNLTKNK 392
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 37/161 (22%), Positives = 57/161 (35%), Gaps = 19/161 (11%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFS--------GPVP 54
S PS F L L L NN + L L L L+L N + G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 55 TSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
L L L L+L SN FD +L +DL N N L+ L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 115 DVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
++ +N++ + +K+ +NL+++ + N
Sbjct: 590 NLQKNLITS-VEKKVFGPAF----------RNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 29/164 (17%), Positives = 55/164 (33%), Gaps = 12/164 (7%)
Query: 1 LTGSIPSEFGD--SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG 58
+ E + L+ L L +NQ+ P +G L L L + + L
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 59 ---NLKGLSHLDLSSNFFDGGWPRSLGNLSYS--TYLDLHDNKFTREIPQNLGNLAQLEH 113
+ +L LS++ + L ++ T LDL N + L QLE+
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276
Query: 114 LDVLRNMLCGKIPEKICK-SRLEGLVSQSGICQNLSKISLAGNK 156
+ N + + + L + + +K S++
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKR----SFTKQSISLAS 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 38/210 (18%), Positives = 64/210 (30%), Gaps = 30/210 (14%)
Query: 1 LTGSIP-SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSL 57
+ + E+ + +YL N+ S + L +L L R P+
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR--------EIPQNLGNLA 109
L+ L+ LDLS+N L L LDL N R L L+
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 110 QLEHLDVLRNMLCGKIPEKICK-SRLEGL--------VSQSGICQNLSKISLAGNKDYNL 160
L L++ N E L+ + + + N + +L
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK-------SL 589
Query: 161 YLSSSRSKGPLRINISMFQQPLLKLTLVDI 190
L + + +F LT +D+
Sbjct: 590 NLQKNLITS---VEKKVFGPAFRNLTELDM 616
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 33/194 (17%), Positives = 60/194 (30%), Gaps = 24/194 (12%)
Query: 3 GSIPSEFGDSL---KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVP-TSLG 58
++ +E SL L L L N+++ + LG L L+L N+ +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 59 NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR--EIPQNLGNLAQLEHLDV 116
L+ + + LS N + S + L L P L L LD+
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINIS 176
N + + + + L + L N L+ I
Sbjct: 488 SNNNIANINDDMLEG------------LEKLEILDLQHNN-----LARLWKHANPGGPIY 530
Query: 177 MFQQPLLKLTLVDI 190
+ L L ++++
Sbjct: 531 FLKG-LSHLHILNL 543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 30/130 (23%), Positives = 39/130 (30%), Gaps = 9/130 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLT--------GSIPRSLGQLGGLVKLNLTRNKFSGP 52
+ KL+ L L +N L G L L L LNL N F
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 53 VPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLG-NLAQL 111
+L L +DL N + N L+L N T + G L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 112 EHLDVLRNML 121
LD+ N
Sbjct: 612 TELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 24/129 (18%), Positives = 35/129 (27%), Gaps = 6/129 (4%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
G L L L +N L L ++L N + + N
Sbjct: 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ 583
Query: 61 KGLSHLDLSSNFFDGGWPRSLG-NLSYSTYLDLHDNKFTREIP-----QNLGNLAQLEHL 114
L L+L N + G T LD+ N F N N
Sbjct: 584 VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIP 643
Query: 115 DVLRNMLCG 123
++ + LC
Sbjct: 644 ELSSHYLCN 652
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 26/142 (18%), Positives = 46/142 (32%), Gaps = 15/142 (10%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74
+ + +LT +P L + LNLT N+ + L+ LD+ N
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 75 GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRL 134
P L L+L N+ ++ + L L ++ N + K +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK- 121
Query: 135 EGLVSQSGICQNLSKISLAGNK 156
NL + L+ N
Sbjct: 122 -----------NLITLDLSHNG 132
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 49/214 (22%), Positives = 76/214 (35%), Gaps = 46/214 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
+TL+ L G FG VY+ + VAVK + ++ F E + K
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNA---TGSHEVLDRAKRYKIACSSA 293
HQN+V +G + ++ E M G L +LR L +A A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 294 RGLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
G +L + DFG+AR I + G
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCAM 247
Query: 327 IP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE + T++ D +SFGV+L E+ +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 66/263 (25%), Positives = 99/263 (37%), Gaps = 71/263 (26%)
Query: 154 GNKDYNLYLSSSRSKGPLRINISMFQQPLL--------KLTLVDILEDGGFGTVYKATLP 205
G+ ++ + S P+ +S ++ P KLTL L +G FG V A
Sbjct: 2 GSSHHHHHHSQD----PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAV 57
Query: 206 DGK--------TVAVKKF-SQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255
TVAVK A + +EME + + KH+N++ LLG C+ D
Sbjct: 58 GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117
Query: 256 LVYEYMVNGSLDLWLRN------------ATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
++ EY G+L +LR E + ARG+ +L
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 302 ----------------------DFGLARLISACETHVSTDI--AGTLGYIP-----PEYG 332
DFGLAR I+ + D T G +P PE
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDIN------NIDYYKKTTNGRLPVKWMAPEAL 231
Query: 333 QSRMSTTRGDVYSFGVILLELVT 355
R+ T + DV+SFGV++ E+ T
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 50/304 (16%), Positives = 94/304 (30%), Gaps = 89/304 (29%)
Query: 184 KLTLVDILEDGGFGTVYKATL--------PDGKTVAVKKFSQAKTQGHRQFTAEMETLGK 235
L + L G F ++K V +K +A F + K
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 236 VKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
+ H++LVL G C +E +LV E++ GSLD +L+ ++ + ++A A
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAA 125
Query: 296 LAFLHQ--------------------------------DFGLARLISACETHVSTDIAGT 323
+ FL + D G++ + + DI
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDI--- 176
Query: 324 LGYIP-----PE---YGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVG 374
PE + D +SFG L E+ + +P
Sbjct: 177 -LQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKP--------------- 218
Query: 375 WVFQKMKKQQADDVLDPTVLNAG---SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431
+ Q+ L P ++ + +C+ P RP+ +++ L+
Sbjct: 219 --LSALDSQR---KLQ--FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 432 EIVD 435
+
Sbjct: 272 SLFT 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 62/294 (21%), Positives = 104/294 (35%), Gaps = 57/294 (19%)
Query: 184 KLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVK 237
L + L +G FG V G+ VAVK HR + E++ L +
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 238 HQNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
H++++ G C LV EY+ GSL +L + L A G
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 146
Query: 296 LAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP--- 328
+A+LH DFGLA+ + + G P
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFW 203
Query: 329 --PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386
PE + DV+SFGV L EL+T + + + L+G +M
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDS--SQSPPTKFLELIGIAQGQMT---VL 258
Query: 387 DVLDPTVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ + +L G +P ++ + +C + RPT +++ +L + +
Sbjct: 259 RLTE--LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 56/201 (27%), Positives = 77/201 (38%), Gaps = 38/201 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L L L G FG V+ AT VAVK F AE + ++H LV
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK 247
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L + E ++ E+M GSL +L++ GS K + A G+AF+ Q
Sbjct: 248 LHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQS 334
DFGLAR+I E P PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-----AKFPIKWTAPEAINF 359
Query: 335 RMSTTRGDVYSFGVILLELVT 355
T + DV+SFG++L+E+VT
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 69/292 (23%)
Query: 184 KLTLVDILEDGGFGTVYKATL--PDGK---TVAVKKFSQAKTQGHRQ-FTAEMETLGKVK 237
+T ++ G FG VYK L GK VA+K T+ R F E +G+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H N++ L G S + +++ EYM NG+LD +LR G + + A G+
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMK 161
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP----- 328
+L DFGL+R++ E + G IP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTA 218
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387
PE R T+ DV+SFG+++ E++T + P + ++ +
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP-----------------YWELSNH---E 258
Query: 388 VLDPTVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
V+ +N G PM + ++ C A RP ++ +L +++
Sbjct: 259 VMK--AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-23
Identities = 48/208 (23%), Positives = 76/208 (36%), Gaps = 40/208 (19%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVK 237
+ ++ G FG VY D A+K S+ + F E + +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 238 HQNLVLLLGYCSFDEE-KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
H N++ L+G E ++ YM +G L ++R+ + ARG+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGM 137
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP---- 328
+L + DFGLAR I E + +P
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR--LPVKWT 195
Query: 329 -PEYGQSRMSTTRGDVYSFGVILLELVT 355
E Q+ TT+ DV+SFGV+L EL+T
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 56/220 (25%), Positives = 84/220 (38%), Gaps = 57/220 (25%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK---TVAVKKF-SQAKTQGHRQFTAEMETLGKV-KH 238
+ D++ +G FG V KA + A+K+ A HR F E+E L K+ H
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY------------ 286
N++ LLG C L EY +G+L +LR + A
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 287 KIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDI-- 320
A ARG+ +L Q DFGL+R ++
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYV 196
Query: 321 AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
T+G +P E + TT DV+S+GV+L E+V+
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQ 239
+ + I+ G G V L P + VA+K T+ R+ F +E +G+ H
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N++ L G + ++V EYM NGSLD +LR G + + G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL 167
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----PE 330
DFGL+R++ E T G IP PE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPE 224
Query: 331 YGQSRMSTTRGDVYSFGVILLELVT 355
R ++ DV+SFGV++ E++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 49/200 (24%), Positives = 74/200 (37%), Gaps = 38/200 (19%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
LT V + G FG V+ + VA+K + F E E + K+ H LV L
Sbjct: 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQL 68
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL----- 299
G C LV E+M +G L +LR G + G+A+L
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEACV 125
Query: 300 -HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQSR 335
H+D FG+ R + + ST P PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-----TKFPVKWASPEVFSFS 180
Query: 336 MSTTRGDVYSFGVILLELVT 355
+++ DV+SFGV++ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 31/170 (18%), Positives = 52/170 (30%), Gaps = 30/170 (17%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLT-------GSIPRSLGQLGGLVKLNLTRNKFSG-P 52
+ F + + L NN +T + L ++L NK +
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLS 744
Query: 53 VPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY------STYLDLHDNKFTREIPQNLG 106
L LS++D+S N F +P N S D N+ R+ P +
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 107 NLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L L + N + K+ E + L + +A N
Sbjct: 804 TCPSLIQLQIGSNDI-RKVDE--------------KLTPQLYILDIADNP 838
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 6e-21
Identities = 29/160 (18%), Positives = 54/160 (33%), Gaps = 13/160 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ-LGGLVKLNLTRNKFSG-PVPTSLGNLK 61
FG ++KL L L NQ+ IP + L + NK P + ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYS-----TYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
+ +D S N ++ + + L N+ + + + + + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N++ IPE K + L+ I L NK
Sbjct: 705 SNNLM-TSIPENSLKPKDGNY----KNTYLLTTIDLRFNK 739
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 29/184 (15%), Positives = 48/184 (26%), Gaps = 45/184 (24%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTG-------------------SIPRSLGQLGGLVKLN 43
I KLQ +Y N+ T + S L L +
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 44 LTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG---------GWPRSLGNLSYSTYLDLHD 94
L +P L +L L L+++ N +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 95 NKFTREIPQN--LGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISL 152
N E P + L + +L LD + N + + G L+ + L
Sbjct: 558 NNLE-EFPASASLQKMVKLGLLDCVHNKV-RHLEA-------------FGTNVKLTDLKL 602
Query: 153 AGNK 156
N+
Sbjct: 603 DYNQ 606
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 30/182 (16%)
Query: 4 SIPSEFGDSLK-LQGLYLGNNQLTGSIPR--SLGQLGGLVKLNLTRNKFSG-----PVPT 55
IP +F ++GL +N+L IP + + + ++ + NK
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT-------REIPQNLGNL 108
S + LS N S + + L +N T + N N
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727
Query: 109 AQLEHLDVLRNMLCGKIPEKICKSRLEGLV-------------SQSGICQNLSKISLAGN 155
L +D+ N L + + + L L +Q L +
Sbjct: 728 YLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQ 786
Query: 156 KD 157
+D
Sbjct: 787 RD 788
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 8e-18
Identities = 26/127 (20%), Positives = 43/127 (33%), Gaps = 13/127 (10%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSL--GQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+ ++ L + L N+LT S+ L L ++++ N FS PT N
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 61 KGLSHLDL------SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
L + N WP + L + N ++ + L QL L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYIL 832
Query: 115 DVLRNML 121
D+ N
Sbjct: 833 DIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 21/170 (12%), Positives = 47/170 (27%), Gaps = 16/170 (9%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
G +P G +L+ L G + T S +L + L
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT------REIPQNLGNLAQLEH 113
+ L+ DL + + + + + + L D + I + + L +L+
Sbjct: 395 DQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 114 LDVLRNMLCGKIPEKICKSRLEGLVSQSGI-------CQNLSKISLAGNK 156
+ + + Q ++L+ + L
Sbjct: 453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 10/99 (10%)
Query: 4 SIPSEFGDSLKLQGLYL------GNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSL 57
S P++ +S +L+ + N++ P + L++L + N V L
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL 825
Query: 58 GNLKGLSHLDLSSN-FFDGGWPRSLGNLSYSTYLDLHDN 95
L LD++ N + Y+ L+D
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 13/73 (17%), Positives = 25/73 (34%), Gaps = 5/73 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF-SGPVPTSLGN 59
+ P+ L L +G+N + + L L L++ N S V +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 60 LK-GLSHLDLSSN 71
++ G+ L
Sbjct: 851 IEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 18/148 (12%), Positives = 42/148 (28%), Gaps = 1/148 (0%)
Query: 42 LNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREI 101
L+ ++ + + + + + + L N T L L +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 102 PQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLY 161
P +G L +L+ L + + + + + + + D L
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVD 189
LS R + +++L D
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKD 427
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 38/201 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
++TL+ L G FG V VAVK + +F E +T+ K+ H LV
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVK 67
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL---- 299
G CS + +V EY+ NG L +LR+ L+ ++ ++ G+AFL
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 300 --HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----PEYGQS 334
H+D FG+ R + + S P PE
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-----TKFPVKWSAPEVFHY 179
Query: 335 RMSTTRGDVYSFGVILLELVT 355
+++ DV++FG+++ E+ +
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 43/207 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL-PDGK----TVAVKKF-SQAKTQGHRQFTAEMETLGKVK 237
+L + +L G FGTV+K P+G+ V +K ++ Q + T M +G +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H ++V LLG C LV +Y+ GSL +R G+ L A+G+
Sbjct: 74 HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMY 129
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP----- 328
+L + DFG+A L+ + + P
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE----AKTPIKWMA 185
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVT 355
E T + DV+S+GV + EL+T
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 52/221 (23%), Positives = 81/221 (36%), Gaps = 55/221 (24%)
Query: 184 KLTLVDILEDGGFGTVYKATLPD------GKTVAVKKF-SQAKTQGHRQFTAEMETLGKV 236
L L G FG V +AT VAVK S A +E++ + +
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 237 -KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN----------ATGSHEVLDRAKR 285
+H+N+V LLG C+ L++ EY G L +LR ++
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 286 YKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD-- 319
+ A+G+AFL DFGLAR I ++
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNY 220
Query: 320 IAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
I +P PE + T + DV+S+G++L E+ +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 44/223 (19%), Positives = 78/223 (34%), Gaps = 52/223 (23%)
Query: 181 PLLKLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQ-FTAEMETL 233
L + ++ L + FG VYK L VA+K R+ F E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 234 GKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY------- 286
+++H N+V LLG + D+ +++ Y +G L +L + +V
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 287 -----KIACSSARGLAFL------HQD------------------FGLARLISACETHVS 317
+ A G+ +L H+D GL R + A + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK- 185
Query: 318 TDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE + D++S+GV+L E+ +
Sbjct: 186 ---LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 40/206 (19%)
Query: 184 KLTLVDILEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
+++ ++ G FG V L P K VA+K T+ R+ F E +G+ H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
N++ L G + + ++V EYM NGSLD +LR + + A G+ +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKY 162
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL R++ E G IP P
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPIRWTSP 219
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R T+ DV+S+G++L E+++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 55/225 (24%), Positives = 80/225 (35%), Gaps = 59/225 (26%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
+L+ L G FG V +AT TVAVK + R+ +E++ L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 237 -KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN--------------ATGSHEVLD 281
H N+V LLG C+ L++ EY G L +LR LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 282 RAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317
+ A+G+AFL DFGLAR I +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI------KN 197
Query: 318 TDI--AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE + + T DV+S+G+ L EL +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 43/206 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL-PDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
+ +L G FGTVYK P+G+ VA+K+ +A + + E + V +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++ LLG C L+ + M G L ++R + + A+G+ +
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNY 132
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGLA+L+ A E + G +P
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG----GKVPIKWMAL 188
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R+ T + DV+S+GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 43/206 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
++ L + +G FG V++ P+ VA+K + R+ F E T+ + H
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++V L+G + + ++ E G L +L+ S LD A A + LA+
Sbjct: 76 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAY 131
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R + + G +P P
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAP 186
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R T+ DV+ FGV + E++
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-22
Identities = 59/292 (20%), Positives = 102/292 (34%), Gaps = 71/292 (24%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK----TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
++ L + +G FG V++ + VA+K + R+ F E T+ + H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++V L+G + + ++ E G L +L+ S LD A A + LA+
Sbjct: 451 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAY 506
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R + + G +P P
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAP 561
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
E R T+ DV+ FGV + E++ +P FQ +K V
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP-----------------FQGVKNND---V 601
Query: 389 LDPTVLNAG---SKPMM--LKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ + G P + + C A +P+ RP + L I++
Sbjct: 602 IG--RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 66/253 (26%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 164 SSRSKGPLRINISMFQQPLL--------KLTLVDILEDGGFGTVYKATLPDGK------- 208
SS + P+ +S ++ P KLTL L +G FG V A
Sbjct: 54 SSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEA 113
Query: 209 -TVAVKKF-SQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGS 265
TVAVK A + +EME + + KH+N++ LLG C+ D ++ EY G+
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 266 LDLWLRN------------ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------ 301
L +LR E + ARG+ +L
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233
Query: 302 ------------DFGLARLISACETHVSTDI--AGTLGYIP-----PEYGQSRMSTTRGD 342
DFGLAR I+ + D T G +P PE R+ T + D
Sbjct: 234 VLVTENNVMKIADFGLARDIN------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 343 VYSFGVILLELVT 355
V+SFGV++ E+ T
Sbjct: 288 VWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 61/225 (27%), Positives = 85/225 (37%), Gaps = 59/225 (26%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK--------TVAVKKF-SQAKTQGHRQFTAEMETLG 234
+L L L +G FG V A VAVK S A + +EME +
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 235 KV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLR------------NATGSHEVLD 281
+ KH+N++ LLG C+ D ++ EY G+L +L+ + E L
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 282 RAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317
A ARG+ +L DFGLAR I
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------H 243
Query: 318 TDI--AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
D T G +P PE R+ T + DV+SFGV+L E+ T
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 51/305 (16%), Positives = 102/305 (33%), Gaps = 66/305 (21%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVK--KFSQAKT 220
+SS + + + ++ ++ + GG V++ + A+K +A
Sbjct: 43 ASSSANECISVKGRIYS-------ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 221 QGHRQFTAEMETLGKVKHQNL--VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHE 278
Q + E+ L K++ + + L Y D+ +V E N L+ WL+
Sbjct: 96 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP 154
Query: 279 VLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACETH 315
++ + + +HQ DFG+A + T
Sbjct: 155 WERKSYWKNMLE----AVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 210
Query: 316 VSTD-IAGTLGYIPPE-----------YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363
V D G + Y+PPE + + DV+S G IL + K P
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---- 266
Query: 364 FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423
FQ+ N + + + + P + + ++ L+ +P R ++
Sbjct: 267 FQQI--INQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKR-------DPKQRISI 315
Query: 424 LHVLK 428
+L
Sbjct: 316 PELLA 320
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 52/207 (25%), Positives = 73/207 (35%), Gaps = 43/207 (20%)
Query: 185 LTLVDILEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ---FTAEMETLGKVK 237
L L++ L DG FG V + P GKT VAVK F E+ + +
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H+NL+ L G +V E GSL LR G + A A G+
Sbjct: 80 HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMG 135
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP----- 328
+L DFGL R + + H + +P
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY---VMQEHRKVPFAWCA 192
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVT 355
PE ++R + D + FGV L E+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 52/230 (22%), Positives = 82/230 (35%), Gaps = 64/230 (27%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
+ V + +G FG V++A P VAVK + + + F E + +
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSS---- 292
+ N+V LLG C+ + L++EYM G L+ +LR+ +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 293 ----------------ARGLAFLHQ------------------------DFGLARLISAC 312
A G+A+L + DFGL+R I
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI--- 224
Query: 313 ETHVSTDI--AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
S D A IP PE TT DV+++GV+L E+ +
Sbjct: 225 ---YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 57/224 (25%), Positives = 82/224 (36%), Gaps = 58/224 (25%)
Query: 184 KLTLVDILEDGGFGTVYKATL------PDGKTVAVKKF-SQAKTQGHRQFTAEMETLGKV 236
+L L L G FG V +A +TVAVK A HR +E++ L +
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 237 -KHQNLVLLLGYCSFDEEKLLV-YEYMVNGSLDLWLRN------------ATGSHEVLDR 282
H N+V LLG C+ L+V E+ G+L +LR+ + L
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 283 AKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318
+ A+G+ FL DFGLAR I
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI------YKD 201
Query: 319 DI--AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+P PE R+ T + DV+SFGV+L E+ +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 43/206 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL--PDGKT--VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
+ L IL +G FG VY+ G+ VAVK + T +++ F +E + + H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++V L+G +E ++ E G L +L S L + + +A+
Sbjct: 73 PHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAY 128
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP-----P 329
L DFGL+R I + ++ +P P
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSP 183
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R TT DV+ F V + E+++
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 50/230 (21%), Positives = 80/230 (34%), Gaps = 64/230 (27%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGK------TVAVKKF-SQAKTQGHRQFTAEMETLGKV 236
L +L G FG V AT VAVK +A + +E++ + ++
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 237 -KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSS--- 292
H+N+V LLG C+ L++EY G L +LR+ + +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 293 ----------------ARGLAFLHQ------------------------DFGLARLISAC 312
A+G+ FL DFGLAR I
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI--- 222
Query: 313 ETHVSTDI--AGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
+S +P PE + T + DV+S+G++L E+ +
Sbjct: 223 ---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 51/277 (18%), Positives = 93/277 (33%), Gaps = 65/277 (23%)
Query: 194 GGFGTVYKATLPDGKTVAVK--KFSQAKTQGHRQFTAEMETLGKVKHQNL--VLLLGYCS 249
GG V++ + A+K +A Q + E+ L K++ + + L Y
Sbjct: 39 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98
Query: 250 FDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ----- 301
++ + +V E N L+ WL+ K Y + + +HQ
Sbjct: 99 -TDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLE----AVHTIHQHGIVH 150
Query: 302 ------------------DFGLARLISACETHVSTD-IAGTLGYIPPE-----------Y 331
DFG+A + T V D GT+ Y+PPE
Sbjct: 151 SDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
+ + DV+S G IL + K P FQ+ N + + + + P
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTP----FQQI--INQISKLHAIIDPNHEIEF--P 262
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + ++ L+ +P R ++ +L
Sbjct: 263 DIPEKDLQDVLKCCLKR-------DPKQRISIPELLA 292
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 31/152 (20%), Positives = 44/152 (28%), Gaps = 12/152 (7%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L + F + L L L Q+ + L L LT N T+L
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
K L HL L N L L N + +L+ LD N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISL 152
+ + K + L Q + +SL
Sbjct: 165 I-----HYLSKEDMSSL-------QQATNLSL 184
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 27/153 (17%), Positives = 44/153 (28%), Gaps = 14/153 (9%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
IP +S + L N L + +L L L+LTR + + + L
Sbjct: 26 EIPGTLPNSTEC--LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L L++N +L +L + L N LE L + N +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI-S 142
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I + L + N
Sbjct: 143 SIKLPKGFP-----------TEKLKVLDFQNNA 164
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 39/159 (24%), Positives = 54/159 (33%), Gaps = 16/159 (10%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+ F LQ L L L+ +P L L L KL L+ NKF S N
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 61 KGLSHLDLSSNFFDGG-WPRSLGNLSYSTYLDLHDNKFTR--EIPQNLGNLAQLEHLDVL 117
L+HL + N L NL LDL + L NL+ L+ L++
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 118 RNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N + + K C L + LA +
Sbjct: 385 YNEP-LSLKTEAFKE-----------CPQLELLDLAFTR 411
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 35/154 (22%), Positives = 55/154 (35%), Gaps = 16/154 (10%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG---PVPTSLGNLKG 62
S F + L+ L L ++ L S + L L LNL N F SL L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122
L L LS + +L ++DL N+ T + L +L + +L++ N +
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536
Query: 123 GKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+P + I I+L N
Sbjct: 537 IILPSLL------------PILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 34/145 (23%), Positives = 58/145 (40%), Gaps = 12/145 (8%)
Query: 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72
+ ++ + L + + GL +L+LT S +P+ L L L L LS+N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCGKIPEKICK 131
F+ S N T+L + N E+ L NL L LD+ + + C
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI-ETSD--CCN 369
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
+L L +L ++L+ N+
Sbjct: 370 LQLRNLS-------HLQSLNLSYNE 387
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 24/174 (13%), Positives = 54/174 (31%), Gaps = 19/174 (10%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
++ + L+ LYLG+N ++ L L+ N + +L
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176
Query: 61 KGLSH--LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGN--LAQLEHLDV 116
+ ++ L+L+ N G + + L+ + I + L N + L
Sbjct: 177 QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 117 LRNMLCG---KIPEKICKSRLEGL-VSQSGI----------CQNLSKISLAGNK 156
+ E +C+ +E + + + L ++ L
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 31/160 (19%), Positives = 51/160 (31%), Gaps = 16/160 (10%)
Query: 1 LTGSIPSEFGDSLKLQGLYL-GNNQLTGSIPRSLGQLGGLVKLNLTRNK--FSGPVPTSL 57
+ L L + GN + L L L +L+L+ + S L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDV 116
NL L L+LS N + LDL + + Q+ NL L+ L++
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
++L + L ++L GN
Sbjct: 433 SHSLLDISSEQLFDG------------LPALQHLNLQGNH 460
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 26/121 (21%), Positives = 44/121 (36%), Gaps = 5/121 (4%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L+ F + + L +N+LT S +L L G+ LNL N S +P+ L L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPIL 546
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
++L N D + N+ + + + K N L + +
Sbjct: 547 SQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 121 L 121
L
Sbjct: 603 L 603
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 39/206 (18%), Positives = 64/206 (31%), Gaps = 21/206 (10%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGN 59
+ P F L+ L +L +GQL L KLN+ N +P N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYST----YLDLHDNKFTREIPQNLGNLAQLEHLD 115
L L H+DLS N+ L L + LD+ N I +L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 116 VLRNMLCGKIPEKICK--SRLEGLVSQSGICQNLSKIS---------LAGNKDYNLYLSS 164
+ N I + + + L G ++ + L L+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 165 SRSKGPLRINISMFQQPLLKLTLVDI 190
+ +I F L ++ + +
Sbjct: 271 TND---FSDDIVKFHC-LANVSAMSL 292
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 33/153 (21%), Positives = 51/153 (33%), Gaps = 13/153 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + S K + L N L S L L+L+R + + L L
Sbjct: 25 KVPDDIPSSTKN--IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
S+L L+ N P S L+ L + K +G L L+ L+V N +
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI-- 140
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ S NL + L+ N
Sbjct: 141 --------HSCKLPAYFSN-LTNLVHVDLSYNY 164
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 30/167 (17%), Positives = 56/167 (33%), Gaps = 14/167 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+ + F +LQ L ++ L S L L+ L+++ L
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 63 LSHLDLSSNFF-DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L+ L ++ N F D N + T+LDL + + L +L+ L++ N L
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 122 CGKIPEKICKS-----------RLEGLVSQS-GICQNLSKISLAGNK 156
+ R+E ++L+ +L N
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 33/157 (21%), Positives = 50/157 (31%), Gaps = 15/157 (9%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGG--LVKLNLTRNKFSGPVPTSLGNL 60
GSI + L L L N L+ S S LG L L+L+ N + L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGL 398
Query: 61 KGLSHLDLSSNFFDGGWPRS-LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
+ L HLD + S +L YLD+ + L L L + N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + NL+ + L+ +
Sbjct: 459 SFKDNTLSNVFAN-----------TTNLTFLDLSKCQ 484
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 20/98 (20%), Positives = 32/98 (32%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
++ + F ++ L L L QL L L LN++ N + L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT 98
LS LD S N + + +L +N
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 34/205 (16%), Positives = 51/205 (24%), Gaps = 64/205 (31%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ---------------------------- 35
I + +KL L L N + +I ++ Q
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 36 LGGLVK-----LNLTRNKFSGPVPTSLGNLKGLSHLDLSSN----FFDGGWPRSLGNLSY 86
+ GL LT L +S + L+ D +LS
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 87 S---------------TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
L L NK + I L L +LD+ RN L
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNAL---------- 362
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
S +L + L+ N
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNG 387
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 33/157 (21%), Positives = 55/157 (35%), Gaps = 14/157 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
E + LQ L L + S+P S+ L L L + + S + ++ +L L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
LDL +P G + L L D +P ++ L QLE LD+ +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNL 160
++P I + I + + L
Sbjct: 292 RLPSLIAQ------------LPANCIILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 28/164 (17%), Positives = 51/164 (31%), Gaps = 27/164 (16%)
Query: 4 SIPSEFGD--SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
+ D L L + L P +L L + + +P ++
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFA 127
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGN---------LAQLE 112
GL L L+ N P S+ +L+ L + E+P+ L + L L+
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 113 HLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L + + +P I QNL + + +
Sbjct: 187 SLRLEWTGIR-SLPASIAN------------LQNLKSLKIRNSP 217
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 20/103 (19%), Positives = 35/103 (33%), Gaps = 3/103 (2%)
Query: 4 SIPSEFGDSLKLQGLYL-GNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
++ KL+ L L G L + P G L +L L +P + L
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL 105
L LDL P + L + + + + ++ Q+
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 28/163 (17%), Positives = 46/163 (28%), Gaps = 38/163 (23%)
Query: 15 LQGLYL-GNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP-------------------VP 54
+ LY G+ L L Q + R +
Sbjct: 14 RENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72
Query: 55 TSLGNLK--GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE 112
L + G L+L S +P LS+ ++ + E+P + A LE
Sbjct: 73 DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130
Query: 113 HLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
L + RN L +P I L ++S+
Sbjct: 131 TLTLARNPL-RALPASIAS------------LNRLRELSIRAC 160
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 41/380 (10%), Positives = 87/380 (22%), Gaps = 89/380 (23%)
Query: 109 AQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSK 168
+ +E D L + E I R E L + + + ++ +
Sbjct: 2 SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTA-------------TVWPQN 48
Query: 169 GPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG---HR 224
+ S+ Q KL LV+ L G V+ + + A+K F+
Sbjct: 49 AETTV-DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE 107
Query: 225 QFTAEMETLGKVKHQNLVLLLGYCSF--------------------------DEEKLLVY 258
+ ++ ++ LL+
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 259 EYMV--NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------- 301
L L + + R A L
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227
Query: 302 ---------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS--TTRGDVYSFGVIL 350
D + + + Y P E+ + + T + + G+ +
Sbjct: 228 MPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 351 LELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN--AGSKPMMLKMLRI 408
+ P F W ++ D + + K ++ + L
Sbjct: 284 YRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339
Query: 409 AADCVADNPATRPTMLHVLK 428
+ R L ++
Sbjct: 340 -------DRRRRLLPLEAME 352
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 184 KLTLVD-ILEDGGFGTVYKATLPDGK---TVAVK--KFSQAKTQGHRQFTAEMETLGKVK 237
LTL D L G FGTV K K TVAVK K + AE + ++
Sbjct: 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
+ +V ++G C E +LV E G L+ +L+ + + ++ + G+
Sbjct: 77 NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMK 131
Query: 298 FL------HQD------------------FGLARLISACETHVSTDIAGTLGYIP----- 328
+L H+D FGL++ + A E + A T G P
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK---AQTHGKWPVKWYA 188
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVT 355
PE +++ DV+SFGV++ E +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 52/276 (18%), Positives = 93/276 (33%), Gaps = 63/276 (22%)
Query: 194 GGFGTVYKATLPDGKTVAVK--KFSQAKTQGHRQFTAEMETLGKVKHQNL--VLLLGYCS 249
GG V++ + A+K +A Q + E+ L K++ + + L Y
Sbjct: 20 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ------ 301
D+ +V E N L+ WL+ K Y + + +HQ
Sbjct: 80 TDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLE----AVHTIHQHGIVHS 132
Query: 302 -----------------DFGLARLISACETHVSTD-IAGTLGYIPPE-----------YG 332
DFG+A + T V D GT+ Y+PPE
Sbjct: 133 DLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392
+ + DV+S G IL + K P FQ+ N + + + ++ P
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTP----FQQII--NQISKLHAIIDPNH--EIEFPD 244
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + ++ L+ +P R ++ +L
Sbjct: 245 IPEKDLQDVLKCCLKR-------DPKQRISIPELLA 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 41/206 (19%)
Query: 184 KLTLVDI-LEDGGFGTVYKATL--PDGKT-VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
L + DI L G FG+V + + VA+K Q + + E + + ++ +
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+V L+G C E +LV E G L +L + + ++ + G+ +
Sbjct: 70 PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKY 125
Query: 299 L------HQD------------------FGLARLISACETHVSTDIAGTLGYIP-----P 329
L H+D FGL++ + A + S A + G P P
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWYAP 182
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVT 355
E R ++R DV+S+GV + E ++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 60/263 (22%), Positives = 92/263 (34%), Gaps = 57/263 (21%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYC-S 249
G F TVYK VA + K ++F E E L ++H N+V S
Sbjct: 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96
Query: 250 FDEEKLLVY---EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301
+ K + E M +G+L +L+ +V+ +GL FLH
Sbjct: 97 TVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
D GLA L A + + GT ++ PE + +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEEK-YDE 208
Query: 340 RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399
DVY+FG+ +LE+ T+ E P + + A + V +K D V P V
Sbjct: 209 SVDVYAFGMCMLEMATS-EY--PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE---- 261
Query: 400 PMMLKMLRIAADCVADNPATRPT 422
I C+ N R +
Sbjct: 262 --------IIEGCIRQNKDERYS 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 60/281 (21%), Positives = 97/281 (34%), Gaps = 75/281 (26%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252
GGFG V+KA DGKT +K+ + R E++ L K+ H N+V +D
Sbjct: 22 GGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHY--NGCWDG 75
Query: 253 EKL------------------LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
+ E+ G+L+ W+ G LD+ ++ +
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLALELFEQITK 133
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
G+ ++H DFGL + T GTL Y+ PE
Sbjct: 134 GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPE 191
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
S+ D+Y+ G+IL EL+ E + F ++ D+ D
Sbjct: 192 QISSQDYGKEVDLYALGLILAELLH------VCDTAFETSKF----FTDLRDGIISDIFD 241
Query: 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431
K ++ K+L P RP +L+ L
Sbjct: 242 KKE-----KTLLQKLLSK-------KPEDRPNTSEILRTLT 270
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 40/195 (20%)
Query: 194 GGFGTVYKATLPDGK---TVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCS 249
G FG+V + K VA+K Q + + E + + ++ + +V L+G C
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
E +LV E G L +L V + A ++ + G+ +L +
Sbjct: 407 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA---ELLHQVSMGMKYLEEKNFVHRNL 462
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQSRMSTTR 340
DFGL++ + A + S A + G P PE R ++R
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 341 GDVYSFGVILLELVT 355
DV+S+GV + E ++
Sbjct: 520 SDVWSYGVTMWEALS 534
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 56/298 (18%), Positives = 103/298 (34%), Gaps = 47/298 (15%)
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK---FSQ 217
+ + + M L + + G F VY+A L DG VA+KK F
Sbjct: 11 PPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 218 AKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL--VYEYMVNGSLDLWLRNATG 275
+ E++ L ++ H N++ SF E+ L V E G L +++
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKK 128
Query: 276 SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311
++ +K L +H D GL R S+
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188
Query: 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371
T + + GT Y+ PE + D++S G +L E+ + P F + N
Sbjct: 189 KTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYG-DKMN 242
Query: 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
L + +K+++ L + + ++ + +P RP + +V +
Sbjct: 243 LYS-LCKKIEQCDYPP-LPSDHYSEELRQLVNMCINP-------DPEKRPDVTYVYDV 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 52/286 (18%), Positives = 94/286 (32%), Gaps = 73/286 (25%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVLLLGYCSFD 251
GGFG V++A D A+K+ + R+ E++ L K++H +V + ++
Sbjct: 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY--FNAWL 73
Query: 252 EE-----------KLLVY---EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
E+ K+ +Y + +L W+ E +R+ I A +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHIFLQIAEAVE 132
Query: 298 FLHQ------------------------DFGLARLIS-----------ACETHVSTDIAG 322
FLH DFGL + T G
Sbjct: 133 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG 192
Query: 323 TLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382
T Y+ PE + + D++S G+IL EL+ F ++
Sbjct: 193 TKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------F---STQMERVRTLTDVRN 242
Query: 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + T M+ ML +P RP +++++
Sbjct: 243 LKFPPL--FTQKYPCEYVMVQDMLSP-------SPMERPEAINIIE 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 54/283 (19%), Positives = 103/283 (36%), Gaps = 60/283 (21%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNL 241
+ D+L G GT+ + D + VAVK+ + E++ L + +H N+
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 242 VLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
+ +C+ D + + E +L ++ +H L+ + S GLA L
Sbjct: 81 IRY--FCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTS---GLAHL 134
Query: 300 HQ-----------------------------DFGLARLISA--CETHVSTDIAGTLGYIP 328
H DFGL + ++ + + GT G+I
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 329 PEY--GQSRMSTTRG-DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385
PE + + T D++S G + +++ P F G +L +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P-F----GKSLQRQANILLGACSL 247
Query: 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
D + + ++ ++ KM+ + +P RP+ HVLK
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHVLK 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 48/290 (16%), Positives = 86/290 (29%), Gaps = 55/290 (18%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+ L +GGF V L DG A+K+ + Q + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 243 LLLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
L+ YC + L+ + G+L + L + + RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIA--------GTLGY 326
+H D G + T+ Y
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 327 IPPE--YGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
PE QS R DV+S G +L ++ + P + + G Q
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----Y---DMVFQKGDSVAL-AVQ 261
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ ++ ++ M+ + +P RP + +L L +
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTV-------DPHQRPHIPLLLSQLEAL 304
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 60/268 (22%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR---QFTAEMETLGKVKHQNLVLLLGYCS 249
G F VY+A + G VA+K + + E++ ++KH +++ L Y
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-- 79
Query: 250 F-DEEKL-LVYEYMVNGSLDLWLRNATGS-HEVLDRAKRY--KIACSSARGLAFLHQ--- 301
F D + LV E NG ++ +L+N E + A+ + +I G+ +LH
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEARHFMHQIIT----GMLYLHSHGI 133
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGLA + T + GT YI PE
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 341 GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
DV+S G + L+ + P F N K+ D P+ L+ +K
Sbjct: 193 SDVWSLGCMFYTLLIGRPP----FDTDTVKNT----LNKVVL---ADYEMPSFLSIEAKD 241
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLK 428
++ ++LR NPA R ++ VL
Sbjct: 242 LIHQLLRR-------NPADRLSLSSVLD 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 67/270 (24%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR---QFTAEMETLGKVKHQNLVLLLGYCS 249
G FG VY A +A+K +A+ + Q E+E ++H N++ L GY
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF- 78
Query: 250 FDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
D ++ L+ EY G++ L+ + E R Y A L++ H
Sbjct: 79 HDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATY--ITELANALSYCHSKRVIHRD 134
Query: 302 -----------------DFGLA------RLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFG + R C GTL Y+PPE + RM
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---------GTLDYLPPEMIEGRMHD 185
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398
+ D++S GV+ E + K P F+ ++++ + + P + G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP----FEANTYQET----YKRISRV---EFTFPDFVTEGA 234
Query: 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ ++ ++L+ NP+ RP + VL+
Sbjct: 235 RDLISRLLKH-------NPSQRPMLREVLE 257
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 55/266 (20%), Positives = 98/266 (36%), Gaps = 57/266 (21%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR---QFTAEMETLGKVKHQNLVLLLGYCS 249
GGF ++ + + A K ++ + + E+ + HQ++V G+
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 250 FDEEKLLVYEYMVNGSL-DLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ----- 301
++ +V E SL +L R + E A+ Y +I G +LH+
Sbjct: 86 DNDFVFVVLELCRRRSLLELHKRRKALT-E--PEARYYLRQIVL----GCQYLHRNRVIH 138
Query: 302 -------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGD 342
DFGLA + + GT YI PE + + D
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVD 197
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402
V+S G I+ L+ K P F+ + ++KK ++ P +N + ++
Sbjct: 198 VWSIGCIMYTLLVGKPP----FETSCLKET----YLRIKK---NEYSIPKHINPVAASLI 246
Query: 403 LKMLRIAADCVADNPATRPTMLHVLK 428
KML+ +P RPT+ +L
Sbjct: 247 QKMLQT-------DPTARPTINELLN 265
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 39/331 (11%), Positives = 86/331 (25%), Gaps = 96/331 (29%)
Query: 166 RSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK----- 219
+ P R+ S + L +L +AT G++ V +
Sbjct: 57 NTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 220 -----------------------TQGHRQFTAEMETLGKVKHQNLVLLLGYCS--FDEEK 254
+ H +F + + + + ++ + + +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 255 LLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------- 301
+Y M + L + + +H+ L R ++ R LA LH
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 302 -------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG------- 341
F A + + G+ PPE R + +
Sbjct: 236 DIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLM 290
Query: 342 ----DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
D ++ G+++ + A P + W+F+ +
Sbjct: 291 TFSFDAWALGLVIYWIWCADLP----ITKDAALGGSEWIFR-----------SCKNIPQP 335
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ ++ LR R L ++
Sbjct: 336 VRALLEGFLRY-------PKEDRLLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 53/265 (20%), Positives = 95/265 (35%), Gaps = 55/265 (20%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR---QFTAEMETLGKVKHQNLVLLLGYCS 249
GGF ++ + + A K ++ + + E+ + HQ++V G+
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ------ 301
++ +V E SL + E A+ Y +I G +LH+
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRKALTE--PEARYYLRQIVL----GCQYLHRNRVIHR 165
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDV 343
DFGLA + + GT YI PE + + DV
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 344 YSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMML 403
+S G I+ L+ K P F+ + ++KK ++ P +N + ++
Sbjct: 225 WSIGCIMYTLLVGKPP----FETSCLKET----YLRIKK---NEYSIPKHINPVAASLIQ 273
Query: 404 KMLRIAADCVADNPATRPTMLHVLK 428
KML+ +P RPT+ +L
Sbjct: 274 KMLQT-------DPTARPTINELLN 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 50/272 (18%), Positives = 97/272 (35%), Gaps = 51/272 (18%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+ + +G FG DG+ +K+ S+ ++ + E+ L +KH N+V
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 243 LLLGYCSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
SF+E L V +Y G L + G + L +H
Sbjct: 87 QYRE--SFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH 142
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
DFG+AR++++ GT Y+ PE +++
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
+ D+++ G +L EL T K F E ++ + K+ V +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA----F---EAGSMKN-LVLKIISGSFPPV--SLHYSY 251
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ ++ ++ + NP RP++ +L+
Sbjct: 252 DLRSLVSQLFKR-------NPRDRPSVNSILE 276
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 56/291 (19%), Positives = 102/291 (35%), Gaps = 42/291 (14%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFS-QAKT 220
R + L + + + L G G V+K + P G +A K + K
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72
Query: 221 QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEV 279
Q E++ L + +V G + + ++ + E+M GSLD L+ A E
Sbjct: 73 AIRNQIIRELQVLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 131
Query: 280 LDRAKRYKIACSSARGLAFLHQ-------------------------DFGLA-RLI-SAC 312
+ K++ + +GL +L + DFG++ +LI S
Sbjct: 132 ILG----KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187
Query: 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANL 372
+ V GT Y+ PE Q + + D++S G+ L+E+ + P P ++
Sbjct: 188 NSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 373 VGWVFQKMKKQQADDVLDPTVLNAGSKPM--MLKMLRIAADCVADNPATRP 421
V + LN + + + V + P P
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 43/195 (22%), Positives = 76/195 (38%), Gaps = 32/195 (16%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252
G +G VY L + +A+K+ + ++ + E+ +KH+N+V LG +
Sbjct: 33 GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SFSEN 91
Query: 253 EKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------- 301
+ ++ E + GSL LR+ G + ++ GL +LH
Sbjct: 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQIVHRDIKG 150
Query: 302 ---------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVY 344
DFG ++ ++ T GTL Y+ PE R D++
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIW 209
Query: 345 SFGVILLELVTAKEP 359
S G ++E+ T K P
Sbjct: 210 SLGCTIIEMATGKPP 224
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 35/171 (20%), Positives = 69/171 (40%), Gaps = 17/171 (9%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
S+P+ +L L+ NN+LT S+P L +L ++ N+ + +P LK
Sbjct: 195 SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLTS-LPVLPSELK-- 244
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L +S N P L L ++ N+ T +P++L +L+ +++ N L
Sbjct: 245 -ELMVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL-S 297
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRIN 174
+ + + I + + A + L+L+++ P R
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 38/172 (22%), Positives = 62/172 (36%), Gaps = 33/172 (19%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL--- 60
S+P+ +L+ L + NQLT S+P L L + +P+ L L
Sbjct: 75 SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIF 129
Query: 61 -----------KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLA 109
GL L +S N P L L ++N+ T +P
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPSG-- 182
Query: 110 QLEHLDVLRNMLCGKIPEKICK-SRLE----GLVSQSGICQNLSKISLAGNK 156
L+ L V N L +P + +L L S + L ++ ++GN+
Sbjct: 183 -LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNR 232
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 19/128 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++P + L + +N LT S+P + L L ++ N+ + +P L L
Sbjct: 54 TLPDCLPAHI--TTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLTS-LPVLPPGLLEL 106
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
S P L L + N+ T +P L+ L V N L
Sbjct: 107 SIFSNPLTHL----PALPSGL---CKLWIFGNQLT-SLPVLPPG---LQELSVSDNQL-A 154
Query: 124 KIPEKICK 131
+P +
Sbjct: 155 SLPALPSE 162
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 25/121 (20%), Positives = 46/121 (38%), Gaps = 11/121 (9%)
Query: 38 GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKF 97
G LN+ + + +P L ++ L + N P L L++ N+
Sbjct: 41 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPEL---RTLEVSGNQL 93
Query: 98 TREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEG--LVSQSGICQNLSKISLAGN 155
T +P L +L L +P +CK + G L S + L ++S++ N
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHL-PALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDN 151
Query: 156 K 156
+
Sbjct: 152 Q 152
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 51/280 (18%), Positives = 96/280 (34%), Gaps = 56/280 (20%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKK--FSQAKTQGHRQFTAEMETLGKVKHQNLV 242
++ + G +G K DGK + K+ + + +E+ L ++KH N+V
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 243 LLLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
Y + +V EY G L + T + LD ++ L
Sbjct: 69 RY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 299 LHQ-----------------------------DFGLARLISACETHVSTDIAGTLGYIPP 329
H+ DFGLAR+++ + T GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSP 185
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389
E + D++S G +L EL P F + + K+++ + +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP----F---TAFSQKE-LAGKIREGKFRRI- 236
Query: 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429
P + ++ +ML + RP++ +L+
Sbjct: 237 -PYRYSDELNEIITRMLNL-------KDYHRPSVEEILEN 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 27/156 (17%), Positives = 52/156 (33%), Gaps = 15/156 (9%)
Query: 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLK 61
G + L+ L L N + ++ + L L L+ + + +L+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNM 120
L +LD+S + LS L + N F + L L LD+ +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L ++ L +L +++A N+
Sbjct: 482 LE-QLSPTA----FNSL-------SSLQVLNMASNQ 505
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 40/218 (18%), Positives = 63/218 (28%), Gaps = 24/218 (11%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF-SGPVPTSLGN 59
+ F LQ L L +G L L +LN+ N S +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTY----LDLHDNKFTREIPQNLGNLAQLEHLD 115
L L HLDLSSN + L L LDL N I +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 116 VLRNMLCGKIPEKICKSRLEGLVSQS-----------------GICQNLSKISLAGNKDY 158
+ N + + + L GL + L +++ +
Sbjct: 207 LRNNFDSLNVMKTCIQG-LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 159 NLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGF 196
L ++ L+ +T+ + +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 34/157 (21%), Positives = 53/157 (33%), Gaps = 9/157 (5%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L F +LQ L L ++ + L L L LT N + L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRN 119
L L +G+L L++ N ++P+ NL LEHLD+ N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + I + L L + +L L+ N
Sbjct: 160 KI-----QSIYCTDLRVLHQMPLLNLSL---DLSLNP 188
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 37/157 (23%), Positives = 54/157 (34%), Gaps = 21/157 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
IP S K L L N L S L L+L+R + + +L L
Sbjct: 21 KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
S L L+ N G L +L L + +G+L L+ L+V N+
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSL---QKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 121 L-CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ K+PE NL + L+ NK
Sbjct: 136 IQSFKLPEYFSN------------LTNLEHLDLSSNK 160
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 1/115 (0%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLS 64
S F L L + + + L L L + N F L+ L+
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 65 HLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
LDLS + P + +LS L++ N+ L L+ + + N
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 31/146 (21%), Positives = 50/146 (34%), Gaps = 15/146 (10%)
Query: 14 KLQGLYLGNNQLT--GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN 71
L+ L L N L+ G +S L L+L+ N + ++ L+ L HLD +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 72 FFDGGWPRS-LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130
S +L YLD+ L+ LE L + N I
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI- 465
Query: 131 KSRLEGLVSQSGICQNLSKISLAGNK 156
L +NL+ + L+ +
Sbjct: 466 ---FTEL-------RNLTFLDLSQCQ 481
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 32/145 (22%), Positives = 50/145 (34%), Gaps = 18/145 (12%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK--FSGPVPTSLGNLKGLSHLDLSSNF 72
L+ L +N+ + S L L L+L+RN F G S L +LDLS N
Sbjct: 327 LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCGKIPEKICK 131
+ L +LD + + + +L L +LD+
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-----RVAFN 438
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
GL +L + +AGN
Sbjct: 439 GIFNGL-------SSLEVLKMAGNS 456
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 21/101 (20%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+ F L+ L + N + +L L L+L++ + PT+ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 60 LKGLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKF 97
L L L+++SN G L +L + LH N +
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSL---QKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 26/172 (15%), Positives = 52/172 (30%), Gaps = 23/172 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGP---VPTSLGN 59
I ++L L L NN + ++ + + L GL L +F
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 60 LKGLSHLDLSSN------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEH 113
L+GL +L + ++ L+ + L + + +H
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQH 308
Query: 114 LDVLRNMLCGKIPEKICKS---------RLEGLVSQSGICQNLSKISLAGNK 156
L+++ P KS + S+ +L + L+ N
Sbjct: 309 LELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFLDLSRNG 358
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 17/75 (22%), Positives = 25/75 (33%), Gaps = 1/75 (1%)
Query: 1 LTGSIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+ + L L L L QL P + L L LN+ N+
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 60 LKGLSHLDLSSNFFD 74
L L + L +N +D
Sbjct: 517 LTSLQKIWLHTNPWD 531
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 55/308 (17%), Positives = 100/308 (32%), Gaps = 98/308 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+ +L G FG V KA D + A+KK + + +E+ L + HQ +V
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRY 67
Query: 245 LGYCSFDEEKL---------------LVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--K 287
Y ++ E + + EY NG+L + + + + D R +
Sbjct: 68 --YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-DEYWRLFRQ 124
Query: 288 IACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIA-- 321
I L+++H DFGLA+ + + D
Sbjct: 125 ILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 322 -----------GTLGYIPPE-------YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363
GT Y+ E Y + + D+YS G+I E++ P
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNE------KIDMYSLGIIFFEMIY------PF 228
Query: 364 FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS---KPMMLKMLRIAADCVADNPATR 420
E N+ +K++ + P + K ++ ++ +P R
Sbjct: 229 STGMERVNI----LKKLRSVSIE--FPPDFDDNKMKVEKKIIRLLIDH-------DPNKR 275
Query: 421 PTMLHVLK 428
P +L
Sbjct: 276 PGARTLLN 283
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 20/150 (13%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
+ + +L L +GNN++T P L L L L + N+ S ++ +L L L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKML 270
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126
++ SN L NLS L L++N+ E + +G L L L + +N + P
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 127 EKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L L + A
Sbjct: 329 -------LASL-------SKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 31/153 (20%), Positives = 56/153 (36%), Gaps = 22/153 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
S S + L L + +++ P + L L L+L N+ P L +L L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ N + N++ L + +NK T P L NL+QL L++ N +
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI-- 255
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
S + + L +++ N+
Sbjct: 256 --------SDINAVKD----LTKLKMLNVGSNQ 276
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 21/153 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+ S + L+ LYL + ++ P L L + LNL N + L N+ GL
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGL 157
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
++L ++ + + NL+ L L+ N+ +I L +L L + N +
Sbjct: 158 NYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIE-DIS-PLASLTSLHYFTAYVNQI-- 211
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + + L+ + + NK
Sbjct: 212 --------TDITPV----ANMTRLNSLKIGNNK 232
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 30/151 (19%), Positives = 60/151 (39%), Gaps = 21/151 (13%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ + L + ++ SI + L L LNL N+ + P L NL L++
Sbjct: 37 VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92
Query: 66 LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125
L + +N +L NL+ L L+++ + +I L NL ++ L++ N +
Sbjct: 93 LYIGTNKITD--ISALQNLTNLRELYLNEDNIS-DIS-PLANLTKMYSLNLGANHNLSDL 148
Query: 126 PEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L + L+ +++ +K
Sbjct: 149 SP------LSNM-------TGLNYLTVTESK 166
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 30/115 (26%), Positives = 52/115 (45%), Gaps = 6/115 (5%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
S + +L L +G NQ++ ++ L L LN+ N+ S + L NL L+ L
Sbjct: 237 SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L++N +G L+ T L L N T P L +L++++ D ++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 27/96 (28%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
S + D KL+ L +G+NQ++ I L L L L L N+ +G L L
Sbjct: 256 SDINAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR 99
+ L LS N R L +LS D + +
Sbjct: 314 TTLFLSQNHITD--IRPLASLSKMDSADFANQVIKK 347
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 48/246 (19%), Positives = 79/246 (32%), Gaps = 51/246 (20%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
L DIL G V++ G A+K F+ E E L K+ H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 244 LLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
L + +E +L+ E+ GSL L + L ++ + G+ L
Sbjct: 72 L--FAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 300 HQ----------------------------DFGLARLISACETHVSTDIAGTLGYIPPEY 331
+ DFG AR + + + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDM 186
Query: 332 GQSRMSTTRG--------DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
+ + D++S GV T P F+ EG V K+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITG 242
Query: 384 QADDVL 389
+ +
Sbjct: 243 KPSGAI 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 60/287 (20%)
Query: 176 SMFQQPLLKLTLVD-----ILEDGGFGTVYKA-TLPDGKTVAVKKFSQAKTQGHR---QF 226
++ + P K T+ D L G FG VY A + +A+K +++ + Q
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 227 TAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKR 285
E+E ++H N++ + Y D +++ L+ E+ G L L+ E R+
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFDE--QRSAT 118
Query: 286 YKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIA 321
+ A L + H+ DFG + + T +
Sbjct: 119 F--MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MC 173
Query: 322 GTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381
GTL Y+PPE + + + D++ GV+ E + P F +++
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSPSHTET----HRRIV 225
Query: 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
D+ P L+ GSK ++ K+LR +P R + V++
Sbjct: 226 N---VDLKFPPFLSDGSKDLISKLLRY-------HPPQRLPLKGVME 262
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 56/290 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
+ + L GGFG V + G+ VA+K+ Q + +R+ + E++ + K+ H N+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 244 LL------GYCSFDEEKLLVYEYMVNGSLDLWLR---NATGSHEVLDRAKRYKIACSSAR 294
+ ++ LL EY G L +L N G E R I+
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS---- 132
Query: 295 GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYI 327
L +LH+ D G A+ + + + T+ GTL Y+
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYL 190
Query: 328 PPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ---------EKEGANLVGWVFQ 378
PE + + T D +SFG + E +T P P +Q EK ++V +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + + P L+ + + L+ + R T
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW---HQRQRGTDPQNPN 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 54/310 (17%), Positives = 95/310 (30%), Gaps = 72/310 (23%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
L DIL G V++ G A+K F+ E E L K+ H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 244 LLGYCSFDEE----KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
L + +E K+L+ E+ GSL L + L ++ + G+ L
Sbjct: 72 L--FAIEEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 300 HQ----------------------------DFGLARLISACETHVSTDIAGTLGYIPPEY 331
+ DFG AR + + + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDM 186
Query: 332 GQSRMSTTRG--------DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
+ + D++S GV T P F+ EG V K+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITG 242
Query: 384 Q------------------ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLH 425
+ + D+ L+ G + ++ +L + +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA---DQEKCWGFDQ 299
Query: 426 VLKLLHEIVD 435
+I+
Sbjct: 300 FFAETSDILH 309
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 22/153 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+I + + + + ++ L ++ + +L+L+ N S L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L+LSSN L +LS LDL++N L +E L N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
++ Q I LA NK
Sbjct: 113 RVS--------------CSRGQGKKNIYLANNK 131
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 34/189 (17%), Positives = 61/189 (32%), Gaps = 41/189 (21%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L ++ S + ++ L L N L+ L L LNL+ N L +L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESL 79
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTR---EIPQNL------------ 105
L LDL++N+ + L L +N +R Q
Sbjct: 80 STLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134
Query: 106 ------GNLAQLEHLDVLRNMLCGKIPEKICKSRLEGL------------VSQSGICQNL 147
G +++++LD+ N + + + + L V + L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEI-DTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKL 193
Query: 148 SKISLAGNK 156
+ L+ NK
Sbjct: 194 KTLDLSSNK 202
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 22/142 (15%), Positives = 47/142 (33%), Gaps = 7/142 (4%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+ S L+ L L N + + + L L+L+ NK + + + G+
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGV 216
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLC 122
+ + L +N ++L + DL N F ++ +++ +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 123 GKIPEKICKSRLEGLVSQSGIC 144
E+ C + L C
Sbjct: 276 TGQNEEECT--VPTLGHYGAYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 19/113 (16%), Positives = 36/113 (31%), Gaps = 6/113 (5%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFS-GPVPTSLGNLKG 62
+ EF + + + L NN+L I ++L L +L N F G + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLG-NLAQLEHL 114
+ + + G + L + ++P L L H
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTV---PTLGHYGAYCCEDLPAPFADRLIALGHH 313
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 19/162 (11%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+ + + L GL L NNQ+T P L L L +L L+ N S ++L L L
Sbjct: 103 ADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSL 158
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L + D + L NL+ LD+ NK + L L LE L N +
Sbjct: 159 QQLSFGNQVTD---LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISD 213
Query: 124 KIPEKICKS---------RLEGLVSQSGICQNLSKISLAGNK 156
P I + +L+ + + + NL+ + LA N+
Sbjct: 214 ITPLGILTNLDELSLNGNQLKDIGTLAS-LTNLTDLDLANNQ 254
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 41/162 (25%), Positives = 63/162 (38%), Gaps = 18/162 (11%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
S S L+ L NNQ++ P LG L L +L+L N+ +L +L L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 245
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ LDL++N L L+ T L L N+ + I L L L +L++ N L
Sbjct: 246 TDLDLANNQISN--LAPLSGLTKLTELKLGANQIS-NIS-PLAGLTALTNLELNENQLED 301
Query: 124 KIPEKICKS---------RLEGLVSQSGICQNLSKISLAGNK 156
P K+ + + S L ++ NK
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISPVSS-LTKLQRLFFYNNK 342
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 24/155 (15%)
Query: 4 SIPSEFGDS--LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
I F D+ + LG +T ++ L + L R + L
Sbjct: 13 PINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLN 68
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L+ ++ S+N L NL+ + +++N+ P L NL L L + N +
Sbjct: 69 NLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
P L+ L NL+++ L+ N
Sbjct: 125 TDIDP-------LKNLT-------NLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 37/153 (24%), Positives = 53/153 (34%), Gaps = 23/153 (15%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
L + NNQLT P L L LV + + N+ + P L NL L
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ L L +N L NL+ L+L N + L L L+ L N +
Sbjct: 115 TGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS-FGNQVTD 169
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
P L L L ++ ++ NK
Sbjct: 170 LKP-------LANL-------TTLERLDISSNK 188
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 38/150 (25%), Positives = 56/150 (37%), Gaps = 23/150 (15%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
+ + KL + + NNQ+ P L L L L L N+ + P L NL L+ L
Sbjct: 84 TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126
+LSSN +L L+ L + + L NL LE LD+ N +
Sbjct: 140 ELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV----- 189
Query: 127 EKICKSRLEGLVSQSGICQNLSKISLAGNK 156
S + L NL + N+
Sbjct: 190 -----SDISVLAK----LTNLESLIATNNQ 210
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 32/162 (19%), Positives = 57/162 (35%), Gaps = 11/162 (6%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
S + L L L N ++ P + L L +L NK S +SL NL ++ L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI- 125
N L NL+ T L L+D +T N + + ++N+ I
Sbjct: 359 SAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKAN---VSIPNTVKNVTGALIA 413
Query: 126 PEKICK-SRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSR 166
P I + +++S ++ + ++
Sbjct: 414 PATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 20/128 (15%), Positives = 40/128 (31%), Gaps = 33/128 (25%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP----------- 52
S S + + L G+NQ++ P L L + +L L ++
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 53 -----------VPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS----TYLDLHDNKF 97
P ++ + + D++ N P +SY+ + F
Sbjct: 402 NTVKNVTGALIAPATISDGGSYTEPDITWNL-----PSYTNEVSYTFSQPVTIGKGTTTF 456
Query: 98 TREIPQNL 105
+ + Q L
Sbjct: 457 SGTVTQPL 464
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 44/178 (24%), Positives = 64/178 (35%), Gaps = 20/178 (11%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSI-PRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLS 64
S F +LQ L LG+ +I + L L L+L +K P + L L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 65 HLDLSSNFF-----DGGWPRSLGNLSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLR 118
L L G+ R+L L T LDL N+ + + G L L+ +D
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKAL---TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINIS 176
N + +C+ LE L + LS SLA N Y+ N+
Sbjct: 158 NQI-----FLVCEHELEPLQG-----KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 12/180 (6%)
Query: 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN 71
++ L L + + R L L LNL NK + + L L L+LS N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 72 FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
+ + L Y+DL N Q L +L+ LD+ N L I
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHF 379
Query: 132 -SRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDI 190
+ + L KI+L N ++LS +R + ++I F + L ++ +
Sbjct: 380 IPSIPDIFLSGNKLVTLPKINLTAN---LIHLSENRLEN---LDILYFLLRVPHLQILIL 433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 31/149 (20%), Positives = 49/149 (32%), Gaps = 20/149 (13%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPV-PTSLGNLKGLSHLDLSSN- 71
+ L L N + S L L L L + + NL L LDL S+
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 72 --FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN--LGNLAQLEHLDVLRNMLCGKIPE 127
F + L +L L L+ + + ++ NL L LD+ +N +
Sbjct: 85 IYFLHPDAFQGLFHL---FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI------ 135
Query: 128 KICKSRLEGLVSQSGICQNLSKISLAGNK 156
L S +L I + N+
Sbjct: 136 ----RSLYLHPSFGK-LNSLKSIDFSSNQ 159
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 8/124 (6%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTG-SIPRSLGQLGGLVKLNLTRNKFSGPVPTSL----- 57
I LQ L L N+ + S ++ + L +L L N T L
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVL 117
L L L L+ N+ + P +L+ L L+ N+ T + N A LE LD+
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDIS 534
Query: 118 RNML 121
RN L
Sbjct: 535 RNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 29/167 (17%), Positives = 54/167 (32%), Gaps = 27/167 (16%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
F LQ L L N L + L + ++L +N + + L+ L
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 66 LDLSSN--------------FFDGGWPRSLGNLSYS-TYLDLHDNKFTR-EIPQNLGNLA 109
LDL N F G +L ++ + + L +N+ +I L +
Sbjct: 367 LDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVP 426
Query: 110 QLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L+ L + +N ++ +L ++ L N
Sbjct: 427 HLQILILNQNRFSSCSGDQTP-----------SENPSLEQLFLGENM 462
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 34/165 (20%), Positives = 56/165 (33%), Gaps = 24/165 (14%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLG-------NL 60
F K+ + L N + ++ L L L+L N + S+ L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393
Query: 61 KGLSHLDLSSNFFDGGWPR--------SLGNLSYSTYLDLHDNKFTR-EIPQNLGNLAQL 111
L ++L++N R L + + L L+ N+F+ Q L
Sbjct: 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
Query: 112 EHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
E L + NML ++C EGL +L + L N
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGL-------SHLQVLYLNHNY 491
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 32/149 (21%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGG- 76
+ LT +P+ L +L L+ N +S L+ L L+L S +
Sbjct: 9 AFYRFCNLT-QVPQVLNTT---ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 77 WPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEG 136
+ NL LDL +K P L L L + L + +
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV---LKDGYFRN 121
Query: 137 LVSQSGICQNLSKISLAGNKDYNLYLSSS 165
L + L+++ L+ N+ +LYL S
Sbjct: 122 L-------KALTRLDLSKNQIRSLYLHPS 143
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 25/109 (22%), Positives = 37/109 (33%), Gaps = 15/109 (13%)
Query: 9 FGDSLKLQGLYLGNNQLTGSI-----PRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++ L+ L+LG N L + L L L L N + P +L L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506
Query: 64 SHLDLSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNL 108
L L+SN P +L LD+ N+ P +L
Sbjct: 507 RGLSLNSNRLTVLSHNDLPANL------EILDISRNQLLAPNPDVFVSL 549
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 32/175 (18%), Positives = 53/175 (30%), Gaps = 34/175 (19%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGG--LVKLNLTRNKFSGPVPTSLGNLK 61
+ FG L+ + +NQ+ L L G L +L N V G
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 62 G------LSHLDLSSNFF------------DGGWPRSLGNLSYSTYLDLHDNKFTREIPQ 103
L LD+S N + SL + +
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 104 NLGNLAQ--LEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
LA+ + HLD+ + + ++ E L ++L ++LA NK
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRV----FETL-------KDLKVLNLAYNK 301
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 32/121 (26%), Positives = 42/121 (34%), Gaps = 9/121 (7%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
F LQ LYL +N L P L L L+L N+ + L L
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEI 530
Query: 66 LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIP----QNLGNLAQLEHLDVLRNML 121
LD+S N P +LS LD+ NKF E N N + ++
Sbjct: 531 LDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELSTFINWLNHTNVTIAGPPADIY 587
Query: 122 C 122
C
Sbjct: 588 C 588
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 22/153 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+I + + + + ++ L ++ + +L+L+ N S L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L+LSSN L +LS LDL++N L +E L N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
++ Q I LA NK
Sbjct: 113 RVS--------------CSRGQGKKNIYLANNK 131
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 34/157 (21%), Positives = 50/157 (31%), Gaps = 25/157 (15%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLKG 62
+ G K +YL NN++T G + L+L N+ +
Sbjct: 113 RVSCSRGQGKKN--IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 63 LSHLDLSSNF---FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L HL+L NF G L LDL NK + + A + + + N
Sbjct: 171 LEHLNLQYNFIYDVKGQVV--FAKL---KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L I + + QNL L GN
Sbjct: 225 KL-VLIEKAL------------RFSQNLEHFDLRGNG 248
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 10/121 (8%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L ++ S + ++ L L N L+ L L LNL+ N L +L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESL 79
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L LDL++N+ + L L +N + + +++ + N
Sbjct: 80 STLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNK 131
Query: 121 L 121
+
Sbjct: 132 I 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 34/166 (20%), Positives = 60/166 (36%), Gaps = 6/166 (3%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTG-SIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+T + G ++Q L L N++ + L LNL N V +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-V 189
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L LDLSSN + + T++ L +NK I + L LEH D+ N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 120 ML-CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSS 164
CG + + K++ V++ + + + + +
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 13/123 (10%), Positives = 27/123 (21%), Gaps = 7/123 (5%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
I S L+ L N R + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 64 SHLDLSSNF---FDGGWPRSLGNLSYSTY--LDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
+ + + L L + L ++ + N A+ +D L+
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALK 345
Query: 119 NML 121
Sbjct: 346 EQY 348
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 66/310 (21%), Positives = 110/310 (35%), Gaps = 74/310 (23%)
Query: 174 NISMFQQPLLKL-TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMET 232
NI F+Q L L IL G GTV G+ VAVK+ E++
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKL 61
Query: 233 LGKVK-HQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIA 289
L + H N++ YCS + L + E N +L + + S E L K Y
Sbjct: 62 LTESDDHPNVIRY--YCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 290 C---SSARGLAFLHQ-------------------------------------DFGLARLI 309
A G+A LH DFGL + +
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 310 SACETHVST---DIAGTLGYIPPEY--GQSRMSTTRG-----DVYSFGVILLELVTA-KE 358
+ ++ T + +GT G+ PE + + T R D++S G + +++ K
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 359 PTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPA 418
P G ++ + + + + L L A + ++ +M+ +P
Sbjct: 239 PFGDKYSRESN------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH-------DPL 285
Query: 419 TRPTMLHVLK 428
RPT + VL+
Sbjct: 286 KRPTAMKVLR 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 35/148 (23%), Positives = 60/148 (40%), Gaps = 10/148 (6%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68
F KL + + + +T +IP+ L L +L+L NK + SL L L+ L L
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223
Query: 69 SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128
S N SL N + L L++NK ++P L + ++ + + N +
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI-----SA 277
Query: 129 ICKSRLEGLVSQSGICQNLSKISLAGNK 156
I + + + S +SL N
Sbjct: 278 IGSNDFCPPGYNTK-KASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 37/157 (23%), Positives = 56/157 (35%), Gaps = 23/157 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + L L L NN++T L L L L NK S P + L L
Sbjct: 45 KVPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L LS N P++L L +H+N+ T+ L Q+ +++ N
Sbjct: 103 ERLYLSKNQLKELPEKMPKTL------QELRVHENEITKVRKSVFNGLNQMIVVELGTNP 156
Query: 121 L-CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L I +G+ + LS I +A
Sbjct: 157 LKSSGIENGA----FQGM-------KKLSYIRIADTN 182
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 34/152 (22%), Positives = 52/152 (34%), Gaps = 23/152 (15%)
Query: 14 KLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72
L L+L N++T + SL L L KL L+ N S SL N L L L++N
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-------LGNLAQLEHLDVLRNML-CGK 124
P L + Y + LH+N + I N A + + N + +
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
Query: 125 IPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I + + + L K
Sbjct: 310 IQPST----FRCV-------YVRAAVQLGNYK 330
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 40/206 (19%), Positives = 62/206 (30%), Gaps = 47/206 (22%)
Query: 187 LVDILEDGGFGTVYKA--TLPDGKTVAVKKFSQAKTQG-HRQFTAEMETLGKVKHQNLVL 243
+ + GG G +Y A +G+ V +K + AE + L +V H ++V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 244 LLGYCSFDEEKL-----LVYEYMVNG-SLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
+ + + +V EY V G SL E + L+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQKLPVAEAIA------YLLEILPALS 196
Query: 298 FLHQ-----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
+LH D G I + GT G+ PE
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI----NSFGY-LYGTPGFQAPE--IV 249
Query: 335 R-MSTTRGDVYSFGVILLELVTAKEP 359
R T D+Y+ G L L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 17/122 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P L+ + NNQLT +P L L++ N+ + +P +L+
Sbjct: 134 MLPELPA---LLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPELPESLE-- 183
Query: 64 SHLDLSSNFFDGGWPRSLGNL----SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
LD+S+N + P + +N+ T IP+N+ +L + + N
Sbjct: 184 -ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 120 ML 121
L
Sbjct: 241 PL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 31/157 (19%), Positives = 48/157 (30%), Gaps = 33/157 (21%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++P L+ L + NNQLT +P L +N N+ + +P +L+
Sbjct: 114 TLPELPA---SLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLTM-LPELPTSLE-- 163
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE----HLDVLRN 119
L + +N P +L LD+ N +P E N
Sbjct: 164 -VLSVRNNQL-TFLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ IPE I I L N
Sbjct: 218 RI-THIPENILS------------LDPTCTIILEDNP 241
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 24/146 (16%)
Query: 22 NNQLTG---SIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP 78
N ++G + + RN+ + L + S L L+ P
Sbjct: 19 YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLP 75
Query: 79 RSLG-NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGL 137
+L + T L++ N +P+ + LE+LD N L +PE + L+ L
Sbjct: 76 DNLPPQI---TVLEITQNALI-SLPELPAS---LEYLDACDNRL-STLPELP--ASLKHL 125
Query: 138 -VSQSGICQ------NLSKISLAGNK 156
V + + L I+ N+
Sbjct: 126 DVDNNQLTMLPELPALLEYINADNNQ 151
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 28/209 (13%), Positives = 53/209 (25%), Gaps = 43/209 (20%)
Query: 194 GGFGTVYKAT------LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGY 247
G F VY+AT + + +K A T ME L +
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135
Query: 248 CSFDEEKLLVYEYMVNGSL-DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----- 301
F +LV E G+L + +V+ + A + +H
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIH 195
Query: 302 ------------------------------DFGLARLISAC-ETHVSTDIAGTLGYIPPE 330
D G + + + + T T G+ E
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
++ + D + + ++
Sbjct: 256 MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 49/204 (24%), Positives = 76/204 (37%), Gaps = 38/204 (18%)
Query: 187 LVDILEDGGFGTVYKATLPD---GKTVAVK----KFSQAKTQGHRQFTAEMETLGKVKHQ 239
+VD L GG TVY A D VA+K + + R F E+ ++ HQ
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQ 71
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V ++ D+ LV EY + G L SH L G+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEY-IEGPT---LSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG+A+ +S + + GT+ Y PE +
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 336 MSTTRGDVYSFGVILLELVTAKEP 359
+ D+YS G++L E++ + P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 35/157 (22%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
SIPS + ++ L L N++T L L L L ++ + + +L L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRN 119
HLDLS N W L +L YL+L N + + NL L+ L +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSL---KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+I GL +L+++ +
Sbjct: 134 ETFSEIRRID----FAGL-------TSLNELEIKALS 159
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 29/153 (18%), Positives = 57/153 (37%), Gaps = 14/153 (9%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ LQ L L ++++ + LG L L+L+ N S + G L L +
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 66 LDLSSNFFDG-GWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCG 123
L+L N + G NL+ L + + + EI + L L L++ L
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL-- 160
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L+ + +++ ++L ++
Sbjct: 161 ---RNYQSQSLKSI-------RDIHHLTLHLSE 183
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 23/118 (19%), Positives = 42/118 (35%), Gaps = 5/118 (4%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68
+++ ++ L++ L + L + ++ + +K + +LK L LDL
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL 341
Query: 69 SSNFF---DGGWPRSLGNLSYSTYLDLHDNKFT--REIPQNLGNLAQLEHLDVLRNML 121
S N G L L N ++ + L L L LD+ RN
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 8/127 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ-LGGLVKLNLTRNKFS---GPVPTS 56
L + + + K++ + + N+++ +P S Q L L L+L+ N
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 57 LGNLKGLSHLDLSSNFFD--GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
G L L LS N L L T LD+ N F +P + ++ L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 115 DVLRNML 121
++ +
Sbjct: 416 NLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 26/117 (22%), Positives = 39/117 (33%), Gaps = 1/117 (0%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+ S F + LQ L +GN + I R L L +L + SL +++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
+ HL L + LS YL+L D R L + L
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 18/120 (15%), Positives = 36/120 (30%), Gaps = 17/120 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P K++ L L + + + + L L+++ N L L+
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQ-- 454
Query: 64 SHLDLSSNFF----DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L +S N D L + + N+ L L+ + + N
Sbjct: 455 -ELYISRNKLKTLPDASLFPVL------LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+LQ LY+ N+L ++P + L+ + ++RN+ L L + L +N +
Sbjct: 452 RLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
Query: 74 D 74
D
Sbjct: 510 D 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 12/87 (13%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN-- 71
L+ L + NN L S L +L +L ++RNK +P L + +S N
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLKT-LP-DASLFPVLLVMKISRNQL 485
Query: 72 -FFDGGWPRSLGNLSYSTYLDLHDNKF 97
G L +L + LH N +
Sbjct: 486 KSVPDGIFDRLTSL---QKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/206 (16%), Positives = 64/206 (31%), Gaps = 38/206 (18%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTG-------SIPRSLGQLGGLVKLNLTRNKFSGPV 53
S S ++ L + LT + R + +L + + T N
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 54 PTSLGNLKG--------LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL 105
P+ + + L + + L + + ++K +P +
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSF 329
Query: 106 G-NLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSS 164
+L LE LD+ N + E+ K+ G +L + L+ N L S
Sbjct: 330 SQHLKSLEFLDLSEN----LMVEEYLKNSAC-----KGAWPSLQTLVLSQNH-----LRS 375
Query: 165 SRSKGPLRINISMFQQPLLKLTLVDI 190
++ + L LT +DI
Sbjct: 376 ------MQKTGEILLT-LKNLTSLDI 394
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 27/187 (14%), Positives = 52/187 (27%), Gaps = 31/187 (16%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+ F D L ++ L L + L L + + S S L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 63 LSHLDLSSNFF----------------DGGWPRSLGNLSYST--YLDLHDNKFTREIPQN 104
L L + + LG + T L + ++
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 105 LGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSS 164
L +++ + V + + +P + ++L + L+ N YL +
Sbjct: 306 YSLLEKVKRITVENSKV-FLVPCSFSQH-----------LKSLEFLDLSENLMVEEYLKN 353
Query: 165 SRSKGPL 171
S KG
Sbjct: 354 SACKGAW 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 41/327 (12%), Positives = 76/327 (23%), Gaps = 89/327 (27%)
Query: 166 RSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGH- 223
+ P R+ S + L +L +AT G++ V +
Sbjct: 62 NTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 224 -----RQFTAEMETLGKVKHQ-------------NLVLLLGYCSFDEEK----------- 254
++ + L +K+Q +LV +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 255 LLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------- 301
+Y M + L + + +H+ L R ++ R LA LH
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 302 -------------DFGLARLISACETHVSTDIAGTLGYIPPE-----YGQSRMSTTRGDV 343
F A + T D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDT 300
Query: 344 YSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK--QQADDVLDPTVLNAGSKPM 401
++ G+ + + A P + W+F+ K Q +L
Sbjct: 301 WTLGLAIYWIWCADLP----NTDDAALGGSEWIFRSCKNIPQPVRALL------------ 344
Query: 402 MLKMLRIAADCVADNPATRPTMLHVLK 428
LR R L ++
Sbjct: 345 -EGFLRY-------PKEDRLLPLQAME 363
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 22/143 (15%), Positives = 45/143 (31%), Gaps = 17/143 (11%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L + L N +T + + + L + + P + L L L +
Sbjct: 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
+L L+ T LD+ + I + L ++ +D+ N I
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP------ 154
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
L+ L L +++ +
Sbjct: 155 LKTLP-------ELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 3/106 (2%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L+ L + +T +L L L L+++ + + T + L ++ +DLS N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L L L++ + + + +L L
Sbjct: 149 ITD-IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 14/98 (14%), Positives = 28/98 (28%), Gaps = 3/98 (3%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+T L L + ++ SI + L + ++L+ N L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTL 158
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT 98
L L++ + R + + L
Sbjct: 159 PELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 15/125 (12%), Positives = 42/125 (33%), Gaps = 25/125 (20%)
Query: 35 QLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST---YLD 91
+ L ++ + + + L+++ L++ L + Y+ L
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLT 72
Query: 92 LHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKIS 151
+++ T + L+ LE L ++ + L GL +L+ +
Sbjct: 73 INNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPN-----LSGLT-------SLTLLD 118
Query: 152 LAGNK 156
++ +
Sbjct: 119 ISHSA 123
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 38/156 (24%), Positives = 55/156 (35%), Gaps = 16/156 (10%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
D LKL L + +LT IP+ L L +L+L NK L L
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKL 219
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L L N + G L L L L +NK + +P L +L L+ + + N
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTL---RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ K+ G+ + ISL N
Sbjct: 276 I-TKVGVNDFCPVGFGVKRAY-----YNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 33/158 (20%), Positives = 54/158 (34%), Gaps = 26/158 (16%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
++P E L L L NN ++ + + L L L L NK S + L+
Sbjct: 47 AVPKEISPDTTL--LDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 63 LSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L L +S N P SL L +HDN+ + L + +++ N
Sbjct: 104 LQKLYISKNHLVEIPPNLPSSL------VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 120 ML-CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L +GL L+ + ++ K
Sbjct: 158 PLENSGFEPGA----FDGL--------KLNYLRISEAK 183
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 29/152 (19%), Positives = 49/152 (32%), Gaps = 23/152 (15%)
Query: 14 KLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72
L L+L +N++ +I L + L +L L N+ SL L L L L +N
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-------LGNLAQLEHLDVLRNML-CGK 124
P L +L + LH N T ++ N A + + N + +
Sbjct: 253 LS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 125 IPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + + I K
Sbjct: 311 VQPAT----FRCV-------TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 11/77 (14%), Positives = 23/77 (29%), Gaps = 10/77 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIP-------RSLGQLGGLVKLNLTRNKFSGPV--P 54
+P+ D LQ +YL N +T + + ++L N P
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 55 TSLGNLKGLSHLDLSSN 71
+ + + +
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 33/157 (21%), Positives = 60/157 (38%), Gaps = 19/157 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P E + L +Y NN L +P L + N L NL L
Sbjct: 187 ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNILE--ELPELQNLPFL 239
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ + +N P +L L++ DN T ++P+ + L LDV N+ G
Sbjct: 240 TTIYADNNLL-KTLPDLPPSL---EALNVRDNYLT-DLPELPQS---LTFLDVSENIFSG 291
Query: 124 --KIPEKICKSRLEG--LVSQSGICQNLSKISLAGNK 156
++P + + S + +L +++++ NK
Sbjct: 292 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 328
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 27/128 (21%), Positives = 47/128 (36%), Gaps = 14/128 (10%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P E +S L+ + + NN L +P L + N+ L NL L
Sbjct: 145 KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE--ELPELQNLPFL 197
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ + +N P +L + +N E+P+ L NL L + N+L
Sbjct: 198 TAIYADNNSLK-KLPDLPLSL---ESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL-K 250
Query: 124 KIPEKICK 131
+P+
Sbjct: 251 TLPDLPPS 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 27/173 (15%), Positives = 48/173 (27%), Gaps = 35/173 (20%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL----- 60
P + LQ ++ LT +P + + +++ P G
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 61 --------KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE 112
+ L+L++ P +L L N T E+P+ +L L
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLL 117
Query: 113 HLDVLRNMLCGKIPEKICKSRLEGL---------VSQSGICQNLSKISLAGNK 156
+ L P LE L + + L I + N
Sbjct: 118 VDNNNLKALSDLPPL------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 20/119 (16%), Positives = 37/119 (31%), Gaps = 20/119 (16%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P+ +L+ L N L +P L +L++ N P +++ L
Sbjct: 331 ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDL 382
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122
+ P NL L + N E P + +E L + +
Sbjct: 383 RMNSHLAEV-----PELPQNL---KQLHVETNPLR-EFPDIPES---VEDLRMNSERVV 429
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 43/208 (20%), Positives = 75/208 (36%), Gaps = 65/208 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+++L G F V+ GK A+K ++ E+ L K+KH+N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSAR----G 295
++ Y+V + L +G E+ DR + K A +
Sbjct: 72 EDI--YESTTHY---YLV---MQL----VSGG-ELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 296 LAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
+ +LH+ DFGL+++ + + + GT GY+
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVA 175
Query: 329 PE------YGQSRMSTTRGDVYSFGVIL 350
PE Y ++ D +S GVI
Sbjct: 176 PEVLAQKPYSKA------VDCWSIGVIT 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 32/159 (20%), Positives = 51/159 (32%), Gaps = 22/159 (13%)
Query: 4 SIPSE--FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF-SGPVPTSLGNL 60
+ F L L + + + L L L + N F +P L
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 61 KGLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDV 116
+ L+ LDLS SL +L L++ N F + L L+ LD
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSL---QVLNMSHNNFFS-LDTFPYKCLNSLQVLDY 230
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
N + K L+ S +L+ ++L N
Sbjct: 231 SLNHI-----MTSKKQELQHFPS------SLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 36/156 (23%), Positives = 56/156 (35%), Gaps = 18/156 (11%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK--FSGPVPTSLGNLK 61
S+P+ S L L +N+L +L L KL+L+ N F G S
Sbjct: 21 SVPTGIPSSA--TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNM 120
L +LDLS N + L +LD + + ++ +L L +LD+
Sbjct: 79 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I GL +L + +AGN
Sbjct: 138 T-RVAFNGI----FNGLS-------SLEVLKMAGNS 161
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 25/99 (25%), Positives = 35/99 (35%), Gaps = 3/99 (3%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
+P F + L L L QL + + L L LN++ N F
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYS-TYLDLHDNKF 97
L L LD S N + L + S +L+L N F
Sbjct: 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 48/264 (18%), Positives = 79/264 (29%), Gaps = 55/264 (20%)
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLL 183
IP K R V + G + +Y + P+ I
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD--- 157
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+ + L G FG V++ T G A K E++T+ ++H LV
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY----KIACSSAR-- 294
L D E +++YE+M G E+ ++ + A R
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGG-------------ELFEKVADEHNKMSEDEAVEYMRQV 264
Query: 295 --GLAFLHQ--------------------------DFGLARLISACETHVSTDIAGTLGY 326
GL +H+ DFGL + GT +
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEF 322
Query: 327 IPPEYGQSRMSTTRGDVYSFGVIL 350
PE + + D++S GV+
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 55/321 (17%), Positives = 102/321 (31%), Gaps = 92/321 (28%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILED---------GGFGTVYKAT-LPDGKTVAV 212
SS R + ++ + + E G +G V A+
Sbjct: 8 SSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67
Query: 213 KKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLW 269
K + T + + E+ L + H N++ L + D+ LV E G
Sbjct: 68 KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-DKRNYYLVMECYKGG----- 121
Query: 270 LRNATGSHEVLDR---AKRY--KIACSSAR----GLAFLHQ------------------- 301
E+ D ++ A + G+ +LH+
Sbjct: 122 --------ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173
Query: 302 --------DFGLARLISACETHVSTDIAGTLGYIPPE-----YGQSRMSTTRGDVYSFGV 348
DFGL+ + + GT YI PE Y + DV+S GV
Sbjct: 174 KDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRKKYDEK------CDVWSIGV 225
Query: 349 ILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP-TVLNAGSKPMMLKMLR 407
IL L+ P G + ++ + +K++K + ++ G+K ++ +ML+
Sbjct: 226 ILFILLAGYPPFGGQTDQE--------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ 277
Query: 408 IAADCVADNPATRPTMLHVLK 428
+ R + L+
Sbjct: 278 F-------DSQRRISAQQALE 291
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 57/300 (19%), Positives = 102/300 (34%), Gaps = 72/300 (24%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNL 241
+L + +L +GGF VY+A + G+ A+K+ + + +R E+ + K+ H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 242 VLLLGYCSFDEEKLL--VYEYMV-----NGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
V S +E+ E+++ G L + S L KI + R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQL-VEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 295 GLAFLHQ--------------------------DFGLARLISACETHVST---------D 319
+ +H+ DFG A IS + + +
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 320 IA--GTLGYIPPE---YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVG 374
I T Y PE + + D+++ G IL L + P F E
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----F---EDGA--- 257
Query: 375 WVFQKMKKQQAD-DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
K++ + ++ ML++ NP R ++ V+ L EI
Sbjct: 258 ----KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQV-------NPEERLSIAEVVHQLQEI 306
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 32/156 (20%), Positives = 44/156 (28%), Gaps = 19/156 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + L L N + + L L L L RN + L L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
+ L+L N G L L L L +N + L LD+
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKL---RELWLRNNPIESIPSYAFNRVPSLMRLDLGELK 182
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I E EGL NL ++L
Sbjct: 183 KLEYISEGA----FEGL-------FNLKYLNLGMCN 207
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 40/158 (25%), Positives = 59/158 (37%), Gaps = 24/158 (15%)
Query: 4 SIPSE-FGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
SIPS F L L LG +L + L L LNL +P L L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLV 218
Query: 62 GLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVL 117
GL L++S N G L +L L + +++ + I +N LA L L++
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSL---KKLWVMNSQVS-LIERNAFDGLASLVELNLA 274
Query: 118 RNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
N L +P + L + L ++ L N
Sbjct: 275 HNNL-SSLPHDL----FTPL-------RYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 28/120 (23%), Positives = 45/120 (37%), Gaps = 5/120 (4%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I F L+ L LG + +P +L L GL +L ++ N F P S L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSS 243
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML 121
L L + ++ + L+ L+L N + +P + L L L + N
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 38/156 (24%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTR-NKFSGPVPTSLGNL 60
IPS F KL+ L+L NN + SIP + ++ L++L+L K + L
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L +L+L +L L L++ N F P + L+ L+ L V+ +
Sbjct: 196 FNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ I +GL +L +++LA N
Sbjct: 254 VS-LIERNA----FDGL-------ASLVELNLAHNN 277
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 44/210 (20%)
Query: 187 LVDILEDGGFGTVYKATLPD---GKTVAVK----KFSQAKTQGHRQFTAEMETLGKVKHQ 239
L +IL GG V+ A D + VAVK ++ + R F E + + H
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHP 72
Query: 240 NLVLLLGYCSFDEEKL----LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
+V + + +V EY V+G LR+ + + + ++ + +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEY-VDGVT---LRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 296 LAFLHQ------------------------DFGLARLISACETHV--STDIAGTLGYIPP 329
L F HQ DFG+AR I+ V + + GT Y+ P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
E + R DVYS G +L E++T + P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 55/270 (20%), Positives = 89/270 (32%), Gaps = 68/270 (25%)
Query: 194 GGFGTVYKAT-LPDGKTVAVK--KFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCS 249
G +G V+K DG+ AVK + + AE+ + KV +H V L +
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL--EQA 125
Query: 250 FDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------ 301
++E +L E SL S L A+ + + LA LH
Sbjct: 126 WEEGGILYLQTEL-CGPSLQQHCEAWGAS---LPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPE-----YGQSRMST 338
DFGL + G Y+ PE YG +
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQGSYGTA---- 235
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398
DV+S G+ +LE+ E P G Q++++ L++
Sbjct: 236 --ADVFSLGLTILEVACNMEL--P----HGGEGW-----QQLRQGYLPPEF-TAGLSSEL 281
Query: 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ +++ ML +P R T +L
Sbjct: 282 RSVLVMMLEP-------DPKLRATAEALLA 304
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 61/208 (29%)
Query: 193 DGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGY----- 247
+G FG V++A L + VA+KK Q K +R E++ + VKH N+V L +
Sbjct: 50 NGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 248 CSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA----------RGL 296
DE L LV EY+ + + + K R L
Sbjct: 106 DKKDEVFLNLVLEYV---PETV--------YRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 297 AFLHQ-------------------------DFGLARLISACETHVSTDIAGTLGYIPPE- 330
A++H DFG A+++ A E +VS I + Y PE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-YIC-SRYYRAPEL 212
Query: 331 -YGQSRMSTTRGDVYSFGVILLELVTAK 357
+G + TT D++S G ++ EL+ +
Sbjct: 213 IFG-ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 49/211 (23%), Positives = 75/211 (35%), Gaps = 62/211 (29%)
Query: 194 GGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLL------G 246
G FGTV G +VA+KK Q +R+ M+ L + H N+V L G
Sbjct: 34 GTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 247 YCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA----------RG 295
+ L +V EY+ L H R ++A R
Sbjct: 93 ERDRRDIYLNVVMEYV---PDTL--------HRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 296 LAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
+ LH DFG A+ +S E +V+ I + Y
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY-IC-SRYYRA 199
Query: 329 PE--YGQSRMSTTRGDVYSFGVILLELVTAK 357
PE +G ++ TT D++S G I E++ +
Sbjct: 200 PELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 35/202 (17%), Positives = 64/202 (31%), Gaps = 52/202 (25%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+++ L G FG V++ G+ K + E+ + ++ H L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY----KIACSSAR---- 294
E +L+ E++ G E+ DR A+ Y + R
Sbjct: 114 HDAFEDKYEMVLILEFLSGG-------------ELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 295 GLAFLHQ--------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
GL +H+ DFGLA ++ + T +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAA 218
Query: 329 PEYGQSRMSTTRGDVYSFGVIL 350
PE D+++ GV+
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 35/158 (22%), Positives = 53/158 (33%), Gaps = 23/158 (14%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++P Q ++L N+++ S L L L N + + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 64 SHLDLSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLR 118
LDLS N D LG L L L + LA L++L +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRL---HTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD 138
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N L +P+ L NL+ + L GN+
Sbjct: 139 NAL-QALPDDT----FRDLG-------NLTHLFLHGNR 164
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 32/119 (26%), Positives = 46/119 (38%), Gaps = 5/119 (4%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
+ F LQ LYL +N L ++P + LG L L L N+ S + L
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRN 119
L L L N P + +L L L N + +P L L L++L + N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 37/158 (23%), Positives = 54/158 (34%), Gaps = 20/158 (12%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
I + F L+ L L +N S+ + LG L L+L R P L
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 62 GLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLR 118
L +L L N R LGNL T+L LH N+ + + L L+ L + +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNL---THLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N + + L L + L N
Sbjct: 187 NRV-AHVHPHA----FRDL-------GRLMTLYLFANN 212
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 36/156 (23%), Positives = 48/156 (30%), Gaps = 19/156 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P S + L L NQ+ S L L L L+RN + L L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
+ L+L N G L L L L +N + L LD+
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKL---KELWLRNNPIESIPSYAFNRIPSLRRLDLGELK 171
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I E EGL NL ++LA
Sbjct: 172 RLSYISEGA----FEGL-------SNLRYLNLAMCN 196
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 30/120 (25%), Positives = 44/120 (36%), Gaps = 5/120 (4%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I F L+ L L L IP +L L L +L+L+ N S P S L
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML 121
L L + + + NL ++L N T +P + L LE + + N
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 41/155 (26%), Positives = 58/155 (37%), Gaps = 18/155 (11%)
Query: 4 SIPSE-FGDSLKLQGLYLG-NNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
SIPS F L+ L LG +L+ + L L LNL +P L L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLI 207
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNM 120
L LDLS N P S L + L + ++ I +N NL L +++ N
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNN 266
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
L +P + L +L +I L N
Sbjct: 267 L-TLLPHDL----FTPL-------HHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTR-NKFSGPVPTSLGNL 60
+IP+ F KL+ L+L NN + SIP + ++ L +L+L + S + L
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L +L+L+ +L L LDL N + P + L L+ L ++++
Sbjct: 185 SNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 121 L 121
+
Sbjct: 243 I 243
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 46/234 (19%), Positives = 80/234 (34%), Gaps = 47/234 (20%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKF-SQAKT 220
SS + G L I +Q + L + + G G V+K G +AVK+
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 221 QGHRQFTAEMETLGK-VKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSH 277
+ +++ +++ + K +V + +F + + E M + L R
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQC--FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP 122
Query: 278 EVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISAC 312
E + K+ + + L +L + DFG IS
Sbjct: 123 ERILG----KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG----ISGR 174
Query: 313 --ETHVSTDIAGTLGYIPPEYGQSRMS-----TTRGDVYSFGVILLELVTAKEP 359
+ AG Y+ PE R DV+S G+ L+EL T + P
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 37/253 (14%), Positives = 76/253 (30%), Gaps = 39/253 (15%)
Query: 187 LVDILEDGGFGTVYKATLPD---GKTVAVK--KFSQAKTQGHRQ-FTAEMETLGKVKHQN 240
L+ ++A D + VA+ Q + L ++
Sbjct: 35 LLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ +L L+V E++ GSL + + S A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAH 146
Query: 301 QDFGLA-RLISACETHVSTD---IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTA 356
+ G+A + VS D + +P + D+ G L L+
Sbjct: 147 RA-GVALSIDHPSRVRVSIDGDVVLAYPATMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 357 KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADN 416
+ P E + + + A ++P ++ ++ +AA V +
Sbjct: 199 RWP----LPEAGVRSGLAPAER----DTAGQPIEPADIDRDIPF---QISAVAARSVQGD 247
Query: 417 PATRP--TMLHVL 427
R T+L+++
Sbjct: 248 GGIRSASTLLNLM 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 60/291 (20%), Positives = 98/291 (33%), Gaps = 86/291 (29%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG---HRQFTAEMETLGKVKHQNL 241
+L G FG V G+ AVK S+ + + E++ L ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 242 VLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR- 294
+ L + D+ LV E G E+ D KR+ A R
Sbjct: 89 MKLYEFFE-DKGYFYLVGEVYTGG-------------ELFDEIISRKRFSEVDAARIIRQ 134
Query: 295 ---GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTL 324
G+ ++H+ DFGL+ + D GT
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTA 192
Query: 325 GYIPPE-----YGQSRMSTTRGDVYSFGVILLELVTAKEP-TGPEFQEKEGANLVGWVFQ 378
YI PE Y + DV+S GVIL L++ P G + + +
Sbjct: 193 YYIAPEVLHGTYDEK------CDVWSTGVILYILLSGCPPFNGANEYD---------ILK 237
Query: 379 KMKKQQADDVLDP-TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
K++K + L ++ +K ++ KML P+ R + L
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTY-------VPSMRISARDALD 281
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 29/159 (18%), Positives = 52/159 (32%), Gaps = 16/159 (10%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
S + ++ L +N + + L L L N + L N GL +
Sbjct: 199 STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEV 253
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126
DLS N + + L + +N+ + + L+ LD+ N L +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 127 EKICK-SRLEGL--------VSQSGICQNLSKISLAGNK 156
+ RLE L + L ++L+ N
Sbjct: 312 RNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 23/144 (15%), Positives = 46/144 (31%), Gaps = 14/144 (9%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+ + N+ + L + LNL + + + L + N
Sbjct: 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLCGKIPEKICKS 132
P N+ T L L N + +P+ + N +L L + N L +I +
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDT--- 160
Query: 133 RLEGLVSQSGICQNLSKISLAGNK 156
+ +L + L+ N+
Sbjct: 161 -FQAT-------TSLQNLQLSSNR 176
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 28/161 (17%), Positives = 53/161 (32%), Gaps = 11/161 (6%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+P+ +++ L L + Q+ + + KL + N P N+
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML 121
L+ L L N N T L + +N R I + L++L + N L
Sbjct: 119 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 177
Query: 122 CGKIPEKICKSRLEGL------VSQSGICQNLSKISLAGNK 156
+ + S L +S I + ++ + N
Sbjct: 178 -THVDLSLIPS-LFHANVSYNLLSTLAIPIAVEELDASHNS 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 5/114 (4%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ + L + L N+L + ++ L +L ++ N+ + + L
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKV 299
Query: 66 LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
LDLS N R+ L L N + L L++L + N
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 36/172 (20%), Positives = 58/172 (33%), Gaps = 39/172 (22%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSL---- 57
I + F + LQ L L +N+LT + L + L N++ N S +P ++
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELD 211
Query: 58 -----------GNLKGLSHLDLSSNFF-DGGWPRSLGNLSYSTYLDLHDNKFTREIPQN- 104
L+ L L N D W + L +DL N+ +I +
Sbjct: 212 ASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGL---VEVDLSYNELE-KIMYHP 267
Query: 105 LGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ +LE L + N RL L L + L+ N
Sbjct: 268 FVKMQRLERLYISNN-------------RLVALNLYGQPIPTLKVLDLSHNH 306
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 14/108 (12%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++ L+ L L +N L + R+ Q L L L N + L L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341
Query: 64 SHLDLSSNFFDG----GWPRSLGNLSYSTYLDLHDNKFTREIPQNLGN 107
+L LS N +D R++ + + D +I L +
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPA------VDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 20/153 (13%), Positives = 40/153 (26%), Gaps = 12/153 (7%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
I S +++ L + + L + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L+L+ + + L + N P N+ L L + RN L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-S 130
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+P I L+ +S++ N
Sbjct: 131 SLPRGI----FHNT-------PKLTTLSMSNNN 152
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 38/180 (21%), Positives = 55/180 (30%), Gaps = 25/180 (13%)
Query: 1 LTGSIPSEFGD--SLKLQGLYLGNNQLTGSIPRSLGQLG-----GLVKLNLTRNKFSGPV 53
+TG+ P + L L L N L +L GL L++ +
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFS 165
Query: 54 PTSLGNLKGLSHLDLSSNFFDGGWPRS----LGNLSYSTYLDLHDNKFTR---EIPQNLG 106
+ LS LDLS N G L L +
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 107 NLAQLEHLDVLRNMLCGKIPEKICK--SRLEGL-VSQ-------SGICQNLSKISLAGNK 156
QL+ LD+ N L C S+L L +S G+ LS + L+ N+
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNR 285
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 27/115 (23%), Positives = 37/115 (32%), Gaps = 15/115 (13%)
Query: 14 KLQGLYLGNNQLT---GSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLKGLSHLDLS 69
LQ L L N + G L L+L+ N S L+ L+LS
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 70 SNFFD---GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
G P L + LDL N+ P L Q+ +L + N
Sbjct: 262 FTGLKQVPKGLPAKL------SVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 26/143 (18%), Positives = 48/143 (33%), Gaps = 11/143 (7%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGG---LVKLNLTRNKFSGPVPTSLGNLKG 62
++ SL L+ L + ++ I ++ G L +L L + +G P L G
Sbjct: 61 FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 63 --LSHLDLSSNFFDGG--WPRSLGNLSYS--TYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
L+ L+L + + W L L + + + L LD+
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 117 LRNMLCGKIP--EKICKSRLEGL 137
N G+ +C + L
Sbjct: 181 SDNPELGERGLISALCPLKFPTL 203
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 29/100 (29%), Positives = 37/100 (37%), Gaps = 8/100 (8%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ-LGGLVKLNLTRNKFSGPVPTSLGN 59
+G + ++LQGL L +N L + L LNL+ VP L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL-- 272
Query: 60 LKGLSHLDLSSNFFDGG-WPRSLGNLSYSTYLDLHDNKFT 98
LS LDLS N D P L + L L N F
Sbjct: 273 PAKLSVLDLSYNRLDRNPSPDELPQV---GNLSLKGNPFL 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 27/157 (17%), Positives = 44/157 (28%), Gaps = 19/157 (12%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
IP F L L + N++ + L L L + N + L
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153
Query: 63 LSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
L L L L L L L + L +L+ L++
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGL---IVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + + L GL NL+ +S+
Sbjct: 211 ----PYLDTMTPNCLYGL--------NLTSLSITHCN 235
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 27/121 (22%), Positives = 50/121 (41%), Gaps = 4/121 (3%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
++ L L L + + LT ++P ++ L L LNL+ N S + L
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270
Query: 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLR 118
L L + L P + L+Y L++ N+ T + +++ ++ LE L +
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDS 329
Query: 119 N 119
N
Sbjct: 330 N 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 36/155 (23%), Positives = 50/155 (32%), Gaps = 20/155 (12%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
EF L+ L L N ++ P + L L L L N+ L L+
Sbjct: 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTK 108
Query: 66 LDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML 121
LD+S N + L NL L++ DN I L LE L + + L
Sbjct: 109 LDISENKIVILLDYMFQDLYNL---KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
IP + L L L + L
Sbjct: 165 -TSIPTEA----LSHL-------HGLIVLRLRHLN 187
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 28/154 (18%), Positives = 50/154 (32%), Gaps = 15/154 (9%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+I F +L+ L + + ++ + L L++T + ++ +L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML 121
L L+LS N L L + L + + L L L+V N L
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+ E + S NL + L N
Sbjct: 309 -TTLEESVFHS-----------VGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 36/153 (23%), Positives = 54/153 (35%), Gaps = 14/153 (9%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++P + + L LG N++ L +L L N S P + NL L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L L SN LS T LD+ +NK + +L L+ L+V N L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-- 140
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
I GL +L +++L
Sbjct: 141 ---VYISHRAFSGLN-------SLEQLTLEKCN 163
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 18/71 (25%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+I + L+LQ + L QL P + L L LN++ N+ + + ++
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321
Query: 63 LSHLDLSSNFF 73
L L L SN
Sbjct: 322 LETLILDSNPL 332
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 62/216 (28%)
Query: 186 TLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
T ++ +G FG VY+A L G+ VA+KK Q K +R E++ + K+ H N+V L
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRL 112
Query: 245 LGY-----CSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA----- 293
+ DE L LV +Y+ + + V R K
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV---PETV--------YRVARHYSRAKQTLPVIYVKLY 161
Query: 294 -----RGLAFLHQ-------------------------DFGLARLISACETHVSTDIAGT 323
R LA++H DFG A+ + E +VS I +
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-IC-S 219
Query: 324 LGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAK 357
Y PE +G + T+ DV+S G +L EL+ +
Sbjct: 220 RYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 58/332 (17%), Positives = 103/332 (31%), Gaps = 103/332 (31%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILED---------GGFGTVYKAT-LPDGKTVAV 212
SS + I++ ++ I E G +G V A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 213 K-------------KFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVY 258
K ++ + H + E+ L + H N++ L D++ LV
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE-DKKYFYLVT 125
Query: 259 EYMVNGSLDLWLRNATGSHEVLDR---AKRY------KIACSSARGLAFLHQ-------- 301
E+ G E+ ++ ++ I G+ +LH+
Sbjct: 126 EFYEGG-------------ELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDI 172
Query: 302 -------------------DFGLARLISACETHVSTDIAGTLGYIPPE-----YGQSRMS 337
DFGL+ S + + D GT YI PE Y +
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAYYIAPEVLKKKYNEK--- 227
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP-TVLNA 396
DV+S GVI+ L+ P F G N + +K++K + + ++
Sbjct: 228 ---CDVWSCGVIMYILLCGYPP----FG---GQNDQD-IIKKVEKGKYYFDFNDWKNISD 276
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+K ++ ML + R T L
Sbjct: 277 EAKELIKLMLTY-------DYNKRCTAEEALN 301
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/260 (19%), Positives = 89/260 (34%), Gaps = 70/260 (26%)
Query: 140 QSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTV 199
+ N S+I+L+ +++ +++ + + + + + L G G V
Sbjct: 96 KRRPLNNNSEIALSLSRNK-VFVFFDLTVDDQSVYPKALRD---EYIMSKTLGSGACGEV 151
Query: 200 YKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--------EMETLGKVKHQNLVLLLGYCSF 250
A K VA++ S+ K A E+E L K+ H ++ + + F
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF--F 209
Query: 251 DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR----GLAFLH 300
D E +V E M G E+ D+ KR + +LH
Sbjct: 210 DAEDYYIVLELMEGG-------------ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 301 Q---------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQ 333
+ DFG ++++ ET + + GT Y+ PE
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLV 314
Query: 334 SRMSTTRG---DVYSFGVIL 350
S + D +S GVIL
Sbjct: 315 SVGTAGYNRAVDCWSLGVIL 334
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 43/205 (20%), Positives = 71/205 (34%), Gaps = 38/205 (18%)
Query: 186 TLVDILEDGGFGTVYKATLPD---GKTVAVK--KFSQAKTQGHRQ-FTAEMETLGKVKHQ 239
L ++ GG G VY+A D + VA+K + + R E T G+++
Sbjct: 37 RLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
++V + + D + + +NG L L + I L
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRL-INGVD---LAAMLRRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 300 HQ------------------------DFGLARLISACE-THVSTDIAGTLGYIPPEYGQS 334
H DFG+A + + T + GTL Y+ PE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
+T R D+Y+ +L E +T P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 45/230 (19%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK--FSQAK 219
L+ +++ + +T + G FG V++ G AVKK +
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97
Query: 220 TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY-EYMVNGSLDLWLRNATGSHE 278
+ E+ + +V L G + + ++ E + GSL ++ E
Sbjct: 98 VE-------ELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149
Query: 279 VLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313
+ GL +LH DFG A +
Sbjct: 150 DRALYYLGQA----LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 314 THVST----DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
S I GT ++ PE + + D++S ++L ++ P
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 44/210 (20%), Positives = 69/210 (32%), Gaps = 65/210 (30%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLV 242
L + L G F V + + G+ A + K H++ E +KH N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSAR--- 294
L S + L+++ + G E+ + A+ Y A +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGG-------------ELFEDIVAREYYSEADASHCIQQIL 120
Query: 295 -GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
+ HQ DFGLA + E AGT GY
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGY 179
Query: 327 IPPE------YGQSRMSTTRGDVYSFGVIL 350
+ PE YG+ D+++ GVIL
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 42/217 (19%), Positives = 66/217 (30%), Gaps = 72/217 (33%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVK-----KFSQAKTQGHRQFTAEMETLGKVKHQ 239
L +++ G F V + G+ AVK KF+ + E +KH
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR-------AKRY--KIAC 290
++V LL S D +V+E+M ++ Y +A
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGA-------------DLCFEIVKRADAGFVYSEAVAS 133
Query: 291 SSAR----GLAFLHQ---------------------------DFGLARLISACETHVSTD 319
R L + H FG+A + V+
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGG 192
Query: 320 IAGTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT ++ PE YG+ DV+ GVIL
Sbjct: 193 RVGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 60/290 (20%), Positives = 99/290 (34%), Gaps = 85/290 (29%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLV 242
+V +L G FG V K + AVK ++A + E+E L K+ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 243 LLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR-- 294
L D +V E G E+ D KR+ A +
Sbjct: 85 KLFEILE-DSSSFYIVGELYTGG-------------ELFDEIIKRKRFSEHDAARIIKQV 130
Query: 295 --GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLG 325
G+ ++H+ DFGL+ + D GT
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAY 188
Query: 326 YIPPE-----YGQSRMSTTRGDVYSFGVILLELVTAKEP-TGPEFQEKEGANLVGWVFQK 379
YI PE Y + DV+S GVIL L++ P G + + ++
Sbjct: 189 YIAPEVLRGTYDEK------CDVWSAGVILYILLSGTPPFYGKNEYD---------ILKR 233
Query: 380 MKKQQADDVLDP-TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ + L ++ +K ++ KML +P+ R T L+
Sbjct: 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTF-------HPSLRITATQCLE 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 40/208 (19%), Positives = 66/208 (31%), Gaps = 65/208 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
TL + + G +G V A A KK + + +F E+E + + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 245 LGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR---- 294
D + LV E G E+ +R + + A +
Sbjct: 72 YETFE-DNTDIYLVMELCTGG-------------ELFERVVHKRVFRESDAARIMKDVLS 117
Query: 295 GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYI 327
+A+ H+ DFGLA + GT Y+
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYV 175
Query: 328 PPE-----YGQSRMSTTRGDVYSFGVIL 350
P+ YG D +S GV++
Sbjct: 176 SPQVLEGLYGP------ECDEWSAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 47/209 (22%), Positives = 70/209 (33%), Gaps = 65/209 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ--FTAEMETLGKVKHQNLV 242
+V +L G FG V K + AVK ++A + E+E L K+ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR--- 294
L +V E G E+ D KR+ A +
Sbjct: 85 KLFEILEDSSSFYIVGELYTGG-------------ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 295 -GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
G+ ++H+ DFGL+ + D GT Y
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYY 189
Query: 327 IPPE-----YGQSRMSTTRGDVYSFGVIL 350
I PE Y + + DV+S GVIL
Sbjct: 190 IAPEVLRGTYDE------KCDVWSAGVIL 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 43/218 (19%)
Query: 178 FQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK-FSQAKTQGHRQFTAEMETLGK 235
+ L + L G +G V K +P G+ +AVK+ + +Q ++ +++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 236 -VKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA 293
V V G F E + + E M + SLD + + + + KIA S
Sbjct: 62 TVDCPFTVTFYG-ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 294 RGLAFLHQ-------------------------DFGL-ARLIS--ACETHVSTDIAGTLG 325
+ L LH DFG+ L+ A + G
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKP 174
Query: 326 YIPPE--YGQSRMS--TTRGDVYSFGVILLELVTAKEP 359
Y+ PE + + + D++S G+ ++EL + P
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 28/143 (19%), Positives = 51/143 (35%), Gaps = 19/143 (13%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+L L L +N LT L GLV+++L+ N+ + ++ L L +S+N
Sbjct: 233 ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
+ LDL N + +N +LE+L + N + +
Sbjct: 291 -VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL------ 341
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
L ++L+ N
Sbjct: 342 --------STHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 24/145 (16%), Positives = 49/145 (33%), Gaps = 16/145 (11%)
Query: 14 KLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72
+ + N+ + +P + L + LNL + + + L + N
Sbjct: 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLCGKIPEKICK 131
P N+ T L L N + +P+ + N +L L + N L +I +
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDT-- 166
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
+ +L + L+ N+
Sbjct: 167 --FQAT-------TSLQNLQLSSNR 182
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 5/114 (4%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ + L + L N+L + ++ L +L ++ N+ + + L
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKV 305
Query: 66 LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
LDLS N R+ L L N + L L++L + N
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 24/123 (19%), Positives = 43/123 (34%), Gaps = 9/123 (7%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+P+ +++ L L + Q+ + + KL + N P N+
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 63 LSHLDLSSNF---FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLR 118
L+ L L N G + L T L + +N R I + L++L +
Sbjct: 125 LTVLVLERNDLSSLPRGIFHNTPKL---TTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 119 NML 121
N L
Sbjct: 181 NRL 183
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 36/172 (20%), Positives = 58/172 (33%), Gaps = 39/172 (22%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSL---- 57
I + F + LQ L L +N+LT + L + L N++ N S +P ++
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELD 217
Query: 58 -----------GNLKGLSHLDLSSNFF-DGGWPRSLGNLSYSTYLDLHDNKFTREIPQN- 104
L+ L L N D W + L +DL N+ +I +
Sbjct: 218 ASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGL---VEVDLSYNELE-KIMYHP 273
Query: 105 LGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ +LE L + N RL L L + L+ N
Sbjct: 274 FVKMQRLERLYISNN-------------RLVALNLYGQPIPTLKVLDLSHNH 312
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 27/145 (18%), Positives = 47/145 (32%), Gaps = 25/145 (17%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
++ L+ L L +N L + R+ Q L L L N + L L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 64 SHLDLSSNFFDG----GWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
+L LS N +D R++ + + Q+ QLEH
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVD------------DADQHCKIDYQLEHG----- 390
Query: 120 MLCGKIPEKICKSRLEGLVSQSGIC 144
+ C + + L+ + S +
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVE 415
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 20/153 (13%), Positives = 40/153 (26%), Gaps = 12/153 (7%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
I S +++ L + + L + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
L+L+ + + L + N P N+ L L + RN L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-S 136
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+P I L+ +S++ N
Sbjct: 137 SLPRGI----FHNT-------PKLTTLSMSNNN 158
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 47/214 (21%), Positives = 71/214 (33%), Gaps = 66/214 (30%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--------EMETLGKV 236
+ L G G V A K VA+K S+ K A E+E L K+
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 237 KHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIAC 290
H ++ + + FD E +V E M G E+ D+ KR
Sbjct: 73 NHPCIIKIKNF--FDAEDYYIVLELMEGG-------------ELFDKVVGNKRLKEATCK 117
Query: 291 SSAR----GLAFLHQ---------------------------DFGLARLISACETHVSTD 319
+ +LH+ DFG ++++ ET +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRT 175
Query: 320 IAGTLGYIPPEYGQSRMSTTRG---DVYSFGVIL 350
+ GT Y+ PE S + D +S GVIL
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 20/159 (12%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVK---LNLTRNKFSGPVPTSL 57
LT ++ G +L+ L L NQL + + + L++++N S
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 58 -GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
K L L++SSN R L LDLH NK IP+ + L L+ L+V
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNV 451
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
N L +P+ I +L KI L N
Sbjct: 452 ASNQL-KSVPDGIFDR-----------LTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 27/120 (22%), Positives = 45/120 (37%), Gaps = 8/120 (6%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + L + N ++ + L L L ++ N+ + + L
Sbjct: 14 HVPKDLSQKT--TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN--LGNLAQLEHLDVLRNML 121
+LDLS N NL +LDL N F +P GN++QL+ L + L
Sbjct: 72 EYLDLSHNKLVKISCHPTVNL---KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 19/122 (15%), Positives = 38/122 (31%), Gaps = 4/122 (3%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L + ++ + N T + + HLD S+N
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLG---NLAQLEHLDVLRNMLCGKIPEKIC 130
+ G+L+ L L N+ E+ + + L+ LD+ +N + + C
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 131 KS 132
Sbjct: 396 SW 397
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 10/101 (9%)
Query: 1 LTGSIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN 59
++ L L + +N LT +I R L + L+L NK +P +
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKS-IPKQVVK 442
Query: 60 LKGLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKF 97
L+ L L+++SN G L +L + LH N +
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSL---QKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL--KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
+ L +++ L L +N++ SIP+ + +L L +LN+ N+ L
Sbjct: 410 ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468
Query: 62 GLSHLDLSSNFFD 74
L + L +N +D
Sbjct: 469 SLQKIWLHTNPWD 481
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 40/210 (19%), Positives = 69/210 (32%), Gaps = 66/210 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLV 242
+ + L G F V + G A K + K ++ E K++H N+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSAR--- 294
L + LV++ + G E+ + A+ + A +
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGG-------------ELFEDIVAREFYSEADASHCIQQIL 138
Query: 295 -GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
+A+ H DFGLA ++ ++ AGT GY
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGY 196
Query: 327 IPPE------YGQSRMSTTRGDVYSFGVIL 350
+ PE Y + D+++ GVIL
Sbjct: 197 LSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 43/309 (13%), Positives = 103/309 (33%), Gaps = 77/309 (24%)
Query: 175 ISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKK--FSQAKTQGHRQFTAEME 231
+ M + + ++ + G FG+V+K DG A+K+ A + + E+
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 232 TLGKV-KHQNLVLLLGYCSFDEEKLLVY-EYMVNGSLDLWLRNATGSHEVLDRAKRYKIA 289
+ +H ++V +++ +L+ EY GSL + A+ +
Sbjct: 63 AHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 290 CSSARGLAFLHQ-------------------------------------------DFGLA 306
RGL ++H D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQ 365
IS+ + G ++ E Q + + D+++ + ++ A+ +
Sbjct: 182 TRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PR 232
Query: 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLH 425
+ + ++++ + + P VL+ ++ M+ +P RP+ +
Sbjct: 233 NGDQ-------WHEIRQGRLPRI--PQVLSQEFTELLKVMIHP-------DPERRPSAMA 276
Query: 426 VLKLLHEIV 434
++K H ++
Sbjct: 277 LVK--HSVL 283
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 36/202 (17%), Positives = 67/202 (33%), Gaps = 53/202 (26%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+ + L G FG V++ KT K F + K E+ L +H+N++ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY----KIACSSAR---- 294
EE ++++E++ ++ +R + + S
Sbjct: 67 HESFESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVHQVCE 113
Query: 295 GLAFLHQ--------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
L FLH +FG AR + + + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYA 171
Query: 329 PEYGQSRMSTTRGDVYSFGVIL 350
PE Q + +T D++S G ++
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 31/161 (19%), Positives = 55/161 (34%), Gaps = 22/161 (13%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I + F L+ L + + L P+SL + + L L + + +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 63 LSHLDLSSNFFDG--------GWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
+ L+L D G SL + + D ++ + L ++ L L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 115 DVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+ RN L +P+ I + L +L KI L N
Sbjct: 283 EFSRNQLKS-VPDGI----FDRL-------TSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 22/158 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
SIPS +++ + L L NN++T L + L L LT N + S +L L
Sbjct: 45 SIPSGLTEAV--KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN--LGNLAQLEHLDVLR 118
HLDLS N W + L +L T+L+L N + + + +L +L+ L V
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSL---TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGN 158
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
KI K GL L ++ + +
Sbjct: 159 MDTFTKIQRKD----FAGLT-------FLEELEIDASD 185
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 36/157 (22%), Positives = 57/157 (36%), Gaps = 22/157 (14%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLS 64
S+ + LQ L L +N + +I S LG L L+L+ N S + L L+
Sbjct: 69 NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLT 127
Query: 65 HLDLSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRN 119
L+L N + L L L + + +I + L LE L++ +
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKL---QILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 120 MLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
L K KS QN+S + L +
Sbjct: 185 DLQ-SYEPKSLKS-----------IQNVSHLILHMKQ 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 51/234 (21%), Positives = 86/234 (36%), Gaps = 45/234 (19%)
Query: 164 SSRSKGPLRINI-SMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKF-SQAKT 220
S S G L+I+ + L + + G +G+V K P G+ +AVK+ S
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 221 QGHRQFTAEMETLGK-VKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGS- 276
+ +Q +++ + + +V Y + E + E M + S D + +
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQF--YGALFREGDCWICMELM-STSFDKFYKYVYSVL 118
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311
+V+ KI ++ + L L + DFG IS
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG----ISG 174
Query: 312 C--ETHVSTDIAGTLGYIPPEYGQSRMS----TTRGDVYSFGVILLELVTAKEP 359
++ T AG Y+ PE S R DV+S G+ L EL T + P
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 40/210 (19%), Positives = 68/210 (32%), Gaps = 66/210 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLV 242
+ + L G F V + G A K + K ++ E K++H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR--- 294
L + LV++ + G E+ + + Y A +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGG-------------ELFEDIVAREFYSEADASHCIQQIL 115
Query: 295 -GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGY 326
+A+ H DFGLA ++ ++ AGT GY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGY 173
Query: 327 IPPE------YGQSRMSTTRGDVYSFGVIL 350
+ PE Y + D+++ GVIL
Sbjct: 174 LSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 57/291 (19%), Positives = 95/291 (32%), Gaps = 85/291 (29%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
L G FG V+ G +K ++ ++Q + AE+E L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 244 LLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDR-------AKRY--KIACSSA 293
+ D + +V E G E+L+R K
Sbjct: 85 IFEVFE-DYHNMYIVMETCEGG-------------ELLERIVSAQARGKALSEGYVAELM 130
Query: 294 R----GLAFLHQ---------------------------DFGLARLISACETHVSTDIAG 322
+ LA+ H DFGLA L ST+ AG
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAG 188
Query: 323 TLGYIPPE-----YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVF 377
T Y+ PE + D++S GV++ L+T P F +
Sbjct: 189 TALYMAPEVFKRDVTF------KCDIWSAGVVMYFLLTGCLP----FTGTSLEEV----Q 234
Query: 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
QK ++ + ++ L + ++ +ML +P RP+ VL
Sbjct: 235 QKATYKEPNYAVECRPLTPQAVDLLKQMLTK-------DPERRPSAAQVLH 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 42/204 (20%), Positives = 68/204 (33%), Gaps = 52/204 (25%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
++ +IL G FG V+K G +A K + + E+ + ++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRYKI----ACSSAR-- 294
L + +LV EY+ G E+ DR + Y + +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGG-------------ELFDRIIDESYNLTELDTILFMKQI 196
Query: 295 --GLAFLHQ--------------------------DFGLARLISACETHVSTDIAGTLGY 326
G+ +HQ DFGLAR GT +
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTPEF 254
Query: 327 IPPEYGQSRMSTTRGDVYSFGVIL 350
+ PE + D++S GVI
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 48/209 (22%), Positives = 75/209 (35%), Gaps = 55/209 (26%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
+ + +G +G V+K G+ VA+KKF +++ + A E+ L ++KH NLV L
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA----------R 294
L LV+EY H VL RY+ +
Sbjct: 68 LEVFRRKRRLHLVFEYC--------------DHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
+ F H+ DFG ARL++ + D T Y PE
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVATRWYRSPE 172
Query: 331 --YGQSRMSTTRGDVYSFGVILLELVTAK 357
G DV++ G + EL++
Sbjct: 173 LLVG-DTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 46/211 (21%), Positives = 78/211 (36%), Gaps = 56/211 (26%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
+ ++ +G +G V K G+ VA+KKF ++ + A E++ L +++H+NLV L
Sbjct: 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA----------R 294
L C + LV+E++ + + L+ +
Sbjct: 90 LEVCKKKKRWYLVFEFV---DHTI--------LDDLE---LFPNGLDYQVVQKYLFQIIN 135
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
G+ F H DFG AR ++A V D T Y PE
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVATRWYRAPE 194
Query: 331 --YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
G DV++ G ++ E+ EP
Sbjct: 195 LLVG-DVKYGKAVDVWAIGCLVTEMFM-GEP 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 35/210 (16%), Positives = 68/210 (32%), Gaps = 69/210 (32%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK-VKHQNLVL 243
+ + + G + + AVK ++K E+E L + +H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIIT 80
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY-------KIACSSAR 294
L + +V E M G E+LD+ +++ + + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGG-------------ELLDKILRQKFFSEREASAVLFTITK 127
Query: 295 GLAFLHQ----------------------------DFGLARLISACETHVSTDIAGTLGY 326
+ +LH DFG A+ + A E + T +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTANF 186
Query: 327 IPPE------YGQSRMSTTRGDVYSFGVIL 350
+ PE Y + D++S GV+L
Sbjct: 187 VAPEVLERQGYDAA------CDIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 43/208 (20%), Positives = 69/208 (33%), Gaps = 66/208 (31%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+ L G VY+ K A+K KT + E+ L ++ H N++ L
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIACSSAR----G 295
E LV E + G E+ DR Y + A + +
Sbjct: 114 KEIFETPTEISLVLELVTGG-------------ELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 296 LAFLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
+A+LH+ DFGL++++ + + GT GY
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCA 218
Query: 329 PE------YGQSRMSTTRGDVYSFGVIL 350
PE YG D++S G+I
Sbjct: 219 PEILRGCAYGPE------VDMWSVGIIT 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 52/230 (22%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG 222
SS R + + +Q+ ++ + +G +G VYKA G+ VA+K+ +
Sbjct: 8 SSGRENLYFQGLMEKYQK-------LEKVGEGTYGVVYKAKDSQGRIVALKRI---RLDA 57
Query: 223 HRQ---FTA--EMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDL--WLRNATG 275
+ TA E+ L ++ H N+V L+ + LV+E+M DL L
Sbjct: 58 EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM---EKDLKKVLDE--- 111
Query: 276 SHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311
+ L ++ RG+A HQ DFGLAR
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
Query: 312 CETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
T TL Y P+ G S+ +T D++S G I E++T +P
Sbjct: 172 -PVRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMIT-GKP 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 43/206 (20%), Positives = 63/206 (30%), Gaps = 67/206 (32%)
Query: 189 DILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLG 246
L +G F K + AVK S+ ++ E+ L + H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSAR----GLA 297
LV E + G E+ +R K++ A R ++
Sbjct: 74 VFHDQLHTFLVMELLNGG-------------ELFERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 298 FLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
+H DFG ARL + TL Y PE
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPE 179
Query: 331 ------YGQSRMSTTRGDVYSFGVIL 350
Y +S D++S GVIL
Sbjct: 180 LLNQNGYDES------CDLWSLGVIL 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 43/260 (16%), Positives = 89/260 (34%), Gaps = 67/260 (25%)
Query: 151 SLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTV 210
+ N +YL+ + IN ++ ++ L G F + D K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYIN--DYR-------IIRTLNQGKFNKIILCE-KDNKFY 57
Query: 211 AVKKFSQAKTQGHRQFTA-----------------EMETLGKVKHQNLVLLLGYCSFDEE 253
A+KK+ ++ + R FT E++ + +K++ + G + + +
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT-NYD 116
Query: 254 KL-LVYEYMVNGSLDLWLRNATGSHEVL------DRAKRYKIACSSARGLAFLHQ----- 301
++ ++YEYM N S+ + + K S +++H
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI--IKSVLNSFSYIHNEKNIC 174
Query: 302 --------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTT 339
DFG + + + S GT ++PPE +S +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 340 RGDVYSFGVILLELVTAKEP 359
+ D++S G+ L + P
Sbjct: 232 KVDIWSLGICLYVMFYNVVP 251
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 9/125 (7%)
Query: 4 SIPSE--FGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+ +E L L L +N L I + + L L+L+ N +L
Sbjct: 53 RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIP----QNLGNLAQLEHLDV 116
+ L L L +N + +++ L L N+ +R P ++ L +L LD+
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDL 170
Query: 117 LRNML 121
N L
Sbjct: 171 SSNKL 175
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 28/118 (23%), Positives = 39/118 (33%), Gaps = 6/118 (5%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
I SE F L+ L L +N L ++ L L L L N + ++
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA 136
Query: 62 GLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
L L LS N F + L LDL NK + +L L +
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 29/100 (29%), Positives = 40/100 (40%), Gaps = 10/100 (10%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVP----TSL 57
++ F D L+ L L NN + + R + + L KL L++N+ S P
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDG 159
Query: 58 GNLKGLSHLDLSSNFFDGGWPRSLGNLSYST--YLDLHDN 95
L L LDLSSN L L L LH+N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 184 KLTLVDILEDGGFGTVYKATL------PDGKTVAVKKF-SQAKTQGHRQFTAEMETLGKV 236
+L L L G FG V +A +TVAVK A HR +E++ L +
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 237 -KHQNLVLLLGYCS-FDEEKLLVYEYMVNGSLDLWLRN 272
H N+V LLG C+ +++ E+ G+L +LR+
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 21/59 (35%), Positives = 29/59 (49%), Gaps = 9/59 (15%)
Query: 302 DFGLARLISACETHVSTDIAGTLGYIP-----PEYGQSRMSTTRGDVYSFGVILLELVT 355
DFGLAR I +V +P PE R+ T + DV+SFGV+L E+ +
Sbjct: 236 DFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 45/206 (21%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ---FTA--EMETLGKVKHQNL 241
++ + +G +GTV+KA + VA+K+ + + +A E+ L ++KH+N+
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
V L D++ LV+E+ DL + + G LD +GL F
Sbjct: 64 VRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFC 117
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQ 333
H +FGLAR + TL Y PP+ +G
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFG- 175
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEP 359
+++ +T D++S G I EL A P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 42/180 (23%), Positives = 61/180 (33%), Gaps = 39/180 (21%)
Query: 2 TGSIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFS--GPVPTSLG 58
T I S L N T S+ + L L L L RN V
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 59 NLKGLSHLDLSSNFFDGG-------WPRSLGNLSYS----------------TYLDLHDN 95
N+ L LD+S N + W S+ L+ S LDLH+N
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
Query: 96 KFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+ IP+++ +L L+ L+V N L +P+ + +L I L N
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDR-----------LTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 32/203 (15%), Positives = 66/203 (32%), Gaps = 24/203 (11%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P + + + L L N ++ + L L L L+ N+ + L
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN--LGNLAQLEHLDVLRNML 121
+LD+S N + +L +LDL N F +P GNL +L L +
Sbjct: 103 EYLDVSHNRLQNISCCPMASL---RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAA-- 156
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQP 181
K + L + +L + + + ++ ++ N ++
Sbjct: 157 ------KFRQLDLLPV-------AHLHLSCILLDLV-SYHIKGGETESLQIPNTTVLHLV 202
Query: 182 LLKLTLVDILEDGGFGTVYKATL 204
+L + + + L
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQL 225
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
K++ L L NN++ SIP+ + L L +LN+ N+ L L ++ L N +
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
Query: 74 D 74
D
Sbjct: 510 D 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
+ + + + L L +N LTGS+ R L + L+L N+ +P + +L+
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIMS-IPKDVTHLQ 473
Query: 62 GLSHLDLSSNF---FDGGWPRSLGNLSYSTYLDLHDNKF 97
L L+++SN G L +L Y+ LHDN +
Sbjct: 474 ALQELNVASNQLKSVPDGVFDRLTSL---QYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 26/122 (21%), Positives = 44/122 (36%), Gaps = 11/122 (9%)
Query: 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQ-----LGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+F ++ L + N +T I R L L+ ++ F
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 63 LSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
++ LS + F P S + T+L+ N FT + Q L +L+ L + RN
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSF---TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 120 ML 121
L
Sbjct: 388 GL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 20/109 (18%), Positives = 33/109 (30%), Gaps = 8/109 (7%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK---FSGPVPTSLGNLKGLSHLDLSSNFFD 74
++ N S + L+ + P S + L+ + N F
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT---FLNFTQNVFT 366
Query: 75 GGWPRSLGNLSYSTYLDLHDNKFTR--EIPQNLGNLAQLEHLDVLRNML 121
+ L L L N ++ N++ LE LDV N L
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 42/215 (19%), Positives = 68/215 (31%), Gaps = 71/215 (33%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA------EMETLGKVKH 238
+ + L G F V K GK A K + + R+ + E+ L +++H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSA 293
N++ L + +L+ E + G E+ D K A
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGG-------------ELFDFLAEKESLTEDEATQFL 114
Query: 294 R----GLAFLHQ----------------------------DFGLARLISACETHVSTDIA 321
+ G+ +LH DFG+A I A +I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIF 172
Query: 322 GTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT ++ PE G D++S GVI
Sbjct: 173 GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 32/125 (25%), Positives = 44/125 (35%), Gaps = 19/125 (15%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
S+P L L + N+LT S+P LG L +L L N+ P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 63 LSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHL 114
L L L++N +G L NL L L +N IP+ L
Sbjct: 150 LEKLSLANNNLTELPAGLLNG-----LENL---DTLLLQENSLYT-IPKGFFGSHLLPFA 200
Query: 115 DVLRN 119
+ N
Sbjct: 201 FLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 32/125 (25%), Positives = 46/125 (36%), Gaps = 21/125 (16%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ +L L L +LT + G L L L+L+ N+ +P L L+
Sbjct: 48 LATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTV 104
Query: 66 LDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDV 116
LD+S N G LG L L L N+ +P L +LE L +
Sbjct: 105 LDVSFNRLTSLPLGALRG-----LGEL---QELYLKGNELKT-LPPGLLTPTPKLEKLSL 155
Query: 117 LRNML 121
N L
Sbjct: 156 ANNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 39/144 (27%), Positives = 54/144 (37%), Gaps = 19/144 (13%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLKGLSHLDLSSNFF 73
L+L N L +L L +LNL R + + V +L L LDLS N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLG---TLDLSHNQL 89
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLCGKIPEKICKS 132
P L T LD+ N+ T +P L +L+ L + N L +P +
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGL--- 143
Query: 133 RLEGLVSQSGICQNLSKISLAGNK 156
L L K+SLA N
Sbjct: 144 -LTPTP-------KLEKLSLANNN 159
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 20/73 (27%), Positives = 26/73 (35%), Gaps = 4/73 (5%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
++P KL+ L L NN LT +P L L L L L N +P
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 62 GLSHLDLSSNFFD 74
L L N +
Sbjct: 196 LLPFAFLHGNPWL 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 52/248 (20%), Positives = 94/248 (37%), Gaps = 55/248 (22%)
Query: 152 LAGNKDYNLYLSSSRSKGPLRINISMFQ--QPLLKLTLVDILEDGGFGTVYKAT-LPDGK 208
+A + +++ ++++GP +++S + + + L +G +G VYKA +
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 209 TVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266
TVA+K+ + TA E+ L +++H+N++ L + L++EY
Sbjct: 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---EN 117
Query: 267 DLWLRNATGSHEVLDRAKRYKIACSSA------RGLAFLHQ------------------- 301
DL + +D+ + + G+ F H
Sbjct: 118 DL--------KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169
Query: 302 ----------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVYSFGVI 349
DFGLAR T TL Y PPE G SR +T D++S I
Sbjct: 170 ASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACI 227
Query: 350 LLELVTAK 357
E++
Sbjct: 228 WAEMLMKT 235
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 43/215 (20%), Positives = 70/215 (32%), Gaps = 71/215 (33%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA------EMETLGKVKH 238
+ + L G F V K G A K + +++ R+ + E+ L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSA 293
N++ L + +L+ E + G E+ D K + A S
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGG-------------ELFDFLAQKESLSEEEATSFI 121
Query: 294 R----GLAFLHQ----------------------------DFGLARLISACETHVSTDIA 321
+ G+ +LH DFGLA I + +I
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIF 179
Query: 322 GTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT ++ PE G D++S GVI
Sbjct: 180 GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 64/327 (19%), Positives = 104/327 (31%), Gaps = 107/327 (32%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQ 221
SS S +++N + TL D + G +G V A D A+K S+ K
Sbjct: 2 SSGSSGDCVQLN---------QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLI 52
Query: 222 GHRQFTA--------------------------EMETLGKVKHQNLVLLLGYCSFD---E 252
F E+ L K+ H N+V L D E
Sbjct: 53 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNE 110
Query: 253 EKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR--------GLAFLHQ-- 301
+ L +V+E + G V++ ++ AR G+ +LH
Sbjct: 111 DHLYMVFELVNQG-------------PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK 157
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFG++ + +S GT ++ PE
Sbjct: 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIF 216
Query: 340 RG---DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
G DV++ GV L V + P F ++ L K+K Q + D +
Sbjct: 217 SGKALDVWAMGVTLYCFVFGQCP----FMDERIMCL----HSKIKSQAL-EFPDQPDIAE 267
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTM 423
K ++ +ML NP +R +
Sbjct: 268 DLKDLITRMLDK-------NPESRIVV 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 22/143 (15%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
++ L L + Q+T P L L L L L N+ + P L L L +L + +
Sbjct: 108 SIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
L NLS T L DNK + +I L +L L + + N + S
Sbjct: 164 SD--LTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI----------SD 209
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
+ L + NL ++L
Sbjct: 210 VSPLAN----TSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 35/143 (24%), Positives = 55/143 (38%), Gaps = 22/143 (15%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L GL L +NQ+T + L L + +L L+ N +++ L+ + LDL+S
Sbjct: 64 NLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
L LS L L N+ T I L L L++L + + S
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQV----------SD 165
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
L L + L+ + NK
Sbjct: 166 LTPLAN----LSKLTTLKADDNK 184
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 31/155 (20%), Positives = 52/155 (33%), Gaps = 24/155 (15%)
Query: 4 SIPSEFGDSL--KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
+I F D + G + +T ++ L G+ L+ + + L
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLN 63
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L L+L N L NL+ T L+L N + + L ++ LD+ +
Sbjct: 64 NLIGLELKDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQI 119
Query: 122 CGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
P L GL NL + L N+
Sbjct: 120 TDVTP-------LAGL-------SNLQVLYLDLNQ 140
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 26/98 (26%), Positives = 36/98 (36%), Gaps = 6/98 (6%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
LQ L +GN Q++ + L L L L NK S P L +L L + L +N
Sbjct: 152 NLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQL 111
L N S + L + T + NL
Sbjct: 208 SD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 51/219 (23%), Positives = 81/219 (36%), Gaps = 60/219 (27%)
Query: 194 GGFGTVYKA---TLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLLG-Y 247
G +G VYKA D K A+K+ + G +A E+ L ++KH N++ L +
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQI---EGTG-ISMSACREIALLRELKHPNVISLQKVF 87
Query: 248 CSFDEEKL-LVYEYMVNGSLDLW-------LRNATGSHEVLDRAKRYKIACSSARGLAFL 299
S + K+ L+++Y DLW A L R + G+ +L
Sbjct: 88 LSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 300 HQ----------------------------DFGLARLISA---CETHVSTDIAGTLGYIP 328
H D G ARL ++ + + T Y
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRA 203
Query: 329 PE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ 365
PE G +R T D+++ G I EL+T++ P F
Sbjct: 204 PELLLG-ARHYTKAIDIWAIGCIFAELLTSE----PIFH 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 46/213 (21%), Positives = 71/213 (33%), Gaps = 66/213 (30%)
Query: 189 DILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLG 246
D+L +G V L + AVK + + E+E L + + H+N++ L+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 247 YCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSAR----G 295
+ F+EE LV+E M GS+ L +R+ A +
Sbjct: 79 F--FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASA 123
Query: 296 LAFLHQ---------------------------DFGLARLI------SACETHVSTDIAG 322
L FLH DF L I S T G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 323 TLGYIPPEYGQSRMSTTRG-----DVYSFGVIL 350
+ Y+ PE ++ D++S GVIL
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 40/249 (16%), Positives = 66/249 (26%), Gaps = 77/249 (30%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVK-----KFSQAKTQGHRQFTAEMETLGKVKHQ 239
L + G +G V A A+K K Q + + E+ + K+ H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR----- 294
N+ L ++ LV E G L + + + +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGG--HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 295 ---------------------------------GLAFLHQ-------------------- 301
L +LH
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 302 ------DFGLARLISAC---ETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVYSFGVIL 350
DFGL++ E + T AGT ++ PE + + D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 351 LELVTAKEP 359
L+ P
Sbjct: 267 HLLLMGAVP 275
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 43/215 (20%), Positives = 69/215 (32%), Gaps = 71/215 (33%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA------EMETLGKVKH 238
+ + L G F V K G A K + +++ R+ E+ L +V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSA 293
N++ L + +L+ E + G E+ D K + A S
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGG-------------ELFDFLAQKESLSEEEATSFI 121
Query: 294 R----GLAFLHQ----------------------------DFGLARLISACETHVSTDIA 321
+ G+ +LH DFGLA I + +I
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIF 179
Query: 322 GTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT ++ PE G D++S GVI
Sbjct: 180 GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 41/214 (19%), Positives = 64/214 (29%), Gaps = 64/214 (29%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--------EMETLGKV 236
D++ G V + G AVK + + E L +V
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 237 K-HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIAC 290
H +++ L+ LV++ M G E+ D K
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKG-------------ELFDYLTEKVALSEKETR 203
Query: 291 SSAR----GLAFLHQ------------------------DFGLARLISACETHVSTDIAG 322
S R ++FLH DFG + + ++ G
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCG 261
Query: 323 TLGYIPPE-YGQSRMSTTRG-----DVYSFGVIL 350
T GY+ PE S T G D+++ GVIL
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 42/215 (19%), Positives = 68/215 (31%), Gaps = 71/215 (33%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA------EMETLGKVKH 238
+ L G F V K G A K + +T+ R+ + E+ L +++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY---KIACSSA 293
N++ L + +L+ E + G E+ D K + A
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGG-------------ELFDFLAEKESLTEEEATEFL 120
Query: 294 R----GLAFLHQ----------------------------DFGLARLISACETHVSTDIA 321
+ G+ +LH DFGLA I +I
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIF 178
Query: 322 GTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT ++ PE G D++S GVI
Sbjct: 179 GTPEFVAPEIVNYEPLGLE------ADMWSIGVIT 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 38/146 (26%), Positives = 52/146 (35%), Gaps = 28/146 (19%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF- 72
+ L+L N+LT I L L L L L NK L +LK L L L N
Sbjct: 66 NVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI 121
Query: 73 --FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130
+G L +L L L +NK T L L +L+ L + N +
Sbjct: 122 SDING-----LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--------- 165
Query: 131 KSRLEGLVSQSGICQNLSKISLAGNK 156
S + L L + L+ N
Sbjct: 166 -SDIVPLAG----LTKLQNLYLSKNH 186
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 28/145 (19%), Positives = 48/145 (33%), Gaps = 28/145 (19%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74
+ + + P +K NL + + V L + + +++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI- 55
Query: 75 GGWPRSLGNLSYST---YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
+S+ + Y L L+ NK T +I + L NL L L + N KI
Sbjct: 56 ----KSVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN----KI------ 99
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
L L + L +SL N
Sbjct: 100 KDLSSLKD----LKKLKSLSLEHNG 120
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 30/118 (25%), Positives = 43/118 (36%), Gaps = 8/118 (6%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
KL+ L L +N ++ I L L L L L NK + T L L L L L N
Sbjct: 110 KLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
L L+ L L N + ++ + L L L+ L++ K
Sbjct: 166 SD--IVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSN 219
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 35/149 (23%), Positives = 52/149 (34%), Gaps = 34/149 (22%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN-- 71
+ + N+ + S+ + L + KL L NK + P L NLK L L L N
Sbjct: 44 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
Query: 72 ----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127
L L L L N + +I L +L QLE L + N +
Sbjct: 100 KDLSSLKD-----LKKL---KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI------ 143
Query: 128 KICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + L L +SL N+
Sbjct: 144 ----TDITVLSR----LTKLDTLSLEDNQ 164
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 22/143 (15%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+ L +T ++ +L + ++ + + L ++ L L+ N
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKL 77
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
P L NL +L L +NK ++ +L +L +L+ L + N + S
Sbjct: 78 TDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI----------SD 123
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
+ GLV L + L NK
Sbjct: 124 INGLVH----LPQLESLYLGNNK 142
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
KL L L +NQ++ I L L L L L++N S +L LK L L+L S
Sbjct: 154 KLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQEC 209
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
NL + D P+ + + E +V ++
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 49/220 (22%)
Query: 174 NISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMET 232
+I P K T + + G GTVY A + G+ VA+++ + + E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 233 LGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL-DLWLRN-------ATGSHEVLDRA 283
+ + K+ N+V L ++L +V EY+ GSL D+ A E L
Sbjct: 71 MRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--- 126
Query: 284 KRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTD 319
+ L FLH DFG I+ ++ ST
Sbjct: 127 ----------QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 175
Query: 320 IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
+ GT ++ PE + + D++S G++ +E++ + P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 67/342 (19%), Positives = 113/342 (33%), Gaps = 68/342 (19%)
Query: 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGIC 144
Y T D + + + L + + L+ +
Sbjct: 94 DYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRA--VL 151
Query: 145 QNLSKISLAGNKDYNLYLSSSRSKGPLRINISM--FQQPLLKLTLVDILEDGGFGTVYKA 202
+L + D +L + K + F + +L GGFG V+
Sbjct: 152 AHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFL--DFR-----VLGRGGFGEVFAC 204
Query: 203 TLPD-GKTVAVKKFSQAKTQGHRQFT---AEMETLGKVKHQNLVLLLGYCSF-DEEKL-L 256
+ GK A KK ++ + + + + E + L KV + +V L +F + L L
Sbjct: 205 QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AYAFETKTDLCL 262
Query: 257 VYEYMVNGSLDLWLRNATGSHEVL--DRAKRY--KIACSSARGLAFLHQ----------- 301
V M G + + N + RA Y +I GL LHQ
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLHQRNIIYRDLKPE 318
Query: 302 -------------DFGLARLISACETHVSTDIAGTLGYIPPE------YGQSRMSTTRGD 342
D GLA + A +T AGT G++ PE Y S D
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSV------D 371
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384
++ GV L E++ A+ P F+ + + Q++ +Q
Sbjct: 372 YFALGVTLYEMIAARGP----FRARGEKVENKELKQRVLEQA 409
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 51/200 (25%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLLL 245
++ + +G +G VYKA G+T A+KK K T E+ L ++KH N+V L
Sbjct: 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 246 GYCSFDEEKLLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
+ +LV+E++ DL L G L+ G+A+ H
Sbjct: 67 DVIHTKKRLVLVFEHL---DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMS 337
DFGLAR T TL Y P+ G S+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMG-SKKY 178
Query: 338 TTRGDVYSFGVILLELVTAK 357
+T D++S G I E+V
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 52/234 (22%)
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT 220
++ S + L ++ P T ++ + G FG V+K K VA+K +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 221 QGHRQ-FTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSL-DLWLRN---- 272
+ + E+ L + + Y S+ + KL ++ EY+ GS DL
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKY--YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE 118
Query: 273 ---ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305
AT E+L +GL +LH DFG+
Sbjct: 119 TQIATILREIL-------------KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV 165
Query: 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
A ++ + +T + GT ++ PE + ++ D++S G+ +EL + P
Sbjct: 166 AGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 50/232 (21%)
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT 220
++ + K LR+ + P L L + +G G V A G+ VAVK K
Sbjct: 25 VTHEQFKAALRMVVDQ-GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ 83
Query: 221 QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL-DLWLRN------ 272
Q E+ + +H N+V + E+L ++ E++ G+L D+ +
Sbjct: 84 QRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ 142
Query: 273 -ATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307
AT VL + LA+LH DFG
Sbjct: 143 IATVCEAVL-------------QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189
Query: 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
IS + + GT ++ PE + T D++S G++++E+V + P
Sbjct: 190 QISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 39/215 (18%), Positives = 59/215 (27%), Gaps = 65/215 (30%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA---------EMETLGK 235
+IL G V + P K AVK E++ L K
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 236 VK-HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR---AKRY--KIA 289
V H N++ L + LV++ M G E+ D K
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKG-------------ELFDYLTEKVTLSEKET 126
Query: 290 CSSAR----GLAFLHQ------------------------DFGLARLISACETHVSTDIA 321
R + LH+ DFG + + ++
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVC 184
Query: 322 GTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
GT Y+ PE D++S GVI+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 33/157 (21%), Positives = 52/157 (33%), Gaps = 26/157 (16%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
+ L L +N +T ++ L Q L L NK + + L L++L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYL 111
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126
+ +N L TYL+ N T EI + + QL LD N K+
Sbjct: 112 NCDTNKLTKLDVSQNPLL---TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 127 EKICKSRLEGLVSQSGICQNLSKISLAGNKDYNLYLS 163
L+ + + NK L +S
Sbjct: 166 --------------VTPQTQLTTLDCSFNKITELDVS 188
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 19/161 (11%)
Query: 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSH 65
+ +L L N++T + + Q L +LN N + L L+
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTF 216
Query: 66 LDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125
LD SSN + L+ TY D N T E+ + L++L L ++ L
Sbjct: 217 LDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL---- 266
Query: 126 PEKICKSRLEGLVS-QSGICQNLSKISLAGNKD-YNLYLSS 164
+I + L+ Q+ C+ + ++ + N Y L +
Sbjct: 267 -LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQA 306
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 26/113 (23%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68
KL L N+LT + + Q L LN RN + + + L+ LD
Sbjct: 102 VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDC 155
Query: 69 SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
N + + T LD NK T E+ + L L+ N +
Sbjct: 156 HLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/157 (11%), Positives = 40/157 (25%), Gaps = 16/157 (10%)
Query: 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLD 67
+ + +L + + + L L+ + L L +L
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLY 324
Query: 68 LSSNFFDGGWPRSL--GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125
L++ L + + L + + ++G + L +
Sbjct: 325 LNNTEL-----TELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMP 377
Query: 126 PEKICKSRLEGLVS--QSGICQNLSKISLAGNKDYNL 160
E + + L VS N I Y+
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
++ L +G + TVYK G VA+K+ +G TA E+ + ++KH+N+V L
Sbjct: 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENIVRL 68
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDL----WLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ + LV+E+M DL R + L+ +GLAF H
Sbjct: 69 YDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQS 334
+ DFGLAR + + TL Y P+ G S
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMG-S 183
Query: 335 RMSTTRGDVYSFGVILLELVTAKEP 359
R +T D++S G IL E++T +P
Sbjct: 184 RTYSTSIDIWSCGCILAEMIT-GKP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 40/201 (19%)
Query: 188 VDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA--EMETLGKVKHQNLVLL 244
+D L +G + TVYK VA+K+ +G TA E+ L +KH N+V L
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTL 65
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
++ LV+EY+ DL +L + +++ RGLA+ H+
Sbjct: 66 HDIIHTEKSLTLVFEYL---DKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRM 336
DFGLAR S T + TL Y PP+ G S
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLG-STD 177
Query: 337 STTRGDVYSFGVILLELVTAK 357
+T+ D++ G I E+ T +
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 34/152 (22%), Positives = 56/152 (36%), Gaps = 32/152 (21%)
Query: 14 KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF 72
++ L +++ ++ +S+ L +L L +N+ + + L L L+LS NF
Sbjct: 276 GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNF 334
Query: 73 --------FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLCG 123
F+ L L LDL N + L L+ L + N L
Sbjct: 335 LGSIDSRMFEN-----LDKL---EVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK- 384
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+P+ I + L S L KI L N
Sbjct: 385 SVPDGI----FDRLTS-------LQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 33/127 (25%), Positives = 47/127 (37%), Gaps = 21/127 (16%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
++ F L+ L L N++ I + L L+KLNL++N NL
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347
Query: 62 GLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLE 112
L LDLS N F G L NL L L N+ +P L L+
Sbjct: 348 KLEVLDLSYNHIRALGDQSFLG-----LPNL---KELALDTNQLKS-VPDGIFDRLTSLQ 398
Query: 113 HLDVLRN 119
+ + N
Sbjct: 399 KIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 24/118 (20%), Positives = 36/118 (30%), Gaps = 19/118 (16%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSN-- 71
+ + L N + S +L L L + + + + L L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 72 ------FFDGGWPRSLGNLSYSTYLDLHDNKFT-REIPQNL-GNLAQLEHLDVLRNML 121
F+G L NL L L + N L LE L + N +
Sbjct: 92 LQLETGAFNG-----LANL---EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 24/162 (14%), Positives = 49/162 (30%), Gaps = 14/162 (8%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNK--------FSGPVPTSLG- 58
F L+ L L +N + P S + L+LT NK
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184
Query: 59 -NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQ---NLGNLAQLEHL 114
L ++ D++ + + + T LDL N F + + + +++ L
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244
Query: 115 DVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ + G + + + L+ +K
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 31/175 (17%), Positives = 51/175 (29%), Gaps = 35/175 (20%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKL-------------NLTRN 47
L + + L L N S+ + K+ +
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 48 KFSGPVPTSLGNLK--GLSHLDLSSNFF---DGGWPRSLGNLSYSTYLDLHDNKFTREIP 102
F P + L+ G+ DLS + +L L L N+ +I
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL---EQLTLAQNEIN-KID 315
Query: 103 QN-LGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N L L L++ +N L G I ++ E L L + L+ N
Sbjct: 316 DNAFWGLTHLLKLNLSQNFL-GSIDSRM----FENLD-------KLEVLDLSYNH 358
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 26/103 (25%), Positives = 32/103 (31%), Gaps = 17/103 (16%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I L L L L N L R L L L+L+ N S L
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372
Query: 63 LSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKF 97
L L L +N FD L +L + LH N +
Sbjct: 373 LKELALDTNQLKSVPDGIFD-----RLTSL---QKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 25/135 (18%), Positives = 43/135 (31%), Gaps = 27/135 (20%)
Query: 28 SIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP----RSLGN 83
+P + ++L+ N + TS L+ L L + R L +
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 84 LSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNML-CGKIPEKICKSRLEGLVSQS 141
L L L N+F ++ LA LE L + + L + + L
Sbjct: 81 L---IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF----FKPLT--- 129
Query: 142 GICQNLSKISLAGNK 156
+L + L N
Sbjct: 130 ----SLEMLVLRDNN 140
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 21/74 (28%), Positives = 33/74 (44%), Gaps = 3/74 (4%)
Query: 3 GSIPSEFGDSL-KLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
GSI S ++L KL+ L L N + ++ +S L L +L L N+ L
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394
Query: 61 KGLSHLDLSSNFFD 74
L + L +N +D
Sbjct: 395 TSLQKIWLHTNPWD 408
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 38/241 (15%), Positives = 70/241 (29%), Gaps = 51/241 (21%)
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVDILEDG--GFGTVYKAT-LPDGKTVAVKKFS-- 216
+ +S F L+ ++ G TV A P G+ V V++ +
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE 63
Query: 217 QAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSL-DLWLRNA 273
+ E+ H N+V +F + +L +V +M GS DL +
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPY--RATFIADNELWVVTSFMAYGSAKDL-ICT- 119
Query: 274 TGSHEVLDRAKRYKIAC---SSARGLAFLHQ------------------------DFGLA 306
+ ++ IA + L ++H
Sbjct: 120 -HFMDGMNELA---IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 307 RLISACETHVST------DIAGTLGYIPPEYGQSRMS--TTRGDVYSFGVILLELVTAKE 358
+ + L ++ PE Q + + D+YS G+ EL
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 359 P 359
P
Sbjct: 236 P 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 48/239 (20%), Positives = 80/239 (33%), Gaps = 53/239 (22%)
Query: 159 NLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVY----KATLPDGKTVAVKK 214
+ +R++ F+ +LK ++ G FG V K K A+K
Sbjct: 57 EWAKPFTSKVKQMRLHREDFE--ILK-----VIGRGAFGEVAVVKLKNA---DKVFAMKI 106
Query: 215 FSQAKTQGHRQ---FTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLW 269
++ + + F E + L + + L + +F D+ L LV +Y V G L
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 270 LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305
L + A+ Y + +HQ DFG
Sbjct: 165 LSKFEDRLP-EEMARFY--LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG-----DVYSFGVILLELVTAKEP 359
+ T S+ GT YI PE Q+ D +S GV + E++ + P
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 49/241 (20%), Positives = 76/241 (31%), Gaps = 55/241 (22%)
Query: 159 NLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVY----KATLPDGKTVAVKK 214
+R+ F+ +LK+ + G F V K T G+ A+K
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFE--ILKV-----IGRGAFSEVAVVKMKQT---GQVYAMKI 93
Query: 215 FSQAKTQGHRQ---FTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLW 269
++ + F E + L + + L + +F DE L LV EY V G L
Sbjct: 94 MNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTL 151
Query: 270 LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305
L G + A+ Y + +H+ DFG
Sbjct: 152 LSKF-GERIPAEMARFY--LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVY-------SFGVILLELVTAKE 358
+ A T S GT Y+ PE Q+ Y + GV E+ +
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
Query: 359 P 359
P
Sbjct: 269 P 269
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 42/204 (20%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ---FTA--EMETLGKVKHQNL 241
+D L +G F TVYKA + VA+KK + TA E++ L ++ H N+
Sbjct: 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
+ LL LV+++M DL +++ + VL + + +GL +L
Sbjct: 75 IGLLDAFGHKSNISLVFDFM---ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE--YGQ 333
HQ DFGLA+ + T T Y PE +G
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFG- 186
Query: 334 SRMSTTRGDVYSFGVILLELVTAK 357
+RM D+++ G IL EL+
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRV 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 45/285 (15%), Positives = 86/285 (30%), Gaps = 93/285 (32%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK--------------H 238
GGFGTV+ L D VA+K + + G + + H
Sbjct: 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW----SPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR-AKRYKIACSSAR--- 294
++ LL + E +LV E + ++ D ++ + +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA------------QDLFDYITEKGPLGEGPSRCFF 145
Query: 295 -----GLAFLHQ-------------------------DFGLARLISACETHVSTDIAGTL 324
+ H DFG L+ GT
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTR 202
Query: 325 GYIPPEYGQSRM-STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
Y PPE+ V+S G++L ++V P F++ ++
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-----------------FERDQEI 245
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ P ++ ++ + L P++RP++ +L
Sbjct: 246 LEAELHFPAHVSPDCCALIRRCLAP-------KPSSRPSLEEILL 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 69/340 (20%), Positives = 119/340 (35%), Gaps = 63/340 (18%)
Query: 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSG-- 142
Y D R + QN + + + + L +++ + + L +
Sbjct: 89 EYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRL 148
Query: 143 ICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKA 202
+ LS A D + + K R ++ + +L GGFG V
Sbjct: 149 THEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR-----VLGKGGFGEVCAC 203
Query: 203 TLPD-GKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-EEKL-L 256
+ GK A KK + K +G E + L KV + +V L +++ ++ L L
Sbjct: 204 QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETKDALCL 261
Query: 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ------------- 301
V M G L + + + RA Y +I C GL LH+
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC----GLEDLHRERIVYRDLKPENI 317
Query: 302 -----------DFGLARLISACETHVSTDIAGTLGYIPPE------YGQSRMSTTRGDVY 344
D GLA + +T GT+GY+ PE Y S D +
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFS------PDWW 369
Query: 345 SFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384
+ G +L E++ + P FQ+++ V + +K+
Sbjct: 370 ALGCLLYEMIAGQSP----FQQRKKKIKREEVERLVKEVP 405
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 46/206 (22%), Positives = 71/206 (34%), Gaps = 44/206 (21%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNL 241
+ + G G V A + VA+KK S+ +T R + E+ + V H+N+
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNI 123
Query: 242 VLLL------GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARG 295
+ LL ++ LV E M +L E+ Y + G
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM---DANLC---QVIQMELDHERMSY-LLYQMLCG 176
Query: 296 LAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEY 331
+ LH DFGLAR +A + + T T Y PE
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 234
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAK 357
D++S G I+ E+V K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 7e-09
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+ L LY+ N Q + L LG L L + ++ P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT 98
LS L+LS N + +++ LS L L N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 15/101 (14%), Positives = 28/101 (27%), Gaps = 2/101 (1%)
Query: 22 NNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSNFFDGGWPRS 80
L L +L + + + L L L +L + + P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 81 LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
+ L+L N + L+ L + N L
Sbjct: 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 36/144 (25%), Positives = 52/144 (36%), Gaps = 14/144 (9%)
Query: 165 SRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGH 223
S K ++ P +V L DG FG VYKA G A K +
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60
Query: 224 RQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL-DLWLRNATGSHEVLD 281
+ E+E L H +V LLG + + KL ++ E+ G++ + L G E
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-- 117
Query: 282 RAKRYKIAC---SSARGLAFLHQD 302
+I L FLH
Sbjct: 118 -----QIQVVCRQMLEALNFLHSK 136
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 49/221 (22%), Positives = 82/221 (37%), Gaps = 48/221 (21%)
Query: 172 RINISMFQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFT--- 227
+N F+ +L+ + G FG V D K A+K ++ K +
Sbjct: 11 DVNFDHFE--ILRA-----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF 63
Query: 228 AEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKR 285
E++ + ++H LV L + SF DEE + +V + ++ G L L+ E + K
Sbjct: 64 KELQIMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKL 119
Query: 286 YKIACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIA 321
+ C L +L DF +A ++ + +A
Sbjct: 120 F--ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 322 GTLGYIPPEYGQSRMSTTRG---DVYSFGVILLELVTAKEP 359
GT Y+ PE SR D +S GV EL+ + P
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 46/279 (16%), Positives = 84/279 (30%), Gaps = 83/279 (29%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA------EMETLGKVKHQ--NLVLL 244
GGFG+VY + D VA+K + + + E+ L KV ++ L
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR-AKRYKIACSSAR--------G 295
L + + +L+ E ++ D +R + AR
Sbjct: 114 LDWFERPDSFVLILER------------PEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 296 LAFLHQ-------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
+ H DFG L+ GT Y PPE
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPE 218
Query: 331 YGQSRM-STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389
+ + V+S G++L ++V P F+ ++ V
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEIIRGQVF 261
Query: 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+++ + ++ L + P+ RPT +
Sbjct: 262 FRQRVSSECQHLIRWCLAL-------RPSDRPTFEEIQN 293
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 27/160 (16%), Positives = 56/160 (35%), Gaps = 20/160 (12%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSG-PVPTSLGNL 60
+ S F + K+ + + N + I L +L L L + P T + +
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYST 129
Query: 61 KGLSHLDLSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
L+++ N + L N + + L L++N FT + N +L+ + +
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLT--LKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 117 LRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+N I + G+ S S + ++
Sbjct: 187 NKNKYLTVIDKDA----FGGVYS------GPSLLDVSQTS 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 24/150 (16%), Positives = 53/150 (35%), Gaps = 23/150 (15%)
Query: 15 LQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSN- 71
Q L L L +IP + L + ++ ++ + + + S NL ++H+++ +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 72 ---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN--LGNLAQLEHLDVLRNMLCGKIP 126
+ D + L L +L + + P + + L++ N IP
Sbjct: 92 NLTYIDPDALKELPLL---KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 127 EKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+GL ++ + L N
Sbjct: 148 VNA----FQGLCNE------TLTLKLYNNG 167
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 23/151 (15%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIP--RSLGQLGGLVKLNLTRNKFSGPVP----TS 56
I + + L+ L + N L P + L +T N + +P
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 57 LGNLKGLSHLDLSSNFFDGGWPRSLG----NLSYSTYLDLHDNKFTREIPQNL--GNLAQ 110
L N L L +N F S+ N + + L+ NK+ I ++ G +
Sbjct: 154 LCNE--TLTLKLYNNGF-----TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 111 LEHLDVLRNMLCGKIPEKICKSRLEGLVSQS 141
LDV + + +P K + L+ L++++
Sbjct: 207 PSLLDVSQTSV-TALPSKGLEH-LKELIARN 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 37/250 (14%), Positives = 69/250 (27%), Gaps = 55/250 (22%)
Query: 214 KFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNA 273
+ + + ++ + +N V L S + + +L W+
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 274 TGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309
+ + I A + FLH DFGL +
Sbjct: 156 CSLED-REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 310 -----------SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKE 358
T GT Y+ PE + + D++S G+IL EL+ +
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF- 273
Query: 359 PTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPA 418
T E + ++ + T M+ ML +P
Sbjct: 274 STQMERVR---------IITDVRNLKFPL--LFTQKYPQEHMMVQDMLSP-------SPT 315
Query: 419 TRPTMLHVLK 428
RP +++
Sbjct: 316 ERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 15/57 (26%), Positives = 28/57 (49%), Gaps = 2/57 (3%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLV 242
+ + GGFG V++A D A+K+ + R+ E++ L K++H +V
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 54/235 (22%), Positives = 84/235 (35%), Gaps = 46/235 (19%)
Query: 162 LSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT 220
+S S P IN + L +++ G V A P + VA+K+ + K
Sbjct: 1 MSEDSSALPWSINRDDY-------ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC 53
Query: 221 QGHRQ-FTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSL-DLWLRNATGS 276
Q E++ + + H N+V Y SF +++L LV + + GS+ D+
Sbjct: 54 QTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 277 HEVLDRAKRYKIAC---SSARGLAFLHQ------------------------DFG----L 305
IA GL +LH+ DFG L
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171
Query: 306 ARLISACETHVSTDIAGTLGYIPPE-YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
A V GT ++ PE Q R + D++SFG+ +EL T P
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 11/124 (8%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
S+PS+ L KL+ LYL +N+L ++P + +L L L +T NK L
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV 109
Query: 62 GLSHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVL 117
L+ L L N SL L TYL L N+ +P+ + L L+ L +
Sbjct: 110 NLAELRLDRNQLKSLPPRVFDSLTKL---TYLSLGYNELQS-LPKGVFDKLTSLKELRLY 165
Query: 118 RNML 121
N L
Sbjct: 166 NNQL 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
S+P DSL KL L LG N+L S+P+ + +L L +L L N+ + L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDN 95
L L L +N + +L L L +N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/122 (25%), Positives = 48/122 (39%), Gaps = 10/122 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+IPS + L L +N+L+ ++ +L L L L NK LK L
Sbjct: 30 AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 64 SHLDLSSNFF---DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRN 119
L ++ N G L NL L L N+ +P + +L +L +L + N
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNL---AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
Query: 120 ML 121
L
Sbjct: 144 EL 145
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
S+P D L L+ L L NNQL +P +L L L L N+ + +L+
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 62 GLSHLDLSSNFFD 74
L L L N +D
Sbjct: 206 KLKMLQLQENPWD 218
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 37/148 (25%), Positives = 50/148 (33%), Gaps = 32/148 (21%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+ L+L N+LT I L L L L L NK L +LK L L L N
Sbjct: 69 NVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHN-- 122
Query: 74 DGGWPR-----SLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128
L +L L L +NK T L L +L+ L + N +
Sbjct: 123 -----GISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI------- 168
Query: 129 ICKSRLEGLVSQSGICQNLSKISLAGNK 156
S + L L + L+ N
Sbjct: 169 ---SDIVPLAG----LTKLQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 32/108 (29%), Positives = 45/108 (41%), Gaps = 6/108 (5%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+L+ LYLGNN++T I L +L L L+L N+ S VP L L L +L LS N
Sbjct: 135 QLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
L L L+L + + + NL + L
Sbjct: 191 SDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 22/143 (15%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+ L +T ++ +L + ++ + + L ++ L L+ N
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKL 80
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
P L NL +L L +NK ++ +L +L +L+ L + N + S
Sbjct: 81 TDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI----------SD 126
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
+ GLV L + L NK
Sbjct: 127 INGLVH----LPQLESLYLGNNK 145
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 50/200 (25%), Positives = 69/200 (34%), Gaps = 43/200 (21%)
Query: 194 GGFGTVYKATLPD-GKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQN---LVLLLG 246
GGFG VY D GK A+K + QG E L V + +V +
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-- 257
Query: 247 YCSF-DEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
+F +KL + + M G L L E + Y A GL +H
Sbjct: 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--ADMRFY--AAEIILGLEHMHNRFV 313
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
D GLA S + H S GT GY+ PE Q ++
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDS 370
Query: 341 G-DVYSFGVILLELVTAKEP 359
D +S G +L +L+ P
Sbjct: 371 SADWFSLGCMLFKLLRGHSP 390
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 35/205 (17%), Positives = 58/205 (28%), Gaps = 69/205 (33%)
Query: 194 GGFGTVYKAT-LPDGKTVAVK--KFSQAKTQGHRQFTAEMETLGKVKHQ-NLVLLLGYCS 249
G F V + G+ A K K + + E+ L K ++ L
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR--AKRY-----KIACSSAR----GLAF 298
E +L+ EY G E+ + + G+ +
Sbjct: 100 NTSEIILILEYAAGG-------------EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 299 LHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIPPE- 330
LHQ DFG++R I +I GT Y+ PE
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACELREIMGTPEYLAPEI 204
Query: 331 -----YGQSRMSTTRGDVYSFGVIL 350
+ D+++ G+I
Sbjct: 205 LNYDPITTA------TDMWNIGIIA 223
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 29/119 (24%), Positives = 46/119 (38%), Gaps = 16/119 (13%)
Query: 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68
F +L+ + NN++T + G+ ++ LT N+ L+ L L L
Sbjct: 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112
Query: 69 SSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119
SN F G L ++ L L+DN+ T P L L L++L N
Sbjct: 113 RSNRITCVGNDSFIG-----LSSV---RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
++ + L L+ L L +N++T + S L + L+L N+ + P + L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 62 GLSHLDLSSNFFD 74
LS L+L +N F+
Sbjct: 154 SLSTLNLLANPFN 166
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 55/289 (19%), Positives = 95/289 (32%), Gaps = 81/289 (28%)
Query: 187 LVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA----EMETLGKVKHQNL 241
+ D+L +G +G V + AVK + K + A E++ L +++H+N+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 242 VLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR----- 294
+ L+ +E++ +V EY G E+LD + A
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEY-CVC----------GMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 295 ---GLAFLHQ------------------------DFGLARLISA------CETHVSTDIA 321
GL +LH G+A + C T
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-----SQ 172
Query: 322 GTLGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQK 379
G+ + PPE G S + D++S GV L + T P F+ L F+
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKL----FEN 224
Query: 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ K P ++ ML PA R ++ + +
Sbjct: 225 IGKG---SYAIPGDCGPPLSDLLKGMLEY-------EPAKRFSIRQIRQ 263
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 41/129 (31%), Positives = 56/129 (43%), Gaps = 25/129 (19%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF-SGP--VPTSLGNL 60
S+P+ G Q LYL +NQ+T P L L +L L N+ + P V SL L
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 61 KGLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE 112
LDL +N FD L +L L + NK T E+P+ + L L
Sbjct: 91 T---VLDLGTNQLTVLPSAVFD-----RLVHL---KELFMCCNKLT-ELPRGIERLTHLT 138
Query: 113 HLDVLRNML 121
HL + +N L
Sbjct: 139 HLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 2/72 (2%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
+PS D L L+ L++ N+LT +PR + +L L L L +N+ + L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 63 LSHLDLSSNFFD 74
L+H L N +D
Sbjct: 161 LTHAYLFGNPWD 172
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 27/122 (22%), Positives = 42/122 (34%), Gaps = 10/122 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
IP + L L N L S L L+L+R + + +L L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 64 SHLDLSSN---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRN 119
S L L+ N G L +L L + + G+L L+ L+V N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSL---QKLVAVETNLAS-LENFPIGHLKTLKELNVAHN 134
Query: 120 ML 121
++
Sbjct: 135 LI 136
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 26/123 (21%), Positives = 43/123 (34%), Gaps = 9/123 (7%)
Query: 4 SIPSE-FGDSLKLQGLYLGNNQLTGSIPRS--LGQLGGLVKLNLTRNKF---SGPVPTSL 57
S+ + G L+ L + +N + S L L L+L+ NK L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
Query: 58 GNLKGLS-HLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
+ L+ LDLS N + P + + L L N+ L L+ + +
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWL 231
Query: 117 LRN 119
N
Sbjct: 232 HTN 234
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 29/145 (20%), Positives = 55/145 (37%), Gaps = 27/145 (18%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+Q N+ + S+ + L +L+L+ N+ S + L +L L L ++ N
Sbjct: 42 GVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNRL 97
Query: 74 DGGWPRSLGNLSYS--TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
++L + + + L L +N+ +L +L LE L + N L
Sbjct: 98 -----KNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL---------- 140
Query: 132 SRLEGLVSQSGICQNLSKISLAGNK 156
+ L L + L GN+
Sbjct: 141 KSIVMLGF----LSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 30/104 (28%), Positives = 37/104 (35%), Gaps = 6/104 (5%)
Query: 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLD 67
S L L+L NN+L SL L L L++ NK V LG L L LD
Sbjct: 101 NGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLD 156
Query: 68 LSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQL 111
L N L L ++DL K E + L
Sbjct: 157 LHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 26/146 (17%), Positives = 46/146 (31%), Gaps = 29/146 (19%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF- 72
LG +T + S +L G+ N + + L L LS N
Sbjct: 20 NAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHNQI 75
Query: 73 --FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130
L +L+ L ++ N+ + + + L L + N L
Sbjct: 76 SDLSP-----LKDLTKLEELSVNRNRLK-NLN-GIPSA-CLSRLFLDNNEL--------- 118
Query: 131 KSRLEGLVSQSGICQNLSKISLAGNK 156
+ L+ +NL +S+ NK
Sbjct: 119 -RDTDSLIH----LKNLEILSIRNNK 139
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 29/140 (20%)
Query: 20 LGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPR 79
+ P L VK NL + + V L G+ + + ++ +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----Q 54
Query: 80 SLGNLSYST---YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEG 136
SL + + T L L N+ + ++ L +L +LE L V RN ++ L G
Sbjct: 55 SLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRN----RL------KNLNG 102
Query: 137 LVSQSGICQNLSKISLAGNK 156
+ S LS++ L N+
Sbjct: 103 IPS-----ACLSRLFLDNNE 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 27/159 (16%), Positives = 49/159 (30%), Gaps = 22/159 (13%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKG 62
IPS+ L +L + G L K+ +++N + NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 63 LSHLDLSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVL 117
L + + + + ++L NL YL + + +P + Q LD+
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNL---QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136
Query: 118 RNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N+ I S G+ + L N
Sbjct: 137 DNINIHTIERN----------SFVGLSFESVILWLNKNG 165
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 26/153 (16%), Positives = 47/153 (30%), Gaps = 19/153 (12%)
Query: 9 FGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLD 67
F + KL + + N L P + L L L ++ + LD
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 68 LSSN----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123
+ N + L S L L+ N EI + N QL+ L++ N
Sbjct: 135 IQDNINIHTIERNSFVGLSFES--VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 124 KIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
++P + G + ++ +
Sbjct: 192 ELPNDV----FHGA-------SGPVILDISRTR 213
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 18/120 (15%), Positives = 36/120 (30%), Gaps = 6/120 (5%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW 77
+++T IP L ++L K + L +++S N
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 78 PRS-LGNLSYSTYLDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCGKIPEKICKSRLE 135
NL + + I NL L++L + + +P+ L+
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 25/114 (21%), Positives = 36/114 (31%), Gaps = 6/114 (5%)
Query: 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDL 68
G S + L+L N + I S L +LNL+ N G LD+
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 69 SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122
S L NL ++ K ++P L L L + C
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPSHC 259
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 1/69 (1%)
Query: 4 SIPSEFGDSLKLQGLYL-GNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I + + +L L L NN L G V L+++R + L NLK
Sbjct: 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227
Query: 63 LSHLDLSSN 71
L +
Sbjct: 228 LRARSTYNL 236
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 9e-08
Identities = 33/145 (22%), Positives = 54/145 (37%), Gaps = 16/145 (11%)
Query: 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSS 70
D ++ L ++ + + L+L + V L L ++HLDLS
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSH 472
Query: 71 NFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130
N P +L L L DN + + NL +L+ L + N L +
Sbjct: 473 NRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAA--- 525
Query: 131 KSRLEGLVSQSGICQNLSKISLAGN 155
++ LVS C L ++L GN
Sbjct: 526 ---IQPLVS----CPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 1e-06
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLKG 62
++P L+ L +N L ++ + L L +L L N+ L +
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 63 LSHLDLSSN 71
L L+L N
Sbjct: 535 LVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 29/161 (18%), Positives = 46/161 (28%), Gaps = 25/161 (15%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTR--------NKFSGPVPT 55
+ E L L + +L L ++ R +KF
Sbjct: 376 ELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSV 435
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLD 115
+ L L+ L L T+LDL N+ +P L L LE L
Sbjct: 436 LKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 116 VLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
N L ++G+ L ++ L N+
Sbjct: 493 ASDNAL----------ENVDGV----ANLPRLQELLLCNNR 519
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 39/212 (18%), Positives = 64/212 (30%), Gaps = 77/212 (36%)
Query: 189 DILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLG 246
+L G G V + G+ A+K + RQ E++ + ++V +L
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQ---EVDHHWQASGGPHIVCILD 89
Query: 247 -YCSFDEEKLLVY---EYMVNGSLDLWLRNATGSHEVLDR-----AKRY--KIACSSAR- 294
Y + K + E M G E+ R + + + A R
Sbjct: 90 VYENMHHGKRCLLIIMECMEGG-------------ELFSRIQERGDQAFTEREAAEIMRD 136
Query: 295 ---GLAFLHQ---------------------------DFGLARLISACETHVSTDIAGTL 324
+ FLH DFG A+ + T
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTP 193
Query: 325 GYIPPE------YGQSRMSTTRGDVYSFGVIL 350
Y+ PE Y +S D++S GVI+
Sbjct: 194 YYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 48/216 (22%)
Query: 179 QQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFT---AEMETLG 234
P + + + G FG VY A + + + VA+KK S + Q + ++ E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 235 KVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIA--CS 291
K++H N + G C E LV EY + + DL + EV +IA
Sbjct: 110 KLRHPNTIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------EIAAVTH 161
Query: 292 SA-RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGY 326
A +GLA+LH DFG A +++ + V GT +
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYW 216
Query: 327 IPPE---YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
+ PE + DV+S G+ +EL K P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 44/204 (21%), Positives = 70/204 (34%), Gaps = 56/204 (27%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLL---- 245
G G V A + VA+KK S+ +T R + E+ + V H+N++ LL
Sbjct: 36 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT 94
Query: 246 ---GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL-----DRAKRYKIACSSARGLA 297
F ++ +V E M +L +V+ Y + G+
Sbjct: 95 PQKSLEEF-QDVYIVMELM---DANL--------CQVIQMELDHERMSY-LLYQMLCGIK 141
Query: 298 FLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQ 333
LH DFGLAR +A + + T T Y PE
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 334 SRMSTTRGDVYSFGVILLELVTAK 357
D++S G I+ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 56/218 (25%), Positives = 78/218 (35%), Gaps = 60/218 (27%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQF--TA--E---METLGKVKH 238
V + G +GTVYKA G VA+K G + E + L +H
Sbjct: 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 239 QNLVLLL----GYCSFDEEKL-LVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACS 291
N+V L+ + E K+ LV+E++ DL +L A + K
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQF- 129
Query: 292 SARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYI 327
RGL FLH DFGLAR+ S T + TL Y
Sbjct: 130 -LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVTLWYR 186
Query: 328 PPE------YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
PE Y T D++S G I E+ ++P
Sbjct: 187 APEVLLQSTYA------TPVDMWSVGCIFAEMFR-RKP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 63/245 (25%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQ 221
S S ++ I++S + P LV+++ +G +G VYK + G+ A+K
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGD 62
Query: 222 GHRQFTAEMETLGKV-KHQNLVLLLG-----YCSFDEEKL-LVYEYMVNGSL-DLWLRNA 273
+ E+ L K H+N+ G +++L LV E+ GS+ DL
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 274 TGS----------HEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301
+ E+L RGL+ LHQ
Sbjct: 123 GNTLKEEWIAYICREIL-------------RGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169
Query: 302 --DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRG-----DVYSFGVILLELV 354
DFG++ + +T I GT ++ PE + D++S G+ +E+
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 355 TAKEP 359
P
Sbjct: 229 EGAPP 233
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 36/134 (26%), Positives = 45/134 (33%), Gaps = 26/134 (19%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKF-SGP--VPTS 56
L + F KL L L NQL ++ + L L L L N+ S P V
Sbjct: 47 LATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDH 105
Query: 57 LGNLKGLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GN 107
L L L L N FD L L L L+ N+ IP
Sbjct: 106 LTQLD---KLYLGGNQLKSLPSGVFD-----RLTKL---KELRLNTNQLQS-IPAGAFDK 153
Query: 108 LAQLEHLDVLRNML 121
L L+ L + N L
Sbjct: 154 LTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 26/73 (35%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
S+PS D L KL+ L L NQL SIP +L L L+L+ N+ + L
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179
Query: 62 GLSHLDLSSNFFD 74
L + L N FD
Sbjct: 180 KLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 29/95 (30%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSL-GNL 60
S+P D L +L LYLG NQL S+P + +L L +L L N+ +P L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKL 154
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDN 95
L L LS+N + L + L N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 37/129 (28%), Positives = 51/129 (39%), Gaps = 25/129 (19%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKF-SGP--VPTSLG 58
++ + D L +L L L NNQL S+P + L L KL L N+ S P V L
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT 131
Query: 59 NLKGLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQ 110
LK L L++N FD L NL L L N+ L +
Sbjct: 132 KLK---ELRLNTNQLQSIPAGAFD-----KLTNL---QTLSLSTNQLQSVPHGAFDRLGK 180
Query: 111 LEHLDVLRN 119
L+ + + N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 27/115 (23%), Positives = 40/115 (34%), Gaps = 18/115 (15%)
Query: 16 QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN---- 71
+ L L + L + L L LNL N+ +L L L L++N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 72 ----FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNML 121
FD L L L L N+ +P + L +L+ L + N L
Sbjct: 98 LPLGVFD-----HLTQL---DKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQL 143
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 174 NISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMET 232
S+ +QP +++ L +G +G+VYKA G+ VA+K+ ++ E+
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISI 77
Query: 233 LGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSL-DLWLRNATGSHEVLDRAKRYKIA- 289
+ + ++V G F L +V EY GS+ D+ E +IA
Sbjct: 78 MQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-------EIAT 129
Query: 290 -CSSA-RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGT 323
S +GL +LH DFG+A ++ +T I GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GT 188
Query: 324 LGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359
++ PE Q D++S G+ +E+ K P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/240 (14%), Positives = 75/240 (31%), Gaps = 78/240 (32%)
Query: 163 SSSRSKGPLRINISMFQQPLLKL--TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK 219
+ ++ + + + ++ +L G G V + + A+K
Sbjct: 40 PQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--D 97
Query: 220 TQGHRQFTAEMETLGKV-KHQNLVLLLGYC----SFDEEKLLVYEYMVNGSLDLWLRNAT 274
R+ E+E + + ++V ++ + + L+V E + G
Sbjct: 98 CPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG---------- 144
Query: 275 GSHEVLDR-----AKRY--KIACSSAR----GLAFLHQ---------------------- 301
E+ R + + + A + + +LH
Sbjct: 145 ---ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 302 -----DFGLARLISACETHVSTDIAGTLGYIPPE------YGQSRMSTTRGDVYSFGVIL 350
DFG A+ ++ + T T Y+ PE Y +S D++S GVI+
Sbjct: 202 ILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 54/222 (24%), Positives = 81/222 (36%), Gaps = 57/222 (25%)
Query: 188 VDILEDGGFGTVYKAT-LPDGKTVAVKK--FSQAKTQGHRQFTA--EMETLGKVKHQNLV 242
+ + G FG V+KA G+ VA+KK K +G TA E++ L +KH+N+V
Sbjct: 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFP-ITALREIKILQLLKHENVV 79
Query: 243 LLLGYCSFDEEKL--------LVYEYMVNGSLDL--WLRNATGSHEVLDRAKRYKIACSS 292
L+ C LV+++ DL L N ++ ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSN---VLVKFTLSEIKRVMQML 133
Query: 293 ARGLAFLHQ------------------------DFGLARLISACETHVSTDIAG---TLG 325
GL ++H+ DFGLAR S + TL
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 326 YIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQ 365
Y PPE G R D++ G I+ E+ T P Q
Sbjct: 194 YRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS----PIMQ 230
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 28/146 (19%), Positives = 43/146 (29%), Gaps = 21/146 (14%)
Query: 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN 71
+ L+ + + +L L L L+ N +SL ++ L L L N
Sbjct: 24 EAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRN 80
Query: 72 FFD--GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129
L L + N+ + L L L + N KI
Sbjct: 81 LIKKIENLDAVADTL---EELWISYNQIAS--LSGIEKLVNLRVLYMSNN----KITNWG 131
Query: 130 CKSRLEGLVSQSGICQNLSKISLAGN 155
+L L L + LAGN
Sbjct: 132 EIDKLAAL-------DKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 25/121 (20%), Positives = 39/121 (32%), Gaps = 24/121 (19%)
Query: 39 LVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF---DGGWPRSLGNLSYSTYLDLHDN 95
V+L+ + +L LK HL LS+N L + L L N
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRN 80
Query: 96 KFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+ I LE L + N + + L G+ NL + ++ N
Sbjct: 81 LIKK-IENLDAVADTLEELWISYNQI----------ASLSGIEK----LVNLRVLYMSNN 125
Query: 156 K 156
K
Sbjct: 126 K 126
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 16 QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN---F 72
+ L N + P + L +++L+ N+ S P + L+ L+ L L N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 73 FDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNML 121
L +L L L+ NK + + +L L L + N L
Sbjct: 95 LPKSLFEGLFSL---QLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 18/73 (24%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQ-LGGLVKLNLTRNKFSGPVPTSLGNLK 61
+P + L LQ L L N++ + Q L L L+L NK + L+
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 62 GLSHLDLSSNFFD 74
+ + L+ N F
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 11 DSLK-LQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68
L+ L L L N++T +P+SL L L L L NK + + +L L+ L L
Sbjct: 77 QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135
Query: 69 SSNFFDGGWPRSLGNLSYSTYLDLHDN 95
N + L + L N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 53/218 (24%), Positives = 80/218 (36%), Gaps = 62/218 (28%)
Query: 188 VDILEDGGFGTVYKA--TLPDGKTVAVKKFSQAKTQGHRQFTA--E---METLGKVKHQN 240
V + +G +G V+KA G+ VA+K+ + + E + L +H N
Sbjct: 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 241 LVLLL----GYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA-- 293
+V L + E KL LV+E++ DL LD+ + +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHV---DQDL--------TTYLDKVPEPGVPTETIKD 124
Query: 294 ------RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGT 323
RGL FLH DFGLAR+ S T + T
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 182
Query: 324 LGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
L Y PE S +T D++S G I E+ ++P
Sbjct: 183 LWYRAPEVLLQ-SSYATPV-DLWSVGCIFAEMFR-RKP 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 52/266 (19%), Positives = 92/266 (34%), Gaps = 58/266 (21%)
Query: 194 GGFGTVYKAT-LPDGKTVAVK---KFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249
G F V A + G+ VA+K K +Q ++ E+ + + H N+V L
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY--KIACSSARGLAFLHQ------ 301
++ L+ EY G + +L E A+ +I + + HQ
Sbjct: 85 TEKTLYLIMEYASGGEVFDYLVAHGRMKE--KEARSKFRQIVS----AVQYCHQKRIVHR 138
Query: 302 ------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST-TRGD 342
DFG + + + G Y PE Q + D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDA-FCGAPPYAAPELFQGKKYDGPEVD 196
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402
V+S GVIL LV+ P F + L +++ + P ++ + ++
Sbjct: 197 VWSLGVILYTLVSGSLP----FDGQNLKEL----RERVLRG---KYRIPFYMSTDCENLL 245
Query: 403 LKMLRIAADCVADNPATRPTMLHVLK 428
+ L + NP R T+ ++K
Sbjct: 246 KRFLVL-------NPIKRGTLEQIMK 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/241 (18%), Positives = 73/241 (30%), Gaps = 96/241 (39%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTA-EMETLGKVKHQNLVLLLGY---- 247
G FG V + + GK A+KK Q ++ E++ + + H N++ L+ Y
Sbjct: 18 GSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72
Query: 248 ---------------------------------CSFDEEKL-LVYEYMVNGSLDLWLRNA 273
+ L ++ EY+ L
Sbjct: 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV---PDTL----- 124
Query: 274 TGSHEVLDRAKRYKIACSSA----------RGLAFLHQ---------------------- 301
H+VL R + R + F+H
Sbjct: 125 ---HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 302 ---DFGLARLISACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTA 356
DFG A+ + E V+ I + Y PE G + T D++S G + EL+
Sbjct: 182 KLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLG-ATEYTPSIDLWSIGCVFGELILG 238
Query: 357 K 357
K
Sbjct: 239 K 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 49/238 (20%), Positives = 77/238 (32%), Gaps = 54/238 (22%)
Query: 159 NLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVY----KATLPDGKTVAVKK 214
+ Y + LR+ ++ ++K+ + G FG V K+T K A+K
Sbjct: 52 SRYKDTINKIRDLRMKAEDYE--VVKV-----IGRGAFGEVQLVRHKST---RKVYAMKL 101
Query: 215 FSQAKTQGHRQ---FTAEMETLGKVKHQNLVLLLGYCSF-DEEKL-LVYEYMVNGSLDLW 269
S+ + F E + + +V L + +F D+ L +V EYM G L
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 270 LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305
+ N A+ Y L +H DFG
Sbjct: 160 MSNYDVPE---KWARFY--TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 306 ARLISACETHVSTDIAGTLGYIPPE----YGQSRMSTTRGDVYSFGVILLELVTAKEP 359
++ GT YI PE G D +S GV L E++ P
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 42/224 (18%), Positives = 62/224 (27%), Gaps = 69/224 (30%)
Query: 186 TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK---------- 235
T+ + G +G V +G VA+K+ + G L K
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 236 -VKHQNLVLLL-----GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKR---- 285
H N++ L + LV E M DL +V+ +
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELM---RTDL--------AQVIHDQRIVISP 133
Query: 286 -------YKIACSSARGLAFLHQ------------------------DFGLARLISACET 314
Y I GL LH+ DF LAR
Sbjct: 134 QHIQYFMYHI----LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTAD 187
Query: 315 HVSTDIAGTLGYIPPEYGQSRMSTTRG-DVYSFGVILLELVTAK 357
T Y PE T+ D++S G ++ E+ K
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 49/245 (20%), Positives = 98/245 (40%), Gaps = 63/245 (25%)
Query: 158 YNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFS 216
++ +++++ + GP + +F + T + + +G +G V A + VA+KK S
Sbjct: 3 HHHHMAAAAAAGPEMVRGQVFDVGP-RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 217 --QAKTQGHRQFTAEMETLGKVKHQNLVLLL-----GYCSFDEEKLLVYEYMVNGSLDLW 269
+ +T R E++ L + +H+N++ + ++ +V + M DL
Sbjct: 62 PFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM---ETDL- 116
Query: 270 LRNATGSHEVLDRAKR----------YKIACSSARGLAFLHQ------------------ 301
+++L + + Y+I RGL ++H
Sbjct: 117 -------YKLL-KTQHLSNDHICYFLYQI----LRGLKYIHSANVLHRDLKPSNLLLNTT 164
Query: 302 ------DFGLARLISACETHVS--TDIAGTLGYIPPEYGQSRMSTTRG-DVYSFGVILLE 352
DFGLAR+ H T+ T Y PE + T+ D++S G IL E
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 353 LVTAK 357
+++ +
Sbjct: 225 MLSNR 229
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 40/125 (32%), Positives = 55/125 (44%), Gaps = 27/125 (21%)
Query: 11 DSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKF-SGP--VPTSLGNLKGLSH 65
L L L L NQL S+P + +L L +L L N+ S P V L NL +
Sbjct: 82 KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT---Y 137
Query: 66 LDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDV 116
L+L+ N FD L NL T LDL N+ +P+ + L QL+ L +
Sbjct: 138 LNLAHNQLQSLPKGVFD-----KLTNL---TELDLSYNQLQS-LPEGVFDKLTQLKDLRL 188
Query: 117 LRNML 121
+N L
Sbjct: 189 YQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 31/114 (27%), Positives = 40/114 (35%), Gaps = 14/114 (12%)
Query: 14 KLQGLYLGNNQLTGSIPRSLG---QLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSS 70
++ L LG N+L + +L L L LT N+ L L L L
Sbjct: 64 NVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 71 N---FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
N G L NL TYL+L N+ L L LD+ N L
Sbjct: 119 NQLQSLPDGVFDKLTNL---TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 47/214 (21%), Positives = 76/214 (35%), Gaps = 57/214 (26%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQ 239
+ G +G+V A G+ VA+KK S+ + R + E+ L ++H+
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHE 83
Query: 240 NLVLLL------GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSS- 292
N++ LL + LV +M DL +++ K +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDL--------QKIM-GLKFSEEKIQYL 131
Query: 293 ----ARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTL 324
+GL ++H DFGLAR A T T
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTR 187
Query: 325 GYIPPEYGQSRMSTTRG-DVYSFGVILLELVTAK 357
Y PE S M + D++S G I+ E++T K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 34/106 (32%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+L+ L N LT SI +L +L L KL L+ N+ SG + L+HL+LS N
Sbjct: 43 ELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 74 -DGGWPRSLGNLSYSTYLDLHDNKFTREI---PQNLGNLAQLEHLD 115
D L L LDL + + T L QL +LD
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 52/282 (18%), Positives = 91/282 (32%), Gaps = 89/282 (31%)
Query: 194 GGFGTVYKAT-LPDGKTVAVK--------KFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
G FG V+ A K V VK + + + T E+ L +V+H N++ +
Sbjct: 35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVL--DRAKRY--KIACSSARGLAFLH 300
L LV E +G LDL+ H L A ++ + +L
Sbjct: 95 LDIFENQGFFQLVMEKHGSG-LDLF--AFIDRHPRLDEPLASYIFRQLVS----AVGYLR 147
Query: 301 Q------------------------DFGLARLISACET-HVSTDIAGTLGYIPPE----- 330
DFG A + + + GT+ Y PE
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPEVLMGN 204
Query: 331 -YGQSRMSTTRG---DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386
Y RG +++S GV L LV + P F ++++
Sbjct: 205 PY--------RGPELEMWSLGVTLYTLVFEENP-----------------FCELEETVEA 239
Query: 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ P +++ ++ +L+ P R T+ ++
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQP-------VPERRTTLEKLVT 274
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/210 (16%), Positives = 64/210 (30%), Gaps = 70/210 (33%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-------HQNLVLLL 245
G + V++A + + + V VK K + + ++K N++ L
Sbjct: 47 GKYSEVFEAINITNNEKVVVKILKPVKKK---------KIKREIKILENLRGGPNIITLA 97
Query: 246 ----GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSH------EVLDRAKRYKIACSSARG 295
S LV+E++ N + T E+L +
Sbjct: 98 DIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KA 142
Query: 296 LAFLHQ-------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
L + H D+GLA + + + + PE
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 200
Query: 331 Y-GQSRMSTTRGDVYSFGVILLELVTAKEP 359
+M D++S G +L ++ KEP
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 16/100 (16%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
+P E + L + L NN+++ +S + L+ L L+ N+ P + LK L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSL 104
Query: 64 SHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDN 95
L L N F+ L L ++L + N
Sbjct: 105 RLLSLHGNDISVVPEGAFN-----DLSAL---SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 22/67 (32%), Positives = 32/67 (47%), Gaps = 5/67 (7%)
Query: 11 DSL-KLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLD 67
++ +L L L N+L IP R+ L L L+L N S VP + +L LSHL
Sbjct: 75 SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLA 132
Query: 68 LSSNFFD 74
+ +N
Sbjct: 133 IGANPLY 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 23/73 (31%), Positives = 35/73 (47%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
I + +Q L LG N++ I + L L LNL N+ S +P S +L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 62 GLSHLDLSSNFFD 74
L+ L+L+SN F+
Sbjct: 127 SLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 30/107 (28%), Positives = 39/107 (36%), Gaps = 28/107 (26%)
Query: 4 SIPSE--FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN-- 59
I S+ FG L L L NQLTG P + + +L L NK + N
Sbjct: 43 RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-----KEISNKM 97
Query: 60 ---LKGLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDN 95
L L L+L N F+ L +L T L+L N
Sbjct: 98 FLGLHQLKTLNLYDNQISCVMPGSFE-----HLNSL---TSLNLASN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 36/130 (27%), Positives = 52/130 (40%), Gaps = 26/130 (20%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF-SGP--VPTSLGNL 60
S+P+ G + L L N L +L L +L L NK S P V L +L
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 61 KGLSHLDLSSN--------FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQL 111
+L+LS+N FD L L L L+ N+ +P + L QL
Sbjct: 79 T---YLNLSTNQLQSLPNGVFD-----KLTQL---KELALNTNQLQS-LPDGVFDKLTQL 126
Query: 112 EHLDVLRNML 121
+ L + +N L
Sbjct: 127 KDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 24/74 (32%), Positives = 36/74 (48%), Gaps = 5/74 (6%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPT-SLGNL 60
S+P+ D L +L+ L L NQL S+P + +L L L L +N+ VP L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147
Query: 61 KGLSHLDLSSNFFD 74
L ++ L N +D
Sbjct: 148 TSLQYIWLHDNPWD 161
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 21/108 (19%), Positives = 40/108 (37%), Gaps = 10/108 (9%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
+ + +N++ + L L L + N+ L L+ L L++N
Sbjct: 43 QFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 74 DG-GWPRSLGNLSYSTYLDLHDNKFTREIPQN-----LGNLAQLEHLD 115
G L +L TYL + N T + ++ + + Q+ LD
Sbjct: 101 VELGDLDPLASLKSLTYLCILRNPVTNK--KHYRLYVIYKVPQVRVLD 146
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 8e-05
Identities = 20/139 (14%), Positives = 42/139 (30%), Gaps = 18/139 (12%)
Query: 12 SLKLQGLYLGNNQLTGSIPRSLG--QLGGLVKLNL---TRNKFSGPVPTSL------GNL 60
L+ L + + L S+ + L L KL L +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 61 KGLSHLDLSSNFFDGGWPRSLGN---LSYSTYLDLHDNKFT----REIPQNLGNLAQLEH 113
L L + L +D+ T R + ++ + L+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 114 LDVLRNMLCGKIPEKICKS 132
+++ N L ++ +++ KS
Sbjct: 312 INMKYNYLSDEMKKELQKS 330
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 50/229 (21%), Positives = 80/229 (34%), Gaps = 52/229 (22%)
Query: 173 INISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFS-QAKTQGHRQFTAEM 230
+NI F + + L GG G V+ A K VA+KK E+
Sbjct: 2 MNIHGFDLGS-RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EI 59
Query: 231 ETLGKVKHQNLVLLL------------GYCSFDEEK--LLVYEYMVNGSLDLWLRNATGS 276
+ + ++ H N+V + S E +V EYM + L N
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQ 114
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311
+L+ R RGL ++H DFGLAR++
Sbjct: 115 GPLLEEHARL-FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 312 CETHVS--TDIAGTLGYIPPEYGQSRMSTTRG-DVYSFGVILLELVTAK 357
+H ++ T Y P S + T+ D+++ G I E++T K
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 33/106 (31%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L+ L L N L S+ +L +L L KL L+ N+ G + L L+HL+LS N
Sbjct: 50 NLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 74 -DGGWPRSLGNLSYSTYLDLHDNKFTREI---PQNLGNLAQLEHLD 115
D L L LDL + + T L QL +LD
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 56/280 (20%), Positives = 99/280 (35%), Gaps = 85/280 (30%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR---QFTAEMETLGKVKHQNLVLLLGYCS 249
G FG V G VAVK ++ K + + E++ L +H +++ L S
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDR-AKRYKIACSSAR--------GLAFLH 300
+ +V EY+ G E+ D K ++ AR + + H
Sbjct: 82 TPTDFFMVMEYVSGG-------------ELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 301 Q------------------------DFGLARLIS-------ACETHVSTDIAGTLGYIPP 329
+ DFGL+ ++S +C G+ Y P
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAP 179
Query: 330 EYGQSRM-STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
E R+ + D++S GVIL L+ P F ++ L F+K++
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP----FDDEHVPTL----FKKIRGG---VF 228
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
P LN +++ ML++ +P R T+ + +
Sbjct: 229 YIPEYLNRSVATLLMHMLQV-------DPLKRATIKDIRE 261
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 3/73 (4%)
Query: 4 SIPSEFGDSL-KLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSLGNLK 61
S+P D L KL LYL N+L S+P + +L L +L L N+ L
Sbjct: 66 SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLT 124
Query: 62 GLSHLDLSSNFFD 74
L + L +N +D
Sbjct: 125 SLQKIWLHTNPWD 137
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 28/107 (26%), Positives = 40/107 (37%), Gaps = 26/107 (24%)
Query: 16 QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG 75
L L +N+L +L L KL+L++N+ L FD
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ----------------SLPDGVFD- 73
Query: 76 GWPRSLGNLSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNML 121
L L T L LH+NK +P + L QL+ L + N L
Sbjct: 74 ----KLTKL---TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 48/209 (22%), Positives = 76/209 (36%), Gaps = 46/209 (22%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQ 239
+ + + G +G+V A G VAVKK S+ R + E+ L +KH+
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 240 NLVLLL------GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA 293
N++ LL + LV M L N ++ D ++ +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF-LIYQIL 142
Query: 294 RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPP 329
RGL ++H DFGLAR + T T Y P
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAP 198
Query: 330 EYGQSRMSTTRG-DVYSFGVILLELVTAK 357
E + M + D++S G I+ EL+T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 46/210 (21%), Positives = 77/210 (36%), Gaps = 68/210 (32%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLL---- 245
G +G V A G VA+KK + + R + E+ L ++H+N++ LL
Sbjct: 36 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFT 94
Query: 246 ---GYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKR----------YKIACSS 292
F + LV +M DL +++ + ++ Y++
Sbjct: 95 PDETLDDF-TDFYLVMPFM---GTDL--------GKLM-KHEKLGEDRIQFLVYQML--- 138
Query: 293 ARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIP 328
+GL ++H DFGLAR T T Y
Sbjct: 139 -KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRA 193
Query: 329 PEYGQSRMSTTRG-DVYSFGVILLELVTAK 357
PE + M T+ D++S G I+ E++T K
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 55/389 (14%), Positives = 113/389 (29%), Gaps = 115/389 (29%)
Query: 65 HLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124
H+D + Y L + ++ F + D+ +++L +
Sbjct: 6 HMDFETGEHQ---------YQYKDILSVFEDAFVDNFDCK-------DVQDMPKSILSKE 49
Query: 125 IPEKICKS--RLEG--------LVSQSGICQNLSKISLAGNKDYNLYLSS--SRSKGPLR 172
+ I S + G L Q + Q + L +Y +S + + P
Sbjct: 50 EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL--RINYKFLMSPIKTEQRQPSM 107
Query: 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMET 232
+ +Q D L + + F++ + + +
Sbjct: 108 MTRMYIEQ-------RDRLYND-----------------NQVFAKYNVSRLQPYLKLRQA 143
Query: 233 LGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSS 292
L +++ VL+ G ++ GS W+ LD YK+ C
Sbjct: 144 LLELRPAKNVLIDG--------------VL-GSGKTWV--------ALDVCLSYKVQCKM 180
Query: 293 ARGLAFLHQDFGLARLISACETHVST-DIAGTLGY-IPPEYGQ--SRMSTTRGDVYSFGV 348
+ +L+ + C + + ++ L Y I P + S + ++S
Sbjct: 181 DFKIFWLN--------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 349 ILLELVTAKEPTGPEFQEKEGAN--LVGWVFQKMKKQQADDVLDPTVLNA---GSKPMML 403
L L + K N LV +V + NA K ++
Sbjct: 233 ELRRL----------LKSKPYENCLLV-----------LLNVQNAKAWNAFNLSCKILLT 271
Query: 404 KMLRIAADCVADNPATRPTMLHVLKLLHE 432
+ D ++ T ++ H L
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTP 300
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 27/133 (20%), Positives = 43/133 (32%), Gaps = 26/133 (19%)
Query: 15 LQGLYLGNNQLT-------------GSIPRSLGQLGGLVKLNLTRNKFSGP----VPTSL 57
L+ LYL NN L ++ + L + RN+ +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 58 GNLKGLSHLDLSSN-FFDGGWPRSLGN-LSYS---TYLDLHDNKFTRE----IPQNLGNL 108
+ + L + + N G L L+Y LDL DN FT + L +
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 109 AQLEHLDVLRNML 121
L L + +L
Sbjct: 244 PNLRELGLNDCLL 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.84 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.78 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.73 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.72 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.72 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.72 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.71 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.71 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.7 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.7 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.7 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.69 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.63 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.62 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.62 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.62 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.61 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.6 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.6 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.6 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.6 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.6 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.59 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.58 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.57 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.57 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.57 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.57 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.56 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.56 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.56 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.55 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.55 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.54 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.54 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.54 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.52 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.52 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.52 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.52 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.51 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.51 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.5 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.5 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.5 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.5 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.49 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.48 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.44 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.43 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.42 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.4 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.4 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.39 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.39 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.38 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.38 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.37 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.36 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.31 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.27 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.26 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.25 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.24 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.23 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.23 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.21 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.21 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.87 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.77 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.7 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.61 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.52 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.48 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.32 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.0 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.94 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.83 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.78 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.67 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.53 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.53 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.93 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.76 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.26 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 95.97 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.75 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.31 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.16 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.18 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 84.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 84.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 83.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 81.32 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=386.75 Aligned_cols=239 Identities=26% Similarity=0.428 Sum_probs=190.6
Q ss_pred cccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
.+++.+|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456678999999999999999999864 46789999998766666788999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhC---------CCCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 253 EKLLVYEYMVNGSLDLWLRNAT---------GSHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
..+||||||++|+|.++|+... .....++|.+++.++.|+|+||+|||+
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999999997642 223469999999999999999999996
Q ss_pred --cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHH
Q 040641 302 --DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 302 --DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~ 377 (435)
|||+|+........ ......||+.|||||++.+..|+.|+|||||||++|||+| |+.||.... ...+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----~~~~~~--- 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVIE--- 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHH---
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH---
Confidence 99999976543322 2334579999999999999999999999999999999999 899985421 112222
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+....... .| . .+..++.+++.+||+.||++||||.||++.|+++.
T Consensus 242 -~i~~~~~~~--~p---~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 -CITQGRVLQ--RP---R----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp -HHHHTCCCC--CC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHcCCCCC--CC---c----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222221111 11 1 12235778999999999999999999999998763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=389.50 Aligned_cols=238 Identities=28% Similarity=0.426 Sum_probs=183.7
Q ss_pred ccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
....++.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45568899999999999999999864 477899999987666667889999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCC-----------CCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 254 KLLVYEYMVNGSLDLWLRNATG-----------SHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
.+||||||++|+|.++++.... ....++|.+++.|+.|+|+||+|||+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 9999999999999999986432 12458999999999999999999996
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+|+.+..... ...+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ...+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~----~~~~~~~- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS----NTEAIDC- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC----HHHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC----HHHHHHH-
Confidence 9999997654332 23345789999999999999999999999999999999999 899985421 1122222
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+..... ...|. .+..++.+++.+||+.||++||||.||++.|+.+.
T Consensus 273 ---i~~g~~--~~~p~-------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 273 ---ITQGRE--LERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ---HHHTCC--CCCCT-------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHcCCC--CCCcc-------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 222111 01111 12235778999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=385.75 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=189.2
Q ss_pred cccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
+.+...+.+.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.+|++++|||||+++|+|..+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 345567888999999999999999863 467899999975433 3457899999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------------ 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------------ 301 (435)
+..+||||||++|+|.++|+.... ....++|..++.|+.|+|+||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 999999999999999999975421 12458999999999999999999996
Q ss_pred ------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHH
Q 040641 302 ------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLV 373 (435)
Q Consensus 302 ------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~ 373 (435)
|||+|+.+..... ...+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..++.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~~~~ 257 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVV 257 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HHHHH
Confidence 9999997654332 23445789999999999999999999999999999999999 788885321 11222
Q ss_pred HHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 374 GWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+....... .. ..+...+.+++.+||+.||++||||.||++.|+++.
T Consensus 258 ----~~i~~~~~~~-----~p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 ----EMIRNRQVLP-----CP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ----HHHHTTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----HHHHcCCCCC-----Cc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222221111 11 112245778999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=374.60 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=182.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.|+.+..++++.+.||+|+||+||+|++.+ .||||.++... .+..+.|.+|+++|++++|||||+++|+|.. +..
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 577888999999999999999999999753 69999986433 3345789999999999999999999999864 678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
+||||||++|+|.++|+... ..++|..++.|+.|+|+||+|||+ |||+|+...
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999999999997543 358999999999999999999996 999998765
Q ss_pred ccC-ccccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 311 ACE-THVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 311 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
... .......+||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ... +...+....
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~~---~~~~~~~~~-- 254 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RDQ---IIFMVGRGY-- 254 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHH---HHHHHHTTC--
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HHH---HHHHHhcCC--
Confidence 322 23344578999999999874 34689999999999999999999999853211 111 122222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..|... .....+...+.+++.+||+.||++||||.||++.|+.+.
T Consensus 255 --~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 255 --ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111110 011122345778999999999999999999999988763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=376.51 Aligned_cols=246 Identities=28% Similarity=0.408 Sum_probs=192.8
Q ss_pred cccccccccccCcceeeeecccCcceEEEEEcCC------CCEEEEEEcccccc-ccHHHHHHHHHHhccCCC-CCceeE
Q 040641 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKH-QNLVLL 244 (435)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l 244 (435)
.+...|+++..+|++.+.||+|+||+||+|++.. ++.||||+++.... ...++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445688899999999999999999999998532 36899999975443 345679999999999965 899999
Q ss_pred EEEEEeC-CeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec----------
Q 040641 245 LGYCSFD-EEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ---------- 301 (435)
Q Consensus 245 ~g~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~---------- 301 (435)
+|+|... +..+||||||++|+|.++|+.... ....+++..++.++.|||+||+|||+
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 9999764 568999999999999999986431 12458999999999999999999996
Q ss_pred --------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcc
Q 040641 302 --------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQ 365 (435)
Q Consensus 302 --------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~ 365 (435)
|||+|+.+..... ...+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999997754433 23445789999999999999999999999999999999998 8999854221
Q ss_pred cccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .+...+....... .| .. +..++.+++.+||+.||++||||.||++.|++++
T Consensus 294 ----~~---~~~~~i~~g~~~~--~p---~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 294 ----DE---EFCRRLKEGTRMR--AP---DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ----SH---HHHHHHHHTCCCC--CC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HH---HHHHHHHcCCCCC--CC---cc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11 1222222221111 11 11 1235778999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=361.46 Aligned_cols=241 Identities=27% Similarity=0.340 Sum_probs=177.2
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC----eeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE----EKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 258 (435)
+++.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|..++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678899999999999999998 5899999999653321 223445677778899999999999998754 579999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------ccccc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------DFGLA 306 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------DfGla 306 (435)
|||++|+|.++|+.. .++|..+.+++.|+|+||+|||+ |||+|
T Consensus 81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999753 38999999999999999999982 99999
Q ss_pred ccccccCcc---ccccccccCCCcCCcCCCCC------CCCCcccchhHHHHHHHHHhCCCCCCCCccccc-------CC
Q 040641 307 RLISACETH---VSTDIAGTLGYIPPEYGQSR------MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE-------GA 370 (435)
Q Consensus 307 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~-------~~ 370 (435)
+........ .....+||+.|||||++.+. .++.|+|||||||++|||+||++|+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 22346899999999987654 467899999999999999999887643211100 00
Q ss_pred cHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.....+...+... ..+|.... ....+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111122222111 12222211 122345667889999999999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=360.42 Aligned_cols=228 Identities=21% Similarity=0.305 Sum_probs=184.6
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+...|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34567999999999999999999865 68999999997665555667899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||++|+|.+++... .+++.....++.|++.||+|||+ |||+|+.+....
T Consensus 151 Ey~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 151 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999999753 38899999999999999999996 999998775432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
...+..+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .... ..+..........+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~----~~i~~~~~~~~~~~--- 293 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM----KMIRDNLPPRLKNL--- 293 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH----HHHHHSSCCCCSCG---
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHH----HHHHcCCCCCCCcc---
Confidence 234567999999999999999999999999999999999999999854311 1121 22222111111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.||++|||+.|+++
T Consensus 294 ----~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 ----HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111235678889999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=358.93 Aligned_cols=228 Identities=19% Similarity=0.331 Sum_probs=177.1
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+++|++++|||||++++++.+++..|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4578999999999999999999864 68999999996543 23456799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|.++|.... ...+++.....++.|++.||+|||+ |||+|+.+....
T Consensus 102 mEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999997643 2347888899999999999999996 999998765321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
...+..+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......... .... ..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~-~~~~-----~~ 245 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIIS-GSFP-----PV 245 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHH-TCCC-----CC
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHc-CCCC-----CC
Confidence 22345789999999999999999999999999999999999999985431 2222222222 1111 01
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11235678889999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=345.76 Aligned_cols=221 Identities=25% Similarity=0.381 Sum_probs=172.6
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKLLV 257 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv 257 (435)
+.+.+.||+|+||+||+|++. +++.||||++.... ....+.|.+|+++|++++|||||+++++|.. ++..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 467788999999999999865 58899999996543 2335679999999999999999999999865 3457999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLIS 310 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~ 310 (435)
||||++|+|.++++.. ..+++.....++.|+++||+|||+ |||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999764 348899999999999999999995 999998644
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... . ..+...+.........+
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~-~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------A-AQIYRRVTSGVKPASFD 252 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------H-HHHHHHHTTTCCCGGGG
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------H-HHHHHHHHcCCCCCCCC
Confidence 3 23345789999999998865 599999999999999999999999853211 1 11223332221111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..++.+++.+||+.||++|||+.|+++
T Consensus 253 ----~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 124667889999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.68 Aligned_cols=230 Identities=17% Similarity=0.204 Sum_probs=179.9
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
....|++.+.||+|+||+||+|+.. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3456888899999999999999864 589999999965332 2479999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccCc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACET 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~~ 314 (435)
||++|+|.++++... .+++.....++.|++.||+|||+ |||+|+.+.....
T Consensus 131 y~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999998643 48999999999999999999996 9999987654321
Q ss_pred c----ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 315 H----VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 315 ~----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...... .+...+.. ......
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~---~~~~~~--- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PLCLKIAS---EPPPIR--- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CCHHHHHH---SCCGGG---
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHHc---CCCCch---
Confidence 1 123468999999999999999999999999999999999999999654321 22221111 110000
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .+. ....+.+++.+||+.||++|||+.|+++.|.+.+
T Consensus 277 -~~-~~~---~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 277 -EI-PPS---CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -GS-CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hc-Ccc---CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 01 111 1234667888999999999999999999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.37 Aligned_cols=228 Identities=21% Similarity=0.304 Sum_probs=184.9
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+...|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 45678999999999999999999864 68999999997665555667899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||++|+|.++++.. .+++.....++.|++.||+|||+ |||+|+.+....
T Consensus 228 Ey~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp ECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred eCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999999753 38899999999999999999996 999998775432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .... ..+..........+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~----~~i~~~~~~~~~~~~-- 371 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM----KMIRDNLPPRLKNLH-- 371 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH----HHHHHSCCCCCSCTT--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHH----HHHHcCCCCCCcccc--
Confidence 334567999999999999999999999999999999999999999854321 1121 222221111111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.||++|||+.|+++
T Consensus 372 -----~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 -----KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -----SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11235667889999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.79 Aligned_cols=223 Identities=22% Similarity=0.315 Sum_probs=180.8
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
++|++.+.||+|+||+||+|+. .+|+.||||.++... ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 468999999997532 334567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE- 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~- 313 (435)
|||++|+|.++++... .+++.....++.|++.||+|||+ |||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998643 48899999999999999999996 999999875432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ..+ ...+...... + |.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~----~~~i~~~~~~--~-p~- 255 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----GLI----FAKIIKLEYD--F-PE- 255 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHTCCC--C-CT-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHcCCCC--C-Cc-
Confidence 2334567999999999999999999999999999999999999999854321 111 2222222111 0 11
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
. ...++.+++.+|++.||++|||+.|++
T Consensus 256 --~----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 --K----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --T----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --c----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 112466788999999999999998863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=327.63 Aligned_cols=221 Identities=19% Similarity=0.327 Sum_probs=163.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999864 68999999996532 233567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||| +|+|.+++... ..+++.....++.|++.||+|||+ |||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999 68999988764 348999999999999999999996 99999876532
Q ss_pred cccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ... +...+...... -|..
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~-~~~~i~~~~~~---~p~~ 234 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPV-LFKNISNGVYT---LPKF 234 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH-HHHHHHHTCCC---CCTT
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHH-HHHHHHcCCCC---CCCC
Confidence 23345789999999999988775 679999999999999999999985421 111 22222222111 0111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.+++.+||+.||++|||+.|+++
T Consensus 235 -------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 -------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1124667889999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=336.96 Aligned_cols=223 Identities=22% Similarity=0.309 Sum_probs=170.1
Q ss_pred cCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|++.+.||+|+||+||+|+.. +++.||||.++... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 46889999996543 2234568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
|||||++|+|.+++.... .+++.....++.|++.||+|||+ |||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998643 48899999999999999999996 99999875432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ..+. ..+...... .|.
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~----~~i~~~~~~---~p~ 247 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----KETM----TMILKAKLG---MPQ 247 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH----HHHHHCCCC---CCT
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----HHHH----HHHHcCCCC---CCC
Confidence 2 233457899999999999999999999999999999999999999854321 1121 222111110 111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
. ...++.+++.+||+.||++||| ++|+++
T Consensus 248 ~-------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 F-------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp T-------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred c-------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 1124677889999999999998 466653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.93 Aligned_cols=226 Identities=22% Similarity=0.359 Sum_probs=163.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC--------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-------- 252 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 252 (435)
.+|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999864 689999999965433 23467999999999999999999999987644
Q ss_pred ----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 253 ----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 253 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
..|+|||||++|+|.+++.... .....++.....++.|+++||+|||+ |||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 3689999999999999997643 22345677788899999999999996 999
Q ss_pred ccccccccCc-----------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHH
Q 040641 305 LARLISACET-----------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV 373 (435)
Q Consensus 305 la~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~ 373 (435)
+|+.+..... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... +..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~~ 234 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ERV 234 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HHH
Confidence 9987654321 11234689999999999999999999999999999999997 664211 111
Q ss_pred HHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 374 GWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. ......... |.. .........+++.+||+.||++|||+.|+++
T Consensus 235 ~~-~~~~~~~~~-----p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RT-LTDVRNLKF-----PPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHTTCC-----CHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHhcCCC-----CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111111 100 1122234567889999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=323.36 Aligned_cols=255 Identities=34% Similarity=0.559 Sum_probs=211.5
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.....+|++.+.||+|+||.||+|++.+++.||||++........+.|.+|++++++++|||||+++++|...+..++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 44567899999999999999999998889999999987766566778999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE- 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~- 313 (435)
||+++|+|.+++.........+++..+..++.++++||+|||+ |||+++......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999887654334468999999999999999999996 899987654321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......|..............++..
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhccccccHHHhcChhh
Confidence 22234456999999999988888999999999999999999999998754432 33455566555555555555666665
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
...........+.+++.+||+.||++|||+.||++.|+.++
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 55556777888999999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.40 Aligned_cols=258 Identities=38% Similarity=0.626 Sum_probs=210.9
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+.....+|++.+.||+|+||.||+|+..+++.||||++...... ....|.+|++++++++|||||+++++|...+..
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3445566789999999999999999999888999999999754322 234689999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLAR 307 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~ 307 (435)
++||||+++|+|.++++........+++..+..++.+++.||+|||+ |||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998765555669999999999999999999984 899998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCc-ccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEF-QEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..............||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..........|+..........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 765444444455679999999999888889999999999999999999999985321 1122344556655555555555
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
...++.............+.+++.+||+.||++|||+.||++.|++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 56666665666778888999999999999999999999999999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.23 Aligned_cols=228 Identities=22% Similarity=0.347 Sum_probs=183.0
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||+||+|+.. +|+.||||.+........+.+.+|+++|+.++|||||++++++.+++..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 357999999999999999999864 6899999999765555567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~ 314 (435)
|++|+|.+++... ...+++.....++.|++.||+|||+ |||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999998653 2358899999999999999999996 99999887543
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ... ...+...... +++...
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~----~~~i~~~~~~--~~~~~~ 380 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DET----LRNVKSCDWN--MDDSAF 380 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHH----HHHHHTTCCC--CCSGGG
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH----HHHHHhCCCC--CCcccc
Confidence 233456899999999999999999999999999999999999999864321 111 1222211110 111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 381 ~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1234668889999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.79 Aligned_cols=236 Identities=19% Similarity=0.245 Sum_probs=173.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEe------CCe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSF------DEE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 253 (435)
.+|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 47999999999999999999864 689999999965432 234678899999999999999999998764 356
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.|||||||+ |+|.+++... ..+++.....++.|++.||+|||+ |||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 7799888653 358999999999999999999996 99999876
Q ss_pred cccC---ccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 310 SACE---THVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 310 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.... ....+..+||+.|||||++.+. .++.++||||+||++|||+||+.||.... ..+....+.........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~----~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN----YVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS----HHHHHHHHHHHHCCCCG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhcCCCCh
Confidence 4321 2234567999999999987764 67999999999999999999999985432 11222222222111110
Q ss_pred Cccc-------------cccccCCCCH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDVL-------------DPTVLNAGSK-----PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~~-------------~~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... .+.. .+... .....+.+++.+|+..||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPR-QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCc-CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000 00000 01134678899999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.90 Aligned_cols=173 Identities=24% Similarity=0.282 Sum_probs=144.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 256 (435)
..+|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+|+++|+.+ +|||||++++++.+.+..++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 357999999999999999999742 46789999986533 345688999999988 69999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
|||||++|+|.++++ .+++.....++.|++.||+|||+ |||+|+....
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999999884 27888899999999999999996 9999986532
Q ss_pred cCc---------------------------cccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 312 CET---------------------------HVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 312 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
... ...+..+||+.|||||++.+. .|+.++||||+|||+|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112345799999999988764 5899999999999999999999998543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=302.39 Aligned_cols=234 Identities=24% Similarity=0.402 Sum_probs=185.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
...+|.+.+.||+|+||.||+|+.. +++.||+|++........+.|.+|++++++++|||||++++++..++..++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 4568899999999999999999865 588999999876655667789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++|+|.+++.... ..+++..+..++.|+++||+|||+ |||+++........
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999998642 348999999999999999999996 99999875432211
Q ss_pred c-------------cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC--CcHHHHHHHHh
Q 040641 316 V-------------STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG--ANLVGWVFQKM 380 (435)
Q Consensus 316 ~-------------~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~--~~~~~~~~~~~ 380 (435)
. .....||+.|+|||++.+..++.++|||||||++|||++|..|+......... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 1 11457999999999999999999999999999999999999987543322211 111111110
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ..+. ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 243 --~-----~~~~--------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 --Y-----CPPN--------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp --T-----CCTT--------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --c-----CCCC--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0000 0114667889999999999999999999998863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.41 Aligned_cols=240 Identities=31% Similarity=0.496 Sum_probs=178.0
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
..+..+..+|++.+.||+|+||.||+|+. +++.||||.+..... ...+.|.+|++++++++|||||++++++...+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34566778999999999999999999987 578999999865432 334679999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLAR 307 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~ 307 (435)
.++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+ |||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999999997532 12348899999999999999999985 889887
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..... ..........
T Consensus 188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~---~~~~~~~~~~ 259 (309)
T 3p86_A 188 LKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVA---AVGFKCKRLE 259 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHH---HHHHSCCCCC
T ss_pred ccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH---HHHhcCCCCC
Confidence 54332 1223346799999999999999999999999999999999999999854321 11111 1111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+ . .....+.+++.+||+.||++|||+.+|++.|++++
T Consensus 260 --~~---~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 260 --IP---R----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --CC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC---c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01 1 11125678889999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.27 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=189.3
Q ss_pred cccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 175 ISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 175 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
...|..+..+|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345677888999999999999999999999888899999997543 34678999999999999999999999986 6678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.++++... ...+++...+.++.|+|+||+|||+ |||+++...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999997542 1247888899999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
...........+|+.|+|||++....++.++|||||||++|||+| |+.||.... ...+... +..... ..
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~~~~~~~----i~~~~~--~~ 405 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRA----LERGYR--MP 405 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHH----HHHTCC--CC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHH----HHcCCC--CC
Confidence 432222334557889999999888889999999999999999999 998985321 1112221 111110 01
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.| ..+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 406 ~~-------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 112235778999999999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=309.61 Aligned_cols=240 Identities=30% Similarity=0.420 Sum_probs=187.4
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGY 247 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~ 247 (435)
+..+..+|++.+.||+|+||.||+|+.. ++..||||.++.... ...+.+.+|+++++++ +|||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4456678999999999999999999752 345799999975432 3456799999999999 89999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec--------------
Q 040641 248 CSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ-------------- 301 (435)
Q Consensus 248 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~-------------- 301 (435)
|...+..++||||+++|+|.+++..... ....+++...+.++.|+++||+|||+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 9999999999999999999999986432 12357899999999999999999996
Q ss_pred ----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccC
Q 040641 302 ----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEG 369 (435)
Q Consensus 302 ----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~ 369 (435)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----~ 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----V 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC----H
Confidence 9999986654322 22234567889999999988899999999999999999999 888875422 1
Q ss_pred CcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+.. .+....... ... .+...+.+++.+||+.||++|||+.|+++.|++++
T Consensus 312 ~~~~~----~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 EELFK----LLKEGHRMD-----KPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GGHHH----HHHTTCCCC-----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH----HHhcCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12222 121111110 111 11235678889999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=294.27 Aligned_cols=236 Identities=25% Similarity=0.422 Sum_probs=188.2
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|.....+|++.+.||+|+||.||+|+..+++.||+|++..... ..+++.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 4455678999999999999999999988888999999975432 346799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999999997542 358899999999999999999996 899998765433
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........||+.|+|||...+..++.++||||+|+++|||+| |+.||..... ... ...+.... ....+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~----~~~~~~~~--~~~~~~ 230 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEV----VEDISTGF--RLYKPR 230 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH----HHHHHTTC--CCCCCT
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHH----HHHHhcCc--cCCCCC
Confidence 333344567888999999988889999999999999999999 8888753211 111 11121110 011111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 231 ~-------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 231 L-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp T-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1 1134678889999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=296.38 Aligned_cols=228 Identities=21% Similarity=0.354 Sum_probs=182.4
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+..+|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|||||++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 3456899999999999999999985 568999999997666566678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++... .+++.....++.+++.||+|||+ |||+++......
T Consensus 97 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred ECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 999999999999753 37889999999999999999996 999987765432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ........... ......+.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~-~~~~~~~~-- 240 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNG-TPELQNPE-- 240 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHC-SCCCSCGG--
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-CCCCCCcc--
Confidence 223456899999999999888999999999999999999999999854321 11111111111 11111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 -----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 -----KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11234678889999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=321.02 Aligned_cols=239 Identities=23% Similarity=0.382 Sum_probs=190.5
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..|+....+|++.+.||+|+||.||+|++.. +..||||.++... ...++|.+|+++|++++|||||+++|+|...+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3466677889999999999999999999764 7899999997543 3467899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.++++... ...+++..++.++.|+++||+|||+ |||+++...
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999998643 2358899999999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
...........+|+.|+|||++....++.++|||||||++|||+| |+.||.... ...+...+ ..... ..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~--~~ 439 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELL----EKDYR--ME 439 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHH----HTTCC--CC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCC--CC
Confidence 433333344567889999999888889999999999999999999 888875322 12222222 11110 00
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.| ..+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 440 ~~-------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 440 RP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CC-------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01 111235678899999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=302.35 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=183.7
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe----
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE---- 253 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 253 (435)
+.....+|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++|||||++++++.....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3455678999999999999999999875 78999999965432 33456779999999999999999999987543
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------- 301 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------- 301 (435)
.++||||+++|+|.++++.. .+++..+..++.|+++||+|||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 69999999999999999753 38999999999999999999983
Q ss_pred --cccccccccccCc-cccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC----
Q 040641 302 --DFGLARLISACET-HVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG---- 369 (435)
Q Consensus 302 --DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~---- 369 (435)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 8999977654322 22334679999999998876 35567899999999999999999998653321110
Q ss_pred -----CcHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 370 -----ANLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 370 -----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.....+ ......... .|.... .........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 252 ~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDM-QEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHH-HHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhh-hhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011111 111111111 111100 011234556889999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=312.67 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=185.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.|.....+|++.+.||+|+||.||+|++. +++.||||.++.... ...+.|.+|+++|++++|||||+++|+|...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 45566778999999999999999999976 689999999875432 2335688999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.++++... ..+++.....++.|+++||+|||+ |||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999997642 247889999999999999999996 999998644
Q ss_pred ccCcccc-ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
....... ....+|+.|+|||.+....++.++|||||||++|||+| |+.||..... ... ...+..... .
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~----~~~~~~~~~--~ 334 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQT----REFVEKGGR--L 334 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHH----HHHHHTTCC--C
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHH----HHHHHcCCC--C
Confidence 3211111 12346778999999888889999999999999999999 8888753211 111 111211110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..|. .+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 335 ~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 PCPE-------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111 11235678899999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=318.14 Aligned_cols=225 Identities=20% Similarity=0.259 Sum_probs=173.4
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHH---HHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQF---TAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
...+|++.++||+|+||+||+|+.. +|+.||||++++.. ......+ ..++.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3467999999999999999999865 58999999996432 1222223 345778889999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.|+|||||+||+|..+|.... .+++.....++.|++.||+|||+ |||+|+.+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999998643 48899999999999999999996 99999876
Q ss_pred cccCccccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ....+||+.|||||++. +..|+.++||||+||++|||+||+.||..... .+... +.........
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~-i~~~i~~~~~--- 411 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLTMAV--- 411 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHH-HHHHHHHCCC---
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHH-HHHhhcCCCC---
Confidence 5432 34578999999999986 46799999999999999999999999964321 11111 1222111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVL 427 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl 427 (435)
.-|.. ...++.+++.+|++.||++|++ +.||+
T Consensus 412 ~~p~~-------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 412 ELPDS-------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCTT-------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCcc-------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 01111 1124667888999999999998 57765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.19 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=182.0
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|..+..+|++.+.||+|+||.||+|.+.++..||||.++... ...++|.+|+++|++++|||||++++++.. +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 35677788999999999999999999999888889999997543 345689999999999999999999999866 7789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.++++... ...+++.....++.|+++||+|||+ |||+++....
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999997532 1247889999999999999999996 9999987654
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..........+|+.|+|||.+....++.++|||||||++|||+| |+.||..... ..+. ..+..... ...
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~----~~i~~~~~--~~~ 402 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL----DQVERGYR--MPC 402 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHH----HHHHTTCC--CCC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHHcCCC--CCC
Confidence 33333334567889999999888889999999999999999999 8888753211 1111 22211110 001
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
| ..+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 403 ~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred C-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1 112235678899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=307.69 Aligned_cols=234 Identities=22% Similarity=0.406 Sum_probs=171.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.+.||+|+||.||+|++. ++..||||.++... ....+.|.+|++++++++|||||+++|+|...+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4467899999999999999999864 46789999997543 234567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.++++... ..+++..+..++.++++||+|||+ |||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999997542 348899999999999999999996 9999987654
Q ss_pred cCccc--cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHV--STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+. ..+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~----~~i~~~~---- 267 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVI----KAVDEGY---- 267 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHH----HHHHTTE----
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHHcCC----
Confidence 32211 122345788999999988889999999999999999998 9999853211 1111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+. .......+.+++.+||+.||++||+|.+|++.|++++
T Consensus 268 ~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 RLPP-----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ECCC-----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC-----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0000 0112235778999999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.26 Aligned_cols=238 Identities=22% Similarity=0.381 Sum_probs=186.6
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|.....+|++.+.||+|+||.||+|.+.++..||||++..... ..+++.+|++++++++||||+++++++...+..+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 355667789999999999999999999998888999999975432 3467999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ..+++.....++.+++.||+|||+ |||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999997632 348899999999999999999996 8999887654
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..........+|+.|+|||...+..++.++||||||+++|||+| |+.||..... .... ..+.... ....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~----~~~~~~~--~~~~ 242 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETA----EHIAQGL--RLYR 242 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHH----HHHHTTC--CCCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHH----HHHhccc--CCCC
Confidence 33233334567888999999888889999999999999999999 9999854221 1111 1111111 0111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+.. . ...+.+++.+||+.||++|||+.++++.|++++
T Consensus 243 ~~~---~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 PHL---A----SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CTT---C----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc---C----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111 1 135678889999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=290.25 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=187.5
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+....+|++.+.||+|+||.||+|...++..||||.+..... ..+++.+|++++.+++||||+++++++...+..++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 345578999999999999999999988888999999975433 3467999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++.... ..+++..+..++.++++||+|||+ |||+++.......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999997642 248899999999999999999996 8999987654433
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+|+.|+|||...+..++.++||||||+++|||+| |+.||..... ..... ...... ....+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~-~~~~~~--~~~~~~~ 229 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVL-KVSQGH--RLYRPHL 229 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHH-HHHTTC--CCCCCTT
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHH-HHHcCC--CCCCCCc
Confidence 33344567788999999888889999999999999999999 8989853221 11111 111111 1111111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
. ...+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 230 ~-------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 230 A-------SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp S-------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred C-------hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1 1246788899999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.47 Aligned_cols=235 Identities=23% Similarity=0.378 Sum_probs=181.5
Q ss_pred ccccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
....+|++.+.||+|+||.||+|++. .+..||||.++... ....+.|.+|++++++++|||||++++++...+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34568999999999999999999874 34569999997543 33456799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.++++... ..+++..+..++.+++.||+|||+ |||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999997542 348999999999999999999996 999998765
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+. ..+......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~----~~~~~~~~~- 273 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVI----SSVEEGYRL- 273 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHH----HHHHTTCCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHH----HHHHcCCCC-
Confidence 4321 12233456788999999988889999999999999999999 9999854221 1111 112111100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+ ......+.+++.+||+.||++|||+.+|++.|++++
T Consensus 274 -~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 274 -PAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCC-------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 111235678899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=310.12 Aligned_cols=232 Identities=27% Similarity=0.392 Sum_probs=183.4
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC-eeE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE-EKL 255 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~ 255 (435)
.|.....+|++.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+++|++++|||||+++++|...+ ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 35567788999999999999999999985 7899999997543 4578999999999999999999999987765 789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.++++... ...+++...+.++.|+++||+|||+ |||+++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999998653 2347888999999999999999996 9999875432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+...+ ..... ...
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~~~i----~~~~~--~~~ 407 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRV----EKGYK--MDA 407 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC----TTTHHHHH----HTTCC--CCC
T ss_pred c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HcCCC--CCC
Confidence 1 122367889999999988899999999999999999999 999985432 12222222 11110 001
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
| . .+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 408 p---~----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 408 P---D----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---C----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 1 11235778899999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.62 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=188.5
Q ss_pred cccccccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeE
Q 040641 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLL 244 (435)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 244 (435)
.....|..+..+|++.+.||+|+||.||+|++ .+++.||||+++.... ...+.|.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34456778889999999999999999999973 2467899999975433 3346799999999999 79999999
Q ss_pred EEEEEeCCe-eEEEEecccCCCHHHHHHhhCCC-----------------------------------------------
Q 040641 245 LGYCSFDEE-KLLVYEYMVNGSLDLWLRNATGS----------------------------------------------- 276 (435)
Q Consensus 245 ~g~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~----------------------------------------------- 276 (435)
+++|...+. .++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-ccc
Q 040641 277 ---------------HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-THV 316 (435)
Q Consensus 277 ---------------~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-~~~ 316 (435)
...+++.....++.|+++||+|||+ |||+++...... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 1128889999999999999999996 999998654322 223
Q ss_pred cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ... ....+....... .+.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~---~~~~~~~~~~~~--~~~--- 319 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEE---FCRRLKEGTRMR--APD--- 319 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHH---HHHHHHHTCCCC--CCT---
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHH---HHHHHHcCCCCC--CCC---
Confidence 345678999999999888889999999999999999999 9999854321 111 111222111111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ....+.+++.+||+.||++|||+.||++.|++++
T Consensus 320 ~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 320 Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 1135678889999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.23 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=181.2
Q ss_pred cccCcceeeeecccCcceEEEEEc-----CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC--Ce
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 253 (435)
...+|++.+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++|||||+++++|... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 456899999999999999999984 25789999999866655667899999999999999999999998653 55
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+++|+|.+++.... ..+++.....++.|++.||+|||+ |||+++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 899999999999999997642 348899999999999999999996 99999876
Q ss_pred cccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc--------ccCCcHHHHHHHH
Q 040641 310 SACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQE--------KEGANLVGWVFQK 379 (435)
Q Consensus 310 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~--------~~~~~~~~~~~~~ 379 (435)
..... .......||..|+|||.+.+..++.++|||||||++|||+||..|+...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43321 1223345788899999988888999999999999999999999987542210 0000011111111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+...... +....+...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 245 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 245 LKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111100 001112235778899999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=292.73 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=179.3
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999854 68899999985432 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... .+++.....++.++++||+|||+ |||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999997642 48899999999999999999996 999998765433
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
........||+.|+|||.+.+..++.++|||||||++|||+||+.||.... .............. .. .+..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~-~~-~~~~ 236 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-------AVSIAIKHIQDSVP-NV-TTDV 236 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-------HHHHHHHHHSSCCC-CH-HHHS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhhccCC-Cc-chhc
Confidence 333345679999999999988889999999999999999999999985432 11122222222111 10 0000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-TMLHVLKLLHEIV 434 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~ 434 (435)
.. .....+.+++.+||+.||++|| ++.++.+.|.++.
T Consensus 237 ~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 237 RK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp CT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11 1123567788999999999999 9999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=292.85 Aligned_cols=224 Identities=21% Similarity=0.311 Sum_probs=179.0
Q ss_pred CcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 184 KLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 4677789999999999999875 699999999976665666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.+++... .+++..+..++.++++||+|||+ |||+++...... ....
T Consensus 126 ~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 126 GGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp SCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred CCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99999988642 48999999999999999999996 999988765422 2234
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
...||+.|+|||+..+..++.++|||||||++|||+||+.||..... ... ...+..........+
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~-~~~~~~~~~~~~~~~------- 264 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQA-MKRLRDSPPPKLKNS------- 264 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH-HHHHHHSSCCCCTTG-------
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHhcCCCCCcCcc-------
Confidence 56899999999999988999999999999999999999999854311 111 111211111111010
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 265 HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011234667888999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.75 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=185.4
Q ss_pred cccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
..+..+|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.++++++|||||++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345678999999999999999999853 36689999996542 33456789999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCC---CCCCCCHHHHHHHHHHhhhccceeec---------------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATG---SHEVLDRAKRYKIACSSARGLAFLHQ--------------------------- 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------- 301 (435)
...++||||+++|+|.++++.... ....+++...+.++.|+++||+|||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999999987542 22458899999999999999999996
Q ss_pred cccccccccccC-ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 DFGLARLISACE-THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||..... ..+. ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----~~~~----~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVL----EF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHH----HH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HH
Confidence 899887653322 122334568999999999888889999999999999999998 8888753211 1121 22
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+....... .+ . .....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 299 i~~~~~~~--~~---~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 299 VTSGGRMD--PP---K----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTCCCC--CC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC--CC---c----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 21111100 00 1 11235678899999999999999999999998763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=298.96 Aligned_cols=241 Identities=27% Similarity=0.448 Sum_probs=186.9
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
+..+..+|++.+.||+|+||.||+|+.. +++.||||.++.... ...+.|.+|++++++++||||++++++|..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 4556788999999999999999999864 347899999975432 335679999999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCC--------------------CCCCCHHHHHHHHHHhhhccceeec---------
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGS--------------------HEVLDRAKRYKIACSSARGLAFLHQ--------- 301 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~--------- 301 (435)
.+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999999999999999999864211 1458899999999999999999996
Q ss_pred ---------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCc
Q 040641 302 ---------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEF 364 (435)
Q Consensus 302 ---------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~ 364 (435)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 8999886543221 22234578999999999888889999999999999999999 888985321
Q ss_pred ccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
. .. ....+........ + . .....+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 282 ~-------~~-~~~~~~~~~~~~~--~---~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 H-------EE-VIYYVRDGNILAC--P---E----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp H-------HH-HHHHHHTTCCCCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h-------HH-HHHHHhCCCcCCC--C---C----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 11 1122222211110 1 1 112356788999999999999999999999998863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=286.52 Aligned_cols=236 Identities=25% Similarity=0.412 Sum_probs=186.7
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
|.....+|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3455678999999999999999999988888999999975433 346799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++......
T Consensus 82 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999997642 347889999999999999999996 899987654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
........||+.|+|||...+..++.++||||||+++|||+| |+.||..... ... ...+..... ...+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~----~~~i~~~~~--~~~~~ 228 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEV----VEDISTGFR--LYKPR 228 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH----HHHHHTTCC--CCCCT
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HHH----HHHHhcCCc--CCCCc
Confidence 222334567889999999888889999999999999999999 8888753211 111 111211110 01111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 229 ~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 229 L-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp T-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-------CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1235678889999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=293.04 Aligned_cols=223 Identities=21% Similarity=0.295 Sum_probs=177.9
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
..+|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999986 578999999996543 234567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++.... .+++.....++.|+++||+|||+ |||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 9999999999997643 38889999999999999999996 99999876532
Q ss_pred cccccccccCCCcCCcCCCCCCCC-CcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMST-TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|+|||++.+..++ .++||||+||++|||+||+.||.... .... ...+...... .|..
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~-~~~i~~~~~~---~p~~ 236 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKEL-RERVLRGKYR---IPFY 236 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHH-HHHHHHCCCC---CCTT
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHH-HHHHHhCCCC---CCCC
Confidence 233457899999999998777664 79999999999999999999985432 1111 1122111110 1111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.+++.+||+.||++|||+.|+++
T Consensus 237 -------~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 -------MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1124667888999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=290.13 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=187.1
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC--eeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE--EKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 257 (435)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357899999999999999999865 48999999997543 334577889999999999999999999998765 67999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLI 309 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~ 309 (435)
|||+++|+|.+++..... ...+++.....++.|+++||+|||+ |||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999999986432 2338999999999999999999995 89998776
Q ss_pred cccCccccccccccCCCcCCcCCC--------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQ--------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
.... ......||+.|+|||++. +..++.++|||||||++|||+||+.||...............+.....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 5432 223467999999999764 577899999999999999999999998643322222222222221111
Q ss_pred cCCCCcc-------c--ccc--ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 382 KQQADDV-------L--DPT--VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 382 ~~~~~~~-------~--~~~--~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
....... . .+. ............+.+++.+||+.||++|||+.|+++...+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1100000 0 000 11122345566777899999999999999999999887764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=289.46 Aligned_cols=237 Identities=21% Similarity=0.320 Sum_probs=173.3
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
.+.....+|++.+.||+|+||.||+|.... +..||+|.+..... ...+.|.+|+.++++++||||+++++++ ..
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence 355667889999999999999999998643 45799999875432 3356799999999999999999999998 45
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+..++||||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 67899999999999999997542 348899999999999999999996 999998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..............+|+.|+|||......++.++|||||||++|||++ |..||..... ......+ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~~~i----~~~~~~ 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRI----ENGERL 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHHH----HTTCCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHHHHH----HcCCCC
Confidence 765433333334567889999999888889999999999999999997 8888854321 1222221 111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ... .....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 237 ~-----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 P-----MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp C-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 001 11235678889999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=289.57 Aligned_cols=236 Identities=27% Similarity=0.421 Sum_probs=175.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhcc--CCCCCceeEEEEEEeC----CeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK--VKHQNLVLLLGYCSFD----EEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 255 (435)
..+|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999988 5889999998643 23455666666655 8999999999987553 4578
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee--------c------------------------cc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH--------Q------------------------DF 303 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~------------------------Df 303 (435)
+||||+++|+|.++++.. .+++..+..++.|+++||+||| + ||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999542 4899999999999999999999 5 99
Q ss_pred cccccccccCccc---cccccccCCCcCCcCCCCC------CCCCcccchhHHHHHHHHHhC----------CCCCCCCc
Q 040641 304 GLARLISACETHV---STDIAGTLGYIPPEYGQSR------MSTTRGDVYSFGVILLELVTA----------KEPTGPEF 364 (435)
Q Consensus 304 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~DV~SfGvil~El~tg----------~~p~~~~~ 364 (435)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998765432221 2335799999999988766 455799999999999999999 77775433
Q ss_pred ccccCCcHHHHHHHHhccCCCCcccccccc-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVL-NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.... .... .......... .+... ..........+.+++.+||+.||++|||+.||++.|++|
T Consensus 238 ~~~~--~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDP--SFED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSC--CHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc--chhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211 1111 1111111111 11111 011224556788999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.59 Aligned_cols=241 Identities=30% Similarity=0.441 Sum_probs=188.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.+..+..+|.+.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+++++++ +|||||++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 34566788999999999999999999852 235799999975432 3446799999999999 9999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhCCC------------CCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATGS------------HEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|..++..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999999999999865321 2358999999999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---- 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 9999987653222 22334567899999999988899999999999999999999 888875321
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... +...+........ + .. ....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 299 ---~~~-~~~~~~~~~~~~~--~---~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 ---VEE-LFKLLKEGHRMDK--P---SN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ---HHH-HHHHHHTTCCCCC--C---SS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHH-HHHHHHcCCCCCC--C---cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1222222211110 1 11 1235678889999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.90 Aligned_cols=238 Identities=27% Similarity=0.412 Sum_probs=187.7
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|+.+..+|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|||||++++++.. +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 45677788999999999999999999999888889999997543 345789999999999999999999999865 7789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.++++.... ..+++...+.++.|+++||+|||+ |||+++....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred EeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999975321 247889999999999999999996 9999987653
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..........+|..|+|||.+....++.++|||||||++|||+| |+.||..... ..+. ..+..... ...
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~----~~i~~~~~--~~~ 485 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL----DQVERGYR--MPC 485 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHH----HHHHTTCC--CCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHHcCCC--CCC
Confidence 22222234567889999999888889999999999999999999 8888753211 1121 22221110 000
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+ ..+...+.+++.+||+.||++||||.+|++.|+++.
T Consensus 486 ~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 112235678899999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.36 Aligned_cols=242 Identities=28% Similarity=0.408 Sum_probs=188.2
Q ss_pred ccccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYC 248 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 248 (435)
..+..+..+|.+.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++++++|||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34566778999999999999999999975 235789999997543 33456799999999999999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC--------------------CCCCCCHHHHHHHHHHhhhccceeec-------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG--------------------SHEVLDRAKRYKIACSSARGLAFLHQ------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~------- 301 (435)
...+..++||||+++|+|.+++..... ....+++.....++.|+++||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986432 12347889999999999999999996
Q ss_pred -----------------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 040641 302 -----------------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGP 362 (435)
Q Consensus 302 -----------------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~ 362 (435)
|||+++........ ......+|+.|+|||...+..++.++|||||||++|||+| |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999866433221 2234567889999999888889999999999999999999 9999854
Q ss_pred CcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 363 EFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... ..+... +....... ... .....+.+++.+||+.||++|||+.||++.|++++
T Consensus 256 ~~~----~~~~~~----~~~~~~~~-----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 256 IPP----ERLFNL----LKTGHRME-----RPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CCG----GGHHHH----HHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCH----HHHHHH----hhcCCcCC-----CCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 322 122221 21111100 011 11235678889999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=287.72 Aligned_cols=244 Identities=33% Similarity=0.520 Sum_probs=186.5
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccc----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+...+.||+|+||.||+|.. +++.||||++.... ....+.|.+|++++++++||||+++++++...+..++||||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 34558999999999999987 57899999986432 22356799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-c
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-H 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~ 315 (435)
+++|+|.+++..... ...+++..+..++.++++||+|||+ |||+++....... .
T Consensus 112 ~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 112 MPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred cCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999875422 3458999999999999999999996 8999876543221 2
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......||+.|+|||...+ .++.++||||||+++|||+||+.||...........+...... ......+.+++.. .
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~ 266 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED--EEKTIEDYIDKKM-N 266 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT--TSCCHHHHSCSSC-S
T ss_pred cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh--hhhhhhhhccccc-c
Confidence 2234579999999998765 4789999999999999999999998654322211111111100 0111122222222 2
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.........+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 334566677889999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=294.65 Aligned_cols=230 Identities=22% Similarity=0.269 Sum_probs=179.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++|||||++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999864 68999999986432 1235779999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~ 309 (435)
|||||++|+|.+++.........+++.....++.|+++||+|||+ |||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999999988886543333458899999999999999999996 89998776
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+ ...+...... .
T Consensus 184 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~----~~~i~~~~~~--~ 251 (351)
T 3c0i_A 184 GESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERL----FEGIIKGKYK--M 251 (351)
T ss_dssp CTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHH----HHHHHHTCCC--C
T ss_pred cCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHH----HHHHHcCCCC--C
Confidence 5422 22345679999999999998899999999999999999999999985421 111 1111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100001 1235678889999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=281.89 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=176.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--Cee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 254 (435)
.....+|++.+.||+|+||.||+|++. ++.||||.+.... ....+.|.+|+.++++++|||||++++++... +..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345568999999999999999999985 8899999987543 23456799999999999999999999999877 778
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------ccccccccccc------------Cc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------DFGLARLISAC------------ET 314 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------DfGla~~~~~~------------~~ 314 (435)
++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+ |.-...++-.. ..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred EeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999997642 2358999999999999999999996 11111110000 01
Q ss_pred cccccccccCCCcCCcCCCCCCCCC---cccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTT---RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~---k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.......||+.|+|||.+.+..++. ++|||||||++|||+||+.||..... ............. +
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~-----~ 230 (271)
T 3kmu_A 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLR-----P 230 (271)
T ss_dssp TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCCC-----C
T ss_pred ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCCC-----C
Confidence 1122356899999999887654444 79999999999999999999854221 1111111111111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
..... ....+.+++..||+.||++|||+.++++.|+++.+
T Consensus 231 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 TIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111 12356788889999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.35 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=185.4
Q ss_pred cccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.|..+..+|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3566778999999999999999999985 235689999997543 23456799999999999 999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCCC-------------------CCCCCHHHHHHHHHHhhhccceeec--------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATGS-------------------HEVLDRAKRYKIACSSARGLAFLHQ-------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~yLH~-------- 301 (435)
...+..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999999999764321 1247899999999999999999996
Q ss_pred ----------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 040641 302 ----------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPE 363 (435)
Q Consensus 302 ----------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~ 363 (435)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999987654322 22334567889999999888889999999999999999998 99898543
Q ss_pred cccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 364 FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... ..+ ...+...... ..+ .. ....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 279 ~~~---~~~----~~~~~~~~~~--~~~---~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVD---ANF----YKLIQNGFKM--DQP---FY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCS---HHH----HHHHHTTCCC--CCC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcH---HHH----HHHHhcCCCC--CCC---CC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 211 111 1111111100 001 11 1235678899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=289.96 Aligned_cols=242 Identities=28% Similarity=0.441 Sum_probs=188.2
Q ss_pred cccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.|+.+..+|++.+.||+|+||.||+|++ .+++.||||.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 4567778999999999999999999984 3467899999975433 3456799999999999 999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCCC--------------CCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATGS--------------HEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
...+..++||||+++|+|.+++...... ...+++.....++.++++||+|||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999999999999865321 1248899999999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++....... .......||+.|+|||...+..++.++|||||||++|||+| |+.||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence 9999987654322 12234567889999999888889999999999999999999 88887543211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .......... ...+ . .....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 255 --~~---~~~~~~~~~~--~~~~---~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 --SK---FYKMIKEGFR--MLSP---E----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp --HH---HHHHHHHTCC--CCCC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hH---HHHHhccCCC--CCCc---c----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11 1111111100 0001 0 11235678889999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=286.65 Aligned_cols=229 Identities=21% Similarity=0.385 Sum_probs=177.5
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC-C-------CEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD-G-------KTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
....+|.+.+.||+|+||.||+|+... + ..||+|.+........+.|.+|++++++++|||||++++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 345689999999999999999998643 3 46999999776666678899999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------------ 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------------ 301 (435)
+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999997642 348889999999999999999995
Q ss_pred --cccccccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 302 --DFGLARLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 --DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+++.... .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.|+..... .... ..
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~-~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------SQRK-LQ 229 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHH-HH
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc------hHHH-HH
Confidence 5555543221 123458899999998877 6789999999999999999997666543221 1111 11
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
...... . ..+. .. ..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 230 ~~~~~~--~-~~~~-~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 230 FYEDRH--Q-LPAP-KA-------AELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHTTC--C-CCCC-SS-------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HhhccC--C-CCCC-CC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111110 0 0000 11 13567888999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=291.24 Aligned_cols=227 Identities=21% Similarity=0.263 Sum_probs=178.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
...|++.+.||+|+||.||+|+.. +|+.||||.++..... ..+.+.+|+.++++++|||||++++++...+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356899999999999999999865 5899999998654321 346799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLA 306 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla 306 (435)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+ |||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999653 358899999999999999999995 88888
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ... ...+......
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----~~~----~~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QET----LANITAVSYD 236 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHH----HHHHHTTCCC
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhcCCC
Confidence 765432 223456799999999999988999999999999999999999999854321 111 1112111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.++..... ....+.+++.+||..||++|||+.|+++
T Consensus 237 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111011 1124667889999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.32 Aligned_cols=233 Identities=22% Similarity=0.349 Sum_probs=176.2
Q ss_pred cccCcceee-eecccCcceEEEEEcC---CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVD-ILEDGGFGTVYKATLP---DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
...++.+.+ .||+|+||.||+|.+. ++..||||.++.... ...++|.+|+++|++++|||||+++|+|.. +..+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344555555 7999999999999764 456799999976432 356789999999999999999999999976 5689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.+++... ...+++..+..++.|+++||+|||+ |||+++.+..
T Consensus 412 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999999653 2358999999999999999999996 9999987643
Q ss_pred cCccc--cccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHV--STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .....+|+.|+|||++....++.++|||||||++|||+| |+.||.... ...+.. .+.......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~----~~~~~~----~i~~~~~~~- 559 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMA----FIEQGKRME- 559 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----SHHHHH----HHHTTCCCC-
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHH----HHHcCCCCC-
Confidence 32211 122346789999999988889999999999999999998 999985432 112222 222211100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.| . .+...+.+++.+||+.||++||+|.+|++.|+++.
T Consensus 560 -~p---~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 560 -CP---P----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -CC---T----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CC---C----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01 1 12235778999999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=285.47 Aligned_cols=238 Identities=23% Similarity=0.369 Sum_probs=189.3
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.|+....+|++.+.||+|+||.||+|.... ++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 456667889999999999999999998754 7889999986533 34577999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ...+++..+..++.+++.||+|||+ |||+++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999997642 3458899999999999999999996 9999987654
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
..........+|+.|+|||...+..++.++||||||+++|||++ |..||.... .......+. ..... ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~----~~~~~~~~~----~~~~~--~~ 233 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLE----KDYRM--ER 233 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHHHHH----TTCCC--CC
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHh----ccCCC--CC
Confidence 44334445667889999999888889999999999999999999 888875321 112222211 11000 00
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+ . .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 234 ~---~----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 234 P---E----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---C----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1 1 11235678889999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=292.15 Aligned_cols=241 Identities=30% Similarity=0.435 Sum_probs=185.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC--------CCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.|..+..+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++++ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 45667789999999999999999999853 467899999975432 3456789999999999 8999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhCCC------------CCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATGS------------HEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|...+..++||||+++|+|.+++...... ...+++..+..++.++++||+|||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999999999999864321 1348889999999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 8999886653322 12233467889999999888889999999999999999999 8888753211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+ ...+....... ... .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 266 -~~~----~~~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 -EEL----FKLLKEGHRMD-----KPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -HHH----HHHHHHTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHH----HHHHhcCCCCC-----CCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 12221111110 011 11235678889999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.19 Aligned_cols=228 Identities=18% Similarity=0.275 Sum_probs=180.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
...|++.+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++|||||++++++......++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999865 5889999999765544556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~ 314 (435)
+++|+|.+++... ...+++.....++.|++.||+|||+ |||+++......
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999988643 2348899999999999999999995 899988765422
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .... ..+...... .++...
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~----~~i~~~~~~--~~~~~~ 274 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETL----QNVKRCDWE--FDEDAF 274 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH----HHHHHCCCC--CCSSTT
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHH----HHHHhCCCC--CCcccc
Confidence 22345799999999999998999999999999999999999999854321 1111 111111110 111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 275 ~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 S----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1 11235678899999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=282.32 Aligned_cols=234 Identities=21% Similarity=0.296 Sum_probs=172.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc---cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ---GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999865 6889999999754322 246789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++++|.+++.... .+++.....++.++++||+|||+ |||+++......
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999997642 48899999999999999999996 899887655433
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
........||+.|+|||...+..++.++||||||+++|||+||+.||..... ......+...... +..
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~----~~~ 256 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPR----PST 256 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCC----GGG
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCC----ccc
Confidence 2333456799999999999988999999999999999999999999854211 1112222211110 100
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhhhh
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-TMLHVLKLLHEIV 434 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~ 434 (435)
..+. ....+.+++.+||+.||++|| ++.++++.|++++
T Consensus 257 ~~~~---~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 257 VRPG---IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp TSTT---CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cCCC---CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0111 112466788999999999999 9999999998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=290.17 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=170.8
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCC----CEEEEEEcccc--ccccHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDG----KTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
.+..+..+|++.+.||+|+||.||+|+.... ..||||.++.. .....+.|.+|++++++++|||||++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3455667899999999999999999987543 27999999754 23345789999999999999999999999987
Q ss_pred CCee------EEEEecccCCCHHHHHHhhCC--CCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 251 DEEK------LLVYEYMVNGSLDLWLRNATG--SHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 251 ~~~~------~lv~ey~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
.... ++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 999999999999999875432 22358899999999999999999996
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~~~~ 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN----AEIYNYL 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh----HHHHHHH
Confidence 9999987643322 22233457889999999888889999999999999999999 8888754321 2222221
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ...... .+ ......+.+++.+||+.||++|||+.++++.|++++
T Consensus 253 ~----~~~~~~--~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 253 I----GGNRLK--QP-------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp H----TTCCCC--CC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h----cCCCCC--CC-------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 111000 00 111235778899999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=282.14 Aligned_cols=229 Identities=28% Similarity=0.438 Sum_probs=168.8
Q ss_pred ccccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccc----ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT----QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
....+|++.+.||+|+||.||+|.+. ++.||||.+..... ...+.+.+|+++++.++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34568999999999999999999975 78999999865432 23467899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------------- 301 (435)
+||||+++|+|.+++.. ..+++.....++.++++||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999999853 248889999999999999999874
Q ss_pred -cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 302 -DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++..... ......||+.|+|||...+..++.++||||||+++|||+||+.||..... ........
T Consensus 158 ~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~ 227 (271)
T 3dtc_A 158 TDFGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVA 227 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHH
T ss_pred ccCCcccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhh
Confidence 56665543321 12235789999999998888899999999999999999999999854211 11111111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
... .. ...... ....+.+++.+||+.||++|||+.|+++.|++|
T Consensus 228 ~~~-~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MNK-LA----LPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSC-CC----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCC-CC----CCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 10 011111 123567889999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=291.14 Aligned_cols=244 Identities=21% Similarity=0.283 Sum_probs=183.0
Q ss_pred ccccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe----
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF---- 250 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---- 250 (435)
.++.....+|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34455667899999999999999999986 5689999999876555566789999999999999999999999873
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
....++||||+++|+|.+++.........+++..+..++.|+++||+|||+ |||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 347889999999999999998754444568999999999999999999996 88887
Q ss_pred ccccccCc--------cccccccccCCCcCCcCCCCCC---CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHH
Q 040641 307 RLISACET--------HVSTDIAGTLGYIPPEYGQSRM---STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGW 375 (435)
Q Consensus 307 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~ 375 (435)
+....... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... .......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~ 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--GDSVALA 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--TSCHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--cchhhHH
Confidence 65432110 0112345799999999887554 688999999999999999999998432111 1111111
Q ss_pred HHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 376 VFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .. . .. +. .......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 260 ~~----~~-~-~~--~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQ----NQ-L-SI--PQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH----CC----C--CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh----cc-C-CC--Cc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 10 0 00 00 0011235778889999999999999999999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=287.89 Aligned_cols=230 Identities=26% Similarity=0.446 Sum_probs=172.5
Q ss_pred ccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
....+|++.+.||+|+||.||+|++. ++.||||++... ...+.|.+|++++++++|||||+++|++. +..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 34568899999999999999999875 788999999643 34567999999999999999999999876 45899999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLISA 311 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~~~ 311 (435)
|+++|+|.+++.... ....+++...+.++.++++||+|||+ |||+++....
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred cCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999997542 22347888899999999999999985 6777654432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .....||+.|+|||+..+..++.++|||||||++|||+||+.||..... .......... .... +
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~~-----~ 223 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFRIMWAVH-NGTR-----P 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHHHHHHHH-TTCC-----C
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHHHHHHHh-cCCC-----C
Confidence 1 2234699999999999988999999999999999999999999854211 1111111111 1111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..... ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 224 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 PLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CCBTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred Ccccc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111 1134678889999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=285.17 Aligned_cols=224 Identities=20% Similarity=0.276 Sum_probs=178.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc---ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+.. +|+.||+|.++.. .......+.+|+++++.++|||||++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999865 5899999999654 233456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|..++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 99999999999987642 47888999999999999999996 99999764322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+..... .-|.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~----~~~i~~~~~---~~p~- 226 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERL----FELILMEEI---RFPR- 226 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCC---CCCT-
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----HHH----HHHHHcCCC---CCCC-
Confidence 2233457899999999999999999999999999999999999999854221 111 111111111 0111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
. ....+.+++.+||+.||++|| ++.||++
T Consensus 227 --~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 --T----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --T----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --C----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1 112466788899999999999 8998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.78 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=174.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345799999999999999999985 468999999986432 2345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.........+++.....++.++++||+|||+ |||+++.....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999999987543334568899999999999999999996 89988765432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. .......||+.|+|||...+..++.++||||||+++|||++|+.||.... ....... ..+.......
T Consensus 190 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~~~~~~----- 257 (310)
T 2wqm_A 190 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLC-KKIEQCDYPP----- 257 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHH-HHHHTTCSCC-----
T ss_pred C-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHH-HHhhcccCCC-----
Confidence 1 22234578999999999988899999999999999999999999985421 1111111 1222111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... .....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 258 ~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 LPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp CCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1101 11235678889999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=289.86 Aligned_cols=232 Identities=23% Similarity=0.389 Sum_probs=174.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCC----EEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|++. +++ .||+|.+.... ....+.|.+|+.++++++|||||+++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 457899999999999999999854 344 46888886433 34557899999999999999999999999875 478
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... ..+++..++.++.++++||+|||+ |||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999997643 348899999999999999999996 9999987654
Q ss_pred cCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 312 CET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 312 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+...+ ..... ..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~----~~~~~--~~ 239 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSIL----EKGER--LP 239 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHHH----HTTCC--CC
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HHHHHHH----HcCCC--CC
Confidence 322 22234567889999999988899999999999999999999 9999854321 1222211 11110 00
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+ ......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 240 ~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 240 QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CC-------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CC-------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 111235778899999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=285.83 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=182.4
Q ss_pred cccCcceeeeecccCcceEEEEEc-----CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC--C
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--E 252 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~ 252 (435)
....|++.+.||+|+||.||+|++ .+++.||||.+.... ....+.+.+|++++++++||||+++++++... .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 446789999999999999999983 357899999997543 33457899999999999999999999999876 6
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++.... ..+++..+..++.+++.||+|||+ |||+++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 6899999999999999996543 348899999999999999999996 9999987
Q ss_pred ccccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc-------ccCCcHHHHHHHH
Q 040641 309 ISACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQE-------KEGANLVGWVFQK 379 (435)
Q Consensus 309 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~-------~~~~~~~~~~~~~ 379 (435)
...... .......||..|+|||.+.+..++.++||||||+++|||+||+.|+...... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654322 2233457888999999988888899999999999999999999885432100 0011111111111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
+....... . .......+.+++.+||+.||++|||+.++++.|+++++
T Consensus 256 ~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 256 LKEGKRLP-----C----PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHTTCCCC-----C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HhccCCCC-----C----CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 21111000 0 01122357788999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.56 Aligned_cols=237 Identities=29% Similarity=0.433 Sum_probs=185.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.|+.+..+|++.+.||+|+||.||+|...+++.||||.+.... ...+.|.+|++++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 4666778999999999999999999998888899999986543 34578999999999999999999999986 456899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... ...+++.....++.++++||+|||+ |||+++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999986432 1248889999999999999999996 89998876543
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.........+|+.|+|||...+..++.++||||||+++|||+| |+.||..... ... ...+..... ...+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~----~~~~~~~~~--~~~~ 232 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEV----IQNLERGYR--MVRP 232 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH----HHHHHTTCC--CCCC
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHH----HHHHhcccC--CCCc
Confidence 3333344567889999999887888999999999999999999 8888753211 111 112211110 0111
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 233 ~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 233 D-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp T-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1 11235678889999999999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=287.82 Aligned_cols=227 Identities=18% Similarity=0.271 Sum_probs=178.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+++++.++|||||++++++...+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357899999999999999999865 57899999986433 3345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~ 314 (435)
|++|+|.+++... ...+++.....++.|+++||+|||+ |||+++......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999998643 2358899999999999999999995 899887764322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......||+.|+|||+..+..++.++|||||||++|||++|+.||..... .... ..+...... .++...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~~i~~~~~~--~~~~~~ 227 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQII----ENIMNAEYT--FDEEAF 227 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH----HHHHHTCCC--CCHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHH----HHHHcCCCC--CChhhh
Confidence 23346799999999999888899999999999999999999999854321 1111 111111110 000000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 11235678899999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=298.05 Aligned_cols=248 Identities=20% Similarity=0.263 Sum_probs=187.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC--eeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE--EKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 257 (435)
..+|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|||||++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999875 48999999997543 234567889999999999999999999998765 67999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLI 309 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~ 309 (435)
|||+++|+|.+++..... ...+++.....++.+++.||+|||+ |||+++..
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999999976432 2238999999999999999999995 89998776
Q ss_pred cccCccccccccccCCCcCCcCCCC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS--------RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
.... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||............ +.....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~~~ 241 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV---MYKIIT 241 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH---HHHHHH
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH---HHHHhc
Confidence 4322 2234679999999998654 46788999999999999999999998643322222122 222222
Q ss_pred cCCCCc---c---------cccc--ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 382 KQQADD---V---------LDPT--VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 382 ~~~~~~---~---------~~~~--~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
...... . .... ............+.+++.+||+.||++||++.|+++.++++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111100 0 0000 1112234556667789999999999999999999999988763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.44 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=178.0
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
+.-..+|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++|||||++++++..++..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 444578999999999999999999988899999999865432 234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++ +|.+++.... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 97 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999985 7877776532 348889999999999999999996 99999875432
Q ss_pred CccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
........||+.|+|||++.+ ..++.++||||+||++|||+||+.||..... ......+...............
T Consensus 173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHHHHHHHCCCCTTTSGGG
T ss_pred -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHHCCCChHHhhhh
Confidence 222344678999999998765 5689999999999999999999999864322 2223333332222111100000
Q ss_pred -----------cccCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 -----------TVLNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 -----------~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....... .....++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 011235678899999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=282.68 Aligned_cols=235 Identities=22% Similarity=0.319 Sum_probs=178.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcCC----CCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
.....+|++.+.||+|+||.||+|++.+ +..||||.+.... ....+.|.+|++++++++||||+++++++.. +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4456789999999999999999998532 3469999997543 2345679999999999999999999999764 56
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 789999999999999997643 347889999999999999999996 89998876
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
............+|+.|+|||...+..++.++||||||+++|||+| |+.||..... ......+.. ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~~~~~~----~~~~-- 233 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVIGVLEK----GDRL-- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHHHHHHH----TCCC--
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHHHHHhc----CCCC--
Confidence 5433333344567889999999888889999999999999999998 9999853221 122222111 1100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+. . ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 234 ~~~~---~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 PKPD---L----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCCT---T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---C----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0111 1 1134678889999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.78 Aligned_cols=225 Identities=22% Similarity=0.280 Sum_probs=171.7
Q ss_pred cceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+...+.||+|+||.||+|+. .+|+.||+|.++.......+.|.+|++++++++|||||++++++...+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 34467899999999999986 46899999999765555567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCcccc
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACETHVS 317 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~~~~ 317 (435)
|+|.+++.... ..+++..+..++.|+++||+|||+ |||+++...... ..
T Consensus 171 ~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 171 GELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp CEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 99998887532 348899999999999999999996 899988764322 22
Q ss_pred ccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 318 ~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
....||+.|+|||++....++.++|||||||++|||+||+.||..... .... ....... .. ..+....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~---~~i~~~~-~~--~~~~~~~-- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETL---NNILACR-WD--LEDEEFQ-- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH---HHHHHTC-CC--SCSGGGT--
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHH---HHHHhcc-CC--CChhhhc--
Confidence 345799999999999888899999999999999999999999854321 1111 1111111 00 0000001
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.||++|||+.|+++
T Consensus 314 --~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 --DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11235678899999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.68 Aligned_cols=226 Identities=20% Similarity=0.276 Sum_probs=177.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|++.+.||+|+||.||+|+.. +|+.||||.+..... ...+.+.+|+.++++++|||||++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46889999999999999999865 589999999865332 13567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLAR 307 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~ 307 (435)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999998643 358899999999999999999995 888887
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .... ..+......
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~~~~~~~~~- 235 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETL----ANVSAVNYE- 235 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH----HHHHHTCCC-
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHH----HHHHhcCCC-
Confidence 654322 22346799999999999888999999999999999999999999854321 1111 111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 -FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000001 1124667889999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=281.89 Aligned_cols=240 Identities=28% Similarity=0.441 Sum_probs=172.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.++.+..+|++.+.||+|+||.||+|+.. ..||||.++... ....+.|.+|++++++++||||+++++++ ..+..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 34667789999999999999999999874 369999986543 23456799999999999999999999975 55678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... ...+++.....++.+++.||+|||+ |||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999998643 2358899999999999999999996 899987654
Q ss_pred ccC-ccccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 311 ACE-THVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 311 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
... ........||+.|+|||.+. ...++.++||||||+++|||+||+.||...... ..+..........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccccC
Confidence 311 22233467999999999875 567888999999999999999999998543211 1111222111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... ... ......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 245 ~~~~-~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS-KVR----SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT-SSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh-hcc----ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1000 001 112235778899999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.02 Aligned_cols=226 Identities=23% Similarity=0.295 Sum_probs=178.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|||||++++++...+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47899999999999999999865 58999999996543 2344678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
|+++|+|.+++... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 109 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999888643 348899999999999999999996 89998766532
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+ ...+...... ...+.
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----~~~----~~~i~~~~~~-~~~~~ 253 (362)
T 2bdw_A 185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL----YAQIKAGAYD-YPSPE 253 (362)
T ss_dssp --CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHTCCC-CCTTG
T ss_pred --cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHH----HHHHHhCCCC-CCccc
Confidence 223356899999999999988999999999999999999999999854321 111 1222111110 00110
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 254 -----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 254 -----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111235678889999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=279.74 Aligned_cols=230 Identities=22% Similarity=0.375 Sum_probs=174.1
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc-------cHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ-------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
...+|++.+.||+|+||.||+|+. .+++.||||.+...... ..+.|.+|++++++++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346899999999999999999986 46889999998643321 1267899999999999999999999986544
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------------
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------------- 301 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------------- 301 (435)
++||||+++|+|.+++... ...+++..+..++.+++.||+|||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 7999999999999888654 2358999999999999999998885
Q ss_pred cccccccccccCccccccccccCCCcCCcCC--CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 DFGLARLISACETHVSTDIAGTLGYIPPEYG--QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...... ........
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIKFINMI 242 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHHHHHHH
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHHHHHHH
Confidence 6666653321 22346799999999988 4456789999999999999999999998543211 11111111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.. .... +.... .....+.+++.+||+.||++|||+.||++.|+++
T Consensus 243 ~~-~~~~----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE-EGLR----PTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH-SCCC----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc-cCCC----CCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1111 11111 1123567888999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.25 Aligned_cols=222 Identities=19% Similarity=0.313 Sum_probs=175.3
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+++++.++|||||++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999986 568999999986432 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+ +|+|.+++.... .+++.....++.|++.||+|||+ |||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999 789988887643 48899999999999999999996 99999876542
Q ss_pred ccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......+||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ..+.. .....|.
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------~~i~~---~~~~~p~ 229 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------KKVNS---CVYVMPD 229 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------CCCCS---SCCCCCT
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------HHHHc---CCCCCcc
Confidence 22345689999999999988765 78999999999999999999998653321110 00000 0001111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~-------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 230 F-------LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp T-------SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred c-------CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1234668899999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=295.63 Aligned_cols=227 Identities=24% Similarity=0.296 Sum_probs=177.7
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5789999999999999999985 468899999986543 2344678999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
||++|+|.+++... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 91 ~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 91 LVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999988764 248899999999999999999995 89999776542
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+ ...+..... ....+.
T Consensus 167 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----~~~----~~~i~~~~~-~~~~~~ 236 (444)
T 3soa_A 167 Q-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRL----YQQIKAGAY-DFPSPE 236 (444)
T ss_dssp C-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH----HHHHHHTCC-CCCTTT
T ss_pred C-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----HHH----HHHHHhCCC-CCCccc
Confidence 2 223456899999999999998999999999999999999999999854321 111 222222111 111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 W-----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 111235678889999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=290.59 Aligned_cols=229 Identities=18% Similarity=0.214 Sum_probs=168.1
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
...+|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++|||||++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999865 688999999965432 33678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccC
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACE 313 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~ 313 (435)
|+++|+|.+++.... .+++.....++.|+++||+|||+ |||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 999999999987643 38899999999999999999995 88888743321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTR-GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ............ .... ..+.
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~~-~~~~-~~~~- 244 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRILS-VKYS-IPDD- 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHHT-TCCC-CCTT-
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhc-CCCC-CCCc-
Confidence 22234579999999999877776655 89999999999999999998643221 112222221111 1110 0000
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 245 ---~---~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 245 ---I---RISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ---S---CCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---C---CCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0 01135678899999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=280.59 Aligned_cols=237 Identities=24% Similarity=0.283 Sum_probs=173.1
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++|||||++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4788999999999999999998789999999986433 22346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+++ +|.+++.... ..+++.....++.|+++||+|||+ |||+++..... ...
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRK 156 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccc
Confidence 985 8988887532 347888999999999999999996 89998765432 122
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc--------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD-------- 387 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 387 (435)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+...........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHHCCCChhhchhhhccc
Confidence 234578999999998765 4589999999999999999999999854321 111222222211111000
Q ss_pred ccccccc-------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVL-------NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~-------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000112235678899999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.48 Aligned_cols=243 Identities=14% Similarity=0.193 Sum_probs=179.1
Q ss_pred cccCcceeeeecccCcceEEEEEcCC------CCEEEEEEccccccc-----------cHHHHHHHHHHhccCCCCCcee
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKTQ-----------GHRQFTAEMETLGKVKHQNLVL 243 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~ 243 (435)
...+|++.+.||+|+||.||+|.+.. ++.||||.+...... ....+.+|+..++.++|||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999998754 478999998654321 1123556777888999999999
Q ss_pred EEEEEEeC----CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------
Q 040641 244 LLGYCSFD----EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------ 301 (435)
Q Consensus 244 l~g~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------ 301 (435)
+++++... ...++||||+ +|+|.+++.... ..+++..+..++.|++.||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 99998765 4579999999 999999997642 358999999999999999999995
Q ss_pred --------cccccccccccCcc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc
Q 040641 302 --------DFGLARLISACETH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367 (435)
Q Consensus 302 --------DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~ 367 (435)
|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 99999876432211 113356999999999999989999999999999999999999998642221
Q ss_pred cCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
............ ......+++....... ...+.+++..||+.+|++||++.+|++.|++++
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 --PKYVRDSKIRYR-ENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp --HHHHHHHHHHHH-HCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHhh-hhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 111111111111 1111222222111111 235677888999999999999999999998874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=294.19 Aligned_cols=232 Identities=28% Similarity=0.432 Sum_probs=167.8
Q ss_pred cCcceeeeecccCcceEEEEEcC--CC--CEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP--DG--KTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 256 (435)
..|.+.+.||+|+||.||+|++. ++ ..||||.++.... ...+.|.+|+.++++++|||||+++++|.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45778899999999999999853 22 4689999865432 345789999999999999999999999764 457899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.++++... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999997542 347888899999999999999996 99999865432
Q ss_pred Cc---cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhC-CCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 313 ET---HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTA-KEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 313 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.. .......+|+.|+|||...+..++.++|||||||++|||+|| .+||... ........+.. .. ..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~----~~~~~~~~~~~----~~--~~ 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLLQ----GR--RL 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CSSCHHHHHHT----TC--CC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC----CHHHHHHHHHc----CC--CC
Confidence 21 122345678899999999888899999999999999999995 5555322 12223222211 11 11
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..|.. ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 316 ~~p~~-------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 316 LQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1235678899999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.61 Aligned_cols=235 Identities=16% Similarity=0.156 Sum_probs=181.0
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|+. .+++.||||.+..... ...+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5789999999999999999985 5688999999864432 24588999999999 999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccccccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARLISA 311 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~~~~ 311 (435)
+ +|+|.+++... ...+++..+..++.|++.||+|||+ |||+++....
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 99999999764 2358999999999999999999996 8999886543
Q ss_pred cCcc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 312 CETH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 312 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.... ......||+.|+|||+..+..++.++|||||||++|||+||+.||..... ....... ..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~-~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERY-QKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHH-HHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHH-HHHHhhhc
Confidence 2221 12456899999999999999999999999999999999999999864321 1121111 11110000
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ..+....... . ++.+++..||+.||.+||++.+|.+.|+++.
T Consensus 238 ~--~~~~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 A--TPIEVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp H--SCHHHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred c--CCHHHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 0000001111 1 5778889999999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=279.32 Aligned_cols=228 Identities=23% Similarity=0.303 Sum_probs=172.4
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 47899999999999999999864 588999999865443 3457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
+++|+|.+++.........+++.....++.++++||+|||+ |||+++.....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 180 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD- 180 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-
Confidence 99999999886543223458999999999999999999995 88888765432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......||+.|+|||.+. ..++.++|||||||++|||++|+.||..... ... ..............
T Consensus 181 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~-~~~~~~~~~~~~~~--- 247 (285)
T 3is5_A 181 -EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEV-QQKATYKEPNYAVE--- 247 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH-HHHHHHCCCCCCC----
T ss_pred -ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHH-HhhhccCCcccccc---
Confidence 2234467999999999875 4678999999999999999999999854221 111 11111111000000
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+ ....+.+++.+||+.||++|||+.||++
T Consensus 248 ~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1134667889999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=286.91 Aligned_cols=236 Identities=23% Similarity=0.391 Sum_probs=176.5
Q ss_pred cccccCcceeeeecccCcceEEEEEcCC-----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPD-----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
+....+|++.+.||+|+||.||+|.... +..||||.+..... .....|.+|++++++++|||||++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3455688999999999999999998642 23599999975432 33457999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++.... ..+++..+..++.++++||+|||+ |||+++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999997642 348899999999999999999996 8999887
Q ss_pred ccccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 309 ISACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 309 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+ ...+.....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~----~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEV----MKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH----HHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHH----HHHHHCCCc
Confidence 6432211 1223456788999999988889999999999999999999 9999853211 111 122211110
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
...+ . .....+.+++.+||+.||++||++.+|++.|++++
T Consensus 269 --~~~~---~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 --LPTP---M----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --CCCC---T----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCc---c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001 0 11235678899999999999999999999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.95 Aligned_cols=226 Identities=20% Similarity=0.281 Sum_probs=162.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|++++++++|||||++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457899999999999999999875 47899999987543 345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
+++|+|.+++... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999999998653 348899999999999999999995 88888765432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+...... ...+
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~-~~~~-- 273 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYY-FISP-- 273 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCC-CCTT--
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCc-cCCc--
Confidence 2233467999999999999889999999999999999999999998543211 1112222211110 1111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
........+.+++.+||+.||++|||+.|+++
T Consensus 274 ---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 ---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112235678899999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=281.72 Aligned_cols=237 Identities=14% Similarity=0.154 Sum_probs=182.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+|+.++.++ +|+||+++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35789999999999999999985 568999999986433 234578899999999 89999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------ccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARLIS 310 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~~~ 310 (435)
|+ +|+|.+++.... ..+++..+..++.|+++||+|||+ |||+++...
T Consensus 87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 999999997642 248899999999999999999996 899887665
Q ss_pred ccCc------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 311 ACET------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 311 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
.... .......||+.|+|||...+..++.++|||||||++|||+||+.||....... .......+........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-cHHHHHHHHhhccCcc
Confidence 3322 12345679999999999998899999999999999999999999986432111 1111111111111110
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... ... .....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 242 ~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 242 LRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 000 000 11235678889999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=287.52 Aligned_cols=245 Identities=28% Similarity=0.433 Sum_probs=187.1
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEE
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLL 245 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~ 245 (435)
+...|..+..+|++.+.||+|+||.||+|++ .+++.||||.+..... ...+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445667778999999999999999999974 3467899999975433 3346799999999999 799999999
Q ss_pred EEEEeCC-eeEEEEecccCCCHHHHHHhhCCC------------CCCCCHHHHHHHHHHhhhccceeec-----------
Q 040641 246 GYCSFDE-EKLLVYEYMVNGSLDLWLRNATGS------------HEVLDRAKRYKIACSSARGLAFLHQ----------- 301 (435)
Q Consensus 246 g~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~----------- 301 (435)
+++...+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9997755 489999999999999999764321 1237889999999999999999996
Q ss_pred -------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccc
Q 040641 302 -------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQE 366 (435)
Q Consensus 302 -------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~ 366 (435)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 8999986543322 22334568899999999888889999999999999999999 88887542211
Q ss_pred ccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 367 KEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+ ...+....... .+ .. ....+.+++.+||+.||++|||+.||++.|++++
T Consensus 258 ---~~~----~~~~~~~~~~~--~~---~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 258 ---EEF----CRRLKEGTRMR--AP---DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ---HHH----HHHHHHTCCCC--CC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHH----HHHhccCccCC--CC---CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11121111100 01 11 1135678889999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=295.97 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=184.6
Q ss_pred cccCcceeeeecccCcceEEEEEc-----CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEE--eCCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS--FDEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~ 253 (435)
...+|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. ....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 346899999999999999999984 357899999998766556678999999999999999999999987 4566
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+++|+|.+++.... ..+++..+..++.+++.||+|||+ |||+++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 899999999999999997643 248999999999999999999996 99999876
Q ss_pred cccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-------cCCcHHHHHHHHh
Q 040641 310 SACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-------EGANLVGWVFQKM 380 (435)
Q Consensus 310 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-------~~~~~~~~~~~~~ 380 (435)
..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43222 12234568889999999888888999999999999999999999975322110 0001111111111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
...... +........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 258 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEGQRL---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111100 011112235678899999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=281.17 Aligned_cols=234 Identities=21% Similarity=0.321 Sum_probs=180.7
Q ss_pred ccccCcceee-eecccCcceEEEEEcC---CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVD-ILEDGGFGTVYKATLP---DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
....++.+.+ .||+|+||.||+|.+. +++.||||.++... ....+.+.+|++++++++||||+++++++ ..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4456677776 9999999999999853 57789999997643 23456799999999999999999999999 55678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... ...+++.....++.++++||.|||+ |||+++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999998643 2358899999999999999999996 899998764
Q ss_pred ccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... ......||+.|+|||...+..++.++|||||||++|||+| |+.||..... ..+.. .+......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~----~i~~~~~~- 232 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMA----FIEQGKRM- 232 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHH----HHHTTCCC-
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHHH----HHhcCCcC-
Confidence 33221 1223457899999999887889999999999999999999 9999854221 11221 11111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... .....+.+++.+||+.||++||++.++++.|+++.
T Consensus 233 ----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 233 ----ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ----CCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111 11235678889999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=282.75 Aligned_cols=242 Identities=25% Similarity=0.367 Sum_probs=186.3
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYC 248 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 248 (435)
..|+....+|++.+.||+|+||.||+|+.. +++.||||.+..... .....|.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345666788999999999999999999754 367899999975432 3345799999999999999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhC------CCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNAT------GSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
...+..++||||+++|+|.+++.... .....+++...+.++.+++.||+|||+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999987532 112346889999999999999999996
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++....... .......||+.|+|||+..+..++.++|||||||++|||+| |+.||..... ...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~---- 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQV---- 249 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----HHH----
Confidence 8999886543322 12233467889999999888889999999999999999999 7888743211 111
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
...+........ .. .....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 250 ~~~~~~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFVMEGGLLDK-----PD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHTTCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHcCCcCCC-----CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 111211111100 01 11234678889999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=288.30 Aligned_cols=233 Identities=21% Similarity=0.195 Sum_probs=172.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|||||++++++...+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 457999999999999999999864 58899999986432 334568999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCC------------------------------------CCCCCCHHHHHHHHHHhhhcccee
Q 040641 256 LVYEYMVNGSLDLWLRNATG------------------------------------SHEVLDRAKRYKIACSSARGLAFL 299 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~gl~yL 299 (435)
+||||+++|+|.+++..... ....+++.....++.|+++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998852110 011235566778999999999999
Q ss_pred ec--------------------------cccccccccccCc---cccccccccCCCcCCcCCCC--CCCCCcccchhHHH
Q 040641 300 HQ--------------------------DFGLARLISACET---HVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGV 348 (435)
Q Consensus 300 H~--------------------------DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGv 348 (435)
|+ |||+++....... .......||+.|+|||.+.+ ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 95 8999876543211 12345679999999998765 67899999999999
Q ss_pred HHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 349 ILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 349 il~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
++|||+||+.||..... .............. ..+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 265 il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVND-------ADTISQVLNKKLCF--ENPNY-----NVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCT--TSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCCh-------HHHHHHHHhccccc--CCccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999854321 11112222211110 01110 011235678889999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=289.72 Aligned_cols=226 Identities=20% Similarity=0.309 Sum_probs=171.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE------- 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------- 253 (435)
.+|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++|||||+++++|...+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46889999999999999999975 689999999965433 345679999999999999999999999866442
Q ss_pred --------------------------------------------------eEEEEecccCCCHHHHHHhhCCCCCCCCHH
Q 040641 254 --------------------------------------------------KLLVYEYMVNGSLDLWLRNATGSHEVLDRA 283 (435)
Q Consensus 254 --------------------------------------------------~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~ 283 (435)
.++|||||++|+|.+++.... ......+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 799999999999999998643 23446777
Q ss_pred HHHHHHHHhhhccceeec------------------------cccccccccccCc-----------cccccccccCCCcC
Q 040641 284 KRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-----------HVSTDIAGTLGYIP 328 (435)
Q Consensus 284 ~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-----------~~~~~~~gt~~y~a 328 (435)
....++.|++.||+|||+ |||+++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 788999999999999996 9999987654321 12234579999999
Q ss_pred CcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHH
Q 040641 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRI 408 (435)
Q Consensus 329 PE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 408 (435)
||.+.+..++.++|||||||++|||++|..|+.. ... ............ ........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVR-IITDVRNLKFPL---------LFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHH-HHHHHHTTCCCH---------HHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHH-HHHHhhccCCCc---------ccccCChhHHHH
Confidence 9999888999999999999999999998766311 000 111111111110 011223356788
Q ss_pred HhcccCCCCCCCCCHHHHHH
Q 040641 409 AADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 409 ~~~C~~~~P~~RPs~~evl~ 428 (435)
+.+||+.||++|||+.|+++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.88 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=185.6
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC------CCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.+..+..+|++.+.||+|+||.||+|.... .+.||+|.+..... ...+.+.+|+++++++ +|||||+++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456677899999999999999999998642 24799999975432 3456799999999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC----------CCCCCCHHHHHHHHHHhhhccceeec-----------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG----------SHEVLDRAKRYKIACSSARGLAFLHQ----------------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~----------------- 301 (435)
...+..++||||+++|+|.+++..... ....+++.....++.+++.||+|||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 999999999999999999999875421 12347889999999999999999996
Q ss_pred -------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcH
Q 040641 302 -------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANL 372 (435)
Q Consensus 302 -------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~ 372 (435)
|||+++....... .......||+.|+|||...+..++.++|||||||++|||+| |..||...... ..+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~ 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---SKF 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---HHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---HHH
Confidence 9999986543322 22334567889999999888889999999999999999999 88887543211 111
Q ss_pred HHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 373 VGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ........ ...+. .. ...+.+++.+||+.||++|||+.||++.|+++.
T Consensus 277 ~----~~~~~~~~--~~~~~---~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 Y----KLVKDGYQ--MAQPA---FA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H----HHHHHTCC--CCCCT---TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHhcCCC--CCCCC---CC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1 11111100 00111 11 135678899999999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=288.91 Aligned_cols=228 Identities=23% Similarity=0.323 Sum_probs=173.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.+++.++|||||++++++..++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999865 689999999864332 233568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-c
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-T 314 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-~ 314 (435)
|+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++...... .
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999998887543 348899999999999999999996 999998654322 1
Q ss_pred cccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||...... ...... ...... ...+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~-----~~~~~~--~~~~-- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSD-----WKEKKT--YLNP-- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHH-----HHTTCT--TSTT--
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHH-----Hhcccc--cCCc--
Confidence 22345689999999999877665 77899999999999999999998643221 011111 111100 0011
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0111234668889999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.09 Aligned_cols=231 Identities=24% Similarity=0.338 Sum_probs=174.1
Q ss_pred ccCcceee-eecccCcceEEEEEcC---CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVD-ILEDGGFGTVYKATLP---DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
...+.+.+ .||+|+||.||+|.+. .++.||||+++.... ...++|.+|+++|++++|||||+++++|. .+..+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~ 445 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWM 445 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEE
Confidence 33444443 7999999999999653 467899999975432 33578999999999999999999999996 45688
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.+++... ..+++..+..++.|++.||+|||+ |||+++.+..
T Consensus 446 lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999999999999753 248899999999999999999996 9999987654
Q ss_pred cCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... ...+...||+.|+|||++....++.++|||||||++|||+| |+.||..... ..+ ...+........
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~----~~~i~~~~~~~~ 593 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV----TAMLEKGERMGC 593 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH----HHHHHTTCCCCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHH----HHHHHcCCCCCC
Confidence 322 22233457889999999988899999999999999999999 9999854321 111 222222111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
| . .+...+.+++..||+.||++||++.+|++.|+++.
T Consensus 594 --p---~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 --P---A----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp --C---T----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --C---C----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1 12235778999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=285.94 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=183.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-----CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC--e
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-----PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE--E 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~ 253 (435)
...+|++.+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346789999999999999999984 358899999997765556678999999999999999999999987644 6
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 899999999999999997642 348899999999999999999996 89999876
Q ss_pred cccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccc--------ccCCcHHHHHHHH
Q 040641 310 SACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQE--------KEGANLVGWVFQK 379 (435)
Q Consensus 310 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~--------~~~~~~~~~~~~~ 379 (435)
...... ......+|..|+|||...+..++.++|||||||++|||+||+.|+...... .........+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 543221 123345778899999988888899999999999999999999887532100 0000011111111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+...... ... ......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 276 ~~~~~~~-----~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRL-----PRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCC-----CCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCC-----CCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111100 000 112235778899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.21 Aligned_cols=238 Identities=24% Similarity=0.344 Sum_probs=179.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-----CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--Cee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-----DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD--EEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 254 (435)
+.|++.+.||+|+||.||++.+. +++.||||++..... ...+.|.+|++++++++||||+++++++... ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 34589999999999999998653 578899999975432 3456799999999999999999999999874 578
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+++|+|.+++... .+++.....++.+++.||+|||+ |||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999999753 28899999999999999999996 999998765
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-------cCCcHHHHHHHHhc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-------EGANLVGWVFQKMK 381 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~ 381 (435)
.... .......||..|+|||.+.+..++.++|||||||++|||+||+.||....... ............+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4322 12334568889999999888888999999999999999999999975421100 00000001111111
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... + +........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 266 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGER-----L----PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccC-----C----CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1110 0 001112235778899999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.06 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=174.1
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCS 249 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 249 (435)
..+.....+|.+.+.||+|+||.||+|... +++.||||.++... ....+.|.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556678999999999999999999753 34589999987543 233467999999999999999999999998
Q ss_pred eCCe-----eEEEEecccCCCHHHHHHhhC--CCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 250 FDEE-----KLLVYEYMVNGSLDLWLRNAT--GSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 250 ~~~~-----~~lv~ey~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
..+. .++||||+++|+|.+++.... .....+++...+.++.++++||.|||+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 7553 499999999999999986432 223468999999999999999999996
Q ss_pred ---cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHH
Q 040641 302 ---DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++....... .......+|+.|+|||...+..++.++||||||+++|||+| |..||..... ......+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~ 262 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----HEMYDYL 262 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHH
Confidence 8999876543221 12233467889999999988899999999999999999999 7778753221 1222221
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. .... .... .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 263 ~~----~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 LH----GHRL-----KQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HT----TCCC-----CCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc----CCCC-----CCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1100 0001 11235678889999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=278.89 Aligned_cols=238 Identities=24% Similarity=0.295 Sum_probs=174.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|||||++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999865 588999999865432 234678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++ ++..++... ...+++.....++.|++.||+|||+ |||+++..... ..
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9986 555555432 2348899999999999999999996 99999876432 22
Q ss_pred ccccccccCCCcCCcCCCCCC-CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc---c--
Q 040641 316 VSTDIAGTLGYIPPEYGQSRM-STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV---L-- 389 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 389 (435)
......||+.|+|||++.+.. ++.++|||||||++|||+||+.|+..... .......+............ .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCCChhhhhhhccc
Confidence 334567899999999887654 89999999999999999999988643221 11222222222211111000 0
Q ss_pred -c----c-----cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 -D----P-----TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 -~----~-----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ + .............+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 0000000112235668889999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.34 Aligned_cols=231 Identities=19% Similarity=0.201 Sum_probs=178.1
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.....+|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++|||||+++++|.+.+..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345678999999999999999999875 58899999986532 22334588999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.++++.. .+++.....++.+++.||+|||+ |||+++...
T Consensus 145 ~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999999998753 37888899999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCCCCC----CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRM----STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..........+||+.|+|||++.... ++.++|||||||++|||+||+.||..... ......+........
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~-- 293 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKNSLT-- 293 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHHHCC--
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhHHHHHHhcccccc--
Confidence 44333344678999999999876654 78999999999999999999999864321 111111111100000
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPAT--RPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 428 (435)
. |.. .. ....+.+++.+|+..+|.+ ||++.||++
T Consensus 294 -~--p~~--~~---~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 294 -F--PDD--ND---ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -C--CTT--CC---CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -C--CCc--cc---ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 100 00 1124667888999999988 999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.95 Aligned_cols=232 Identities=23% Similarity=0.348 Sum_probs=169.1
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe----
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE---- 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 253 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+..... .....|.+|++++++++|||||++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35799999999999999999985 5688999999975432 234578999999999999999999999876554
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+++|+|.++++... .+++.....++.|++.||+|||+ |||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 399999999999999997642 48899999999999999999996 99999866
Q ss_pred cccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 310 SACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 310 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~- 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPIP- 238 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCC-
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCCC-
Confidence 43221 12234579999999999988899999999999999999999999985432 112222222221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH-HHHh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL-KLLH 431 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl-~~L~ 431 (435)
+...... ....+.+++.+||+.||++||++.+++ ..+.
T Consensus 239 ---~~~~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 239 ---PSARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp ---HHHHSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---cccccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 1000011 123567888999999999999776655 4443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=291.57 Aligned_cols=240 Identities=14% Similarity=0.146 Sum_probs=173.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccccc-----------cHHHHHHHHHHhccCCCCCceeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAKTQ-----------GHRQFTAEMETLGKVKHQNLVLLLG 246 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 246 (435)
..+|.+.+.||+|+||.||+|+.. ++..||||.+...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 457999999999999999999875 5678999998654321 1235778999999999999999999
Q ss_pred EEEe----CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 247 YCSF----DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 247 ~~~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
++.. ....++||||+ +|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 9988 67889999999 999999987542 58999999999999999999996
Q ss_pred -----cccccccccccCc------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 302 -----DFGLARLISACET------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 -----DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
|||+++.+..... .......||+.|+|||+..+..++.++|||||||++|||+||+.||.......
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--- 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--- 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH---
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc---
Confidence 8999977643221 11244679999999999988889999999999999999999999985322111
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
.............. .......... ......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 268 ~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLDEL-PQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHHTT-THHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhcccc-cHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111111111111 1100000000 01123577888999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.61 Aligned_cols=234 Identities=20% Similarity=0.217 Sum_probs=179.0
Q ss_pred cccccCcceeeeecccCcceEEEEEcCC-CCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.....+|++.++||+|+||.||+|+..+ ++.||||+++.... .....+.+|..++..++|||||+++++|.+.+..
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3456789999999999999999999764 78999999965321 2233488999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.+++.... ..+++.....++.+++.||+|||+ |||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 99999999999999997632 348899999999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
..........+||+.|||||++. ...++.++|||||||++|||+||+.||..... ......+.........
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKERFQF 302 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHHHCCC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhhccccccC
Confidence 54444445578999999999875 56789999999999999999999999864321 1111111111111110
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPAT--RPTMLHVLK 428 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 428 (435)
|..... ....+.+++.+|+..+|++ ||++.|+++
T Consensus 303 -----p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 -----PTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -----CSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -----Cccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111011 1124567788888888887 999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=281.83 Aligned_cols=225 Identities=23% Similarity=0.296 Sum_probs=168.4
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--------------------------ccHHHHHHHHHHhc
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--------------------------QGHRQFTAEMETLG 234 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 234 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 457999999999999999999864 588999999864321 11246889999999
Q ss_pred cCCCCCceeEEEEEEe--CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------
Q 040641 235 KVKHQNLVLLLGYCSF--DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------- 301 (435)
Q Consensus 235 ~l~H~niv~l~g~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------- 301 (435)
+++|||||++++++.. .+..++||||+++|+|.+++. ...+++.....++.|+++||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999999986 567899999999999876543 2358999999999999999999996
Q ss_pred -------------cccccccccccCccccccccccCCCcCCcCCCCCC---CCCcccchhHHHHHHHHHhCCCCCCCCcc
Q 040641 302 -------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM---STTRGDVYSFGVILLELVTAKEPTGPEFQ 365 (435)
Q Consensus 302 -------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~SfGvil~El~tg~~p~~~~~~ 365 (435)
|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 999998765432 2234567999999999987654 4788999999999999999999985421
Q ss_pred cccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 366 EKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ...+...... ..+. +. ....+.+++.+||+.||++|||+.|+++
T Consensus 245 ------~~~~-~~~~~~~~~~-~~~~----~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ------IMCL-HSKIKSQALE-FPDQ----PD---IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHH-HHHHHHCCCC-CCSS----SC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHH-HHHHhcccCC-CCCc----cc---cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111 1112111111 0000 01 1135678889999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=287.65 Aligned_cols=228 Identities=18% Similarity=0.294 Sum_probs=174.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|..++.++ +|||||++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999865 578999999975432 2334578899999876 8999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|..++.... .+++.....++.+++.||+|||+ |||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999987642 48899999999999999999996 9999986332
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCccccc-CCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE-GANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+...+...... -
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~ 281 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---I 281 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC---C
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC---C
Confidence 2 2234457899999999999999999999999999999999999999953221111 111122223332222111 1
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
|. . ....+.+++.+||+.||++||++
T Consensus 282 p~---~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 PR---S----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CT---T----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CC---c----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 1 12246688899999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.37 Aligned_cols=237 Identities=28% Similarity=0.415 Sum_probs=173.5
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhcc--CCCCCceeEEEEEEeC----CeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK--VKHQNLVLLLGYCSFD----EEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 255 (435)
..+|++.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++.. ++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 457999999999999999999875 8899999985432 2345555555554 4999999999999887 7789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee----------c----------------------cc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH----------Q----------------------DF 303 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH----------~----------------------Df 303 (435)
+||||+++|+|.++++.. .+++.....++.+++.||+||| . ||
T Consensus 112 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999753 3889999999999999999998 2 89
Q ss_pred cccccccccCccc---cccccccCCCcCCcCCCCCCCCCc------ccchhHHHHHHHHHhC----------CCCCCCCc
Q 040641 304 GLARLISACETHV---STDIAGTLGYIPPEYGQSRMSTTR------GDVYSFGVILLELVTA----------KEPTGPEF 364 (435)
Q Consensus 304 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~DV~SfGvil~El~tg----------~~p~~~~~ 364 (435)
|+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9987654322211 124579999999999877766655 9999999999999999 55554322
Q ss_pred ccccCCcHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... .. ............ .+.... .....+...+.+++.+||+.||++|||+.||++.|+++.
T Consensus 267 ~~~~--~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 267 PSDP--SY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CSSC--CH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC--ch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 2111 11 111111111111 111110 111245667889999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=273.75 Aligned_cols=225 Identities=21% Similarity=0.254 Sum_probs=176.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
.+|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 46899999999999999999865 47799999997766666788999999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccCc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACET 314 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~~ 314 (435)
++|+|.+++.... .+++.....++.+++.||+|||+ |||+++......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 89 TGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999887642 47899999999999999999995 888887654322
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......||+.|+|||...+. ++.++||||||+++|||+||+.||..... .. ....+...... .+...
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~~---~~~~~ 230 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SE-VMLKIREGTFT---FPEKD 230 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCCCC---CCHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHhCCCC---CCchh
Confidence 22345799999999988654 89999999999999999999999854321 11 11111111110 00000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. .....+.+++.+||+.||++|||+.++++
T Consensus 231 ~~---~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL---NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 01235678889999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=284.95 Aligned_cols=226 Identities=21% Similarity=0.249 Sum_probs=156.1
Q ss_pred eeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEecccCCC
Q 040641 188 VDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYMVNGS 265 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~g~ 265 (435)
.+.||+|+||.||+|+.. +++.||||.+... ....+.+|+.+++++. |||||++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999875 5899999998643 3456789999999997 9999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccCccccc
Q 040641 266 LDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 266 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~~~~~~ 318 (435)
|.+++... ..+++.....++.+++.||+|||+ |||+++...... ....
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 99999764 348999999999999999999995 899987654322 2234
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ....+...... ..+ ...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~--~~~----~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFS--FEG----EAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCC--CCS----HHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCC--CCc----ccc
Confidence 56789999999999999999999999999999999999999865432222222222 22222222111 000 000
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112235678899999999999999998863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=284.28 Aligned_cols=226 Identities=20% Similarity=0.295 Sum_probs=176.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++|||||++++++...+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999865 58899999986532 3345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|..++... ..+++.....++.+++.||.|||+ |||+++.+...
T Consensus 93 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999753 348889999999999999999996 99999876432
Q ss_pred CccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
......+||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ..... .......... .
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~-~~~~~~~~~~---~ 238 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKE-IVHTFETTVV---T 238 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHH-HHHHHHHCCC---C
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHH-HHHHHhhccc---C
Confidence 23345789999999998864 4589999999999999999999999864321 11111 1111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPT-MLHVL 427 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl 427 (435)
.|. .....+.+++.+||+.||++||+ +.+|.
T Consensus 239 ~p~-------~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 239 YPS-------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCT-------TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCC-------cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 011 11235678889999999999998 66665
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=286.58 Aligned_cols=232 Identities=24% Similarity=0.389 Sum_probs=175.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCE----EEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKT----VAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++|||||+++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457899999999999999999864 3443 7888875432 233456788999999999999999999986 56789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++... ...+++.....++.|+++||+|||+ |||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999998753 2357888999999999999999996 9999987654
Q ss_pred cCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 312 CET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 312 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ...+...+ .... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~----~~~~--~~~ 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LAEVPDLL----EKGE--RLA 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----TTHHHHHH----HTTC--BCC
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC----HHHHHHHH----HcCC--CCC
Confidence 322 22345678889999999988889999999999999999999 999985432 11222221 1111 111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+.... ..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 238 ~~~~~~-------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 QPQICT-------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCTTBC-------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcCc-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 13567888999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=277.66 Aligned_cols=221 Identities=20% Similarity=0.309 Sum_probs=176.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+.. +|+.||+|.++... ....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 457899999999999999999865 68999999996532 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++... ..+++.....++.+++.||+|||+ |||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999999764 247888999999999999999996 9999986543
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...+..... .-|..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~-~~~i~~~~~---~~p~~ 225 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKT-YEKILNAEL---RFPPF 225 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH-HHHHHHCCC---CCCTT
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHH-HHHHHhCCC---CCCCC
Confidence 12346899999999999999999999999999999999999999854321 111 111111111 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+|++.||++|| ++.||++
T Consensus 226 -------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 -------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112466788899999999999 8888863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.65 Aligned_cols=183 Identities=18% Similarity=0.210 Sum_probs=152.6
Q ss_pred ccccccCcceeeeeccc--CcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 178 FQQPLLKLTLVDILEDG--GFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
+.....+|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++..++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34455789999999999 99999999875 68999999996543 233467888999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++|||||++|+|.+++.... ...+++.....++.|++.||+|||+ |||.+..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999997642 2348899999999999999999996 8888764
Q ss_pred ccccCc------cccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 309 ISACET------HVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 309 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 422111 11123478999999998877 6799999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=284.46 Aligned_cols=224 Identities=25% Similarity=0.370 Sum_probs=173.7
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+...|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++..++..+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 3445688999999999999999985 568899999986432 223467899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||++ |+|.+++.... ..+++..+..++.++++||+|||+ |||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9999997 67887776432 348899999999999999999996 8999876543
Q ss_pred cCccccccccccCCCcCCcCC---CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHVSTDIAGTLGYIPPEYG---QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
. ....||+.|+|||++ ....++.++|||||||++|||+||+.||.... ............ .
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~-~--- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE-S--- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSC-C---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-C---
Confidence 2 345799999999986 35678999999999999999999999985321 112222222111 1
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+....... ...+.+++.+||+.||++|||+.++++
T Consensus 271 --~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 --PALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111111 124567888999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=283.93 Aligned_cols=237 Identities=27% Similarity=0.386 Sum_probs=179.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhcc--CCCCCceeEEEEEEeCC----eeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGK--VKHQNLVLLLGYCSFDE----EKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~ 255 (435)
..+|++.+.||+|+||.||+|+. +++.||||.+... ....+.+|++++.. ++||||+++++++.... ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 35789999999999999999998 4899999998643 34567888888876 79999999999998876 789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee--------c------------------------cc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH--------Q------------------------DF 303 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~------------------------Df 303 (435)
+||||+++|+|.+++... .+++..+..++.+++.||+||| + ||
T Consensus 117 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999753 3889999999999999999999 4 89
Q ss_pred cccccccccCcc---ccccccccCCCcCCcCCCCC------CCCCcccchhHHHHHHHHHhC----------CCCCCCCc
Q 040641 304 GLARLISACETH---VSTDIAGTLGYIPPEYGQSR------MSTTRGDVYSFGVILLELVTA----------KEPTGPEF 364 (435)
Q Consensus 304 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~SfGvil~El~tg----------~~p~~~~~ 364 (435)
|+++........ ......||+.|+|||.+.+. .++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998776543221 22345799999999987765 234689999999999999999 66765432
Q ss_pred ccccCCcHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... .....+ ...+.... ..+.... .........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 272 ~~~--~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 272 PSD--PSVEEM-RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CSS--CCHHHH-HHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCc--ccHHHH-HHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 211 111111 22221111 1111111 012345567888999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=279.47 Aligned_cols=234 Identities=28% Similarity=0.425 Sum_probs=175.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCC----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 255 (435)
...|++.+.||+|+||.||+|+..+ ...||||.+..... ...+.+.+|+.++++++||||++++++|.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568899999999999999998643 23589999875433 345679999999999999999999999754 56789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.++++... ..+++.....++.++++||+|||+ |||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999997532 347888999999999999999996 9999986543
Q ss_pred cCc---cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CET---HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... .......||+.|+|||...+..++.++||||||+++|||+||+.|+.... ............. ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~------~~ 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGR------RL 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS---CTTTHHHHHHTTC------CC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC---CHHHHHHHHhcCC------CC
Confidence 221 22334567889999999988889999999999999999999655543222 1222222211111 01
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+.. ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 252 ~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 252 LQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1125678889999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=284.92 Aligned_cols=239 Identities=25% Similarity=0.365 Sum_probs=179.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
+....+|++.+.||+|+||.||+|++. +++.||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 345678999999999999999999842 46789999996432 33456799999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCC---CCCCCHHHHHHHHHHhhhccceeec---------------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGS---HEVLDRAKRYKIACSSARGLAFLHQ--------------------------- 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------- 301 (435)
+..++||||+++|+|.+++...... ...+++...+.++.+++.||.|||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999999865321 2458899999999999999999995
Q ss_pred cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHH
Q 040641 302 DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 302 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~----~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVL----EF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHH----HH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----HHHH----HH
Confidence 7887765432221 12233567899999999888889999999999999999999 8888753211 1111 11
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+....... .... ....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 258 ~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGGRMD-----PPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCC-----CCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111100 0011 1235678889999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.98 Aligned_cols=220 Identities=23% Similarity=0.250 Sum_probs=167.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +|||||+++++|..++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999876 689999999864322 2334556666666555 9999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+ +|+|.+++.... ..+++..+..++.+++.||+|||+ |||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 999 779998887653 358999999999999999999995 99998765432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......||++|+|||++.+ .++.++|||||||++|||++|..|+.... . ...+...... +...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------~----~~~~~~~~~~----~~~~ 274 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------G----WQQLRQGYLP----PEFT 274 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------H----HHHHTTTCCC----HHHH
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------H----HHHHhccCCC----cccc
Confidence 22334579999999998876 68999999999999999999987753210 0 1112111111 1111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 275 ~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 1235678889999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=277.94 Aligned_cols=233 Identities=26% Similarity=0.363 Sum_probs=177.8
Q ss_pred cCcceeeeecccCcceEEEEEcCC-C---CEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee-EE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPD-G---KTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK-LL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~l 256 (435)
..|...+.||+|+||.||+|++.+ + ..||+|.+..... ...+.|.+|++++++++|||||++++++...+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 345677999999999999998532 2 3799999875433 3456799999999999999999999999876655 99
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+.+|+|.+++... ...+++..+..++.+++.||+|||+ |||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999999763 2347888999999999999999996 99999765432
Q ss_pred C---ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 313 E---THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 313 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
. ........||+.|+|||...+..++.++|||||||++|||+||+.|+..... .......+.. ... ..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~----~~~--~~ 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---PFDLTHFLAQ----GRR--LP 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---GGGHHHHHHT----TCC--CC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC---HHHHHHHhhc----CCC--CC
Confidence 2 1122345688999999999998999999999999999999997776543222 2222222211 110 00
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+. .....+.+++.+||+.||++|||+.++++.|++++
T Consensus 249 ~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 249 QPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp CCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc-------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 11135678889999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=286.32 Aligned_cols=225 Identities=23% Similarity=0.355 Sum_probs=172.5
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc---ccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA---KTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++..+ +|||||++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467999999999999999999865 5899999999753 233456788999999988 7999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|..++.... .+++.....++.+++.||+|||+ |||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999997643 48899999999999999999996 9999975432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ..+ ...+..... .-|
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~----~~~i~~~~~---~~p 244 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDL----FEAILNDEV---VYP 244 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCC---CCC
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----HHH----HHHHHcCCC---CCC
Confidence 2 2233456899999999999888899999999999999999999999864321 111 222221111 111
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCH------HHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTM------LHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~------~evl~ 428 (435)
.. ....+.+++.+||+.||++||++ .||++
T Consensus 245 ~~-------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TW-------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TT-------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC-------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 11246678889999999999998 66653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=281.22 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=164.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|... +++.||||.++.... ...+.+.+|++++++++|||||++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 57889999999999999999865 588999999865432 3346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhC--CCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNAT--GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
++ |+|.+++.... .....+++.....++.|+++||+|||+ |||+++......
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 162 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV- 162 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-
Confidence 98 69999887542 122358889999999999999999996 999998754321
Q ss_pred cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC---cc--
Q 040641 315 HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---DV-- 388 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 388 (435)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+.......... ..
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhHhhhhhh
Confidence 22334678999999998865 4689999999999999999999999864322 11222222221111000 00
Q ss_pred ---ccccc---cCCCC---------HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 ---LDPTV---LNAGS---------KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ---~~~~~---~~~~~---------~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00000 011235778899999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.18 Aligned_cols=228 Identities=21% Similarity=0.323 Sum_probs=171.3
Q ss_pred cccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCC--CCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKH--QNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|...+++.||||++.... ....+.|.+|++++.+++| ||||++++++..++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 345789999999999999999998889999999986433 2334678999999999987 999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccccC
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACE 313 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~~~ 313 (435)
||| +.+|+|.+++... ..+++..+..++.|+++||+|||+ |||+++......
T Consensus 87 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC----
T ss_pred EEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCccc
Confidence 999 5688999999764 248889999999999999999996 999998765432
Q ss_pred c-cccccccccCCCcCCcCCCC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 314 T-HVSTDIAGTLGYIPPEYGQS-----------RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 314 ~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
. ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ..........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~ 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHhc
Confidence 2 12345689999999998643 6789999999999999999999999854221 1111222221
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... .+. .. ...+.+++..||+.||++|||+.|+++
T Consensus 236 ~~~~~~--~~~---~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 236 PNHEIE--FPD---IP----EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp TTSCCC--CCC---CS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcccC--Ccc---cC----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111100 011 11 124668889999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=288.48 Aligned_cols=227 Identities=20% Similarity=0.325 Sum_probs=172.2
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCC--CCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVK--HQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv 257 (435)
...|++.+.||+|+||.||+|...+++.||||.+.... ....+.+.+|++++++++ |||||++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 34699999999999999999998889999999986433 234567999999999996 59999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccccCc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISACET 314 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~~~~ 314 (435)
|| +.+|+|.+++.... .+++..+..++.|++.||+|||+ |||+++.......
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-----
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCc
Confidence 99 57899999997642 47888899999999999999996 9999987653322
Q ss_pred -cccccccccCCCcCCcCCCC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 315 -HVSTDIAGTLGYIPPEYGQS-----------RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 315 -~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~~~ 283 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDP 283 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHCT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHhCc
Confidence 22345689999999998754 4688999999999999999999999854221 11112222211
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... .|.. . ...+.+++.+||+.||++|||+.||++
T Consensus 284 ~~~~~--~~~~---~----~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 284 NHEIE--FPDI---P----EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TSCCC--CCCC---S----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCC--CCcc---c----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11000 0111 1 124678889999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=280.07 Aligned_cols=225 Identities=24% Similarity=0.323 Sum_probs=167.4
Q ss_pred cccCcceeeeecccCcceEEEEEc----CCCCEEEEEEccccc----cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
...+|++.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.++++++|||||++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346899999999999999999986 468999999997542 223456889999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+ |||+++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999997642 47888899999999999999996 8999875
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+......
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~----~~i~~~~~~-- 239 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----KKTI----DKILKCKLN-- 239 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH----HHHHHTCCC--
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----HHHH----HHHHhCCCC--
Confidence 43221 223456799999999999888899999999999999999999999854321 1111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
. |. . ....+.+++.+||+.||++|| ++.|+++
T Consensus 240 ~-p~----~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 L-PP----Y---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C-CT----T---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C-CC----C---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 11 0 113567788999999999999 7777764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.18 Aligned_cols=225 Identities=23% Similarity=0.383 Sum_probs=156.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45789999999999999999986 468999999986432 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++... ...+++.....++.|+++||+|||+ |||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999753 2358899999999999999999996 899887654221
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......||+.|+|||...+..++.++||||||+++|||+||+.||...... ... .... ..+...|.
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~----~~~~---~~~~~~~~- 233 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----NTL----NKVV---LADYEMPS- 233 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC---SSCCCCCT-
T ss_pred -CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----HHH----HHHh---hcccCCcc-
Confidence 1223457999999999998888999999999999999999999998643211 110 0010 01111111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.++++
T Consensus 234 --~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 --F----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --T----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --c----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 1235678899999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.38 Aligned_cols=227 Identities=19% Similarity=0.296 Sum_probs=174.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 256 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|..++.++ +|||||++++++...+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457899999999999999999865 588999999975432 2345688999999887 89999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|..++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999997642 48889999999999999999996 99999764322
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC-CcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG-ANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+...+...... -|
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p 239 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IP 239 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC---CC
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC---CC
Confidence 12234568999999999999999999999999999999999999998542111110 11112222222222111 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
. . ....+.+++.+||+.||++||++
T Consensus 240 ~---~----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 R---S----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp T---T----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C---C----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 1 12346678889999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=278.10 Aligned_cols=234 Identities=24% Similarity=0.302 Sum_probs=177.9
Q ss_pred cccccCcceee-eecccCcceEEEEEc---CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 179 QQPLLKLTLVD-ILEDGGFGTVYKATL---PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 179 ~~~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
.....+|.+.+ .||+|+||.||+|.+ .+++.||||.++.... ...+.|.+|++++++++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34556788888 999999999999954 2467899999975432 2356799999999999999999999999 567
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++... ..+++.....++.++++||+|||+ |||+++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 789999999999999999763 248889999999999999999996 8999887
Q ss_pred ccccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 309 ISACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 309 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
....... ......||+.|+|||...+..++.++||||||+++|||+| |+.||..... ..+ ...+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~----~~~~~~~~~ 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV----TAMLEKGER 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH----HHHHHTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHH----HHHHHcCCC
Confidence 6443221 1223456789999999888888999999999999999999 9999854211 111 122221111
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. .... .....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 239 ~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 M-----GCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp C-----CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C-----CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 0111 11235678899999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=275.16 Aligned_cols=237 Identities=18% Similarity=0.225 Sum_probs=180.2
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEE-EeCCeeEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYC-SFDEEKLLVYE 259 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 259 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+..... ...+.+|+.++++++|+|++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35799999999999999999985 5689999999865332 34688999999999998877776666 56677899999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
|+ +|+|.+++.... ..+++..+..++.|++.||+|||+ |||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999997532 348999999999999999999995 89998876543
Q ss_pred Ccc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 313 ETH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 313 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
... ......||+.|+|||...+..++.++|||||||++|||+||+.||....... .......+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHHHHHHHHHHHSCH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-hhhhhhhhcccccCCch-
Confidence 221 1245679999999999999899999999999999999999999986532221 12222222111111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... ... ....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 240 ~~~----~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 EVL----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHH----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred HHH----Hhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 000 001 1135678899999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=283.84 Aligned_cols=224 Identities=21% Similarity=0.338 Sum_probs=176.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.+.||+|+||.||+|+.. +++.||||.++... ......+..|..++..+ +|||||++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3468999999999999999999875 58899999997542 23456788899999876 9999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... .+++.....++.|++.||+|||+ |||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999997642 48889999999999999999996 9999986432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+..... .-|
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~----~~~i~~~~~---~~p 238 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EEL----FHSIRMDNP---FYP 238 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCC---CCC
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHH----HHHHHhCCC---CCC
Confidence 21 223457899999999999998999999999999999999999999854321 111 122221111 011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTML-HVL 427 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 427 (435)
.. ....+.+++.+||+.||++||++. +|+
T Consensus 239 ~~-------~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 RW-------LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp TT-------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred cc-------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 113466788999999999999987 554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=278.16 Aligned_cols=222 Identities=25% Similarity=0.420 Sum_probs=176.4
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe-----------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----------- 250 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 250 (435)
.+|++.+.||+|+||.||+|+.. +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46889999999999999999875 68999999986533 356789999999999999999998854
Q ss_pred -----CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 251 -----DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 251 -----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
....++||||+++|+|.+++.... ...+++..+..++.++++||.|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 345799999999999999997643 2358899999999999999999996
Q ss_pred cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 302 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
|||+++...... ......||+.|+|||...+..++.++||||||+++|||+||..|+... ........
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~~~~ 232 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFTDLR 232 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHHHHH
T ss_pred cchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHHHhh
Confidence 899987765422 223457999999999998888999999999999999999999885311 01111222
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
....... . ...+.+++.+||+.||++|||+.|+++.|..+.
T Consensus 233 ~~~~~~~--------~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DGIISDI--------F----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TTCCCTT--------S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccccccc--------C----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 2111111 1 124567888999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=283.44 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=173.3
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHH--HHhccCCCCCceeEEEEEEe-----C
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEM--ETLGKVKHQNLVLLLGYCSF-----D 251 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~H~niv~l~g~~~~-----~ 251 (435)
.....+|++.+.||+|+||.||+|+. +++.||||++.... ...+..|. ..+..++||||+++++++.. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 34557899999999999999999987 57899999986433 23444444 44566899999999986643 2
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee-----------c-------------------
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH-----------Q------------------- 301 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-----------~------------------- 301 (435)
...++||||+++|+|.+++.... .++.....++.|+++||+||| .
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 35689999999999999997542 478889999999999999998 2
Q ss_pred ---cccccccccccC-------ccccccccccCCCcCCcCCCC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 040641 302 ---DFGLARLISACE-------THVSTDIAGTLGYIPPEYGQS-------RMSTTRGDVYSFGVILLELVTAKEPTGPEF 364 (435)
Q Consensus 302 ---DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~SfGvil~El~tg~~p~~~~~ 364 (435)
|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.|+.+..
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 899997654321 112234579999999998876 456778999999999999999988765432
Q ss_pred ccccCCcH----------HHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 365 QEKEGANL----------VGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 365 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
........ ................+.. ...........+.+++.+||+.||++|||+.||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21111100 0001111111111111111 11112335557889999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.85 Aligned_cols=223 Identities=23% Similarity=0.359 Sum_probs=177.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+++++.++|||||++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357899999999999999999865 68999999996542 22346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999999998643 348899999999999999999996 99999876532
Q ss_pred ccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ..+ ...+..... ..|.
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~----~~~i~~~~~---~~p~ 237 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTL----FKKICDGIF---YTPQ 237 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHH----HHHHHTTCC---CCCT
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHH----HHHHhcCCc---CCCc
Confidence 22345689999999999887765 6899999999999999999999864321 111 122221111 0111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.||++
T Consensus 238 ~-------~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 Y-------LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp T-------CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-------CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 1124677889999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=278.01 Aligned_cols=226 Identities=20% Similarity=0.253 Sum_probs=176.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc------cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ------GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46899999999999999999865 5889999998653321 3567999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLAR 307 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~ 307 (435)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999753 347889999999999999999995 788877
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... .......||+.|+|||...+..++.++|||||||++|||+||+.||..... ... ...+.....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~-~~~i~~~~~-- 235 (321)
T 2a2a_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QET-LANITSVSY-- 235 (321)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHH-HHHHHTTCC--
T ss_pred ecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHH-HHHHHhccc--
Confidence 65432 122345799999999999888999999999999999999999999854321 111 111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111111 124678899999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=277.61 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=172.9
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+..+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34568999999999999999999975 58899999997666666788999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
||+++|+|.+++.... ..+++.....++.++++||.|||+ |||++...... .
T Consensus 96 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred EeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 9999999999987642 348899999999999999999996 78876543211 1
Q ss_pred cccccccccCCCcCCcCC-----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 315 HVSTDIAGTLGYIPPEYG-----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.......||+.|+|||+. ....++.++||||||+++|||+||+.||..... ......... .......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~ 243 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAK-SDPPTLL 243 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-SCCCCCS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhc-cCCcccC
Confidence 112335789999999986 467789999999999999999999999854211 111111111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+. .....+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPS-------KWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGG-------GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Ccc-------ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 11235678889999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=292.07 Aligned_cols=233 Identities=19% Similarity=0.172 Sum_probs=177.7
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.....+|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|..++..++|||||++++++.+.+..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 345578999999999999999999875 68999999996532 22334588999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.+++.... ..+++.....++.+++.||+|||+ |||+++...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999999999999997642 248888999999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCC-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQ-------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
..........+||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+.......
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AETYGKIVHYKEHL 289 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHHHC
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccCc
Confidence 44333334568999999999876 45789999999999999999999999864321 11111111100000
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCC---CCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR---PTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R---Ps~~evl~ 428 (435)
. .|... . .....+.+++.+||. +|++| |++.||++
T Consensus 290 ~-----~p~~~-~---~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 S-----LPLVD-E---GVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp C-----CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred C-----CCccc-c---CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 01100 0 112356778889998 99998 68988864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=271.64 Aligned_cols=226 Identities=23% Similarity=0.295 Sum_probs=177.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 57899999999999999999865 58899999986543 2334678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
|+++|+|.+++... ..+++.....++.+++.||+|||+ |||++......
T Consensus 86 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 86 LVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999998888764 248889999999999999999995 88888665432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......||+.|+|||...+..++.++||||||+++|||++|+.||..... ... ...+...... ...+.
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~----~~~~~~~~~~-~~~~~ 230 (284)
T 3kk8_A 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL----YAQIKAGAYD-YPSPE 230 (284)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHTCCC-CCTTT
T ss_pred --ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHH----HHHHHhcccc-CCchh
Confidence 222346799999999999998999999999999999999999999854321 111 1111111110 01111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 -----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111235678888999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=276.58 Aligned_cols=231 Identities=26% Similarity=0.391 Sum_probs=173.9
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC-CeeEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-EEKLL 256 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~l 256 (435)
|.....+|++.+.||+|+||.||+|... |+.||||.++... ..+.|.+|++++++++||||+++++++... +..++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 4456678999999999999999999874 7899999997533 456799999999999999999999997654 47899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... ...+++.....++.++++||+|||+ |||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999997542 1237888899999999999999996 88888754322
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.....+|+.|+|||...+..++.++||||||+++|||+| |+.||..... .... ..+..... +
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~----~~~~~~~~-----~ 233 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV----PRVEKGYK-----M 233 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHH----HHHTTTCC-----C
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHhcCCC-----C
Confidence 123467889999999888889999999999999999999 9988754321 1121 11211110 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..... ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 234 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 DAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccc----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11111 1235677889999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=285.58 Aligned_cols=227 Identities=17% Similarity=0.202 Sum_probs=165.1
Q ss_pred cCccee-eeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHh-ccCCCCCceeEEEEEEe----CCeeE
Q 040641 183 LKLTLV-DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETL-GKVKHQNLVLLLGYCSF----DEEKL 255 (435)
Q Consensus 183 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 255 (435)
.+|.+. ++||+|+||.||+|... +++.||||++.. ...+.+|+.++ +..+|||||++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 355555 78999999999999865 588999999853 24567888887 45589999999999865 56789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARL 308 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~ 308 (435)
+|||||++|+|.+++.... ...+++.....++.|++.||+|||+ |||+++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999997632 2358999999999999999999995 8999876
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...............+. .... ..
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~-~~ 286 (400)
T 1nxk_A 214 TTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY-EF 286 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-CC
T ss_pred cCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-cC
Confidence 5432 223456899999999999999999999999999999999999999865432211111222111 1111 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+. .......+.+++.+||+.||++|||+.||++
T Consensus 287 ~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 287 PNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0110 1112235678899999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.17 Aligned_cols=237 Identities=21% Similarity=0.324 Sum_probs=180.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC----CCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
.+.....+|++.+.||+|+||.||+|.+.. +..||||.+..... ...+.|.+|+.++++++|||||+++|++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 345566789999999999999999998642 45799999875432 33467999999999999999999999984 5
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+..++||||+++|+|.++++... ..+++..+..++.|+++||+|||+ |||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 67899999999999999997542 348899999999999999999996 999998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
..............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ...... +......
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~----i~~~~~~ 611 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGR----IENGERL 611 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHH----HHHTCCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH----HHcCCCC
Confidence 765433333344567889999999888889999999999999999997 8888753211 112211 1111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ... .....+.+++.+||+.||++|||+.+|++.|++++
T Consensus 612 ~-----~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 P-----MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp C-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 001 11235678899999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=274.25 Aligned_cols=225 Identities=22% Similarity=0.331 Sum_probs=173.7
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
.+|.+.+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 47889999999999999999865 68999999997655444567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccCc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACET 314 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~~ 314 (435)
++|+|.+++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 89 SGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999887642 47889999999999999999995 77777653321
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......||+.|+|||...+..++.++|||||||++|||++|+.||..... ..+ ...+...... . .....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~----~~~i~~~~~~-~-~~~~~ 231 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKL----FEKIKEGYYE-F-ESPFW 231 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH----HHHHHHCCCC-C-CTTTT
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHH----HHHHHcCCCC-C-Ccccc
Confidence 22335699999999999998999999999999999999999999854321 111 1122211110 0 00000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 232 ----DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111235678889999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.99 Aligned_cols=236 Identities=27% Similarity=0.426 Sum_probs=178.3
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCE--EEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKT--VAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
....+|++.+.||+|+||.||+|+.. ++.. ||||.+.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 34568999999999999999999864 4554 5999886432 23446789999999999 999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhC------------CCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNAT------------GSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
++||||+++|+|.+++.... .....+++.....++.|+++||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997642 123468999999999999999999996
Q ss_pred ---cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHH
Q 040641 302 ---DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVF 377 (435)
Q Consensus 302 ---DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~ 377 (435)
|||+++..... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ... ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~-~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAE-LY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-------HHH-HH
Confidence 89988743321 12233467889999999888888999999999999999998 999985421 111 12
Q ss_pred HHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+..... +.... .....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 252 ~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKLPQGYR-----LEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHGGGTCC-----CCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCC-----CCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22222110 00000 11235678889999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=288.65 Aligned_cols=238 Identities=17% Similarity=0.211 Sum_probs=178.8
Q ss_pred ccCcceeeeecccCcceEEEEEcCC---------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCcee---------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPD---------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL--------- 243 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 243 (435)
..+|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998753 789999998643 35789999999999999988
Q ss_pred ------EEEEEEe-CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------
Q 040641 244 ------LLGYCSF-DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------- 301 (435)
Q Consensus 244 ------l~g~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------- 301 (435)
+++++.. +...++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6778876 77889999999 999999998642 2458999999999999999999996
Q ss_pred -----------cccccccccccCcc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCc
Q 040641 302 -----------DFGLARLISACETH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEF 364 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~ 364 (435)
|||+++........ ......||+.|+|||+..+..++.++|||||||++|||+||+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 89999765432211 1234579999999999998899999999999999999999999985432
Q ss_pred ccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 365 QEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... ..+... ....... .....++...... ....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 273 ~~~--~~~~~~-~~~~~~~-~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PNT--EDIMKQ-KQKFVDK-PGPFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TCH--HHHHHH-HHHHHHS-CCCEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCH--HHHHHH-HHhccCC-hhhhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 111 111111 1111111 1111111100001 1135678888999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=279.27 Aligned_cols=222 Identities=19% Similarity=0.249 Sum_probs=178.0
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++++.++|||||++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3468999999999999999999865 68999999996542 2345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999998643 37889999999999999999996 99999865432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. +...+...... -|.
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~-~~~~i~~~~~~---~p~ 259 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQ-IYEKIVSGKVR---FPS 259 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCCCC---CCT
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HH-HHHHHHcCCCC---CCC
Confidence 2346899999999999988999999999999999999999999854321 11 12222221110 011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
. ....+.+++.+||+.||++||+ +.||++
T Consensus 260 ---~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 ---H----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---T----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---C----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 1235678889999999999998 788763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=279.70 Aligned_cols=232 Identities=23% Similarity=0.381 Sum_probs=172.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCC----EEEEEEcccc-ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQA-KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|++. +++ .||+|.+... .....+.+.+|+.++++++|||||+++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999854 344 3578877543 2345678999999999999999999999998654 78
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|+||+++|+|.+++.... ..+++.....++.|+++||+|||+ |||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999997643 348889999999999999999996 9999987643
Q ss_pred cCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 312 CET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 312 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+...+ ...... .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~~~~----~~~~~~--~ 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSIL----EKGERL--P 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHHHH----HTTCCC--C
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHHH----HcCCCC--C
Confidence 221 22233457889999999988889999999999999999999 9999854322 1222211 111100 0
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+. .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 240 ~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 QPP-------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc-------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011 11225678889999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=274.39 Aligned_cols=236 Identities=17% Similarity=0.228 Sum_probs=176.9
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEE-EeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYC-SFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|+. .+++.||||.+..... ...+.+|+++++.++|+|++..++++ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 5799999999999999999985 5688999998654332 23578999999999998888777766 567778999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
+ +|+|.+++.... ..+++..+..++.|++.||+|||+ |||+++......
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 999999987532 248999999999999999999995 899988765432
Q ss_pred c------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 314 T------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 314 ~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
. .......||+.|+|||...+..++.++|||||||++|||+||+.||........ ......+......... .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~-~ 240 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTPI-E 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHHSCH-H
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccccchh-h
Confidence 2 122346799999999999998999999999999999999999999865332222 1222211111111100 0
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. ... ....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 241 ~~----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 241 VL----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HH----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hh----hcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 000 1135678889999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=286.28 Aligned_cols=231 Identities=21% Similarity=0.291 Sum_probs=177.0
Q ss_pred cccCcceeeeecccCcceEEEEEc----CCCCEEEEEEccccc----cccHHHHHHHHHHhccC-CCCCceeEEEEEEeC
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQAK----TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFD 251 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 251 (435)
...+|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346899999999999999999986 368999999987532 22345677899999999 699999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+..++||||+++|+|.+++.... .+++.....++.|+++||+|||+ |||+++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999997643 47889999999999999999996 999998
Q ss_pred cccccCccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
.............+||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE-- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHCC--
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hHHHHHHHHhccC--
Confidence 765433344455689999999998875 457899999999999999999999986432211 1111111111111
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLKL 429 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~~ 429 (435)
+.... .....+.+++.+||+.||++|| ++.|+++.
T Consensus 283 -----~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -----PPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11111 1123466788999999999999 99998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=277.10 Aligned_cols=232 Identities=21% Similarity=0.287 Sum_probs=177.0
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 256 (435)
..+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357899999999999999999865 68999999986533 2345679999999999999999999998854 567899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLAR 307 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~ 307 (435)
||||+++|+|.+++.........+++.....++.+++.||+|||+ |||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999998654344558999999999999999998883 777776
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... .......||+.|+|||...+..++.++||||||+++|||+||+.||..... ..+. ..+.......
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~----~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELA----GKIREGKFRR 235 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH----HHHHHTCCCC
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHH----HHHhhccccc
Confidence 554321 112335789999999998888899999999999999999999999854311 1111 1222221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 431 (435)
... .....+.+++.+||+.||++|||+.||++.+.
T Consensus 236 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -----IPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----CCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111 11235678889999999999999999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=291.46 Aligned_cols=225 Identities=18% Similarity=0.256 Sum_probs=168.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+++++.++|||||+++++|...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999854 68999999997532 2334568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
|||||++|+|..++.... .+++.....++.|+++||+|||+ |||+++....
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999987642 48899999999999999999994 8999876433
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+. ..+...... -|
T Consensus 302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~----~~i~~~~~~---~p 369 (446)
T 4ejn_A 302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLF----ELILMEEIR---FP 369 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH----HHHHHCCCC---CC
T ss_pred C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHH----HHHHhCCCC---CC
Confidence 2 2223457899999999999889999999999999999999999999854321 1111 111111110 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
. . ....+.+++.+||+.||++|| ++.|+++
T Consensus 370 ~---~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 R---T----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp T---T----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c---c----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 1 113567888999999999999 9999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=271.16 Aligned_cols=226 Identities=21% Similarity=0.299 Sum_probs=173.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999875 589999999864321 13578999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLAR 307 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~ 307 (435)
+||||+++++|.+++.... .+++.....++.+++.||+|||+ |||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999997642 48899999999999999999995 777776
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
...... ......||+.|+|||...+..++.++||||||+++|||+||+.||..... .. ....+......
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~~- 229 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QE-TLTNISAVNYD- 229 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHTTCCC-
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HH-HHHHhHhcccC-
Confidence 543321 22345689999999999888999999999999999999999999854321 11 11111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 230 -~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 01110011 1124678899999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.68 Aligned_cols=227 Identities=22% Similarity=0.301 Sum_probs=178.3
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.++||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999875 58999999996532 23456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|..++.........+++.....++.|++.||+|||+ |||+++.+....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999999998654334568999999999999999999996 999998765432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||....... .... +...+...... -|.
T Consensus 344 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~-~~~~i~~~~~~---~p~- 414 (543)
T 3c4z_A 344 -TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKE-LKQRVLEQAVT---YPD- 414 (543)
T ss_dssp -CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHH-HHHHHHHCCCC---CCT-
T ss_pred -cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHH-HHHHHhhcccC---CCc-
Confidence 22334689999999999999999999999999999999999999986532211 1111 12222111110 011
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTM 423 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 423 (435)
.....+.+++.+||+.||++||++
T Consensus 415 ------~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 415 ------KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------ccCHHHHHHHHHhccCCHhHCCCC
Confidence 112356678889999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=291.55 Aligned_cols=225 Identities=22% Similarity=0.280 Sum_probs=176.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|||||++++++...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57899999999999999999865 68999999986432 3345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
||++|+|.+++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 102 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999998887642 48889999999999999999995 89998765432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......+||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ..+ ...+....... ..+.
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~~i~~~~~~~-~~~~ 245 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDI----LKRVETGKYAF-DLPQ 245 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHTCCCS-CSGG
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCCCC-CCcc
Confidence 22345679999999999875 589999999999999999999999854321 111 12222111110 0011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111235678889999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=278.76 Aligned_cols=224 Identities=22% Similarity=0.288 Sum_probs=175.9
Q ss_pred cccCcceeeeecccCcceEEEEEcCC-CCEEEEEEccccc---cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAK---TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.+.||+|+||.||+|+... ++.||||.++... ....+.+.+|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999998764 7899999997542 23456788999999988 8999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|.+++.... .+++.....++.+++.||+|||+ |||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997642 48889999999999999999996 9999986432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+...... -|
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~----~~~i~~~~~~---~p 241 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DEL----FQSIMEHNVA---YP 241 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCCC---CC
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----HHH----HHHHHhCCCC---CC
Confidence 2 1223457899999999999999999999999999999999999999854321 111 2222211110 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVL 427 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl 427 (435)
. .....+.+++.+||+.||++||+ +.+|+
T Consensus 242 ~-------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 242 K-------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp T-------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred C-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 11235677889999999999996 46665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=269.61 Aligned_cols=225 Identities=24% Similarity=0.359 Sum_probs=171.7
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEE 253 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~ 253 (435)
....|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|||||++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3456888999999999999999864 57899999986543 2345678999999999999999999999865 355
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLA 306 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla 306 (435)
.++||||+++|+|.+++... ..+++.....++.+++.||+|||+ |||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 89999999999999999764 247888999999999999999985 77877
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
+.... .......||+.|+|||.+.+ .++.++||||+||++|||+||+.||..... ... ...........
T Consensus 180 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~-~~~~~~~~~~~ 248 (290)
T 1t4h_A 180 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ-IYRRVTSGVKP 248 (290)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH-HHHHHTTTCCC
T ss_pred ccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHH-HHHHHhccCCc
Confidence 65432 12234579999999998764 589999999999999999999999854211 111 12222221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+. .. ...+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ASFDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCC----CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 11 124678889999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=269.42 Aligned_cols=223 Identities=25% Similarity=0.402 Sum_probs=173.5
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999865 57799999986432 2234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... .+++.....++.+++.||+|||+ |||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999987642 37889999999999999999996 88887554321
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+...... .|.
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~~---~~~ 228 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QE-TYKRISRVEFT---FPD 228 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHTCCC---CCT
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HH-HHHHHHhCCCC---CCC
Confidence 22346799999999999988999999999999999999999999854221 11 11111111100 011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.||++
T Consensus 229 ---~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 229 ---F----VTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---T----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---c----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 1124667889999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=291.14 Aligned_cols=225 Identities=21% Similarity=0.280 Sum_probs=172.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++.++|||||+++++|...+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46899999999999999999865 68899999986543 3345778999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
||++|+|.+++.... .+++.....++.|+++||+|||+ |||+++.....
T Consensus 117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999998887642 47888999999999999999995 89998776532
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......+||+.|+|||++. ..++.++||||+||++|||++|+.||..... ..+ ...+...... ...+.
T Consensus 193 --~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~~i~~~~~~-~~~~~ 260 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEI----LRKVEKGKYT-FDSPE 260 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHTCCC-CCSGG
T ss_pred --ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCCC-CCchh
Confidence 2234567999999999876 4689999999999999999999999854321 111 1222211111 01111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. . .....+.+++.+||+.||++|||+.|+++
T Consensus 261 ~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 W-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp G-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1 1 11235678889999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=280.88 Aligned_cols=237 Identities=22% Similarity=0.301 Sum_probs=170.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 47889999999999999999875 5899999998654322 34668899999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+++++|..++... ..+++.....++.++++||+|||+ |||+++...... .
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-D 157 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-c
Confidence 99999999887643 348889999999999999999995 899987754322 2
Q ss_pred ccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-----------C
Q 040641 316 VSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK-----------Q 383 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~ 383 (435)
......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+...... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV----DQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhcccccccccccccc
Confidence 2234579999999998765 67899999999999999999999998543221 111111111100 0
Q ss_pred ---CCCccccccccCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 ---QADDVLDPTVLNA---GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ---~~~~~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......++..... ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000111110000 00012234678899999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=285.22 Aligned_cols=226 Identities=18% Similarity=0.222 Sum_probs=173.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+..... .+.+|++++.++ +|||||++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 56899999999999999999865 588999999965433 235688888887 799999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccccccccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLARLISAC 312 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~~~~~~ 312 (435)
|++|+|.+++... ..+++.....++.+++.||+|||+ |||+++.....
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999988753 248899999999999999999996 88988765432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... .+...+...... ....
T Consensus 174 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~-~~~~~i~~~~~~--~~~~ 245 (342)
T 2qr7_A 174 N-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTPE-EILARIGSGKFS--LSGG 245 (342)
T ss_dssp T-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCHH-HHHHHHHHCCCC--CCST
T ss_pred C-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCHH-HHHHHHccCCcc--cCcc
Confidence 2 223456899999999998877789999999999999999999999864211 1111 122222222111 0000
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 246 ~----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 Y----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp T----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0111235677888999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=282.19 Aligned_cols=175 Identities=25% Similarity=0.353 Sum_probs=149.8
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
...+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|||||++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3467999999999999999999865 68899999987543 234567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccC
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~ 313 (435)
||+++|+|.+++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999997643 47888999999999999999985 88888654321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22345799999999999998999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.26 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=160.2
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
+.....+|++.+.||+|+||.||+|... +++.||||.+.... ....+++.+|++++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3455678999999999999999999864 68899999986543 234567889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhC----CCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 256 LVYEYMVNGSLDLWLRNAT----GSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+||||+++|+|.+++.... .....+++.....++.|+++||+|||+ |||+++
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999999987421 123458999999999999999999995 888887
Q ss_pred cccccCc----cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 308 LISACET----HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 308 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
....... .......||+.|+|||.... ..++.++|||||||++|||+||+.||..... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKVLMLTLQNDPP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHHHHHTSSCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch----hhHHHHHhccCCC
Confidence 6543211 11234579999999998765 5688999999999999999999999864321 1111111110000
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000111111111111 234677889999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=282.25 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=181.1
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
....+..+..+|++.+.||+|+||.||+|...+ .||+|.++... ....+.|.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 445667778899999999999999999998753 59999986532 22345688999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------ccccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARL 308 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~ 308 (435)
+..++||||+++|+|.+++... ...+++.....++.++++||+|||+ |||+++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSI 178 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC-
T ss_pred CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccc
Confidence 9999999999999999999753 2358889999999999999999996 8998876
Q ss_pred ccccC----ccccccccccCCCcCCcCCCC---------CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHH
Q 040641 309 ISACE----THVSTDIAGTLGYIPPEYGQS---------RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGW 375 (435)
Q Consensus 309 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~ 375 (435)
..... ........||+.|+|||.... ..++.++|||||||++|||+||+.||..... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~- 250 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EA- 250 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HH-
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-
Confidence 43211 112233568999999998754 4578899999999999999999999854221 11
Q ss_pred HHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 376 VFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
....+............ ....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 251 IIWQMGTGMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHTTCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHhccCCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11112111111111100 1124668889999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=273.57 Aligned_cols=232 Identities=21% Similarity=0.296 Sum_probs=172.4
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.....+....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|||||++++++...+..++||
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 3344555666999999999999985 468899999997665555678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccC
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~ 313 (435)
||+++|+|.+++..... ...+++.....++.++++||+|||+ |||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp ECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999999976432 2346788888899999999999996 888887654321
Q ss_pred ccccccccccCCCcCCcCCCCC--CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSR--MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.......||+.|+|||+..+. .++.++||||||+++|||+||+.||..... . ... ........ ..+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~-~~~-~~~~~~~~-----~~~ 245 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE----P-QAA-MFKVGMFK-----VHP 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS----H-HHH-HHHHHHHC-----CCC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc----h-hHH-HHhhcccc-----ccc
Confidence 122345799999999987654 378999999999999999999999853211 0 111 11110000 011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPES----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 1235677889999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=280.74 Aligned_cols=222 Identities=20% Similarity=0.287 Sum_probs=166.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHH-hccCCCCCceeEEEEEEeCCeeEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMET-LGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
..+|++.+.||+|+||.||+|+.. +++.||||.++.... .....+.+|..+ ++.++|||||++++++...+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457999999999999999999865 578999999965432 233456778777 578999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|..++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999997642 47788888999999999999996 99999864322
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ +..+...... ..+
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~----~~~i~~~~~~--~~~- 260 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEM----YDNILNKPLQ--LKP- 260 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----HHH----HHHHHHSCCC--CCS-
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHH----HHHHHhcccC--CCC-
Confidence 2233457899999999999999999999999999999999999999864321 111 1222111110 111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHV 426 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~ev 426 (435)
. ....+.+++.+||+.||++||++.+.
T Consensus 261 ----~---~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 261 ----N---ITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ----S---SCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ----C---CCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1 11246678889999999999998543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=272.32 Aligned_cols=226 Identities=23% Similarity=0.357 Sum_probs=178.7
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.+...|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3456789999999999999999985 468899999986543 33457899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.. ..+++.....++.+++.||+|||+ |||+++......
T Consensus 99 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999999864 248899999999999999999996 899987654322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......||+.|+|||+..+..++.++||||||+++|||++|+.||..... .... ..+..... +..
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~----~~~~~~~~-----~~~ 239 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVL----FLIPKNNP-----PTL 239 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH----HHHHHSCC-----CCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHH----HHhhcCCC-----CCC
Confidence 222346799999999999988999999999999999999999999853211 1111 11111111 111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 124678889999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=278.41 Aligned_cols=238 Identities=21% Similarity=0.254 Sum_probs=169.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
...+|++.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++++++|||||++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 456899999999999999999985 46889999999654322 245688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------ccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARL 308 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~ 308 (435)
|||++ |+|.+++.... .+++.....++.|+++||+|||+ |||+++.
T Consensus 112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99998 59999987542 38889999999999999999995 8888876
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...........
T Consensus 187 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 187 FGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTT
T ss_pred cCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHHHHhCCCchhh
Confidence 5432 122334578999999998876 4589999999999999999999999854321 111111222111110000
Q ss_pred c---c--------cccccCCCCHH-----HHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 V---L--------DPTVLNAGSKP-----MMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~---~--------~~~~~~~~~~~-----~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. . .+......... ....+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0 00000000010 1235678999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=271.68 Aligned_cols=225 Identities=20% Similarity=0.283 Sum_probs=177.5
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3457899999999999999999875 47899999986542 2234678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++++|.+++.... .+++.....++.|+++||+|||+ |||+++.....
T Consensus 93 v~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999887642 48899999999999999999996 89998765432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. .......||+.|+|||...+..++.++||||||+++|||+||+.||..... ... ......... ..|.
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~-~~~~~~~~~---~~~~ 236 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KET-YLRIKKNEY---SIPK 236 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH-HHHHHTTCC---CCCT
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHhhccC---CCcc
Confidence 2 223346799999999999888899999999999999999999999854321 111 111111111 0011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 ---H----INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---T----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---c----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 1124667888999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=272.88 Aligned_cols=229 Identities=22% Similarity=0.373 Sum_probs=173.0
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+..+|++.+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345678999999999999999999865 58999999986532 346789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++|+|.+++.... ..+++.....++.+++.||.|||+ |||+++......
T Consensus 103 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999987432 348899999999999999999996 899887654321
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......||+.|+|||...+..++.++||||||+++|||++|+.||..... ...... ...........+..
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~~~~ 250 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAIFM-IPTNPPPTFRKPEL 250 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHH-HHHSCCCCCSSGGG
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHH-HhcCCCcccCCccc
Confidence 223345799999999999888899999999999999999999999853211 111111 11111111111111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.+++.+||+.||++|||+.++++
T Consensus 251 -------~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 251 -------WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1235678899999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=275.56 Aligned_cols=236 Identities=20% Similarity=0.274 Sum_probs=171.6
Q ss_pred cCccee-eeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLV-DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 259 (435)
..|.+. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++...+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 78999999999999854 6899999999766555567899999999884 79999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
|+++|+|.+++.... .+++.....++.|+++||+|||+ |||+++.....
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999997642 47889999999999999999996 78887654321
Q ss_pred Cc------cccccccccCCCcCCcCCCC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCc-------HHH
Q 040641 313 ET------HVSTDIAGTLGYIPPEYGQS-----RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN-------LVG 374 (435)
Q Consensus 313 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~-------~~~ 374 (435)
.. ......+||+.|+|||++.. ..++.++|||||||++|||+||+.||........... ...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223469999999998764 4578999999999999999999999865432111000 011
Q ss_pred HHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 375 WVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+...... ...+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDKD-WA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHHH-HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCchh-cc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112222221110 00000 00 01235678899999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=288.13 Aligned_cols=227 Identities=22% Similarity=0.277 Sum_probs=165.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
..+|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++|||||++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 457999999999999999999864 588999999865321 11235889999999999999999999975 45
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGL 305 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGl 305 (435)
..++||||+++|+|.+++... ..+++.....++.|+++||+|||+ |||+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 689999999999998877542 358899999999999999999995 8999
Q ss_pred cccccccCccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
++..... ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+...+ ..
T Consensus 289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~i----~~ 359 (419)
T 3i6u_A 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQI----TS 359 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCCHHHHH----HT
T ss_pred ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHHHHHHH----hc
Confidence 8876432 22345689999999998753 5678899999999999999999999864322 11222221 11
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 360 ~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC--CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1110 00110011 1235678899999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.50 Aligned_cols=226 Identities=23% Similarity=0.260 Sum_probs=173.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-------------ccHHHHHHHHHHhccCCCCCceeEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-------------QGHRQFTAEMETLGKVKHQNLVLLLGY 247 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 247 (435)
..+|.+.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 357899999999999999999865 578999999865321 234678999999999999999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------
Q 040641 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------- 301 (435)
Q Consensus 248 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------- 301 (435)
+......++|||||++|+|.+++.... .+++.....++.|++.||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999999999887642 48899999999999999999995
Q ss_pred -cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 302 -DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
|||+++..... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ..+ ...+
T Consensus 191 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~~i 259 (504)
T 3q5i_A 191 VDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDI----IKKV 259 (504)
T ss_dssp CCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHH
T ss_pred EECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHH
Confidence 89998776432 22345679999999998764 689999999999999999999999864321 111 2222
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... .+..... .....+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222111 0000000 01235678889999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=278.67 Aligned_cols=235 Identities=24% Similarity=0.305 Sum_probs=163.2
Q ss_pred ccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEE------
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCS------ 249 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~------ 249 (435)
+.....+|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. |||||++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3444568999999999999999999864 68999999986655555678999999999996 999999999994
Q ss_pred --eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------
Q 040641 250 --FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------- 301 (435)
Q Consensus 250 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------- 301 (435)
.....++||||+. |+|.+++..... ...+++.....++.+++.||+|||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3344789999996 799988875322 2358999999999999999999985
Q ss_pred cccccccccccCcc-----------ccccccccCCCcCCcCC---CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccc
Q 040641 302 DFGLARLISACETH-----------VSTDIAGTLGYIPPEYG---QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367 (435)
Q Consensus 302 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~ 367 (435)
|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||+||+.||.....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-- 258 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-- 258 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--
Confidence 89988765432211 11134689999999987 567789999999999999999999999853211
Q ss_pred cCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+ ...... ...+. .. ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 259 --~~~---~~~~~~------~~~~~---~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 --LRI---VNGKYS------IPPHD---TQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------------CC------CCTTC---CS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHh---hcCccc------CCccc---cc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 000000 00000 00 113567888999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.14 Aligned_cols=225 Identities=23% Similarity=0.281 Sum_probs=177.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++...+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999865 68999999986432 334678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISA 311 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~ 311 (435)
||+++|+|.+++... ..+++.....++.|++.||+|||+ |||+++....
T Consensus 106 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999988753 348899999999999999999995 8998876643
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ..+ ...+....... ..+
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~~i~~~~~~~-~~~ 249 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDI----LKKVEKGKYTF-ELP 249 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCCCC-CSG
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHH----HHHHHcCCCCC-CCc
Confidence 22 2344679999999998865 689999999999999999999999854321 111 12222221110 001
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 Q-----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp G-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1 0112235678889999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=277.60 Aligned_cols=225 Identities=20% Similarity=0.289 Sum_probs=177.6
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467999999999999999999865 47899999986542 2345678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++++|.+++... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 119 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999988764 248899999999999999999996 89998776432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ... ...+...... .+.
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~-~~~~~~~~~~---~~~ 262 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KET-YLRIKKNEYS---IPK 262 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH-HHHHHHTCCC---CCT
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHH-HHHHhcCCCC---CCc
Confidence 2 223346799999999999888899999999999999999999999854221 111 1111111110 011
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 263 ---~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 ---H----INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---T----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---c----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1124667888999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=294.35 Aligned_cols=230 Identities=22% Similarity=0.294 Sum_probs=180.3
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|++++|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4467899999999999999999865 68999999996532 2345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|..++.... ...+++.....++.+++.||+|||+ |||+++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987542 2348899999999999999999996 99999876532
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+..... .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~~~------~ 407 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVPE------E 407 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHCCC------C
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhcccc------c
Confidence 2 23346899999999999988899999999999999999999999865322111 1112222211110 0
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
.. . .....+.+++.+||+.||++|| ++.||++
T Consensus 408 ~p-~---~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 YS-E---RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CC-T---TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CC-c---cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 0 1123567788899999999999 7788864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=276.70 Aligned_cols=238 Identities=26% Similarity=0.314 Sum_probs=173.7
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc-----ccHHHHHHHHHHhccCC---CCCceeEEEEEEeCC
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT-----QGHRQFTAEMETLGKVK---HQNLVLLLGYCSFDE 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~ 252 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+..... .....+.+|++++++++ |||||+++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 35899999999999999999996 4688999999864321 12356778888877665 999999999998765
Q ss_pred -----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cc
Q 040641 253 -----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DF 303 (435)
Q Consensus 253 -----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------Df 303 (435)
..++||||+. |+|.+++.... ...+++..+..++.|+++||+|||+ ||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4789999997 69999987643 2348999999999999999999996 99
Q ss_pred cccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 304 GLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 304 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......
T Consensus 165 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 165 GLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFDLIGLP 238 (308)
T ss_dssp SCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----HHHHHHHHHHHCCC
T ss_pred ccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 999865432 223456899999999999888899999999999999999999999864322 12222222222111
Q ss_pred CCCcccc----cc--c--cCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLD----PT--V--LNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~----~~--~--~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....... +. . ..+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1110000 00 0 00000 011235678889999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=271.05 Aligned_cols=227 Identities=23% Similarity=0.321 Sum_probs=175.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57889999999999999999865 689999999865432 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc-c
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET-H 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~-~ 315 (435)
+++|+|.+++... ..+++.....++.++++||+|||+ |||+++....... .
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999998887542 358899999999999999999996 8998876543211 2
Q ss_pred ccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
......||+.|+|||...+..+ +.++||||||+++|||+||+.||....... ..... ...... ...+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~-----~~~~~~--~~~~--- 230 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSD-----WKEKKT--YLNP--- 230 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHH-----HHTTCT--TSTT---
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHH-----hhhccc--ccCc---
Confidence 2334679999999999887665 779999999999999999999986432211 11111 111100 0000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0111234667889999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=280.36 Aligned_cols=218 Identities=22% Similarity=0.284 Sum_probs=173.7
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+..... .....+.+|+.++++++|||||++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35789999999999999999985 4688999999865421 12345778999999999999999999999999
Q ss_pred eeEEEEecccCC-CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 253 EKLLVYEYMVNG-SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 253 ~~~lv~ey~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
..++||||+.+| +|..++... ..+++..+..++.+++.||+|||+ |||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999877 999998753 248899999999999999999995 999998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ...
T Consensus 179 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~---- 239 (335)
T 3dls_A 179 YLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEA---- 239 (335)
T ss_dssp ECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTT----
T ss_pred ECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhh----
Confidence 765432 2234679999999999887776 88999999999999999999998532110 000
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
....|.. ....+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIHPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 11246788899999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=272.38 Aligned_cols=221 Identities=17% Similarity=0.273 Sum_probs=170.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... .....++.+|+..+.++ +|||||++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999875 68999999987532 23456788999999999 9999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------------------
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------------------- 301 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------------------- 301 (435)
||+++|+|.+++.........+++.....++.|+++||+|||+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999997653323458999999999999999999985
Q ss_pred ------cccccccccccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHH
Q 040641 302 ------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVG 374 (435)
Q Consensus 302 ------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~ 374 (435)
|||.++.... .....||+.|+|||.+.+. .++.++|||||||++|||++|.+|+... ...
T Consensus 171 ~~~kl~Dfg~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~- 237 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-------DQW- 237 (289)
T ss_dssp CCEEECCCTTCEETTC-----SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------HHH-
T ss_pred eEEEEcccccccccCC-----ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------hHH-
Confidence 4555443322 1224589999999988765 6678999999999999999998775321 111
Q ss_pred HHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 375 WVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+....... ..... ...+.+++.+||+.||++|||+.|+++
T Consensus 238 ---~~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ---HEIRQGRLPR-----IPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHHTTCCCC-----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHcCCCCC-----CCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111111 11111 135677888999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=280.08 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=173.8
Q ss_pred cccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.....+|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 345678999999999999999999865 4899999998644322 3456889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++++|..++... ..+++.....++.+++.||+|||+ |||+++....
T Consensus 101 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999998886543 248899999999999999999996 8999876543
Q ss_pred cCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc---------
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK--------- 381 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 381 (435)
.. .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+.....
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhH
Confidence 22 223346799999999988765 7899999999999999999999998643221 11111111000
Q ss_pred --c-CCCCccccccccCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 --K-QQADDVLDPTVLNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 --~-~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ........+....... ......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000011111111110 012345778999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=265.64 Aligned_cols=223 Identities=22% Similarity=0.332 Sum_probs=168.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357899999999999999999875 68999999986532 23456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+++++|.+++.... .+++.....++.++++||+|||+ |||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999997642 37889999999999999999996 899887654321
Q ss_pred ccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......||+.|+|||...+..+ +.++||||||+++|||++|+.||..... .. ....+..... ..|.
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~---~~~~ 232 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PT-LFKKIRGGVF---YIPE 232 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCCC---CCCT
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HH-HHHHhhcCcc---cCch
Confidence 2234578999999999887765 6899999999999999999999854211 11 1222221110 0111
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ---~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 233 ---Y----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---T----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---h----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 1124667889999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=270.60 Aligned_cols=232 Identities=20% Similarity=0.281 Sum_probs=163.3
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
+....+|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.++...++.++||||+++++++..++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 34557899999999999999999986 46889999999654222 2234555566688999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLIS 310 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~ 310 (435)
+||||++ |+|.+++.........+++.....++.|++.||+|||+ |||+++...
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999997 58888876543334568999999999999999999995 888887654
Q ss_pred ccCccccccccccCCCcCCcCC----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 311 ACETHVSTDIAGTLGYIPPEYG----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
.. .......||+.|+|||.+ ....++.++|||||||++|||+||+.||..... ..............
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~- 232 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSP- 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCC-
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCC-
Confidence 32 122334799999999985 566789999999999999999999999853211 11111222221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .... .....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~-----~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 Q-----LPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C-----CCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----cccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 0011 11235678889999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=277.09 Aligned_cols=232 Identities=13% Similarity=0.098 Sum_probs=177.9
Q ss_pred ccccccCcceeeeecccCcceEEEEE------cCCCCEEEEEEccccccccHHHHHHHHHHhccCC---CCCceeEEEEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKAT------LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK---HQNLVLLLGYC 248 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~ 248 (435)
+.....+|.+.+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 44556789999999999999999994 345889999999653 3456777888777776 99999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC-CCCCCCHHHHHHHHHHhhhccceeec--------------------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG-SHEVLDRAKRYKIACSSARGLAFLHQ-------------------------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------- 301 (435)
...+..++|||||++|+|.+++..... ....+++..+..++.|+++||+|||+
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999999975322 23469999999999999999999995
Q ss_pred ---------ccccccccccc-CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCc
Q 040641 302 ---------DFGLARLISAC-ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371 (435)
Q Consensus 302 ---------DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~ 371 (435)
|||+|+.+... .....+..+||+.|||||++.+..++.++|||||||++|||+||+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 78888765321 22334556899999999999999999999999999999999999999843211100
Q ss_pred HHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCC-CCHHHHHHHHhhhh
Q 040641 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR-PTMLHVLKLLHEIV 434 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R-Ps~~evl~~L~~i~ 434 (435)
.+..........+ .+.+++..|++.+|.+| |++.++.+.|++++
T Consensus 294 ----------------~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 ----------------KPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ----------------EECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ----------------eechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0000011111222 34456678999999988 67888888887754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=292.12 Aligned_cols=223 Identities=16% Similarity=0.174 Sum_probs=166.7
Q ss_pred ccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccc---ccccHHHHHHHH---HHhccCCCCCceeEE-----
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQA---KTQGHRQFTAEM---ETLGKVKHQNLVLLL----- 245 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~----- 245 (435)
+..+..+|++.+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 344567899999999999999999996 46899999999643 233457799999 566677899999998
Q ss_pred --EEEEeCCe-----------------eEEEEecccCCCHHHHHHhhCCC---CCCCCHHHHHHHHHHhhhccceeec--
Q 040641 246 --GYCSFDEE-----------------KLLVYEYMVNGSLDLWLRNATGS---HEVLDRAKRYKIACSSARGLAFLHQ-- 301 (435)
Q Consensus 246 --g~~~~~~~-----------------~~lv~ey~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gl~yLH~-- 301 (435)
+++...+. .++||||+ +|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 66665532 78999999 68999999764211 1234467888899999999999996
Q ss_pred ----------------------cccccccccccCccccccccccCCCcCCcCCCCC-----------CCCCcccchhHHH
Q 040641 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR-----------MSTTRGDVYSFGV 348 (435)
Q Consensus 302 ----------------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~SfGv 348 (435)
|||+++.... .....+| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999986332 2345678 999999998776 7999999999999
Q ss_pred HHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 349 ILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 349 il~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
++|||+||+.||......... ..... .. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~~-~~-~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIFR-SC-KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGGS-SC-CC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhhh-hc-cC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999998543211100 00000 00 01 1135678889999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.33 Aligned_cols=226 Identities=22% Similarity=0.293 Sum_probs=174.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--------ccHHHHHHHHHHhccC-CCCCceeEEEEEEeCC
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--------QGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDE 252 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 252 (435)
.+|.+.+.||+|+||.||+|+.. +|+.||||.+..... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56889999999999999999975 689999998864321 1135688999999999 7999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++|+|.+++... ..+++.....++.|++.||.|||+ |||+++.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999999764 248899999999999999999996 9999877
Q ss_pred ccccCccccccccccCCCcCCcCCC------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQ------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
+.... ......||+.|+|||++. ...++.++|||||||++|||+||+.||..... .... ..+..
T Consensus 250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~----~~i~~ 319 (365)
T 2y7j_A 250 LEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILML----RMIME 319 (365)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH----HHHHH
T ss_pred cCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHHH----HHHHh
Confidence 65322 234568999999999764 34688999999999999999999999854211 1111 11111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ...+.. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 320 ~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 000100 01 1124678889999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=281.66 Aligned_cols=175 Identities=30% Similarity=0.408 Sum_probs=136.2
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCC-CCCceeEEEEEEeCC--eeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDE--EKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 255 (435)
..+|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++. |||||++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 35789999999999999999985 468999999986432 234467889999999997 999999999997654 689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||+ |+|..+++.. .+++.....++.|+++||+|||+ |||+|+....
T Consensus 88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 9999998 6899988753 47888899999999999999996 9999986532
Q ss_pred c--------------------CccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 312 C--------------------ETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 312 ~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
. .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1112345689999999998876 6789999999999999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=266.06 Aligned_cols=223 Identities=19% Similarity=0.292 Sum_probs=176.5
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
...+|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3467899999999999999999865 57889999986432 2234678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... .+++.....++.++++||+|||+ |||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999997642 47889999999999999999996 88888654321
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
......||+.|+|||...+..++.++||||||+++|||++|+.||..... ... ...+..... .
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~-~~~~~~~~~------~ 230 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TET-HRRIVNVDL------K 230 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH-HHHHHTTCC------C
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHH-HHHHhcccc------C
Confidence 22346799999999999988999999999999999999999999854221 111 111111110 0
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ....+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPF----LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1011 1124667889999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=288.18 Aligned_cols=234 Identities=22% Similarity=0.220 Sum_probs=167.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999854 58899999996542 234567889999999999999999999996553
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++|||||+++ |...+.. .+++.....++.|+++||+|||+ |||+|+.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 569999999865 5555532 27888999999999999999996 9999987
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC----
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ---- 384 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 384 (435)
.... ...+..+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+...+....
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHHH
Confidence 6532 233557899999999999999999999999999999999999999854321 111111111111000
Q ss_pred ----------------CCc-----cccccccCCC---CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ----------------ADD-----VLDPTVLNAG---SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ----------------~~~-----~~~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... .......... .......+.+++.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000000 0112345788999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.94 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=168.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++|||||++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47889999999999999999865 6889999998654322 122456799999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
++ |+|.+++.... ..+++.....++.+++.||+|||+ |||+++..... ...
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKT 156 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccc
Confidence 97 58988887642 358888999999999999999995 89998765432 122
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC---cccc--
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD---DVLD-- 390 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 390 (435)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+.......... ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHhchhhhcch
Confidence 234578999999998765 5789999999999999999999999864321 12222222222211110 0000
Q ss_pred -------ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 -------PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 -------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0011234678899999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=281.07 Aligned_cols=237 Identities=21% Similarity=0.224 Sum_probs=170.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC--------
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-------- 251 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 251 (435)
...+|++.+.||+|+||.||+|+. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 456899999999999999999985 5689999999864332 234799999999999999999998543
Q ss_pred ------------------------------CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 252 ------------------------------EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 252 ------------------------------~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
...++||||++ |+|.+.+.........+++.....++.|+++||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 33789999998 58888776533334568999999999999999999996
Q ss_pred -------------------------cccccccccccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHh
Q 040641 302 -------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVT 355 (435)
Q Consensus 302 -------------------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~t 355 (435)
|||+++...... ......||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 899998764332 23346789999999987664 58999999999999999999
Q ss_pred CCCCCCCCcccccCCcHHHHHHHHhccCC----------CCccccccccCCC-----CHHHHHHHHHHHhcccCCCCCCC
Q 040641 356 AKEPTGPEFQEKEGANLVGWVFQKMKKQQ----------ADDVLDPTVLNAG-----SKPMMLKMLRIAADCVADNPATR 420 (435)
Q Consensus 356 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~R 420 (435)
|+.||..... .+....+........ ..+..-|...... .......+.+++.+||+.||++|
T Consensus 238 g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 238 GKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp SSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred CCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999864322 111111111111100 0000001110000 00112346788999999999999
Q ss_pred CCHHHHHH
Q 040641 421 PTMLHVLK 428 (435)
Q Consensus 421 Ps~~evl~ 428 (435)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=277.27 Aligned_cols=238 Identities=25% Similarity=0.328 Sum_probs=170.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-----cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-----GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..+|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 457899999999999999999975 5899999999643221 1346889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++ +|..++... ...+++.....++.++++||+|||+ |||+++....
T Consensus 89 lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999986 888888653 2347788889999999999999996 9999987643
Q ss_pred cCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||..... ......+.............+
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTTSSS
T ss_pred Cc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHcCCCChhhhhh
Confidence 22 23345679999999998765 4589999999999999999999988754321 112222222221111110000
Q ss_pred ----ccc-----cCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 ----PTV-----LNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ----~~~-----~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00000 111245778899999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=273.04 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=170.6
Q ss_pred ccccCcceeeeecccCcceEEEEEcC--CCC--EEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP--DGK--TVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
....+|++.+.||+|+||.||+|++. +++ .||||.++... ....+.|.+|++++++++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34568999999999999999999853 333 68999986542 234567999999999999999999999997654
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
.++||||+++|+|.+++.... ..+++.....++.++++||+|||+ |||+++.
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999997642 347889999999999999999996 8999887
Q ss_pred ccccCcc--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 309 ISACETH--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 309 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
....... ......+|+.|+|||...+..++.++||||||+++|||++ |+.||..... ........... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~-~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEG-E 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSC-C
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccC-C
Confidence 6443221 2234567889999999888888999999999999999999 9999854211 11111111111 0
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ...+ ......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 243 ~-~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 R-LPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C-CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-CCCC-------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 0001 111235678889999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=272.77 Aligned_cols=235 Identities=23% Similarity=0.362 Sum_probs=171.9
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEe-
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSF- 250 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 250 (435)
+.........+|++.+.||+|+||.||+|+. .+++.||||.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3444556678899999999999999999986 468999999986433 3346789999999998 89999999999977
Q ss_pred -----CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 251 -----DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 251 -----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
.+..++||||+++|+|.+++.... ...+++.....++.+++.||+|||+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999997642 2358888899999999999999996
Q ss_pred cccccccccccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHH
Q 040641 302 DFGLARLISACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWV 376 (435)
Q Consensus 302 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~ 376 (435)
|||+++...... .......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ....
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~ 243 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRAL 243 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHH
Confidence 899887654321 1223457999999999876 56789999999999999999999999853211 1111
Q ss_pred HHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... .... ....... ...+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~-~~~~-----~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPR-NPAP-----RLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHH-SCCC-----CCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhc-Cccc-----cCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 1111 1111111 125677888999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=265.15 Aligned_cols=225 Identities=22% Similarity=0.283 Sum_probs=174.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 57899999999999999999875 68899999986543 2345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccccc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISAC 312 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~ 312 (435)
|+++++|.+++.... .+++.....++.+++.||+|||+ |||+++.....
T Consensus 102 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999998887542 47899999999999999999995 78887765432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (435)
. ......||+.|+|||...+. ++.++||||||+++|||++|+.||..... ..+ ...+........ .+.
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~----~~~~~~~~~~~~-~~~ 245 (287)
T 2wei_A 178 T--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE----YDI----LKRVETGKYAFD-LPQ 245 (287)
T ss_dssp S--SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCCCCC-SGG
T ss_pred C--ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHcCCCCCC-chh
Confidence 1 12334689999999988764 88999999999999999999999854321 111 112211111100 000
Q ss_pred ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 246 -~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 -WR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 11235678889999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=273.39 Aligned_cols=232 Identities=17% Similarity=0.207 Sum_probs=173.0
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEe--CCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSF--DEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.++.. ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999985 56899999998643 3467899999999997 9999999999987 6678999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISAC 312 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~ 312 (435)
|||+++++|..++.. +++.....++.|+++||+|||+ |||+++.....
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999988753 7788899999999999999996 89999865432
Q ss_pred CccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh---------cc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM---------KK 382 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~ 382 (435)
. ......||..|+|||...+ ..++.++|||||||++|||+||+.||....... .....+.... ..
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHHHHCHHHHHHHHHH
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHHHHHhcCCchhhhHHHH
Confidence 2 2234578999999998776 678999999999999999999999985432211 0111000000 00
Q ss_pred CCC--------------CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQA--------------DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ...................+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000000111112345778999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=282.94 Aligned_cols=236 Identities=17% Similarity=0.212 Sum_probs=178.3
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCC-CCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH-QNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|.+.+.||+|+||.||+|+. .+++.||||.+..... ..++.+|+++++.++| ++|..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5789999999999999999985 5689999998764332 2357899999999987 5566666677788889999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
+ +|+|.+++.... ..+++..++.++.|++.||+|||+ |||+++......
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 999999997532 348999999999999999999995 999998765432
Q ss_pred cc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 314 TH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 314 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+...........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhccccccHHH
Confidence 21 12256899999999999999999999999999999999999999864322111 111111111110000000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ... ...++.+++..||+.+|++||++.+|++.|+++.
T Consensus 240 l-----~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 240 L-----CRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp H-----HTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred H-----hcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0 000 1235778899999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=279.52 Aligned_cols=235 Identities=22% Similarity=0.237 Sum_probs=168.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------eeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------EKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 255 (435)
.+|++.+.||+|+||.||+|++. +|+.||||++..... .+.+|+++|++++|||||+++++|.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999975 589999999864322 2347999999999999999999985421 267
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLIS 310 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~ 310 (435)
+||||+++ +|..++.........+++.....++.|+++||+|||+ |||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999986 5665554322233468999999999999999999996 999998764
Q ss_pred ccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-------
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK------- 382 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 382 (435)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+....+...+..
T Consensus 209 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 209 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHHH
T ss_pred cCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHH
Confidence 322 22346799999999987654 789999999999999999999999864321 1111111111110
Q ss_pred ---CCCCccccccccCCCCH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 ---QQADDVLDPTVLNAGSK-----PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+...|........ .....+.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00111111111100000 11235778999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=274.40 Aligned_cols=173 Identities=24% Similarity=0.266 Sum_probs=146.0
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-----CCCceeEEEEEEeCCeeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-----HQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~ 255 (435)
..+|.+.+.||+|+||.||+|+. .+++.||||.++... ...+.+..|+.++++++ |||||++++++...+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 46899999999999999999986 468899999996432 33456788999998886 999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------------
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------------- 301 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------------- 301 (435)
+||||+ +|+|.+++.... ...+++.....++.|++.||+|||+
T Consensus 113 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 999999 999999997643 2348889999999999999999984
Q ss_pred ---------------cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 302 ---------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 302 ---------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 4555544321 12345789999999999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=265.92 Aligned_cols=227 Identities=21% Similarity=0.234 Sum_probs=175.1
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---------cccHHHHHHHHHHhccCC-CCCceeEEEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---------TQGHRQFTAEMETLGKVK-HQNLVLLLGYCSF 250 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 250 (435)
..+|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999875 58899999986432 112356889999999996 9999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
.+..++||||+++|+|.+++... ..+++.....++.+++.||+|||+ |||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999764 248889999999999999999996 89988
Q ss_pred ccccccCccccccccccCCCcCCcCCC------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQ------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
+...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ... ...+
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~----~~~~ 241 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLM----LRMI 241 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHH
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----HHH----HHHH
Confidence 7654322 223467999999999763 45688999999999999999999999854211 111 1111
Q ss_pred ccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... ...+ ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111110 0001 11112235678899999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.54 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=174.0
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEe-------
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSF------- 250 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 250 (435)
...+|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++|||||++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 456899999999999999999986 4689999999864432 234678899999999999999999999977
Q ss_pred -CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 251 -DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 251 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
.+..++||||+++ +|...+.... ..+++..+..++.|++.||+|||+ |||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999985 7777765432 348899999999999999999996 9999
Q ss_pred cccccccC---ccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 306 ARLISACE---THVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 306 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~ 246 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLALISQLCG 246 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhC
Confidence 98764221 122345678999999998765 5689999999999999999999999864321 112222222111
Q ss_pred cCCCC---ccccccc---------cCCCCHHH------HHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQAD---DVLDPTV---------LNAGSKPM------MLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~~~---~~~~~~~---------~~~~~~~~------~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... ....... ........ ...+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11100 0000000 00001111 123678999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=271.66 Aligned_cols=227 Identities=21% Similarity=0.290 Sum_probs=170.7
Q ss_pred Cccee-eeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEE
Q 040641 184 KLTLV-DILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 184 ~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+|.+. +.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++.++ +||||+++++++...+..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 45555 88999999999999865 58999999987543 23457899999999999 4699999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISA 311 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~ 311 (435)
||+++|+|.+++... ....+++.....++.|++.||+|||+ |||+++....
T Consensus 109 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp ECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999887543 23458999999999999999999995 8888876543
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .. ...+..... .. .+
T Consensus 187 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~----~~~i~~~~~-~~-~~ 254 (327)
T 3lm5_A 187 A--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ET----YLNISQVNV-DY-SE 254 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HH----HHHHHHTCC-CC-CT
T ss_pred c--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HH----HHHHHhccc-cc-Cc
Confidence 2 1223467999999999999899999999999999999999999998543211 11 111111110 00 00
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ......+.+++.+||+.||++|||+.++++
T Consensus 255 ~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 255 ETF----SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTT----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 111234677889999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.91 Aligned_cols=234 Identities=20% Similarity=0.310 Sum_probs=175.7
Q ss_pred ccCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccccc-----------------HHHHHHHHHHhccCCCCCceeE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQG-----------------HRQFTAEMETLGKVKHQNLVLL 244 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 244 (435)
..+|++.+.||+|+||.||+|.. +++.||||.+....... .+.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45899999999999999999998 89999999986433211 1789999999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHH------HHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------
Q 040641 245 LGYCSFDEEKLLVYEYMVNGSLDLW------LRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------- 301 (435)
Q Consensus 245 ~g~~~~~~~~~lv~ey~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------- 301 (435)
++++...+..++||||+++|+|.++ +... ....+++..+..++.+++.||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 9999999999999999999999888 4331 13468999999999999999999994
Q ss_pred --------cccccccccccCccccccccccCCCcCCcCCCCC-CCCC-cccchhHHHHHHHHHhCCCCCCCCcccccCCc
Q 040641 302 --------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR-MSTT-RGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371 (435)
Q Consensus 302 --------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~ 371 (435)
|||+++..... ......||+.|+|||...+. .++. ++|||||||++|||+||+.||...... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---VE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---HH
Confidence 78887765332 23446799999999998876 6666 999999999999999999998643221 11
Q ss_pred HHHHHHHHhccCCCCccc------cccc---cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 372 LVGWVFQKMKKQQADDVL------DPTV---LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. ...+......... .+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 261 ~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 L----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1122211111000 0000 00000112235678899999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=279.76 Aligned_cols=175 Identities=25% Similarity=0.288 Sum_probs=142.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----Ce
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 253 (435)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367999999999999999999864 57899999997532 23456789999999999999999999999776 56
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+. |+|.++++.. ..+++.....++.|+++||.|||+ |||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999996 6999998753 348999999999999999999996 99999876
Q ss_pred cccCc---------------------cccccccccCCCcCCcCC-CCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 040641 310 SACET---------------------HVSTDIAGTLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTAKEPTG 361 (435)
Q Consensus 310 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~SfGvil~El~tg~~p~~ 361 (435)
..... ...+..+||+.|+|||++ ....++.++||||+||++|||++|..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43221 123567899999999974 56779999999999999999998766553
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=267.37 Aligned_cols=231 Identities=20% Similarity=0.320 Sum_probs=171.8
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCC--CCCceeEEEEEEeCCe
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVK--HQNLVLLLGYCSFDEE 253 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 253 (435)
......+|++.+.||+|+||.||+|...+++.||||.+.... ....+.+.+|++++.+++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 344556799999999999999999998889999999986432 234567899999999997 5999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------ccccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLIS 310 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~ 310 (435)
.++||| +.+|+|.+++... ..+++..+..++.++++||+|||+ |||+++...
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeecccccccc
Confidence 999999 6689999999764 247888999999999999999996 899987654
Q ss_pred ccCc-cccccccccCCCcCCcCCCC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 311 ACET-HVSTDIAGTLGYIPPEYGQS-----------RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 311 ~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
.... .......||+.|+|||...+ ..++.++|||||||++|||+||+.||..... .......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~ 251 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHA 251 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHH
Confidence 3221 12234579999999998765 4688899999999999999999999854221 1111122
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......... .+ ... ...+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~--~~---~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 IIDPNHEIE--FP---DIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHCTTSCCC--CC---CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcccccC--Cc---ccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 221111000 01 111 125677888999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.32 Aligned_cols=226 Identities=22% Similarity=0.274 Sum_probs=169.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 253 (435)
.+|.+.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 47899999999999999999865 578999999864321 12345889999999999999999999987654
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLA 306 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla 306 (435)
.++||||+++|+|.+++... ..+++.....++.|+++||+|||+ |||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 89999999999999988643 358889999999999999999995 78888
Q ss_pred ccccccCccccccccccCCCcCCcCC---CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYG---QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+..... .......||+.|+|||++ ....++.++|||||||++|||+||+.||..... ...+...+.. .
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~----~ 235 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVSLKDQITS----G 235 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---SSCHHHHHHH----T
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---HHHHHHHHHh----C
Confidence 765432 222345799999999985 356789999999999999999999999864322 1122222211 1
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..+..... ....+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 110 00111011 1235678899999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=272.90 Aligned_cols=234 Identities=21% Similarity=0.209 Sum_probs=164.1
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++|||||++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357999999999999999999854 58899999986532 233467889999999999999999999997655
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+++ +|.+++.. .+++.....++.|++.||+|||+ |||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999974 78777752 27888899999999999999996 9999976
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc------
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK------ 382 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 382 (435)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+......
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHC-CCCCCHHHH
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHH
Confidence 5432 2234568999999999998889999999999999999999999998543211 111111100000
Q ss_pred -------------C-CCCc----cccccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 -------------Q-QADD----VLDPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 -------------~-~~~~----~~~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .... ...+....+. .......+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000 0000000000 1122456788999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=275.65 Aligned_cols=232 Identities=21% Similarity=0.234 Sum_probs=166.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35799999999999999999986 468999999996432 223467899999999999999999999997653
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+ +++|.++++.. .+++.....++.|+++||+|||+ |||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 88999998752 37888999999999999999996 9999987
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC--
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA-- 385 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 385 (435)
... ..+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+....+.........
T Consensus 178 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 178 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHH
T ss_pred ccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 542 2345679999999998766 6789999999999999999999999864321 1111111111110000
Q ss_pred ----------------CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 ----------------DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000 0000011235678888999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.71 Aligned_cols=231 Identities=14% Similarity=0.076 Sum_probs=155.0
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHH---HHhccCCCCCceeEE-------
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEM---ETLGKVKHQNLVLLL------- 245 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~------- 245 (435)
.....|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+ ++|+. +|||||+++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS 137 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence 34456899999999999999999864 688999999976432 2345677784 55555 799988755
Q ss_pred EEEEeC-----------------CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHH------HHHHHHhhhccceeec-
Q 040641 246 GYCSFD-----------------EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKR------YKIACSSARGLAFLHQ- 301 (435)
Q Consensus 246 g~~~~~-----------------~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~- 301 (435)
+++... ...++|||||+ |+|.+++..... .+.+..+ ..++.|+++||+|||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 455433 23799999999 899999986421 2344455 7788999999999996
Q ss_pred -----------------------cccccccccccCccccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhC
Q 040641 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTA 356 (435)
Q Consensus 302 -----------------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg 356 (435)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999865421 113467799999999887 6799999999999999999999
Q ss_pred CCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 357 KEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 357 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+.||.......... ................+........+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99986542211100 0000000000000000100112235678889999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.13 Aligned_cols=224 Identities=22% Similarity=0.290 Sum_probs=177.4
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc---ccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA---KTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 255 (435)
...+|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999865 5789999999753 233456788999999987 7999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++|+|..+++... .+++..+..++.|++.||+|||+ |||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998653 48899999999999999999996 9999986432
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. .......+||+.|||||++.+..++.++|||||||++|||+||+.||..... .. ++..+..... .-|
T Consensus 495 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~----~~~~i~~~~~---~~p 562 (674)
T 3pfq_A 495 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DE----LFQSIMEHNV---AYP 562 (674)
T ss_dssp T-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH----HHHHHHSSCC---CCC
T ss_pred C-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HH----HHHHHHhCCC---CCC
Confidence 2 2234457899999999999999999999999999999999999999864321 11 1222222111 011
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCH-----HHHH
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTM-----LHVL 427 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~-----~evl 427 (435)
. ....++.+++..||+.||++||++ .||+
T Consensus 563 ~-------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 563 K-------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp T-------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred c-------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1 112356788889999999999997 6665
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=262.32 Aligned_cols=225 Identities=20% Similarity=0.320 Sum_probs=169.2
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc----cccHHHHHHHHHHhccCCCCCceeEEEEEE--eCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK----TQGHRQFTAEMETLGKVKHQNLVLLLGYCS--FDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 255 (435)
.+|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++. ..+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 57889999999999999999864 58899999997543 234567999999999999999999999984 455789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+++| |.+++.... ...+++.....++.|+++||+|||+ |||+++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999999987 777776532 2358899999999999999999996 8998876543
Q ss_pred cC-ccccccccccCCCcCCcCCCCCC--CCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CE-THVSTDIAGTLGYIPPEYGQSRM--STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.. ........||+.|+|||+..+.. ++.++|||||||++|||++|+.||.... ... ....+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~-~~~~i~~~~~~-- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYK-LFENIGKGSYA-- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHH-HHHHHHHCCCC--
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHH-HHHHHhcCCCC--
Confidence 21 12223457999999999876543 4789999999999999999999985421 111 11222221110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ....+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 232 ----IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ----CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111 1124667889999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=284.15 Aligned_cols=169 Identities=24% Similarity=0.323 Sum_probs=129.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----Cee
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EEK 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 254 (435)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999865 68899999986532 23456789999999999999999999998543 568
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|+||||+ +|+|..+++.. ..+++.....++.|++.||+|||+ |||+|+...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 57899888653 348899999999999999999996 999998764
Q ss_pred ccCc--------------------------cccccccccCCCcCCcCC-CCCCCCCcccchhHHHHHHHHHhC
Q 040641 311 ACET--------------------------HVSTDIAGTLGYIPPEYG-QSRMSTTRGDVYSFGVILLELVTA 356 (435)
Q Consensus 311 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~SfGvil~El~tg 356 (435)
.... ...+..+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2211 123456889999999975 567799999999999999999994
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=269.36 Aligned_cols=237 Identities=20% Similarity=0.315 Sum_probs=154.8
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHH-HhccCCCCCceeEEEEEEeCCe
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEME-TLGKVKHQNLVLLLGYCSFDEE 253 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~ 253 (435)
.+.....+|++.+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 34556678999999999999999999874 688999999965432 23345666666 7888999999999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNAT-GSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLAR 307 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~ 307 (435)
.++||||+++ +|.+++.... .....+++.....++.++++||.|||+ |||+++
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999985 7877765321 123458899999999999999999985 888887
Q ss_pred cccccCccccccccccCCCcCCcCC----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYG----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
..... .......||+.|+|||++ .+..++.++|||||||++|||+||+.||...... .... ......
T Consensus 175 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~-~~~~~~ 245 (327)
T 3aln_A 175 QLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQL-TQVVKG 245 (327)
T ss_dssp C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCS
T ss_pred ecccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHH-HHHhcC
Confidence 65432 122334799999999998 4567899999999999999999999998542110 0000 001011
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .+.............+.+++.+||+.||++|||+.+|++
T Consensus 246 ~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 D-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 011111111112235678889999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=268.70 Aligned_cols=238 Identities=24% Similarity=0.297 Sum_probs=173.1
Q ss_pred ccCcceeeeecccCcceEEEEEc--CCCCEEEEEEcccccc--ccHHHHHHHHHHhccC---CCCCceeEEEEEE-----
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL--PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKV---KHQNLVLLLGYCS----- 249 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~----- 249 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46799999999999999999987 4578999999864332 1233567788777666 8999999999987
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
.....++||||++ |+|.+++.... ...+++.....++.|+++||+|||+ |||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567899999998 69999987643 2348899999999999999999996 8999
Q ss_pred cccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.........
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 167 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCG
T ss_pred cccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCCCc
Confidence 8765432 223456799999999999888899999999999999999999999864321 1122222221111100
Q ss_pred Ccc----ccc---------cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 386 DDV----LDP---------TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 386 ~~~----~~~---------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..+ .............+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000 0000000112235668889999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=274.86 Aligned_cols=238 Identities=20% Similarity=0.189 Sum_probs=166.3
Q ss_pred ccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccc-----------cHHHHHHHHHHhccCCCCCceeEEEEE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQ-----------GHRQFTAEMETLGKVKHQNLVLLLGYC 248 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~~ 248 (435)
....+|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++|||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 345689999999999999999999888999999998543211 136799999999999999999999998
Q ss_pred EeC-----CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 249 SFD-----EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 249 ~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
... ...++||||++ |+|.+++... ...+++.....++.|++.||+|||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 543 35799999998 6888887643 2358999999999999999999996
Q ss_pred --cccccccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 302 --DFGLARLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 --DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+..
T Consensus 175 l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~i~~ 248 (362)
T 3pg1_A 175 ICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY----NQLNKIVE 248 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHH
T ss_pred EEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHH
Confidence 89998754432 22344678999999998766 67899999999999999999999998643211 11111111
Q ss_pred HhccCCC-------------------CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 379 KMKKQQA-------------------DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 379 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....... ........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111000 00000000 0000011234678899999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.42 Aligned_cols=226 Identities=22% Similarity=0.343 Sum_probs=163.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe-----------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----------- 250 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------- 250 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46889999999999999999864 6899999999643 2345678999999999999999999998865
Q ss_pred --CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 251 --DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 251 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
.+..++||||+++|+|.+++.... ..+++.....++.|+++||+|||+ |||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 356789999999999999997532 346788889999999999999996 899
Q ss_pred ccccccccC-------------ccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 305 LARLISACE-------------THVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 305 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ |+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~----- 233 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME----- 233 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-----
Confidence 987654211 1122345789999999988754 78999999999999999998 5432111
Q ss_pred cHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ....+..... ...+... ......+.+++.+||+.||++|||+.++++
T Consensus 234 -~~~-~~~~~~~~~~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 -RVN-ILKKLRSVSI--EFPPDFD----DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHH-HHHHHHSTTC--CCCTTCC----TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-HHHhcccccc--ccCcccc----ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111 1122211110 0111111 112234667889999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=267.98 Aligned_cols=236 Identities=21% Similarity=0.223 Sum_probs=165.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEE------------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCS------------ 249 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------------ 249 (435)
.+|.+.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57899999999999999999876 48899999987665556678999999999999999999999873
Q ss_pred --eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------c
Q 040641 250 --FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------D 302 (435)
Q Consensus 250 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------D 302 (435)
.....++||||++ |+|.+++.. ..+++.....++.|+++||+|||+ |
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999998 699998864 247888999999999999999995 8
Q ss_pred ccccccccccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHH
Q 040641 303 FGLARLISACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 303 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
||+++....... .......||..|+|||.... ..++.++|||||||++|||+||+.||...... .....+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~ 240 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL----EQMQLILES 240 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHh
Confidence 998876543211 12234567999999997654 67899999999999999999999998643211 111111111
Q ss_pred hccCC----------CCc-----ccccccc-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 380 MKKQQ----------ADD-----VLDPTVL-NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 380 ~~~~~----------~~~-----~~~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... ... ...+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 000 0000000 0000011235678999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=279.11 Aligned_cols=227 Identities=21% Similarity=0.292 Sum_probs=160.7
Q ss_pred cceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEEEecccC
Q 040641 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLVYEYMVN 263 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~ 263 (435)
+...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++...+..++|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4557889999999998776667999999998643 235678999999876 89999999999999999999999995
Q ss_pred CCHHHHHHhhCCCCCC---CCHHHHHHHHHHhhhccceeec-------------------------------------cc
Q 040641 264 GSLDLWLRNATGSHEV---LDRAKRYKIACSSARGLAFLHQ-------------------------------------DF 303 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gl~yLH~-------------------------------------Df 303 (435)
|+|.+++......... ..+.....++.|++.||+|||+ ||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 6999999764322111 1233456799999999999995 67
Q ss_pred cccccccccCcc---ccccccccCCCcCCcCCCC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcH
Q 040641 304 GLARLISACETH---VSTDIAGTLGYIPPEYGQS-------RMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANL 372 (435)
Q Consensus 304 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~ 372 (435)
|+++........ .....+||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~ 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----E 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----H
Confidence 887765432211 1234579999999998765 678999999999999999999 88898543221 1
Q ss_pred HHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 373 VGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. +..... .. +.............+.+++.+||+.||++|||+.||++
T Consensus 248 ~~-i~~~~~--~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SN-IIRGIF--SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-HHHTCC--CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HhcCCC--Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 111100 00 11111223445567889999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.07 Aligned_cols=235 Identities=22% Similarity=0.240 Sum_probs=167.2
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe------eEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE------KLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 256 (435)
.+|++.+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++|||||++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 478999999999999999999877777999988543321 2379999999999999999999965443 789
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISA 311 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~ 311 (435)
||||++++.+....... .....+++.....++.|+++||+|||+ |||+++....
T Consensus 116 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEECCSEEHHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeeccCccHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99999876554433221 223458899999999999999999996 9999987643
Q ss_pred cCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC------
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ------ 384 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 384 (435)
.. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+........
T Consensus 195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 195 GE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp TC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHHHHHH
T ss_pred CC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHHHh
Confidence 22 22346789999999987654 5899999999999999999999998643211 11111111111000
Q ss_pred ----CCccccccccCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ----ADDVLDPTVLNAG-----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ----~~~~~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....-+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000000 0011235778999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=278.55 Aligned_cols=242 Identities=21% Similarity=0.226 Sum_probs=157.2
Q ss_pred Ccce-eeeecccCcceEEEEEcC---CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEEE
Q 040641 184 KLTL-VDILEDGGFGTVYKATLP---DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLLV 257 (435)
Q Consensus 184 ~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 257 (435)
.|++ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+++|++++|||||++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3454 457999999999999865 47889999997543 23578899999999999999999999954 6788999
Q ss_pred EecccCCCHHHHHHhhC-----CCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccc
Q 040641 258 YEYMVNGSLDLWLRNAT-----GSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFG 304 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfG 304 (435)
|||++ |+|.+++.... .....+++.....++.|++.||+|||+ |||
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 99997 57777765321 112248899999999999999999995 899
Q ss_pred ccccccccCc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccc-----cCCcHHHHH
Q 040641 305 LARLISACET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK-----EGANLVGWV 376 (435)
Q Consensus 305 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~-----~~~~~~~~~ 376 (435)
+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ........+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 9887643211 22344689999999998876 458999999999999999999999986432210 001122222
Q ss_pred HHHhccCCCCccccc----------------cccCCCCHH--------HHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 377 FQKMKKQQADDVLDP----------------TVLNAGSKP--------MMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 377 ~~~~~~~~~~~~~~~----------------~~~~~~~~~--------~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+.........+. ......... ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 222221111000000 000000000 0124678899999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=263.75 Aligned_cols=236 Identities=18% Similarity=0.262 Sum_probs=158.4
Q ss_pred cccccccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccc--cHHHHHHHHHHhccCCCCCceeEEEEEE
Q 040641 173 INISMFQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ--GHRQFTAEMETLGKVKHQNLVLLLGYCS 249 (435)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~ 249 (435)
++...+.....+|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.++..+++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp ESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 344456667788999999999999999999875 6899999999654322 2233455556788899999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccc
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFG 304 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfG 304 (435)
..+..++||||+ ++.+..+..... ..+++.....++.++++||+|||+ |||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 566665554322 348889999999999999999995 788
Q ss_pred ccccccccCccccccccccCCCcCCcCCC-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHH
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQ-----SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQK 379 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~ 379 (435)
+++...... ......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ........
T Consensus 171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~ 242 (318)
T 2dyl_A 171 ISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKV 242 (318)
T ss_dssp TC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHH
T ss_pred CchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHH
Confidence 876554321 223457999999999874 55688999999999999999999999854211 11111111
Q ss_pred hccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... ....... . .....+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~-~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 243 LQEE-PPLLPGH----M---GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSC-CCCCCSS----S---CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hccC-CCCCCcc----C---CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 1111000 0 01124677889999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=270.31 Aligned_cols=236 Identities=22% Similarity=0.273 Sum_probs=172.7
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----CeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 255 (435)
.+|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|||||++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 57999999999999999999864 578999999975332 2346789999999999999999999999765 3689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+||||+. |+|.+++... .+++.....++.|++.||+|||+ |||+++....
T Consensus 107 iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9999997 5899988753 38889999999999999999996 9999987653
Q ss_pred cCcc--ccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETH--VSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... ......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......+............
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG----GGHHHHHHHHHCSCCHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHHHhCCCCHHHH
Confidence 2221 124468999999999754 45589999999999999999999999854322 1222222211111100000
Q ss_pred -----------c--cccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 -----------L--DPTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 -----------~--~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .+...... .......+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000000 0001235678899999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.96 Aligned_cols=228 Identities=22% Similarity=0.295 Sum_probs=163.3
Q ss_pred cccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEE
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 257 (435)
.....+|...++||+|+||.||.....+++.||||++...... .+.+|+++++++ +|||||++++++......++|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3445678999999999999966555557899999998653322 356899999999 899999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------ccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARL 308 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~ 308 (435)
||||. |+|.+++..... ...+.....++.|+++||+|||+ |||+++.
T Consensus 97 ~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99996 699999976432 23334456899999999999995 8998877
Q ss_pred ccccCc--cccccccccCCCcCCcCCC---CCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhcc
Q 040641 309 ISACET--HVSTDIAGTLGYIPPEYGQ---SRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKK 382 (435)
Q Consensus 309 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (435)
...... ......+||+.|+|||++. ...++.++|||||||++|||+| |..||..... .. .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~---~~~~~~~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQ---ANILLGA 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HH---HHHHTTC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HH---HHHHhcc
Confidence 643221 2234567999999999887 4567889999999999999999 8888743211 11 1111111
Q ss_pred CCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 QQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. .....+ .......+.+++.+||+.||++|||+.||++
T Consensus 245 ~~-~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CS-LDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-CTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-ccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11 111111 1122334668899999999999999999983
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.82 Aligned_cols=174 Identities=24% Similarity=0.260 Sum_probs=145.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccC------CCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKV------KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 254 (435)
..+|++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++..+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999865 58899999996532 2345677888887766 677999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------ccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARL 308 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~ 308 (435)
++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+ |||+++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99999996 68998887643 2348899999999999999999995 8998865
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 252 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 252 EHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 432 223467999999999998889999999999999999999999998543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=273.62 Aligned_cols=241 Identities=21% Similarity=0.201 Sum_probs=162.1
Q ss_pred ccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-----
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE----- 253 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 253 (435)
....+|++.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++.++.++|||||++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34568999999999999999999864 589999999854332 23456788888999999999999999976443
Q ss_pred --eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee--c-------------------------ccc
Q 040641 254 --KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH--Q-------------------------DFG 304 (435)
Q Consensus 254 --~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--~-------------------------DfG 304 (435)
.++||||+++ +|...+.........+++.....++.+++.||+||| + |||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 7899999986 555545443333456888899999999999999999 4 899
Q ss_pred ccccccccCccccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...... .....+.......
T Consensus 178 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 178 SAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQLHEIVRVLGCP 251 (360)
T ss_dssp TCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCC
T ss_pred CceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHHHHHHHHcCCC
Confidence 998765432 22346789999999987654 5899999999999999999999998643221 1111111111100
Q ss_pred C-----------C-Ccccccc------ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 Q-----------A-DDVLDPT------VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~-----------~-~~~~~~~------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. . .+..+.. ............+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 0000000 000011112346788999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=272.47 Aligned_cols=232 Identities=21% Similarity=0.256 Sum_probs=155.1
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeC------Ce
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------EE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 253 (435)
.+|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6799999999999999999985 468899999996532 23456788999999999999999999998654 56
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||+ +++|.+++.. ..+++.....++.|+++||+|||+ |||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 7899888864 248899999999999999999996 89998765
Q ss_pred cccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC--
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD-- 386 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 386 (435)
.. ..+...||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+..........
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 42 1345689999999998776 6789999999999999999999999854321 11222222211110000
Q ss_pred -cc--------cc--ccccCCCCH----HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 -DV--------LD--PTVLNAGSK----PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 -~~--------~~--~~~~~~~~~----~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.+ +. +........ .....+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 00 000000000 01134678889999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=266.74 Aligned_cols=227 Identities=18% Similarity=0.199 Sum_probs=145.5
Q ss_pred cCccee-eeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeEE
Q 040641 183 LKLTLV-DILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKLL 256 (435)
Q Consensus 183 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 256 (435)
.+|.+. ++||+|+||.||+|+.. +++.||||.+.... ....+....+..++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 567774 57999999999999875 68999999986422 111222234566799999999999876 445899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLI 309 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~ 309 (435)
||||+++|+|.+++.... ...+++.....++.|+++||+|||+ |||+++..
T Consensus 104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999999997642 2458999999999999999999995 78887654
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
... ......||+.|+|||++....++.++|||||||++|||+||+.||........ ............. ..
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~-~~- 252 (336)
T 3fhr_A 182 TQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGMKRRIRLGQY-GF- 252 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CC-
T ss_pred ccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhHHHhhhcccc-cc-
Confidence 321 22345789999999999888899999999999999999999999854322111 0000111110000 00
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+ .+........+.+++.+||+.||++|||+.|+++
T Consensus 253 -~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 -P---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -C---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0111112235678889999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=268.44 Aligned_cols=230 Identities=21% Similarity=0.226 Sum_probs=166.9
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee-----
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK----- 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----- 254 (435)
.+|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|||||++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57899999999999999999864 588999999975332 2346788999999999999999999999877655
Q ss_pred -EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 255 -LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 255 -~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
++||||+. |+|..++.. .+++.....++.+++.||+|||+ |||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 688777632 38899999999999999999996 89998765
Q ss_pred cccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+........ .+.
T Consensus 195 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~-~~~ 265 (371)
T 4exu_A 195 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPG-TEF 265 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCC-HHH
T ss_pred cc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCc-HHH
Confidence 42 2234678999999998776 7889999999999999999999999864321 111111111110000 000
Q ss_pred cc--------------ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LD--------------PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~--------------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. +...... .......+.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000 0011235678899999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=269.91 Aligned_cols=237 Identities=24% Similarity=0.281 Sum_probs=170.8
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeC-----Cee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-----EEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 254 (435)
..+|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357899999999999999999865 588999999964332 2346788999999999999999999998764 678
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++||||+. |+|.+++... .+++.....++.|++.||+|||+ |||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 6899988752 48899999999999999999996 999998754
Q ss_pred ccCcc---------ccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh
Q 040641 311 ACETH---------VSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM 380 (435)
Q Consensus 311 ~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~ 380 (435)
..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~ 239 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY----RHQLLLIFGII 239 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHh
Confidence 32111 122357899999999754 46789999999999999999999999864321 11111111111
Q ss_pred ccCCCCcccc--------------ccccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 KKQQADDVLD--------------PTVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......... +...... .......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1100000000 0000000 0011235678899999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.57 Aligned_cols=173 Identities=24% Similarity=0.238 Sum_probs=145.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCC-CC-----CceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQ-----NLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~ 254 (435)
..+|++.+.||+|+||.||+|+.. +++.||||+++... ....++.+|++++..++ |+ +||++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 468999999999999999999865 57899999997432 23456778888888775 44 499999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------ccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLA 306 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla 306 (435)
++||||++ |+|.+++.... ...+++.....++.|++.||+|||. |||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 59999987643 2348899999999999999999982 88888
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGP 362 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~ 362 (435)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765421 2346799999999999998999999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=286.93 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=174.6
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccc-ccccHHHHHHHHHHhccCCCCCceeEEEEEEe------CCe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA-KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF------DEE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 253 (435)
..+|++.+.||+|+||.||+|... +|+.||||.+... .....+.|.+|++++++++|||||++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367899999999999999999864 5889999998654 23345679999999999999999999998755 667
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLA 306 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla 306 (435)
.++||||+++|+|.+++.... ....+++.....++.+++.||+|||+ |||++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 899999999999999997643 22347888899999999999999995 88888
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHH-HHHHH-HhccCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLV-GWVFQ-KMKKQQ 384 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~-~~~~~-~~~~~~ 384 (435)
+..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||............. ..... ......
T Consensus 172 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 172 KELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 765432 22345689999999999999999999999999999999999999986432110000000 00000 000000
Q ss_pred CCcc--cccc--ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHH-----HHHHHhhh
Q 040641 385 ADDV--LDPT--VLNAGSKPMMLKMLRIAADCVADNPATRPTMLH-----VLKLLHEI 433 (435)
Q Consensus 385 ~~~~--~~~~--~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~e-----vl~~L~~i 433 (435)
.... .... ............+.+++..||+.||++|||+.| ..+.++++
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 0000 0000 011112234456778999999999999999987 34555554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=261.95 Aligned_cols=235 Identities=20% Similarity=0.254 Sum_probs=172.6
Q ss_pred ccCcceeeeecccCcceEEEEEc--CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCC------ceeEEEEEEeCCe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL--PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN------LVLLLGYCSFDEE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 253 (435)
..+|++.+.||+|+||.||+|.. .+++.||||.++... ...+.+.+|+++++.++|+| |+++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35899999999999999999985 357899999986532 33467888999998887654 9999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------- 301 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------- 301 (435)
.++||||+ +|+|.+++.... ...+++.....++.|+++||+|||+
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999999 899999987643 2357889999999999999999995
Q ss_pred -----------cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 302 -----------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK---- 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH----
T ss_pred ccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH----
Confidence 4555543221 123457899999999999889999999999999999999999998643211
Q ss_pred cHHHHHHHHhccCC--------CCccc---------------------cc-cccCCCCHHHHHHHHHHHhcccCCCCCCC
Q 040641 371 NLVGWVFQKMKKQQ--------ADDVL---------------------DP-TVLNAGSKPMMLKMLRIAADCVADNPATR 420 (435)
Q Consensus 371 ~~~~~~~~~~~~~~--------~~~~~---------------------~~-~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 420 (435)
.....+........ ..... .+ .............+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 11111111110000 00000 00 00001122344567899999999999999
Q ss_pred CCHHHHHH
Q 040641 421 PTMLHVLK 428 (435)
Q Consensus 421 Ps~~evl~ 428 (435)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=254.60 Aligned_cols=224 Identities=14% Similarity=0.132 Sum_probs=164.4
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
.+|++.+.||+|+||.||+|+.. +++.||||.+..... ...+.|.+|+.++++++|||||++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999875 489999999975432 23467999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------cccccccccccCccccccccccCCCcCCcCC
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------DFGLARLISACETHVSTDIAGTLGYIPPEYG 332 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 332 (435)
||+++|+|.++++.. ........++.|+++||+|||+ |.-...++-..+.. ...++++|++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~---~kl~~~~~~~~--- 178 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD---VVLAYPATMPD--- 178 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC---EEECSCCCCTT---
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC---EEEEeccccCC---
Confidence 999999999998532 2445678899999999999996 44433333221111 13457788875
Q ss_pred CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcc
Q 040641 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADC 412 (435)
Q Consensus 333 ~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 412 (435)
++.++|||||||++|||+||+.||............ ..........+....+. ....+.+++.+|
T Consensus 179 ----~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~l~~li~~~ 243 (286)
T 3uqc_A 179 ----ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQPIEPADIDRD---IPFQISAVAARS 243 (286)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSCBCCHHHHCTT---SCHHHHHHHHHH
T ss_pred ----CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccCCCChhhcccC---CCHHHHHHHHHH
Confidence 688999999999999999999998654321100000 00000000000001111 123467888999
Q ss_pred cCCCCCCCCCHHHHHHHHhhhh
Q 040641 413 VADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 413 ~~~~P~~RPs~~evl~~L~~i~ 434 (435)
|+.||++| |+.|+++.|+++.
T Consensus 244 l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HCTTSSCC-CHHHHHHHHHHHH
T ss_pred cccCCccC-CHHHHHHHHHHHh
Confidence 99999999 9999999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=267.16 Aligned_cols=239 Identities=18% Similarity=0.180 Sum_probs=173.1
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-----------CCCceeEEEEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-----------HQNLVLLLGYCS 249 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 249 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+.... .....+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999986 468899999986432 23467889999998886 899999999987
Q ss_pred eCC----eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------
Q 040641 250 FDE----EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------ 301 (435)
Q Consensus 250 ~~~----~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------ 301 (435)
..+ ..++||||+ +|+|.+++.... ...+++.....++.|++.||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 654 689999999 999999987643 2348889999999999999999985
Q ss_pred -------cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC--CcH
Q 040641 302 -------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG--ANL 372 (435)
Q Consensus 302 -------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~--~~~ 372 (435)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 67777654321 23457999999999998888999999999999999999999998643221110 011
Q ss_pred HHHHHHHhccCC-------------------CCcccccc---------ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHH
Q 040641 373 VGWVFQKMKKQQ-------------------ADDVLDPT---------VLNAGSKPMMLKMLRIAADCVADNPATRPTML 424 (435)
Q Consensus 373 ~~~~~~~~~~~~-------------------~~~~~~~~---------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~ 424 (435)
...+........ ........ ............+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111111111000 00000000 00112345566788999999999999999999
Q ss_pred HHHH
Q 040641 425 HVLK 428 (435)
Q Consensus 425 evl~ 428 (435)
|+++
T Consensus 330 ell~ 333 (373)
T 1q8y_A 330 GLVN 333 (373)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-33 Score=264.97 Aligned_cols=230 Identities=20% Similarity=0.194 Sum_probs=165.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe------
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE------ 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 253 (435)
.+|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57899999999999999999864 689999999865322 234678999999999999999999999987654
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.++||||++ |+|.+++.. .+++.....++.|+++||+|||+ |||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 687766532 38889999999999999999996 89988764
Q ss_pred cccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC----
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ---- 384 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 384 (435)
... .....||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..... ......+........
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHHHHHHCBCCHHHH
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 321 234578999999998766 6789999999999999999999999854321 111111111110000
Q ss_pred --------------CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 --------------ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
......+.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 0000112235678889999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=267.69 Aligned_cols=239 Identities=20% Similarity=0.177 Sum_probs=169.4
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC--------CCCceeEEEEEE---
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK--------HQNLVLLLGYCS--- 249 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 249 (435)
..+|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 35799999999999999999985 458899999996432 33467889999999886 788999999987
Q ss_pred -eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeecc--------------------------
Q 040641 250 -FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQD-------------------------- 302 (435)
Q Consensus 250 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~D-------------------------- 302 (435)
.....++||||+ +|+|.+++.... ...+++.....++.|+++||+|||+.
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 456789999999 566666555432 23588999999999999999999952
Q ss_pred ------------------------------------------------ccccccccccCccccccccccCCCcCCcCCCC
Q 040641 303 ------------------------------------------------FGLARLISACETHVSTDIAGTLGYIPPEYGQS 334 (435)
Q Consensus 303 ------------------------------------------------fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 334 (435)
||+++.... ......||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcC
Confidence 222222111 1223568999999999988
Q ss_pred CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC--CcHHHHHHHHhccCCC---------Ccccccc-----c-----
Q 040641 335 RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG--ANLVGWVFQKMKKQQA---------DDVLDPT-----V----- 393 (435)
Q Consensus 335 ~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~---------~~~~~~~-----~----- 393 (435)
..++.++|||||||++|||+||+.||......... ......+......... ....... .
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 88999999999999999999999998654322111 0111111111111000 0000000 0
Q ss_pred ---------cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 ---------LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ---------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...........+.+++.+||+.||++|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00123455667889999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=260.99 Aligned_cols=216 Identities=24% Similarity=0.367 Sum_probs=162.9
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc------cHHHHHHHHHHhccC----CCCCceeEEEEEEe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ------GHRQFTAEMETLGKV----KHQNLVLLLGYCSF 250 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~~~~ 250 (435)
..+|++.+.||+|+||.||+|+. .+++.||||.+...... ....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 45799999999999999999986 46889999999654321 223456789988888 89999999999999
Q ss_pred CCeeEEEEec-ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccc
Q 040641 251 DEEKLLVYEY-MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFG 304 (435)
Q Consensus 251 ~~~~~lv~ey-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfG 304 (435)
.+..++|||| +++++|.+++.... .+++..+..++.++++||+|||+ |||
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9999999999 89999999997642 48899999999999999999996 889
Q ss_pred ccccccccCccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
+++..... ......||..|+|||+..+..+ +.++|||||||++|||++|+.||.... . .... ..
T Consensus 186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~-~~~~--~~ 250 (312)
T 2iwi_A 186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E-ILEA--EL 250 (312)
T ss_dssp SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-HHHT--CC
T ss_pred hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H-Hhhh--cc
Confidence 88766432 2234679999999998766555 458999999999999999999985310 0 0100 00
Q ss_pred CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. . + .. ....+.+++.+||+.||++|||+.|+++
T Consensus 251 ~----~-~---~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 H----F-P---AH----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp C----C-C---TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C----C-c---cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0 01 1124677889999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=262.31 Aligned_cols=217 Identities=22% Similarity=0.338 Sum_probs=170.5
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc------cHHHHHHHHHHhccCC--CCCceeEEEEEEeC
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ------GHRQFTAEMETLGKVK--HQNLVLLLGYCSFD 251 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~ 251 (435)
...+|++.+.||+|+||.||+|+. .+++.||||.+...... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346799999999999999999985 46889999998654321 2245778999999996 59999999999999
Q ss_pred CeeEEEEecccC-CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccc
Q 040641 252 EEKLLVYEYMVN-GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGL 305 (435)
Q Consensus 252 ~~~~lv~ey~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGl 305 (435)
+..++||||+.+ ++|.+++.... .+++.....++.|+++||+|||+ |||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999986 89999997642 47889999999999999999996 8998
Q ss_pred cccccccCccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC
Q 040641 306 ARLISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384 (435)
Q Consensus 306 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (435)
++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... . . .....
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~-~---~~~~~ 260 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E-I---IRGQV 260 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-H---HHCCC
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------h-h---hcccc
Confidence 8766432 2234679999999998766555 678999999999999999999985321 0 0 01000
Q ss_pred CCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+ . ....+.+++.+||+.||++|||+.||++
T Consensus 261 ---~~~~----~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ---FFRQ----R----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---CCSS----C----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cccc----c----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1 1125678889999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=258.42 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=170.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CC-CEEEEEEccccccccHHHHHHHHHHhccCCCCC------ceeEEEEEEeCCe
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DG-KTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN------LVLLLGYCSFDEE 253 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 253 (435)
..+|++.+.||+|+||.||+|... ++ +.||||.++... ...+.+.+|+.++++++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 358999999999999999999864 34 689999996432 33467888999999988766 9999999999999
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------------- 301 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------- 301 (435)
.++||||+ +|+|.+++.... ...+++.....++.|+++||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 99999999 667766665532 2358899999999999999999995
Q ss_pred -----------cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCC
Q 040641 302 -----------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGA 370 (435)
Q Consensus 302 -----------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~ 370 (435)
|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR---- 245 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred cccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 5666554321 123457999999999998889999999999999999999999998643211
Q ss_pred cHHHHHHHHhccCCC--------Ccc-cc--------------------c-cccCCCCHHHHHHHHHHHhcccCCCCCCC
Q 040641 371 NLVGWVFQKMKKQQA--------DDV-LD--------------------P-TVLNAGSKPMMLKMLRIAADCVADNPATR 420 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~--------~~~-~~--------------------~-~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 420 (435)
.....+......... ... .. + .............+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 111111111110000 000 00 0 00001112234467889999999999999
Q ss_pred CCHHHHHH
Q 040641 421 PTMLHVLK 428 (435)
Q Consensus 421 Ps~~evl~ 428 (435)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=285.60 Aligned_cols=215 Identities=20% Similarity=0.284 Sum_probs=166.8
Q ss_pred cCcceeeeecccCcceEEEEEcC--CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe-----e
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP--DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE-----K 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 254 (435)
.+|++.+.||+|+||.||+|++. +++.||||.+.... ......|.+|++++++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57999999999999999999865 58899999986533 2344678999999999999999999999987665 6
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------cccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------DFGLARLISA 311 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------DfGla~~~~~ 311 (435)
|+||||+++++|.+++.. .+++..++.++.|+++||+|||+ |||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhccc
Confidence 999999999999887643 48999999999999999999996 8999887543
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ....||++|+|||++.+. ++.++|||||||++|||++|..|+........ . .
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------~---~- 286 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------P---E- 286 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------C---T-
T ss_pred C-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------------c---c-
Confidence 2 346799999999987654 48899999999999999999888643221100 0 0
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHHHhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPT-MLHVLKLLHEI 433 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl~~L~~i 433 (435)
..........+.+++.+||+.||++||+ +.++...|..+
T Consensus 287 ---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 ---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000112235678899999999999995 55566666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=240.40 Aligned_cols=227 Identities=15% Similarity=0.132 Sum_probs=152.5
Q ss_pred cCccee-eeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHh-ccCCCCCceeEEEEEEe----CCeeE
Q 040641 183 LKLTLV-DILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETL-GKVKHQNLVLLLGYCSF----DEEKL 255 (435)
Q Consensus 183 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 255 (435)
.+|.+. ++||+|+||.||+|.. .+++.||||.+.. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7899999999999986 4688999999853 24577899887 66799999999999876 67789
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------cccccccccccCccccccccccCCCcCC
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------DFGLARLISACETHVSTDIAGTLGYIPP 329 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------DfGla~~~~~~~~~~~~~~~gt~~y~aP 329 (435)
+||||+++|+|.+++.... ...+++.....++.+++.||+|||+ |.-...++-........-..+ .|-..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~--Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT--DFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC--CCTTC
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe--ccccc
Confidence 9999999999999998643 2358899999999999999999986 443333322110000000001 11112
Q ss_pred cCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHH
Q 040641 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIA 409 (435)
Q Consensus 330 E~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 409 (435)
+...+..++.++|||||||++|||+||+.||........ ........... ......+........+.+++
T Consensus 168 ~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li 237 (299)
T 3m2w_A 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------SPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLI 237 (299)
T ss_dssp EECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------CCSCCSSCTT--CCSSCHHHHTTSCHHHHHHH
T ss_pred cccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh--------hHHHHHHHhhc--cccCCchhcccCCHHHHHHH
Confidence 233456688999999999999999999999854321100 00000000000 00000000001123567888
Q ss_pred hcccCCCCCCCCCHHHHHH
Q 040641 410 ADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 410 ~~C~~~~P~~RPs~~evl~ 428 (435)
.+||+.||++|||+.|+++
T Consensus 238 ~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 238 RNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHT
T ss_pred HHHcccChhhCCCHHHHhc
Confidence 9999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=254.42 Aligned_cols=221 Identities=16% Similarity=0.155 Sum_probs=156.3
Q ss_pred cccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCC-CCcee----------
Q 040641 179 QQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKH-QNLVL---------- 243 (435)
Q Consensus 179 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~---------- 243 (435)
..+...|...+.||+|+||.||+|++ .+|+.||||++..... ...+.|.+|+.+++.++| +|...
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 34456688899999999999999994 5689999999873322 235789999999999987 32211
Q ss_pred -----------EEEEEEe-----CCeeEEEEecccCCCHHHHHHhh---CCCCCCCCHHHHHHHHHHhhhccceeec---
Q 040641 244 -----------LLGYCSF-----DEEKLLVYEYMVNGSLDLWLRNA---TGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301 (435)
Q Consensus 244 -----------l~g~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gl~yLH~--- 301 (435)
+..++.. ....+++|+++ +|+|.+++... ......+++..++.++.|+++||+|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111111 12356777765 68999887521 2223457888999999999999999996
Q ss_pred ---------------------cccccccccccCccccccccccCCCcCCcCC----------CCCCCCCcccchhHHHHH
Q 040641 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYG----------QSRMSTTRGDVYSFGVIL 350 (435)
Q Consensus 302 ---------------------DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DV~SfGvil 350 (435)
|||+++..... ....+| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99998765432 344678 999999988 666788999999999999
Q ss_pred HHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 351 LELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 351 ~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
|||+||+.||......... ....... .. ....+.+++.+||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~----------------~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS----------------EWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS----------------GGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhH----------------HHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999998643221110 0000000 00 113577888999999999999987775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=231.86 Aligned_cols=218 Identities=16% Similarity=0.134 Sum_probs=157.0
Q ss_pred cccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--------cccHHHHHHHHHHhccCC---------CCCcee
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--------TQGHRQFTAEMETLGKVK---------HQNLVL 243 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~ 243 (435)
...+|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ |||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346789999999999999999998 68999999997542 223477889999988885 888888
Q ss_pred EEEEEE------------------------------eCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhh
Q 040641 244 LLGYCS------------------------------FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSA 293 (435)
Q Consensus 244 l~g~~~------------------------------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia 293 (435)
+.+++. ..+..++|||||++|++.+.+.. ..+++.....++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 888653 26789999999999976554432 2478899999999999
Q ss_pred hccceee-c--------------------------------------------cccccccccccCccccccccccCCCcC
Q 040641 294 RGLAFLH-Q--------------------------------------------DFGLARLISACETHVSTDIAGTLGYIP 328 (435)
Q Consensus 294 ~gl~yLH-~--------------------------------------------DfGla~~~~~~~~~~~~~~~gt~~y~a 328 (435)
.||+||| + |||+|+.... ...+||+.|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 9999999 3 6777765432 23479999999
Q ss_pred CcCCCCCCCCCcccchhHHHH-HHHHHhCCCCCCCCcccccCCcHHHHHHHHhc-cCCCCccccccccCCCCHHHHHHHH
Q 040641 329 PEYGQSRMSTTRGDVYSFGVI-LLELVTAKEPTGPEFQEKEGANLVGWVFQKMK-KQQADDVLDPTVLNAGSKPMMLKML 406 (435)
Q Consensus 329 PE~~~~~~~~~k~DV~SfGvi-l~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (435)
||++.+.. +.++||||++++ .+++++|..||... .........+. ...... .............+.
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKIQ 313 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccCc----ccchhhhhhcCHHHH
Confidence 99988766 889999998776 78888898886210 00000111111 111100 000111234556788
Q ss_pred HHHhcccCCCCCCCCCHHHHH
Q 040641 407 RIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 407 ~l~~~C~~~~P~~RPs~~evl 427 (435)
+++.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 8999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.6e-23 Score=205.88 Aligned_cols=161 Identities=19% Similarity=0.067 Sum_probs=105.9
Q ss_pred eecccCcceEEEEE-cCCCCEEEEEEccccc----------cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCeeEEE
Q 040641 190 ILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK----------TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 190 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 257 (435)
..+.|++|.++.++ ...|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35677777766654 3358899999986431 12346799999999999 799999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||++||+|.++|.... .++.. +|+.||+.||+|+|+ |||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999997642 34543 488999999999996 999998765432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEP 359 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p 359 (435)
...+..+||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 233457899999999998764 56789999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-21 Score=195.56 Aligned_cols=161 Identities=14% Similarity=0.088 Sum_probs=123.7
Q ss_pred eeeeecccCcceEEEEEcCCCCEEEEEEcccccc--------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 187 LVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT--------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 187 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
..++||+|+||.||+|.. .++.+|+|+...... ...+.|.+|++++++++|||||++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999965 468899998643221 11345899999999999999997777777888889999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------cccccccccccCcc-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------DFGLARLISACETH- 315 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------DfGla~~~~~~~~~- 315 (435)
||+++|+|.+++.. +..++.|+++||+|||+ |||+++........
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHH
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECCeEEEEECccCEECCCccccc
Confidence 99999999999864 34789999999999995 99999886543221
Q ss_pred -----ccccccccCCCcCCcCCCC--CCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 316 -----VSTDIAGTLGYIPPEYGQS--RMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 316 -----~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
.....+||+.|||||++.. ..|+.++|+||..+-..|.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999998876 56788899999999999998888775
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=193.44 Aligned_cols=128 Identities=36% Similarity=0.625 Sum_probs=80.5
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCc------------------------
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSL------------------------ 57 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~------------------------ 57 (435)
+|.+|.+++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|.++|.+|..+
T Consensus 503 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (768)
T 3rgz_A 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCS
T ss_pred CCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccc
Confidence 45666666666666666666666666666666666666666666666665555432
Q ss_pred ----------------------------------------------cCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEe
Q 040641 58 ----------------------------------------------GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLD 91 (435)
Q Consensus 58 ----------------------------------------------~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 91 (435)
+.+++|+.|||++|.++|.+|..+++++.|+.|+
T Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 662 (768)
T 3rgz_A 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662 (768)
T ss_dssp CCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEe
Confidence 2234556666666666666666666666666666
Q ss_pred CCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 92 LHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 92 l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+++|+++|.+|..++++++|+.||+++|+++|.+|..+
T Consensus 663 Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l 700 (768)
T 3rgz_A 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGG
T ss_pred CcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHH
Confidence 66666666666666666666666666666666666544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.2e-20 Score=194.23 Aligned_cols=129 Identities=36% Similarity=0.651 Sum_probs=85.7
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
+|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.||+++|.++|.+|..+
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 45666666666777777777777766666666667777777777777766666666666677777777666666555432
Q ss_pred ----------------------------------------------------------------------CCCCCCCEEe
Q 040641 82 ----------------------------------------------------------------------GNLSYSTYLD 91 (435)
Q Consensus 82 ----------------------------------------------------------------------~~l~~L~~L~ 91 (435)
+.+++|++|+
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 2234566667
Q ss_pred CCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 92 LHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 92 l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
+++|+++|.+|..+++++.|+.|++++|.++|.+|..+.
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~ 677 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHh
Confidence 777777666776666677777777777777766666543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=168.97 Aligned_cols=131 Identities=32% Similarity=0.547 Sum_probs=122.7
Q ss_pred Ccc--cCCccccCCCCCCeeecCC-CcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcC
Q 040641 1 LTG--SIPSEFGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW 77 (435)
Q Consensus 1 l~g--~lp~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 77 (435)
++| .+|..++++++|++|+|++ |.+.+.+|..++++++|++|+|++|.+++.+|..+..+++|++|+|++|.+++.+
T Consensus 62 l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 141 (313)
T 1ogq_A 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141 (313)
T ss_dssp CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred ccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcC
Confidence 456 7999999999999999995 9999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCEEeCCCCCCcccCCccccCcC-CCCcccccCCcceecCCccccc
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLA-QLEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~-~L~~l~l~~n~l~g~~p~~~~~ 131 (435)
|..++.+++|++|++++|.+++.+|..+++++ +|+.|++++|.+++.+|..+..
T Consensus 142 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~ 196 (313)
T 1ogq_A 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred ChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC
Confidence 99999999999999999999999999999998 9999999999999999987654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=167.78 Aligned_cols=119 Identities=25% Similarity=0.401 Sum_probs=103.9
Q ss_pred CCCCeeecCCCcccc--cCCcccCCCCCCcEEECCC-CcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 13 LKLQGLYLGNNQLTG--SIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~ls~-n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
.+++.|+|++|.++| .+|..++++++|++|+|++ |.+.+.+|..++.+++|++|+|++|.+++.+|..++++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578889999999988 8888899999999999984 8888888888889999999999999998888888888999999
Q ss_pred EeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccccc
Q 040641 90 LDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 90 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~~ 131 (435)
|++++|.+++.+|..++++++|++|++++|.++|.+|..+..
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 171 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhh
Confidence 999999988888888888999999999999988888876643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-20 Score=184.33 Aligned_cols=30 Identities=13% Similarity=0.062 Sum_probs=25.2
Q ss_pred cHHHHHHHHHHhccCCCCCceeEEEEEEeC
Q 040641 222 GHRQFTAEMETLGKVKHQNLVLLLGYCSFD 251 (435)
Q Consensus 222 ~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 251 (435)
..++|.+|++.+++++|+|+|+++|||...
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 356899999999999999999999999654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-18 Score=146.51 Aligned_cols=122 Identities=25% Similarity=0.324 Sum_probs=109.5
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCc-ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
+.||..+.. +|+.|+|++|++++..+. .++.+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|..|
T Consensus 21 ~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 98 (192)
T 1w8a_A 21 KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMF 98 (192)
T ss_dssp SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSS
T ss_pred CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHh
Confidence 357776654 899999999999865554 48999999999999999998888999999999999999999998888889
Q ss_pred CCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
.++++|++|++++|++++.+|..+..+++|+.|++++|.+.+..+
T Consensus 99 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 99 LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999999999999999999999999999999999999999987655
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-18 Score=160.08 Aligned_cols=124 Identities=22% Similarity=0.291 Sum_probs=70.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCC---------CCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ---------LGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~---------l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 74 (435)
.||..++++++|+.|+|++|++.+.+|..++. +++|+.|+|++|.++ .+|..++.+++|+.|+|++|.++
T Consensus 141 ~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 35555666666666666665555555555443 555555555555555 45555555555555555555555
Q ss_pred CcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 75 GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 75 ~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+ +|..++.+++|++|++++|++.+.+|..++++++|+.|++++|.+.+.+|..+
T Consensus 220 ~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~ 273 (328)
T 4fcg_A 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273 (328)
T ss_dssp C-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred c-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence 3 44455555555555555555555555555555555555555555555555443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=148.37 Aligned_cols=124 Identities=21% Similarity=0.233 Sum_probs=84.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCc-ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPR-SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~-~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.||..+.. .++.|+|++|++++..|. .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..|.
T Consensus 25 ~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 102 (220)
T 2v70_A 25 KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFK 102 (220)
T ss_dssp SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGT
T ss_pred cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhc
Confidence 35655533 346777777777755443 366777777777777777765555677777777777777777766666677
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
.+++|++|++++|++++..|..+..+++|+.|++++|.+++..|..+
T Consensus 103 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 149 (220)
T 2v70_A 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149 (220)
T ss_dssp TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT
T ss_pred CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh
Confidence 77777777777777776667777777777777777777776555444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-17 Score=147.98 Aligned_cols=115 Identities=23% Similarity=0.216 Sum_probs=53.6
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.|+.+++|+.|+|++|++++..|..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..+..+..+++|
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 133 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc
Confidence 34444444445554444444444444444445555555554443333334444445555555554443333334444445
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++++|++++..+..++++++|+.|++++|.++
T Consensus 134 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 134 KELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 55555555444333334444444555555555444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=176.91 Aligned_cols=98 Identities=16% Similarity=0.231 Sum_probs=55.5
Q ss_pred CCcccCCCCCCcEEECCCCcCccC-----------------CCcCcc--CCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 29 IPRSLGQLGGLVKLNLTRNKFSGP-----------------VPTSLG--NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 29 ~p~~~~~l~~L~~L~ls~n~l~~~-----------------~p~~~~--~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
+|.+++++++|++|+|++|.++|. +|..++ ++++|++|+|++|.+.|.+|..++++++|++
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 277 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence 555555556666666666665553 555555 5555666666666555555555555555556
Q ss_pred EeCCCCC-Ccc-cCCccccCc------CCCCcccccCCcceecCCc
Q 040641 90 LDLHDNK-FTR-EIPQNLGNL------AQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 90 L~l~~n~-~~~-~~p~~~~~l------~~L~~l~l~~n~l~g~~p~ 127 (435)
|++++|+ ++| .+|..++++ ++|+.|++++|.++ .+|.
T Consensus 278 L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred EECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 6655555 555 555555444 55555555555555 4444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.9e-18 Score=176.25 Aligned_cols=126 Identities=21% Similarity=0.314 Sum_probs=118.6
Q ss_pred CcccCCccccCCCCCCeeecCCCccccc-----------------CCcccC--CCCCCcEEECCCCcCccCCCcCccCCC
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGS-----------------IPRSLG--QLGGLVKLNLTRNKFSGPVPTSLGNLK 61 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g~-----------------~p~~~~--~l~~L~~L~ls~n~l~~~~p~~~~~l~ 61 (435)
|+| ||.+++++++|++|+|++|.++|. +|.+++ ++++|++|+|++|.+.|.+|..+++++
T Consensus 195 l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 273 (636)
T 4eco_A 195 ITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273 (636)
T ss_dssp EEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS
T ss_pred Ccc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCC
Confidence 357 999999999999999999999986 999999 999999999999999999999999999
Q ss_pred CCCeEECcCcc-cCC-cCCCcCCCC------CCCCEEeCCCCCCcccCCc--cccCcCCCCcccccCCcceecCCccc
Q 040641 62 GLSHLDLSSNF-FDG-GWPRSLGNL------SYSTYLDLHDNKFTREIPQ--NLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 62 ~L~~L~l~~n~-l~~-~~p~~~~~l------~~L~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+|+.|+|++|. ++| .+|..++.+ ++|++|++++|+++ .+|. .++++++|+.|++++|.++|.+| .+
T Consensus 274 ~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 99999999998 998 899988887 99999999999998 8999 89999999999999999999999 44
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.72 E-value=7.6e-17 Score=143.04 Aligned_cols=122 Identities=20% Similarity=0.217 Sum_probs=104.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+. ++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|.++...+..|..
T Consensus 25 ~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~ 102 (220)
T 2v9t_B 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEG 102 (220)
T ss_dssp SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTT
T ss_pred cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccC
Confidence 3666554 68999999999999766778999999999999999999877888999999999999999998655556788
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
+++|++|++++|++++..|..+..+++|+.|++++|.+++..+.
T Consensus 103 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 103 LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 99999999999999988888899999999999999998865544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.9e-17 Score=143.75 Aligned_cols=118 Identities=24% Similarity=0.265 Sum_probs=108.2
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|..++
T Consensus 49 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 128 (220)
T 2v9t_B 49 PGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128 (220)
T ss_dssp TTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCC
Confidence 45789999999999999999988899999999999999999999954444578999999999999999998899999999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+|++|++++|++++..+..+..+++|+.|++++|.+..
T Consensus 129 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99999999999998777789999999999999998864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-16 Score=143.05 Aligned_cols=122 Identities=28% Similarity=0.288 Sum_probs=107.3
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+.+|..+. ++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..+..|.
T Consensus 32 ~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 109 (229)
T 3e6j_A 32 ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFD 109 (229)
T ss_dssp SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhC
Confidence 35776664 7899999999999988899999999999999999999854445679999999999999999977677789
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
.+++|++|++++|+++ .+|..+..+++|+.|++++|.+++..+.
T Consensus 110 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp TCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred cchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 9999999999999998 7999999999999999999999854443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-16 Score=143.04 Aligned_cols=125 Identities=25% Similarity=0.290 Sum_probs=110.2
Q ss_pred CcccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS 80 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 80 (435)
+++..|..|..+++|+.|+|++|+++...+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.++ .+|..
T Consensus 52 i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~ 130 (229)
T 3e6j_A 52 ITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred cCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence 34556788999999999999999998555566799999999999999999765666899999999999999998 78999
Q ss_pred CCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 81 LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 81 ~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+..+++|++|++++|++++..+..+..+++|+.|++++|.+.+..+
T Consensus 131 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999999999999987666778999999999999999876543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-17 Score=154.88 Aligned_cols=124 Identities=23% Similarity=0.322 Sum_probs=114.1
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccC---------CCCCCeEECcCcccC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN---------LKGLSHLDLSSNFFD 74 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~---------l~~L~~L~l~~n~l~ 74 (435)
.+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|++.+.+|..++. +++|+.|+|++|.++
T Consensus 118 ~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 196 (328)
T 4fcg_A 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196 (328)
T ss_dssp CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC
T ss_pred chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC
Confidence 68999999999999999999999 89999999999999999999998999988765 999999999999998
Q ss_pred CcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 75 GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 75 ~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
.+|..++.+++|++|++++|.+++ +|..++++++|+.|++++|.+.+.+|..+.
T Consensus 197 -~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~ 250 (328)
T 4fcg_A 197 -SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG 250 (328)
T ss_dssp -CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT
T ss_pred -cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc
Confidence 799999999999999999999984 778899999999999999999999887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-16 Score=141.41 Aligned_cols=119 Identities=24% Similarity=0.247 Sum_probs=107.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.|..+++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..|..+++|
T Consensus 52 ~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 131 (220)
T 2v70_A 52 IFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131 (220)
T ss_dssp CGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTC
T ss_pred hhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccC
Confidence 47899999999999999997777789999999999999999997666679999999999999999998889999999999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++++|++++..|..+..+++|+.|++++|.+.+..+
T Consensus 132 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999999998889999999999999999999886544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-16 Score=139.06 Aligned_cols=120 Identities=23% Similarity=0.227 Sum_probs=86.0
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+ .++|+.|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+
T Consensus 22 ~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 99 (208)
T 2o6s_A 22 VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL 99 (208)
T ss_dssp CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCc
Confidence 45433 3477888888888875555567778888888888888875444456777888888888888876555567778
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++|++++|++++..+..+.++++|+.|++++|.+++..+
T Consensus 100 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 100 TQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred cCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 888888888888876555557777888888888887775433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.8e-18 Score=176.96 Aligned_cols=98 Identities=20% Similarity=0.242 Sum_probs=69.3
Q ss_pred CCcccCCCCCCcEEECCCCcCcc-----------------CCCcCcc--CCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 29 IPRSLGQLGGLVKLNLTRNKFSG-----------------PVPTSLG--NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 29 ~p~~~~~l~~L~~L~ls~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
+|.+++++++|+.|+|++|.++| .+|..++ ++++|+.|+|++|.+.+.+|..|+++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 66667777777777777777776 3777766 7777777777777777777777777777777
Q ss_pred EeCCCCC-Ccc-cCCccccCcC-------CCCcccccCCcceecCCc
Q 040641 90 LDLHDNK-FTR-EIPQNLGNLA-------QLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 90 L~l~~n~-~~~-~~p~~~~~l~-------~L~~l~l~~n~l~g~~p~ 127 (435)
|++++|+ ++| .+|..+++++ +|+.|++++|.++ .+|.
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 7777776 766 6666655554 6777777777776 5665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-16 Score=145.45 Aligned_cols=122 Identities=24% Similarity=0.212 Sum_probs=99.3
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
+.++.+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..++.+++|+.|++++|.+++..|..++.+++
T Consensus 79 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 158 (272)
T 3rfs_A 79 SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTN 158 (272)
T ss_dssp GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCcc
Confidence 36788888888999988888766667788888899999888888666666888888888888888888766666788888
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|++|++++|++++..|..++.+++|+.|++++|.+++..|..
T Consensus 159 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 200 (272)
T 3rfs_A 159 LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGV 200 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHH
Confidence 888888888888766666788888888888888888765543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-16 Score=143.18 Aligned_cols=123 Identities=22% Similarity=0.213 Sum_probs=110.2
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
++..|..|..+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..|..|
T Consensus 72 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 72 QTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHc
Confidence 44456678999999999999999997777788999999999999999996555568999999999999999997666689
Q ss_pred CCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
+.+++|++|++++|++++..|..+.++++|+.|++++|.+.+.
T Consensus 152 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999999999999987777899999999999999999865
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-16 Score=137.04 Aligned_cols=118 Identities=28% Similarity=0.361 Sum_probs=101.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+. ++|+.|+|++|+++ .+|..+.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..|..
T Consensus 24 ~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~ 100 (193)
T 2wfh_A 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDG 100 (193)
T ss_dssp SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTT
T ss_pred cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCC
Confidence 4676554 58999999999998 78889999999999999999999766677999999999999999999877788999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
+++|++|++++|+++...+..+..+++|+.|++++|.+...
T Consensus 101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 101 LKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999999999999865555688899999999999988643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-16 Score=133.66 Aligned_cols=121 Identities=21% Similarity=0.194 Sum_probs=103.0
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+|..+ .++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..+..+..
T Consensus 21 ~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 98 (177)
T 2o6r_A 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDK 98 (177)
T ss_dssp SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhC
Confidence 356544 368999999999999766667899999999999999999655556899999999999999999777777899
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+++|++|++++|++++..+..+..+++|+.|++++|.+.+..|
T Consensus 99 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 99 LTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999999999986555556889999999999999987655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.3e-16 Score=141.80 Aligned_cols=120 Identities=25% Similarity=0.235 Sum_probs=105.2
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
+.++.+++|+.|+|++|.+++ + +.+..+++|++|+|++|.+++..|..++.+++|+.|+|++|.+++..|..++.+++
T Consensus 57 ~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 134 (272)
T 3rfs_A 57 QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134 (272)
T ss_dssp TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCC
Confidence 358889999999999999985 4 48899999999999999999766667899999999999999999877777899999
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|++|++++|++++..|..++++++|+.|++++|.+++..|..
T Consensus 135 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 176 (272)
T 3rfs_A 135 LTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGV 176 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHH
Confidence 999999999998766777889999999999999998765543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-17 Score=173.31 Aligned_cols=122 Identities=22% Similarity=0.258 Sum_probs=111.8
Q ss_pred cccCCccccCCCCCCeeecCCCcccc-----------------cCCcccC--CCCCCcEEECCCCcCccCCCcCccCCCC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTG-----------------SIPRSLG--QLGGLVKLNLTRNKFSGPVPTSLGNLKG 62 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g-----------------~~p~~~~--~l~~L~~L~ls~n~l~~~~p~~~~~l~~ 62 (435)
+| ||.+|+++++|+.|+|++|+|+| .+|++++ ++++|++|+|++|.+.|.+|..++++++
T Consensus 438 ~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~ 516 (876)
T 4ecn_A 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516 (876)
T ss_dssp EE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSS
T ss_pred cc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCC
Confidence 45 99999999999999999999998 4999988 9999999999999999999999999999
Q ss_pred CCeEECcCcc-cCC-cCCCcCCCCC-------CCCEEeCCCCCCcccCCc--cccCcCCCCcccccCCcceecCC
Q 040641 63 LSHLDLSSNF-FDG-GWPRSLGNLS-------YSTYLDLHDNKFTREIPQ--NLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 63 L~~L~l~~n~-l~~-~~p~~~~~l~-------~L~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
|+.|+|++|. ++| .+|..++.+. +|++|++++|+++ .+|. .++++++|+.|++++|.++ .+|
T Consensus 517 L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp CCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred CCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence 9999999998 998 8888666555 9999999999998 8998 8999999999999999998 777
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=9e-16 Score=141.74 Aligned_cols=122 Identities=23% Similarity=0.245 Sum_probs=100.1
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCc-CccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK-FSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
|..|..+++|+.|+|++|.+++..|..+..+++|++|+|++|. +....|..+..+++|+.|++++|.+++..|..+.++
T Consensus 49 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 128 (285)
T 1ozn_A 49 AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred HHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCC
Confidence 4568888889999999998887778888888899999999887 765557778888888999999888887777888888
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
++|++|++++|.+++..+..++++++|+.|++++|.+++..+.
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 8888888888888766666688888888888888888765443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.5e-16 Score=154.37 Aligned_cols=111 Identities=23% Similarity=0.224 Sum_probs=63.6
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
++|+.|+|++|.+++.+|..++.+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..++.+++|++|++
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 35555555555555555555555555555555555555544555555555555555555555544555555555555555
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++++..|..+.++++|+.|++++|.+++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcccccChhhccccccccEEECCCCcccc
Confidence 5555555555555555555555555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-15 Score=139.05 Aligned_cols=123 Identities=22% Similarity=0.206 Sum_probs=107.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcc-cCCcCCCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF-FDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~ 83 (435)
+|..+ .++|+.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|. ++...|..+..
T Consensus 26 ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~ 103 (285)
T 1ozn_A 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103 (285)
T ss_dssp CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTT
T ss_pred CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcC
Confidence 55544 4689999999999997777789999999999999999998778899999999999999997 77666888999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+++|++|++++|.+++..|..+.++++|+.|++++|.+++..+..+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 149 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHh
Confidence 9999999999999998778889999999999999999986554433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-15 Score=132.15 Aligned_cols=121 Identities=22% Similarity=0.236 Sum_probs=106.4
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+..++.+++|+.|+|++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..+..+..++
T Consensus 45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 124 (208)
T 2o6s_A 45 NGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124 (208)
T ss_dssp TTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCC
Confidence 34578999999999999999966566679999999999999999965555689999999999999999977677789999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++|++++|++++..+..+.++++|+.|++++|.+.+..|
T Consensus 125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99999999999987666668999999999999999887665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.3e-15 Score=136.83 Aligned_cols=111 Identities=23% Similarity=0.192 Sum_probs=63.9
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
++|+.|+|++|++++..+..+.++++|++|+|++|.++...+..|..+++|+.|+|++|.+++..+..+..+++|++|++
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 35666666666666444445666666666666666665322223455666666666666665444445555666666666
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|.+++..|..++++++|++|++++|.+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 147 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCc
Confidence 6666655444555566666666666665553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=132.69 Aligned_cols=110 Identities=26% Similarity=0.286 Sum_probs=86.2
Q ss_pred CCCCCeeecCCCccc-ccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 12 SLKLQGLYLGNNQLT-GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 12 l~~L~~L~l~~n~l~-g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
.++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 467888888888887 77887778888888888888888754 677788888888888888887677777778888888
Q ss_pred eCCCCCCcccCC--ccccCcCCCCcccccCCcceec
Q 040641 91 DLHDNKFTREIP--QNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 91 ~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
++++|.+++ +| ..+..+++|+.|++++|.+++.
T Consensus 101 ~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~ 135 (168)
T 2ell_A 101 NLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNL 135 (168)
T ss_dssp ECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTS
T ss_pred eccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcch
Confidence 888888865 33 6677888888888888887754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.1e-16 Score=131.09 Aligned_cols=114 Identities=22% Similarity=0.239 Sum_probs=102.0
Q ss_pred CCCCCCeeecCCCccc-ccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 11 DSLKLQGLYLGNNQLT-GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~-g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
..++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.+++|+.|++++|.+++.+|..++.+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 88999999999999999999999864 78999999999999999999888888888999999
Q ss_pred EeCCCCCCccc-CCccccCcCCCCcccccCCcceecCC
Q 040641 90 LDLHDNKFTRE-IPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 90 L~l~~n~~~~~-~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
|++++|.+++. .|..++.+++|+.|++++|.+++..+
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999999863 44789999999999999999986544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-15 Score=139.29 Aligned_cols=106 Identities=29% Similarity=0.255 Sum_probs=49.6
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
.|+.|+|++|.+++..|..+.++++|+.|+|++|.+++ +|.. +.+++|+.|+|++|.++ .+|..+..+++|++|+++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 45555555555554444445555555555555555442 2221 34444444444444444 344444444444444444
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcce
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+|++++..|..|.++++|+.|++++|.++
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 44444333334444444444444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=155.59 Aligned_cols=127 Identities=21% Similarity=0.195 Sum_probs=110.5
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+-.|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++
T Consensus 46 ~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 125 (606)
T 3vq2_A 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIG 125 (606)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCT
T ss_pred EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccC
Confidence 43455788999999999999999987788899999999999999999987788899999999999999999877778899
Q ss_pred CCCCCCEEeCCCCCCcc-cCCccccCcCCCCcccccCCcceecCCccc
Q 040641 83 NLSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
++++|++|++++|.+++ .+|..++++++|++|++++|.+++..|..+
T Consensus 126 ~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp TCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 99999999999999875 679999999999999999999988766543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-15 Score=139.21 Aligned_cols=123 Identities=24% Similarity=0.227 Sum_probs=83.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+. ++|+.|+|++|++++..+..+.++++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..|..+.++
T Consensus 22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (276)
T 2z62_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99 (276)
T ss_dssp CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence 455443 357777777777775555577777777777777777775555567777777777777777776666667777
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee-cCCccc
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG-KIPEKI 129 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g-~~p~~~ 129 (435)
++|++|++++|.+++..+..++++++|+.|++++|.+.+ .+|..+
T Consensus 100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~ 145 (276)
T 2z62_A 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145 (276)
T ss_dssp TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG
T ss_pred ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhh
Confidence 777777777777766555567777777777777777664 234433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.1e-16 Score=128.77 Aligned_cols=114 Identities=28% Similarity=0.232 Sum_probs=102.2
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCc-CCCcC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGG-WPRSL 81 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~ 81 (435)
|.+|..++.+++|+.|+|++|.+++. ..++.+++|++|+|++|.+++.+|..++.+++|+.|++++|.+++. .|..+
T Consensus 32 ~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~ 109 (149)
T 2je0_A 32 GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109 (149)
T ss_dssp TBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGG
T ss_pred hHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHH
Confidence 68999999999999999999999965 7899999999999999999987888888899999999999999873 44889
Q ss_pred CCCCCCCEEeCCCCCCcccCC---ccccCcCCCCcccccC
Q 040641 82 GNLSYSTYLDLHDNKFTREIP---QNLGNLAQLEHLDVLR 118 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p---~~~~~l~~L~~l~l~~ 118 (435)
+.+++|++|++++|.+++..+ ..++.+++|+.|++++
T Consensus 110 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 110 KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp GGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred hhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999999999999986555 4788999999999863
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.7e-16 Score=163.52 Aligned_cols=121 Identities=29% Similarity=0.356 Sum_probs=108.4
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
.|..+..+..|+.|+|++|.+. .+|..+.++++|+.|+|++|.|+ .+|..|+.|++|+.|||++|.|+ .+|..|++|
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3567889999999999999998 89999999999999999999999 89999999999999999999999 789999999
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
++|++|+|++|.++ .+|..|+++++|+.|+|++|.++|.+|..+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 99999999999996 899999999999999999999998888654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=156.47 Aligned_cols=119 Identities=23% Similarity=0.214 Sum_probs=59.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
+|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|+++++|
T Consensus 71 ~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L 150 (635)
T 4g8a_A 71 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 150 (635)
T ss_dssp TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred HHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCccc
Confidence 45555555555555555554334445555555555555555553333344555555555555555554333445555555
Q ss_pred CEEeCCCCCCcc-cCCccccCcCCCCcccccCCcceecCC
Q 040641 88 TYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 88 ~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++++|.+++ .+|..++.+++|++|++++|.+++..|
T Consensus 151 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 151 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 555555555533 234445555555555555555554433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=140.99 Aligned_cols=121 Identities=20% Similarity=0.258 Sum_probs=83.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCC-cccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCC-cCCCcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG-GWPRSLG 82 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~ 82 (435)
+|..+..+++|+.|+|++|.+++..+ ..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.+++ .+|..+.
T Consensus 93 l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 172 (306)
T 2z66_A 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172 (306)
T ss_dssp EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHh
Confidence 55566777777777777777764433 466777777777777777776666667777777777777777765 4666777
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecC
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~ 125 (435)
.+++|++|++++|.+++..|..+.++++|+.|++++|.+++..
T Consensus 173 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence 7777777777777777666666777777777777777766543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=2.8e-15 Score=127.21 Aligned_cols=110 Identities=23% Similarity=0.215 Sum_probs=98.1
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
..+.|++++|.++ .+|..+. ++|+.|+|++|++++..|..|..+++|+.|+|++|.|++..|..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4678999999998 6888774 899999999999998778889999999999999999997766678999999999999
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++++..+..+.++++|+.|++++|.+....+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999997666679999999999999999876543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=2e-15 Score=140.92 Aligned_cols=124 Identities=22% Similarity=0.220 Sum_probs=113.9
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCcc-CCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG-PVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
..+..+++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|.+++..|..+..++
T Consensus 120 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 199 (306)
T 2z66_A 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199 (306)
T ss_dssp TTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC
Confidence 478899999999999999998889999999999999999999987 5888999999999999999999988899999999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
+|++|++++|.+++..+..+..+++|+.|++++|.+.+..|..+.
T Consensus 200 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp TCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred CCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 999999999999877777889999999999999999988776554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.2e-15 Score=135.02 Aligned_cols=122 Identities=26% Similarity=0.268 Sum_probs=102.5
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
|..|..+++|++|+|++|.++...+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|.+++..|..|+.++
T Consensus 54 ~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 133 (270)
T 2o6q_A 54 SKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT 133 (270)
T ss_dssp TTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCc
Confidence 34788999999999999999854444568899999999999999865555678899999999999999987777889999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
+|++|++++|.+++..+..+..+++|+.|++++|.+++..+.
T Consensus 134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 999999999999865555688899999999999988865443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-15 Score=149.02 Aligned_cols=114 Identities=18% Similarity=0.141 Sum_probs=57.9
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCC-cCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEe
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVP-TSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLD 91 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 91 (435)
++|++|+|++|.+++..|..++++++|++|+|++|.+.+.+| ..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 345555555555554445555555555555555555544332 2355555555555555555544455555555555555
Q ss_pred CCCCCCcccCCcc--ccCcCCCCcccccCCcceecCC
Q 040641 92 LHDNKFTREIPQN--LGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 92 l~~n~~~~~~p~~--~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+++|++++.+|.. ++++++|+.|++++|.+++..|
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 146 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCC
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCc
Confidence 5555554433333 4455555555555555544434
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-15 Score=154.35 Aligned_cols=124 Identities=23% Similarity=0.226 Sum_probs=108.0
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
+||..+. ++++.|||++|+|++..|.+|.++++|++|+|++|++++..|.+|.++++|++|+|++|.|++..|..|.+
T Consensus 45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~ 122 (635)
T 4g8a_A 45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 122 (635)
T ss_dssp SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence 3666553 47899999999999766778999999999999999999766668999999999999999999766678999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee-cCCccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG-KIPEKI 129 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g-~~p~~~ 129 (435)
+++|++|++++|++++..+..|+++++|+.|++++|.+.+ .+|..+
T Consensus 123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~ 169 (635)
T 4g8a_A 123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 169 (635)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG
T ss_pred CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhh
Confidence 9999999999999997666779999999999999999875 345543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.60 E-value=6.4e-15 Score=127.68 Aligned_cols=113 Identities=23% Similarity=0.254 Sum_probs=101.9
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCc-CccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
-+.|++++|+++ .+|..+.. +|+.|+|++|.+++..+. .++.+++|+.|+|++|.+++..|..|.++++|++|+++
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 378999999996 89987765 999999999999865544 38999999999999999999889999999999999999
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
+|++++..|..+.++++|+.|++++|.+++..|..+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 123 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSST
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhh
Confidence 9999988888899999999999999999998887553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=7e-15 Score=135.10 Aligned_cols=124 Identities=22% Similarity=0.210 Sum_probs=111.4
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+..|.++++|+.|+|++|++++..+..+.++++|++|+|++|.+++..|..+..+++|+.|++++|.+++..+..++.++
T Consensus 45 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 124 (276)
T 2z62_A 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124 (276)
T ss_dssp TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCC
Confidence 44799999999999999999977777899999999999999999987778899999999999999999987777899999
Q ss_pred CCCEEeCCCCCCcc-cCCccccCcCCCCcccccCCcceecCCccc
Q 040641 86 YSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 86 ~L~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+|++|++++|.+++ .+|..++++++|+.|++++|.+++..+..+
T Consensus 125 ~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 99999999999976 479999999999999999999987655433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-15 Score=143.29 Aligned_cols=117 Identities=22% Similarity=0.175 Sum_probs=84.3
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccC-CCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLG-QLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
||..+.. .++.|+|++|+|++..+..+. ++++|+.|+|++|++++..|..|..+++|+.|+|++|.|++..+..|.+
T Consensus 33 iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 110 (361)
T 2xot_A 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSD 110 (361)
T ss_dssp CCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCC
Confidence 5555433 467777777777765555565 7777777777777777655556777777777777777777655566777
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++|++|+|++|++++..|..|.++++|+.|++++|.+++
T Consensus 111 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 111 LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred CcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 7777777777777776667777777777777777777764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.59 E-value=9.3e-15 Score=135.21 Aligned_cols=119 Identities=28% Similarity=0.253 Sum_probs=105.3
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
+.+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|..|..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 78899999999999998 89999999999999999999999766677999999999999999999777777889999999
Q ss_pred EeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcccc
Q 040641 90 LDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKIC 130 (435)
Q Consensus 90 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~ 130 (435)
|++++|++++..+..+.++++|+.|++++|.++ .+|..+.
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~ 192 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhc
Confidence 999999998655555688999999999999998 5676554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-14 Score=148.38 Aligned_cols=119 Identities=18% Similarity=0.142 Sum_probs=83.3
Q ss_pred CCcc-ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 5 IPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~-~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
+|+. ++++++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..|++
T Consensus 66 lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 145 (597)
T 3oja_B 66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145 (597)
T ss_dssp ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhcc
Confidence 4543 566777777777777777666667777777777777777777655556677777777777777777544444577
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++|++|++++|.+++..|..++++++|+.|++++|.+++
T Consensus 146 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 7777777777777776666667777777777777776654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.5e-15 Score=124.67 Aligned_cols=107 Identities=23% Similarity=0.234 Sum_probs=95.1
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCC
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHD 94 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~ 94 (435)
-+.+++++|+++ .+|..+. ++|+.|+|++|++++..|..|..+++|+.|+|++|.|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 478999999997 8998775 8999999999999987788999999999999999999975555678999999999999
Q ss_pred CCCcccCCccccCcCCCCcccccCCcceec
Q 040641 95 NKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 95 n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
|++++..+..+.++++|+.|++++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999865555699999999999999988743
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.4e-15 Score=152.80 Aligned_cols=125 Identities=18% Similarity=0.179 Sum_probs=90.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCC-cccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCC-cCCCcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG-GWPRSLG 82 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~ 82 (435)
+|..+..+++|+.|++++|.+.+..| ..+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|.+++ .+|..++
T Consensus 391 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 470 (606)
T 3vq2_A 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470 (606)
T ss_dssp ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhc
Confidence 55667777777777777777776666 567777777777777777777677777777777777777777776 3666777
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
.+++|++|++++|++++..|..++++++|+.|++++|.+++.+|..+
T Consensus 471 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 517 (606)
T 3vq2_A 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517 (606)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGT
T ss_pred cCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHc
Confidence 77777777777777777667777777777777777777776655544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.3e-15 Score=145.87 Aligned_cols=121 Identities=26% Similarity=0.223 Sum_probs=73.9
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+. +.|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++..+..|.++
T Consensus 26 ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 103 (477)
T 2id5_A 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103 (477)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTC
T ss_pred CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCC
Confidence 444442 356666666666665555666666666666666666665556666666666666666666664434445666
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
++|++|++++|++++..|..+.++++|+.|++++|.+.+..|.
T Consensus 104 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 146 (477)
T 2id5_A 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence 6666666666666665566666666666666666666554443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-15 Score=129.76 Aligned_cols=116 Identities=19% Similarity=0.243 Sum_probs=103.8
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+| .+..+++|+.|++++|.++ .++.+..+++|++|++++|.+++..|..++.+++|+.|++++|.+++..|..++.
T Consensus 58 ~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~ 134 (197)
T 4ezg_A 58 DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134 (197)
T ss_dssp CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTT
T ss_pred ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhh
Confidence 456 6889999999999999775 3458999999999999999999888899999999999999999999888889999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++|++|++++|.+.+.+| .+..+++|+.|++++|.+++
T Consensus 135 l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred CCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 9999999999998445677 68899999999999998875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.4e-16 Score=145.18 Aligned_cols=104 Identities=13% Similarity=0.107 Sum_probs=79.5
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEcccccc------------------ccHHHHHHHHHHhccCCCCCceeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT------------------QGHRQFTAEMETLGKVKHQNLVLL 244 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l 244 (435)
..+.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 34567799999999999999987799999999864321 12456899999999999 4 666
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 245 ~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.+++.. +..++||||+++|+|.+ +.. . ....++.|+++||.|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~--~~~~i~~qi~~~l~~lH~ 211 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------E--NPDEVLDMILEEVAKFYH 211 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------S--CHHHHHHHHHHHHHHHHH
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------h--hHHHHHHHHHHHHHHHHH
Confidence 665543 56699999999999877 421 1 233689999999999885
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3e-15 Score=126.75 Aligned_cols=118 Identities=28% Similarity=0.231 Sum_probs=105.8
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcC-CCcC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW-PRSL 81 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~ 81 (435)
|.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|+.|+|++|.+++.. +..+
T Consensus 39 ~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l 116 (168)
T 2ell_A 39 GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116 (168)
T ss_dssp TBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGG
T ss_pred hhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHH
Confidence 68999899999999999999999965 78999999999999999999878888888999999999999998632 2789
Q ss_pred CCCCCCCEEeCCCCCCcccCC---ccccCcCCCCcccccCCcce
Q 040641 82 GNLSYSTYLDLHDNKFTREIP---QNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p---~~~~~l~~L~~l~l~~n~l~ 122 (435)
..+++|++|++++|.+++..+ ..+..+++|+.|+++.|.+.
T Consensus 117 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp SSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred hcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 999999999999999986444 37899999999999999876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-15 Score=151.38 Aligned_cols=120 Identities=26% Similarity=0.279 Sum_probs=75.9
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
||..+. ++|++|+|++|++++..|..+.++++|++|+|++|++++..|..|+.+++|++|||++|.+++..|..|+++
T Consensus 20 ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 97 (549)
T 2z81_A 20 IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97 (549)
T ss_dssp CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTC
T ss_pred ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccC
Confidence 555443 466666666666666556666666666666666666665555566666666666666666665555556666
Q ss_pred CCCCEEeCCCCCCcc-cCCccccCcCCCCcccccCCcceecCC
Q 040641 85 SYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++|++++|.+++ .+|..++++++|++|++++|.+.+.+|
T Consensus 98 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140 (549)
T ss_dssp TTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred CCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC
Confidence 666666666666654 345556666666666666666444444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=139.26 Aligned_cols=118 Identities=22% Similarity=0.190 Sum_probs=102.6
Q ss_pred Ccccc-CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 6 PSEFG-DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 6 p~~~~-~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+..+. .+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|.++
T Consensus 56 ~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 135 (361)
T 2xot_A 56 AEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135 (361)
T ss_dssp TTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred hhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCc
Confidence 44566 89999999999999997777889999999999999999997666679999999999999999998888899999
Q ss_pred CCCCEEeCCCCCCcccCCccc----cCcCCCCcccccCCcceec
Q 040641 85 SYSTYLDLHDNKFTREIPQNL----GNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~----~~l~~L~~l~l~~n~l~g~ 124 (435)
++|++|+|++|++++ +|..+ ..+++|+.|++++|.+++.
T Consensus 136 ~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 136 AQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp TTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred ccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 999999999999985 66554 5789999999999999853
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-15 Score=142.45 Aligned_cols=111 Identities=24% Similarity=0.192 Sum_probs=87.9
Q ss_pred CCCCCCeeecCCCcccccCCccc--CCCCCCcEEECCCCcCccCCCcCccCC-----CCCCeEECcCcccCCcCCCcCCC
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSL--GQLGGLVKLNLTRNKFSGPVPTSLGNL-----KGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~--~~l~~L~~L~ls~n~l~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|.+++..|..|+.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 67888888888888888888876 7888888888888888865 7767666 78888888888888777778888
Q ss_pred CCCCCEEeCCCCCCccc--CCccc--cCcCCCCcccccCCcce
Q 040641 84 LSYSTYLDLHDNKFTRE--IPQNL--GNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~--~p~~~--~~l~~L~~l~l~~n~l~ 122 (435)
+++|++|++++|++++. +|..+ +++++|+.|++++|.++
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 88888888888887765 33344 77788888888888776
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6.4e-15 Score=148.65 Aligned_cols=108 Identities=27% Similarity=0.335 Sum_probs=101.0
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
.|+.|+|++|+|++ +|. ++.+++|+.|+|++|.++ .+|..++.+++|+.|+|++|.|++ +| .++.+++|++|+++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999995 786 999999999999999999 899999999999999999999996 78 89999999999999
Q ss_pred CCCCcccC-CccccCcCCCCcccccCCcceecCC
Q 040641 94 DNKFTREI-PQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 94 ~n~~~~~~-p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++++.. |..++++++|+.|++++|.+++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999876 9999999999999999999997655
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.2e-16 Score=160.31 Aligned_cols=125 Identities=22% Similarity=0.292 Sum_probs=112.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+..+++|+.|+|++|.|+ .+|..++++++|++|+|++|.|+ .+|..|+.|++|+.|+|++|.|+ .+|..|++
T Consensus 238 ~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~ 314 (727)
T 4b8c_D 238 NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGN 314 (727)
T ss_dssp CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTS
T ss_pred CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhc
Confidence 58888999999999999999999 89999999999999999999999 89999999999999999999997 78999999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCC-CCcccccCCcceecCCccccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQ-LEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~-L~~l~l~~n~l~g~~p~~~~~ 131 (435)
|++|++|+|++|.+++.+|..+..+.. +..+++++|.++|.+|..+..
T Consensus 315 l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~ 363 (727)
T 4b8c_D 315 LCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRF 363 (727)
T ss_dssp CTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---
T ss_pred CCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccce
Confidence 999999999999999999988765532 235789999999999987654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=9.3e-15 Score=155.13 Aligned_cols=127 Identities=24% Similarity=0.191 Sum_probs=94.3
Q ss_pred ccCCccccCCCCCCeeecCCCcccccC-CcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc-
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSI-PRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS- 80 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~- 80 (435)
+..|..|+++++|++|+|++|.+.+.+ |..+.++++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++.+|..
T Consensus 38 ~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 117 (844)
T 3j0a_A 38 TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG 117 (844)
T ss_dssp EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTC
T ss_pred ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCc
Confidence 445667777888888888877665566 667788888888888888887777777888888888888888887766654
Q ss_pred -CCCCCCCCEEeCCCCCCcccCC-ccccCcCCCCcccccCCcceecCCccc
Q 040641 81 -LGNLSYSTYLDLHDNKFTREIP-QNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 81 -~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
++++++|++|++++|.+++..| ..++++++|+.|++++|.+++..|..+
T Consensus 118 ~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence 7778888888888888776544 467778888888888887776655443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-14 Score=147.96 Aligned_cols=124 Identities=20% Similarity=0.253 Sum_probs=91.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCC-cccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC-CcCCCcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIP-RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD-GGWPRSLG 82 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p-~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~-~~~p~~~~ 82 (435)
+|+.+..+++|+.|++++|.+.+..| ..+.++++|+.|++++|.+.+..|..+..+++|+.|++++|.++ +.+|..+.
T Consensus 388 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~ 467 (570)
T 2z63_A 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467 (570)
T ss_dssp EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred ccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence 34447777777777777777776555 45677777777777777777777777777777777777777776 56777777
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
.+++|++|++++|++++..|..++++++|+.|++++|.+++..|..
T Consensus 468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 513 (570)
T 2z63_A 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513 (570)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHH
Confidence 7777777777777777766777777777777777777777655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=9.7e-15 Score=149.05 Aligned_cols=114 Identities=16% Similarity=0.056 Sum_probs=54.0
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
.+++.|++++|.+....+..+.++++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..|+++++|++|++
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 44455555555554222223344555555555555555444444555555555555555555444444455555555555
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|.+++..+..++++++|++|++++|.+++..|
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh
Confidence 5555543222223445555555555555544433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.9e-14 Score=141.53 Aligned_cols=123 Identities=22% Similarity=0.198 Sum_probs=112.2
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
++-.|..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|
T Consensus 45 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 124 (477)
T 2id5_A 45 KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124 (477)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHc
Confidence 34446789999999999999999998889999999999999999999996444568999999999999999999889999
Q ss_pred CCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
..+++|++|++++|.+++..|..+.++++|+.|++++|.+++.
T Consensus 125 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp TTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred cccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 9999999999999999988888999999999999999988753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-14 Score=146.30 Aligned_cols=123 Identities=22% Similarity=0.191 Sum_probs=97.7
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
.|..|.++++|++|+|++|++++..|..+.++++|++|+|++|.+++..|..|+.+++|++|++++|.+++..+..++++
T Consensus 44 ~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l 123 (570)
T 2z63_A 44 GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123 (570)
T ss_dssp CTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTC
T ss_pred ChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccc
Confidence 34567888888888888888887667778888888888888888886666778888888888888888876545568888
Q ss_pred CCCCEEeCCCCCCcc-cCCccccCcCCCCcccccCCcceecCCc
Q 040641 85 SYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
++|++|++++|.+++ .+|..++++++|++|++++|.+++..|.
T Consensus 124 ~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred ccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 888888888888876 4788888888888888888888765554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=144.97 Aligned_cols=110 Identities=23% Similarity=0.226 Sum_probs=50.1
Q ss_pred CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCcc--CCCcCccCCCCCCeEECcCcccCCcCCCc-CCCCCCC
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSNFFDGGWPRS-LGNLSYS 87 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L 87 (435)
.+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++ .+|..++.+++|+.|++++|.+++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34444444444444444444444444444444444444443 23334444444444444444444433332 3444444
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++++|.+++.+|..+. ++|+.|++++|.++
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 4444444444444443332 34444444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.5e-15 Score=127.44 Aligned_cols=115 Identities=16% Similarity=0.169 Sum_probs=102.6
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
..+.+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .++.+..+++|+.|++++|.+++..|..++.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467889999999999998 778 7999999999999999775 34589999999999999999998889999999999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++++|.+++..|..++++++|+.|++++|.+.+.+|
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~ 153 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH
Confidence 999999999998889999999999999999998444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-15 Score=141.15 Aligned_cols=125 Identities=23% Similarity=0.192 Sum_probs=91.7
Q ss_pred CcccCCccc--cCCCCCCeeecCCCcccccCCcccCCC-----CCCcEEECCCCcCccCCCcCccCCCCCCeEECcCccc
Q 040641 1 LTGSIPSEF--GDSLKLQGLYLGNNQLTGSIPRSLGQL-----GGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73 (435)
Q Consensus 1 l~g~lp~~~--~~l~~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l 73 (435)
++|.+|..+ +.+++|+.|+|++|++++. |..++.+ ++|++|+|++|++++..|..++.+++|+.|+|++|.+
T Consensus 107 l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 185 (312)
T 1wwl_A 107 VTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185 (312)
T ss_dssp CBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred ccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence 356777766 7788888888888888865 7777666 7888888888888876667788888888888888887
Q ss_pred CCc--CCCcC--CCCCCCCEEeCCCCCCcc--cCC-ccccCcCCCCcccccCCcceecCC
Q 040641 74 DGG--WPRSL--GNLSYSTYLDLHDNKFTR--EIP-QNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 74 ~~~--~p~~~--~~l~~L~~L~l~~n~~~~--~~p-~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
.+. +|..+ +.+++|++|++++|++++ .++ ..+.++++|+.|++++|.+++.+|
T Consensus 186 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 765 33344 778888888888888762 223 223566788888888888877554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=148.31 Aligned_cols=121 Identities=21% Similarity=0.029 Sum_probs=71.2
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|++|++++|.+++..|..+++++
T Consensus 50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~ 129 (606)
T 3t6q_A 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK 129 (606)
T ss_dssp TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCT
T ss_pred hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCC
Confidence 44566666666666666666655566666666666666666666655555666666666666666666654455566666
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++|++++|.+++..++.+..+++|+.|++++|.+++..|
T Consensus 130 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred cccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 66666666666654222223335666666666666554433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.2e-14 Score=121.97 Aligned_cols=108 Identities=25% Similarity=0.281 Sum_probs=98.5
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCC
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHD 94 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~ 94 (435)
-+.+++++|.++ .+|..+. ++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++..|..|.++++|++|++++
T Consensus 12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 368999999998 8898765 68999999999998 7999999999999999999999988888899999999999999
Q ss_pred CCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 95 NKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 95 n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
|++++..|..|..+++|+.|++++|.+++..+
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~ 119 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPE 119 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeCh
Confidence 99998778889999999999999999985433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.7e-14 Score=144.72 Aligned_cols=116 Identities=23% Similarity=0.234 Sum_probs=76.5
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCcc--CCCcCccCCCCCCeEECcCcccCCcCCC-cCCCCCC
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSNFFDGGWPR-SLGNLSY 86 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~ 86 (435)
+.+++|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+|..++.+++|+.|++++|.+++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 556677777777777776677777777777777777777764 2334566777777777777777764554 3556666
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|++|++++|++++.+|..+. ++|+.|++++|.++ .+|..
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence 77777777776666655443 46666666666665 45543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=146.53 Aligned_cols=130 Identities=22% Similarity=0.236 Sum_probs=116.4
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCC-cCCCc
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDG-GWPRS 80 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~ 80 (435)
++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|.+++..|..++.+++|++|+|++|.+++ ..|..
T Consensus 39 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 118 (549)
T 2z81_A 39 TYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118 (549)
T ss_dssp CEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCS
T ss_pred CccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhh
Confidence 44457789999999999999999998888999999999999999999997666669999999999999999986 46788
Q ss_pred CCCCCCCCEEeCCCCCCcccCC-ccccCcCCCCcccccCCcceecCCccccc
Q 040641 81 LGNLSYSTYLDLHDNKFTREIP-QNLGNLAQLEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 81 ~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~l~g~~p~~~~~ 131 (435)
++++++|++|++++|.+.+.+| ..++++++|+.|++++|.+++.+|..+..
T Consensus 119 ~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp CTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred hhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 9999999999999999666776 57999999999999999999988876643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6e-14 Score=138.27 Aligned_cols=121 Identities=21% Similarity=0.148 Sum_probs=93.0
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+. ++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..+..|..+
T Consensus 69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 146 (452)
T 3zyi_A 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL 146 (452)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSC
T ss_pred cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhccc
Confidence 555443 578888888888887778888888888888888888887666778888888888888888886666668888
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
++|++|++++|+++...+..+.++++|+.|++++|+..+.+|.
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence 8888888888888765555777888888888887554444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=150.06 Aligned_cols=121 Identities=22% Similarity=0.177 Sum_probs=89.8
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++
T Consensus 43 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 122 (680)
T 1ziw_A 43 ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122 (680)
T ss_dssp GGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTT
T ss_pred HHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCC
Confidence 45777777888888877777777777777778888888888777433335777778888888888777666667777788
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
|++|++++|.+++..|..++++++|++|++++|.+++..|.
T Consensus 123 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred CCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 88888888877777777777777788888877777665443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-13 Score=132.99 Aligned_cols=119 Identities=18% Similarity=0.142 Sum_probs=86.5
Q ss_pred CCcc-ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 5 IPSE-FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 5 lp~~-~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
+|.. +..+++|++|+|++|.+++..|..+..+++|++|+|++|.+++..|..++.+++|+.|+|++|.++...+..+++
T Consensus 60 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 139 (390)
T 3o6n_A 60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139 (390)
T ss_dssp ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcC
Confidence 5544 566777888888888877666667777888888888888877665666777778888888888777433333577
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++|++|++++|.+++..|..++++++|+.|++++|.+++
T Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 7778888888887776666667777777777777777664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=137.42 Aligned_cols=117 Identities=17% Similarity=0.179 Sum_probs=92.4
Q ss_pred CCCCCCeeecCCCcccccCCcc-cCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRS-LGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~-~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
.+.+++.|++++|.++ .+|.. +..+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++..|..++++++|++
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4578888888888887 45544 678888888888888888666667888888888888888888777777888888888
Q ss_pred EeCCCCCCcccCCcc-ccCcCCCCcccccCCcceecCCccc
Q 040641 90 LDLHDNKFTREIPQN-LGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 90 L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
|++++|.++ .+|.. ++++++|++|++++|.+.+..|..+
T Consensus 122 L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 161 (390)
T 3o6n_A 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161 (390)
T ss_dssp EECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred EECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhc
Confidence 888888887 45554 5788888888888888876555433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.6e-14 Score=145.10 Aligned_cols=124 Identities=22% Similarity=0.191 Sum_probs=103.3
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
|..++.+++|+.|+|++|.+++..|..+..+++|+.|++++|.+.+..|+. +..+++|+.|++++|.+++..|..++.+
T Consensus 369 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 448 (606)
T 3t6q_A 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448 (606)
T ss_dssp TTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTC
T ss_pred chhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCC
Confidence 667888889999999999988888888888999999999999988776654 8888889999999999888888888888
Q ss_pred CCCCEEeCCCCCCccc---CCccccCcCCCCcccccCCcceecCCccc
Q 040641 85 SYSTYLDLHDNKFTRE---IPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~---~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
++|++|++++|.+++. .+..+..+++|+.|++++|.+++..|..+
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 496 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTT
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhh
Confidence 8999999999988762 33567888888899998888887766554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=137.51 Aligned_cols=121 Identities=28% Similarity=0.289 Sum_probs=96.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+. ++|+.|+|++|++++..+..+.++++|++|+|++|.+++..|..+..+++|++|+|++|.+++..+..+++
T Consensus 45 ~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 122 (353)
T 2z80_A 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKP 122 (353)
T ss_dssp SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTT
T ss_pred ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCC
Confidence 3666554 48899999999998665668889999999999999998766778889999999999999998644445888
Q ss_pred CCCCCEEeCCCCCCcccCCc--cccCcCCCCcccccCCc-ceecCCc
Q 040641 84 LSYSTYLDLHDNKFTREIPQ--NLGNLAQLEHLDVLRNM-LCGKIPE 127 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~-l~g~~p~ 127 (435)
+++|++|++++|+++ .+|. .+.++++|+.|++++|. +.+..|.
T Consensus 123 l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 168 (353)
T 2z80_A 123 LSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168 (353)
T ss_dssp CTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTT
T ss_pred CccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHH
Confidence 999999999999887 4555 68888999999999884 5443333
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=135.84 Aligned_cols=128 Identities=20% Similarity=0.129 Sum_probs=101.1
Q ss_pred CcccCCccc--cCCCCCCeeecCCCcccccCC----cccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC
Q 040641 1 LTGSIPSEF--GDSLKLQGLYLGNNQLTGSIP----RSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74 (435)
Q Consensus 1 l~g~lp~~~--~~l~~L~~L~l~~n~l~g~~p----~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 74 (435)
++|.+|..+ +.+++|+.|+|++|.+++..| ..+..+++|++|+|++|.+++..|..++.+++|++|||++|.+.
T Consensus 103 l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 182 (310)
T 4glp_A 103 ITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGL 182 (310)
T ss_dssp CBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTC
T ss_pred eccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCc
Confidence 456778877 889999999999999987666 34567889999999999998777788999999999999999886
Q ss_pred Cc--CC--CcCCCCCCCCEEeCCCCCCcccCCc----cccCcCCCCcccccCCcceecCCccc
Q 040641 75 GG--WP--RSLGNLSYSTYLDLHDNKFTREIPQ----NLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 75 ~~--~p--~~~~~l~~L~~L~l~~n~~~~~~p~----~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+. ++ ..++.+++|++|++++|+++ .+|. .++++++|++|++++|.+++..|..+
T Consensus 183 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~ 244 (310)
T 4glp_A 183 GERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA 244 (310)
T ss_dssp HHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC
T ss_pred cchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhH
Confidence 52 32 23467888899999999886 3333 24677888899999998888766544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.8e-15 Score=146.20 Aligned_cols=115 Identities=22% Similarity=0.209 Sum_probs=97.1
Q ss_pred CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCcc-CCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG-NLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
.+++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.+++. |. +..+++|++
T Consensus 118 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 195 (487)
T 3oja_A 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKT 195 (487)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCE
T ss_pred ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCE
Confidence 467899999999999988888899999999999999999988888776 789999999999999865 43 346889999
Q ss_pred EeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 90 LDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 90 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
|++++|.+++ +|..++.+++|+.|++++|.+++ +|..+
T Consensus 196 L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred EECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 9999999986 55668899999999999999986 55544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.7e-14 Score=146.31 Aligned_cols=124 Identities=20% Similarity=0.166 Sum_probs=111.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+. ++|+.|+|++|.+++..+..+.++++|++|+|++|.+++..|..++.+++|+.|+|++|.+++..+..|++
T Consensus 18 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 95 (680)
T 1ziw_A 18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95 (680)
T ss_dssp SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhcc
Confidence 4777665 68999999999999777778999999999999999999888888999999999999999999655557999
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+++|++|++++|++++..|..++++++|++|++++|.+++..|..+
T Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 141 (680)
T 1ziw_A 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141 (680)
T ss_dssp CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSS
T ss_pred CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhh
Confidence 9999999999999987777889999999999999999998777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.3e-14 Score=132.70 Aligned_cols=116 Identities=23% Similarity=0.274 Sum_probs=70.7
Q ss_pred cccCCCCCCeeecCCCccc--ccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLT--GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~--g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
.+..+++|+.|+|++|.+. +..+..+..+++|+.|++++|.++ .+|..+. ++|+.|++++|.+++..|..+..++
T Consensus 140 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~ 216 (330)
T 1xku_A 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLN 216 (330)
T ss_dssp HHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCT
T ss_pred HhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCC
Confidence 4566666677777766664 245556666666666666666665 3554433 5566666666666655555666666
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
+|++|++++|.+++..+..+..+++|+.|++++|.++ .+|.
T Consensus 217 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred CCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 6666666666666555555666666666666666655 4444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-14 Score=143.03 Aligned_cols=124 Identities=31% Similarity=0.386 Sum_probs=111.7
Q ss_pred CcccCCccccCCCCCCeeecCCCcccc--cCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcC
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTG--SIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGW 77 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~ 77 (435)
+++.+|..++.+++|+.|+|++|++++ .+|..++.+++|++|+|++|.+++.+|.. +..+++|+.|++++|.+++.+
T Consensus 336 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 415 (520)
T 2z7x_B 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415 (520)
T ss_dssp CCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGG
T ss_pred cChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcch
Confidence 356689999999999999999999996 67788999999999999999999868875 888999999999999999988
Q ss_pred CCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|..+. ++|++|++++|+++ .+|..+..+++|+.|++++|.++ .+|..
T Consensus 416 ~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 462 (520)
T 2z7x_B 416 FRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG 462 (520)
T ss_dssp GGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTT
T ss_pred hhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHH
Confidence 88765 78999999999998 89998889999999999999998 46654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=151.72 Aligned_cols=126 Identities=25% Similarity=0.286 Sum_probs=111.8
Q ss_pred ccC-CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC--ccCCCCCCeEECcCcccCCcCC-
Q 040641 3 GSI-PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS--LGNLKGLSHLDLSSNFFDGGWP- 78 (435)
Q Consensus 3 g~l-p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~--~~~l~~L~~L~l~~n~l~~~~p- 78 (435)
+.| |..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++.+|.. ++.+++|++|||++|.+++..|
T Consensus 62 ~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 141 (844)
T 3j0a_A 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141 (844)
T ss_dssp CEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCC
T ss_pred cccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccc
Confidence 456 678999999999999999999888999999999999999999999877765 9999999999999999987655
Q ss_pred CcCCCCCCCCEEeCCCCCCcccCCccccCc--CCCCcccccCCcceecCCcc
Q 040641 79 RSLGNLSYSTYLDLHDNKFTREIPQNLGNL--AQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 79 ~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l--~~L~~l~l~~n~l~g~~p~~ 128 (435)
..|+++++|++|++++|.+++..|..++.+ ++|+.|+++.|.+.+..|..
T Consensus 142 ~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~ 193 (844)
T 3j0a_A 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193 (844)
T ss_dssp GGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCC
T ss_pred hhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccc
Confidence 578999999999999999998888888777 78888888888887766654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.1e-14 Score=118.27 Aligned_cols=98 Identities=27% Similarity=0.312 Sum_probs=85.4
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+.||..+. ++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..+..|.
T Consensus 25 ~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 102 (174)
T 2r9u_A 25 ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFD 102 (174)
T ss_dssp SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhc
Confidence 46787775 8999999999999988899999999999999999999964444578999999999999999976555699
Q ss_pred CCCCCCEEeCCCCCCcccCCc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQ 103 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~ 103 (435)
.+++|++|++++|.+.. .+.
T Consensus 103 ~l~~L~~L~L~~N~~~c-~~~ 122 (174)
T 2r9u_A 103 NLKSLTHIYLYNNPWDC-ECR 122 (174)
T ss_dssp TCTTCSEEECCSSCBCT-TBG
T ss_pred cccCCCEEEeCCCCccc-ccc
Confidence 99999999999999974 444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=143.85 Aligned_cols=108 Identities=22% Similarity=0.247 Sum_probs=96.4
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcC-CCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW-PRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~ 83 (435)
||. ++.+++|+.|+|++|+|+ .+|..++++++|+.|+|++|.+++ +| .++.+++|+.|+|++|.|++.. |..++.
T Consensus 456 lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~ 531 (567)
T 1dce_A 456 LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531 (567)
T ss_dssp CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGG
T ss_pred CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhc
Confidence 786 999999999999999999 899999999999999999999996 77 8999999999999999999876 999999
Q ss_pred CCCCCEEeCCCCCCcccCCcc---ccCcCCCCcccc
Q 040641 84 LSYSTYLDLHDNKFTREIPQN---LGNLAQLEHLDV 116 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~---~~~l~~L~~l~l 116 (435)
+++|++|++++|.+++..|.. +..+++|+.|++
T Consensus 532 l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 999999999999998755432 233678887753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1e-14 Score=136.35 Aligned_cols=111 Identities=18% Similarity=0.125 Sum_probs=93.5
Q ss_pred CCCCCeeecCCCcccccCCccc--CCCCCCcEEECCCCcCccCCC----cCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSL--GQLGGLVKLNLTRNKFSGPVP----TSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~--~~l~~L~~L~ls~n~l~~~~p----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+++|+.|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..+++|+.|+|++|.+++..|..++.++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4679999999999999999888 899999999999999987665 3455788999999999999888888899999
Q ss_pred CCCEEeCCCCCCccc--C--CccccCcCCCCcccccCCcce
Q 040641 86 YSTYLDLHDNKFTRE--I--PQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~--~--p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+|++|++++|++.+. + +..++++++|++|++++|.++
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 210 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME 210 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC
Confidence 999999999987653 2 233468889999999999886
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.6e-14 Score=132.21 Aligned_cols=121 Identities=25% Similarity=0.347 Sum_probs=92.7
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCC--cCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPR--SLGN 83 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~--~~~~ 83 (435)
..+.++++|+.|+|++|++++..|..+.++++|++|+|++|++++ +|.. ++.+++|++|+|++|.+++ +|. .+..
T Consensus 70 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~ 147 (353)
T 2z80_A 70 SDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSH 147 (353)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTT
T ss_pred HHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcc-cCchhhhcc
Confidence 367888888888888888887667778888888888888888874 4544 7788888888888888874 554 6778
Q ss_pred CCCCCEEeCCCCC-CcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 84 LSYSTYLDLHDNK-FTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 84 l~~L~~L~l~~n~-~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+++|++|++++|+ ++...|..++++++|+.|++++|.+.+..|..+
T Consensus 148 l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 194 (353)
T 2z80_A 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194 (353)
T ss_dssp CTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred CCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHH
Confidence 8888888888884 555556677888888888888888877666544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-14 Score=128.49 Aligned_cols=108 Identities=16% Similarity=0.252 Sum_probs=64.8
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCc-CccCCCcCccCCCCCCeEECcC-cccCCcCCCcCCCCCCCCEEe
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK-FSGPVPTSLGNLKGLSHLDLSS-NFFDGGWPRSLGNLSYSTYLD 91 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~ 91 (435)
+|+.|+|++|++++..+..+.++++|++|++++|. +++..+..|..+++|+.|++++ |.+++..|..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666664444456666666666666665 5533333566666666666666 666644445566666666666
Q ss_pred CCCCCCcccCCccccCcCCCC---cccccCC-ccee
Q 040641 92 LHDNKFTREIPQNLGNLAQLE---HLDVLRN-MLCG 123 (435)
Q Consensus 92 l~~n~~~~~~p~~~~~l~~L~---~l~l~~n-~l~g 123 (435)
+++|.+++ +|. +..+++|+ .|++++| .+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~ 145 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS 145 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhh
Confidence 66666654 554 55566665 6666666 5554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.50 E-value=8.2e-14 Score=137.28 Aligned_cols=122 Identities=20% Similarity=0.122 Sum_probs=104.2
Q ss_pred cccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcC
Q 040641 2 TGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSL 81 (435)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~ 81 (435)
++-.|..|.++++|+.|+|++|++++..|..+.++++|++|+|++|.+++..+..+..+++|+.|+|++|.++...+..|
T Consensus 88 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 167 (452)
T 3zyi_A 88 QMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167 (452)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTT
T ss_pred ceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHH
Confidence 34457789999999999999999998888999999999999999999996556669999999999999999997666688
Q ss_pred CCCCCCCEEeCCCCCCcccCCc-cccCcCCCCcccccCCccee
Q 040641 82 GNLSYSTYLDLHDNKFTREIPQ-NLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 82 ~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~l~g 123 (435)
.++++|++|++++|+..+.+|. .+.++++|+.|++++|.+++
T Consensus 168 ~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp TTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred hcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 8899999999998655555655 57888889999999988874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-13 Score=117.05 Aligned_cols=96 Identities=26% Similarity=0.299 Sum_probs=85.3
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+|..+. ++|+.|+|++|+|++..|..+.++++|++|+|++|++++..|..|..+++|+.|+|++|.|++..|..|..
T Consensus 23 ~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~ 100 (170)
T 3g39_A 23 SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDN 100 (170)
T ss_dssp SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcC
Confidence 4777664 78999999999999888999999999999999999999655556899999999999999999766667999
Q ss_pred CCCCCEEeCCCCCCcccC
Q 040641 84 LSYSTYLDLHDNKFTREI 101 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~ 101 (435)
+++|++|++++|.++...
T Consensus 101 l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 101 LKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CTTCCEEECCSSCBCTTB
T ss_pred CCCCCEEEeCCCCCCCCc
Confidence 999999999999997543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.5e-14 Score=141.47 Aligned_cols=124 Identities=27% Similarity=0.371 Sum_probs=109.8
Q ss_pred CcccCCccccCCCCCCeeecCCCcccc--cCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcC
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTG--SIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGW 77 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~ 77 (435)
+++.+|..++.+++|+.|+|++|++++ .+|..+.++++|+.|+|++|.+++.+|.. +..+++|+.|++++|.+++.+
T Consensus 365 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 444 (562)
T 3a79_B 365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444 (562)
T ss_dssp CCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG
T ss_pred cccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch
Confidence 356688999999999999999999996 34578999999999999999999867765 888999999999999999888
Q ss_pred CCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
|..+. ++|++|++++|+++ .+|..+.++++|+.|++++|.++ .+|..
T Consensus 445 ~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 491 (562)
T 3a79_B 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG 491 (562)
T ss_dssp GSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTT
T ss_pred hhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHH
Confidence 87765 78999999999997 79998889999999999999998 56654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-13 Score=128.06 Aligned_cols=114 Identities=25% Similarity=0.271 Sum_probs=90.4
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+|..+. ++|+.|+|++|.+++..|..+.++++|++|+|++|.+++..|..++.+++|++|+|++|.++ .+|..+.
T Consensus 47 ~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~- 122 (332)
T 2ft3_A 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP- 122 (332)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC-
T ss_pred ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc-
Confidence 3666553 57888888888888666778888888888888888888766778888888888888888887 5776665
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++|++++|++++..+..+.++++|+.|++++|.++
T Consensus 123 -~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 123 -SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp -TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred -ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc
Confidence 78888888888887655556788888888888888875
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.3e-13 Score=115.14 Aligned_cols=109 Identities=25% Similarity=0.247 Sum_probs=95.1
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
..+.+++++|+++ .+|..+. ++|+.|++++|++++..+..++.+++|+.|+|++|.+++..+..++.+++|++|+++
T Consensus 8 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 4678999999998 7886654 799999999999996555668999999999999999997666678999999999999
Q ss_pred CCCCcccCCccccCcCCCCcccccCCcceecC
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~ 125 (435)
+|++++..+..+.++++|+.|++++|.+++..
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 116 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVP 116 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeC
Confidence 99999766667899999999999999998543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.6e-13 Score=128.07 Aligned_cols=121 Identities=20% Similarity=0.247 Sum_probs=87.0
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
.|..|+++++|+.|+|++|++++..|..++++++|++|+|++|.++ .+|..+. ++|+.|++++|.+++..+..+..+
T Consensus 70 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l 146 (332)
T 2ft3_A 70 RKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGL 146 (332)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSC
T ss_pred CHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCC
Confidence 3567888999999999999998777888999999999999999887 6776654 677888888887775555557777
Q ss_pred CCCCEEeCCCCCCc--ccCCccccCc--------------------CCCCcccccCCcceecCCcc
Q 040641 85 SYSTYLDLHDNKFT--REIPQNLGNL--------------------AQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 85 ~~L~~L~l~~n~~~--~~~p~~~~~l--------------------~~L~~l~l~~n~l~g~~p~~ 128 (435)
++|++|++++|.++ +..|..+..+ ++|+.|++++|.+++..|..
T Consensus 147 ~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~ 212 (332)
T 2ft3_A 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELED 212 (332)
T ss_dssp SSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTS
T ss_pred ccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHH
Confidence 77777777777764 2344444333 35566666666666544443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=135.28 Aligned_cols=120 Identities=22% Similarity=0.149 Sum_probs=74.4
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
||..+. ++++.|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..+..|..+
T Consensus 58 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 135 (440)
T 3zyj_A 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYL 135 (440)
T ss_dssp CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSC
T ss_pred CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhcc
Confidence 454443 456666666666665555666666666666666666665444566666666666666666665444456666
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++|++++|.++...+..+.++++|+.|++++|+..+.+|
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~ 177 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS 177 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC
Confidence 666666666666665444456666666666666644333333
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.3e-14 Score=125.39 Aligned_cols=120 Identities=16% Similarity=0.222 Sum_probs=104.4
Q ss_pred CccccCCCCCCeeecCCCc-ccccCCcccCCCCCCcEEECCC-CcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQ-LTGSIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~-l~g~~p~~~~~l~~L~~L~ls~-n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
+..|.++++|+.|+|++|. +++..+..+.++++|++|+|++ |.+++..+..|..+++|+.|++++|.+++ +|. ++.
T Consensus 48 ~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~ 125 (239)
T 2xwt_C 48 SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTK 125 (239)
T ss_dssp TTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTT
T ss_pred HHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccc
Confidence 3478999999999999997 8855556899999999999998 99996556689999999999999999986 786 888
Q ss_pred CCCCC---EEeCCCC-CCcccCCccccCcCCCC-cccccCCcceecCCcc
Q 040641 84 LSYST---YLDLHDN-KFTREIPQNLGNLAQLE-HLDVLRNMLCGKIPEK 128 (435)
Q Consensus 84 l~~L~---~L~l~~n-~~~~~~p~~~~~l~~L~-~l~l~~n~l~g~~p~~ 128 (435)
+++|+ +|++++| .+++..+..+.++++|+ .|++++|.++ .+|..
T Consensus 126 l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174 (239)
T ss_dssp CCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred ccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence 99998 9999999 89866666799999999 9999999988 56653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=7.3e-14 Score=119.16 Aligned_cols=114 Identities=20% Similarity=0.193 Sum_probs=96.6
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCC-CCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLG-GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~-~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|.+++. +.++.+++|+.|+|++|.+++..|..++.+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4677889999999999999 5664 55555 999999999999964 68999999999999999999644444589999
Q ss_pred CCEEeCCCCCCcccCCc--cccCcCCCCcccccCCcceecCCc
Q 040641 87 STYLDLHDNKFTREIPQ--NLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
|++|++++|.++ .+|. .++.+++|+.|++++|.++ .+|.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~ 130 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKH 130 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHh
Confidence 999999999995 6776 7899999999999999987 3443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.8e-13 Score=134.33 Aligned_cols=123 Identities=21% Similarity=0.164 Sum_probs=106.4
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+-.|..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.++...+..|.
T Consensus 78 ~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 157 (440)
T 3zyj_A 78 IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157 (440)
T ss_dssp EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTT
T ss_pred eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhh
Confidence 33457899999999999999999987778999999999999999999965555799999999999999999976677899
Q ss_pred CCCCCCEEeCCCCCCcccCCc-cccCcCCCCcccccCCcceecCC
Q 040641 83 NLSYSTYLDLHDNKFTREIPQ-NLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++++|++|++++|+..+.+|. .+.++++|+.|++++|.++ .+|
T Consensus 158 ~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp TCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred hCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 999999999999665556655 6889999999999999987 444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-16 Score=137.71 Aligned_cols=122 Identities=26% Similarity=0.260 Sum_probs=100.7
Q ss_pred CcccCCc------cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC
Q 040641 1 LTGSIPS------EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74 (435)
Q Consensus 1 l~g~lp~------~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~ 74 (435)
|+|.+|. .++.+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.++
T Consensus 30 l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~ 106 (198)
T 1ds9_A 30 LHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106 (198)
T ss_dssp CCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC
T ss_pred eccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCC
Confidence 4566666 88889999999999999985 77 8888999999999999998 68887777888999999999998
Q ss_pred CcCCCcCCCCCCCCEEeCCCCCCcccCC-ccccCcCCCCcccccCCcceecCCc
Q 040641 75 GGWPRSLGNLSYSTYLDLHDNKFTREIP-QNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 75 ~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
+ +| .++.+++|++|++++|++++..+ ..+..+++|+.|++++|.+.+.+|.
T Consensus 107 ~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 107 S-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp C-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred c-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 6 56 67888899999999999874222 4678889999999999988876554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=6.5e-14 Score=119.49 Aligned_cols=112 Identities=21% Similarity=0.266 Sum_probs=97.3
Q ss_pred CCccccCCC-CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCCC--c
Q 040641 5 IPSEFGDSL-KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWPR--S 80 (435)
Q Consensus 5 lp~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~--~ 80 (435)
+| .+..+. +|+.|+|++|.+++. ..+..+++|++|+|++|.+++ +|+. +..+++|+.|+|++|.++ .+|. .
T Consensus 34 i~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~ 108 (176)
T 1a9n_A 34 IE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDP 108 (176)
T ss_dssp CC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGG
T ss_pred hH-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHh
Confidence 44 355655 999999999999964 689999999999999999995 5655 599999999999999996 5776 8
Q ss_pred CCCCCCCCEEeCCCCCCcccCCcc----ccCcCCCCcccccCCcce
Q 040641 81 LGNLSYSTYLDLHDNKFTREIPQN----LGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 81 ~~~l~~L~~L~l~~n~~~~~~p~~----~~~l~~L~~l~l~~n~l~ 122 (435)
+..+++|++|++++|.++ .+|.. ++.+++|+.||++.|...
T Consensus 109 l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 109 LASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp GGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred hhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 899999999999999997 67775 889999999999999764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-13 Score=127.27 Aligned_cols=113 Identities=26% Similarity=0.279 Sum_probs=96.3
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|..+. +.|+.|+|++|.+++..+..+.++++|++|+|++|.+++..|..++.+++|+.|+|++|.++ .+|..+.
T Consensus 46 lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-- 120 (330)
T 1xku_A 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-- 120 (330)
T ss_dssp CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--
T ss_pred cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--
Confidence 565554 57899999999999766678999999999999999999777888999999999999999988 5777665
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++|++++|.+++..+..+.++++|+.|++++|.+.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 158 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCC
Confidence 78999999999998766677888999999999999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=128.83 Aligned_cols=105 Identities=19% Similarity=0.140 Sum_probs=76.3
Q ss_pred CeeecCCC-cccccCCcccCCCCCCcEEECCC-CcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 16 QGLYLGNN-QLTGSIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 16 ~~L~l~~n-~l~g~~p~~~~~l~~L~~L~ls~-n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
..++++++ +|+ .+|. +..+++|+.|+|++ |.|++..|..|+.+++|+.|+|++|.|++..|..|++|++|++|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35677777 777 5777 77788888888875 78876555677788888888888888887777777788888888888
Q ss_pred CCCCcccCCccccCcCCCCcccccCCccee
Q 040641 94 DNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 94 ~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+|+|++..|..+..+. |+.|++.+|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 8888754444444444 7888888887754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.43 E-value=7.9e-14 Score=130.75 Aligned_cols=113 Identities=22% Similarity=0.205 Sum_probs=80.2
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCc-cCCCCCCeEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSL-GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
+++|+.|+|++|++++..|..++.+++|+.|+|++|.+++..|..+ ..+++|+.|+|++|.+++. |. ...+++|++|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 5667788888888876666677777888888888888776555555 3677788888888877743 33 2347777888
Q ss_pred eCCCCCCcccCCccccCcCCCCcccccCCcceecCCcc
Q 040641 91 DLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEK 128 (435)
Q Consensus 91 ~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~ 128 (435)
++++|++++ +|..+..+++|+.|++++|.+++ +|..
T Consensus 197 ~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~ 232 (317)
T 3o53_A 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA 232 (317)
T ss_dssp ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred ECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhH
Confidence 888887764 55557777778888888877773 4543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-12 Score=122.52 Aligned_cols=108 Identities=28% Similarity=0.351 Sum_probs=69.8
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|+|++|.+++ ++. +..+++|++|+|++|.+++ +| .+..+++|+.|++++|.+++ +|. +..+++|
T Consensus 58 ~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L 131 (308)
T 1h6u_A 58 GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNL 131 (308)
T ss_dssp TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTC
T ss_pred hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCC
Confidence 46667777777777777763 443 6777777777777777764 33 56667777777777777664 332 6666666
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++++|.+++ ++. ++.+++|+.|++++|.+++
T Consensus 132 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 132 QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC
T ss_pred CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC
Confidence 666666666654 332 5566666666666666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.9e-13 Score=136.09 Aligned_cols=105 Identities=27% Similarity=0.395 Sum_probs=49.7
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC----
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS---- 87 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L---- 87 (435)
+++|+.|+|++|+|++ +|. .+++|+.|+|++|.+++ +|. +. ++|+.|+|++|.|+ .+|. +.. +|
T Consensus 139 l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~ 206 (571)
T 3cvr_A 139 PALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSE 206 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------
T ss_pred CccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhccc
Confidence 3444444444444442 333 33444455555554443 444 33 44555555555554 3444 332 44
Q ss_pred ---CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 88 ---TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 88 ---~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+.|++++|+++ .+|..+.++++|+.|++++|.+++.+|..+
T Consensus 207 ~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp -CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred ccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 55555555554 355555555555555555555555555433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.40 E-value=8.1e-13 Score=122.20 Aligned_cols=111 Identities=31% Similarity=0.343 Sum_probs=88.3
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|+|++|++++ ++. +..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++ + ..+..+++|
T Consensus 63 ~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L 136 (291)
T 1h6t_A 63 GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQL 136 (291)
T ss_dssp TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTC
T ss_pred hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCC
Confidence 37788889999999999885 444 8888899999999998875 44 48888888889988888875 3 467788888
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++++|++++. ..++.+++|+.|++++|.+++..|
T Consensus 137 ~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 137 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 8888888888753 567888888888888888876443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=133.08 Aligned_cols=111 Identities=31% Similarity=0.345 Sum_probs=80.1
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|+|++|++++..| +..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++ + ..+..+++|
T Consensus 60 ~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L 133 (605)
T 1m9s_A 60 GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQL 133 (605)
T ss_dssp TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTC
T ss_pred HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCcc
Confidence 47777888888888888875433 7778888888888888774 33 67777778888888887774 3 346777777
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+.|+|++|.+++. ..++.+++|+.|+|++|.+.+..|
T Consensus 134 ~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 134 ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 7777777777653 456777777777777777776544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=7e-13 Score=125.90 Aligned_cols=94 Identities=26% Similarity=0.264 Sum_probs=84.1
Q ss_pred cCCccccCCCCCCeeecCC-CcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.||. |+.+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|||++|.|++..|..+.
T Consensus 23 ~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 101 (347)
T 2ifg_A 23 SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101 (347)
T ss_dssp TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcc
Confidence 3898 99999999999996 999977778999999999999999999998888899999999999999999965555555
Q ss_pred CCCCCCEEeCCCCCCcc
Q 040641 83 NLSYSTYLDLHDNKFTR 99 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~ 99 (435)
.++ |+.|+|.+|.+..
T Consensus 102 ~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 102 GLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCC-CCEEECCSSCCCC
T ss_pred cCC-ceEEEeeCCCccC
Confidence 555 9999999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=118.99 Aligned_cols=105 Identities=22% Similarity=0.262 Sum_probs=51.0
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
+..+++|+.|++++|.++ .+| .+..+++|+.|+|++|++++ +|+ +..+++|+.|+|++|.+++ +|.... ++|+
T Consensus 37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~ 109 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLS 109 (263)
T ss_dssp HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCC
T ss_pred hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--Cccc
Confidence 444555555555555554 344 45555555555555555553 332 5555555555555555543 332211 4455
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+|++++|++++ +| .++++++|+.|++++|.++
T Consensus 110 ~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 110 RLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp EEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCC
T ss_pred EEEccCCccCC-Ch-hhcCcccccEEECCCCcCC
Confidence 55555555543 22 2444555555555555444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=3.3e-13 Score=126.47 Aligned_cols=113 Identities=22% Similarity=0.191 Sum_probs=66.2
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccC-----------------
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD----------------- 74 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~----------------- 74 (435)
+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.++
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~ 110 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNN 110 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSC
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCc
Confidence 3345555555555554444455555555555555555543222 444445555555444443
Q ss_pred --CcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 75 --GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 75 --~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+..+. .+++|++|++++|++++..|..++.+++|+.|++++|.+++..|..+
T Consensus 111 l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 164 (317)
T 3o53_A 111 ISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164 (317)
T ss_dssp CSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred cCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHH
Confidence 32222 25667888888888877667777788888888888888876655443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1e-12 Score=121.47 Aligned_cols=107 Identities=28% Similarity=0.339 Sum_probs=70.8
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
+..+++|+.|++++|.+. .+| .+..+++|+.|+|++|++++ +++ +..+++|+.|+|++|.+++ +| .++.+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 345666777777777776 344 36667777777777777764 333 6677777777777777764 33 366777777
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+|++++|++++ + ..+..+++|+.|++++|.+++
T Consensus 116 ~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~ 148 (291)
T 1h6t_A 116 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD 148 (291)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC
T ss_pred EEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc
Confidence 77777777754 3 346667777777777776664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.3e-13 Score=132.78 Aligned_cols=117 Identities=21% Similarity=0.285 Sum_probs=67.1
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCcccCCCCCC-------------cEEECCCCcCccCCCcCc------------
Q 040641 3 GSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGL-------------VKLNLTRNKFSGPVPTSL------------ 57 (435)
Q Consensus 3 g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L-------------~~L~ls~n~l~~~~p~~~------------ 57 (435)
|+||++++++++|+.|++++|.++|.+|.+++++++| +.|++++|.+++ +|...
T Consensus 24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~~~~L~~L~l~~n~ 102 (454)
T 1jl5_A 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPELPPHLESLVASCNS 102 (454)
T ss_dssp ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSCCTTCSEEECCSSC
T ss_pred hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCCcCCCCEEEccCCc
Confidence 6678778888888888888888877788777776543 555555555553 33211
Q ss_pred -----cCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCc
Q 040641 58 -----GNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 58 -----~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
..+++|+.|++++|.+++ +|.. .++|++|++++|++++ +| .++++++|++|++++|.+++ +|.
T Consensus 103 l~~lp~~~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~ 170 (454)
T 1jl5_A 103 LTELPELPQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPD 170 (454)
T ss_dssp CSSCCCCCTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCC
T ss_pred CCccccccCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCC
Confidence 011344444444444442 2211 1577888888888875 77 58888888888888888875 554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.6e-12 Score=121.32 Aligned_cols=111 Identities=24% Similarity=0.369 Sum_probs=88.7
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|+ +..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++ +|. +..+++|+.|++++|.+++..+ ++.+
T Consensus 78 ~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l 150 (308)
T 1h6u_A 78 LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGL 150 (308)
T ss_dssp CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGC
T ss_pred Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCC
Confidence 444 8888899999999999884 44 68888999999999998885 443 8888889999999888875433 7788
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
++|++|++++|.+++ ++. +.++++|+.|++++|.+++.
T Consensus 151 ~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 151 TNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred CCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC
Confidence 888888888888875 444 77888888888888888754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=132.04 Aligned_cols=110 Identities=28% Similarity=0.391 Sum_probs=93.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
+|+ ++.+++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++ + +.+..|++|+.|+|++|.+++. ..++.+
T Consensus 80 ~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l 152 (605)
T 1m9s_A 80 IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRL 152 (605)
T ss_dssp CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSC
T ss_pred Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhccc
Confidence 444 8889999999999999984 44 78899999999999999985 4 4688899999999999999864 578889
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|+.|+|++|.+++..| +..+++|+.|+|++|.+++
T Consensus 153 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 153 TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 999999999999987655 8889999999999998875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.1e-12 Score=128.55 Aligned_cols=101 Identities=28% Similarity=0.401 Sum_probs=54.0
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
||..+. ++|+.|+|++|+|+ .+| ..+++|+.|+|++|++++ +|. +.. +|+.|+|++|.|++ +|. .+
T Consensus 74 lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l 139 (571)
T 3cvr_A 74 LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LP 139 (571)
T ss_dssp CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CC
T ss_pred cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cC
Confidence 454442 45566666666655 455 334556666666666654 554 433 55555555555554 444 34
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++|++++|++++ +|. .+++|+.|++++|.+++
T Consensus 140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 555555555555553 444 34455555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=117.47 Aligned_cols=111 Identities=29% Similarity=0.328 Sum_probs=95.1
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.+| .++.+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++ +|.... ++|+.|+|++|.+++ +| .++.
T Consensus 55 ~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~ 126 (263)
T 1xeu_A 55 SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIH 126 (263)
T ss_dssp CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTT
T ss_pred cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcC
Confidence 355 68899999999999999995 554 9999999999999999985 665433 889999999999986 44 5889
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
+++|++|++++|++++ +| .++.+++|+.|++++|.+++.
T Consensus 127 l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 127 LKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred cccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence 9999999999999985 55 688999999999999998864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=122.82 Aligned_cols=112 Identities=28% Similarity=0.392 Sum_probs=100.2
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
+..+++|+.|+|++|.+++ +|. +..+++|+.|++++|.+++ + +.+..+++|+.|++++|.+++ +| .+..+++|+
T Consensus 217 ~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~ 290 (347)
T 4fmz_A 217 VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLN 290 (347)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCS
T ss_pred hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCC
Confidence 7889999999999999985 554 8999999999999999985 4 478999999999999999986 44 588999999
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++++|.+++..|..++++++|+.|++++|.+++..|
T Consensus 291 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 99999999998888889999999999999999987655
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.2e-12 Score=125.84 Aligned_cols=107 Identities=26% Similarity=0.306 Sum_probs=68.6
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+.+++++++|+.|+|++|.+++ +| .++.+++|++|+|++|++++ +| ++.+++|++|++++|.+++ +| ++.++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCC
Confidence 3456666677777777777664 34 56666777777777777664 33 6666667777777766665 33 66666
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+|++|++++|++++ +| ++++++|+.|++++|.+++
T Consensus 107 ~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 107 KLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp TCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred cCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence 66666666666654 43 5666666666666666655
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-12 Score=124.99 Aligned_cols=108 Identities=31% Similarity=0.441 Sum_probs=70.4
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|++++|.+++..| +..+++|+.|++++|.+++ +|+ +..+++|+.|++++|.+++..| ++.+++|
T Consensus 238 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 311 (466)
T 1o6v_A 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNL 311 (466)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTC
T ss_pred hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCC
Confidence 46667777777777777765433 6677777777777777764 333 6666777777777777765333 5666677
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++++|++++..| +..+++|+.|++++|.+++
T Consensus 312 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 777777777665444 5566666666666666654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.31 E-value=9.7e-12 Score=122.92 Aligned_cols=110 Identities=33% Similarity=0.451 Sum_probs=86.2
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
++.+++|+.|++++|++++ + +.+..+++|+.|++++|.+++..| +..+++|+.|++++|.+++..| +..+++|+
T Consensus 217 ~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 290 (466)
T 1o6v_A 217 LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290 (466)
T ss_dssp GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence 6778888888888888874 4 367788888888888888886443 7788888888888888886443 77888888
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++++|++++..| ++.+++|+.|++++|.+++..|
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence 88888888876433 6788888888888888877654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.3e-12 Score=120.37 Aligned_cols=113 Identities=26% Similarity=0.329 Sum_probs=98.1
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++ +|. +..+++|+.|++++|.+++ + ..+..+++|+
T Consensus 195 ~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~ 268 (347)
T 4fmz_A 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLK 268 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCC
T ss_pred ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcC
Confidence 7889999999999999985444 8899999999999999985 454 8999999999999999986 4 4688999999
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+|++++|.+++ + ..+..+++|+.|++++|.+++..|..+
T Consensus 269 ~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 269 MLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp EEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred EEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 99999999975 4 458899999999999999987666544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.7e-11 Score=120.56 Aligned_cols=107 Identities=23% Similarity=0.193 Sum_probs=86.7
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
++.+++|+.|++++|...+.+ .++.+++|+.|++++|++++ +| ++.+++|+.|++++|.+++. .++.+++|+
T Consensus 144 l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~ 215 (457)
T 3bz5_A 144 VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLT 215 (457)
T ss_dssp CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCS
T ss_pred cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCC
Confidence 778888888888888666666 47788888888888888886 55 77888888888888888864 377888888
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
+|++++|++++ +| ++.+++|+.|++++|.+++..+
T Consensus 216 ~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~ 250 (457)
T 3bz5_A 216 FLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV 250 (457)
T ss_dssp EEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred EEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence 88888888876 66 7788888888888888887543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.2e-11 Score=119.78 Aligned_cols=101 Identities=25% Similarity=0.357 Sum_probs=62.1
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
++|++|+|++|++++ +| +++++++|++|++++|++++ +|..+ .+|+.|++++|.+++ +| .++++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 467777777777764 66 47777777777777777764 55433 366666777776665 55 4666666666666
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCcceecCC
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
++|++++ +|... ++|+.|++++|.+. .+|
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence 6666654 44322 35555666665555 344
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.9e-13 Score=131.88 Aligned_cols=118 Identities=16% Similarity=0.197 Sum_probs=86.3
Q ss_pred CCccccCCCCCCeeecCCC---cccccCCccc-------CCCCCCcEEECCCCcCcc----CCCcCccCCCCCCeEECcC
Q 040641 5 IPSEFGDSLKLQGLYLGNN---QLTGSIPRSL-------GQLGGLVKLNLTRNKFSG----PVPTSLGNLKGLSHLDLSS 70 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n---~l~g~~p~~~-------~~l~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~l~~ 70 (435)
|+..+..+++|+.|+|++| ++++.+|..+ ..+++|++|+|++|.+++ .+|..+..+++|++|+|++
T Consensus 52 l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~ 131 (386)
T 2ca6_A 52 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 131 (386)
T ss_dssp HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcC
Confidence 3345777888888888884 5556666655 678888888888888886 4677788888888888888
Q ss_pred cccCCcCCCcCC----CC---------CCCCEEeCCCCCCc-ccCC---ccccCcCCCCcccccCCcce
Q 040641 71 NFFDGGWPRSLG----NL---------SYSTYLDLHDNKFT-REIP---QNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 71 n~l~~~~p~~~~----~l---------~~L~~L~l~~n~~~-~~~p---~~~~~l~~L~~l~l~~n~l~ 122 (435)
|.+++..+..+. .+ ++|++|++++|.++ +.+| ..+..+++|+.|++++|.++
T Consensus 132 n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 132 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 888644333333 33 78888888888886 4455 35667778888888888776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.6e-13 Score=129.66 Aligned_cols=115 Identities=22% Similarity=0.257 Sum_probs=99.5
Q ss_pred CccccCCCCCCeeecCCCccccc-CCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCc-ccCC-cCCCcCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGS-IPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSN-FFDG-GWPRSLG 82 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~-~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n-~l~~-~~p~~~~ 82 (435)
++.+..+++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..++.+++|+.|+|++| .+++ .+|..+.
T Consensus 86 ~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~ 165 (336)
T 2ast_B 86 LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 165 (336)
T ss_dssp CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH
T ss_pred chhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh
Confidence 34477899999999999999866 8888999999999999999998888888999999999999999 6775 3677788
Q ss_pred CCCCCCEEeCCCC-CCccc-CCccccCcC-CCCcccccCCc
Q 040641 83 NLSYSTYLDLHDN-KFTRE-IPQNLGNLA-QLEHLDVLRNM 120 (435)
Q Consensus 83 ~l~~L~~L~l~~n-~~~~~-~p~~~~~l~-~L~~l~l~~n~ 120 (435)
++++|++|++++| .+++. ++..+..++ +|++|++++|.
T Consensus 166 ~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 166 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp HCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred cCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 8999999999999 88764 677788889 99999999983
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.6e-13 Score=129.89 Aligned_cols=111 Identities=21% Similarity=0.246 Sum_probs=86.6
Q ss_pred CCCCeeecCCCccc-ccCC---cccCCCCCCcEEECCCCcCc--c---CCCcCccCCCCCCeEECcCcccC----CcCCC
Q 040641 13 LKLQGLYLGNNQLT-GSIP---RSLGQLGGLVKLNLTRNKFS--G---PVPTSLGNLKGLSHLDLSSNFFD----GGWPR 79 (435)
Q Consensus 13 ~~L~~L~l~~n~l~-g~~p---~~~~~l~~L~~L~ls~n~l~--~---~~p~~~~~l~~L~~L~l~~n~l~----~~~p~ 79 (435)
++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|.++ | .+|..+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 78888888888887 4455 46677888888888888887 2 34447788888888888888885 56777
Q ss_pred cCCCCCCCCEEeCCCCCCccc----CCccc--cCcCCCCcccccCCccee
Q 040641 80 SLGNLSYSTYLDLHDNKFTRE----IPQNL--GNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 80 ~~~~l~~L~~L~l~~n~~~~~----~p~~~--~~l~~L~~l~l~~n~l~g 123 (435)
.+..+++|++|++++|.+++. +|..+ +.+++|+.|++++|.+++
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 888888888888888888765 55655 347888888888888876
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=124.07 Aligned_cols=81 Identities=23% Similarity=0.281 Sum_probs=39.4
Q ss_pred CCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCccccc
Q 040641 38 GLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVL 117 (435)
Q Consensus 38 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~ 117 (435)
+|+.|+|++|.+++ +| ..+++|+.|+|++|.|+ .+|. .+++|++|++++|+++ .+|..+.++++|+.|+++
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 34444444444442 33 22344445555555444 2333 3345555555555554 455555555555555555
Q ss_pred CCcceecCCc
Q 040641 118 RNMLCGKIPE 127 (435)
Q Consensus 118 ~n~l~g~~p~ 127 (435)
+|.+++.+|.
T Consensus 293 ~N~l~~~~~~ 302 (622)
T 3g06_A 293 GNPLSERTLQ 302 (622)
T ss_dssp SCCCCHHHHH
T ss_pred CCCCCCcCHH
Confidence 5555554444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.23 E-value=6.2e-14 Score=122.06 Aligned_cols=110 Identities=20% Similarity=0.247 Sum_probs=99.5
Q ss_pred ccCCCCCCeeecCCCcccccCCc------ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPR------SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~------~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+.....++.++++.|.++|.+|. .+..+++|++|+|++|.+++ +| .+..+++|+.|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45567889999999999999887 89999999999999999996 78 8999999999999999998 6888888
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
.+++|++|++++|++++ +| .++.+++|+.|++++|.+++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~ 129 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN 129 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence 88999999999999986 66 68899999999999998874
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.6e-13 Score=126.41 Aligned_cols=124 Identities=21% Similarity=0.185 Sum_probs=99.1
Q ss_pred CcccCCccccCCCCCCeeecCCCcccccCC----cccCCCC-CCcEEECCCCcCccCCCcCccCC-----CCCCeEECcC
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIP----RSLGQLG-GLVKLNLTRNKFSGPVPTSLGNL-----KGLSHLDLSS 70 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g~~p----~~~~~l~-~L~~L~ls~n~l~~~~p~~~~~l-----~~L~~L~l~~ 70 (435)
++|.+|..+...++|+.|+|++|.+++..+ ..+..++ +|+.|+|++|.+++..+..+..+ ++|+.|+|++
T Consensus 10 ~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~ 89 (362)
T 3goz_A 10 GSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSG 89 (362)
T ss_dssp TCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCS
T ss_pred chHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcC
Confidence 466777767777779999999999986665 6788888 89999999999997777777665 8999999999
Q ss_pred cccCCcCCCcCCC----C-CCCCEEeCCCCCCcccCCccccC-----cCCCCcccccCCcceec
Q 040641 71 NFFDGGWPRSLGN----L-SYSTYLDLHDNKFTREIPQNLGN-----LAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 71 n~l~~~~p~~~~~----l-~~L~~L~l~~n~~~~~~p~~~~~-----l~~L~~l~l~~n~l~g~ 124 (435)
|.+++..+..++. + ++|++|++++|.+++..+..++. .++|++|++++|.++..
T Consensus 90 n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 90 NFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp SCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred CcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 9998766664443 3 79999999999998766555433 25899999999988743
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1e-12 Score=124.01 Aligned_cols=114 Identities=12% Similarity=0.094 Sum_probs=101.0
Q ss_pred ccCC--CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccC-CCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 9 FGDS--LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP-VPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 9 ~~~l--~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+..+ +.++.|++++|.+.+..+. +..+++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..++.++
T Consensus 64 ~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~ 142 (336)
T 2ast_B 64 TGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 142 (336)
T ss_dssp HHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCT
T ss_pred HHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCC
Confidence 4445 7899999999999976654 67899999999999999876 888899999999999999999988899999999
Q ss_pred CCCEEeCCCC-CCcc-cCCccccCcCCCCcccccCC-ccee
Q 040641 86 YSTYLDLHDN-KFTR-EIPQNLGNLAQLEHLDVLRN-MLCG 123 (435)
Q Consensus 86 ~L~~L~l~~n-~~~~-~~p~~~~~l~~L~~l~l~~n-~l~g 123 (435)
+|++|++++| .+++ .+|..+.++++|+.|++++| .+++
T Consensus 143 ~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 143 NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp TCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred CCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 9999999999 6776 37777889999999999999 8875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=8e-12 Score=113.33 Aligned_cols=105 Identities=19% Similarity=0.191 Sum_probs=76.1
Q ss_pred cceeeeecccCcceEEEEEc-CCCCE--EEEEEccccccc------------------------cHHHHHHHHHHhccCC
Q 040641 185 LTLVDILEDGGFGTVYKATL-PDGKT--VAVKKFSQAKTQ------------------------GHRQFTAEMETLGKVK 237 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 237 (435)
+.+.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999987 67888 999987532111 0135788999999998
Q ss_pred CCCc--eeEEEEEEeCCeeEEEEecccC-C----CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceee
Q 040641 238 HQNL--VLLLGYCSFDEEKLLVYEYMVN-G----SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300 (435)
Q Consensus 238 H~ni--v~l~g~~~~~~~~~lv~ey~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 300 (435)
|+++ ...+++ +..++||||+.+ | +|.++... .++.....++.+++.||.|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHH
Confidence 8864 334432 357899999953 4 67665432 123345678899999999999
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.16 E-value=4.3e-11 Score=113.68 Aligned_cols=113 Identities=19% Similarity=0.156 Sum_probs=70.5
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCc-CccCCCCCCe-EECcCcccCCcCCCcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSH-LDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~-L~l~~n~l~~~~p~~~~ 82 (435)
||..+ .++++.|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++|.. +++++|+++...|..|.
T Consensus 24 iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~ 101 (350)
T 4ay9_X 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ 101 (350)
T ss_dssp CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBC
T ss_pred cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhh
Confidence 55555 24677777777777632233567777777777777776655554 4566666553 55556777665566677
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCC
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
.+++|++|++++|+++...+..+....++..+++.++
T Consensus 102 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp CCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC
T ss_pred hccccccccccccccccCCchhhcccchhhhhhhccc
Confidence 7777777777777776544444445555566666543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.9e-10 Score=114.61 Aligned_cols=102 Identities=26% Similarity=0.328 Sum_probs=75.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
.||..+. ++|+.|+|++|.++ .+|. .+++|++|+|++|+++ .+|. .+++|+.|+|++|.+++ +|. .
T Consensus 54 ~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~ 119 (622)
T 3g06_A 54 TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---L 119 (622)
T ss_dssp CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---C
T ss_pred ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---C
Confidence 4676665 68888888888888 6776 5678888888888887 4776 66788888888888874 554 4
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++|++|++++|++++ +|.. +++|++|++++|.+++
T Consensus 120 l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 120 PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred CCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence 5677778888887764 6653 3677777787777764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.07 E-value=5.7e-12 Score=120.35 Aligned_cols=121 Identities=24% Similarity=0.258 Sum_probs=94.8
Q ss_pred ccccCCC-CCCeeecCCCcccccCCcccCCC-----CCCcEEECCCCcCccCCCcCc----cCC-CCCCeEECcCcccCC
Q 040641 7 SEFGDSL-KLQGLYLGNNQLTGSIPRSLGQL-----GGLVKLNLTRNKFSGPVPTSL----GNL-KGLSHLDLSSNFFDG 75 (435)
Q Consensus 7 ~~~~~l~-~L~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~ls~n~l~~~~p~~~----~~l-~~L~~L~l~~n~l~~ 75 (435)
..+..++ +|+.|+|++|.+++..+..+..+ ++|+.|+|++|.+++..+..+ ..+ ++|+.|+|++|.+++
T Consensus 44 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 123 (362)
T 3goz_A 44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS 123 (362)
T ss_dssp HHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred HHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence 4567777 89999999999998777777775 999999999999987666544 444 899999999999987
Q ss_pred cCCCcC----CC-CCCCCEEeCCCCCCccc----CCccccCcC-CCCcccccCCcceecCCc
Q 040641 76 GWPRSL----GN-LSYSTYLDLHDNKFTRE----IPQNLGNLA-QLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 76 ~~p~~~----~~-l~~L~~L~l~~n~~~~~----~p~~~~~l~-~L~~l~l~~n~l~g~~p~ 127 (435)
..+..+ .. .++|++|++++|.++.. ++..+..++ +|+.|++++|.+++..+.
T Consensus 124 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~ 185 (362)
T 3goz_A 124 KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCA 185 (362)
T ss_dssp SCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred HHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHH
Confidence 655443 33 36899999999999853 344445565 899999999998765543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.96 E-value=9.6e-10 Score=104.30 Aligned_cols=114 Identities=21% Similarity=0.120 Sum_probs=65.2
Q ss_pred cccCCCCCCe-eecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-------------------------ccCCC
Q 040641 8 EFGDSLKLQG-LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-------------------------LGNLK 61 (435)
Q Consensus 8 ~~~~l~~L~~-L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-------------------------~~~l~ 61 (435)
.|.++++|+. +.+++|+++...|..+..+++|++|++++|++++..+.. |..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 3555665543 445556666555556666666666666666665332222 23332
Q ss_pred -CCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCc-cccCcCCCCcccccCCcce
Q 040641 62 -GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQ-NLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 62 -~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~l~ 122 (435)
.++.|+|++|.++ .+|..+....+|++|++++|+..+.+|. .|..+++|+.||+++|.++
T Consensus 154 ~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred hhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 3556666666666 3555555555666677664333345554 3566777777777777666
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-11 Score=122.35 Aligned_cols=113 Identities=19% Similarity=0.162 Sum_probs=84.6
Q ss_pred CCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccCCCcCccC-----CCCCCeEECcCcccCCc----C
Q 040641 11 DSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGPVPTSLGN-----LKGLSHLDLSSNFFDGG----W 77 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~-----l~~L~~L~l~~n~l~~~----~ 77 (435)
.+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|++++|.+++. +
T Consensus 254 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 333 (461)
T 1z7x_W 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 333 (461)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence 578899999999988854 6777778889999999999887543333322 35788888888888765 5
Q ss_pred CCcCCCCCCCCEEeCCCCCCcccCCccccC-----cCCCCcccccCCccee
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTREIPQNLGN-----LAQLEHLDVLRNMLCG 123 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~-----l~~L~~l~l~~n~l~g 123 (435)
|..+..+++|++|++++|.+++..+..+.. .++|+.|++++|.+++
T Consensus 334 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 666677788888888888887655554443 5688888888888774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.87 E-value=5.1e-11 Score=117.40 Aligned_cols=123 Identities=20% Similarity=0.120 Sum_probs=98.5
Q ss_pred CCccccCCCCCCeeecCCCcccccC-----CcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSI-----PRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDG 75 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~-----p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~ 75 (435)
+|..+..+++|+.|+|++|.+++.- +..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 219 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 298 (461)
T 1z7x_W 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred HHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch
Confidence 5666788999999999999987542 22334689999999999999864 67778889999999999999875
Q ss_pred cCCCcCCC-----CCCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCcceecCCc
Q 040641 76 GWPRSLGN-----LSYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLCGKIPE 127 (435)
Q Consensus 76 ~~p~~~~~-----l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~g~~p~ 127 (435)
..+..+.. .++|++|++++|.+++. +|..+..+++|+.|++++|.+++..+.
T Consensus 299 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 44433332 36899999999999865 567777889999999999998765443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.77 E-value=6.4e-10 Score=100.23 Aligned_cols=80 Identities=23% Similarity=0.281 Sum_probs=53.8
Q ss_pred CCCCCCcEEECCCCcCcc--CCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC--CCCEEeCCCCCCcccCCc------
Q 040641 34 GQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS--YSTYLDLHDNKFTREIPQ------ 103 (435)
Q Consensus 34 ~~l~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~l~~n~~~~~~p~------ 103 (435)
.++++|+.|+||+|++++ .+|..++.+++|+.|+|++|.|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456778888888888876 4556666777888888888887753 2334444 777777777777766653
Q ss_pred -cccCcCCCCccc
Q 040641 104 -NLGNLAQLEHLD 115 (435)
Q Consensus 104 -~~~~l~~L~~l~ 115 (435)
-+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 245566666665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.77 E-value=6.1e-10 Score=105.48 Aligned_cols=106 Identities=7% Similarity=-0.004 Sum_probs=68.3
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEcccccc--------------ccHHH--------HHHHHHHhccCCCCCc
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT--------------QGHRQ--------FTAEMETLGKVKHQNL 241 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~H~ni 241 (435)
-|.+...||+|+||.||+|...+|+.||||.++.... ..... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4788999999999999999998999999998753210 01111 2346666766654443
Q ss_pred eeEEEEEEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 242 v~l~g~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.-..-+.. ...+|||||+++++|..+.. .+ ....++.|++.+|.|||+
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~--~~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VP--DPASLYADLIALILRLAK 223 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CS--CHHHHHHHHHHHHHHHHH
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcc--------cH--HHHHHHHHHHHHHHHHHH
Confidence 21111111 12379999999988754321 11 123567788888888875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.70 E-value=7.6e-10 Score=105.66 Aligned_cols=111 Identities=23% Similarity=0.171 Sum_probs=78.0
Q ss_pred CCCCeeecCCCcccccCCccc-CCCCCCcEEECCCCcCccCCCcCc-----cCCCCCCeEECcCcccCC----cCCCcCC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSL-GQLGGLVKLNLTRNKFSGPVPTSL-----GNLKGLSHLDLSSNFFDG----GWPRSLG 82 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~-~~l~~L~~L~ls~n~l~~~~p~~~-----~~l~~L~~L~l~~n~l~~----~~p~~~~ 82 (435)
++|+.|+|++|.++..-...+ ..+++|+.|+|++|.++..-...+ ...++|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 688899999998864333333 245678899999998864333333 245778899999988864 2444556
Q ss_pred CCCCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCccee
Q 040641 83 NLSYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
.+++|++|+|++|.++.. ++..+...++|+.|++++|.++.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 678888999998888642 34456667788889998888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.61 E-value=1.8e-08 Score=90.80 Aligned_cols=80 Identities=24% Similarity=0.243 Sum_probs=66.9
Q ss_pred cCCCCCCeeecCCCcccc--cCCcccCCCCCCcEEECCCCcCccCCCcCccCCC--CCCeEECcCcccCCcCCC------
Q 040641 10 GDSLKLQGLYLGNNQLTG--SIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLK--GLSHLDLSSNFFDGGWPR------ 79 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g--~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~--~L~~L~l~~n~l~~~~p~------ 79 (435)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++++. ..+..++ +|+.|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 357899999999999997 5667788999999999999999964 3455555 899999999999987773
Q ss_pred -cCCCCCCCCEEe
Q 040641 80 -SLGNLSYSTYLD 91 (435)
Q Consensus 80 -~~~~l~~L~~L~ 91 (435)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356788999887
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=4.2e-09 Score=90.16 Aligned_cols=114 Identities=16% Similarity=0.168 Sum_probs=89.1
Q ss_pred ccCCCCCCeeecCCC-ccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCCc---
Q 040641 9 FGDSLKLQGLYLGNN-QLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDGG--- 76 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n-~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~--- 76 (435)
+...+.|+.|+|++| .+... +...+...++|++|+|++|.+... +...+...++|+.|+|++|.++..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 456789999999999 87632 456677789999999999999742 344556668899999999999743
Q ss_pred -CCCcCCCCCCCCEEeC--CCCCCccc----CCccccCcCCCCcccccCCcce
Q 040641 77 -WPRSLGNLSYSTYLDL--HDNKFTRE----IPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 77 -~p~~~~~l~~L~~L~l--~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+...+...+.|++|++ ++|.++.. +...+...++|+.|++++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566777889999999 88998754 3334555688999999999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=3.6e-09 Score=101.00 Aligned_cols=112 Identities=20% Similarity=0.155 Sum_probs=82.8
Q ss_pred CCCCCeeecCCCcccccCCcccCC-----CCCCcEEECCCCcCccCCCcCc-cCCCCCCeEECcCcccCCcCCCcC----
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQ-----LGGLVKLNLTRNKFSGPVPTSL-GNLKGLSHLDLSSNFFDGGWPRSL---- 81 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~-----l~~L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~p~~~---- 81 (435)
++.|+.|+|++|.++..-...+.. .++|+.|+|++|.++..-...+ ..+++|+.|||++|.++..-...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 467999999999998544333332 3799999999999975323232 345689999999999975433333
Q ss_pred -CCCCCCCEEeCCCCCCcc----cCCccccCcCCCCcccccCCccee
Q 040641 82 -GNLSYSTYLDLHDNKFTR----EIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 82 -~~l~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
...++|++|+|++|.++. .++..+...++|++|++++|.++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 346789999999999864 244455778899999999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.8e-09 Score=109.73 Aligned_cols=114 Identities=13% Similarity=0.087 Sum_probs=73.5
Q ss_pred cCCCCCCeeecCCCcccccCCcccCC-CCCCcEEECC----CCcCccC-----CCcCccCCCCCCeEECcCc--ccCCcC
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQ-LGGLVKLNLT----RNKFSGP-----VPTSLGNLKGLSHLDLSSN--FFDGGW 77 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~-l~~L~~L~ls----~n~l~~~-----~p~~~~~l~~L~~L~l~~n--~l~~~~ 77 (435)
..+++|+.|+|+.|.+++..+..++. +++|+.|+++ .|.+++. ++..+..+++|+.|+++++ .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34678888888888887766666655 7788888885 6667642 2233556777777777642 355444
Q ss_pred CCcCCC-CCCCCEEeCCCCCCcc-cCCccccCcCCCCcccccCCccee
Q 040641 78 PRSLGN-LSYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 78 p~~~~~-l~~L~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+..++. +++|++|++++|.+++ .++..+..+++|+.|++++|.+++
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 444433 6677777777777765 344445666777777777776653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.52 E-value=6.5e-07 Score=83.86 Aligned_cols=58 Identities=17% Similarity=0.146 Sum_probs=45.1
Q ss_pred CCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCC-cccccC
Q 040641 60 LKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLE-HLDVLR 118 (435)
Q Consensus 60 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~-~l~l~~ 118 (435)
+++|+.|+|++|.++..-+..|.++.+|+.+++++| ++..-+..|.++.+|+ .+++..
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 678888999988887544457888889999999887 6544455688888888 888877
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.48 E-value=3.4e-07 Score=85.78 Aligned_cols=102 Identities=17% Similarity=0.069 Sum_probs=64.0
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCC-eEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLS-HLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
+++|+.|+|++|+++..-+..|.++++|+.|+|++| +...-+.+|.+|.+|+ .+++.+ .++..-+..|.+|++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 566777777777776333345667777777777766 5532333567777777 777766 4553344566777777777
Q ss_pred eCCCCCCcccCCccccCcCCCCccc
Q 040641 91 DLHDNKFTREIPQNLGNLAQLEHLD 115 (435)
Q Consensus 91 ~l~~n~~~~~~p~~~~~l~~L~~l~ 115 (435)
+++.|+++..-+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 7777776644445666666666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.45 E-value=2e-08 Score=101.99 Aligned_cols=81 Identities=11% Similarity=0.043 Sum_probs=41.0
Q ss_pred CCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCc----cCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 11 DSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFS----GPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~----~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.+++|+.|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+..+++|+.|++++|.+.+ +|..+.
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~ 240 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK 240 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence 455666666666665543 2333345556666666666654 2233334455666666666665543 333333
Q ss_pred CCCCCCEEeC
Q 040641 83 NLSYSTYLDL 92 (435)
Q Consensus 83 ~l~~L~~L~l 92 (435)
.+++|++|++
T Consensus 241 ~~~~L~~L~l 250 (592)
T 3ogk_B 241 AAANLEEFCG 250 (592)
T ss_dssp HCTTCCEEEE
T ss_pred hhhHHHhhcc
Confidence 3344444433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=7.5e-07 Score=80.48 Aligned_cols=109 Identities=14% Similarity=0.002 Sum_probs=84.8
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
..+++...++.|+++.||++... ++.+++|............+.+|+++++.+. |.++.++++++...+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 35777888898999999999864 6889999986532223345889999998884 677889999999889999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+|.+|...+.. ......++.+++++++.||+
T Consensus 93 ~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 93 DGVLCSEEYED---------EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp SSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHH
T ss_pred CCeehhhccCC---------cccHHHHHHHHHHHHHHHhC
Confidence 99998765311 11234678889999999997
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=4.2e-07 Score=86.05 Aligned_cols=117 Identities=16% Similarity=0.173 Sum_probs=79.5
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCcc--CCCCCCeEECcC--cccCCc----
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLG--NLKGLSHLDLSS--NFFDGG---- 76 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~--~l~~L~~L~l~~--n~l~~~---- 76 (435)
|+.-+..+++|+.|+|++|.-. .++. +. +++|+.|+|+.+.+.......+. .+++|+.|+|+. |...|.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 4445567889999999988411 3444 43 88999999998877643333333 689999999863 332221
Q ss_pred -CCCcC--CCCCCCCEEeCCCCCCcccCCcccc---CcCCCCcccccCCcceec
Q 040641 77 -WPRSL--GNLSYSTYLDLHDNKFTREIPQNLG---NLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 77 -~p~~~--~~l~~L~~L~l~~n~~~~~~p~~~~---~l~~L~~l~l~~n~l~g~ 124 (435)
+...+ ..+++|++|++.+|.+....+..+. .+++|++|+++.|.+...
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 11122 3578999999999988754433332 578999999999988753
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.3e-07 Score=96.05 Aligned_cols=112 Identities=13% Similarity=0.103 Sum_probs=76.2
Q ss_pred CCCCCCeeecCCCcccccCCcccC-CCCCCcEEECC--C----CcCccC-----CCcCccCCCCCCeEECcCcccCCcCC
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLG-QLGGLVKLNLT--R----NKFSGP-----VPTSLGNLKGLSHLDLSSNFFDGGWP 78 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~ls--~----n~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p 78 (435)
.+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..+
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 367888888888888766665554 47888888888 3 555521 111255677888888866 5555444
Q ss_pred CcCCC-CCCCCEEeCCCCCCcccCCccc-cCcCCCCcccccCCccee
Q 040641 79 RSLGN-LSYSTYLDLHDNKFTREIPQNL-GNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 79 ~~~~~-l~~L~~L~l~~n~~~~~~p~~~-~~l~~L~~l~l~~n~l~g 123 (435)
..++. +++|++|++++|.+++..+..+ ..+++|+.|++++|.+++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 45554 7778888888888766554444 557788888888887743
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.00 E-value=5.2e-07 Score=91.55 Aligned_cols=109 Identities=16% Similarity=0.120 Sum_probs=70.0
Q ss_pred CCCCCCeeecCCCcccccCCcccC-CCCCCcEEECCCC-cCccC-CCcCccCCCCCCeEECcCcccCCcCCCcC----CC
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLG-QLGGLVKLNLTRN-KFSGP-VPTSLGNLKGLSHLDLSSNFFDGGWPRSL----GN 83 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~-~l~~L~~L~ls~n-~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~~----~~ 83 (435)
.+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|+.|+|++|.+++..+..+ ..
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 466788888888877766666664 5778888888877 44432 34444567788888888887765433333 35
Q ss_pred CCCCCEEeCCCCC--Ccc-cCCccccCcCCCCcccccCC
Q 040641 84 LSYSTYLDLHDNK--FTR-EIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 84 l~~L~~L~l~~n~--~~~-~~p~~~~~l~~L~~l~l~~n 119 (435)
+++|++|++++|. ++. .++.-+.++++|++|++++|
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 6678888888776 211 11111234577888888776
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.97 E-value=7e-07 Score=76.16 Aligned_cols=91 Identities=14% Similarity=0.119 Sum_probs=72.4
Q ss_pred cccCCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEEC--cCcccCCc-
Q 040641 8 EFGDSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDL--SSNFFDGG- 76 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l--~~n~l~~~- 76 (435)
.+...++|++|+|++|.+... +...+...++|++|+|++|.++.. +...+...++|+.|+| ++|.++..
T Consensus 60 ~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g 139 (185)
T 1io0_A 60 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 139 (185)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHH
Confidence 456678999999999998642 455666778999999999999853 4567778889999999 88998743
Q ss_pred ---CCCcCCCCCCCCEEeCCCCCCc
Q 040641 77 ---WPRSLGNLSYSTYLDLHDNKFT 98 (435)
Q Consensus 77 ---~p~~~~~l~~L~~L~l~~n~~~ 98 (435)
+...+...+.|++|++++|.+.
T Consensus 140 ~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 140 EMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3344556689999999999874
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=2.4e-06 Score=80.77 Aligned_cols=116 Identities=12% Similarity=0.113 Sum_probs=77.5
Q ss_pred CccccCCCCCCeeecCCCccc---------ccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCc
Q 040641 6 PSEFGDSLKLQGLYLGNNQLT---------GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGG 76 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~---------g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 76 (435)
..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .+++ +. +++|+.|+|..+.+...
T Consensus 132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~ 208 (362)
T 2ra8_A 132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDS 208 (362)
T ss_dssp HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHH
T ss_pred HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChH
Confidence 445667889999999765431 234555677899999999988422 3444 43 78999999998887643
Q ss_pred CCCcCC--CCCCCCEEeCCC--CCCccc-----CCccc--cCcCCCCcccccCCcceec
Q 040641 77 WPRSLG--NLSYSTYLDLHD--NKFTRE-----IPQNL--GNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 77 ~p~~~~--~l~~L~~L~l~~--n~~~~~-----~p~~~--~~l~~L~~l~l~~n~l~g~ 124 (435)
....++ .+++|++|+|+. |...+. +...+ ..+++|++|++++|.+...
T Consensus 209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~ 267 (362)
T 2ra8_A 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267 (362)
T ss_dssp HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHH
T ss_pred HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchH
Confidence 333343 689999999863 222111 11122 3578999999999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=1.4e-05 Score=71.72 Aligned_cols=103 Identities=12% Similarity=0.044 Sum_probs=74.8
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCC--ceeEEEEEEeCCeeEEEEecc
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQN--LVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~ey~ 261 (435)
.+.+..+.+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34444444566679999998877888999987543 2245778999998886545 455888888878889999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+|.+|. ... .+ ...++.++++.++.||+
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~ 125 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHT 125 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTT
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhC
Confidence 998874 110 11 22567888888999996
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00011 Score=70.48 Aligned_cols=78 Identities=14% Similarity=0.126 Sum_probs=37.9
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCC
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLH 93 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~ 93 (435)
+|+.+.|.+ .++..-+..|.++++|+.++|+.|.++ .+|...-.+.+|+.+.|..| ++..-...|.++.+|+.+++.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 455555553 444233345555666666666655555 33333222455555555533 332223345555555555554
Q ss_pred C
Q 040641 94 D 94 (435)
Q Consensus 94 ~ 94 (435)
.
T Consensus 235 ~ 235 (401)
T 4fdw_A 235 E 235 (401)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00015 Score=69.68 Aligned_cols=109 Identities=17% Similarity=0.102 Sum_probs=85.0
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCc-----cCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFS-----GPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~-----~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
|.+ .+|+.+.|. |.++..-+..|.++++|+.+++.+|.+. ..-+..|.+|++|+.++|.+ .++..-...|.+
T Consensus 245 F~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~ 321 (401)
T 4fdw_A 245 FRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGG 321 (401)
T ss_dssp TTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTT
T ss_pred ccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcC
Confidence 444 789999995 5566444678999999999999998875 22345799999999999994 576444568889
Q ss_pred CCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 84 LSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
|.+|+.+++..| ++..-+..|.++ +|+.++++.|.+.
T Consensus 322 c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 322 NRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred CCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 999999999665 554445678888 9999999998654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.53 E-value=1.2e-05 Score=67.08 Aligned_cols=83 Identities=12% Similarity=0.055 Sum_probs=46.5
Q ss_pred CCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcc-cCCcCCCcCCCC----CCCCEEeCCCCC-CcccCCccccCcCC
Q 040641 37 GGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF-FDGGWPRSLGNL----SYSTYLDLHDNK-FTREIPQNLGNLAQ 110 (435)
Q Consensus 37 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l----~~L~~L~l~~n~-~~~~~p~~~~~l~~ 110 (435)
-.|+.||||++.++..--..+..|++|+.|+|+++. ++..--..++.+ ++|++|+|++|. +|..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356677777666653322335566777777777664 442211223332 357777777663 54332234566777
Q ss_pred CCcccccCC
Q 040641 111 LEHLDVLRN 119 (435)
Q Consensus 111 L~~l~l~~n 119 (435)
|++|++++.
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 777777765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.53 E-value=7.3e-05 Score=70.67 Aligned_cols=108 Identities=16% Similarity=0.213 Sum_probs=78.0
Q ss_pred eeeeecccCcceEEEEEcCCCCEEEEEEcc--cccc-ccHHHHHHHHHHhccCC--CCCceeEEEEEEeC---CeeEEEE
Q 040641 187 LVDILEDGGFGTVYKATLPDGKTVAVKKFS--QAKT-QGHRQFTAEMETLGKVK--HQNLVLLLGYCSFD---EEKLLVY 258 (435)
Q Consensus 187 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~ 258 (435)
..+.++.|.++.||+....+ ..+++|+.. .... .....+.+|..+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 678888875 3221 22346788999998887 45678899988766 4589999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
||++|..+.+. ....++...+..++.++++.|+.||+
T Consensus 121 e~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 121 EFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp ECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999876321 11236677888899999999999997
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.28 E-value=3.8e-05 Score=64.09 Aligned_cols=92 Identities=17% Similarity=0.135 Sum_probs=61.4
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCc-CccCCCcCccCC----CCCCeEECcCcc-cCCcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK-FSGPVPTSLGNL----KGLSHLDLSSNF-FDGGWP 78 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l----~~L~~L~l~~n~-l~~~~p 78 (435)
+|.....--.|+.|||+++.++..--..+.++++|+.|+|+++. ++..--..+..+ ++|+.|||+++. ++..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 55543333568889999888775544567788899999998874 553222234443 368899998874 653222
Q ss_pred CcCCCCCCCCEEeCCCCC
Q 040641 79 RSLGNLSYSTYLDLHDNK 96 (435)
Q Consensus 79 ~~~~~l~~L~~L~l~~n~ 96 (435)
..+..+++|++|+++++.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 346678888999888775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.19 E-value=5.6e-05 Score=64.33 Aligned_cols=113 Identities=13% Similarity=0.143 Sum_probs=77.2
Q ss_pred cCCCCCCeeecCCC-cccc----cCCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCCc----
Q 040641 10 GDSLKLQGLYLGNN-QLTG----SIPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDGG---- 76 (435)
Q Consensus 10 ~~l~~L~~L~l~~n-~l~g----~~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~---- 76 (435)
.+-+.|+.|+|++| .+.. .+-..+..-+.|+.|+|++|++... +-..+..-+.|+.|+|++|.|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 44578999999986 6642 2455677788999999999999743 223344557899999999999742
Q ss_pred CCCcCCCCCCCCEEeCCCCC---Ccc----cCCccccCcCCCCcccccCCcce
Q 040641 77 WPRSLGNLSYSTYLDLHDNK---FTR----EIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 77 ~p~~~~~l~~L~~L~l~~n~---~~~----~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+-..+..=..|++|+|++|. +.. .+...+..-+.|+.|+++.|...
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 23344455679999998653 321 12333444567888888877543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0014 Score=51.88 Aligned_cols=36 Identities=22% Similarity=0.151 Sum_probs=18.4
Q ss_pred CCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCC
Q 040641 62 GLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKF 97 (435)
Q Consensus 62 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 97 (435)
+|+.|+|++|.|+..-+..|..+++|++|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 355555555555533333444555555555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0019 Score=51.05 Aligned_cols=55 Identities=27% Similarity=0.320 Sum_probs=33.4
Q ss_pred eeecCCCccc-ccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCccc
Q 040641 17 GLYLGNNQLT-GSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73 (435)
Q Consensus 17 ~L~l~~n~l~-g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l 73 (435)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5666666664 34554432 3567777777777643333466667777777777655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0078 Score=57.36 Aligned_cols=107 Identities=8% Similarity=0.164 Sum_probs=60.7
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCC-cCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVP-TSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
|.++..|+.+.+.++..+ .-...+.++++|+.+.+.. .+. .|+ ..|.+|.+|+.++|..+ ++..-..+|.++.+|
T Consensus 261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccEEecccccce-ecCcccccccccccccCCC-ccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 455566666666654433 3334566667777777653 343 233 34666777777777654 332223456667777
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCc
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~ 120 (435)
+.+.+..+ ++..-...|.++.+|+.+++.+|.
T Consensus 337 ~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 337 ERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 77777544 432223456666777777666553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.014 Score=55.27 Aligned_cols=108 Identities=12% Similarity=0.078 Sum_probs=62.3
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYST 88 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 88 (435)
+.....|+.+.+..+ +...-...+.++..|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|.++.+|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 445566777766544 23233445666777777777655 33222335666777777776544 3322233566677777
Q ss_pred EEeCCCCCCcccCCccccCcCCCCcccccCC
Q 040641 89 YLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 89 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
.+.+.++.++..-...|.++.+|+.+++..+
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 7777666665333455666677777766543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0076 Score=55.33 Aligned_cols=102 Identities=16% Similarity=0.054 Sum_probs=74.8
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCC---CceeEEEEEE-eCCeeEEEEecccC
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ---NLVLLLGYCS-FDEEKLLVYEYMVN 263 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~ey~~~ 263 (435)
.+.++.|....||+. +..++||.-.. ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899988 56788887432 22345788999999998753 2456666664 44567899999999
Q ss_pred CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 264 GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 264 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
..+...... .++...+..++.++++.|+-||+
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhc
Confidence 988663221 24667778889999999999997
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0056 Score=56.33 Aligned_cols=94 Identities=21% Similarity=0.197 Sum_probs=69.5
Q ss_pred ceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCC---CCCceeEEEEEEeCCeeEEEEeccc
Q 040641 186 TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK---HQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.-.+.++.|.+..+|+... ++..++||..... ....|..|.+.|+.+. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999986 4678888886532 2456888998888774 3567888888888888999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+..+.. ..+.++++.|+-||+
T Consensus 115 G~~~~~------------------~~~~~lG~~LA~LH~ 135 (312)
T 3jr1_A 115 KSKNKQ------------------SSFTIFAEKIAQLHQ 135 (312)
T ss_dssp CCCCCT------------------THHHHHHHHHHHHHH
T ss_pred CCCCCc------------------hhHHHHHHHHHHHHc
Confidence 876310 134456667777885
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.011 Score=56.37 Aligned_cols=108 Identities=10% Similarity=0.142 Sum_probs=73.1
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.|.++..|+.+.+. +.++..-...|.++++|+.+.|..+ ++..-..+|.+|.+|+.+.|..+ ++..-..+|.++.+|
T Consensus 283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 46678899999997 4555333457889999999999865 55222457999999999999765 553334588999999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcc
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l 121 (435)
+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 360 ~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 360 NNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 999999886432 3456677888888776644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0096 Score=54.01 Aligned_cols=78 Identities=18% Similarity=0.249 Sum_probs=57.4
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCC---CceeEEEEEEeCCeeEEEEec
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ---NLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~ey 260 (435)
.+.-.+.+|.|..+.||+.+..+|+.|.||+-..........|..|...|+.+.-. -+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 34556778999999999999999999999987654444445688899988877422 24455554 235799999
Q ss_pred ccCCC
Q 040641 261 MVNGS 265 (435)
Q Consensus 261 ~~~g~ 265 (435)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.016 Score=51.85 Aligned_cols=101 Identities=17% Similarity=0.069 Sum_probs=71.5
Q ss_pred eecccCcc-eEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 190 ILEDGGFG-TVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 190 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
.+..|..| .||+.... ++..+.+|.-... ....+.+|...|+.+. +--+-++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34456555 68998765 4567888876432 2356788999888774 22356788999999999999999999998
Q ss_pred HHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 267 DLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 267 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
.+..... ......++.++++.++-||+
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHT
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcC
Confidence 7765421 12234567778888888886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0044 Score=56.77 Aligned_cols=102 Identities=18% Similarity=0.167 Sum_probs=71.9
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCC--ceeEEEEEEeCC---eeEEEEecc
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQN--LVLLLGYCSFDE---EKLLVYEYM 261 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~ey~ 261 (435)
.+.++.|.+..||+.. ..+++|..... .....+.+|.++|+.+. +.. +.++++.....+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3558999999999864 46888886432 23457889999998873 332 334454443332 348999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+|.++...... .++..++..++.++++.++.||+
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHc
Confidence 99887653321 26677888899999999999996
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.017 Score=55.05 Aligned_cols=106 Identities=10% Similarity=0.104 Sum_probs=77.2
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+..++.+.+..+.+. ...+..+.+|+.+.+..+ +...-..+|.+|.+|+.++|..+ ++..-..+|.++.+|
T Consensus 271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 4566777888877765432 246778899999999765 55222346889999999999755 553334678899999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
+.+++..| ++..-...|.++.+|+.+++..+
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 99999877 55444567888999999988655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.65 E-value=0.04 Score=52.36 Aligned_cols=106 Identities=12% Similarity=0.055 Sum_probs=81.3
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+..|+.+.+..+... .-...+..+..|+.+....+.+. ...+..+.+|+.+.+..+ ++..-...|.++.+|
T Consensus 248 ~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L 322 (394)
T 4fs7_A 248 VFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL 322 (394)
T ss_dssp TTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCC
Confidence 3567788999999888665 55667889999999988776542 235888999999999765 553334578899999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCC
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
+.+++.++ ++..-...|.++.+|+.+++..|
T Consensus 323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 323 VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 99999755 55333567889999999998766
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.006 Score=57.26 Aligned_cols=115 Identities=10% Similarity=0.021 Sum_probs=75.1
Q ss_pred eeeee-cccCcceEEEEEcC-------CCCEEEEEEccccc---cccHHHHHHHHHHhccCCC---CCceeEEEEEEeC-
Q 040641 187 LVDIL-EDGGFGTVYKATLP-------DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKH---QNLVLLLGYCSFD- 251 (435)
Q Consensus 187 ~~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~- 251 (435)
..+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. -.+.++++++...
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88999999998754 25678888765432 1012356788888887742 3466788887654
Q ss_pred --CeeEEEEecccCCCHHHHHHhhCC--CCCCCCHHHHHHHHHHhhhccceeec
Q 040641 252 --EEKLLVYEYMVNGSLDLWLRNATG--SHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 252 --~~~~lv~ey~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+..++||||++|..+.+.+..... ....++..++..++.++++.|+-||+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~ 157 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHS 157 (357)
T ss_dssp TTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTT
T ss_pred ccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 356899999998776432211000 00124556667788889999999996
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.16 E-value=0.0029 Score=53.70 Aligned_cols=89 Identities=10% Similarity=0.061 Sum_probs=63.3
Q ss_pred ccCCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcc---cCC--
Q 040641 9 FGDSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNF---FDG-- 75 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~---l~~-- 75 (435)
+..-+.|+.|+|++|++... +...+..-+.|+.|+|++|.++.. +-..+..-+.|+.|+|++|. +..
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g 145 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 145 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence 55678999999999998743 334555678899999999999742 33345555679999998753 332
Q ss_pred --cCCCcCCCCCCCCEEeCCCCCC
Q 040641 76 --GWPRSLGNLSYSTYLDLHDNKF 97 (435)
Q Consensus 76 --~~p~~~~~l~~L~~L~l~~n~~ 97 (435)
.+-..+..=+.|+.|+++.|..
T Consensus 146 ~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 146 EMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCCcCeEeccCCCc
Confidence 1233344457889999987765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.97 E-value=0.14 Score=48.20 Aligned_cols=85 Identities=12% Similarity=0.033 Sum_probs=33.2
Q ss_pred ccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCC
Q 040641 32 SLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQL 111 (435)
Q Consensus 32 ~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L 111 (435)
.+....+|+.+.+..+ +...-...+..+..|+.+.+..+ ++..-...+.++..|+.+.+..+ ++..-...|.++.+|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3344444444444333 21112223444444555544433 22111223444444555444332 221112234444455
Q ss_pred CcccccCC
Q 040641 112 EHLDVLRN 119 (435)
Q Consensus 112 ~~l~l~~n 119 (435)
+.+.+..+
T Consensus 289 ~~i~l~~~ 296 (379)
T 4h09_A 289 TKVVMDNS 296 (379)
T ss_dssp CEEEECCT
T ss_pred cccccccc
Confidence 55444443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.36 E-value=0.043 Score=52.21 Aligned_cols=75 Identities=13% Similarity=0.073 Sum_probs=49.2
Q ss_pred eeeecccCcceEEEEEcC-CCCEEEEEEcccccc-------ccHHHHHHHHHHhccCCC--CCc-eeEEEEEEeCCeeEE
Q 040641 188 VDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-------QGHRQFTAEMETLGKVKH--QNL-VLLLGYCSFDEEKLL 256 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~ni-v~l~g~~~~~~~~~l 256 (435)
.+.+|.|.++.||++... +++.++||....... .....+..|.++++.+.. |.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 467899997643211 123456778888877632 333 355544 3456789
Q ss_pred EEecccCC
Q 040641 257 VYEYMVNG 264 (435)
Q Consensus 257 v~ey~~~g 264 (435)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.18 E-value=0.62 Score=39.84 Aligned_cols=92 Identities=14% Similarity=0.165 Sum_probs=50.2
Q ss_pred CHHHHHHhhCCCCCCCCHHHHHHHHHHhhhcccee-----eccc--ccccc-ccccCc-ccc--ccccccCCCcCCcCCC
Q 040641 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL-----HQDF--GLARL-ISACET-HVS--TDIAGTLGYIPPEYGQ 333 (435)
Q Consensus 265 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL-----H~Df--Gla~~-~~~~~~-~~~--~~~~gt~~y~aPE~~~ 333 (435)
+|.++|.... .++++.+.+.++.|.+++|.-+ +..+ +...+ +..+.. ... ........+.|||...
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~~~~~~~~~pe~~~ 110 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGY 110 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC------------CCSS
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccccccccccCCCChhhcc
Confidence 6889887653 4699999999999988876443 1000 00000 000000 000 0001123467888763
Q ss_pred CCCCCCcccchhHHHHHHHHHhCCCCC
Q 040641 334 SRMSTTRGDVYSFGVILLELVTAKEPT 360 (435)
Q Consensus 334 ~~~~~~k~DV~SfGvil~El~tg~~p~ 360 (435)
...+.+.=|||+|+++|..+-...|.
T Consensus 111 -~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 111 -SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 34467788999999999999877664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.67 E-value=0.017 Score=56.26 Aligned_cols=62 Identities=5% Similarity=0.001 Sum_probs=18.5
Q ss_pred ceeeeecccCcceEEEEEcCC-CCEEEE------EEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe
Q 040641 186 TLVDILEDGGFGTVYKATLPD-GKTVAV------KKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF 250 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 250 (435)
.+.+.+| ||.||+|.+.. ..+||| |..+... .+....|.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3455566 99999998864 357888 7665322 2234578899999999999999999887643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=84.59 E-value=1.7 Score=41.38 Aligned_cols=80 Identities=14% Similarity=0.155 Sum_probs=48.0
Q ss_pred eeeecccCcceEEEEEcCCCCEEEEEEccc-------c-c-cccHHHHHHHHHHhc-cCCCCCceeEEEEEEeCCeeEEE
Q 040641 188 VDILEDGGFGTVYKATLPDGKTVAVKKFSQ-------A-K-TQGHRQFTAEMETLG-KVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------~-~-~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.+.+|.|..+.||++.. +++.++||.... . . ......+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46689999999999975 467899994321 1 0 012233444443322 22234566666665 5678999
Q ss_pred Eecc-cCC-CHHHHH
Q 040641 258 YEYM-VNG-SLDLWL 270 (435)
Q Consensus 258 ~ey~-~~g-~L~~~l 270 (435)
|||+ ++. .+...+
T Consensus 116 ~e~l~~g~~~l~~~l 130 (420)
T 2pyw_A 116 MRYLEPPHIILRKGL 130 (420)
T ss_dssp ECCCCTTCEEHHHHH
T ss_pred EeecCCcchhHHHHH
Confidence 9999 773 444444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=84.50 E-value=1 Score=41.14 Aligned_cols=73 Identities=14% Similarity=0.318 Sum_probs=41.2
Q ss_pred eeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccC-----CCCCceeEE-E--EEEeCCeeEEEEec
Q 040641 189 DILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-----KHQNLVLLL-G--YCSFDEEKLLVYEY 260 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lv~ey 260 (435)
+.++.|..+.||+....+| .+++|...... .....|..++..+ ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987654 58899886521 2233444444433 234444311 1 12346678999999
Q ss_pred ccCCCH
Q 040641 261 MVNGSL 266 (435)
Q Consensus 261 ~~~g~L 266 (435)
++|..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=83.86 E-value=0.62 Score=44.67 Aligned_cols=96 Identities=19% Similarity=0.262 Sum_probs=61.2
Q ss_pred eeeecccCcceEEEEEcCC--------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCc-eeEEEEEEeCCeeEEEE
Q 040641 188 VDILEDGGFGTVYKATLPD--------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNL-VLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 188 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 258 (435)
.+.++.|....||++...+ ++.+.+|...... ....+.+|..++..+...++ .++++.+. + .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4567888889999998753 4788888874321 11456689988887754444 56676653 2 3899
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
||++|.++.. ....+ ..++.++|+.|+-||.
T Consensus 152 e~l~G~~l~~--------~~l~~----~~~~~~ia~~La~LH~ 182 (429)
T 1nw1_A 152 EYIPSRPLSC--------HEISL----AHMSTKIAKRVAKVHQ 182 (429)
T ss_dssp CCCCEEECCT--------TGGGS----HHHHHHHHHHHHHHTT
T ss_pred EEeCCcccCh--------hhcCC----HHHHHHHHHHHHHHhC
Confidence 9998655421 00111 1346677777888886
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=81.32 E-value=0.89 Score=42.73 Aligned_cols=96 Identities=18% Similarity=0.236 Sum_probs=55.8
Q ss_pred eeecccCcceEEEEEcCC--------CCEEEEEEccccccccHHHHHHHHHHhccCCCCCc-eeEEEEEEeCCeeEEEEe
Q 040641 189 DILEDGGFGTVYKATLPD--------GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNL-VLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 189 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 259 (435)
+.+..|-...+|++...+ ++.+.+|+... .......+.+|.++++.+.-.++ .++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456678888999998752 46888888633 22334566789998877743233 456666542 39999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
|++|..|.. . .+.. -.+...+|+.|+-||+
T Consensus 131 ~i~G~~l~~---~------~l~~---p~~~~~ia~~La~LH~ 160 (379)
T 3feg_A 131 YIPSRPLKT---Q------ELRE---PVLSAAIATKMAQFHG 160 (379)
T ss_dssp CCSEEECCG---G------GGGC---HHHHHHHHHHHHHHHT
T ss_pred EecCccCCh---h------HhCC---HHHHHHHHHHHHHHhC
Confidence 999865421 0 0111 1345567777777776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 435 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-51
Identities = 66/274 (24%), Positives = 107/274 (39%), Gaps = 44/274 (16%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L LV+ L G FG V+ VAVK Q F AE + +++HQ LV
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L + E ++ EYM NGSL +L+ +G L K +A A G+AF+ +
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN 129
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGLARLI E + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 340 RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399
+ DV+SFG++L E+VT + ++ + + + + D+ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLERGYRMVRPDNCPE--------- 237
Query: 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
++ ++ C + P RPT ++ +L +
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-49
Identities = 60/278 (21%), Positives = 106/278 (38%), Gaps = 44/278 (15%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
++T+ + G FGTVYK V + + Q + F E+ L K +H N++L
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
+GY + + +V ++ SL L + K IA +A+G+ +LH
Sbjct: 69 FMGYST-APQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 302 ----------------------DFGLARLISACE-THVSTDIAGTLGYIPPEY---GQSR 335
DFGLA + S +H ++G++ ++ PE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ + DVY+FG++L EL+T + P N + + + L N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY-------SNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
M R+ A+C+ RP +L + +
Sbjct: 238 CPK-----AMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-48
Identities = 53/273 (19%), Positives = 95/273 (34%), Gaps = 44/273 (16%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
LT + L G FG V VA+K + +F E + + + H+ LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
G C+ ++ EYM NG L +LR + ++ + +L
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFGL+R + E S + + PPE +++
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 341 GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
D+++FGV++ E+ + + F E A + + + A +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
K+ I C + RPT +L + ++
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-46
Identities = 59/275 (21%), Positives = 98/275 (35%), Gaps = 44/275 (16%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
LT V + G FG V+ + VA+K + F E E + K+ H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
G C LV+E+M +G L +LR + + G+A+L +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTR 340
DFG+ R + + ST + + PE +++
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 341 GDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKP 400
DV+SFGV++ E+ + + E + F+ K + A
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229
Query: 401 MMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ +I C + P RP +L+ L EI +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-45
Identities = 65/274 (23%), Positives = 101/274 (36%), Gaps = 44/274 (16%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
L L L G FG V+ T VA+K T F E + + K++H+ LV
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L S + +V EYM GSL +L+ TG + L + +A A G+A++ +
Sbjct: 77 LYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIASGMAYVERMN 133
Query: 302 ----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTT 339
DFGLARLI E + + PE T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 340 RGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSK 399
+ DV+SFG++L EL T P +E ++ V + + + +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGYRMPCPPECPE--------- 241
Query: 400 PMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ + C P RPT ++ L +
Sbjct: 242 ----SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-43
Identities = 62/275 (22%), Positives = 103/275 (37%), Gaps = 50/275 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+L L+ + G FG V G VAVK T + F AE + +++H NLV
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 244 LLGYCSFDEEKL-LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LLG ++ L +V EYM GSL +LR+ VL K + + +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGL + S+ + + + PE + + +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFS 178
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398
T+ DV+SFG++L E+ + + ++V V + K D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDAPDGCPP-------- 227
Query: 399 KPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ + +C + A RP+ L + + L I
Sbjct: 228 -----AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-43
Identities = 66/301 (21%), Positives = 109/301 (36%), Gaps = 56/301 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVL 243
+ L + + G FG V++ G+ VAVK FS + + AE+ ++H+N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILG 61
Query: 244 LLGYCSFDEEKL----LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
+ + D LV +Y +GSL +L T + K+A S+A GLA L
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHL 116
Query: 300 HQ--------------------------------DFGLARLISACETHVS---TDIAGTL 324
H D GLA + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 325 GYIPPEYGQSRM------STTRGDVYSFGVILLELVTAKEPTGPEFQEK---EGANLVGW 375
Y+ PE + S R D+Y+ G++ E+ G +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 376 VFQKMKKQQADDVLDPTVLNAG-SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
++M+K + L P + N S + M +I +C N A R T L + K L ++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 435 D 435
Sbjct: 297 Q 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-42
Identities = 70/284 (24%), Positives = 110/284 (38%), Gaps = 52/284 (18%)
Query: 183 LKLTLVDILEDGGFGTVYKATLPDGKT----VAVKKFSQAKTQGH-RQFTAEMETLGKVK 237
L + +++ G FG VY TL D AVK ++ G QF E +
Sbjct: 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 238 HQNLVLLLGYCSFDEEK-LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
H N++ LLG C E L+V YM +G L ++RN T + V D A+G+
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGM 143
Query: 297 AFLHQ------------------------DFGLARLISACE---THVSTDIAGTLGYIPP 329
FL DFGLAR + E H T + ++
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389
E Q++ TT+ DV+SFGV+L EL+T P + + ++ ++ Q + Q +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQGRRLLQPEYCP 260
Query: 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
DP + + C RP+ ++ + I
Sbjct: 261 DP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-41
Identities = 53/281 (18%), Positives = 109/281 (38%), Gaps = 51/281 (18%)
Query: 184 KLTLVDI-LEDGGFGTVYKATLPDGKT---VAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
L + DI L G FG+V + K VA+K Q + + E + + ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+V L+G C E +LV E G L +L G E + + ++ + G+ +
Sbjct: 69 PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKY 124
Query: 299 LHQ------------------------DFGLARLISACETH--VSTDIAGTLGYIPPEYG 332
L + DFGL++ + A +++ + L + PE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392
R ++R DV+S+GV + E ++ + +++ +G ++ ++ Q + + +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKGPEVMAFIEQGKRMECPPECPP-- 239
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
++ + +DC RP L V + +
Sbjct: 240 -----------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 69/298 (23%), Positives = 107/298 (35%), Gaps = 62/298 (20%)
Query: 184 KLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
+L+ L G FG V +AT TVAVK + R+ +E++ L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 237 K-HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGS--------------HEVLD 281
H N+V LLG C+ L++ EY G L +LR S LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 282 RAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH-V 316
+ A+G+AFL DFGLAR I + V
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 317 STDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWV 376
+ + ++ PE + + T DV+S+G+ L EL + P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-------K 256
Query: 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
F KM K+ + +M I C +P RPT +++L+ + +
Sbjct: 257 FYKMIKEGFRMLSPEHAPA--------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 8e-41
Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 68/302 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQGHR-QFTAEMETLGKV 236
+ V + +G FG V++A P VAVK + + + F E + +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN--------------------ATGS 276
+ N+V LLG C+ + L++EYM G L+ +LR+ ++
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI-SA 311
L A++ IA A G+A+L + DFGL+R I SA
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371
+ A + ++PPE TT DV+++GV+L E+ + +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---YYGMAHEE 250
Query: 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLH 431
++ +V ++ ++ + C + PA RP+ + ++L
Sbjct: 251 VIYYVRDGNILACPENCPL-------------ELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 432 EI 433
+
Sbjct: 298 RM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 8e-41
Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 44/289 (15%)
Query: 170 PLRINISMFQQPLLKLTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTA 228
P N ++ +T+ L G +G VY+ TVAVK + + +F
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLK 62
Query: 229 EMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKI 288
E + ++KH NLV LLG C+ + ++ E+M G+L +LR + + + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYM 120
Query: 289 ACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTL 324
A + + +L + DFGL+RL++ +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 325 GYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384
+ PE + + DV++FGV+L E+ T + + Q
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQ 224
Query: 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
++L+ + K+ + C NP+ RP+ + + +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-40
Identities = 56/296 (18%), Positives = 95/296 (32%), Gaps = 60/296 (20%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKVKHQNLVL 243
+ L G G V+K + P G +A K R Q E++ L + +V
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
G D E + E+M GSLD L+ + K++ + +GL +L +
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFG++ + ++ GT Y+ PE Q +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYS 181
Query: 339 TRGDVYSFGVILLELVTAKEP----------------------TGPEFQEKEGANLVGWV 376
+ D++S G+ L+E+ + P P G L +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAAD----CVADNPATRPTMLHVLK 428
++LD V K D C+ NPA R + ++
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 2e-40
Identities = 48/273 (17%), Positives = 99/273 (36%), Gaps = 46/273 (16%)
Query: 181 PLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQ 239
P K T + + G GTVY A + G+ VA+++ + + E+ + + K+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N+V L +E +V EY+ GSL + + + + L FL
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVCRECLQALEFL 132
Query: 300 HQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSR 335
H DFG I+ E + + GT ++ PE +
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ D++S G++ +E++ + P + + + ++ +P L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLR----ALYLIATNGTPELQNPEKLS 243
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
A + + + L + + R + +L+
Sbjct: 244 AIFRDFLNRCLDM-------DVEKRGSAKELLQ 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-40
Identities = 47/271 (17%), Positives = 93/271 (34%), Gaps = 52/271 (19%)
Query: 194 GGFGTVYKATLPD---GKTVAVKKFSQAKTQG--HRQFTAEMETLGKVKHQNLVLLLGYC 248
G FGTV K KTVAVK + AE + ++ + +V ++G C
Sbjct: 18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 77
Query: 249 SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------- 301
+ +LV E G L+ +L+ + + ++ + G+ +L +
Sbjct: 78 EAES-WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 302 -----------------DFGLARLISACETHVSTD--IAGTLGYIPPEYGQSRMSTTRGD 342
DFGL++ + A E + + + PE +++ D
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402
V+SFGV++ E + + ++ +G+ + + + +
Sbjct: 193 VWSFGVLMWEAFSYGQKP---YRGMKGSEVTAMLEKGERMGCPAGCPR------------ 237
Query: 403 LKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+M + C + RP V L
Sbjct: 238 -EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-39
Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 52/283 (18%)
Query: 185 LTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQ 239
+ + ++ G FG V L VA+K T + R F +E +G+ H
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFL 299
N++ L G + +++ E+M NGSLD +LR G V+ + A G+ +L
Sbjct: 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV---GMLRGIAAGMKYL 144
Query: 300 HQ------------------------DFGLARLI----SACETHVSTDIAGTLGYIPPEY 331
DFGL+R + S + + + PE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
Q R T+ DV+S+G+++ E+++ E + + +++ + Q + D
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYRLPPPMDCPS- 260
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
+ ++ DC + RP ++ L +++
Sbjct: 261 ------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-39
Identities = 52/273 (19%), Positives = 94/273 (34%), Gaps = 49/273 (17%)
Query: 186 TLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
++ L DG FG VYKA + A K + + E++ L H N+V L
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
L ++ ++ E+ G++D + L ++ + + L +LH
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDNKI 131
Query: 302 ---------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS--- 337
DFG++ + + GT ++ PE S
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190
Query: 338 --TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ DV+S G+ L+E+ + P E V K+ K + + P+ +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP----HHELNPMR----VLLKIAKSEPPTLAQPSRWS 242
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ K + K L N R T +L+
Sbjct: 243 SNFKDFLKKCLEK-------NVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-38
Identities = 51/281 (18%), Positives = 100/281 (35%), Gaps = 49/281 (17%)
Query: 184 KLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKH 238
++ L + +G FG V++ VA+K + R+ F E T+ + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
++V L+G + + ++ E G L +L+ S LD A A + LA+
Sbjct: 68 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAY 123
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
L DFGL+R + + ++ + ++ PE
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 335 RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394
R T+ DV+ FGV + E++ + + ++G + + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLPMPPNCPP---- 236
Query: 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ + C A +P+ RP + L I++
Sbjct: 237 ---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-38
Identities = 52/277 (18%), Positives = 93/277 (33%), Gaps = 52/277 (18%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLV 242
++ + G +G K DGK + K+ + +E+ L ++KH N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 243 LLLGYCSFDEEKLL--VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
L V EY G L + T + LD ++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 301 Q-----------------------------DFGLARLISACETHVSTDIAGTLGYIPPEY 331
+ DFGLAR+++ +T + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQ 185
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
+ D++S G +L EL P F L K+++ + + P
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKEL----AGKIREGKFRRI--P 235
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ ++ +ML + RP++ +L+
Sbjct: 236 YRYSDELNEIITRMLNL-------KDYHRPSVEEILE 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-38
Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 54/290 (18%)
Query: 184 KLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKTQGHR-QFTAEMETLGKV 236
K+T+ L G FG VY+ VA+K ++A + R +F E + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 237 KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEV------LDRAKRYKIAC 290
++V LLG S + L++ E M G L +LR+ + +K ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 291 SSARGLAFLHQ------------------------DFGLARLISACE-THVSTDIAGTLG 325
A G+A+L+ DFG+ R I + +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 326 YIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385
++ PE + + TT DV+SFGV+L E+ T E +Q ++ +V + +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDKP 257
Query: 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
D+ D + + C NP RP+ L ++ + E ++
Sbjct: 258 DNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 3e-38
Identities = 56/266 (21%), Positives = 98/266 (36%), Gaps = 56/266 (21%)
Query: 194 GGFGTVYKAT-LPDGKTVAVKKFSQAKTQGH---RQFTAEMETLGKVKHQNLVLLLGYCS 249
G FG VY A + + + VA+KK S + Q + + E+ L K++H N + G
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 250 FDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------- 301
+ LV EY + + DL + + L + + + +GLA+LH
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 302 ----------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS---TTRGD 342
DFG A +++ + V GT ++ PE + + D
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVD 196
Query: 343 VYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMM 402
V+S G+ +EL K P N + ++ + + L + + +
Sbjct: 197 VWSLGITCIELAERKPPL-------FNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFV 247
Query: 403 LKMLRIAADCVADNPATRPTMLHVLK 428
L+ P RPT +LK
Sbjct: 248 DSCLQK-------IPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-38
Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 52/282 (18%)
Query: 185 LTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQ---AKTQGHRQFTAEMETLGKVK 237
L L++ L DG FG V + +VAVK ++ + F E+ + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 238 HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
H+NL+ L G +V E GSL LR G H +L RY + A G+
Sbjct: 70 HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQV--AEGMG 125
Query: 298 FLHQ------------------------DFGLARLISACETH--VSTDIAGTLGYIPPEY 331
+L DFGL R + + H + + PE
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
++R + D + FGV L E+ T + + G+ ++ + ++ ++ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ + C A P RPT + + L E
Sbjct: 243 ------------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-37
Identities = 58/271 (21%), Positives = 98/271 (36%), Gaps = 53/271 (19%)
Query: 186 TLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNL 241
+ L G FG VY A +A+K +A K Q E+E ++H N+
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
+ L GY L+ EY G++ L+ D + A L++ H
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS 124
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFG + + + GTL Y+PPE + RM
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMH 181
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
+ D++S GV+ E + K P F+ K+ + P + G
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP----FEANTYQET-------YKRISRVEFTFPDFVTEG 230
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ ++ ++L+ NP+ RP + VL+
Sbjct: 231 ARDLISRLLKH-------NPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-37
Identities = 59/282 (20%), Positives = 106/282 (37%), Gaps = 51/282 (18%)
Query: 185 LTLVDILEDGGFGTVYKATLPDG-----KTVAVKKFSQAKTQGHR-QFTAEMETLGKVKH 238
+T ++ G FG VYK L VA+K T+ R F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
N++ L G S + +++ EYM NG+LD +LR + + A G+ +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKY 125
Query: 299 LHQ------------------------DFGLARLISACE--THVSTDIAGTLGYIPPEYG 332
L DFGL+R++ T+ ++ + + PE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT 392
R T+ DV+SFG+++ E++T E E E ++ + + D
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDGFRLPTPMDCPS-- 240
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
+ ++ C A RP ++ +L +++
Sbjct: 241 -----------AIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 59/292 (20%)
Query: 185 LTLVDILEDGGFGTVYKATLPDGKT---VAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQ 239
+ D++ +G FG V KA + A+K+ + + HR F E+E L K+ H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 240 NLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN------------ATGSHEVLDRAKRYK 287
N++ LLG C L EY +G+L +LR A + L +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 288 IACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGT 323
A ARG+ +L Q DFGL+R T
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLP 189
Query: 324 LGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
+ ++ E + TT DV+S+GV+L E+V+ G + A L + Q + +
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMTCAELYEKLPQGYRLE 246
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435
+ + D ++ + C + P RP+ +L L+ +++
Sbjct: 247 KPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-37
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 67/299 (22%)
Query: 184 KLTLVDILEDGGFGTVYKATLPD------GKTVAVKKFSQAKTQGHRQ-FTAEMETLGKV 236
L +L G FG V AT VAVK + R+ +E++ + ++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 237 -KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATG-------------------S 276
H+N+V LLG C+ L++EY G L +LR+
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 277 HEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312
VL A A+G+ FL DFGLAR I +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 313 ETHVS-TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN 371
+V + + ++ PE + T + DV+S+G++L E+ + P AN
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDAN 275
Query: 372 LVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLL 430
+ K Q + ++ I C A + RP+ ++ L
Sbjct: 276 FYKLIQNGFKMDQPFYATE-------------EIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-36
Identities = 54/278 (19%), Positives = 95/278 (34%), Gaps = 57/278 (20%)
Query: 185 LTLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNL 241
L + G F TVYK + VA + K ++F E E L ++H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 242 VLLLGYCSFDEEK----LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
V + +LV E M +G+L +L+ +V+ +GL
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQ 126
Query: 298 FLHQ---------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
FLH D GLA L + + GT ++ PE
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE 183
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
+ + DVY+FG+ +LE+ T++ P +++++ D
Sbjct: 184 MYEEKY-DESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYRRVTSGVKPASFD 235
Query: 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ ++ I C+ N R ++ +L
Sbjct: 236 KVAIP--------EVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 50/271 (18%), Positives = 89/271 (32%), Gaps = 47/271 (17%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVL 243
LV L +G +G V A + VAVK + E+ + H+N+V
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
G+ + L EY G L + + + G+ +LH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 302 ----------------------DFGLARLISAC-ETHVSTDIAGTLGYIPPEYGQSR-MS 337
DFGLA + + + GTL Y+ PE + R
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
DV+S G++L ++ + P + K++ + +++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------EYSDWKEKKTYLNPWKKIDSA 235
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ K+L NP+ R T+ + K
Sbjct: 236 PLALLHKILVE-------NPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (334), Expect = 9e-36
Identities = 51/270 (18%), Positives = 92/270 (34%), Gaps = 46/270 (17%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+ + L G FG V++ T G A K E++T+ ++H LV L
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
D E +++YE+M G L + + + + + +GL +H+
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGL + ++ T GT + PE + +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398
D++S GV+ L++ P G N + D + ++
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP-------FGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 399 KPMMLKMLRIAADCVADNPATRPTMLHVLK 428
K + K+L +P TR T+ L+
Sbjct: 257 KDFIRKLLLA-------DPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 8e-35
Identities = 65/297 (21%), Positives = 107/297 (36%), Gaps = 61/297 (20%)
Query: 184 KLTLVDILEDGGFGTVYKAT------LPDGKTVAVKKFSQAKTQG-HRQFTAEMETLGKV 236
+L L L G FG V +A +TVAVK + T HR +E++ L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 237 KHQNLVLLLGYCSFDEEK--LLVYEYMVNGSLDLWLRNATGSH------------EVLDR 282
H V+ L +++ E+ G+L +LR+ + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 283 AKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV-S 317
+ A+G+ FL DFGLAR I +V
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 318 TDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVF 377
D L ++ PE R+ T + DV+SFGV+L E+ + P G +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFC 247
Query: 378 QKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
+++K+ D +M + DC P+ RPT +++ L ++
Sbjct: 248 RRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (327), Expect = 1e-34
Identities = 43/271 (15%), Positives = 89/271 (32%), Gaps = 48/271 (17%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
+++ L G FG V++ G+ K + E+ + ++ H L+ L
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 245 LGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--- 301
E +L+ E++ G L + + A+ + GL +H+
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEHSI 148
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGLA ++ + T + PE
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 339 TRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD-PTVLNAG 397
D+++ GV+ L++ P F ++ Q +K+ + D + ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP----FAGEDDLET----LQNVKRCDWEFDEDAFSSVSPE 258
Query: 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+K + +L+ P R T+ L+
Sbjct: 259 AKDFIKNLLQK-------EPRKRLTVHDALE 282
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-34
Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 63/298 (21%)
Query: 184 KLTLVDILEDGGFGTVYKATLP--------DGKTVAVKKFSQAKTQGH-RQFTAEMETLG 234
+L L L +G FG V A VAVK T+ +EME +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 235 KV-KHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRN------------ATGSHEVLD 281
+ KH+N++ LLG C+ D ++ EY G+L +L+ + E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 282 RAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVS 317
A ARG+ +L DFGLAR I + +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 318 TD-IAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWV 376
T + ++ PE R+ T + DV+SFGV+L E+ T + L +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVPVEELFKLL 250
Query: 377 FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434
+ + + + + ++ + DC P+ RPT +++ L IV
Sbjct: 251 KEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 5e-34
Identities = 51/272 (18%), Positives = 86/272 (31%), Gaps = 49/272 (18%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNLVL 243
D+L G F V A K VA+K ++ +G E+ L K+KH N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L L+ + + G L + ++ + +LH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 302 -------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
DFGL+++ V + GT GY+ PE +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKP 185
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
+ D +S GVI L+ P N Q +K + D ++
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPF-------YDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+K + ++ +P R T L+
Sbjct: 239 SAKDFIRHLMEK-------DPEKRFTCEQALQ 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 52/278 (18%), Positives = 103/278 (37%), Gaps = 51/278 (18%)
Query: 187 LVDILEDGGFGTVYKAT-LPDGKT----VAVKKFSQAKT-QGHRQFTAEMETLGKVKHQN 240
+ +L G FGTVYK +P+G+ VA+K+ +A + + +++ E + V + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ LLG C L+ + M G L ++R + A+G+ +L
Sbjct: 73 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGMNYLE 128
Query: 301 ------------------------QDFGLARLISACET-HVSTDIAGTLGYIPPEYGQSR 335
DFGLA+L+ A E + + + ++ E R
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 336 MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395
+ T + DV+S+GV + EL+T + + + +L+
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASEISSILEKGERL 232
Query: 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
+ + I C + +RP ++ ++
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-32
Identities = 53/267 (19%), Positives = 89/267 (33%), Gaps = 51/267 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNL 241
IL +G F TV A L + A+K + K T E + + ++ H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V L DE+ Y NG L ++R D L +LH
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG 126
Query: 302 ------------------------DFGLARLISAC-ETHVSTDIAGTLGYIPPEYGQSRM 336
DFG A+++S + + GT Y+ PE +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
+ D+++ G I+ +LV P F+ + FQK+ K + D P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI----FQKIIKLEYD---FPEKFFP 235
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTM 423
++ ++ K+L + + R
Sbjct: 236 KARDLVEKLLVL-------DATKRLGC 255
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-32
Identities = 44/272 (16%), Positives = 85/272 (31%), Gaps = 47/272 (17%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
K + + L G FG V++ KT K T E+ L +H+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
L EE ++++E++ + + + L+ + L FLH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSH 121
Query: 302 -------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
+FG AR + + Y PE Q +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDV 179
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
+T D++S G ++ L++ P F + M + D ++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINP----FL---AETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + ++L +R T L+
Sbjct: 233 EAMDFVDRLLVK-------ERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 2e-31
Identities = 43/284 (15%), Positives = 87/284 (30%), Gaps = 49/284 (17%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+ L + G FG +Y T + G+ VA+K H Q E + ++ +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGI 65
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
+ +C + + ++ ++ SL+ + +A + ++H
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSK 122
Query: 302 --------------------------DFGLARLISACETHV------STDIAGTLGYIPP 329
DFGLA+ TH + ++ GT Y
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389
+ R D+ S G +L+ +Q + A + +K+ +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMST--- 235
Query: 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
VL G L C + +P ++ +L +
Sbjct: 236 PIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (295), Expect = 7e-31
Identities = 61/284 (21%), Positives = 101/284 (35%), Gaps = 56/284 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQG---HRQFTAEMETLGKVKHQNL 241
L +IL GG V+ A L + VAVK + + +F E + + H +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 242 VLLLGYCSFDEEKL----LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLA 297
V + + +V EY+ +L + + + ++ + + L
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALN 125
Query: 298 FLHQ------------------------DFGLARLISACETHV--STDIAGTLGYIPPEY 331
F HQ DFG+AR I+ V + + GT Y+ PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 332 GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
+ R DVYS G +L E++T + P F G + V +Q +++
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP----FT---GDSPVSVAYQHVREDPIPPSARH 238
Query: 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPT----MLHVLKLLH 431
L+A ++LK L NP R M L +H
Sbjct: 239 EGLSADLDAVVLKALAK-------NPENRYQTAAEMRADLVRVH 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-29
Identities = 52/290 (17%), Positives = 95/290 (32%), Gaps = 57/290 (19%)
Query: 176 SMFQQPLLK--LTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ------F 226
++F+Q + + L G F V K G A K + +T+ R+
Sbjct: 1 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 227 TAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRY 286
E+ L +++H N++ L + +L+ E + G L + E L +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEAT 116
Query: 287 KIACSSARGLAFLHQ----------------------------DFGLARLISACETHVST 318
+ G+ +LH DFGLA I +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFK 174
Query: 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378
+I GT ++ PE D++S GVI L++ P G +
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-------LGDTKQETLAN 227
Query: 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + +A +K + ++L +P R T+ L+
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVK-------DPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 8e-29
Identities = 55/286 (19%), Positives = 100/286 (34%), Gaps = 49/286 (17%)
Query: 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNL 241
K ++ + +G +G VYKA G+T A+KK K E+ L ++KH N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
V L + +LV+E++ L G V ++ ++ G+A+ H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL----LNGIAYCHD 118
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFGLAR + +I P S+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD---------- 387
+T D++S G I E+V F A+ + +F+ + + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 388 -----VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
V +P + K + + + + + +P R T L+
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-28
Identities = 53/272 (19%), Positives = 88/272 (32%), Gaps = 52/272 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ---FTAEMETLGKV-KHQN 240
L +L G FG V+ A + A+K + E L +H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 241 LVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
L + E V EY+ G L +++ D ++ A GL FLH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH 120
Query: 301 Q------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
DFG+ + + +T GT YI PE +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQK 179
Query: 337 STTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNA 396
D +SFGV+L E++ + P F ++ L + D+ P L
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEEL-------FHSIRMDNPFYPRWLEK 228
Query: 397 GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+K +++K+ P R + ++
Sbjct: 229 EAKDLLVKLFVR-------EPEKRLGVRGDIR 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (284), Expect = 1e-28
Identities = 52/272 (19%), Positives = 89/272 (32%), Gaps = 54/272 (19%)
Query: 186 TLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKT---QGHRQFTAE---METLGKVKH 238
++ I+ GGFG VY D GK A+K + + QG E + +
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+V + ++ + + M G L L E A A GL
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEH 122
Query: 299 LHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQS 334
+H D GLA S + H S GT GY+ PE Q
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 179
Query: 335 RMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393
++ + D +S G +L +L+ P F++ + + + + V P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDK----HEIDRMTLTMAVELPDS 231
Query: 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLH 425
+ + ++ +L+ + R L
Sbjct: 232 FSPELRSLLEGLLQR-------DVNRRLGCLG 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-28
Identities = 49/278 (17%), Positives = 86/278 (30%), Gaps = 65/278 (23%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGH------RQFTAEMETLGKVK- 237
+ +L GGFG+VY + D VA+K + + + E+ L KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 238 -HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
++ LL + + +L+ E G+ L +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAV 123
Query: 297 AFLHQ-------------------------DFGLARLISACETHVSTDIAGTLGYIPPEY 331
H DFG L+ + V TD GT Y PPE+
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 332 -GQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390
R V+S G++L ++V P F+ ++ V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP-----------------FEHDEEIIRGQVFF 223
Query: 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+++ + ++ L + P+ RPT +
Sbjct: 224 RQRVSSECQHLIRWCLAL-------RPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 8e-28
Identities = 35/285 (12%), Positives = 76/285 (26%), Gaps = 53/285 (18%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH-QNLVL 243
+ + +G FG +++ T L + + VA+K + Q E T + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
+ + +LV + + DL A + +H+
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 302 ---------------------------DFGLARLISACETHV------STDIAGTLGYIP 328
DFG+ + T +++GT Y+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 329 PEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388
R + R D+ + G + + + +G + + +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGS-------LPWQGLKAATNKQKYERIGEKKQS 234
Query: 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433
L AG K + P ++ L ++
Sbjct: 235 TPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 62/294 (21%), Positives = 100/294 (34%), Gaps = 65/294 (22%)
Query: 186 TLVDILEDGGFGTVYKATLPD-GKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL 244
T ++ +G FG VY+A L D G+ VA+KK Q K R E++ + K+ H N+V L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRL 78
Query: 245 LGYCSFDEEK------LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAF 298
+ EK LV +Y+ + R+ + + + L R LA+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 299 LHQ-------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQ 333
+H DFG A+ + E +VS I P
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFG 196
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEP-------------------TGPEFQEKEGANLVG 374
+ T+ DV+S G +L EL+ + E + N
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 375 WVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ F ++K V P + + ++L P R T L
Sbjct: 257 FKFPQIKAHPWTKVFRPR-TPPEAIALCSRLLEY-------TPTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-27
Identities = 53/288 (18%), Positives = 91/288 (31%), Gaps = 55/288 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKF--SQAKTQGHRQFTAEMETLGKVKHQNLV 242
V+ + +G +G VYKA G+ VA+KK E+ L ++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LL + + LV+E++ +A + +GLAF H
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSH 121
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGLAR + ++ P + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 339 TRGDVYSFGVILLELVTAKEP------------------TGPEFQEKEGANLVGWVFQKM 380
T D++S G I E+VT + T E ++ +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 381 KKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
K + D L+ + ++ +ML +P R + L
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHY-------DPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 62/289 (21%), Positives = 97/289 (33%), Gaps = 62/289 (21%)
Query: 189 DILEDGGFGTVYKAT-LPDGKTVAVKKF-----SQAKTQGHRQFTAEMETLGKVKHQNLV 242
D L +G F TVYKA + VA+KK S+AK +R E++ L ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LL LV+++M + N+ + + +GL +LHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP----SHIKAYMLMTLQGLEYLHQH 119
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPE-YGQSRMS 337
DFGLA+ + T T Y PE +RM
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 338 TTRGDVYSFGVILLELVTAKEP------------------TGPEFQEKEGANLVGWVFQK 379
D+++ G IL EL+ T E Q + +L +V K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + ++ + NP R T LK
Sbjct: 239 SFPGIPLHHIFSAAGDDL-LDLIQGLFLF-------NPCARITATQALK 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 108 bits (270), Expect = 2e-27
Identities = 51/284 (17%), Positives = 85/284 (29%), Gaps = 61/284 (21%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT---------QGHRQFTAEMETLGK 235
+IL G V + P K AVK + E++ L K
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 236 VK-HQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
V H N++ L + LV++ M G L +L L + KI +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLE 121
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
+ LH+ DFG + + ++ GT Y+ PE
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAPE 179
Query: 331 YGQSRMSTTRG------DVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ 384
+ M+ D++S GVI+ L+ P F + + M
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FW---HRKQMLMLRMIMSGNY 232
Query: 385 ADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + K ++ + L + P R T L
Sbjct: 233 QFGSPEWDDYSDTVKDLVSRFLVV-------QPQKRYTAEEALA 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 9e-27
Identities = 53/294 (18%), Positives = 97/294 (32%), Gaps = 57/294 (19%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ-FTAEMETLGKVKHQNL 241
+ T + + +G +G V A + VA+KK S + Q + Q E++ L + +H+N+
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
+ + + + Y+V + L + L RGL ++H
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHS 127
Query: 302 ------------------------DFGLARLISACETHVS--TDIAGTLGYIPPEY-GQS 334
DFGLAR+ H T+ T Y PE S
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 335 RMSTTRGDVYSFGVILLELVTAK--------------------EPTGPEFQEKEGANLVG 374
+ T D++S G IL E+++ + P+ +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 375 WVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ K + ++ + ++ KML NP R + L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF-------NPHKRIEVEQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-26
Identities = 54/288 (18%), Positives = 86/288 (29%), Gaps = 50/288 (17%)
Query: 186 TLVDILEDGGFGTVYKAT--LPDGKTVAVKKFSQAKTQGHRQFT-----AEMETLGKVKH 238
V + +G +G V+KA G+ VA+K+ + + A + L +H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 239 QNLVLLLGYCSFDEEKLLVYEYMV-----NGSLDLWLRNATGSHEVLDRAKRYKIACSSA 293
N+V L C+ +V + + +
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLL 126
Query: 294 RGLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPP 329
RGL FLH DFGLAR+ S T + TL Y P
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAP 184
Query: 330 EYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389
E T D++S G I E+ K + ++ + ++ DV
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 390 DPTVLNAGSKPMMLKMLRIAAD---------CVADNPATRPTMLHVLK 428
P ++ D C+ NPA R + L
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 54/289 (18%), Positives = 91/289 (31%), Gaps = 57/289 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKF--SQAKTQGHRQFTAEMETLGKVKHQNLV 242
++ + +G +GTV+KA + VA+K+ E+ L ++KH+N+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
L D++ LV+E+ + +GL F H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP----EIVKSFLFQLLKGLGFCHSR 120
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
+FGLAR S ++ P +++ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 339 TRGDVYSFGVILLELVTAKEP-------------------TGPEFQEKEGANLVGWVFQK 379
T D++S G I EL A P T E Q L +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 380 MKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
M V LNA + ++ +L+ NP R + L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKC-------NPVQRISAEEALQ 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-25
Identities = 41/276 (14%), Positives = 91/276 (32%), Gaps = 54/276 (19%)
Query: 187 LVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKV-KHQNLVLL 244
+L G G V + + A+K + E+E + + ++V +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRI 70
Query: 245 LGYC----SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLH 300
+ + + L+V E + G L +++ + + +I S + +LH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH 128
Query: 301 Q---------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQ 333
DFG A+ ++ + + T Y+ PE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 334 SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD-DVLDPT 392
D++S GVI+ L+ P F G + + +++ Q + + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 393 VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428
++ K ++ +L+ P R T+ +
Sbjct: 243 EVSEEVKMLIRNLLKT-------EPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.8 bits (248), Expect = 4e-24
Identities = 46/267 (17%), Positives = 93/267 (34%), Gaps = 54/267 (20%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQ---FTAEMETLGKVKHQNL 241
++ L G FG V+ +G+ A+K + +Q E L V H +
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 242 VLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
+ + G ++ ++ +Y+ G L LR + + + ++ + L +LH
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLHS 122
Query: 302 ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMS 337
DFG A+ + V+ + GT YI PE ++
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPY 178
Query: 338 TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397
D +SFG+++ E++ P F + +K ++ P N
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP----FYDSNTMKT-------YEKILNAELRFPPFFNED 227
Query: 398 SKPMMLKMLRIAADCVADNPATRPTML 424
K ++ +++ + + R L
Sbjct: 228 VKDLLSRLITR-------DLSQRLGNL 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 3e-23
Identities = 49/290 (16%), Positives = 90/290 (31%), Gaps = 57/290 (19%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQ--AKTQGHRQFTAEMETLGKVKHQNLV 242
+ + G +G V A G VA+KK + ++ E+ L ++H+N++
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 243 LLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ- 301
LL + DE ++ + HE L + + +GL ++H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 140
Query: 302 -----------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMST 338
DFGLAR ++ ++ + P T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYT 197
Query: 339 TRGDVYSFGVILLELVTAKEP------------------TGPEFQEKEGANLVGWVFQKM 380
D++S G I+ E++T K T P + + + K
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 381 KKQQADDVLDPTVLNAGS--KPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + NA ++ KML + + R T L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVL-------DAEQRVTAGEALA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 4e-23
Identities = 58/305 (19%), Positives = 99/305 (32%), Gaps = 71/305 (23%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKF--SQAKTQGHRQFTAEMETLGKVKHQN 240
K + + G FG V+KA G+ VA+KK K E++ L +KH+N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 241 LVLLLGYCSFDEEK--------LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSS 292
+V L+ C LV+++ + L ++ ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQML 126
Query: 293 ARGLAFLHQ------------------------DFGLARLISACET---HVSTDIAGTLG 325
GL ++H+ DFGLAR S + + T+ TL
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 326 YIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEP------------------TGPEFQE 366
Y PPE D++ G I+ E+ T +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 367 KEGANLVGWV---FQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423
N + K +K++ D L V + + ++ K+L + +PA R
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL-------DPAQRIDS 299
Query: 424 LHVLK 428
L
Sbjct: 300 DDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 4e-23
Identities = 59/296 (19%), Positives = 106/296 (35%), Gaps = 60/296 (20%)
Query: 163 SSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKATL----PDGKTVAVKKFSQA 218
+++ + ++ I F+ L+ +L G +G V+ GK A+K +A
Sbjct: 11 TANLTGHAEKVGIENFE-------LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63
Query: 219 ----KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL-LVYEYMVNGSLDLWLRNA 273
K + E + L ++ ++ L Y E KL L+ +Y+ G L L
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ- 122
Query: 274 TGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309
E + L LH+ DFGL++
Sbjct: 123 ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 310 SACETHVSTDIAGTLGYIPPE--YGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEK 367
A ET + D GT+ Y+ P+ G D +S GV++ EL+T P F
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVD 235
Query: 368 EGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423
N + +++ K + P ++A +K ++ ++L +P R
Sbjct: 236 GEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQRLLMK-------DPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 45/293 (15%), Positives = 88/293 (30%), Gaps = 62/293 (21%)
Query: 186 TLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVL 243
LV L G + V++A + + + V VK K ++ E++ L ++ N++
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIIT 94
Query: 244 LLGYCSFDEEKL--LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301
L + LV+E++ N + L + L + H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS 147
Query: 302 -------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRM 336
D+GLA + + + + PE
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQ 205
Query: 337 S-TTRGDVYSFGVILLELVTAKEP----TGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391
D++S G +L ++ KEP Q A ++G + + LDP
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 392 TVLNAGSKPMMLKMLRI------------AAD----CVADNPATRPTMLHVLK 428
+ + + R A D + + +R T ++
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 8e-21
Identities = 46/280 (16%), Positives = 82/280 (29%), Gaps = 58/280 (20%)
Query: 172 RINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKT---QGHRQFT 227
++ ++ F + +L G FG V G+ A+K +
Sbjct: 1 KVTMNDFD-------YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 53
Query: 228 AEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYK 287
E L +H L L + V EY G L L V +
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARF 109
Query: 288 IACSSARGLAFLHQ------------------------DFGLARLISACETHVSTDIAGT 323
L +LH DFGL + + GT
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGT 168
Query: 324 LGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383
Y+ PE + D + GV++ E++ + P F ++ L +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERL-------FELI 217
Query: 384 QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTM 423
+++ P L+ +K ++ +L+ +P R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKK-------DPKQRLGG 250
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (217), Expect = 7e-20
Identities = 57/302 (18%), Positives = 93/302 (30%), Gaps = 66/302 (21%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQN 240
+ + + G G V A + VA+KK S+ ++ E+ + V H+N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 241 LVLLLGYCSFD------EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSAR 294
++ LL + ++ LV E M + D + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLC 130
Query: 295 GLAFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPE 330
G+ LH DFGLAR +A + + T T Y PE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPE 188
Query: 331 YGQSRMSTTRGDVYSFGVILLELVTAKEP-------------------TGPEFQEKEGAN 371
D++S G I+ E+V K PEF +K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 372 LVGWVFQKMKKQQADDV-LDPTVLNAGSKPMMLKMLRIAAD----CVADNPATRPTMLHV 426
+ +V + K L P L A D + +PA R ++
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 427 LK 428
L+
Sbjct: 309 LQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 9e-20
Identities = 53/296 (17%), Positives = 92/296 (31%), Gaps = 65/296 (21%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQA--KTQGHRQFTAEMETLGKVKHQN 240
+ + + G +G+V A G VAVKK S+ ++ E+ L +KH+N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 241 LVLLLGYC----SFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGL 296
++ LL S +E + + G+ + + + Y+I RGL
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI----LRGL 134
Query: 297 AFLHQ------------------------DFGLARLISACETHVSTDIAGTLGYIPPEYG 332
++H DFGLAR T +A P
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIML 191
Query: 333 QSRMSTTRGDVYSFGVILLELVTAKEP------------------TGPEFQEKEGANLVG 374
D++S G I+ EL+T + T K+ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 375 WVFQKMKKQQADDVLDPTVLNAGS--KPMMLKMLRIAADCVADNPATRPTMLHVLK 428
+ + Q + A ++ KML + + R T L
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL-------DSDKRITAAQALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 83.7 bits (206), Expect = 2e-18
Identities = 51/301 (16%), Positives = 89/301 (29%), Gaps = 63/301 (20%)
Query: 149 KISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTLVDILEDGGFGTVYKAT-LPDG 207
K LA K+ L + S+ +++ + + L G FG V G
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLD---------QFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 208 KTVAVKKFSQAKTQGHRQ---FTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMVNG 264
A+K + K +Q E L V LV L + +V EY+ G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 265 SLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------- 301
+ LR A +LH
Sbjct: 127 EMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 302 -DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPT 360
DFG A+ + + GT + PE S+ D ++ GV++ E+ P
Sbjct: 183 TDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP- 237
Query: 361 GPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATR 420
F + + + V P+ ++ K ++ +L++ + R
Sbjct: 238 ---FFADQPIQIYEKIVS-------GKVRFPSHFSSDLKDLLRNLLQV-------DLTKR 280
Query: 421 P 421
Sbjct: 281 F 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 74.7 bits (182), Expect = 3e-15
Identities = 40/220 (18%), Positives = 71/220 (32%), Gaps = 41/220 (18%)
Query: 184 KLTLVDILEDGGFGTVYKAT-LPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLV 242
+ LV L G F TV+ A + + VA+K K E++ L +V +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNT 72
Query: 243 LLLGYCSFDEEKLL-VYEYMVNGSLDLWLRNATGSHEVLDRAKRYK-----------IAC 290
+ KLL + + + + + +L K+Y+ I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 291 SSARGLAFLHQ--------------------------DFGLARLISACETHVS-TDIAGT 323
GL ++H+ +A L +AC T+ T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 324 LGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363
Y PE D++S ++ EL+T P+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 2e-13
Identities = 31/139 (22%), Positives = 47/139 (33%), Gaps = 28/139 (20%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIP--------------------RSLGQLGGLV 40
++ P KL L LG NQ++ P + L L
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 41 KLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTRE 100
L L N S P + +L L L ++N SL NL+ +L N+ +
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 101 IPQNLGNLAQLEHLDVLRN 119
P L NL ++ L +
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.9 bits (149), Expect = 4e-11
Identities = 36/172 (20%), Positives = 56/172 (32%), Gaps = 40/172 (23%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVP--------- 54
L L L NNQ++ P L L L +L L N+ S P
Sbjct: 232 KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN 289
Query: 55 -----------TSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQ 103
+ + NLK L++L L N P + +L+ L +NK +
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVS 345
Query: 104 NLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGN 155
+L NL + L N + P L L ++++ L
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP-------LANL-------TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 7e-06
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 12/82 (14%)
Query: 36 LGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNF---FDGGWPRSLGNLSYSTYLDL 92
L +K L + + V + +L ++ L DG + L+ T ++
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 93 HDNKFTREIPQNLGNLAQLEHL 114
+N+ T P L NL +L +
Sbjct: 74 SNNQLTDITP--LKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 7e-05
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 8/95 (8%)
Query: 5 IPSEFGDS--LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKG 62
I F D+ + LG +T ++ ++ L + L R + L
Sbjct: 12 INQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNN 67
Query: 63 LSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKF 97
L+ ++ S+N P L NL+ + +++N+
Sbjct: 68 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 3e-13
Identities = 20/60 (33%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 19 YLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP 78
L NN++ G++P+ L QL L LN++ N G +P GNL+ ++N G P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 2e-10
Identities = 23/68 (33%), Positives = 31/68 (45%), Gaps = 3/68 (4%)
Query: 64 SHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN-MLC 122
+ LDL +N G P+ L L + L++ N EIPQ GNL + + N LC
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305
Query: 123 GKIPEKIC 130
G P C
Sbjct: 306 G-SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 6e-10
Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 1/60 (1%)
Query: 43 NLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIP 102
+L N+ G +P L LK L L++S N G P GNL +NK P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 7e-10
Identities = 22/72 (30%), Positives = 29/72 (40%), Gaps = 13/72 (18%)
Query: 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRLEGLVSQSGIC 144
LDL +N+ +PQ L L L L+V N LCG+IP+ G
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-------------GGNL 290
Query: 145 QNLSKISLAGNK 156
Q + A NK
Sbjct: 291 QRFDVSAYANNK 302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 5e-09
Identities = 15/56 (26%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKF--SGPVP 54
+ G++P L L + N L G IP G L NK P+P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 8e-05
Identities = 29/124 (23%), Positives = 48/124 (38%), Gaps = 3/124 (2%)
Query: 10 GDSLKLQGLYLGNNQLTG--SIPRSLGQLGGLVKLNLTRN-KFSGPVPTSLGNLKGLSHL 66
+ ++ L L L IP SL L L L + GP+P ++ L L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIP 126
++ G P L + LD N + +P ++ +L L + N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 127 EKIC 130
+
Sbjct: 167 DSYG 170
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 34 GQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSN-FFDGGWPRSLGNLSYSTYL 90
Q + L+L+ P+P+SL NL L+ L + G P ++ L+ YL
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 91 DLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
+ + IP L + L LD N L G +P I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 3e-10
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 10/156 (6%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+G F KL + + + +T +IP+ L L +L+L NK + SL L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L+ L LS N SL N + L L++NK + +P L + ++ + + N
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNN 253
Query: 121 LCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ C + S +SL N
Sbjct: 254 ISAIGSNDFCPPGYNTK------KASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 1e-09
Identities = 28/173 (16%), Positives = 53/173 (30%), Gaps = 6/173 (3%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74
L+ + + L +P+ L L+L NK + NLK L L L +N
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 75 GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRL 134
P + L L L N+ + L +L + + + + + +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 135 EGLVSQSGICQNLSKISLAGNKDYNLYLSSSRSKGPLRINISMFQQPLLKLTL 187
+ + ++ + A L I + L +L L
Sbjct: 129 --VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS-LTELHL 178
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 6e-09
Identities = 29/158 (18%), Positives = 57/158 (36%), Gaps = 20/158 (12%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
+T +F + L L L NN+++ P + L L +L L++N+
Sbjct: 43 ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE---KMP 99
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHD--NKFTREIPQNLGNLAQLEHLDVLR 118
K L L + N L+ ++L K + + +L ++ +
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159
Query: 119 NMLCGKIPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+ IP+ G+ +L+++ L GNK
Sbjct: 160 TNIT-TIPQ--------------GLPPSLTELHLDGNK 182
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 27/131 (20%), Positives = 40/131 (30%), Gaps = 32/131 (24%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPV---------- 53
+IP SL L+L N++T SL L L KL L+ N S
Sbjct: 164 TIPQGLPPSL--TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221
Query: 54 -------------PTSLGNLKGLSHLDLSSNFFDG------GWPRSLGNLSYSTYLDLHD 94
P L + K + + L +N P + + + L
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 95 NKFT-REIPQN 104
N EI +
Sbjct: 282 NPVQYWEIQPS 292
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 6e-10
Identities = 22/123 (17%), Positives = 39/123 (31%), Gaps = 3/123 (2%)
Query: 16 QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF-D 74
Q L L L + L G ++ R+ P+ + + H+DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 75 GGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSRL 134
L S L L + + I L + L L++ + + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 135 EGL 137
L
Sbjct: 121 SRL 123
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 4/87 (4%)
Query: 22 NNQLTGSIPRSLGQLGGLVKLNLTR-NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS 80
+ L + QL L L+L+R LG + L L + DG
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL 244
Query: 81 LGNLSYSTYLDLHDNKFTREIPQNLGN 107
L +L ++ + FT +GN
Sbjct: 245 KEAL---PHLQINCSHFTTIARPTIGN 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (134), Expect = 2e-09
Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 1/137 (0%)
Query: 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNL 60
L F D L L+L N+++ R+ L L +L L +N+ + P + +L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 61 KGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNM 120
L L L +N +L L YL L+DN + + A L+ +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSE 259
Query: 121 LCGKIPEKICKSRLEGL 137
+ +P+++ L+ L
Sbjct: 260 VPCSLPQRLAGRDLKRL 276
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 2e-08
Identities = 34/143 (23%), Positives = 49/143 (34%), Gaps = 13/143 (9%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
LQ LYL +N L + LG L L L N+ S + L L L L N
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKSR 133
P + +L L L N + + L L L++L + N +C R
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW-------VCDCR 242
Query: 134 LEGLVSQSGICQNLSKISLAGNK 156
L L K + ++
Sbjct: 243 ARPLW------AWLQKFRGSSSE 259
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 26/153 (16%), Positives = 40/153 (26%), Gaps = 27/153 (17%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPV---------- 53
++P + Q ++L N+++ S L L L N +
Sbjct: 25 AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 54 ---------------PTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT 98
P + L L L L P L+ YL L DN
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 99 REIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131
+L L HL + N +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.002
Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 4/62 (6%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
LQ L L +N R+ L K + ++ +P L G L++N
Sbjct: 226 ALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDL 281
Query: 74 DG 75
G
Sbjct: 282 QG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.0 bits (129), Expect = 3e-09
Identities = 16/150 (10%), Positives = 30/150 (20%), Gaps = 40/150 (26%)
Query: 194 GGFGTVYKATLPDGKTVAVKKFSQAKT----------QGHRQFTAEMETLGKVKHQNLVL 243
G V+ VK T G F+ + + + L
Sbjct: 11 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 70
Query: 244 LLGYCSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-- 301
L G + Y G+ L + ++ +A +
Sbjct: 71 LQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 302 ---------------------DFGLARLIS 310
DF + +
Sbjct: 124 IVHGDLSQYNVLVSEEGIWIIDFPQSVEVG 153
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 2e-08
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 19 YLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP 78
N + I L +LN++ NK +P L+ L S N P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHL-AEVP 320
Query: 79 RSLGNLSYSTYLDLHDNKFTR--EIPQNLGNL 108
NL L + N +IP+++ +L
Sbjct: 321 ELPQNL---KQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 6e-08
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 10/73 (13%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFF 73
L+ L + NN+L +P + L +L + N + VP NLK L + N
Sbjct: 285 SLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQNLK---QLHVEYNPL 336
Query: 74 DG--GWPRSLGNL 84
P S+ +L
Sbjct: 337 REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 4e-06
Identities = 22/94 (23%), Positives = 32/94 (34%), Gaps = 10/94 (10%)
Query: 43 NLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIP 102
N S + + L L++S+N P L L N E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP 320
Query: 103 QNLGNLAQLEHLDVLRNMLCG--KIPEKICKSRL 134
+ N L+ L V N L IPE + R+
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 8e-06
Identities = 12/60 (20%), Positives = 24/60 (40%), Gaps = 9/60 (15%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSLGNLK 61
+P+ +L+ L N L +P L +L++ N +P S+ +L+
Sbjct: 298 ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.002
Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 20/92 (21%)
Query: 65 HLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124
N L++ +NK E+P LE L N L +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AE 318
Query: 125 IPEKICKSRLEGLVSQSGICQNLSKISLAGNK 156
+PE + QNL ++ + N
Sbjct: 319 VPE---------------LPQNLKQLHVEYNP 335
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 7e-08
Identities = 15/75 (20%), Positives = 24/75 (32%), Gaps = 5/75 (6%)
Query: 63 LSHLDLSSNFF-DGGWPRSLGNLSYSTYLDLHDNKFT----REIPQNLGNLAQLEHLDVL 117
+ LD+ D W L L + L D T ++I L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 118 RNMLCGKIPEKICKS 132
N L + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 1e-07
Identities = 14/78 (17%), Positives = 27/78 (34%), Gaps = 5/78 (6%)
Query: 12 SLKLQGLYLGNNQLTGS-IPRSLGQLGGLVKLNLTRNKFSG----PVPTSLGNLKGLSHL 66
SL +Q L + +L+ + L L + L + + ++L L+ L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 67 DLSSNFFDGGWPRSLGNL 84
+L SN +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 2e-07
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 10/89 (11%)
Query: 39 LVKLNLTRNKFSG----PVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG-----NLSYSTY 89
L L L S + +L L LDLS+N L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 90 LDLHDNKFTREIPQNLGNLAQ-LEHLDVL 117
L L+D ++ E+ L L + L V+
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 12/80 (15%), Positives = 21/80 (26%), Gaps = 9/80 (11%)
Query: 59 NLKGLSHLDLSSNFFDG----GWPRSLGNLSYSTYLDLHDNKFTREIPQNLG-----NLA 109
L L L+ +L LDL +N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 110 QLEHLDVLRNMLCGKIPEKI 129
LE L + ++ +++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.9 bits (83), Expect = 0.004
Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 6/73 (8%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQ-----LGGLVKLNLTRNKFSGPVPTSLG 58
S+ + + L+ L L NN L + L + L +L L +S + L
Sbjct: 388 SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ 447
Query: 59 NL-KGLSHLDLSS 70
L K L + S
Sbjct: 448 ALEKDKPSLRVIS 460
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 1e-07
Identities = 24/106 (22%), Positives = 37/106 (34%), Gaps = 26/106 (24%)
Query: 42 LNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL----------------- 84
L+L + V L L ++HLDLS N P +L L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 85 -----SYSTYLDLHDNKFTR-EIPQNLGNLAQLEHLDVLRNMLCGK 124
L L +N+ + Q L + +L L++ N LC +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 1e-07
Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 29/123 (23%)
Query: 18 LYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL-------------- 63
L+L + LT + L QL + L+L+ N+ P +L L+ L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 64 --------SHLDLSSN-FFDGGWPRSLGNLSYSTYLDLHDNKFTRE---IPQNLGNLAQL 111
L L +N + L + L+L N +E + L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 112 EHL 114
+
Sbjct: 120 SSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 1e-06
Identities = 17/66 (25%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGL 63
S + + KL L +N+++ P L L L++++L N+ S P L N L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 64 SHLDLS 69
+ L+
Sbjct: 220 FIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 17/63 (26%), Positives = 25/63 (39%), Gaps = 5/63 (7%)
Query: 57 LGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDV 116
L NL L+ L N P L +L + L +N+ + P L N + L +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT- 223
Query: 117 LRN 119
L N
Sbjct: 224 LTN 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 1e-05
Identities = 17/111 (15%), Positives = 31/111 (27%), Gaps = 10/111 (9%)
Query: 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSG--PVPTSLGNLKGLSHLDLSSN 71
L ++ ++ + L+ LNL+ N+ + + + L L+LS N
Sbjct: 43 IDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGN 101
Query: 72 FFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQN-------LGNLAQLEHLD 115
L L N + +L LD
Sbjct: 102 ELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 12/70 (17%), Positives = 21/70 (30%), Gaps = 3/70 (4%)
Query: 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLD 67
E + LT ++P L + L+L+ N +L L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 68 LSSNFFDGGW 77
L
Sbjct: 62 LDRAELTKLQ 71
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 3e-05
Identities = 14/53 (26%), Positives = 16/53 (30%), Gaps = 1/53 (1%)
Query: 22 NNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFD 74
NN LT L L L L L N +P L L N +
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 17/109 (15%), Positives = 30/109 (27%), Gaps = 13/109 (11%)
Query: 47 NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT-------- 98
N + L L+ L L L N P+ + LH N +
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYF 216
Query: 99 -REIPQNLGNLAQLEHLDVLRNMLCGKIPEKICKS--RLEGLVSQSGIC 144
R + N N+ + ++ M + C + + C
Sbjct: 217 RRWLQDNAENVYVWKQGVDVKAM-TSNVASVQCDNSDKFPVYKYPGKGC 264
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.001
Identities = 16/73 (21%), Positives = 22/73 (30%), Gaps = 1/73 (1%)
Query: 47 NKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLG 106
N+ P L L L L++N L L L L +N IP+
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 107 NLAQLEHLDVLRN 119
L + N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.003
Identities = 11/77 (14%), Positives = 21/77 (27%), Gaps = 3/77 (3%)
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLD 115
+ + ++ P L +T L L +N L +L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 116 VLRNMLCGKIPEKICKS 132
+ R L +
Sbjct: 62 LDRAELTKLQVDGTLPV 78
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 10/70 (14%)
Query: 8 EFGDSLKLQGLYLGNNQLTGSIPRSL-----GQLGGLVKLNLTRNKFS--GPVPTSLGNL 60
+++ LQ L L N++ R+L ++ L+ L L N+FS V + +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 61 ---KGLSHLD 67
+G LD
Sbjct: 328 FSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.001
Identities = 9/67 (13%), Positives = 23/67 (34%), Gaps = 5/67 (7%)
Query: 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHL 66
+ L+ + S+ L + + ++ L+ N + ++ + K L
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 67 DLSSNFF 73
+ S F
Sbjct: 65 EFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.001
Identities = 17/75 (22%), Positives = 29/75 (38%), Gaps = 10/75 (13%)
Query: 56 SLGNLKGLSHLDLSSNFFDGGWPRSL-----GNLSYSTYLDLHDNKFTREIP-----QNL 105
S GL L L N + R+L + +L+L+ N+F+ E + +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 106 GNLAQLEHLDVLRNM 120
+ LD L +M
Sbjct: 328 FSTRGRGELDELDDM 342
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.003
Identities = 13/79 (16%), Positives = 25/79 (31%), Gaps = 13/79 (16%)
Query: 19 YLGNNQLTGSIPRSLGQ------LGGLVKLNLTRNKFSGPVPTSL-----GNLKGLSHLD 67
L + L+ ++ GL L L N+ +L + L L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 68 LSSNFF--DGGWPRSLGNL 84
L+ N F + + +
Sbjct: 309 LNGNRFSEEDDVVDEIREV 327
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 8e-04
Identities = 14/92 (15%), Positives = 33/92 (35%), Gaps = 3/92 (3%)
Query: 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHL 66
+++ ++++ + L L ++ I L ++ + N+ L+ L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 67 DLSSNFFDGGWPRSLGNLSYSTYLDLHDNKFT 98
+++N L T L L +N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.5 bits (80), Expect = 0.004
Identities = 17/108 (15%), Positives = 31/108 (28%), Gaps = 3/108 (2%)
Query: 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSNFF 73
GL + L L +L + + + L L L +L + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 74 DGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNML 121
P + + L+L N + L+ L + N L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 435 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.73 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.52 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.51 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.49 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.48 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.32 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.3 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.08 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.06 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.93 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.26 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.15 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.99 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.69 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.37 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.97 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=360.86 Aligned_cols=233 Identities=24% Similarity=0.421 Sum_probs=177.1
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888899999997533 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|.+++... ...+++..++.++.|+|+||+|||+ |||+|+...........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999998754 2458899999999999999999996 99999887654444444
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGS 398 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (435)
...||+.|||||++.+..++.|+|||||||++|||+|++.|+..... ...+.. .+.... ....|..
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~----~i~~~~--~~~~p~~----- 226 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVE----DISTGF--RLYKPRL----- 226 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHH----HHHHTC--CCCCCTT-----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHH----HHHhcC--CCCCccc-----
Confidence 56799999999999999999999999999999999997666533211 111222 222111 1111211
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 399 KPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 399 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
+..++.+++.+||+.||++||||+||++.|++|.+
T Consensus 227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 12357789999999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=360.01 Aligned_cols=239 Identities=28% Similarity=0.435 Sum_probs=190.8
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|+++..+|++.+.||+|+||.||+|++++++.||||+++... ...++|.+|+++|++++|||||+++|+|. ++..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeE
Confidence 35677888999999999999999999999888899999997543 34578999999999999999999999875 46679
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|.+++.... ...+++..++.|+.|+|+||+|||+ |||+|+.+..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999998876432 2348999999999999999999996 9999998765
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
..........||+.|||||++....++.++|||||||++|||+||+.|+..... ...+. ..+.... ....|
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~----~~i~~~~--~~~~p 232 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVI----QNLERGY--RMVRP 232 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH----HHHHTTC--CCCCC
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHhcC--CCCCc
Confidence 544455567899999999999888899999999999999999998777543221 11122 2222211 11111
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
. ....++.+++.+||+.||++||||.||++.|+++.
T Consensus 233 ~-------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 D-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp T-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1 11235678899999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=358.17 Aligned_cols=242 Identities=23% Similarity=0.385 Sum_probs=195.4
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
+...|+.+..+|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 34457788889999999999999999999875 58899999997543 34578999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++|||||++|+|..++.... ...+++..+..++.|+|+||+|||+ |||+|+.
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eeEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999999997642 3468999999999999999999996 9999998
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.........+...||+.|||||++.+..++.|+|||||||++|||+||+.|+...... .. +...+.....
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~----~~~~i~~~~~--- 234 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQ----VYELLEKDYR--- 234 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH----HHHHHHTTCC---
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HH----HHHHHhcCCC---
Confidence 7655444455567899999999998889999999999999999999988876432211 11 1222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+..... ...++.+++.+||+.||++||||.||++.|+.+.
T Consensus 235 --~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 --MERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 1235778999999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=353.86 Aligned_cols=240 Identities=26% Similarity=0.417 Sum_probs=180.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
.|+.+..+|++.+.||+|+||+||+|++. ..||||+++... ....+.|.+|+++|++++|||||+++|++. .+..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 36677889999999999999999999875 369999996542 344578999999999999999999999975 4568
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.++++... ..+++..++.++.|+|+||+|||+ |||+|+...
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 99999999999999997542 348999999999999999999996 999998765
Q ss_pred ccC-ccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 311 ACE-THVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 311 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ... +...+.....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~---~~~~~~~~~~- 227 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQ---IIFMVGRGYL- 227 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHH---HHHHHHHTSC-
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HHH---HHHHHhcCCC-
Confidence 432 223345789999999998754 3589999999999999999999999854211 111 1112211111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.|... .....+...+.+++.+||+.||++||||.||++.|+.+.
T Consensus 228 ---~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 228 ---SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ---CCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11100 000112235678899999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=349.26 Aligned_cols=230 Identities=23% Similarity=0.387 Sum_probs=188.0
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEeccc
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.+|++.+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999975433 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccccc
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHVST 318 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~~~ 318 (435)
+|+|..++.... ..+++..+.+++.|+|+||+|||+ |||+++...........
T Consensus 83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999876543 347889999999999999999996 99999887655544455
Q ss_pred cccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccCCC
Q 040641 319 DIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAG 397 (435)
Q Consensus 319 ~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (435)
...||+.|||||.+....++.|+|||||||++|||+| |+.||..... .++ ...+.... ....|..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~----~~~i~~~~--~~~~p~~---- 225 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SET----AEHIAQGL--RLYRPHL---- 225 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHH----HHHHHTTC--CCCCCTT----
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHH----HHHHHhCC--CCCCccc----
Confidence 5779999999999988899999999999999999998 7888753321 112 22222211 1112211
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 398 SKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 398 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
...++.+++.+||+.||++||||.||++.|.+|
T Consensus 226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 113567899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-47 Score=352.37 Aligned_cols=235 Identities=21% Similarity=0.372 Sum_probs=174.3
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC-C---CEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD-G---KTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
....+|++.++||+|+||+||+|++.. + ..||||++.... ....+.|.+|+++|++++|||||+++|+|..++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 345678999999999999999998753 3 358999986543 33456799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.+++.... ..+++..++.++.|+|+||+|||+ |||+|+.+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999999887542 358999999999999999999996 999998765
Q ss_pred ccCcc----ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 311 ACETH----VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 311 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
..... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.... ...+... +.....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~~----i~~~~~ 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVINA----IEQDYR 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH----HHTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HHHHHHH----HHcCCC
Confidence 43221 1223468999999999988999999999999999999998 788875321 1122222 211110
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+... ..+...+.+++.+||+.||++||||.||++.|++++
T Consensus 252 -----~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 252 -----LPPP----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0000 112235778999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=348.64 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=183.2
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
..|+++.++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++|+|. .+..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence 35677788999999999999999999999888899999996543 34578999999999999999999999985 56689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|..++.... ...++|..++.++.++|+||+|||+ |||+|+....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999998887542 2348999999999999999999996 9999988765
Q ss_pred cCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
......+...||+.|+|||++....++.++|||||||++|||+||+.|+..... ...+... +..... +
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~----i~~~~~-----~ 233 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ----VERGYR-----M 233 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH----HHTTCC-----C
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHH----HHhcCC-----C
Confidence 444444557899999999999999999999999999999999998777643221 1112222 221111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... .+..++.+++.+||+.||++||||.+|+++|++..
T Consensus 234 ~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 PCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1111 11235778899999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=347.89 Aligned_cols=233 Identities=22% Similarity=0.353 Sum_probs=182.1
Q ss_pred ccccCcceeee-ecccCcceEEEEEcC---CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDI-LEDGGFGTVYKATLP---DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
...+++.+.++ ||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 34567888885 999999999999764 34579999997543 3345789999999999999999999999865 568
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|+|.+++... ...+++..+..++.|+|+||+|||+ |||+|+.+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999988643 2358999999999999999999996 999998875
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... .......||+.|||||++....++.++|||||||++|||+| |+.||.... ..++.. .+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~----~~~~~~----~i~~~~~~~ 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK----GPEVMA----FIEQGKRME 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----THHHHH----HHHTTCCCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC----HHHHHH----HHHcCCCCC
Confidence 4332 22234578999999999988899999999999999999998 899985421 112222 222221111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
... .+..++.+++.+||+.||++||||.+|++.|+.+
T Consensus 233 -----~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 -----CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1123567899999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=344.78 Aligned_cols=235 Identities=23% Similarity=0.374 Sum_probs=177.0
Q ss_pred cccCcceeeeecccCcceEEEEEcCCC-----CEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLPDG-----KTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
...+|+..++||+|+||.||+|.+... ..||||+++.... ....+|.+|++++++++|||||+++|+|...+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 445788999999999999999986532 3699999965433 3345799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||.+|++.+++.... ..+++..++.++.|+|+||+|||+ |||+|+.+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999998887543 358999999999999999999996 999998865
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
.... .......||+.|||||++.+..++.++|||||||++|||+|++.|+..... ...+. ..+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~----~~i~~~~~--- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVM----KAINDGFR--- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----HHHHTTCC---
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHHH----HHHhccCC---
Confidence 4322 223345789999999999999999999999999999999998777643221 11122 22222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
+.... .....+.+++.+||+.||++||||.||++.|++++
T Consensus 232 --~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 --LPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp --CCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11111 12235778999999999999999999999998874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=340.24 Aligned_cols=227 Identities=21% Similarity=0.350 Sum_probs=183.4
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
+..+|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 456899999999999999999986 4689999999976665566789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||++|+|.+++... .+++.....++.|++.||+|||+ |||+|+.+.... .
T Consensus 98 y~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 99999999987653 38899999999999999999996 999998765432 2
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
.....+||+.|||||++.+..++.++||||+||++|||+||+.||.... ............. .....+.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~~~~~~~-~~~~~~~--- 240 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGT-PELQNPE--- 240 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCS-CCCSSGG---
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCC-CCCCCcc---
Confidence 3345689999999999999999999999999999999999999985322 1111222221111 1111111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 ----KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11235667889999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=340.93 Aligned_cols=236 Identities=21% Similarity=0.332 Sum_probs=175.3
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCC----CCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEEEeCC
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPD----GKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYCSFDE 252 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 252 (435)
|+++..+|++.+.||+|+||.||+|++.. +..||||+++..... ..+.|.+|+++|++++|||||+++|+|. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 67788899999999999999999998643 356999998654333 3567999999999999999999999985 56
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++|||||++|+|.+++.... ..+++..++.++.|+++||+|||+ |||+|+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 7899999999999999876542 358999999999999999999996 9999988
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.........+...||+.|+|||++....++.++|||||||++|||+| |.+||.... ...+...+ .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~----~~~~~~~i----~~~~~~~ 229 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRI----ENGERLP 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHHHHH----HTTCCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC----HHHHHHHH----HcCCCCC
Confidence 76544444556778999999999988899999999999999999998 777775432 22232222 2211111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
... .....+.+++.+||+.||++||||.||++.|++|+
T Consensus 230 -----~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 -----MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 11235778899999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=339.63 Aligned_cols=231 Identities=26% Similarity=0.375 Sum_probs=175.5
Q ss_pred ccccccCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEE
Q 040641 178 FQQPLLKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLL 256 (435)
Q Consensus 178 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 256 (435)
|.....+|++.+.||+|+||.||+|++. |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ ++..++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 5566778999999999999999999985 789999999653 344779999999999999999999999965 466899
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
||||+++|+|.+++.... ...++|..+++++.|+|+||+|||+ |||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999997642 2358999999999999999999996 89998865432
Q ss_pred CccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 313 ETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 313 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.|+... ...++...+. .... +
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~i~----~~~~-----~ 219 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVE----KGYK-----M 219 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHHT----TTCC-----C
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHHHHH----cCCC-----C
Confidence 223568999999999988899999999999999999999 56665332 2223333322 1111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..... ...++.+++.+||+.||++||||.||+++|++|.
T Consensus 220 ~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11111 1135678899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=340.45 Aligned_cols=228 Identities=21% Similarity=0.315 Sum_probs=174.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe--CCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF--DEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 257 (435)
++|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.|.+|+++|++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999864 68999999986543 2334678999999999999999999999865 4568999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------ccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARL 308 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~ 308 (435)
||||++|+|.+++.........+++.....++.|++.||+|||+ |||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987543334568999999999999999999983 9999988
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
+.... ......+||+.|||||++.+..++.++|||||||++|||+||+.||..... ..+ ...+........
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~----~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KEL----AGKIREGKFRRI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH----HHHHHHTCCCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHH----HHHHHcCCCCCC
Confidence 75432 233457899999999999999999999999999999999999999854221 111 222222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
| .. ...++.+++.+||+.||++|||+.|+++
T Consensus 235 --~---~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --P---YR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --C---TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C---cc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11 1235678889999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-46 Score=345.62 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=190.0
Q ss_pred ccccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccccc-cHHHHHHHHHHhccCCCCCceeEEEEE
Q 040641 176 SMFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKTQ-GHRQFTAEMETLGKVKHQNLVLLLGYC 248 (435)
Q Consensus 176 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~ 248 (435)
..++.|+.+|++.+.||+|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++|||||+++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 356788899999999999999999999853 3578999999754333 356799999999999999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC--------------------CCCCCCHHHHHHHHHHhhhccceeec-------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG--------------------SHEVLDRAKRYKIACSSARGLAFLHQ------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~------- 301 (435)
...+..++||||+++|+|.++++.... ....+++..++.++.|+|+||+|||+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 999999999999999999999975321 12348899999999999999999996
Q ss_pred -----------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 302 -----------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 302 -----------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
|||+|+....... ...+...||+.|||||++.+..++.|+|||||||++|||+||..|+...
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999987654332 2334567899999999999999999999999999999999997543222
Q ss_pred cccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 364 FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
.. ..++. ..+........ | . ....++.+++.+||+.||++||||.||+++|++|++
T Consensus 246 ~~---~~e~~----~~v~~~~~~~~--p---~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MA---HEEVI----YYVRDGNILAC--P---E----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SC---HHHHH----HHHHTTCCCCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CC---HHHHH----HHHHcCCCCCC--C---c----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 11122 22222221111 1 1 112357789999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=341.06 Aligned_cols=229 Identities=21% Similarity=0.340 Sum_probs=181.2
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
|.+.|++.+.||+|+||.||+|+.. +++.||||+++.......+.|.+|+++|++++|||||++++++.+++..++|||
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4457899999999999999999864 688999999976655666789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
||++|+|.+++.+.. ..+++.....++.|+++||+|||+ |||+|+...... .
T Consensus 90 y~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 999999999887543 348999999999999999999996 999997654321 2
Q ss_pred ccccccccCCCcCCcCC-----CCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 316 VSTDIAGTLGYIPPEYG-----QSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~-----~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.....+||+.|||||++ ....|+.++|||||||++|||+||+.||..... ..... .... ........
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~~~~---~i~~-~~~~~~~~ 237 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRVLL---KIAK-SEPPTLAQ 237 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHH---HHHH-SCCCCCSS
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHH---HHHc-CCCCCCCc
Confidence 23457899999999986 356689999999999999999999999854321 12221 1111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
+. .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~-------~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 PS-------RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GG-------GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc-------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11235678889999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=340.22 Aligned_cols=227 Identities=25% Similarity=0.345 Sum_probs=172.9
Q ss_pred cceee-eecccCcceEEEEEcCC---CCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 185 LTLVD-ILEDGGFGTVYKATLPD---GKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 185 ~~~~~-~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
+.+.+ .||+|+||.||+|.+.+ ++.||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..++||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 44443 69999999999998643 46899999965332 234679999999999999999999999864 5678999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||++|+|.++++.. ..+++..++.++.|+|+||+|||+ |||+|+.+.....
T Consensus 87 E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp ECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999999999763 348999999999999999999996 9999987654332
Q ss_pred c--ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 315 H--VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 315 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
. ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.... ...+ ...+......
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~~----~~~i~~~~~~----- 229 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEV----TAMLEKGERM----- 229 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHH----HHHHHTTCCC-----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC----HHHH----HHHHHcCCCC-----
Confidence 2 2234579999999999988889999999999999999998 888875321 1112 2222222111
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
..... +..++.+++.+||+.||++||||.+|+++|+..
T Consensus 230 ~~p~~----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcc----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11111 123567899999999999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=347.19 Aligned_cols=240 Identities=25% Similarity=0.364 Sum_probs=184.4
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC-C-----CEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD-G-----KTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.|+.+.++|++.+.||+|+||+||+|++.. + ..||||++.... ......|.+|+.+|.++ +|||||+++|+|
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 366788899999999999999999998642 2 369999986533 33456799999999998 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCCC-------------------CCCCCHHHHHHHHHHhhhccceeec--------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATGS-------------------HEVLDRAKRYKIACSSARGLAFLHQ-------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~yLH~-------- 301 (435)
.+.+..++|||||++|+|.++|+..... ...+++..++.++.|+|+||+|||+
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999764321 2358899999999999999999996
Q ss_pred ----------------cccccccccccCcc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 040641 302 ----------------DFGLARLISACETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPE 363 (435)
Q Consensus 302 ----------------DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~ 363 (435)
|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999876543322 3345678999999999988999999999999999999998 78887532
Q ss_pred cccccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhh
Q 040641 364 FQEKEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHE 432 (435)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 432 (435)
.. ... +...+..... +..... ....+.+++.+||+.||++||||.||++.|..
T Consensus 271 ~~----~~~---~~~~~~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PV----DAN---FYKLIQNGFK-----MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CC----SHH---HHHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CH----HHH---HHHHHhcCCC-----CCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 111 1122221110 111111 12357789999999999999999999999963
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=330.22 Aligned_cols=222 Identities=25% Similarity=0.402 Sum_probs=179.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.++|++.+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999875 58899999986432 23456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|.+++.... .+++.....++.|+++||+|||+ |||+|+.....
T Consensus 85 mEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999999997643 48899999999999999999996 99999876532
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......||+.|||||++.+..++.++|||||||++|||+||+.||.... ... ....+...... -|..
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~-~~~~i~~~~~~---~p~~ 226 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQE-TYKRISRVEFT---FPDF 226 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHH-HHHHHHTTCCC---CCTT
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHH-HHHHHHcCCCC---CCcc
Confidence 2345689999999999999999999999999999999999999985421 111 12222221110 1111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...++.+++.+||+.||++|||+.|+++
T Consensus 227 -------~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 -------VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1134667888999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=329.94 Aligned_cols=221 Identities=25% Similarity=0.382 Sum_probs=171.9
Q ss_pred cceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe----CCeeEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF----DEEKLLV 257 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv 257 (435)
+.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|+++|++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467788999999999999865 58899999986543 2345679999999999999999999999865 3457999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccccc
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLIS 310 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~ 310 (435)
||||++|+|.+++... ..+++.....++.|+++||+|||+ |||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999764 248889999999999999999995 999998654
Q ss_pred ccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
.. .....+||+.|||||++.+ .++.++|||||||++|||+||+.||..... . ..+...+.........+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~-~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------A-AQIYRRVTSGVKPASFD 235 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------H-HHHHHHHTTTCCCGGGG
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------H-HHHHHHHHcCCCCcccC
Confidence 32 2345789999999998865 599999999999999999999999853211 1 11222222221111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..++.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 124667889999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=334.84 Aligned_cols=227 Identities=23% Similarity=0.320 Sum_probs=175.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... +..+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 47899999999999999999864 689999999865432 2345689999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-cc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE-TH 315 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~-~~ 315 (435)
|++|+|.+++... ..+++.....++.|+++||+|||+ |||+|+...... ..
T Consensus 85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999888642 358999999999999999999996 999998865432 22
Q ss_pred ccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
..+..+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... .... ......... ..+
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~----~~~~~~~~~--~~~--- 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEY----SDWKEKKTY--LNP--- 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---SHHH----HHHHTTCTT--STT---
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---HHHH----HHHhcCCCC--CCc---
Confidence 3456789999999999877765 67899999999999999999998543211 1111 111111100 000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234567888999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=335.52 Aligned_cols=226 Identities=22% Similarity=0.287 Sum_probs=164.3
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
+.|++.+.||+|+||+||+|+.. +++.||||.+..... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 46899999999999999999865 689999999975432 2345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
|++|+|.+++... ..+++.....++.|++.||+|||+ |||+|+.....
T Consensus 89 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 89 VSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 9999999999753 358999999999999999999996 99999876532
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..+. ..+...... .++..
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~----~~i~~~~~~--~~~~~ 232 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLF----EQILKAEYE--FDSPY 232 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH----HHHHTTCCC--CCTTT
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHH----HHHhccCCC--CCCcc
Confidence 223456899999999999999999999999999999999999999854321 1111 111111110 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 ----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111235678889999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=340.52 Aligned_cols=237 Identities=26% Similarity=0.410 Sum_probs=180.1
Q ss_pred ccccCcceeeeecccCcceEEEEEcCC-CC--EEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEEEEEEeCCee
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATLPD-GK--TVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 254 (435)
....+|++.+.||+|+||+||+|++.+ |. .||||+++... ....++|.+|+++|+++ +|||||+++|+|...+..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 455789999999999999999998754 43 57888885433 33456799999999998 799999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhC------------CCCCCCCHHHHHHHHHHhhhccceeec---------------------
Q 040641 255 LLVYEYMVNGSLDLWLRNAT------------GSHEVLDRAKRYKIACSSARGLAFLHQ--------------------- 301 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------- 301 (435)
++||||+++|+|.++|+... .....+++..+..++.|+|+||.|+|+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 99999999999999997531 233568999999999999999999996
Q ss_pred ---cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 302 ---DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 ---DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+|+..... .......||..|+|||.+....++.++|||||||++|||+||..|+.... +... +..
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~-~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAE-LYE 237 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHH-HHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHH-HHH
Confidence 99999865432 22234579999999999988899999999999999999999876542211 1111 222
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+..... +.... ....++.+++.+||+.||++||||.||++.|++++
T Consensus 238 ~i~~~~~-----~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KLPQGYR-----LEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HGGGTCC-----CCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCC-----CCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222111 11111 11235778899999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=338.11 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=189.6
Q ss_pred cccccccCcceeeeecccCcceEEEEEc------CCCCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL------PDGKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLGYC 248 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 248 (435)
.|+.+..+|++.+.||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 5778889999999999999999999975 2457899999975433 3456799999999999 699999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHHhhCC--------------CCCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 249 SFDEEKLLVYEYMVNGSLDLWLRNATG--------------SHEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 249 ~~~~~~~lv~ey~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
..++..++|||||++|+|.++++.... ....+++..+..++.|+|+||+|||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 999999999999999999999976432 12358899999999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccC
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEG 369 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~ 369 (435)
|||+++....... ...+...||+.|+|||++....++.++|||||||++|||+|++.|+..... .
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~---~ 253 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---V 253 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---S
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC---H
Confidence 9999987654332 334457899999999999988999999999999999999996666533221 1
Q ss_pred CcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 370 ANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... ...+...... ..| . .....+.+++.+||+.||++||||.||+++|++++
T Consensus 254 ~~~~---~~~i~~~~~~--~~~---~----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 254 DSKF---YKMIKEGFRM--LSP---E----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SHHH---HHHHHHTCCC--CCC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HHHHhcCCCC--CCc---c----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1111 1111111100 011 1 11235778999999999999999999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=329.30 Aligned_cols=226 Identities=20% Similarity=0.273 Sum_probs=179.6
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc------ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT------QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
++|++.+.||+|+||+||+|+. .+|+.||||.++.... ...+.|.+|+++|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4689999999999999999986 4689999999864321 23578999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------cccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ----------------------------DFGLAR 307 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------DfGla~ 307 (435)
+|||||++|+|.+++.... .+++.....++.|++.||+|||+ |||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999997653 48999999999999999999996 899998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||..... ... ...+......
T Consensus 166 ~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~----~~~i~~~~~~- 234 (293)
T d1jksa_ 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QET----LANVSAVNYE- 234 (293)
T ss_dssp ECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHTTCCC-
T ss_pred hcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH----HHH----HHHHHhcCCC-
Confidence 76543 233456899999999999999999999999999999999999999864321 111 1111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001 1124667899999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=334.61 Aligned_cols=231 Identities=28% Similarity=0.439 Sum_probs=178.4
Q ss_pred cceeeeecccCcceEEEEEcCCC----CEEEEEEcccc-ccccHHHHHHHHHHhccCCCCCceeEEEEEEe-CCeeEEEE
Q 040641 185 LTLVDILEDGGFGTVYKATLPDG----KTVAVKKFSQA-KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSF-DEEKLLVY 258 (435)
Q Consensus 185 ~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~ 258 (435)
+.+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.. ++..++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34578999999999999987542 25899999753 33345789999999999999999999999876 46889999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACET 314 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~ 314 (435)
|||++|+|.++++... ...++..+++++.|+|+||.|+|+ |||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999987542 347788899999999999999996 9999987654322
Q ss_pred ---cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccc
Q 040641 315 ---HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDP 391 (435)
Q Consensus 315 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (435)
.......||+.|+|||......++.++|||||||++|||+||+.||..... ..++...+.. .. ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~i~~----g~--~~~~p 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQ----GR--RLLQP 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHT----TC--CCCCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHHHHc----CC--CCCCc
Confidence 223346789999999999888999999999999999999999888754322 1222222221 11 11112
Q ss_pred cccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 392 TVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 392 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.. ...++.+++.+||+.||++||||.||++.|+++.
T Consensus 257 ~~-------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 257 EY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc-------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1235778999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=338.77 Aligned_cols=176 Identities=24% Similarity=0.350 Sum_probs=153.1
Q ss_pred cccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3468999999999999999999864 68999999986543 233467999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccC
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~ 313 (435)
|||++|+|.+++.+.. .+++.....++.|+++||.|||+ |||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997643 48899999999999999999994 99999876432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPE 363 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~ 363 (435)
.....+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 234578999999999999999999999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=334.42 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=189.7
Q ss_pred cccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEcccccc-ccHHHHHHHHHHhccCCCCCceeEEEEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAKT-QGHRQFTAEMETLGKVKHQNLVLLLGYCS 249 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 249 (435)
.|+++..+|++.+.||+|+||.||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 47788899999999999999999999863 257899999975432 33457999999999999999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHHhhC------CCCCCCCHHHHHHHHHHhhhccceeec----------------------
Q 040641 250 FDEEKLLVYEYMVNGSLDLWLRNAT------GSHEVLDRAKRYKIACSSARGLAFLHQ---------------------- 301 (435)
Q Consensus 250 ~~~~~~lv~ey~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------- 301 (435)
.++..++|||||++|+|.+++.... .....+++..+..++.++|+||.|||+
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999999886432 222357899999999999999999996
Q ss_pred --cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHH
Q 040641 302 --DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQ 378 (435)
Q Consensus 302 --DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~ 378 (435)
|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.|+... .+.... ..
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~~~~~-~~ 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LSNEQV-LR 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCHHHH-HH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC------CCHHHH-HH
Confidence 9999987654332 2234457899999999999999999999999999999999996543222 112222 22
Q ss_pred HhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhhC
Q 040641 379 KMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIVD 435 (435)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 435 (435)
.+......+. | . .+...+.+++.+||+.||++||||.+|+++|++.++
T Consensus 247 ~i~~~~~~~~--p---~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLDK--P---D----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCCC--c---c----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222211111 1 1 112357789999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=333.74 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=179.1
Q ss_pred ccccccccccCcceeeeecccCcceEEEEEcC------CCCEEEEEEccccc-cccHHHHHHHHHHhccC-CCCCceeEE
Q 040641 174 NISMFQQPLLKLTLVDILEDGGFGTVYKATLP------DGKTVAVKKFSQAK-TQGHRQFTAEMETLGKV-KHQNLVLLL 245 (435)
Q Consensus 174 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~ 245 (435)
+...|+.+..+|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+|||.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44567788899999999999999999999853 34689999997543 23456788888888776 689999999
Q ss_pred EEEEeC-CeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec-----------
Q 040641 246 GYCSFD-EEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ----------- 301 (435)
Q Consensus 246 g~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~----------- 301 (435)
+++... +..++|||||++|+|.++++.... ....+++..+..++.|+|+||+|||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 998765 468999999999999999976431 12358899999999999999999996
Q ss_pred -------------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCC-CCCCCccc
Q 040641 302 -------------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKE-PTGPEFQE 366 (435)
Q Consensus 302 -------------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~-p~~~~~~~ 366 (435)
|||+|+....... ...+...||+.|||||++.+..++.++|||||||++|||+||.. ||... .
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-~- 241 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-K- 241 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-C-
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-C-
Confidence 9999987654332 23345689999999999999999999999999999999999865 44321 1
Q ss_pred ccCCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 367 KEGANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.... +...+....... .... ...++.+++.+||+.||++||||.||++.|++|+
T Consensus 242 --~~~~---~~~~~~~~~~~~-----~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 242 --IDEE---FCRRLKEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp --CSHH---HHHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHH---HHHHHhcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 122222221111 1111 1235678999999999999999999999999886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.4e-44 Score=336.50 Aligned_cols=228 Identities=22% Similarity=0.345 Sum_probs=182.7
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999986 46899999999766555567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~ 314 (435)
|++|+|.+++... ...+++.....++.|++.||+|||+ |||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 9999999998643 2358999999999999999999996 99999876543
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......||+.|||||++.+..++.++||||+||++|||+||+.||..... .... ..+...... .++...
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~----~~i~~~~~~--~~~~~~ 249 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETL----RNVKSCDWN--MDDSAF 249 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH----HHHHHTCCC--SCCGGG
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----HHHH----HHHHhCCCC--CCcccc
Confidence 223456899999999999999999999999999999999999999854321 1111 111111110 011110
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 S----GISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp G----GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 11234667889999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=334.55 Aligned_cols=241 Identities=27% Similarity=0.337 Sum_probs=176.5
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCC----eeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE----EKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 258 (435)
++|.+.+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|...+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4688999999999999999997 588999999864322 1122344566667899999999999998754 578999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------------ccccc
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------------DFGLA 306 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------------DfGla 306 (435)
|||++|+|.++++.. .++|..++.++.++|.||+|+|+ |||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999753 38999999999999999999983 99999
Q ss_pred ccccccCcc---ccccccccCCCcCCcCCCCC------CCCCcccchhHHHHHHHHHhCCCCCCCCccccc-------CC
Q 040641 307 RLISACETH---VSTDIAGTLGYIPPEYGQSR------MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKE-------GA 370 (435)
Q Consensus 307 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~-------~~ 370 (435)
+........ ......||+.|||||++... .++.|+|||||||++|||+||..|+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877543322 23456899999999987654 257799999999999999999887643211110 00
Q ss_pred cHHHHHHHHhccCCCCccccccccC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 371 NLVGWVFQKMKKQQADDVLDPTVLN-AGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
............. ..+|.... ....+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111122222111 11222211 112345567889999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-44 Score=331.42 Aligned_cols=224 Identities=24% Similarity=0.356 Sum_probs=176.0
Q ss_pred ccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeE
Q 040641 180 QPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKL 255 (435)
Q Consensus 180 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 255 (435)
.|...|+..+.||+|+||+||+|+. .+++.||||+++.... ...+.|.+|+++|++++|||||++++++.+++..+
T Consensus 12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 3455689999999999999999985 4688999999865432 23457899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISA 311 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~ 311 (435)
+|||||++|+|..++... ..+++..+..++.|++.||.|||+ |||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999999998776543 348999999999999999999996 9999986543
Q ss_pred cCccccccccccCCCcCCcCCCC---CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 312 CETHVSTDIAGTLGYIPPEYGQS---RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... ............ ...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-------~~~~~~~i~~~~-~~~- 233 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE-SPA- 233 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSC-CCC-
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCC-CCC-
Confidence 234679999999998753 468999999999999999999999985321 111122222111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ----LQSGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CSCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCC---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 1235677889999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=328.14 Aligned_cols=223 Identities=22% Similarity=0.313 Sum_probs=176.5
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 258 (435)
++|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999864 68999999986432 234567999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC-
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE- 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~- 313 (435)
|||++|+|.+++.... .+++.....++.|++.||+|||+ |||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999887653 48899999999999999999996 999999875432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
.......+||+.|||||++.+..++.++||||+||++|||+||+.||..... .. +...+...... + |
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~-~~~~i~~~~~~--~-p-- 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YL-IFQKIIKLEYD--F-P-- 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHTTCCC--C-C--
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HH-HHHHHHcCCCC--C-C--
Confidence 2233456899999999999999999999999999999999999999854311 11 12222222110 0 1
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTMLHVL 427 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 427 (435)
.. ...++.+++.+||+.||++|||+.|++
T Consensus 231 -~~----~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 231 -EK----FFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -TT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -cc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11 123467889999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=325.80 Aligned_cols=232 Identities=25% Similarity=0.351 Sum_probs=170.2
Q ss_pred ccCcceeeeecccCcceEEEEEcC--CC--CEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP--DG--KTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+|++.+.||+|+||.||+|++. ++ ..||||+++... .+..++|.+|+++|++++|||||+++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999853 23 378999986532 2335689999999999999999999999965 567
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
++|||||++|++.+++.... ..+++..++.++.|+|+||.|||+ |||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 89999999999998877543 348999999999999999999996 999999865
Q ss_pred ccCc--cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 311 ACET--HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 311 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.... .......||..|+|||++.+..++.++|||||||++|||+| |+.||... .......+ ..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~----~~~~~~~~---i~~~~~~-- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHK---IDKEGER-- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHH---HHTSCCC--
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc----CHHHHHHH---HHhCCCC--
Confidence 4322 22334568899999999998999999999999999999998 78887432 11122222 1222111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
+..... ....+.+++.+||+.||++||||.||.+.|++.
T Consensus 234 ---~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ---LPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 113567899999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=329.85 Aligned_cols=230 Identities=23% Similarity=0.386 Sum_probs=174.6
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCC----EEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGK----TVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 256 (435)
.+|++.++||+|+||+||+|++. +|+ .||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46899999999999999999864 343 58999986543 3456789999999999999999999999976 46788
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
+|||+.+|+|.+++... ...+++..++.++.|+|+||+|||+ |||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999888764 3458999999999999999999996 99999987543
Q ss_pred Ccc-ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCcccccCCcHHHHHHHHhccCCCCcccc
Q 040641 313 ETH-VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLD 390 (435)
Q Consensus 313 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (435)
... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ...+...+....+. ..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~~~~~i~~~~~~------~~ 234 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERL------PQ 234 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGGHHHHHHHTCCC------CC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHHHHHHHHcCCCC------CC
Confidence 322 2334578999999999988899999999999999999999 677764321 12232222221110 01
Q ss_pred ccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 391 PTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 391 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
|. .+...+.+++.+||+.||++||||.||++.|.++
T Consensus 235 p~-------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 235 PP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11 1123567899999999999999999999998875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=329.64 Aligned_cols=241 Identities=29% Similarity=0.414 Sum_probs=184.1
Q ss_pred cccccccCcceeeeecccCcceEEEEEcCC--------CCEEEEEEcccccc-ccHHHHHHHHHHhccC-CCCCceeEEE
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATLPD--------GKTVAVKKFSQAKT-QGHRQFTAEMETLGKV-KHQNLVLLLG 246 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g 246 (435)
.|..+.++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++|
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 477888999999999999999999997522 34799999976443 3457789999999888 8999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHHhhCC------------CCCCCCHHHHHHHHHHhhhccceeec-------------
Q 040641 247 YCSFDEEKLLVYEYMVNGSLDLWLRNATG------------SHEVLDRAKRYKIACSSARGLAFLHQ------------- 301 (435)
Q Consensus 247 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~------------- 301 (435)
+|.+++..++|||||++|+|.++++.... ....+++..++.++.|+|.||+|||+
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 99999999999999999999999976532 12458999999999999999999996
Q ss_pred -----------cccccccccccCc-cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHh-CCCCCCCCccccc
Q 040641 302 -----------DFGLARLISACET-HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVT-AKEPTGPEFQEKE 368 (435)
Q Consensus 302 -----------DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~t-g~~p~~~~~~~~~ 368 (435)
|||+++....... .......||+.|+|||.+.+..|+.|+|||||||++|||+| |..||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 8999987654322 23345679999999999988999999999999999999999 5666532211
Q ss_pred CCcHHHHHHHHhccCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 369 GANLVGWVFQKMKKQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
..+...+...... ..... ....+.+++.+||+.||++||||.||++.|++|+
T Consensus 244 -----~~~~~~i~~~~~~-----~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -----EELFKLLKEGHRM-----DKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -----HHHHHHHHTTCCC-----CCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCC-----CCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1122233222111 11111 1235778999999999999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-43 Score=330.16 Aligned_cols=227 Identities=18% Similarity=0.273 Sum_probs=181.5
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEecc
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEYM 261 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~ 261 (435)
.+|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5699999999999999999986 468999999997655555667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCcc
Q 040641 262 VNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACETH 315 (435)
Q Consensus 262 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~~ 315 (435)
++|+|.+++... ...+++.....++.|++.||+|||+ |||+|+.+... .
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--E 183 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--S
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--C
Confidence 999998877543 2348999999999999999999996 99999887543 2
Q ss_pred ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccccC
Q 040641 316 VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVLN 395 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (435)
......||+.|||||++.+..++.++||||+||++|||+||+.||..... ... ...+...... ..+....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~----~~~i~~~~~~--~~~~~~~ 253 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LET----LQNVKRCDWE--FDEDAFS 253 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHH----HHHHHHCCCC--CCSSTTT
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCCC--CCccccc
Confidence 33456899999999999999999999999999999999999999853211 111 1112111110 0111111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 396 AGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 396 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.....+.+++.+||+.||++|||+.|+++
T Consensus 254 ----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 ----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11235678899999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-42 Score=318.50 Aligned_cols=234 Identities=23% Similarity=0.340 Sum_probs=175.3
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc---ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCe----e
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT---QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEE----K 254 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 254 (435)
++|++.+.||+|+||.||+|+. .+|+.||||.++.... ...+.|.+|++++++++|||||++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4689999999999999999986 4689999999975432 234579999999999999999999999876543 7
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|+|||||++|+|..++.... .+++.....++.|+++||+|||+ |||.++...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 89999999999999887643 48899999999999999999996 788876543
Q ss_pred ccC--ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 311 ACE--THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 311 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.... ........+......
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPIP-- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCCC--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHHHHhcCCCC--
Confidence 321 123345689999999999999999999999999999999999999985421 122222333222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHhhhh
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRP-TMLHVLKLLHEIV 434 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~ 434 (435)
+....+. ...++.+++.+||+.||++|| |+++++..|.++.
T Consensus 234 --~~~~~~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 --PSARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GGGTSSS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --CchhccC---CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111 113566788899999999999 8999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=316.88 Aligned_cols=224 Identities=20% Similarity=0.276 Sum_probs=179.5
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45789999999999999999986 468999999997542 33457789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|..++.... .+++.....++.|++.||+|||+ |||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999988653 47888888999999999999996 999998764322
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ..+ .......... -|..
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~----~~~i~~~~~~---~p~~ 227 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERL----FELILMEEIR---FPRT 227 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHHHCCCC---CCTT
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHH----HHHHhcCCCC---CCcc
Confidence 234457899999999999999999999999999999999999999854321 111 2222222110 1111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
...++.+++.+||+.||++||+ +.|+++
T Consensus 228 -------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 -------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1124567889999999999995 777764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=317.90 Aligned_cols=227 Identities=19% Similarity=0.271 Sum_probs=179.7
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
.++|++.+.||+|+||+||+|... +++.||||.++.... ....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999865 688999999975432 345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec--------------------------cccccccccccCc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ--------------------------DFGLARLISACET 314 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--------------------------DfGla~~~~~~~~ 314 (435)
|++|+|.+++.... ..+++.....++.|+++||+|||+ |||+++.....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999996532 348999999999999999999996 99999876432
Q ss_pred cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccccc
Q 040641 315 HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTVL 394 (435)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (435)
.......||+.|+|||...+..++.++||||+||++|||+||+.||..... ..+ ...+...... .+....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~----~~~i~~~~~~--~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQI----IENIMNAEYT--FDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH----HHHHHHTCCC--CCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHhCCCC--CChhhc
Confidence 223446799999999999999999999999999999999999999864321 111 1112111110 000000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 395 NAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 395 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. ...++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1224678899999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-41 Score=309.27 Aligned_cols=226 Identities=21% Similarity=0.240 Sum_probs=177.4
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc---------cHHHHHHHHHHhccCC-CCCceeEEEEEEeC
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ---------GHRQFTAEMETLGKVK-HQNLVLLLGYCSFD 251 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 251 (435)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999986 46899999998653211 1245889999999997 99999999999999
Q ss_pred CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccc
Q 040641 252 EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLAR 307 (435)
Q Consensus 252 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~ 307 (435)
+..|||||||++|+|.++++... .+++.....++.|+++||+|||+ |||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999997643 48999999999999999999996 999998
Q ss_pred cccccCccccccccccCCCcCCcCCC------CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQ------SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
.+... ...+..+||+.|+|||++. ...++.++||||+||++|||+||+.||..... ... ...+.
T Consensus 159 ~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~----~~~i~ 228 (277)
T d1phka_ 159 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLM----LRMIM 228 (277)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH----HHHHH
T ss_pred EccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHH----HHHHH
Confidence 77543 2334578999999999753 34678999999999999999999999864321 111 12121
Q ss_pred cCCCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..... ...+. ......++.+++.+||+.||++|||+.||++
T Consensus 229 ~~~~~-~~~~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-CCCcc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 01111 1112235678899999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5e-41 Score=312.99 Aligned_cols=221 Identities=19% Similarity=0.308 Sum_probs=177.3
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccc---ccccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQA---KTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
..+|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35789999999999999999986 46899999999643 233457799999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|..++.... .+++.....++.|++.||+|||+ |||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999999887643 36777888899999999999996 99999876532
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ... ...+..... .-|..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~-~~~i~~~~~---~~p~~ 223 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKT-YEKILNAEL---RFPPF 223 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHH-HHHHHHCCC---CCCTT
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHH-HHHHHcCCC---CCCCC
Confidence 2357899999999999999999999999999999999999999854321 111 122211111 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
....+.+++.+||+.||++|| |+.|+++
T Consensus 224 -------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 -------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 112466788899999999996 8998874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=316.71 Aligned_cols=222 Identities=21% Similarity=0.318 Sum_probs=175.8
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhc-cCCCCCceeEEEEEEeCCeeEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLG-KVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 257 (435)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47899999999999999999865 68999999996432 334566778887765 68999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
||||++|+|.++++... .+++.....++.|++.||+|||+ |||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence 99999999999998653 37888899999999999999996 99999865432
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
....+...||+.|+|||++.+..++.++|||||||++|||+||+.||..... . .+...+..... .-|..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~-~~~~~i~~~~~---~~p~~ 225 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------E-ELFHSIRMDNP---FYPRW 225 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------H-HHHHHHHHCCC---CCCTT
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------H-HHHHHHHcCCC---CCCcc
Confidence 2333457899999999999999999999999999999999999999854321 1 12222222111 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRPTML-HVL 427 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 427 (435)
...++.+++.+||+.||++|||+. |++
T Consensus 226 -------~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 226 -------LEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 112467888999999999999995 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=318.35 Aligned_cols=227 Identities=17% Similarity=0.199 Sum_probs=172.4
Q ss_pred cCccee-eeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhcc-CCCCCceeEEEEEEe----CCeeE
Q 040641 183 LKLTLV-DILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGK-VKHQNLVLLLGYCSF----DEEKL 255 (435)
Q Consensus 183 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 255 (435)
.+|.+. ++||+|+||+||+|+. .+++.||||+++. ...+.+|++++.+ .+|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467776 5699999999999986 5689999999853 2457789998765 589999999999865 45689
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------ccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARL 308 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~ 308 (435)
+|||||+||+|.+++.... ...+++.....++.|++.||+|||+ |||+|+.
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 9999999999999997542 2458999999999999999999996 9999987
Q ss_pred ccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV 388 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (435)
..... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... ......+.........
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~----~~~~~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 164 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIRMGQY--- 234 (335)
T ss_dssp CCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC----C--------CCCSCSS---
T ss_pred ccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH----HHHHHHHHHHHhcCCC---
Confidence 65432 23456899999999999999999999999999999999999999853321 1111111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
....+.......++.+++.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111122345778899999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-40 Score=314.22 Aligned_cols=225 Identities=20% Similarity=0.262 Sum_probs=172.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHH---HHHHHhccCCCCCceeEEEEEEeCCee
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFT---AEMETLGKVKHQNLVLLLGYCSFDEEK 254 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~ 254 (435)
..+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+. +|+++++.++|||||++++++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 357899999999999999999865 68999999986432 12223344 457788899999999999999999999
Q ss_pred EEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccc
Q 040641 255 LLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLIS 310 (435)
Q Consensus 255 ~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~ 310 (435)
|+|||||++|+|.+++.... .+++.....++.|++.||+|||+ |||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999997643 47888899999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccc
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVL 389 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (435)
.. .....+||+.|||||++. +..|+.++|||||||++|||+||+.||..... ..... +........ ..
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~-~~~~~~~~~---~~ 227 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHE-IDRMTLTMA---VE 227 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHH-HHHHSSSCC---CC
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHH-HHHhcccCC---CC
Confidence 43 234568999999999876 45789999999999999999999999864321 11211 122111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 390 DPTVLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
.|. . ...++.+++.+||+.||++||| +.|+++
T Consensus 228 ~~~---~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LPD---S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCS---S----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC---C----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111 1 1124678889999999999999 577763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-40 Score=311.08 Aligned_cols=221 Identities=19% Similarity=0.248 Sum_probs=178.5
Q ss_pred ccCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc---cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEE
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK---TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLV 257 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 257 (435)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 357999999999999999999864 68999999986432 23456789999999999999999999999999999999
Q ss_pred EecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccC
Q 040641 258 YEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACE 313 (435)
Q Consensus 258 ~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~ 313 (435)
|||+.+|+|..++.... .+++.....++.|++.||.|||+ |||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999987653 48899999999999999999996 99999876532
Q ss_pred ccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCccccccc
Q 040641 314 THVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPTV 393 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (435)
....+||+.|||||++.+..++.++|||||||++|||+||+.||.... ... ....+...... .|.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~-~~~~i~~~~~~---~p~- 259 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQ-IYEKIVSGKVR---FPS- 259 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH-HHHHHHHCCCC---CCT-
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-------HHH-HHHHHhcCCCC---CCc-
Confidence 234689999999999999999999999999999999999999985321 111 12222221110 111
Q ss_pred cCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 040641 394 LNAGSKPMMLKMLRIAADCVADNPATRP-----TMLHVLK 428 (435)
Q Consensus 394 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 428 (435)
. ....+.+++.+||+.||++|+ |+.|+++
T Consensus 260 --~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 --H----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --T----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --c----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 112467788899999999994 8999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=310.58 Aligned_cols=233 Identities=25% Similarity=0.292 Sum_probs=169.0
Q ss_pred eeeeecccCcceEEEEEcC-CCCEEEEEEccccccc-----cHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 187 LVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQ-----GHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 187 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
..++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 5899999999654322 134688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
|++|++..+... ...+++.....++.|++.||+|||+ |||+|+...... ..
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RA 156 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cc
Confidence 999887665532 2357788889999999999999996 999998765432 22
Q ss_pred cccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcccccc---
Q 040641 317 STDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDVLDPT--- 392 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 392 (435)
....+||+.|||||++. ...++.++|||||||++|||+||+.||.... ..+....+.............+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC----HHHHHHHHHHhcCCCChhhccchhccc
Confidence 33468999999999875 4568999999999999999999999985432 122222222222111111000000
Q ss_pred ------ccCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 393 ------VLNAGS-----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 393 ------~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...... ......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 011235678899999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=305.67 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=173.0
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999986 5689999999965432 235689999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+.++.+. ++... ....+++.....++.|++.||+|||+ |||+|+..... ..
T Consensus 82 ~~~~~~~~-~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~ 157 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VR 157 (298)
T ss_dssp CCSEEHHH-HHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SB
T ss_pred ecCCchhh-hhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-cc
Confidence 99766544 44332 12358999999999999999999996 99999876543 23
Q ss_pred ccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCC---CCccc-c
Q 040641 316 VSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQ---ADDVL-D 390 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~ 390 (435)
......||+.|+|||..... .++.++||||+||++|||++|+.||..... ......+........ ..... .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhccccccc
Confidence 34456899999999976554 458899999999999999999999864321 111111111111100 00000 0
Q ss_pred c-------cccCCC----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 040641 391 P-------TVLNAG----SKPMMLKMLRIAADCVADNPATRPTMLHVLKL 429 (435)
Q Consensus 391 ~-------~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 429 (435)
+ ...... .......+.+++.+|+..||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000000 00112356778899999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-39 Score=299.04 Aligned_cols=237 Identities=23% Similarity=0.255 Sum_probs=173.9
Q ss_pred cCcceeeeecccCcceEEEEEcCCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey 260 (435)
++|++.+.||+|+||+||+|+.++|+.||||+++... ....+.|.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999899999999996543 23357899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETHV 316 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~~ 316 (435)
+.++.+..+.+.. ..++......++.|++.||+|||+ |||+|....... ..
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 9988777665432 358999999999999999999996 999988765322 22
Q ss_pred cccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCcc-------
Q 040641 317 STDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADDV------- 388 (435)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 388 (435)
.....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+....+............
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCChhhccchhhhh
Confidence 344578999999998765 4679999999999999999999999864321 1111112211111100000
Q ss_pred --------ccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 --------LDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 --------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
..+.............+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000111235668889999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=301.13 Aligned_cols=215 Identities=22% Similarity=0.352 Sum_probs=170.0
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccc------cHHHHHHHHHHhccCC--CCCceeEEEEEEeCCe
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQ------GHRQFTAEMETLGKVK--HQNLVLLLGYCSFDEE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 253 (435)
.+|++.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4689999999999999999986 46899999998643211 1234678999999986 8999999999999999
Q ss_pred eEEEEecccC-CCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccc
Q 040641 254 KLLVYEYMVN-GSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLAR 307 (435)
Q Consensus 254 ~~lv~ey~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~ 307 (435)
.++||||+.+ +++.+++.... .+++.....++.|+++||+|||+ |||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 68888886542 48899999999999999999996 999998
Q ss_pred cccccCccccccccccCCCcCCcCCCCCCC-CCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 308 LISACETHVSTDIAGTLGYIPPEYGQSRMS-TTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
.... ...+..+||+.|||||++.+..+ +.++||||+||++|||+||+.||.... . +. + ...
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~----i~---~-~~~- 221 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----II---R-GQV- 221 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HH---H-CCC-
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H----Hh---h-ccc-
Confidence 7543 23345789999999998876654 677999999999999999999985311 0 11 1 100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+. ...++.+++.+||+.||++|||+.|+++
T Consensus 222 -~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111 1124677889999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-38 Score=294.81 Aligned_cols=235 Identities=17% Similarity=0.190 Sum_probs=172.7
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeE-EEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLL-LGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||+||+|++ .+|+.||||.+..... ..++.+|+++++.++|+|+|.. .++....+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 3689999999999999999986 4688999998765332 2457899999999988776555 4555777888999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec---------------------------cccccccccccC
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------DFGLARLISACE 313 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------DfGla~~~~~~~ 313 (435)
+ +|++...+.... ..+++.....++.|+++||+|||+ |||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 556666555432 348899999999999999999996 999999875432
Q ss_pred cc------ccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc
Q 040641 314 TH------VSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD 387 (435)
Q Consensus 314 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (435)
.. ......||+.|||||...+..++.++|||||||++|||+||+.||...................... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch--
Confidence 21 2345689999999999999999999999999999999999999986543322211121111111110 00
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhh
Q 040641 388 VLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEI 433 (435)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 433 (435)
+..... ...++.+++..||+.+|++||++.++.+.|+++
T Consensus 238 ---~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 ---EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000011 113567888899999999999999999988875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=298.59 Aligned_cols=237 Identities=23% Similarity=0.284 Sum_probs=169.1
Q ss_pred cCcceeeeecccCcceEEEEEc-CC-CCEEEEEEcccccc--ccHHHHHHHHHHhccC---CCCCceeEEEEEEe-----
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PD-GKTVAVKKFSQAKT--QGHRQFTAEMETLGKV---KHQNLVLLLGYCSF----- 250 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 250 (435)
.+|++.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+|+.+ +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5899999999999999999986 34 56799999864322 2234566788776655 89999999999853
Q ss_pred CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccc
Q 040641 251 DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLA 306 (435)
Q Consensus 251 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla 306 (435)
....+++|||+.+|++....... ...+++.....++.|++.||+|||+ |||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 34678999999998876554432 3357888889999999999999996 89998
Q ss_pred ccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 307 RLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
+..... .......||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+....+..........
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCGG
T ss_pred hhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCchh
Confidence 765432 233457899999999999999999999999999999999999999864321 11222222211110000
Q ss_pred cc----c---------cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 387 DV----L---------DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 387 ~~----~---------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. . .+.............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0 000000000111234567888999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-38 Score=288.37 Aligned_cols=236 Identities=14% Similarity=0.165 Sum_probs=178.4
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCC-CCceeEEEEEEeCCeeEEEEec
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH-QNLVLLLGYCSFDEEKLLVYEY 260 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~ey 260 (435)
.+|++.+.||+|+||+||+|+.. +|+.||||.++.... ...+.+|+++++.++| +||+.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 47899999999999999999864 688999998854332 2346788888888865 8999999999999999999999
Q ss_pred ccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-----------------------------cccccccccc
Q 040641 261 MVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-----------------------------DFGLARLISA 311 (435)
Q Consensus 261 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----------------------------DfGla~~~~~ 311 (435)
+ +|+|.++++... ..+++.....++.|++.||+|||+ |||+|+....
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 789999887543 348889999999999999999996 9999987653
Q ss_pred cCc------cccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCC
Q 040641 312 CET------HVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQA 385 (435)
Q Consensus 312 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (435)
... ......+||+.|||||.+.+..++.++|||||||++|||+||+.||........ ......+.........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-HHHHHHHHhccCCCCh
Confidence 221 123346899999999999999999999999999999999999999864322111 1111111111111100
Q ss_pred CccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHhhhh
Q 040641 386 DDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLKLLHEIV 434 (435)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 434 (435)
.+ +... ...++.+++..||+.+|++||++..+.+.|++++
T Consensus 238 ~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 0011 1135677888999999999999999998888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=289.50 Aligned_cols=240 Identities=22% Similarity=0.222 Sum_probs=169.6
Q ss_pred cccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe-------
Q 040641 181 PLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF------- 250 (435)
Q Consensus 181 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 250 (435)
+..+|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 457899999999999999999986 468999999986432 2345678999999999999999999999855
Q ss_pred -CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccc
Q 040641 251 -DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGL 305 (435)
Q Consensus 251 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGl 305 (435)
.+..++|||||+++.+..+... ...++......++.|+++||.|||+ |||+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 3457999999998877655432 2347778888999999999999996 9999
Q ss_pred cccccccCc---cccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhc
Q 040641 306 ARLISACET---HVSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMK 381 (435)
Q Consensus 306 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 381 (435)
++....... ......+||+.|+|||.+.+. .++.++||||+||++|||+||+.||..... ......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~i~~~~~ 239 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQLALISQLCG 239 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH----HHHHHHHHHhcC
Confidence 987653221 222345799999999987654 689999999999999999999999854321 111111222111
Q ss_pred cCC---CCccc---------cccccCCCCHHH------HHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 382 KQQ---ADDVL---------DPTVLNAGSKPM------MLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 382 ~~~---~~~~~---------~~~~~~~~~~~~------~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... ..... ..........+. ...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 110 00000 000000011111 123567899999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-38 Score=291.86 Aligned_cols=229 Identities=21% Similarity=0.301 Sum_probs=174.9
Q ss_pred ccCcceeeeecccCcceEEEEEcC----CCCEEEEEEccccc----cccHHHHHHHHHHhccCCC-CCceeEEEEEEeCC
Q 040641 182 LLKLTLVDILEDGGFGTVYKATLP----DGKTVAVKKFSQAK----TQGHRQFTAEMETLGKVKH-QNLVLLLGYCSFDE 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~ 252 (435)
..+|++.+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|++++++++| ||||++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 357999999999999999999742 47899999986532 2234568899999999977 89999999999999
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||+.+|+|..++.... .+.......++.|++.|++|+|+ |||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987653 35677888899999999999996 9999987
Q ss_pred ccccCccccccccccCCCcCCcCCCCC--CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCC
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQSR--MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQAD 386 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (435)
.............||+.|+|||...+. .++.++||||+||++|||+||+.||....... ....+........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSE-- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccCC--
Confidence 655444444567899999999987553 57889999999999999999999986543221 1111222111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 040641 387 DVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPT-----MLHVLK 428 (435)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 428 (435)
+.... ....++.+++.+||+.||++||| ++|+++
T Consensus 253 ----~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 11235677888999999999994 788874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=293.86 Aligned_cols=235 Identities=21% Similarity=0.220 Sum_probs=167.1
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccccccHHHHHHHHHHhccCCCCCceeEEEEEEeC------CeeE
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKHQNLVLLLGYCSFD------EEKL 255 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 255 (435)
.+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||+++++|... ...+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36888899999999999999965 689999999965432 234799999999999999999998643 2468
Q ss_pred EEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------ccccccccc
Q 040641 256 LVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLIS 310 (435)
Q Consensus 256 lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~ 310 (435)
+|||||++|.+..+... ......+++.....++.|+++||+|||+ |||+++...
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999987755444332 2233468999999999999999999996 999998765
Q ss_pred ccCccccccccccCCCcCCcCCC-CCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhcc-------
Q 040641 311 ACETHVSTDIAGTLGYIPPEYGQ-SRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKK------- 382 (435)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 382 (435)
... .....+||+.|+|||.+. ...++.++||||+||++|||++|+.||..... .+....+......
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHHHHH
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHHhhh
Confidence 432 233468999999999765 45789999999999999999999999854321 1111111111000
Q ss_pred ----C----CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 383 ----Q----QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 383 ----~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .....................+.+++.+|+..||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000000000111234677888999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=290.23 Aligned_cols=229 Identities=21% Similarity=0.247 Sum_probs=164.7
Q ss_pred ccCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC------
Q 040641 182 LLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE------ 252 (435)
Q Consensus 182 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 252 (435)
..+|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999986 468999999997532 223467899999999999999999999997654
Q ss_pred eeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccc
Q 040641 253 EKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARL 308 (435)
Q Consensus 253 ~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~ 308 (435)
..++||||| +++|..+.+.. .+++.....++.|++.||+|||+ |||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 469999999 66788777542 38999999999999999999996 9999987
Q ss_pred ccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC----
Q 040641 309 ISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ---- 383 (435)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 383 (435)
... ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL----DQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHHH
T ss_pred cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH----HHHHHHHhccCCCcHHH
Confidence 543 2345689999999998765 56789999999999999999999998543211 1111111100000
Q ss_pred -----------------CCCccccccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 -----------------QADDVLDPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 -----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.......+... ... ...+.+++.+|+..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASIL-TNA---SPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTC-TTC---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccchHHhc-cCC---CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000001 111 124567888999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=281.54 Aligned_cols=238 Identities=23% Similarity=0.264 Sum_probs=175.6
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEeCCeeEEEEe
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDEEKLLVYE 259 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 259 (435)
++|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+|+.++|||||+++++|......++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999986 468899999986433 2345789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccccccCcc
Q 040641 260 YMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISACETH 315 (435)
Q Consensus 260 y~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~~~~ 315 (435)
|+.+++|..++... ..+++.....++.|+++||+|||+ |||.|+...... .
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-S
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-c
Confidence 99999998877643 347888899999999999999996 999998765432 2
Q ss_pred ccccccccCCCcCCcCCCCC-CCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc------c
Q 040641 316 VSTDIAGTLGYIPPEYGQSR-MSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD------V 388 (435)
Q Consensus 316 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 388 (435)
......+++.|+|||.+... .++.++||||+||++|||++|+.||..... ..+....+........... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC---HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 23345678899999987655 468999999999999999999999743221 1111111111111100000 0
Q ss_pred c----ccc-----ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 389 L----DPT-----VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 389 ~----~~~-----~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
. .+. ............+.+++.+|++.||++|||+.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 000001111234567888999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=286.80 Aligned_cols=237 Identities=20% Similarity=0.244 Sum_probs=168.2
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccc-cccHHHHHHHHHHhccCCCCCceeEEEEEEeCC----eeEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAK-TQGHRQFTAEMETLGKVKHQNLVLLLGYCSFDE----EKLL 256 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 256 (435)
.+|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 3699999999999999999985 579999999997543 234567899999999999999999999997643 2355
Q ss_pred EEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccccccccccc
Q 040641 257 VYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLISAC 312 (435)
Q Consensus 257 v~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~~~~ 312 (435)
+++|+.+|+|.+++... .+++.....++.|++.||+|||+ |||+|+.....
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 56677899999999753 38899999999999999999996 99999876443
Q ss_pred Cc--cccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccCCCCc--
Q 040641 313 ET--HVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQQADD-- 387 (435)
Q Consensus 313 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 387 (435)
.. ......+||+.|+|||.+.. ..++.++||||+||++|||++|+.||...... +................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL----DQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH----HHHHHHhhhccCCChhhhh
Confidence 22 22345679999999998744 56789999999999999999999998643211 11111111110000000
Q ss_pred -----------cccccccCCCCH----HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 388 -----------VLDPTVLNAGSK----PMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 388 -----------~~~~~~~~~~~~----~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+........ ....++.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 01124678899999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.6e-37 Score=286.66 Aligned_cols=231 Identities=18% Similarity=0.228 Sum_probs=170.0
Q ss_pred cCcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeC--CeeEEEE
Q 040641 183 LKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFD--EEKLLVY 258 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 258 (435)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ |||||++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999986 46899999998643 3467889999999995 99999999999754 5689999
Q ss_pred ecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec-------------------------cccccccccccC
Q 040641 259 EYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ-------------------------DFGLARLISACE 313 (435)
Q Consensus 259 ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------DfGla~~~~~~~ 313 (435)
|||++|+|..+. ..+++.....++.|++.||+|||+ |||+|+......
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999986543 248888999999999999999996 999998765432
Q ss_pred ccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh---------ccC
Q 040641 314 THVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM---------KKQ 383 (435)
Q Consensus 314 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~ 383 (435)
.....+||+.|+|||...+ ..++.++||||+||++|||++|+.||........ ....+.... ...
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~---~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHHHHHHCHHHHHHHHHHT
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH---HHHHHHHHHCCchhhhhhhhc
Confidence 2345679999999998665 4579999999999999999999999864322111 100010000 000
Q ss_pred CC---C---ccc--------cccccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QA---D---DVL--------DPTVLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~---~---~~~--------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.. . ... ..............++.+++.+|+..||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 000 000000111112235678899999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=284.87 Aligned_cols=233 Identities=21% Similarity=0.216 Sum_probs=161.0
Q ss_pred cCcceeeeecccCcceEEEEEcC-CCCEEEEEEccccc--cccHHHHHHHHHHhccCCCCCceeEEEEEEe------CCe
Q 040641 183 LKLTLVDILEDGGFGTVYKATLP-DGKTVAVKKFSQAK--TQGHRQFTAEMETLGKVKHQNLVLLLGYCSF------DEE 253 (435)
Q Consensus 183 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 253 (435)
.+|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999865 68999999996543 2234568899999999999999999999964 367
Q ss_pred eEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------cccccccc
Q 040641 254 KLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFGLARLI 309 (435)
Q Consensus 254 ~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfGla~~~ 309 (435)
.|+|||||.++.+..+ . ..+++.....++.|++.||+|||+ |||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHhh-h------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 8999999977655433 2 237888999999999999999996 78887765
Q ss_pred cccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHh---------
Q 040641 310 SACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKM--------- 380 (435)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 380 (435)
... ...+..+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHT
T ss_pred ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCCCHHHHH
Confidence 432 233456799999999999999999999999999999999999999853211 00111111000
Q ss_pred ----------ccC-CCCc-----cccccccCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 381 ----------KKQ-QADD-----VLDPTVLNA---GSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 381 ----------~~~-~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
... .... ......... ........+.+++.+|++.||++|||++||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000 000000001 11223456788999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=278.59 Aligned_cols=238 Identities=20% Similarity=0.231 Sum_probs=167.8
Q ss_pred cccccccCcceeeeecccCcceEEEEEc-CCCCEEEEEEcccccc--ccHHHHHHHHHHhccCCCCCceeEEEEEEeC--
Q 040641 177 MFQQPLLKLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKT--QGHRQFTAEMETLGKVKHQNLVLLLGYCSFD-- 251 (435)
Q Consensus 177 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-- 251 (435)
.|..+ ++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...
T Consensus 13 ~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 44443 6799999999999999999985 5699999999975432 3345788999999999999999999998643
Q ss_pred ---CeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec------------------------ccc
Q 040641 252 ---EEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ------------------------DFG 304 (435)
Q Consensus 252 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------DfG 304 (435)
...++||||+.+|+|.+++... .+++.....++.|++.||+|||+ |||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred cccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence 3447778888999999998542 38999999999999999999996 788
Q ss_pred ccccccccCccccccccccCCCcCCcCCCC-CCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCcHHHHHHHHhccC
Q 040641 305 LARLISACETHVSTDIAGTLGYIPPEYGQS-RMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGANLVGWVFQKMKKQ 383 (435)
Q Consensus 305 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 383 (435)
++..... ......||+.|+|||...+ ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTP 238 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCC
T ss_pred hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCC
Confidence 8765432 2334678999999997555 4568999999999999999999999854321 11111111111100
Q ss_pred CCCc-----------cc--cccccCCCC----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 384 QADD-----------VL--DPTVLNAGS----KPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 384 ~~~~-----------~~--~~~~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
.... .. .+....... ......+.+++.+|+..||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 00 000000000 001124567889999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=3.3e-31 Score=252.28 Aligned_cols=239 Identities=19% Similarity=0.153 Sum_probs=163.4
Q ss_pred CcceeeeecccCcceEEEEEc-CCCCEEEEEEccccccccHHHHHHHHHHhccCC-----------CCCceeEEEEEEe-
Q 040641 184 KLTLVDILEDGGFGTVYKATL-PDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-----------HQNLVLLLGYCSF- 250 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~- 250 (435)
+|++.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999999986 4689999999975432 2456788999888775 5789999998764
Q ss_pred -CCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec----------------------------
Q 040641 251 -DEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ---------------------------- 301 (435)
Q Consensus 251 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~---------------------------- 301 (435)
....+++|+++..+......... .....+++.....++.|+++||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 35567777777665433222222 223457888889999999999999985
Q ss_pred ---cccccccccccCccccccccccCCCcCCcCCCCCCCCCcccchhHHHHHHHHHhCCCCCCCCcccccCCc--HHHHH
Q 040641 302 ---DFGLARLISACETHVSTDIAGTLGYIPPEYGQSRMSTTRGDVYSFGVILLELVTAKEPTGPEFQEKEGAN--LVGWV 376 (435)
Q Consensus 302 ---DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~SfGvil~El~tg~~p~~~~~~~~~~~~--~~~~~ 376 (435)
|||.|+.... .....+||+.|+|||+.....++.++||||+||+++||++|+.||.+......... .....
T Consensus 172 kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 6777764432 22346799999999998888899999999999999999999999865322111110 00000
Q ss_pred HHHhccCC------------------CCcccccc----------ccCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 040641 377 FQKMKKQQ------------------ADDVLDPT----------VLNAGSKPMMLKMLRIAADCVADNPATRPTMLHVLK 428 (435)
Q Consensus 377 ~~~~~~~~------------------~~~~~~~~----------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 428 (435)
...+.... ........ ............+.+++.+|+..||++|||+.|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110000 00000000 011123455667889999999999999999999985
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.73 E-value=3.6e-18 Score=157.89 Aligned_cols=128 Identities=33% Similarity=0.565 Sum_probs=111.7
Q ss_pred cCCccccCCCCCCeeecCC-CcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGN-NQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~-n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+||+++++|+.|++|+|++ |+++|.+|.+++++++|++|+|++|++.+..|..+..+.+|+.++++.|.+.+.+|..++
T Consensus 67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~ 146 (313)
T d1ogqa_ 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146 (313)
T ss_dssp ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc
Confidence 5888999999999999986 888889999999999999999999999888888888888999999999998888898999
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCC-CcccccCCcceecCCccccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQL-EHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L-~~l~l~~n~l~g~~p~~~~~ 131 (435)
+++.|+++++++|.+++.+|..++.+..+ +.++++.|.++|..|..+..
T Consensus 147 ~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred cCcccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999988899888888776 78888999998888876543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.72 E-value=4.8e-18 Score=157.06 Aligned_cols=80 Identities=33% Similarity=0.588 Sum_probs=60.8
Q ss_pred CcccCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc
Q 040641 1 LTGSIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS 80 (435)
Q Consensus 1 l~g~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 80 (435)
|+|.||++|+++++|++|+|++|++.+..|..+..+.+|+.++++.|.+.+.+|..++.+++|+.+++++|.++|.+|..
T Consensus 89 l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~ 168 (313)
T d1ogqa_ 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGG
T ss_pred cccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccc
Confidence 46899999999999999999999988877777777777777777777777667766777766766666666665554443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=8.6e-17 Score=137.43 Aligned_cols=119 Identities=26% Similarity=0.359 Sum_probs=104.5
Q ss_pred cCCccccCCCCCCeeecCCCcccccC-CcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSI-PRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
+||..+. +.+++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+..+..+..+++|+.|+|++|+++...|..|.
T Consensus 22 ~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~ 99 (192)
T d1w8aa_ 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL 99 (192)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSST
T ss_pred ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHh
Confidence 4777664 68999999999998655 45678999999999999999988888899999999999999999987778899
Q ss_pred CCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 83 NLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
++++|++|+|++|++++..|..|..+++|+++++++|.+...
T Consensus 100 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 100 GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp TCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 999999999999999987777889999999999999988654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=1.9e-15 Score=118.91 Aligned_cols=103 Identities=28% Similarity=0.359 Sum_probs=90.8
Q ss_pred CeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeCCCC
Q 040641 16 QGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDLHDN 95 (435)
Q Consensus 16 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n 95 (435)
|.|+|++|+++ .+| .+..+++|++|++++|+++ .+|+.++.+++|+.|++++|.+++ +| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999998 666 5899999999999999998 689899999999999999999985 55 5899999999999999
Q ss_pred CCcccC-CccccCcCCCCcccccCCccee
Q 040641 96 KFTREI-PQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 96 ~~~~~~-p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+++... ...++.+++|+.+++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 997432 2468889999999999998864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.9e-14 Score=129.36 Aligned_cols=124 Identities=25% Similarity=0.271 Sum_probs=109.5
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
|..|.++++|+.|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|.+++..|..|.+++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~ 177 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcccc
Confidence 56789999999999999999877777888899999999999999865566788899999999999999987788889999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
+|+.+++++|++++..|..|.++++|++|++++|.+.+..|..+
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~ 221 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred ccchhhhhhccccccChhHhhhhhhccccccccccccccccccc
Confidence 99999999999998889999999999999999999987555443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.1e-15 Score=120.69 Aligned_cols=111 Identities=19% Similarity=0.185 Sum_probs=96.0
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+.+..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|.++ .++ .+..+++|+.|++++|.++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4778889999999999998 67877788999999999999998 564 58999999999999999986444445679999
Q ss_pred CEEeCCCCCCcccCC--ccccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTREIP--QNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++++|+++. ++ ..+..+++|+++++++|.++
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccc
Confidence 999999999973 44 36788999999999999886
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.52 E-value=1.2e-15 Score=130.09 Aligned_cols=101 Identities=12% Similarity=0.084 Sum_probs=76.3
Q ss_pred ceeeeecccCcceEEEEEcCCCCEEEEEEcccccc------------------ccHHHHHHHHHHhccCCCCCceeEEEE
Q 040641 186 TLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKT------------------QGHRQFTAEMETLGKVKHQNLVLLLGY 247 (435)
Q Consensus 186 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 247 (435)
.+.+.||+|+||+||+|+..+|+.||||.++.... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46889999999999999988899999998653210 011235678899999999999998866
Q ss_pred EEeCCeeEEEEecccCCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 248 CSFDEEKLLVYEYMVNGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 248 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
. ..++||||++++.+.. ++......++.++++|++|||+
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~ 121 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH 121 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh
Confidence 3 2379999999865421 2333345788999999999996
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.51 E-value=2e-14 Score=122.47 Aligned_cols=127 Identities=24% Similarity=0.213 Sum_probs=102.8
Q ss_pred cccCC-ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCc
Q 040641 2 TGSIP-SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRS 80 (435)
Q Consensus 2 ~g~lp-~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~ 80 (435)
++.++ ..|..+++|+.|+|++|.+.+..+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|.|++..|..
T Consensus 42 ~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~ 121 (192)
T d1w8aa_ 42 GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121 (192)
T ss_dssp CSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTS
T ss_pred cccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHH
Confidence 34443 56789999999999999999888999999999999999999999766677999999999999999999877888
Q ss_pred CCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccc
Q 040641 81 LGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKI 129 (435)
Q Consensus 81 ~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~ 129 (435)
|..+++|++|+|++|.+....+... -...+..+.+..|.+....|..+
T Consensus 122 f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 122 FEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp STTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTTT
T ss_pred hcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCChhh
Confidence 9999999999999999875433221 11234556666676665555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=4.9e-14 Score=127.77 Aligned_cols=120 Identities=26% Similarity=0.277 Sum_probs=109.8
Q ss_pred CccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCC
Q 040641 6 PSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLS 85 (435)
Q Consensus 6 p~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 85 (435)
+..+....+|+.+++++|++++..+..+..+++|+.|++++|++++..|..|..+++|+.+++++|.+++..|..|.+++
T Consensus 122 ~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~ 201 (284)
T d1ozna_ 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred ccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhh
Confidence 45677889999999999999966677889999999999999999977777899999999999999999998899999999
Q ss_pred CCCEEeCCCCCCcccCCccccCcCCCCcccccCCcceecC
Q 040641 86 YSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKI 125 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~ 125 (435)
+|++|++++|++++..|..++++++|+.+++++|.+.+..
T Consensus 202 ~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999999999888888999999999999999987644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.5e-13 Score=123.33 Aligned_cols=113 Identities=27% Similarity=0.246 Sum_probs=71.2
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
..|.++++|+.|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+..+++|+.|++++|.+.+..+..+..+.+
T Consensus 49 ~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~ 125 (266)
T d1p9ag_ 49 ATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125 (266)
T ss_dssp GGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTT
T ss_pred HHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccc
Confidence 46788888888888888887 555 3567888888888888887 45667777777777777777766544444444444
Q ss_pred CCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 87 STYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
+.+|++++|.++...+..+..++.|+.+++++|+++
T Consensus 126 l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccccccceeccccccccccchhccccccccc
Confidence 444444444444333333334444444444444444
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=2.3e-13 Score=122.04 Aligned_cols=122 Identities=27% Similarity=0.226 Sum_probs=107.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.++.+++|+.|+|++|+++ .+|..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..++.|
T Consensus 72 ~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l 150 (266)
T d1p9ag_ 72 VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150 (266)
T ss_dssp CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccc
Confidence 3678999999999999998 568889999999999999999987677778889999999999999997667777889999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcceecCCccccc
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGKIPEKICK 131 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~~p~~~~~ 131 (435)
+.|++++|++++..+..+..+++|++|++++|.++ .+|..+..
T Consensus 151 ~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~ 193 (266)
T d1p9ag_ 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193 (266)
T ss_dssp CEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred hhcccccccccccCccccccccccceeecccCCCc-ccChhHCC
Confidence 99999999999877778899999999999999998 78876543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.5e-13 Score=107.84 Aligned_cols=91 Identities=24% Similarity=0.299 Sum_probs=80.5
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcC-CCcCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGW-PRSLGN 83 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~ 83 (435)
+| .++++++|++|++++|+++ .+|+.++.+++|+.|++++|.+++ +| .+..+++|+.|++++|.++... +..++.
T Consensus 13 l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~ 88 (124)
T d1dcea3 13 LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 88 (124)
T ss_dssp CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGG
T ss_pred Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcC
Confidence 44 4899999999999999998 789899999999999999999984 55 5999999999999999998532 246889
Q ss_pred CCCCCEEeCCCCCCcc
Q 040641 84 LSYSTYLDLHDNKFTR 99 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~ 99 (435)
+++|++|++++|.++.
T Consensus 89 ~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 89 CPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CTTCCEEECTTSGGGG
T ss_pred CCCCCEEECCCCcCCc
Confidence 9999999999999874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.4e-12 Score=106.55 Aligned_cols=112 Identities=15% Similarity=0.041 Sum_probs=92.1
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCc-CccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNK-FSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~-l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+.......++.+++.+. .+|..+..+++|+.|++++|+ ++..-+..|.++++|+.|+|++|+|+..-|..|..+++|
T Consensus 4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 345556678899999988 788889999999999997664 775444568999999999999999997767889999999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|+|++|+++ .+|.......+|+.|+|++|.+.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999997 56666555667999999999774
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=9.1e-13 Score=108.41 Aligned_cols=108 Identities=19% Similarity=0.207 Sum_probs=90.0
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcC-ccCCCCCCeEECcCcccCCcCC--Cc
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTS-LGNLKGLSHLDLSSNFFDGGWP--RS 80 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p--~~ 80 (435)
.||..+..+++|+.|+|++|.++ .++ .+..+++|++|++++|+++. +|+. +..+++|+.|++++|.++. ++ ..
T Consensus 32 ~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~ 107 (162)
T d1a9na_ 32 VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLVE-LGDLDP 107 (162)
T ss_dssp SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCCC-GGGGGG
T ss_pred ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC-CCccccccccccccceeccccccc-cccccc
Confidence 46665678999999999999998 564 58999999999999999985 5554 5789999999999999974 44 36
Q ss_pred CCCCCCCCEEeCCCCCCcccCCc----cccCcCCCCcccc
Q 040641 81 LGNLSYSTYLDLHDNKFTREIPQ----NLGNLAQLEHLDV 116 (435)
Q Consensus 81 ~~~l~~L~~L~l~~n~~~~~~p~----~~~~l~~L~~l~l 116 (435)
+..+++|++|++++|.++ ..|. .+..+++|+.||-
T Consensus 108 l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 108 LASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp GGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred cccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 788999999999999986 4554 3677889988874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.30 E-value=8.6e-12 Score=113.86 Aligned_cols=115 Identities=26% Similarity=0.319 Sum_probs=100.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNL 84 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l 84 (435)
.+..+..+++|+.+++++|.++ .+|..+ .++|+.|++++|..++..+..+..++.++.|++++|.+++..|..+.++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred CccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence 4556788889999999999987 677654 6789999999999998888889999999999999999998778888899
Q ss_pred CCCCEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 85 SYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 85 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++|+|++|+++ .+|..+.++++|+.|++++|+++.
T Consensus 219 ~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 99999999999997 688889999999999999998873
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.29 E-value=5.2e-12 Score=115.32 Aligned_cols=109 Identities=28% Similarity=0.284 Sum_probs=80.1
Q ss_pred CCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEe
Q 040641 12 SLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLD 91 (435)
Q Consensus 12 l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 91 (435)
+++|+.|++++|..++..+..+..++.++.|++++|.+.+..|..+..+++|+.|+|++|.|+ .+|..|..+++|++|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 567778888888877777777778888888888888887666667777788888888888776 5677777788888888
Q ss_pred CCCCCCcccCCc-------cccCcCCCCcccccCCcce
Q 040641 92 LHDNKFTREIPQ-------NLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 92 l~~n~~~~~~p~-------~~~~l~~L~~l~l~~n~l~ 122 (435)
+++|+++ .++. ....+.+|+.+++++|.+.
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8888776 3432 2234566777778777663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=7.3e-12 Score=102.17 Aligned_cols=94 Identities=22% Similarity=0.201 Sum_probs=80.1
Q ss_pred cCCccccCCCCCCeeecCCC-cccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNN-QLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLG 82 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n-~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 82 (435)
.+|..+..+++|+.|++++| .++..-+..|.++++|+.|+|++|+++..-|..|..+++|+.|+|++|.|+ .+|....
T Consensus 22 ~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~ 100 (156)
T d2ifga3 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV 100 (156)
T ss_dssp TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTT
T ss_pred cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhh
Confidence 46888899999999999766 588555567999999999999999999766777999999999999999999 5666555
Q ss_pred CCCCCCEEeCCCCCCc
Q 040641 83 NLSYSTYLDLHDNKFT 98 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~ 98 (435)
...+|++|+|++|.+.
T Consensus 101 ~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 101 QGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCCEEECCSSCCC
T ss_pred ccccccccccCCCccc
Confidence 5557999999999884
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=1.4e-14 Score=123.69 Aligned_cols=114 Identities=24% Similarity=0.231 Sum_probs=95.7
Q ss_pred ccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCC
Q 040641 7 SEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSY 86 (435)
Q Consensus 7 ~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 86 (435)
.+++.+++|+.|+|++|+++ .++ .+.++++|+.|+|++|.++ .+|..+..+++|+.|++++|.++. ++ .+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccc
Confidence 46888999999999999998 665 5889999999999999997 677666666789999999999984 43 4778899
Q ss_pred CCEEeCCCCCCcccCC--ccccCcCCCCcccccCCcceecCC
Q 040641 87 STYLDLHDNKFTREIP--QNLGNLAQLEHLDVLRNMLCGKIP 126 (435)
Q Consensus 87 L~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~l~g~~p 126 (435)
|++|++++|+++. ++ ..+..+++|+.|++++|++....+
T Consensus 117 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 117 LRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 9999999999874 44 467899999999999998865433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=9.3e-11 Score=99.79 Aligned_cols=105 Identities=27% Similarity=0.371 Sum_probs=73.0
Q ss_pred cCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCE
Q 040641 10 GDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTY 89 (435)
Q Consensus 10 ~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 89 (435)
..+.+|+.|++++|.++ .++ .+..+++|++|+|++|++++ +++ ++.+++|+.|++++|.+.. +| .+.+++.|++
T Consensus 37 ~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccc-cc-cccccccccc
Confidence 34667777888887776 343 46677788888888887775 333 7777778888888777763 44 3667777777
Q ss_pred EeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 90 LDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 90 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
|++++|.... + ..+..+++|+.+++++|.+.
T Consensus 111 L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 111 LTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp EECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred cccccccccc-c-cccchhhhhHHhhhhhhhhc
Confidence 7777777653 2 23567777777777777665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=9.6e-11 Score=99.71 Aligned_cols=108 Identities=29% Similarity=0.379 Sum_probs=88.0
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|++|+|++|++++ +++ ++++++|+.|++++|.+. .+| .+..+++|+.|++++|.+... ..+..+++|
T Consensus 57 ~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L 130 (199)
T d2omxa2 57 GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNL 130 (199)
T ss_dssp TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTC
T ss_pred ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhh
Confidence 47789999999999999985 443 899999999999999987 455 488889999999998888743 347788899
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+.|++++|++. .+| .+..+++|+.|++++|.+++
T Consensus 131 ~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 131 NRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp SEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred HHhhhhhhhhc-ccc-cccccccccccccccccccC
Confidence 99999999886 344 47788889999998888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=1.5e-10 Score=99.27 Aligned_cols=108 Identities=31% Similarity=0.330 Sum_probs=86.3
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|+|++|++++ ++ .++.+++|++|++++|++++ +| .+..+++|+.|++++|.+.. + ..+..++.+
T Consensus 63 ~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l 136 (210)
T d1h6ta2 63 GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQL 136 (210)
T ss_dssp TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTC
T ss_pred hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccc
Confidence 37889999999999999985 55 47889999999999999984 65 58889999999999998863 3 356777888
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
+.++++.|.+++ +..+..+++|+.+++++|.+++
T Consensus 137 ~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 137 ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccccccc--cccccccccccccccccccccc
Confidence 888888888763 3345677788888888887764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=1.4e-10 Score=99.51 Aligned_cols=105 Identities=28% Similarity=0.357 Sum_probs=90.1
Q ss_pred CCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEE
Q 040641 11 DSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYL 90 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 90 (435)
.+.+|+.|++++|.++. ++ .+..+++|+.|+|++|++++ ++ .++.+++|+.|++++|.+++ +| .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 47789999999999984 44 48889999999999999986 55 47889999999999999984 66 58889999999
Q ss_pred eCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 91 DLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 91 ~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++++|.+. .+ ..+..++.++.++++.|.++.
T Consensus 118 ~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~ 148 (210)
T d1h6ta2 118 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD 148 (210)
T ss_dssp ECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC
T ss_pred cccccccc-cc-ccccccccccccccccccccc
Confidence 99999985 34 457889999999999998864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.08 E-value=1.7e-10 Score=108.39 Aligned_cols=108 Identities=28% Similarity=0.359 Sum_probs=49.5
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCC--------------------cCccCCCCCCeEEC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVP--------------------TSLGNLKGLSHLDL 68 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p--------------------~~~~~l~~L~~L~l 68 (435)
+..+++|+.|++++|.+++.. .++.+++|+.|++++|.+++..+ ..+..+++++.|++
T Consensus 237 l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~l 314 (384)
T d2omza2 237 LASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEEC
T ss_pred hhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEEC
Confidence 445555555555555555322 24455555555555555543211 11233344444444
Q ss_pred cCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCCcce
Q 040641 69 SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLC 122 (435)
Q Consensus 69 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~ 122 (435)
++|++++. + .+..+++|++|++++|++++ +| .++++++|+.|++++|+++
T Consensus 315 s~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 315 YFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCC
Confidence 44444432 1 14444455555555554432 22 3444555555555555444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.06 E-value=1.7e-10 Score=108.27 Aligned_cols=105 Identities=27% Similarity=0.362 Sum_probs=85.4
Q ss_pred ccCCCCCCeeecCCCcccccC--------------------CcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEEC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSI--------------------PRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDL 68 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~--------------------p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l 68 (435)
++.+++|+.|++++|.+++.. +..+..+++++.|++++|++++ ++ .+..+++|+.|++
T Consensus 259 ~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L 336 (384)
T d2omza2 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFF 336 (384)
T ss_dssp GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEEC
T ss_pred ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEEC
Confidence 566667777777777665432 2346677899999999999996 44 3889999999999
Q ss_pred cCcccCCcCCCcCCCCCCCCEEeCCCCCCcccCCccccCcCCCCcccccCC
Q 040641 69 SSNFFDGGWPRSLGNLSYSTYLDLHDNKFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 69 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
++|.+++ +| .++++++|++|++++|++++..| +.++++|+.|++++|
T Consensus 337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 9999984 55 68999999999999999986544 889999999999988
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.93 E-value=3.4e-12 Score=108.62 Aligned_cols=106 Identities=25% Similarity=0.312 Sum_probs=87.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCC--CcCC
Q 040641 5 IPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWP--RSLG 82 (435)
Q Consensus 5 lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p--~~~~ 82 (435)
|+ .|..+++|+.|+|++|.++ .+|.....+++|+.|++++|+++. ++ .+..+++|+.|++++|.++. ++ ..+.
T Consensus 63 i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~-~~~~~~l~ 137 (198)
T d1m9la_ 63 IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLA 137 (198)
T ss_dssp CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHT
T ss_pred cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhcc-cccccccc
Confidence 44 4888999999999999998 788766677889999999999984 54 47889999999999999984 44 4688
Q ss_pred CCCCCCEEeCCCCCCcccCCcc----------ccCcCCCCccc
Q 040641 83 NLSYSTYLDLHDNKFTREIPQN----------LGNLAQLEHLD 115 (435)
Q Consensus 83 ~l~~L~~L~l~~n~~~~~~p~~----------~~~l~~L~~l~ 115 (435)
.+++|++|++++|.+....+.. +..+++|+.||
T Consensus 138 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 138 ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp TTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred CCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999987554432 45677888776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=2.4e-09 Score=92.78 Aligned_cols=108 Identities=26% Similarity=0.304 Sum_probs=88.7
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|+++++...+. ..+...+.+..+.++.+.+... ..+..+++|+.|++++|.++... .++++++|
T Consensus 102 ~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L 175 (227)
T d1h6ua2 102 AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKL 175 (227)
T ss_dssp GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTC
T ss_pred ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccc
Confidence 478899999999999998743 3466788999999999988743 34778889999999999987432 37889999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++++|++++ +|. ++++++|++|++++|+++.
T Consensus 176 ~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 176 TTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB
T ss_pred eecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC
Confidence 999999999875 544 7889999999999998874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.83 E-value=7.2e-09 Score=89.67 Aligned_cols=108 Identities=24% Similarity=0.324 Sum_probs=90.3
Q ss_pred cccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCC
Q 040641 8 EFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYS 87 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 87 (435)
.+..+++|+.|++++|.++ .++ .+..+++|+.++++.+...+. ..+...+.+..+.++.+.+.... .+..+++|
T Consensus 80 ~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L 153 (227)
T d1h6ua2 80 PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNL 153 (227)
T ss_dssp GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTC
T ss_pred ccccccccccccccccccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhcccccc
Confidence 3888999999999999987 555 588999999999999998753 34667888999999999987533 46778999
Q ss_pred CEEeCCCCCCcccCCccccCcCCCCcccccCCccee
Q 040641 88 TYLDLHDNKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 88 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++|++++|.++... .++++++|+.|++++|.+++
T Consensus 154 ~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 154 QYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccccch--hhcccccceecccCCCccCC
Confidence 99999999986433 37899999999999999875
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=5e-09 Score=91.56 Aligned_cols=85 Identities=18% Similarity=0.208 Sum_probs=46.3
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCc-CccCCCCCCeEECcC-cccCCcCCCcCCCCCCCCEEe
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSS-NFFDGGWPRSLGNLSYSTYLD 91 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~ 91 (435)
++++|+|++|+++...+..|.++++|++|++++|.+...+|. .|..+++++.+++.. |.+....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 456666666666532233455666666666666655543333 355555666655543 445544445555566666666
Q ss_pred CCCCCCc
Q 040641 92 LHDNKFT 98 (435)
Q Consensus 92 l~~n~~~ 98 (435)
+++|.+.
T Consensus 110 l~~~~l~ 116 (242)
T d1xwdc1 110 ISNTGIK 116 (242)
T ss_dssp EESCCCC
T ss_pred cchhhhc
Confidence 6666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.76 E-value=2e-08 Score=92.45 Aligned_cols=98 Identities=24% Similarity=0.290 Sum_probs=80.8
Q ss_pred CCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCCCCCCCEEeC
Q 040641 13 LKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGNLSYSTYLDL 92 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 92 (435)
.+++.|||++|.++ .+|+. .++|++|+|++|+++ .+|..+ .+|+.|++++|.++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36899999999998 78864 578999999999998 788764 57999999999987 45431 146999999
Q ss_pred CCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 93 HDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 93 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
++|.+. .+|. ++.+++|+.+++++|.+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred cccccc-cccc-hhhhccceeecccccccccc
Confidence 999997 6775 67899999999999987643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=1.2e-08 Score=89.12 Aligned_cols=105 Identities=16% Similarity=0.202 Sum_probs=88.6
Q ss_pred CCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCc-CccCCCCCCeEECcCcccCCcCCC-cCCCCCCCCEEeC
Q 040641 15 LQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPT-SLGNLKGLSHLDLSSNFFDGGWPR-SLGNLSYSTYLDL 92 (435)
Q Consensus 15 L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l 92 (435)
.+.++.+++.++ .+|+.+. +++++|+|++|.++. +|. .|.++++|++|++++|.+...+|. .|.+++.++++.+
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~-l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCE-ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCc-cChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 367889999998 8998774 589999999999985 554 689999999999999998866554 6788999999987
Q ss_pred CC-CCCcccCCccccCcCCCCcccccCCccee
Q 040641 93 HD-NKFTREIPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 93 ~~-n~~~~~~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
.. |++....+..+.++++|+.+++++|.+..
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccccccchhhhcc
Confidence 64 67777777888999999999999998864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.49 E-value=4.4e-07 Score=83.06 Aligned_cols=83 Identities=25% Similarity=0.362 Sum_probs=67.5
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCcCCCcCCC
Q 040641 4 SIPSEFGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGGWPRSLGN 83 (435)
Q Consensus 4 ~lp~~~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 83 (435)
+||+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++||+++|.++ .+|. ++.
T Consensus 52 ~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~ 118 (353)
T d1jl5a_ 52 SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQN 118 (353)
T ss_dssp CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTT
T ss_pred CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhh
Confidence 46753 467999999999999 888764 57899999999998 45532 146999999999998 5774 688
Q ss_pred CCCCCEEeCCCCCCcc
Q 040641 84 LSYSTYLDLHDNKFTR 99 (435)
Q Consensus 84 l~~L~~L~l~~n~~~~ 99 (435)
++.|++|++++|.+..
T Consensus 119 l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 119 SSFLKIIDVDNNSLKK 134 (353)
T ss_dssp CTTCCEEECCSSCCSC
T ss_pred hccceeeccccccccc
Confidence 9999999999998864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=4e-09 Score=86.16 Aligned_cols=106 Identities=21% Similarity=0.067 Sum_probs=58.4
Q ss_pred CCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccCCCcCccCCCCCCeEECcCcccCCc--CCCcCCCCCCCCEEe
Q 040641 14 KLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGPVPTSLGNLKGLSHLDLSSNFFDGG--WPRSLGNLSYSTYLD 91 (435)
Q Consensus 14 ~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~--~p~~~~~l~~L~~L~ 91 (435)
..+.|+++++... +.+..+..+..++++.|... .++..+..+++|+.|||++|+++.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4556677665432 12344444444444444333 3333445567777777777777642 233455667777777
Q ss_pred CCCCCCcccCCccccCcCCCCcccccCCcceec
Q 040641 92 LHDNKFTREIPQNLGNLAQLEHLDVLRNMLCGK 124 (435)
Q Consensus 92 l~~n~~~~~~p~~~~~l~~L~~l~l~~n~l~g~ 124 (435)
+++|.++..-+....+...|+.+++++|.++..
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 777777532222223344567777777766543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=2e-07 Score=83.23 Aligned_cols=115 Identities=28% Similarity=0.288 Sum_probs=74.2
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCC-cCccC-CCcCccCCCCCCeEECcCc-ccCCc---------
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRN-KFSGP-VPTSLGNLKGLSHLDLSSN-FFDGG--------- 76 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n-~l~~~-~p~~~~~l~~L~~L~l~~n-~l~~~--------- 76 (435)
+..+++|++|+|+++.+++..+..++.+++|+.|+|+++ .++.. +..-+..+++|+.|+++++ .++..
T Consensus 67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~ 146 (284)
T d2astb2 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV 146 (284)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHS
T ss_pred HHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccc
Confidence 455667777777777776666667777777777777763 44321 1112345666777776653 22200
Q ss_pred --------------------CCCcCCCCCCCCEEeCCCC-CCcccCCccccCcCCCCcccccCC-ccee
Q 040641 77 --------------------WPRSLGNLSYSTYLDLHDN-KFTREIPQNLGNLAQLEHLDVLRN-MLCG 123 (435)
Q Consensus 77 --------------------~p~~~~~l~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~l~l~~n-~l~g 123 (435)
+...+.++++|++|++++| .+++.....++++++|++|+++++ .++.
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence 0111234688999999986 577777888899999999999984 5554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=3.2e-08 Score=94.35 Aligned_cols=111 Identities=21% Similarity=0.224 Sum_probs=82.4
Q ss_pred CCCCeeecCCCcccccC-CcccCCCCCCcEEECCCCcCcc----CCCcCccCCCCCCeEECcCcccCCc----CCCcCCC
Q 040641 13 LKLQGLYLGNNQLTGSI-PRSLGQLGGLVKLNLTRNKFSG----PVPTSLGNLKGLSHLDLSSNFFDGG----WPRSLGN 83 (435)
Q Consensus 13 ~~L~~L~l~~n~l~g~~-p~~~~~l~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~ 83 (435)
.+|+.||+++|++++.- ..-+..+++|++|+|++|.++. .++..+..+++|+.|||++|.++.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 46889999999998532 3335567899999999998873 3455567889999999999988521 2233322
Q ss_pred -CCCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCccee
Q 040641 84 -LSYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 84 -l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
..+|++|++++|+++.. ++..+..+++|+.|++++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 34799999999998743 45567788999999999998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=1.3e-07 Score=76.76 Aligned_cols=105 Identities=16% Similarity=0.076 Sum_probs=73.1
Q ss_pred ccCCCCCCeeecCCCcccccCCcccCCCCCCcEEECCCCcCccC--CCcCccCCCCCCeEECcCcccCCcCCC-cCCCCC
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRSLGQLGGLVKLNLTRNKFSGP--VPTSLGNLKGLSHLDLSSNFFDGGWPR-SLGNLS 85 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~~~~l~~L~~L~ls~n~l~~~--~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~ 85 (435)
+..+..+..+++.+|... .++.....+++|++|+||+|+++.. ++..+..+++|+.|||++|.++. +++ ......
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhcc
Confidence 333444444555555443 4555556789999999999999842 23446789999999999999984 443 333445
Q ss_pred CCCEEeCCCCCCcccCCcc-------ccCcCCCCccc
Q 040641 86 YSTYLDLHDNKFTREIPQN-------LGNLAQLEHLD 115 (435)
Q Consensus 86 ~L~~L~l~~n~~~~~~p~~-------~~~l~~L~~l~ 115 (435)
.|+.|++++|.+....... +..+++|+.||
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7899999999997655432 45688898886
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.15 E-value=1.2e-07 Score=87.22 Aligned_cols=112 Identities=18% Similarity=0.188 Sum_probs=67.1
Q ss_pred CCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccC-----CCcCccCCCCCCeEECcCcccCCc----C
Q 040641 11 DSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP-----VPTSLGNLKGLSHLDLSSNFFDGG----W 77 (435)
Q Consensus 11 ~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~----~ 77 (435)
....|+.|++++|.++.. +...+...+.|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 345677777777766522 333445566777777777776531 233456667777777777776422 3
Q ss_pred CCcCCCCCCCCEEeCCCCCCcccCCccc----c--CcCCCCcccccCCcce
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTREIPQNL----G--NLAQLEHLDVLRNMLC 122 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~~p~~~----~--~l~~L~~l~l~~n~l~ 122 (435)
...+..+++|++|++++|.+++.-...+ . ....|++|++++|.++
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 3445566777777777777654322222 1 1245777777777664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.99 E-value=5.2e-07 Score=82.80 Aligned_cols=116 Identities=21% Similarity=0.231 Sum_probs=83.4
Q ss_pred cccCCCCCCeeecCCCccc--------cc-----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcC
Q 040641 8 EFGDSLKLQGLYLGNNQLT--------GS-----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSS 70 (435)
Q Consensus 8 ~~~~l~~L~~L~l~~n~l~--------g~-----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~ 70 (435)
.+...++|+.|++++|.+. .. ........+.|+.|++++|.++.. +...+..++.|+.|+|++
T Consensus 116 ~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~ 195 (344)
T d2ca6a1 116 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195 (344)
T ss_dssp HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCS
T ss_pred hhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccc
Confidence 4557789999999998741 01 111224567899999999988632 333455678899999999
Q ss_pred cccCCc-----CCCcCCCCCCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCccee
Q 040641 71 NFFDGG-----WPRSLGNLSYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 71 n~l~~~-----~p~~~~~l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
|.++.. +...+..+++|+.|++++|.++.. +...+..+++|+.|++++|.+++
T Consensus 196 n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp SCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred ccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 988632 344567788999999999988533 44556778899999999998764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.82 E-value=4.7e-06 Score=74.01 Aligned_cols=110 Identities=22% Similarity=0.297 Sum_probs=82.8
Q ss_pred cCCCCCCeeecCCC-cccc-cCCcccCC-CCCCcEEECCCC--cCccC-CCcCccCCCCCCeEECcCc-ccCCcCCCcCC
Q 040641 10 GDSLKLQGLYLGNN-QLTG-SIPRSLGQ-LGGLVKLNLTRN--KFSGP-VPTSLGNLKGLSHLDLSSN-FFDGGWPRSLG 82 (435)
Q Consensus 10 ~~l~~L~~L~l~~n-~l~g-~~p~~~~~-l~~L~~L~ls~n--~l~~~-~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~ 82 (435)
.++++|+.|+++++ .++. .+...+.. .++|+.|++++. .++.. +...+..+++|+.|++++| .+++..+..++
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~ 197 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 197 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred HHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhc
Confidence 46789999999985 4432 12233333 468999999864 34321 3333467899999999986 57777778899
Q ss_pred CCCCCCEEeCCCC-CCcccCCccccCcCCCCcccccCC
Q 040641 83 NLSYSTYLDLHDN-KFTREIPQNLGNLAQLEHLDVLRN 119 (435)
Q Consensus 83 ~l~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~l~l~~n 119 (435)
++++|++|++++| .++......++++++|+.|+++++
T Consensus 198 ~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 198 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 9999999999995 677766777889999999999877
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.82 E-value=8.8e-07 Score=84.02 Aligned_cols=115 Identities=23% Similarity=0.193 Sum_probs=78.4
Q ss_pred ccCCCCCCeeecCCCcccccCCcc----c-CCCCCCcEEECCCCcCccCCCc----CccCCCCCCeEECcCcccCCc---
Q 040641 9 FGDSLKLQGLYLGNNQLTGSIPRS----L-GQLGGLVKLNLTRNKFSGPVPT----SLGNLKGLSHLDLSSNFFDGG--- 76 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~~p~~----~-~~l~~L~~L~ls~n~l~~~~p~----~~~~l~~L~~L~l~~n~l~~~--- 76 (435)
+...+.++.+++++|.++..-... + ...+.|+.+++++|.++..... .+..+++|+.|||++|.++..
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc
Confidence 455778888999998876322211 1 2345788999999888754222 234556899999999988632
Q ss_pred -CCCcCC-CCCCCCEEeCCCCCCccc----CCccccCcCCCCcccccCCccee
Q 040641 77 -WPRSLG-NLSYSTYLDLHDNKFTRE----IPQNLGNLAQLEHLDVLRNMLCG 123 (435)
Q Consensus 77 -~p~~~~-~l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~l~g 123 (435)
++..+. ..+.|++|++++|.++.. ++..+..+++|++|++++|+++.
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 333343 356788999999988642 44456667889999999998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.69 E-value=4.9e-06 Score=67.55 Aligned_cols=111 Identities=13% Similarity=0.121 Sum_probs=78.0
Q ss_pred CCCCCCeeecCCC-ccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCCc----C
Q 040641 11 DSLKLQGLYLGNN-QLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDGG----W 77 (435)
Q Consensus 11 ~l~~L~~L~l~~n-~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~----~ 77 (435)
+.+.|+.|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4688999999974 45422 344677788999999999998742 223445678899999999998743 2
Q ss_pred CCcCCCCCCCCEEeCCCCCCccc-------CCccccCcCCCCcccccCCcc
Q 040641 78 PRSLGNLSYSTYLDLHDNKFTRE-------IPQNLGNLAQLEHLDVLRNML 121 (435)
Q Consensus 78 p~~~~~l~~L~~L~l~~n~~~~~-------~p~~~~~l~~L~~l~l~~n~l 121 (435)
-..+...++|++|++++|.+... +...+..-++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 33566678899999998865421 233344557788888876643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=5.6e-05 Score=60.94 Aligned_cols=112 Identities=17% Similarity=0.194 Sum_probs=78.2
Q ss_pred cCCCCCCeeecCC-Cccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCCc----
Q 040641 10 GDSLKLQGLYLGN-NQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDGG---- 76 (435)
Q Consensus 10 ~~l~~L~~L~l~~-n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~---- 76 (435)
.+.++|+.|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...++++.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4568999999997 455422 334566789999999999988643 223455678899999999988632
Q ss_pred CCCcCCCCCCCCEEeC--CCCCCcc----cCCccccCcCCCCcccccCCcc
Q 040641 77 WPRSLGNLSYSTYLDL--HDNKFTR----EIPQNLGNLAQLEHLDVLRNML 121 (435)
Q Consensus 77 ~p~~~~~l~~L~~L~l--~~n~~~~----~~p~~~~~l~~L~~l~l~~n~l 121 (435)
+-..+...++|+.++| +.|.+.. .+...+...++|+.|+++.+..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3345667788887665 4566643 2344455678899999877754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.80 E-value=0.00013 Score=58.68 Aligned_cols=89 Identities=10% Similarity=0.014 Sum_probs=65.8
Q ss_pred ccCCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEECcCcccCCc----
Q 040641 9 FGDSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDLSSNFFDGG---- 76 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~---- 76 (435)
+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.++.. +-..+...+.|+.|+|++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 55678899999999998733 334555678999999999999743 233567778899999999875521
Q ss_pred ---CCCcCCCCCCCCEEeCCCCCC
Q 040641 77 ---WPRSLGNLSYSTYLDLHDNKF 97 (435)
Q Consensus 77 ---~p~~~~~l~~L~~L~l~~n~~ 97 (435)
+...+..-+.|+.|+++.+..
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCCccEeeCcCCCc
Confidence 334445568899999977654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.37 E-value=0.0029 Score=54.30 Aligned_cols=108 Identities=14% Similarity=0.019 Sum_probs=71.6
Q ss_pred CcceeeeecccCcceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCC-CCCceeEEEEEEeCCeeEEEEeccc
Q 040641 184 KLTLVDILEDGGFGTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVK-HQNLVLLLGYCSFDEEKLLVYEYMV 262 (435)
Q Consensus 184 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~ 262 (435)
.++.....+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+-+++.++..++..++|||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 444444444444568999875 45677888876554444445678888876653 3335677888888889999999999
Q ss_pred CCCHHHHHHhhCCCCCCCCHHHHHHHHHHhhhccceeec
Q 040641 263 NGSLDLWLRNATGSHEVLDRAKRYKIACSSARGLAFLHQ 301 (435)
Q Consensus 263 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 301 (435)
+.++....... .....++.++++.++-||+
T Consensus 94 G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 94 GVLCSEEYEDE---------QSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp SEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccc---------ccHHHHHHHHHHHHHHHhc
Confidence 99886543211 1233456777788888886
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.83 E-value=0.0013 Score=52.49 Aligned_cols=89 Identities=15% Similarity=0.121 Sum_probs=65.3
Q ss_pred ccCCCCCCeeecCCCccccc----CCcccCCCCCCcEEECCCCcCccC----CCcCccCCCCCCeEEC--cCcccCC---
Q 040641 9 FGDSLKLQGLYLGNNQLTGS----IPRSLGQLGGLVKLNLTRNKFSGP----VPTSLGNLKGLSHLDL--SSNFFDG--- 75 (435)
Q Consensus 9 ~~~l~~L~~L~l~~n~l~g~----~p~~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l--~~n~l~~--- 75 (435)
+...+.|+.|+|++|.++.. +-..+...++|+.|++++|.+... +-..+...++|+.++| +.|.+..
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 45678999999999998644 334556688999999999998643 3346677888987655 5666653
Q ss_pred -cCCCcCCCCCCCCEEeCCCCCC
Q 040641 76 -GWPRSLGNLSYSTYLDLHDNKF 97 (435)
Q Consensus 76 -~~p~~~~~l~~L~~L~l~~n~~ 97 (435)
.+...+...++|++|+++.|..
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCcCEEeCcCCCC
Confidence 2444556788999999987764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.97 E-value=1.1 Score=36.95 Aligned_cols=73 Identities=12% Similarity=0.073 Sum_probs=51.4
Q ss_pred ecccCc-ceEEEEEcCCCCEEEEEEccccccccHHHHHHHHHHhccCCC--CCceeEEEEEEeCCeeEEEEecccCCCH
Q 040641 191 LEDGGF-GTVYKATLPDGKTVAVKKFSQAKTQGHRQFTAEMETLGKVKH--QNLVLLLGYCSFDEEKLLVYEYMVNGSL 266 (435)
Q Consensus 191 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~ey~~~g~L 266 (435)
+..|.. +.||+....++..+.+|.-..... ..+..|...++.+.. -.+.++++++..++..++||||++|-++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344543 679999987787888887654322 245677777766533 3356678888888889999999988664
|